PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Smith, J; Lipsitch, M; Almond, JW				Smith, Jon; Lipsitch, Marc; Almond, Jeffrey W.			New Decade of Vaccines 3 Vaccine production, distribution, access, and uptake	LANCET			English	Article							INFLUENZA VACCINE; PANDEMIC INFLUENZA; VIRUS; PROTECTION; EPIDEMIC; SPREAD; INTERVENTIONS; STRATEGIES; MORTALITY; PERTUSSIS	For human vaccines to be available on a global scale, complex production methods, meticulous quality control, and reliable distribution channels are needed to ensure that the products are potent and effective at the point of use. The technologies used to manufacture different types of vaccines can strongly affect vaccine cost, ease of industrial scale-up, stability, and, ultimately, worldwide availability. The complexity of manufacturing is compounded by the need for different formulations in different countries and age-groups. Reliable vaccine production in appropriate quantities and at affordable prices is the cornerstone of developing global vaccination policies. However, to ensure, optimum access and uptake, strong partnerships are needed between private manufacturers, regulatory authorities, and national and international public health services. For vaccines whose supply is insufficient to meet demand, prioritisation of target groups can increase the effect of these vaccines. In this report, we draw from our experience of vaccine development and focus on influenza vaccines as an example to consider production, distribution, access, and other factors that affect vaccine uptake and population-level effectiveness.	[Smith, Jon; Almond, Jeffrey W.] Sanofi Pasteur, F-69280 Marcy Letoile, France; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Almond, JW (corresponding author), Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	jeffrey.almond@sanofipasteur.com		Lipsitch, Marc/0000-0003-1504-9213	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML's work on this report was supported by the National Institute of General Medical Sciences (award number U54GM088558). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Abramson JS, 2000, PEDIATRICS, V106, P362; Allgaier S, 2009, BIOLOGICALS, V37, P128, DOI 10.1016/j.biologicals.2009.02.006; Almond JW, 2007, NAT REV MICROBIOL, V5, P478, DOI 10.1038/nrmicro1702; ANDERSON R M, 1991; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; [Anonymous], 2011, US PHARM NAT FORM 20, P3132; [Anonymous], 2011, US PHARM NAT FORM 20, P4377; [Anonymous], 2009, GLOB AL RESP PAND H1; [Anonymous], 2011, US PHARM NAT FORM 20, P3384; [Anonymous], WHO GLOB INFL SURV N; [Anonymous], 2011, US PHARM NAT FORM 20, P3570; [Anonymous], 2011, US PHARM NAT FORM 20, P3949; [Anonymous], 2011, US PHARM NAT FORM 20, P1993; [Anonymous], 2011, US PHARM NAT FORM 20, P4187; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; Cassone A, 2010, MBIO, V1, DOI 10.1128/mBio.00042-10; D'Aoust MA, 2010, PLANT BIOTECHNOL J, V8, P607, DOI 10.1111/j.1467-7652.2009.00496.x; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; European Agency for the Evaluation of Medicinal Products (EMEA), CPMPBWP21496 EUR AG; European Council, COMM PROC AUTH SUP M; European Medicines Agency, EMEACPMPVEG47172003R; European Medicines Agency, ANN 1 SUMM PROD CHAR; Fedson DS, 2005, J PUBLIC HEALTH POL, V26, P4, DOI 10.1057/palgrave.jphp.3200008; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; G-Con, 2010, TEX BAS CONS ANN PRO; GAVI Alliance, WHAT YOU CAN APPL; GAVI Alliance, KEY IND MEAS ALL PRO; GAVI Alliance, INN FIN; GAVI Alliance, FACTS FIG; GAVI Alliance, EL COUNTR; GAVI Alliance, INV IMM GAVI ALL EV; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Goldstein E, 2009, MATH BIOSCI, V221, P11, DOI 10.1016/j.mbs.2009.06.002; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Koudstaal W, 2009, VACCINE, V27, P2588, DOI 10.1016/j.vaccine.2009.02.033; Lessler J, 2010, EPIDEMICS-NETH, V2, P132, DOI 10.1016/j.epidem.2010.07.001; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; McNeil C, 2006, J NATL CANCER I, V98, P433, DOI 10.1093/jnci/djj144; Meghrous J, 2009, VACCINE, V28, P309, DOI 10.1016/j.vaccine.2009.10.048; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Minor PD, 2009, VACCINE, V27, P2907, DOI 10.1016/j.vaccine.2009.02.064; Modlin JF, 2010, NEW ENGL J MED, V362, P2346, DOI 10.1056/NEJMp1005405; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; NIELSEN A, 1994, INT J EPIDEMIOL, V23, P1300, DOI 10.1093/ije/23.6.1300; Nishiura H, 2009, EUROSURVEILLANCE, V14; Novavax, RES DEV PROGR; Pan American Health Organization, 2006, POL ER FIELD GUID; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2007, LANCET INFECT DIS, V7, P658, DOI 10.1016/S1473-3099(07)70236-0; SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; UK Health Protection Agency, ROUT CHILDH IMM SCHE; UNICEF, SUPPL LOG GAVI; US Centers for Disease Control and Prevention, IMM SCHED; Waldor MK, 2010, NEW ENGL J MED, V363, P2279, DOI 10.1056/NEJMp1012300; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; WHO, GLOB AL RESP CONF HU; WHO, 2006, UN PREQ VACC WHO LIS; WHO, WHO AFR RG ROUT EPI; WHO, 2009, UPD H1N1 PAND SEAS V; WHO, CHOL FACT SHEET; WHO, SYST PREQ VACC UN SU; Wolfson LJ, 2008, B WORLD HEALTH ORGAN, V86, P27, DOI 10.2471/BLT.07.045096	83	54	55	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					428	438		10.1016/S0140-6736(11)60478-9	http://dx.doi.org/10.1016/S0140-6736(11)60478-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21664680	Green Accepted			2022-12-28	WOS:000293615900034
J	Bonaguidi, MA; Wheeler, MA; Shapiro, JS; Stadel, RP; Sun, GJ; Ming, GL; Song, HJ				Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun			In Vivo Clonal Analysis Reveals Self-Renewing and Multipotent Adult Neural Stem Cell Characteristics	CELL			English	Article							RADIAL GLIAL-CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; NEURONS; ASTROCYTES; LINEAGE; PTEN; QUIESCENT; DIFFERENTIATION; PROGENITOR	Neurogenesis and gliogenesis continue in discrete regions of the adult mammalian brain. A fundamental question remains whether cell genesis occurs from distinct lineage-restricted progenitors or from self-renewing and multipotent neural stem cells in the adult brain. Here, we developed a genetic marking strategy for lineage tracing of individual, quiescent, and nestin-expressing radial glia-like (RGL) precursors in the adult mouse dentate gyrus. Clonal analysis identified multiple modes of RGL activation, including asymmetric and symmetric self-renewal. Long-term lineage tracing in vivo revealed a significant percentage of clones that contained RGL(s), neurons, and astrocytes, indicating capacity of individual RGLs for both self-renewal and multilineage differentiation. Furthermore, conditional Pten deletion in RGLs initially promotes their activation and symmetric self-renewal but ultimately leads to terminal astrocytic differentiation and RGL depletion in the adult hippocampus. Our study identifies RGLs as self-renewing and multipotent neural stem cells and provides novel insights into in vivo properties of adult neural stem cells.	[Bonaguidi, Michael A.; Wheeler, Michael A.; Shapiro, Jason S.; Stadel, Ryan P.; Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Bonaguidi, Michael A.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Stadel, Ryan P.; Song, Hongjun] Johns Hopkins Univ, Sch Med, Human Genet Predoctoral Training Program, Baltimore, MD 21205 USA; [Sun, Gerald J.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu; shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013	Ming, Guo-li/0000-0002-2517-6075	NIH [NS047344, AG024984, NS048271, HD069184]; NARSAD; MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048271, R56NS047344, R37NS047344, R01NS047344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); MSCRF; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. Lee and members of Song and Ming laboratories for discussion; G. Fishell for sharing nestin-CreER<SUP>T2</SUP> mice; L. DeBiase for NG2 antibodies; J. Song, S. Danzer, C. Song, Y. Namgung, X. Duan and K. Sailor for help; and Q. Hussaini, Y. Cai, and L. Liu for technical support. This work was supported by grants from NIH (NS047344, AG024984) and NARSAD to H. S. and from NIH (NS048271, HD069184) and MSCRF to G.-l. M. M. A. B. was a MSCRF fellow.	ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; BRONNERFRASER M, 1991, DEVELOPMENT, P17; Brunne B, 2010, GLIA, V58, P1553, DOI 10.1002/glia.21029; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Hill R, 2009, J BIOL CHEM, V284, P11755, DOI 10.1074/jbc.R800071200; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Palmer TD, 1999, J NEUROSCI, V19, P8487; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	48	566	587	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1142	1155		10.1016/j.cell.2011.05.024	http://dx.doi.org/10.1016/j.cell.2011.05.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21664664	Bronze, Green Accepted			2022-12-28	WOS:000292025700019
J	Unal, E; Kinde, B; Amon, A				Unal, Elcin; Kinde, Benyam; Amon, Angelika			Gametogenesis Eliminates Age-Induced Cellular Damage and Resets Life Span in Yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MEIOSIS-I; PROTEIN; GENE; MUTANTS; SEGREGATION; DIVISION; NDT80; RDNA	Eukaryotic organisms age, yet detrimental age-associated traits are not passed on to progeny. How life span is reset from one generation to the next is not known. We show that in budding yeast resetting of life span occurs during gametogenesis. Gametes (spores) generated by aged cells show the same replicative potential as gametes generated by young cells. Age-associated damage is no longer detectable in mature gametes. Furthermore, transient induction of a transcription factor essential for later stages of gametogenesis extends the replicative life span of aged cells. Our results indicate that gamete formation brings about rejuvenation by eliminating age-induced cellular damage.	[Unal, Elcin; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Howard Hughes Med Inst, E76-543,500 Main St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; Unal, Elcin/0000-0002-6768-609X	NIH [GM62207]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056800, R01GM062207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Alpert, M. Boselli, A. Thompson, and J. Chen for technical help; D. Koshland for reagents; and T. Orr-Weaver, F. Solomon, and members of the Amon laboratory for comments on the manuscript. Research was supported by NIH grant GM62207 to A.A. A.A. is also an HHMI investigator. E.U. is a fellow of the Jane Coffin Childs Memorial Fund. The authors declare no competing financial interests.	Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Boselli M, 2009, DEV CELL, V16, P844, DOI 10.1016/j.devcel.2009.05.013; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fuchs J, 2004, CHROMOSOME RES, V12, P427, DOI 10.1023/B:CHRO.0000034726.05374.db; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; KASSIR Y, 1988, CELL, V52, P853, DOI 10.1016/0092-8674(88)90427-8; KLAPHOLZ S, 1980, GENETICS, V96, P567; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LENZ AG, 1984, ARCH MICROBIOL, V137, P104, DOI 10.1007/BF00414448; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Sinclair D, 1998, ANNU REV MICROBIOL, V52, P533, DOI 10.1146/annurev.micro.52.1.533; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; XU LZ, 1995, MOL CELL BIOL, V15, P6572	25	85	87	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1554	1557		10.1126/science.1204349	http://dx.doi.org/10.1126/science.1204349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700873	Green Submitted, Green Accepted			2022-12-28	WOS:000291990000044
J	Nenoff, P; Woitek, G				Nenoff, Pietro; Woitek, Gerald			Knuckle Pads	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woitek, Gerald] Kinderchirurg Praxis Leipzig, Leipzig, Germany			pietro.nenoff@gmx.de							0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2451	2451		10.1056/NEJMicm1008915	http://dx.doi.org/10.1056/NEJMicm1008915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696311				2022-12-28	WOS:000291936100011
J	Payne, D				Payne, David			RISK COMMUNICATION Watching the detectives: tracking the source of Europe's latest E coli outbreak	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Payne, D (corresponding author), BMJ, London WC1H 9JR, England.	dpayne@bmj.com						[Anonymous], 2011, LANCET, V377, P1978; EVANS S, 2011, BBC NEWS        0607; *R KOCH I, 2011, INF UPD EHEC REC BAS	3	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3884	10.1136/bmj.d3884	http://dx.doi.org/10.1136/bmj.d3884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697228	Bronze, Green Submitted			2022-12-28	WOS:000292200500010
J	Shapses, SA; Manson, JE				Shapses, Sue A.; Manson, JoAnn E.			Vitamin D and Prevention of Cardiovascular Disease and Diabetes Why the Evidence Falls Short	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; 25-HYDROXYVITAMIN-D; SUPPLEMENTATION; CALCIUM		[Shapses, Sue A.] Rutgers State Univ, Dept Nutr Sci, Obes Grp, New Brunswick, NJ USA; [Manson, JoAnn E.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA	Rutgers State University New Brunswick; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Shapses, SA (corresponding author), Rutgers State Univ, Dept Nutr Sci, Obes Grp, 96 Lipman Dr, New Brunswick, NJ USA.	shapses@aesop.rutgers.edu		Shapses, Sue/0000-0002-3128-2325	NATIONAL INSTITUTE ON AGING [R01AG012161] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG012161] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Avenell A, 2009, AGE AGEING, V38, P606, DOI 10.1093/ageing/afp109; Chung M, 2009, 183 AG HEALTHC RES Q; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Institute of Medicine, DIET REF INT CALC VI; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Shankar A, 2011, DIABETES CARE, V34, P1114, DOI 10.2337/dc10-1203; Wang L, 2010, ANN INTERN MED, V152, P315, DOI 10.7326/0003-4819-152-5-201003020-00010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127	9	62	65	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2565	2566		10.1001/jama.2011.881	http://dx.doi.org/10.1001/jama.2011.881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693745	Green Accepted			2022-12-28	WOS:000291860400024
J	Frieden, R				Frieden, Rick			Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Lakeland Reg Hlth Syst, St Joseph, MI USA		Frieden, R (corresponding author), Lakeland Reg Hlth Syst, St Joseph, MI USA.							Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-5	10.7326/0003-4819-154-12-201106210-02005	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690583				2022-12-28	WOS:000291800500004
J	Oakhill, JS; Steel, R; Chen, ZP; Scott, JW; Ling, N; Tam, S; Kemp, BE				Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.			AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase	SCIENCE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ACETYL-COA CARBOXYLASE; SKELETAL-MUSCLE; ENERGY-CHARGE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; ADP; PHOSPHORYLATION; INACTIVATION; METABOLISM; EXERCISE	The adenosine monophosphate (AMP)-activated protein kinase (AMPK) regulates whole-body and cellular energy balance in response to energy demand and supply. AMPK is an alpha beta gamma heterotrimer activated by decreasing concentrations of adenosine triphosphate (ATP) and increasing AMP concentrations. AMPK activation depends on phosphorylation of the alpha catalytic subunit on threonine-172 (Thr(172)) by kinases LKB1 or CaMKK beta, and this is promoted by AMP binding to the gamma subunit. AMP sustains activity by inhibiting dephosphorylation of alpha-Thr(172), whereas ATP promotes dephosphorylation. Adenosine diphosphate (ADP), like AMP, bound to gamma sites 1 and 3 and stimulated alpha-Thr(172) phosphorylation. However, in contrast to AMP, ADP did not directly activate phosphorylated AMPK. In this way, both ADP/ATP and AMP/ATP ratios contribute to AMPK regulation.	[Oakhill, Jonathan S.; Steel, Rohan; Chen, Zhi-Ping; Scott, John W.; Ling, Naomi; Tam, Shanna; Kemp, Bruce E.] Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; University of Melbourne	Oakhill, JS (corresponding author), Univ Melbourne, St Vincents Inst Med Res, Dept Prot Chem & Metab, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au	Scott, John W/AAA-2676-2021; Scott, John W/P-1170-2018; Oakhill, Jonathan S/F-5724-2011; Kemp, Bruce/G-9602-2019; Kemp, Bruce E/L-2633-2014	Scott, John W/0000-0002-1896-9798; Scott, John W/0000-0002-1896-9798; Oakhill, Jonathan S/0000-0002-9475-1440; Kemp, Bruce/0000-0001-6735-5082; Kemp, Bruce E/0000-0001-6735-5082; Ling, Naomi/0000-0001-6240-4092; /0000-0002-0423-6120	Australian Research Council; National Health and Medical Research Council (NHMRC); Victorian Government	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	We thank F. Katsis for the preparation of antibodies and L. Macaulay at Commonwealth Scientific and Industrial Research Organisation Parkville, Victoria, Australia, for CaMKK beta expression constructs. We are most grateful to S. Gamblin and D. Carling and their colleagues at Medical Research Council National Institute of Medical Research and Hammersmith Hospital, respectively, for generously sharing with us the observation that ADP inhibited the dephosphorylation of AMPK by PP2c (30), which prompted us to test whether ADP also controlled the kinase kinase reaction. This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC), and the Victorian Government Operational Infrastructure Support Scheme. B. E. K. is an NHMRC Fellow.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Atkinson D E, 1979, Methods Enzymol, V55, P229; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; BROWN MS, 1975, J BIOL CHEM, V250, P2502; CARLING D, 1989, EUR J BIOCHEM, V186, P129, DOI 10.1111/j.1432-1033.1989.tb15186.x; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; Hancock CR, 2005, AM J PHYSIOL-CELL PH, V288, pC1298, DOI 10.1152/ajpcell.00621.2004; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; HARDIE DG, 1989, TRENDS BIOCHEM SCI, V14, P20; HARWOOD HJ, 1984, J BIOL CHEM, V259, P2810; JANSSON E, 1987, CLIN PHYSIOL, V7, P337, DOI 10.1111/j.1475-097X.1987.tb00177.x; Jin XS, 2007, STRUCTURE, V15, P1285, DOI 10.1016/j.str.2007.07.017; KREBS H, 1964, PROC R SOC SER B-BIO, V159, P545, DOI 10.1098/rspb.1964.0019; KUSHMERICK MJ, 1992, P NATL ACAD SCI USA, V89, P7521, DOI 10.1073/pnas.89.16.7521; MEYER RA, 1985, AM J PHYSIOL, V248, pC279, DOI 10.1152/ajpcell.1985.248.3.C279; MEYER RA, 1979, AM J PHYSIOL, V237, pC111, DOI 10.1152/ajpcell.1979.237.3.C111; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; SAHLIN K, 1989, ACTA PHYSIOL SCAND, V136, P193, DOI 10.1111/j.1748-1716.1989.tb08652.x; SERAYDARIAN K, 1962, BIOCHIM BIOPHYS ACTA, V65, P443, DOI 10.1016/0006-3002(62)90447-X; SHERBAN DG, 1985, J BIOL CHEM, V260, P2579; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YEH LA, 1980, J BIOL CHEM, V255, P2308	27	403	428	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1433	1435		10.1126/science.1200094	http://dx.doi.org/10.1126/science.1200094			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680840				2022-12-28	WOS:000291689000042
J	Krimigis, SM; Roelof, EC; Decker, RB; Hill, ME				Krimigis, Stamatios M.; Roelof, Edmond C.; Decker, Robert B.; Hill, Matthew E.			Zero outward flow velocity for plasma in a heliosheath transition layer	NATURE			English	Article							TERMINATION SHOCK; VOYAGER-1	Voyager 1 has been in the reservoir of energetic ions and electrons that constitutes the heliosheath since it crossed the solar wind termination shock(1-3) on 16 December 2004 at a distance from the Sun of 94 astronomical units (1 AU = 1.5 x 10(8) km). It is now similar to 22 AU past the termination shock crossing(4). The bulk velocity of the plasma in the radial-transverse plane has been determined(5) using measurements of the anisotropy of the convected energetic ion distribution(6). Here we report that the radial component of the velocity has been decreasing almost linearly over the past three years, from similar to 70 km s(-1) to similar to 0 km s(-1), where it has remained for the past eight months. It now seems that Voyager 1 has entered a finite transition layer of zero-radial-velocity plasma flow, indicating that the spacecraft may be close to the heliopause, the border between the heliosheath and the interstellar plasma. The existence of a flow transition layer in the heliosheath contradicts current predictions(7)-generally assumed by conceptual models-of a sharp discontinuity at the heliopause.	[Krimigis, Stamatios M.; Roelof, Edmond C.; Decker, Robert B.; Hill, Matthew E.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Krimigis, Stamatios M.] Acad Athens, Athens 11527, Greece	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Academy of Athens	Krimigis, SM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA.	tom.krimigis@jhuapl.edu	Hill, Matthew/H-4312-2016; Roelof, Edmond/G-6654-2019; Krimigis, Stamatios/G-4591-2019	Hill, Matthew/0000-0002-5674-4936; Roelof, Edmond/0000-0002-2270-0652; Krimigis, Stamatios/0000-0003-2781-2386				Burlaga LF, 2005, SCIENCE, V309, P2027, DOI 10.1126/science.1117542; Decker RB, 2010, AIP CONF PROC, V1302, P51, DOI 10.1063/1.3529990; Decker R. B., 2011, PHYS HELIOSPHERE 10; Decker RB, 2005, SCIENCE, V309, P2020, DOI 10.1126/science.1117569; Florinski V, 2009, SPACE SCI REV, V143, P57, DOI 10.1007/s11214-009-9488-7; Izmodenov VV, 2009, SPACE SCI REV, V146, P329, DOI 10.1007/s11214-009-9528-3; Krimigis SM, 2010, AIP CONF PROC, V1302, P79, DOI 10.1063/1.3529994; Krimigis SM, 2009, SCIENCE, V326, P971, DOI 10.1126/science.1181079; Krimigis SM, 2003, NATURE, V426, P45, DOI 10.1038/nature02068; KRIMIGIS SM, 1977, SPACE SCI REV, V21, P329, DOI 10.1007/BF00211545; Krimigis S, 2008, NATURE, V454, P24, DOI 10.1038/454024a; Roelof EC, 2010, AIP CONF PROC, V1302, P133, DOI 10.1063/1.3529960; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; SUESS ST, 1990, REV GEOPHYS, V28, P97, DOI 10.1029/RG028i001p00097; Zank GP, 2009, SPACE SCI REV, V146, P295, DOI 10.1007/s11214-009-9497-6	15	106	106	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					359	361		10.1038/nature10115	http://dx.doi.org/10.1038/nature10115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677754				2022-12-28	WOS:000291647100041
J	Spence, D				Spence, Des			FROM THE FRONTLINE Undoing diagnoses	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3751	10.1136/bmj.d3751	http://dx.doi.org/10.1136/bmj.d3751			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677010				2022-12-28	WOS:000291932700011
J	Laurance, J				Laurance, Jeremy			On Reflection Costing lives	LANCET			English	Editorial Material												j.laurance@independent.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1996	1996		10.1016/S0140-6736(11)60852-0	http://dx.doi.org/10.1016/S0140-6736(11)60852-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21665025	Bronze			2022-12-28	WOS:000292011700016
J	Randolph, GJ				Randolph, Gwendalyn J.			No Need to Coax Monocytes	SCIENCE			English	Editorial Material							CELLS; MACROPHAGES; INFLAMMATION; ACTIVATION; RESOLUTION; TISSUES; BLOOD		Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Randolph, GJ (corresponding author), Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA.	gwendalyn.randolph@mssm.edu						Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; TARLING JD, 1987, J LEUKOCYTE BIOL, V42, P443, DOI 10.1002/jlb.42.5.443; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475	14	21	23	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1268	1269		10.1126/science.1208480	http://dx.doi.org/10.1126/science.1208480			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659591				2022-12-28	WOS:000291441700029
J	Thomson, M; Liu, SJ; Zou, LN; Smith, Z; Meissner, A; Ramanathan, S				Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Smith, Zack; Meissner, Alexander; Ramanathan, Sharad			Pluripotency Factors in Embryonic Stem Cells Regulate Differentiation into Germ Layers	CELL			English	Article							SELF-RENEWAL; ES CELLS; MOUSE EPIBLAST; NEURAL DIFFERENTIATION; IN-VITRO; FATE; SOX2; EXPRESSION; NETWORK; COMPLEX	Cell fate decisions are fundamental for development, but we do not know how transcriptional networks reorganize during the transition from a pluripotent to a differentiated cell state. Here, we asked how mouse embryonic stem cells (ESCs) leave the pluripotent state and choose between germ layer fates. By analyzing the dynamics of the transcriptional circuit that maintains pluripotency, we found that Oct4 and Sox2, proteins that maintain ESC identity, also orchestrate germ layer fate selection. Oct4 suppresses neural ectodermal differentiation and promotes mesendodermal differentiation; Sox2 inhibits mesendodermal differentiation and promotes neural ectodermal differentiation. Differentiation signals continuously and asymmetrically modulate Oct4 and Sox2 protein levels, altering their binding pattern in the genome, and leading to cell fate choice. The same factors that maintain pluripotency thus also integrate external signals and control lineage selection. Our study provides a framework for understanding how complex transcription factor networks control cell fate decisions in progenitor cells.	[Thomson, Matt; Liu, Siyuan John; Zou, Ling-Nan; Ramanathan, Sharad] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Thomson, Matt; Ramanathan, Sharad] Harvard Univ, Biophys Program, Cambridge, MA 02138 USA; [Thomson, Matt; Zou, Ling-Nan; Meissner, Alexander; Ramanathan, Sharad] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zack; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Liu, Siyuan John; Ramanathan, Sharad] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Harvard University	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	sharad@post.harvard.edu			Harvard Stem Cell Institute; Massachusetts Life Science Center;  [NIH-P50-NS40828];  [NIH-P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008197] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; Massachusetts Life Science Center; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Doug Melton, Sean Eddy, Areez Mody, and Alexander Schier for scientific discussions and Rene Maehr, Masa Yamagata, and Dawen Cai for discussions and technical assistance. We thank Manfred Baetscher and the Harvard Genome Modification Facility for assistance with the cell line generation. We thank Bodo Stern, Nicole Francis, and in particular Sean Eddy and three anonymous referees for extensive comments on the manuscript. We thank the Harvard Stem Cell Institute Seed Grant (S.R.) and the Massachusetts Life Science Center (A.M.) for support. Microarray hybridization and measurements were performed by the Molecular Genetics Core Facility at Children's Hospital Boston supported by NIH-P50-NS40828, and NIH-P30-HD18655. M.T. and S.R. conceived the project. M.T. established the experimental system and performed the immunofluorescence and perturbation experiments. S.J.L. and M.T. built the cell lines and performed microarray experiments. L.N.Z. performed the FACS experiments and established techniques for long term microscopy of ESCs on glass. M.T. and S.J.L. performed the time-lapse microscopy experiments. Z.S. and A.M. did the ChIP for Oct4 and Sox2. S.J.L., M.T., and S.R. performed the tiling qPCR experiments. M.T., S.R., and S.J.L. performed the data and mathematical analyses and wrote the manuscript.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cantor AB, 2001, CURR OPIN GENET DEV, V11, P513, DOI 10.1016/S0959-437X(00)00226-4; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyagi S, 2006, J BIOL CHEM, V281, P13374, DOI 10.1074/jbc.M512669200; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2010, DEV GROWTH DIFFER, V52, P275, DOI 10.1111/j.1440-169X.2009.01166.x; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	49	374	385	2	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					875	889		10.1016/j.cell.2011.05.017	http://dx.doi.org/10.1016/j.cell.2011.05.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663792	Green Accepted, hybrid			2022-12-28	WOS:000291461600015
J	Petersen, RC				Petersen, Ronald C.			Mild Cognitive Impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALZHEIMERS-DISEASE; CSF BIOMARKERS; CLINICAL CHARACTERIZATION; AMYLOID DEPOSITION; AMERICAN-ACADEMY; FOLLOW-UP; DEMENTIA; PREVALENCE; PROGRESSION; PREDICTION	A 70-year-old woman has been noticing increasing forgetfulness over the past 6 to 12 months. Although she has always had some difficulty recalling the names of acquaintances, she is now finding it difficult to keep track of appointments and recent telephone calls, but the process has been insidious. She lives independently in the community; she drives a car, pays her bills, and is normal in appearance. A mental status examination revealed slight difficulty on delayed recall of four words, but the results were otherwise normal. Does the patient have mild cognitive impairment? How should her case be managed?	[Petersen, Ronald C.] Mayo Clin, Dept Neurol, Coll Med, Rochester, MN 55905 USA; [Petersen, Ronald C.] Mayo Clin, Alzheimers Dis Res Ctr, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Petersen, RC (corresponding author), Mayo Clin, Dept Neurol, Coll Med, Gonda 8 S,200 First St SW, Rochester, MN 55905 USA.	peter8@mayo.edu			Elan Pharmaceuticals; GE Healthcare; Oxford University Press	Elan Pharmaceuticals; GE Healthcare(General ElectricGE Healthcare); Oxford University Press	Dr. Petersen reports receiving consulting fees from Elan Pharmaceuticals and GE Healthcare, receiving royalties from Oxford University Press, and serving as chair of data monitoring committees for Pfizer and Janssen Alzheimer Immunotherapy. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the author are available with the full text of this article at NEJM.org.	ALBERT MS, 2011, ALZHEIMERS DEME 0420; Apostolova LG, 2007, ARCH NEUROL-CHICAGO, V64, P1360; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Busse A, 2006, NEUROLOGY, V67, P2176, DOI 10.1212/01.wnl.0000249117.23318.e1; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; De Meyer G, 2010, ARCH NEUROL-CHICAGO, V67, P949, DOI 10.1001/archneurol.2010.179; Di Carlo A, 2007, NEUROLOGY, V68, P1909, DOI 10.1212/01.wnl.0000263132.99055.0d; Dickerson BC, 2007, ARCH GEN PSYCHIAT, V64, P1443, DOI 10.1001/archpsyc.64.12.1443; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Drzezga A, 2005, J NUCL MED, V46, P1625; Engler H, 2006, BRAIN, V129, P2856, DOI 10.1093/brain/awl178; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Feldman HH, 2007, LANCET NEUROL, V6, P501, DOI 10.1016/S1474-4422(07)70109-6; Fennema-Notestine C, 2009, BEHAV NEUROL, V21, P3, DOI [10.3233/BEN-2009-0230, 10.1155/2009/698156]; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Ganguli M, 2011, AM J GERIAT PSYCHIAT, V19, P205, DOI 10.1097/JGP.0b013e3182051ab4; Ganguli M, 2010, AM J GERIAT PSYCHIAT, V18, P674, DOI 10.1097/JGP.0b013e3181cdee4f; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; HANSSON O, 2010, LANCET NEUROL, V67, P949; Jack CR, 2008, NEUROLOGY, V70, P1740, DOI 10.1212/01.wnl.0000281688.77598.35; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; JACK CR, ALZHEIMERS IN PRESS; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jean L, 2010, AM J GERIAT PSYCHIAT, V18, P281, DOI 10.1097/JGP.0b013e3181c37ce9; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Knopman DS, 2003, J NEUROPATH EXP NEUR, V62, P1087, DOI 10.1093/jnen/62.11.1087; Landau SM, 2010, NEUROLOGY, V75, P230, DOI 10.1212/WNL.0b013e3181e8e8b8; Lautenschlager NT, 2009, JAMA-J AM MED ASSOC, V301, P276; Lopez OL, 2003, ARCH NEUROL-CHICAGO, V60, P1385, DOI 10.1001/archneur.60.10.1385; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Massoud F, 2007, ALZHEIMERS DEMENT, V3, P283, DOI 10.1016/j.jalz.2007.07.002; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Molano J, 2010, BRAIN, V133, P540, DOI 10.1093/brain/awp280; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2009, ANN INTERN MED, V151, P291, DOI 10.7326/0003-4819-151-4-200908180-00024; Roberts JS, 2010, NEUROLOGY, V75, P425, DOI 10.1212/WNL.0b013e3181eb5872; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Tang-Wai DF, 2003, ARCH NEUROL-CHICAGO, V60, P1777, DOI 10.1001/archneur.60.12.1777; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Winblad B, 2008, NEUROLOGY, V70, P2024, DOI 10.1212/01.wnl.0000303815.69777.26; Winblad B, 2010, NEUROLOGY, V75, P1485; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598	52	762	801	5	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2227	2234		10.1056/NEJMcp0910237	http://dx.doi.org/10.1056/NEJMcp0910237			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651394				2022-12-28	WOS:000291392100009
J	Horton, R; Dos, P				Horton, Richard; Dos, Pamela			The vaccine paradox	LANCET			English	Editorial Material							IMMUNIZATION; INITIATIVES; PROGRESS		[Horton, Richard; Dos, Pamela] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Clemens J, 2010, NAT IMMUNOL, V11, P1069, DOI 10.1038/ni1210-1069; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 23	2011	378	9788					296	298		10.1016/S0140-6736(11)60765-4	http://dx.doi.org/10.1016/S0140-6736(11)60765-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664684				2022-12-28	WOS:000293615800007
J	Neunuebel, MR; Chen, Y; Gaspar, AH; Backlund, PS; Yergey, A; Machner, MP				Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Backlund, Peter S., Jr.; Yergey, Alfred; Machner, Matthias P.			De-AMPylation of the Small GTPase Rab1 by the Pathogen Legionella pneumophila	SCIENCE			English	Article							EFFECTOR PROTEIN DRRA; ENDOPLASMIC-RETICULUM; VESICULAR TRANSPORT; BINDING; SYSTEM; MUTANTS	The bacterial pathogen Legionella pneumophila exploits host cell vesicle transport by transiently manipulating the activity of the small guanosine triphosphatase (GTPase) Rab1. The effector protein SidM recruits Rab1 to the Legionella-containing vacuole (LCV), where it activates Rab1 and then AMPylates it by covalently adding adenosine monophosphate (AMP). L. pneumophila GTPase-activating protein LepB inactivates Rab1 before its removal from LCVs. Because LepB cannot bind AMPylated Rab1, the molecular events leading to Rab1 inactivation are unknown. We found that the effector protein SidD from L. pneumophila catalyzed AMP release from Rab1, generating de-AMPylated Rab1 accessible for inactivation by LepB. L. pneumophila mutants lacking SidD were defective for Rab1 removal from LCVs, identifying SidD as the missing link connecting the processes of early Rab1 accumulation and subsequent Rab1 removal during infection.	[Neunuebel, M. Ramona; Chen, Yang; Gaspar, Andrew H.; Machner, Matthias P.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Backlund, Peter S., Jr.; Yergey, Alfred] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Biomed Mass Spectrometry Facil, NIH, Bethesda, MD 20892 USA; [Chen, Yang] Peking Univ, Ctr Hlth Sci, Beijing 100191, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University	Machner, MP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	machnerm@mail.nih.gov	Machner, Matthias/G-2758-2015	Machner, Matthias/0000-0002-6971-7451	NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZICHD001421, ZIAHD008893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank G. Storz, S. Gottesman, J. Bonifacino, J. Neunuebel, and M. Barzik for critical reading and insightful discussion and R. Isberg and V. Losick for kindly providing reagents. This work was supported by the Intramural Research Program of the NIH.	ANDERSON WB, 1970, BIOCHEM BIOPH RES CO, V41, P704, DOI 10.1016/0006-291X(70)90070-7; BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2007, SCIENCE, V318, P974, DOI 10.1126/science.1149121; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; MANTEL M, 1970, P NATL ACAD SCI USA, V65, P660, DOI 10.1073/pnas.65.3.660; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Roy CR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.262pe14; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	161	167	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					453	456		10.1126/science.1207193	http://dx.doi.org/10.1126/science.1207193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680813	Green Accepted			2022-12-28	WOS:000292959600046
J	Bushey, D; Tononi, G; Cirelli, C				Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara			Sleep and Synaptic Homeostasis: Structural Evidence in Drosophila	SCIENCE			English	Article							MENTAL-RETARDATION PROTEIN; MUSHROOM BODIES; DENDRITIC SPINES; CIRCADIAN CLOCK; PLASTICITY; INCREASES; NEURONS; NEED; WAKE; MICROSCOPY	The functions of sleep remain elusive, but a strong link exists between sleep need and neuronal plasticity. We tested the hypothesis that plastic processes during wake lead to a net increase in synaptic strength and sleep is necessary for synaptic renormalization. We found that, in three Drosophila neuronal circuits, synapse size or number increases after a few hours of wake and decreases only if flies are allowed to sleep. A richer wake experience resulted in both larger synaptic growth and greater sleep need. Finally, we demonstrate that the gene Fmr1 (fragile X mental retardation 1) plays an important role in sleep-dependent synaptic renormalization.	[Bushey, Daniel; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Cirelli, C (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.	ccirelli@wisc.edu			National Institute of General Medical Sciences [R01 GM075315]; NIH; Army Research Office [W911NF-08-1-0169]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075315] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000579] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Army Research Office; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by National Institute of General Medical Sciences (R01 GM075315 to C.C.), NIH Director's Pioneer award (to G.T.), Army Research Office (DURIP award W911NF-08-1-0169 to C.C.), and Canadian Institutes of Health Research (to D.B.). We thank G. Tavosanis for technical advice.	Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Bushey D, 2009, J NEUROSCI, V29, P1948, DOI 10.1523/JNEUROSCI.4830-08.2009; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gatto CL, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.008.2009; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Irwin SA, 2005, NEUROBIOL LEARN MEM, V83, P180, DOI 10.1016/j.nlm.2004.11.004; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee T, 1999, DEVELOPMENT, V126, P4065; Leiss F, 2009, DEV NEUROBIOL, V69, P221, DOI 10.1002/dneu.20699; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; Mignot E, 2008, PLOS BIOL, V6, P661, DOI 10.1371/journal.pbio.0060106; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Tessier CR, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.008.2009; Todd PK, 2000, MOL BRAIN RES, V80, P17, DOI 10.1016/S0169-328X(00)00098-X; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	230	235	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1576	1581		10.1126/science.1202839	http://dx.doi.org/10.1126/science.1202839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700878	Green Accepted			2022-12-28	WOS:000291990000050
J	Ceccarelli, DF; Tang, XJ; Pelletier, B; Orlicky, S; Xie, WL; Plantevin, V; Neculai, D; Chou, YC; Ogunjimi, A; Al-Hakim, A; Varelas, X; Koszela, J; Wasney, GA; Vedadi, M; Dhe-Paganon, S; Cox, S; Xu, SC; Lopez-Girona, A; Mercurio, F; Wrana, J; Durocher, D; Meloche, S; Webb, DR; Tyers, M; Sicheri, F				Ceccarelli, Derek F.; Tang, Xiaojing; Pelletier, Benoit; Orlicky, Stephen; Xie, Weilin; Plantevin, Veronique; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Koszela, Joanna; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Wrana, Jeff; Durocher, Daniel; Meloche, Sylvain; Webb, David R.; Tyers, Mike; Sicheri, Frank			An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme	CELL			English	Article							F-BOX PROTEINS; CELL-DIVISION; LIGASE; ACTIVATION; SUBSTRATE; E2; PROTEOLYSIS; P27(KIP1); COMPLEX; E3	In the ubiquitin-proteasome system (UPS), E2 enzymes mediate the conjugation of ubiquitin to substrates and thereby control protein stability and interactions. The E2 enzyme hCdc34 catalyzes the ubiquitination of hundreds of proteins in conjunction with the cullin-RING (CRL) superfamily of E3 enzymes. We identified a small molecule termed CC0651 that selectively inhibits hCdc34. Structure determination revealed that CC0651 inserts into a cryptic binding pocket on hCdc34 distant from the catalytic site, causing subtle but wholesale displacement of E2 secondary structural elements. CC0651 analogs inhibited proliferation of human cancer cell lines and caused accumulation of the SCFSkp2 substrate p27(Kip1). CC0651 does not affect hCdc34 interactions with E1 or E3 enzymes or the formation of the ubiquitin thioester but instead interferes with the discharge of ubiquitin to acceptor lysine residues. E2 enzymes are thus susceptible to noncatalytic site inhibition and may represent a viable class of drug target in the UPS.	[Xie, Weilin; Plantevin, Veronique; Cox, Sarah; Xu, Shuichan; Lopez-Girona, Antonia; Mercurio, Frank; Webb, David R.] Celgene Signal Res Div, San Diego, CA 92121 USA; [Ceccarelli, Derek F.; Tang, Xiaojing; Orlicky, Stephen; Neculai, Dante; Chou, Yang-Chieh; Ogunjimi, Abiodun; Al-Hakim, Abdallah; Varelas, Xaralabos; Wrana, Jeff; Durocher, Daniel; Tyers, Mike; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Meloche, Sylvain] Univ Montreal, Program Mol Biol, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Neculai, Dante; Wasney, Gregory A.; Vedadi, Masoud; Dhe-Paganon, Sirano] Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Koszela, Joanna; Tyers, Mike] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Tyers, Mike; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pelletier, Benoit; Meloche, Sylvain] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Universite de Montreal; Universite de Montreal; University of Toronto; Structural Genomics Consortium; University of Edinburgh; University of Toronto; Universite de Montreal	Webb, DR (corresponding author), Celgene Signal Res Div, 4550 Towne Ctr Court, San Diego, CA 92121 USA.	dwebb@celgene.com; m.tyers@ed.ac.uk; sicheri@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013; Neculai, Dante/A-9923-2011; Tyers, Michael/ABE-3194-2021; Varelas, Xaralabos/ABB-9141-2020; Sicheri, Frank/F-8856-2013; Neculai, Dante/M-2884-2013; 高, 雨莉/HGU-8187-2022; Durocher, Daniel/A-7733-2010	Neculai, Dante/0000-0001-8887-9168; Durocher, Daniel/0000-0003-3863-8635; Varelas, Xaralabos/0000-0002-2882-4541; Orlicky, Stephen/0000-0002-8172-2042; Ceccarelli, Derek/0000-0002-2674-9234	National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. Department of Energy [DE-AC02-06CH11357]; Canadian Institutes of Health Research [MOP-57795, MOP-14339, MOP-14168]; National Cancer Institute of Canada; Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society; Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy(United States Department of Energy (DOE)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canada Research Chair in Cellular Signaling; Research Chair of the Scottish Universities Life Sciences Alliance; Royal Society(Royal Society of London); Canada Research Chair in Structural Biology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Jean O'Donoghue and Ted Hupp for cell culture advice, Michele Pagano for SCF reagents, and Thimo Kurz for MLN4924. We also thank I. Kourinov and staff at Argonne National Laboratory for assistance with micro-diffraction experiments at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, as supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health and contract DE-AC02-06CH11357 from the U.S. Department of Energy. This work was supported by grants to F. S., M. T., J.W., and S. M. from the Canadian Institutes of Health Research (MOP-57795, MOP-14339, and MOP-14168). B. P. is recipient of a fellowship from the National Cancer Institute of Canada. S. M. is supported by a Canada Research Chair in Cellular Signaling, M. T. by a Research Chair of the Scottish Universities Life Sciences Alliance and a Royal Society Wolfson Research Merit Award, and F. S. by a Canada Research Chair in Structural Biology.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Butz N, 2005, EXP CELL RES, V303, P482, DOI 10.1016/j.yexcr.2004.10.008; Chauhan D, 2004, ONCOGENE, V23, P3597, DOI 10.1038/sj.onc.1207458; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eliseeva E, 2001, CELL GROWTH DIFFER, V12, P427; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wang YS, 1999, CURR BIOL, V9, P1191, DOI 10.1016/S0960-9822(00)80024-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	52	163	170	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1075	1087		10.1016/j.cell.2011.05.039	http://dx.doi.org/10.1016/j.cell.2011.05.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21683433	Bronze			2022-12-28	WOS:000292025700014
J	Marty, B; Chaussidon, M; Wiens, RC; Jurewicz, AJG; Burnett, DS				Marty, B.; Chaussidon, M.; Wiens, R. C.; Jurewicz, A. J. G.; Burnett, D. S.			A N-15-Poor Isotopic Composition for the Solar System As Shown by Genesis Solar Wind Samples	SCIENCE			English	Article							CONCENTRATOR TARGET; NITROGEN ISOTOPES; FRACTIONATION; ABUNDANCES; CARBON; HYDROGEN; PRESOLAR; HELIUM; ORIGIN; RATIO	The Genesis mission sampled solar wind ions to document the elemental and isotopic compositions of the Sun and, by inference, of the protosolar nebula. Nitrogen was a key target element because the extent and origin of its isotopic variations in solar system materials remain unknown. Isotopic analysis of a Genesis Solar Wind Concentrator target material shows that implanted solar wind nitrogen has a N-15/N-14 ratio of 2.18 +/- 0.02 x 10(-3) (that is, approximate to 40% poorer in N-15 relative to terrestrial atmosphere). The N-15/N-14 ratio of the protosolar nebula was 2.27 +/- 0.03 x 10(-3), which is the lowest N-15/N-14 ratio known for solar system objects. This result demonstrates the extreme nitrogen isotopic heterogeneity of the nascent solar system and accounts for the N-15-depleted components observed in solar system reservoirs.	[Marty, B.; Chaussidon, M.] Nancy Univ, CRPG, F-54501 Vandoeuvre Les Nancy, France; [Wiens, R. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Jurewicz, A. J. G.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Burnett, D. S.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA	Universite de Lorraine; United States Department of Energy (DOE); Los Alamos National Laboratory; Arizona State University; Arizona State University-Tempe; California Institute of Technology	Marty, B (corresponding author), Nancy Univ, CRPG, BP 20, F-54501 Vandoeuvre Les Nancy, France.	bmarty@crpg.cnrs-nancy.fr	Chaussidon, Marc/E-7067-2017	Jurewicz, Amy/0000-0002-3282-5782	NASA through the Genesis Discovery Mission; NASA through the Laboratory Analysis of Returned Samples; Centre National d'Etudes Spatiales, France; Centre National de la Recherche Scientifique, France; French Ministery of Higher Education and Research, France; Region Lorraine, France; Fonds Europeen de Developpement Regional, France; European Research Council under the European Community [226846, 267255]	NASA through the Genesis Discovery Mission; NASA through the Laboratory Analysis of Returned Samples; Centre National d'Etudes Spatiales, France(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS)); French Ministery of Higher Education and Research, France; Region Lorraine, France(Region Grand-Est); Fonds Europeen de Developpement Regional, France; European Research Council under the European Community(European Research Council (ERC))	Funding in the U.S. was provided by NASA through the Genesis Discovery Mission and through the Laboratory Analysis of Returned Samples program. The ultimate success of the mission would not have been possible without major engineering contributions from the Los Alamos National Laboratory (Genesis Concentrator), Jet Propulsion Laboratory (payload, mission operations, management), Lockheed Martin Aerospace (spacecraft and reentry capsule), and the Johnson Space Center (payload integration and curation). This study was funded in France by the Centre National d'Etudes Spatiales, the Centre National de la Recherche Scientifique, the French Ministery of Higher Education and Research, the Region Lorraine, the Fonds Europeen de Developpement Regional, and the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013 grant agreements no. 226846 to M.C. and no. 267255 to B.M.). We particularly thank J. D. Allton for excellent sample curation and C. Olinger for ion trajectory calculations. The SiC standard was provided by A. Kallio. This work benefitted from discussions with the members of the Genesis Science Team, in particular, R. O. Pepin, R. Wieler, and A. N. Davies. Comments on the draft by V. S. Heber, K. McKeegan, P. Bochsler, and three reviewers were appreciated. The full data set is available as supporting online material (SOM).	Aleon J, 2010, ASTROPHYS J, V722, P1342, DOI 10.1088/0004-637X/722/2/1342; Bahcall JN, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.131301; Becker R.H., 1975, P LUNAR PLANET SCI C, P2131; Bochsler P, 2000, REV GEOPHYS, V38, P247, DOI 10.1029/1999RG000063; Bockelee-Morvan D, 2008, ASTROPHYS J LETT, V679, pL49, DOI 10.1086/588781; Bodmer P, 1998, ASTRON ASTROPHYS, V337, P921; Bonal L, 2010, GEOCHIM COSMOCHIM AC, V74, P6590, DOI 10.1016/j.gca.2010.08.017; Briani G, 2009, P NATL ACAD SCI USA, V106, P10522, DOI 10.1073/pnas.0901546106; Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; Chakraborty S, 2008, SCIENCE, V321, P1328, DOI 10.1126/science.1159178; Chaussidon M, 1999, NATURE, V402, P270, DOI 10.1038/46235; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; Clayton RN, 2003, SPACE SCI REV, V106, P19, DOI 10.1023/A:1024669116828; GEISS J, 1982, GEOCHIM COSMOCHIM AC, V46, P529, DOI 10.1016/0016-7037(82)90156-9; GEISS J, 1981, ASTRON ASTROPHYS, V93, P189; Grimberg A, 2006, SCIENCE, V314, P1133, DOI 10.1126/science.1133568; Grossman L, 2008, REV MINERAL GEOCHEM, V68, P93, DOI 10.2138/rmg.2008.68.7; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Heber VS, 2007, SPACE SCI REV, V130, P309, DOI 10.1007/s11214-007-9179-1; Heber V. S., 2008, LUNAR PLANETARY SCI; Heber VS, 2011, METEORIT PLANET SCI, V46, P493, DOI 10.1111/j.1945-5100.2011.01170.x; Heber VS, 2003, ASTROPHYS J, V597, P602, DOI 10.1086/378402; Kallio A. P., 2010, LUNAR PLANETARY SCI; KERRIDGE JF, 1993, REV GEOPHYS, V31, P423, DOI 10.1029/93RG01953; KERRIDGE JF, 1975, SCIENCE, V188, P162, DOI 10.1126/science.188.4184.162; KUNG CC, 1978, EARTH PLANET SC LETT, V38, P421, DOI 10.1016/0012-821X(78)90117-6; Marty B, 2010, GEOCHIM COSMOCHIM AC, V74, P340, DOI 10.1016/j.gca.2009.09.007; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; Meibom A, 2007, ASTROPHYS J, V656, pL33, DOI 10.1086/512052; MING T, 1988, GEOCHIM COSMOCHIM AC, V52, P1235, DOI 10.1016/0016-7037(88)90277-3; Nordholt JE, 2003, SPACE SCI REV, V105, P561, DOI 10.1023/A:1024422011514; Owen T, 2001, ASTROPHYS J, V553, pL77, DOI 10.1086/320501; Owen T, 1999, NATURE, V402, P269, DOI 10.1038/46232; Pepin R. O., 2009, LUNAR PLANETARY SCI; PROMBO CA, 1993, GEOCHIM COSMOCHIM AC, V57, P3749, DOI 10.1016/0016-7037(93)90153-N; PROMBO CA, 1985, SCIENCE, V230, P935, DOI 10.1126/science.230.4728.935; Russell SS, 1996, METORIT PLANET SCI, V31, P343, DOI 10.1111/j.1945-5100.1996.tb02071.x; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; Taylor F. W., 2004, JUPITER, P60; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Turcotte S, 1998, ASTROPHYS J, V504, P539, DOI 10.1086/306055; Turcotte S., 2002, J GEOPHYS RES, V107, P11; Wieler R, 1999, EARTH PLANET SC LETT, V167, P47, DOI 10.1016/S0012-821X(99)00012-6; Wiens RC, 2003, SPACE SCI REV, V105, P601, DOI 10.1023/A:1024474028352; Zinner EK, 2005, TREATISE GEOCHEM, V1, P17; Zinner E, 2007, GEOCHIM COSMOCHIM AC, V71, P4786, DOI 10.1016/j.gca.2007.07.012	49	210	211	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1533	1536		10.1126/science.1204656	http://dx.doi.org/10.1126/science.1204656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700869	Green Submitted			2022-12-28	WOS:000291990000038
J	Roelfsema, PR				Roelfsema, Pieter R.			Attention-Voluntary Control of Brain Cells	SCIENCE			English	Editorial Material							SINGLE NEURONS; CORTEX; REPRESENTATION		[Roelfsema, Pieter R.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Vis & Cognit, NL-1105 BA Amsterdam, Netherlands; [Roelfsema, Pieter R.] Vrije Univ Amsterdam, Dept Integrat Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam	Roelfsema, PR (corresponding author), Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Vis & Cognit, Meibergdreef 47, NL-1105 BA Amsterdam, Netherlands.	p.roelfsema@nin.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; FETZ EB, 1971, SCIENCE, V174, P431, DOI 10.1126/science.174.4007.431; Goebel R., 2010, IMAGING MED, V2, P407; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hatsopoulos NG, 2009, ANNU REV NEUROSCI, V32, P249, DOI 10.1146/annurev.neuro.051508.135241; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Moro SI, 2010, J NEUROSCI, V30, P16293, DOI 10.1523/JNEUROSCI.1256-10.2010; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Roelfsema PR, 2006, ANNU REV NEUROSCI, V29, P203, DOI 10.1146/annurev.neuro.29.051605.112939; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SELF M, 45306003 NWO NETH OR; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	16	8	9	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1512	1513		10.1126/science.1208564	http://dx.doi.org/10.1126/science.1208564			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700861				2022-12-28	WOS:000291990000030
J	Mozaffarian, D; Hao, T; Rimm, EB; Willett, WC; Hu, FB				Mozaffarian, Dariush; Hao, Tao; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.			Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUGAR-SWEETENED BEVERAGES; CORONARY-HEART-DISEASE; TIME PHYSICAL-ACTIVITY; BODY-MASS INDEX; ENERGY DENSITY; FOOD-CONSUMPTION; ALCOHOL INTAKE; RISK-FACTORS; AGED MEN; TELEVISION	Background Specific dietary and other lifestyle behaviors may affect the success of the straight-forward-sounding strategy "eat less and exercise more" for preventing long-term weight gain. Methods We performed prospective investigations involving three separate cohorts that included 120,877 U. S. women and men who were free of chronic diseases and not obese at baseline, with follow-up periods from 1986 to 2006, 1991 to 2003, and 1986 to 2006. The relationships between changes in lifestyle factors and weight change were evaluated at 4-year intervals, with multivariable adjustments made for age, baseline body-mass index for each period, and all lifestyle factors simultaneously. Cohort-specific and sex-specific results were similar and were pooled with the use of an inverse-variance-weighted meta-analysis. Results Within each 4-year period, participants gained an average of 3.35 lb (5th to 95th percentile, -4.1 to 12.4). On the basis of increased daily servings of individual dietary components, 4-year weight change was most strongly associated with the intake of potato chips (1.69 lb), potatoes (1.28 lb), sugar-sweetened beverages (1.00 lb), unprocessed red meats (0.95 lb), and processed meats (0.93 lb) and was inversely associated with the intake of vegetables (-0.22 lb), whole grains (-0.37 lb), fruits (-0.49 lb), nuts (-0.57 lb), and yogurt (-0.82 lb) (P <= 0.005 for each comparison). Aggregate dietary changes were associated with substantial differences in weight change (3.93 lb across quintiles of dietary change). Other lifestyle factors were also independently associated with weight change (P<0.001), including physical activity (-1.76 lb across quintiles); alcohol use (0.41 lb per drink per day), smoking (new quitters, 5.17 lb; former smokers, 0.14 lb), sleep (more weight gain with <6 or >8 hours of sleep), and television watching (0.31 lb per hour per day). Conclusions Specific dietary and lifestyle factors are independently associated with long-term weight gain, with a substantial aggregate effect and implications for strategies to prevent obesity.	[Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush; Hao, Tao; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Rimm, Eric B.; Willett, Walter C.; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008		National Institutes of Health [DK46200, DK58845, HL085710, HL60712, HL35464, CA87969, CA50385, CA55075, CA95589]; Searle Scholars Program; Nutrition Impact; Foodminds; Aramark; Unilever; SPRIM; UpToDate; GlaxoSmithKline; Sigma-Tau; Pronova; Amgen; Institute of Food Technologies; Merck; California Walnut Commission; NATIONAL CANCER INSTITUTE [P01CA087969, R01CA050385, P01CA055075, R01CA095589] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085710, R01HL060712, R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056690, P30DK046200, P30DK040561, R01DK058845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Program; Nutrition Impact; Foodminds; Aramark; Unilever(Unilever); SPRIM; UpToDate; GlaxoSmithKline(GlaxoSmithKline); Sigma-Tau; Pronova; Amgen(Amgen); Institute of Food Technologies; Merck(Merck & Company); California Walnut Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (DK46200, DK58845, HL085710, HL60712, HL35464, CA87969, CA50385, CA55075, and CA95589) from the National Institutes of Health and by the Searle Scholars Program.; Dr. Mozaffarian reports receiving consulting fees from Nutrition Impact and Foodminds, lecture fees from Aramark, Unilever, and SPRIM, royalties from UpToDate, and grant support on behalf of Harvard Medical School from GlaxoSmithKline, Sigma-Tau, and Pronova and being listed as a coinventor on a provisional patent application filed by and assigned to Harvard University for the use of trans-palmitoleic acid to prevent and treat insulin resistance, type 2 diabetes, and related conditions. Dr. Hu reports receiving lecture fees from Amgen, Nutrition Impact, Unilever, and the Institute of Food Technologies and grant support on behalf of the Harvard School of Public Health from Merck and the California Walnut Commission. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2010, 2010 SLEEP AM POLL; Bornet FRJ, 2007, APPETITE, V49, P535, DOI 10.1016/j.appet.2007.04.006; Buijsse B, 2009, AM J CLIN NUTR, V90, P202, DOI 10.3945/ajcn.2008.27394; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chen LW, 2009, AM J CLIN NUTR, V89, P1299, DOI 10.3945/ajcn.2008.27240; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Coon KA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e7; Dove ER, 2009, AM J CLIN NUTR, V90, P70, DOI 10.3945/ajcn.2008.27411; Dubois L, 2008, PUBLIC HEALTH NUTR, V11, P1267, DOI 10.1017/S1368980008002887; Eliassen AH, 2006, JAMA-J AM MED ASSOC, V296, P193, DOI 10.1001/jama.296.2.193; Ello-Martin JA, 2005, AM J CLIN NUTR, V82, p236S, DOI 10.1093/ajcn/82.1.236S; Ello-Martin JA, 2007, AM J CLIN NUTR, V85, P1465, DOI 10.1093/ajcn/85.6.1465; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Escobar-Chaves SL, OBESITY SILVER SP S1, V18, pS99; Flint AJ, 2010, OBESITY, V18, P377, DOI 10.1038/oby.2009.223; GARDNER CD, 2007, JAMA-J AM MED ASSOC, V298, P178; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gordon-Larsen P, 2009, AM J CLIN NUTR, V89, P19, DOI 10.3945/ajcn.2008.26147; Haapanen N, 1997, INT J OBESITY, V21, P288, DOI 10.1038/sj.ijo.0800403; Kinross James M, 2008, Curr Gastroenterol Rep, V10, P396, DOI 10.1007/s11894-008-0075-y; Lanou AJ, 2008, NUTR REV, V66, P272, DOI 10.1111/j.1753-4887.2008.00032.x; Ledikwe JH, 2007, AM J CLIN NUTR, V85, P1212, DOI 10.1093/ajcn/85.5.1212; Lee IM, 2010, JAMA-J AM MED ASSOC, V303, P1173, DOI 10.1001/jama.2010.312; LIU SM, 1994, AM J EPIDEMIOL, V140, P912, DOI 10.1093/oxfordjournals.aje.a117179; Liu SM, 2003, AM J CLIN NUTR, V78, P920, DOI 10.1093/ajcn/78.5.920; Lloyd-Jones, 2010, CIRCULATION, V121, pE260, DOI 10.1161/CIR.0b013e3181d7cf32; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Manios Y, 2009, EUR J PEDIATR, V168, P801, DOI 10.1007/s00431-008-0838-3; Micha R, 2009, NAT REV ENDOCRINOL, V5, P335, DOI 10.1038/nrendo.2009.79; Office on Smoking and Health National Center for Chronic Disease Prevention and Health Promotion, 2001, WOM SMOK REP SURG GE; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Plachta-Danielzik S, 2008, OBESITY, V16, P777, DOI 10.1038/oby.2008.5; Rajpathak SN, 2006, AM J CLIN NUTR, V83, P559, DOI 10.1093/ajcn.83.3.559; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Robinson TN, 2001, PEDIATR CLIN N AM, V48, P1017, DOI 10.1016/S0031-3955(05)70354-0; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Rolls BJ, 2005, OBES RES, V13, P1052, DOI 10.1038/oby.2005.123; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; Rosenheck R, 2008, OBES REV, V9, P535, DOI 10.1111/j.1467-789X.2008.00477.x; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Shai I, 2009, NEW ENGL J MED, V361, P2681; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Stull AJ, 2008, J AM DIET ASSOC, V108, P1226, DOI 10.1016/j.jada.2008.04.014; Temple JL, 2007, AM J CLIN NUTR, V85, P355, DOI 10.1093/ajcn/85.2.355; Thygesen LC, 2008, INT J CANCER, V123, P1160, DOI 10.1002/ijc.23612; Tong X, 2011, EUR J CLIN NUTR 0511; Tremblay A, 2009, J AM COLL NUTR, V28, p91S, DOI 10.1080/07315724.2009.10719809; US Department of Agriculture Agricultural Research Service, USDA NAT NUTR DAT ST; Utter J, 2006, PUBLIC HEALTH NUTR, V9, P606, DOI 10.1079/PHN2005899; Van Cauter E, 2008, SLEEP MED, V9, pS23, DOI 10.1016/S1389-9457(08)70013-3; van Dam R, 2007, EUR J CLIN NUTR, V61, pS75, DOI 10.1038/sj.ejcn.1602939; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Wagner A, 2001, INT J OBESITY, V25, P940, DOI 10.1038/sj.ijo.0801635; Wang L, 2010, ARCH INTERN MED, V170, P453, DOI 10.1001/archinternmed.2009.527; Wannamethee SG, 2004, OBES RES, V12, P1386, DOI 10.1038/oby.2004.175; Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wolff Emily, 2008, Medscape J Med, V10, P189; Zhai F, 2008, OBES REV, V9, P107, DOI 10.1111/j.1467-789X.2007.00450.x	61	1532	1564	16	416	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2392	2404		10.1056/NEJMoa1014296	http://dx.doi.org/10.1056/NEJMoa1014296			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696306	Green Accepted			2022-12-28	WOS:000291936100005
J	Zeuzem, S; Andreone, P; Pol, S; Lawitz, E; Diago, M; Roberts, S; Focaccia, R; Younossi, Z; Foster, GR; Horban, A; Ferenci, P; Nevens, F; Mullhaupt, B; Pockros, P; Terg, R; Shouval, D; van Hoek, B; Weiland, O; Van Heeswijk, R; De Meyer, S; Luo, D; Boogaerts, G; Polo, R; Picchio, G; Beumont, M				Zeuzem, Stefan; Andreone, Pietro; Pol, Stanislas; Lawitz, Eric; Diago, Moises; Roberts, Stuart; Focaccia, Roberto; Younossi, Zobair; Foster, Graham R.; Horban, Andrzej; Ferenci, Peter; Nevens, Frederik; Muellhaupt, Beat; Pockros, Paul; Terg, Ruben; Shouval, Daniel; van Hoek, Bart; Weiland, Ola; Van Heeswijk, Rolf; De Meyer, Sandra; Luo, Don; Boogaerts, Griet; Polo, Ramon; Picchio, Gaston; Beumont, Maria		REALIZE Study Team	Telaprevir for Retreatment of HCV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; PEGINTERFERON ALPHA-2A; RIBAVIRIN; BOCEPREVIR	Background Up to 60% of patients with hepatitis C virus (HCV) genotype 1 infection do not have a sustained virologic response to therapy with peginterferon alfa plus ribavirin. Methods In this randomized, phase 3 trial, we evaluated the addition of telaprevir to peginterferon alfa-2a plus ribavirin in patients with HCV genotype 1 infection who had no response or a partial response to previous therapy or who had a relapse after an initial response. A total of 663 patients were assigned to one of three groups: the T12PR48 group, which received telaprevir for 12 weeks and peginterferon plus ribavirin for a total of 48 weeks; the lead-in T12PR48 group, which received 4 weeks of peginterferon plus ribavirin followed by 12 weeks of telaprevir and peginterferon plus ribavirin for a total of 48 weeks; and the control group (PR48), which received peginterferon plus ribavirin for 48 weeks. The primary end point was the rate of sustained virologic response, which was defined as undetectable HCV RNA 24 weeks after the last planned dose of a study drug. Results Rates of sustained virologic response were significantly higher in the two telaprevir groups than in the control group among patients who had a previous relapse (83% in the T12PR48 group, 88% in the lead-in T12PR48 group, and 24% in the PR48 group), a partial response (59%, 54%, and 15%, respectively), and no response (29%, 33%, and 5%, respectively) (P<0.001 for all comparisons). Grade 3 adverse events (mainly anemia, neutropenia, and leukopenia) were more frequent in the telaprevir groups than in the control group (37% vs. 22%). Conclusions Telaprevir combined with peginterferon plus ribavirin significantly improved rates of sustained virologic response in patients with previously treated HCV infection, regardless of whether there was a lead-in phase.	[Zeuzem, Stefan] Johann Wolfgang Goethe Univ Hosp, Dept Internal Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Zeuzem, S (corresponding author), Johann Wolfgang Goethe Univ Hosp, Dept Internal Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	van Hoek, Bart/AAU-8953-2020; Hug, Balthasar L./G-1568-2010; Hezode, Christophe/U-4659-2018; Zeuzem, Stefan/AAE-7435-2019; Shouval, Daniel/U-2779-2017; correa, maria cassia mendes/A-6779-2013; Andreone, Pietro/K-8050-2016; DIAGO, MOISES/AAH-5364-2019; Mathurin, Philippe/A-9121-2018; FOCACCIA, ROBERTO/I-3970-2013	Shouval, Daniel/0000-0002-0512-6513; Andreone, Pietro/0000-0002-4794-9809; Mathurin, Philippe/0000-0003-3447-2025; Foster, Graham/0000-0002-3704-386X; FOCACCIA, ROBERTO/0000-0002-8688-8711; Van Vlierberghe, Hans/0000-0003-0647-9238; Afdhal, Nezam/0000-0002-7342-6593; Weiland, Ola/0000-0002-6934-9724; Luth, Stefan/0000-0001-9946-0960; van Hoek, Bart/0000-0001-6527-764X	Tibotec; Vertex Pharmaceuticals	Tibotec; Vertex Pharmaceuticals(Vertex Pharmaceuticals)	Supported by Tibotec and Vertex Pharmaceuticals.	[Anonymous], 2010, GUID IND CHRON HEP C; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Berg T, 2010, J HEPATOL, V52, pS2, DOI 10.1016/S0168-8278(10)60006-2; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Marcellin P, 2011, GASTROENTEROLOGY, V140, p459e1; McHutchison JG, 2010, NEW ENGL J MED, V362, P1647; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2009, NEW ENGL J MED, V361, P1027; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Schiff E, 2008, J HEPATOL, V48, pS46, DOI 10.1016/S0168-8278(08)60106-3; Sherman KE, 2010, HEPATOLOGY, V52, p401A, DOI 10.1002/hep.23394; Shiffman ML, 2004, GASTROENTEROLOGY, V126, P1015, DOI 10.1053/j.gastro.2004.01.014; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013	22	1251	1330	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2417	2428		10.1056/NEJMoa1013086	http://dx.doi.org/10.1056/NEJMoa1013086			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696308	Green Published			2022-12-28	WOS:000291936100007
J	Gheorghiade, M; Peterson, ED				Gheorghiade, Mihai; Peterson, Eric D.			Improving Postdischarge Outcomes in Patients Hospitalized for Acute Heart Failure Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Gheorghiade, Mihai] Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, Chicago, IL 60611 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Northwestern University; Feinberg School of Medicine; Duke University	Gheorghiade, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Cardiovasc Innovat, 645 N Michigan Ave,Ste 1006, Chicago, IL 60611 USA.	m-gheorghiade@northwestern.edu	Peterson, Eric David/ABF-5033-2021					Albert NM, 2009, JAMA-J AM MED ASSOC, V302, P1658, DOI 10.1001/jama.2009.1493; Dunlay SM, 2010, EUR J HEART FAIL, V12, P367, DOI 10.1093/eurjhf/hfq019; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Fonarow GC, 2011, CIRCULATION, V123, P1601, DOI 10.1161/CIRCULATIONAHA.110.989632; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Gheorghiade M, 2010, EUR J HEART FAIL, V12, P423, DOI 10.1093/eurjhf/hfq045; Gheorghiade M, 2009, JAMA-J AM MED ASSOC, V302, P2146, DOI 10.1001/jama.2009.1657; Metra M, 2010, CIRCULATION, V122, P1782, DOI 10.1161/CIRCULATIONAHA.110.982207; Pang PS, 2010, EUR HEART J, V31, P784, DOI 10.1093/eurheartj/ehq040; Shah SJ, 2008, JAMA-J AM MED ASSOC, V300, P431, DOI 10.1001/jama.300.4.431	10	35	36	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2456	2457		10.1001/jama.2011.836	http://dx.doi.org/10.1001/jama.2011.836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673297				2022-12-28	WOS:000291597300026
J	Ana, J; Harrison, KA				Ana, Joseph; Harrison, Kelsey A.			Are traditional birth attendants good for improving maternal and perinatal health? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kelseyharrison50@gmail.com						African Development Bank, 2011, MARKET BRIEF     APR, P1; [Anonymous], 2010, NIGERIA HLTH WA 0807; HARRISON KA, 1990, BRIT J OBSTET GYNAEC, V97, P88, DOI 10.1111/j.1471-0528.1990.tb01725.x; HARRISON KA, 1980, LANCET, V2, P43; HARRISON KA, 1989, BRIT J OBSTET GYNAEC, V96, P1, DOI 10.1111/j.1471-0528.1989.tb01567.x; Harrison KA, 2003, LANCET, V362, P582, DOI 10.1016/S0140-6736(03)14138-4; HARRISON KA, 1985, BRIT J OBSTET GYNAEC, V92, P1; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; WHO, 2010, TRENDS MAT MORT 1990, P20; *WHO, 2000, REP M FUT DIR ROT VA, P1	10	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3308	10.1136/bmj.d3308	http://dx.doi.org/10.1136/bmj.d3308			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781KY	21673000				2022-12-28	WOS:000291932100005
J	Creighton, FX; Leeds, IL; Master, VA; Srinivasan, JK				Creighton, Francis X., Jr.; Leeds, Ira L.; Master, Viraj A.; Srinivasan, Jahnavi K.			Learning from Haiti	LANCET			English	Editorial Material							ULTRASONOGRAPHY		[Creighton, Francis X., Jr.; Leeds, Ira L.; Master, Viraj A.; Srinivasan, Jahnavi K.] Emory Univ, Sch Med, Atlanta, GA USA	Emory University	Creighton, FX (corresponding author), 486 Ponce Leon Manor, Atlanta, GA 30307 USA.	fcreigh@emory.edu	Leeds, Ira L./H-5520-2019	Leeds, Ira L./0000-0001-6572-8658; Creighton, Francis/0000-0003-3131-1162				Adler D, 2008, INT J EMERG MED, V1, P261, DOI 10.1007/s12245-008-0074-7; Kongnyuy EJ, 2007, TROP DOCT, V37, P70, DOI 10.1258/004947507780609310; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Shah S, 2008, INT J EMERG MED, V1, P193, DOI 10.1007/s12245-008-0053-z; Shah SP, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-4	5	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					2054	2054		10.1016/S0140-6736(11)60409-1	http://dx.doi.org/10.1016/S0140-6736(11)60409-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21665039				2022-12-28	WOS:000292011700040
J	Rabbani, P; Takeo, M; Chou, WC; Myung, P; Bosenberg, M; Chin, L; Taketo, MM; Ito, M				Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Myung, Peggy; Bosenberg, Marcus; Chin, Lynda; Taketo, M. Mark; Ito, Mayumi			Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration	CELL			English	Article							BETA-CATENIN; NEURAL CREST; FOLLICLE MORPHOGENESIS; TRANSCRIPTION FACTOR; SKIN; GROWTH; DIFFERENTIATION; EXPRESSION; NICHE; CYCLE	Melanocyte stem cells (McSCs) intimately interact with epithelial stem cells (EpSCs) in the hair follicle bulge and secondary hair germ (sHG). Together, they undergo activation and differentiation to regenerate pigmented hair. However, the mechanisms behind this coordinated stem cell behavior have not been elucidated. Here, we identified Wnt signaling as a key pathway that couples the behavior of the two stem cells. EpSCs and McSCs coordinately activate Wnt signaling at the onset of hair follicle regeneration within the sHG. Using genetic mouse models that specifically target either EpSCs or McSCs, we show that Wnt activation in McSCs drives their differentiation into pigment-producing melanocytes, while EpSC Wnt signaling not only dictates hair follicle formation but also regulates McSC proliferation during hair regeneration. Our data define a role for Wnt signaling in the regulation of McSCs and also illustrate a mechanism for regeneration of complex organs through collaboration between heterotypic stem cell populations.	[Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA; [Rabbani, Piul; Takeo, Makoto; Chou, WeiChin; Ito, Mayumi] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Myung, Peggy] Univ Hosp Case Western Reserve, Dept Dermatol, Cleveland, OH USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Taketo, M. Mark] Kyoto Univ, Dept Pharmacol, Grad Sch Med, Kyoto 6068501, Japan	New York University; New York University; Case Western Reserve University; Yale University; Harvard University; Dana-Farber Cancer Institute; Kyoto University	Ito, M (corresponding author), NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA.	mayumi.ito@nyumc.org		Takeo, Makoto/0000-0002-5597-5994; Rabbani, Piul/0000-0001-8302-8225	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation; Yan Deng; Microscopy Core of NYU [NCRR S10 RR023704-01A1, NCRR S10 RR024708]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024708, S10RR023704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059768] Funding Source: NIH RePORTER	Department of Dermatology; Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU); Dermatology Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Yan Deng; Microscopy Core of NYU; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank funds from the Department of Dermatology and the Helen and Martin Kimmel Center for Stem Cell Biology at New York University (NYU), the Dermatology Foundation Career Development Award, and the New Scholar Award in aging from the Ellison Medical Foundation to M.I. We thank Tung-Tien Sun for critical reading of the manuscript. We thank Seth Orlow and Prashiela Manga for providing Melan-a cells and helpful advice. We thank our mentors George Cotsarelis and Sarah Millar for their helpful advice and constant encouragement. We thank Radhika Atit for her input and collaboration for this work. We thank Yan Deng and the Microscopy Core of NYU for use of confocal microscopes (grants NCRR S10 RR023704-01A1 and NCRR S10 RR024708).	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brault V, 2001, DEVELOPMENT, V128, P1253; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; DORAN TI, 1980, CELL, V22, P17, DOI 10.1016/0092-8674(80)90150-6; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Fu J, 2009, P NATL ACAD SCI USA, V106, P18598, DOI 10.1073/pnas.0904894106; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Imokawa G, 2004, PIGM CELL RES, V17, P96, DOI 10.1111/j.1600-0749.2003.00126.x; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Larue L, 2006, FRONT BIOSCI-LANDMRK, V11, P733, DOI 10.2741/1831; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nishikawa SI, 2007, PIGM CELL RES, V20, P263, DOI 10.1111/j.1600-0749.2007.00388.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; RAWLES ME, 1947, PHYSIOL ZOOL, V20, P248, DOI 10.1086/physzool.20.3.30151958; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; Saldana-Caboverde A, 2010, PIGM CELL MELANOMA R, V23, P160, DOI 10.1111/j.1755-148X.2010.00678.x; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Sharov A, 2005, J INVEST DERMATOL, V125, P1259, DOI 10.1111/j.0022-202X.2005.23959.x; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tanimura S, 2011, CELL STEM CELL, V8, P177, DOI 10.1016/j.stem.2010.11.029; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	58	207	229	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					941	955		10.1016/j.cell.2011.05.004	http://dx.doi.org/10.1016/j.cell.2011.05.004			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663796	Green Accepted, Bronze			2022-12-28	WOS:000291461600020
J	Wardle, DA; Bardgett, RD; Callaway, RM; Van der Putten, WH				Wardle, David A.; Bardgett, Richard D.; Callaway, Ragan M.; Van der Putten, Wim H.			Terrestrial Ecosystem Responses to Species Gains and Losses	SCIENCE			English	Review							CLIMATE-CHANGE; CHANGING ENVIRONMENT; NITROGEN-FIXATION; PLANT-COMMUNITIES; DIVERSITY; BIODIVERSITY; INVASION; IMPACTS; RESTORATION; HERBIVORES	Ecosystems worldwide are losing some species and gaining others, resulting in an interchange of species that is having profound impacts on how these ecosystems function. However, research on the effects of species gains and losses has developed largely independently of one another. Recent conceptual advances regarding effects of species gain have arisen from studies that have unraveled the mechanistic basis of how invading species with novel traits alter biotic interactions and ecosystem processes. In contrast, studies on traits associated with species loss are fewer, and much remains unknown about how traits that predispose species to extinction affect ecological processes. Species gains and losses are both consequences and drivers of global change; thus, explicit integration of research on how both processes simultaneously affect ecosystem functioning is key to determining the response of the Earth system to current and future human activities.	[Wardle, David A.] Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden; [Bardgett, Richard D.] Univ Lancaster, Lancaster Environm Ctr, Soil & Ecosyst Ecol Lab, Lancaster LA1 4YQ, England; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Van der Putten, Wim H.] Netherlands Inst Ecol, Dept Terr Ecol, NL-6700 AB Wageningen, Netherlands; [Van der Putten, Wim H.] Wageningen Univ, Dept Nematol, NL-6708 PB Wageningen, Netherlands	Swedish University of Agricultural Sciences; Lancaster University; University of Montana System; University of Montana; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Wardle, DA (corresponding author), Swedish Univ Agr Sci, Fac Forestry, Dept Forest Vegetat Ecol, SE-90183 Umea, Sweden.	david.wardle@svek.slu.se	van der Putten, Wim H/C-3707-2011; Wardle, David A./F-6031-2011	van der Putten, Wim H/0000-0002-9341-4442; Wardle, David A./0000-0002-0476-7335	Earth and Life Sciences section of the Dutch Research Council [865.05.002]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Earth and Life Sciences section of the Dutch Research Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank T. Fukami, F. Maestre, J. Tylianakis, and anonymous reviewers for helpful comments and A. Bardgett and K. Gundale for help with figure preparation. D. A. W. was supported by a Wallenberg Scholars award and W.v.d.P. by a Vici award from the Earth and Life Sciences section of the Dutch Research Council, grant no. 865.05.002.	Anderson CB, 2009, MAMMAL REV, V39, P33, DOI 10.1111/j.1365-2907.2008.00136.x; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Augustine DJ, 2006, ECOSYSTEMS, V9, P1242, DOI 10.1007/s10021-005-0020-y; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Berg MP, 2010, GLOBAL CHANGE BIOL, V16, P587, DOI 10.1111/j.1365-2486.2009.02014.x; Bohlen PJ, 2004, FRONT ECOL ENVIRON, V2, P427, DOI 10.1890/1540-9295(2004)002[0427:NIEAAO]2.0.CO;2; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; Bunker D.E., 2009, BIODIVERSITY ECOSYST; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Classen AT, 2007, J ECOL, V95, P1181, DOI 10.1111/j.1365-2745.2007.01297.x; Cornelissen JHC, 2007, ECOL LETT, V10, P619, DOI 10.1111/j.1461-0248.2007.01051.x; Crutsinger GM, 2008, OECOLOGIA, V158, P65, DOI 10.1007/s00442-008-1130-y; De Deyn G. B., 2001, J APPL ECOL, V16, P600; Diaz S, 2009, CURR OPIN ENV SUST, V1, P55, DOI 10.1016/j.cosust.2009.08.001; Diez JM, 2010, ECOL LETT, V13, P803, DOI 10.1111/j.1461-0248.2010.01474.x; Dorrepaal E, 2005, J ECOL, V93, P817, DOI 10.1111/j.1365-2745.2005.01024.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Feng ZL, 2009, ECOSYSTEMS, V12, P534, DOI 10.1007/s10021-009-9240-x; Frank DA, 2008, OIKOS, V117, P1718, DOI 10.1111/j.1600-0706.2008.16846.x; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Fukami T, 2006, ECOL LETT, V9, P1299, DOI 10.1111/j.1461-0248.2006.00983.x; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Kurokawa H, 2010, FUNCT ECOL, V24, P513, DOI 10.1111/j.1365-2435.2009.01676.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Lankau RA, 2009, P NATL ACAD SCI USA, V106, P15362, DOI 10.1073/pnas.0905446106; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Leishman MR, 2007, NEW PHYTOL, V176, P635, DOI 10.1111/j.1469-8137.2007.02189.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Leps J, 2004, BASIC APPL ECOL, V5, P529, DOI 10.1016/j.baae.2004.06.003; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Maestre FT, 2009, ECOL LETT, V12, P930, DOI 10.1111/j.1461-0248.2009.01352.x; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; McLaren JR, 2010, J ECOL, V98, P459, DOI 10.1111/j.1365-2745.2009.01630.x; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING; Peltzer DA, 2010, GLOBAL CHANGE BIOL, V16, P732, DOI 10.1111/j.1365-2486.2009.02038.x; Peltzer DA, 2009, OIKOS, V118, P1001, DOI 10.1111/j.1600-0706.2009.17244.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Ripple William J., 2010, P141; Rodriguez-Echeverria S, 2009, BIOL INVASIONS, V11, P651, DOI 10.1007/s10530-008-9280-8; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Sharma S, 2009, GLOBAL CHANGE BIOL, V15, P2549, DOI 10.1111/j.1365-2486.2009.01945.x; Simberloff D., 2011, ENCY INVASIVE INTRO; Smith RS, 2008, J APPL ECOL, V45, P670, DOI 10.1111/j.1365-2664.2007.01425.x; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Suding KN, 2008, ECOL MONOGR, V78, P313, DOI 10.1890/07-1092.1; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; van Kleunen M, 2010, ECOL LETT, V13, P947, DOI 10.1111/j.1461-0248.2010.01503.x; Venette RC, 2006, FOREST ECOL MANAG, V231, P18, DOI 10.1016/j.foreco.2006.04.036; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wardle DA, 2005, NATURE, V435, P806, DOI 10.1038/nature03611; Yelenik SG, 2010, ECOL APPL, V20, P716, DOI 10.1890/08-2365.1; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643; Zimov SA, 2005, SCIENCE, V308, P796, DOI 10.1126/science.1113442	75	301	312	12	414	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1273	1277		10.1126/science.1197479	http://dx.doi.org/10.1126/science.1197479			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659595	Green Accepted			2022-12-28	WOS:000291441700033
J	Reulen, RC; Frobisher, C; Winter, DL; Kelly, J; Lancashire, ER; Stiller, CA; Pritchard-Jones, K; Jenkinson, HC; Hawkins, MM				Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Stiller, Charles A.; Pritchard-Jones, Kathryn; Jenkinson, Helen C.; Hawkins, Michael M.		British Childhood Canc Survivor St	Long-term Risks of Subsequent Primary Neoplasms Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; COLORECTAL-CANCER; REGRESSION-MODELS; RELATIVE SURVIVAL; 5-YEAR SURVIVORS; FAMILY-HISTORY; SURVEILLANCE; METAANALYSIS; GUIDELINES; MORTALITY	Context Survivors of childhood cancer are at excess risk of developing subsequent primary neoplasms but the long-term risks are uncertain. Objectives To investigate long-term risks of subsequent primary neoplasms in survivors of childhood cancer, to identify the types that contribute most to long-term excess risk, and to identify subgroups of survivors at substantially increased risk of particular subsequent primary neoplasms that may require specific interventions. Design, Setting, and Participants British Childhood Cancer Survivor Study-a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer at younger than 15 years between 1940 and 1991 in Great Britain, followed up through December 2006. Main Outcome Measures Standardized incidence ratios (SIRs), absolute excess risks (AERs), and cumulative incidence of subsequent primary neoplasms. Results After a median follow-up time of 24.3 years (mean=25.6 years), 1354 subsequent primary neoplasms were ascertained; the most frequently observed being central nervous system (n=344), nonmelanoma skin cancer (n=278), digestive (n=105), genitourinary (n=100), breast (n=97), and bone (n=94). The overall SIR was 4 times more than expected (SIR, 3.9; 95% confidence interval [CI], 3.6-4.2; AER, 16.8 per 10 000 person-years). The AER at older than 40 years was highest for digestive and genitourinary subsequent primary neoplasms (AER, 5.9 [95% CI, 2.5-9.3]; and AER, 6.0 [95% CI, 2.3-9.6] per 10 000 person-years, respectively); 36% of the total AER was attributable to these 2 subsequent primary neoplasm sites. The cumulative incidence of colorectal cancer for survivors treated with direct abdominopelvic irradiation was 1.4% (95% CI, 0.7%-2.6%) by age 50 years, comparable with the 1.2% risk in individuals with at least 2 first-degree relatives affected by colorectal cancer. Conclusion Among a cohort of British childhood cancer survivors, the greatest excess risk associated with subsequent primary neoplasms at older than 40 years was for digestive and genitourinary neoplasms. JAMA. 2011;305(22):2311-2319 www.jama.com	[Reulen, Raoul C.; Frobisher, Clare; Winter, David L.; Kelly, Julie; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Pritchard-Jones, Kathryn] Inst Canc Res, Dept Paediat Oncol, Surrey, England; [Jenkinson, Helen C.] Birmingham Childrens Hosp NHS Fdn Trust, Dept Paediat Oncol, Birmingham, W Midlands, England	University of Birmingham; University of Oxford; University of London; Institute of Cancer Research - UK; University of Birmingham	Reulen, RC (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Ctr Childhood Canc Survivor Studies, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Pritchard-Jones, Kathy/F-4286-2014; Reulen, Raoul/AAO-1033-2020	Frobisher, Clare/0000-0003-1099-163X; Pritchard-Jones, Kathy/0000-0002-2384-9475; Reulen, Raoul/0000-0002-7328-0467; Stiller, Charles/0000-0002-3006-7869; Kelly, Julie S/0000-0003-1155-735X	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and Kay Kendall Leukaemia Fund. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.	Baglietto L, 2006, J CLIN EPIDEMIOL, V59, P114, DOI 10.1016/j.jclinepi.2005.07.018; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; Butterworth AS, 2006, EUR J CANCER, V42, P216, DOI 10.1016/j.ejca.2005.09.023; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Cancer Research UK, 2008, CANCERSTATS INC UK; Cardous-Ubbink MC, 2007, EUR J CANCER, V43, P351, DOI 10.1016/j.ejca.2006.10.004; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; Cooper N, 2005, CANC ATLAS UK IRELAN, P39; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dickman PW, 2004, STAT MED, V23, P51, DOI 10.1002/sim.1597; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Fritz APC., 2013, INT CLASSIFICATION D; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Inskip PD, 2007, INT J CANCER, V121, P2233, DOI 10.1002/ijc.22827; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; Kroll ME, 2011, BRIT J CANCER, V104, P1227, DOI 10.1038/bjc.2011.70; Lambert PC, 2005, STAT MED, V24, P3871, DOI 10.1002/sim.2399; Magnani C, 1996, INT J CANCER, V67, P6; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; National Health Service, CANC SCREEN PROGR; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Office of National Statistics, 2006, CANC STAT REG MB1; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Shah A, 2008, BRIT J CANCER, V99, pS86, DOI 10.1038/sj.bjc.6604599; Thernau TM, 2000, MODELING SURVIVAL DA; Vincent TJ, 2007, CHILDHOOD CANC BRITA; Wilson CL, 2010, MED J AUSTRALIA, V193, P258, DOI 10.5694/j.1326-5377.2010.tb03902.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044	30	219	222	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2311	2319		10.1001/jama.2011.747	http://dx.doi.org/10.1001/jama.2011.747			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642683	Bronze			2022-12-28	WOS:000291349100024
J	Rodrigues, LRE; Barbosa, M; Ramos, S; Pontes, M; Coelho, E; Proenca, E				Rodrigues e Rodrigues, Lia; Barbosa, Mafalda; Ramos, Sandra; Pontes, Margarida; Coelho, Elisabete; Proenca, Elisa			PICTURE QUIZ A newborn with hypotonia and abnormal facies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONGENITAL MYOTONIC-DYSTROPHY; TYPE-1		[Rodrigues e Rodrigues, Lia] Ctr Hosp Povoa Varzim Vila Conde Largo Misericord, Dept Paediat, P-4490421 Povoa De Varzim, Portugal; [Barbosa, Mafalda] Dr Jacinto Magalhaes Nacl Heath Inst, Ctr Genet Med, Dr Ricardo Jorge, Portugal; [Ramos, Sandra; Pontes, Margarida; Coelho, Elisabete; Proenca, Elisa] Ctr Hosp, Dept Paediat, Povoa Varzim Vila Conde, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge	Rodrigues, LRE (corresponding author), Rua Calouste GulbenKian 225,4 Hab2, P-4050 Oporto, Portugal.	lyar2@hotmail.com	RODRIGUES, LIA/AAE-8230-2019					Argov Z, 2009, NEUROMUSCULAR DISORD, V19, P675, DOI 10.1016/j.nmd.2009.07.004; Echenne B, 2008, EUR J PAEDIATR NEURO, V12, P210, DOI 10.1016/j.ejpn.2007.07.014; Harper P.S., 1989, MYOTONIC DYSTROPHY; Logigian EL, 2010, NEUROLOGY, V74, P1441, DOI 10.1212/WNL.0b013e3181dc1a3a; Logigian EL, 2005, MUSCLE NERVE, V32, P35, DOI 10.1002/mus.20339; NCBI, DYSTR MYOT; REARDON W, 1993, ARCH DIS CHILD, V68, P177, DOI 10.1136/adc.68.2.177; Rosales-Reynoso MA, 2009, REV NEUROLOGIA, V49, P79, DOI 10.33588/rn.4902.2008633; Rudnik-Schoneborn S, 1998, AM J MED GENET, V80, P314, DOI 10.1002/(SICI)1096-8628(19981204)80:4<314::AID-AJMG3>3.0.CO;2-I; RUTHERFORD MA, 1989, ARCH DIS CHILD, V64, P191, DOI 10.1136/adc.64.2.191; Sanchez-Diaz A, 2006, Rev Neurol, V42 Suppl 1, pS33; Schara Ulrike, 2006, Semin Pediatr Neurol, V13, P71	12	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2011	342								d2938	10.1136/bmj.d2938	http://dx.doi.org/10.1136/bmj.d2938			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SO	21659364				2022-12-28	WOS:000291645500002
J	Marcantonio, ER				Marcantonio, Edward R.			Delirium	ANNALS OF INTERNAL MEDICINE			English	Editorial Material													Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250				[Anonymous], 2001, ANN INTERN MED, V135, P653, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00004; Bergmann MA, 2005, J AM GERIATR SOC, V53, P1817, DOI 10.1111/j.1532-5415.2005.53519.x; Boland RJ, 1996, GEN HOSP PSYCHIAT, V18, P28, DOI 10.1016/0163-8343(95)00089-5; Breitbart W, 1997, J PAIN SYMPTOM MANAG, V13, P128, DOI 10.1016/S0885-3924(96)00316-8; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Campbell N, 2009, J GEN INTERN MED, V24, P848, DOI 10.1007/s11606-009-0996-7; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x; Cole MG, 2009, AGE AGEING, V38, P19, DOI 10.1093/ageing/afn253; Cole MG, 2002, CAN MED ASSOC J, V167, P753; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Fick DM, 2002, J AM GERIATR SOC, V50, P1723, DOI 10.1046/j.1532-5415.2002.50468.x; Flaherty JH, 2003, J AM GERIATR SOC, V51, P1031, DOI 10.1046/j.1365-2389.2003.51320.x; FONG TG, 2010, ARCH INTERN MED; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; Hirano LA, 2006, J AM GERIATR SOC, V54, P587, DOI 10.1111/j.1532-5415.2006.00692.x; Inouye SK, 2007, ARCH INTERN MED, V167, P1406, DOI 10.1001/archinte.167.13.1406; Inouye SK, 2007, J AM GERIATR SOC, V55, P780, DOI 10.1111/j.1532-5415.2007.01156.x; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Kales HC, 2003, J GERIATR PSYCH NEUR, V16, P32, DOI 10.1177/0891988702250535; Kalisvaart KJ, 2005, J AM GERIATR SOC, V53, P1658, DOI 10.1111/j.1532-5415.2005.53503.x; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; Kiely DK, 2006, J GERONTOL A-BIOL, V61, P204, DOI 10.1093/gerona/61.2.204; Lacasse H, 2006, ANN PHARMACOTHER, V40, P1966, DOI 10.1345/aph.1H241; Lawrence KR, 1997, PHARMACOTHERAPY, V17, P531; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Lemiengre J, 2006, J AM GERIATR SOC, V54, P685, DOI 10.1111/j.1532-5415.2006.00667.x; Liptzin B, 2005, AM J GERIAT PSYCHIAT, V13, P1100, DOI 10.1176/appi.ajgp.13.12.1100; Lonergan E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005594.pub2; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Marcantonio E, 2002, J AM GERIATR SOC, V50, P850, DOI 10.1046/j.1532-5415.2002.50210.x; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V272, P1518, DOI 10.1001/jama.272.19.1518; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; McDowell JA, 1998, J AM GERIATR SOC, V46, P700, DOI 10.1111/j.1532-5415.1998.tb03803.x; McNicoll L, 2005, J AM GERIATR SOC, V53, P495, DOI 10.1111/j.1532-5415.2005.53171.x; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; O'Keeffe ST, 2005, J AM GERIATR SOC, V53, P867, DOI 10.1111/j.1532-5415.2005.53266.x; O'Mahony R, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00006; Pitkala KH, 2006, J GERONTOL A-BIOL, V61, P176, DOI 10.1093/gerona/61.2.176; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rudolph JL, 2008, ARCH INTERN MED, V168, P508, DOI 10.1001/archinternmed.2007.106; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Seitz DP, 2007, J CLIN PSYCHIAT, V68, P11, DOI 10.4088/JCP.v68n0102; Sheng AZ, 2006, J AM GERIATR SOC, V54, P1192, DOI 10.1111/j.1532-5415.2006.00806.x; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; van Eijk MMJ, 2010, LANCET, V376, P1829, DOI 10.1016/S0140-6736(10)61855-7; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wong CL, 2010, JAMA-J AM MED ASSOC, V304, P779, DOI 10.1001/jama.2010.1182; YOUNG J, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C3704	56	55	57	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11							ITC6	10.7326/0003-4819-154-11-201106070-01006	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-01006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646553				2022-12-28	WOS:000291312300018
J	Coates, AJ				Coates, Andrew J.			Io's Tortured Interior	SCIENCE			English	Editorial Material							INTERNAL STRUCTURE; SUBSURFACE OCEANS; ENCELADUS; MAGNETOMETER; ATMOSPHERE; SATELLITES; DYNAMICS; EUROPA		[Coates, Andrew J.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Coates, Andrew J.] UCL Birkbeck, Ctr Planetary Sci, London WC1E 6BT, England	University of London; University College London; University of London; Birkbeck University London; University College London	Coates, AJ (corresponding author), Univ Coll London, Mullard Space Sci Lab, Holmbury St Mary, Dorking RH5 6NT, Surrey, England.	ajc@mssl.ucl.ac.uk	Coates, Andrew/C-2396-2008	Coates, Andrew/0000-0002-6185-3125	Science and Technology Facilities Council [ST/H00260X/1] Funding Source: researchfish; UK Space Agency [ST/I002170/1, ST/J002275/1, ST/H004181/1] Funding Source: researchfish; STFC [ST/H00260X/1] Funding Source: UKRI	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Castillo-Rogez J, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2004JE002379; Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Grasset O, 2000, PLANET SPACE SCI, V48, P617, DOI 10.1016/S0032-0633(00)00039-8; Hussmann H, 2006, ICARUS, V185, P258, DOI 10.1016/j.icarus.2006.06.005; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; Khurana KK, 2011, SCIENCE, V332, P1186, DOI 10.1126/science.1201425; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Kivelson MG, 2002, ICARUS, V157, P507, DOI 10.1006/icar.2002.6834; Lorenz RD, 2008, SCIENCE, V319, P1649, DOI 10.1126/science.1151639; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Pryor WR, 2011, NATURE, V472, P331, DOI 10.1038/nature09928; Sotin C, 2004, CR PHYS, V5, P769, DOI 10.1016/j.crhy.2004.08.001; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Tokar RL, 2006, SCIENCE, V311, P1409, DOI 10.1126/science.1121061	15	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1157	1158		10.1126/science.1206534	http://dx.doi.org/10.1126/science.1206534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636762				2022-12-28	WOS:000291205200034
J	Karim, SSA				Karim, Salim S. Abdool			Stigma impedes AIDS prevention	NATURE			English	Editorial Material							HIV		[Karim, Salim S. Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa; [Karim, Salim S. Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	Karim, SSA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4001 Durban, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133				*BLOOMB, BLOOMB REP; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2007, NATURE, V449, P24, DOI 10.1038/449024c; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; SHIVANA O, 2009, S AFRICAN NATL HIV P; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	10	17	17	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					29	31		10.1038/474029a	http://dx.doi.org/10.1038/474029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637237	Green Published, Bronze			2022-12-28	WOS:000291156700019
J	OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ				OCarroll, DC; Bidwell, NJ; Laughlin, SB; Warrant, EJ			Insect motion detectors matched to visual ecology	NATURE			English	Article							SENSITIVE NEURON; DETECTION SYSTEM; ADAPTATION; SELECTIVITY	To detect motion, primates, birds and insects all use local detectors to correlate signals sampled at one location in the image with those sampled after a delay at adjacent locations(1-10) These detectors can adapt to high image velocities by shortening the delay(11-13). To investigate whether they use long delays for detecting low velocities, we compared motion-sensitive neurons in ten species of fast-flying insects, some of which encounter low velocities while hovering. Neurons of bee-flies and hawkmoths, which hover, are tuned to lower temporal frequencies than those of butterflies and bumblebees, which do not. Tuning to low frequencies indicates longer delays and extends sensitivity to lower velocities, Hoverflies retain fast temporal tuning but use their high spatial acuity for sensing low-velocity motion. Thus an unexpectedly wide range of spatio-temporal tuning matches motion detection to visual ecology.	UNIV SUSSEX,CTR NEUROSCI,BRIGHTON BN1 9QG,E SUSSEX,ENGLAND; LUND UNIV,DEPT ZOOL,S-22362 LUND,SWEDEN	University of Sussex; Lund University	OCarroll, DC (corresponding author), UNIV CAMBRIDGE,DEPT ZOOL,DOWNING ST,CAMBRIDGE CB2 3EJ,ENGLAND.		O'Carroll, David C/C-4320-2008	O'Carroll, David C/0000-0002-2352-4320; Warrant, Eric/0000-0001-7480-7016				ANDERSON SJ, 1985, VISION RES, V25, P1147, DOI 10.1016/0042-6989(85)90104-X; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; BIDWELL NJ, 1993, APIDOLOGIE, V24, P333, DOI 10.1051/apido:19930311; BORST A, 1989, TRENDS NEUROSCI, V12, P297, DOI 10.1016/0166-2236(89)90010-6; Buchner E, 1984, PLENUM, P561, DOI DOI 10.1007/978-1-4613-2743-1_16; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; COLLETT TS, 1975, J COMP PHYSIOL, V99, P1, DOI 10.1007/BF01464710; EGELHAAF M, 1989, J OPT SOC AM A, V6, P1070, DOI 10.1364/JOSAA.6.001070; FARINA WM, 1994, J COMP PHYSIOL A, V174, P239; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hausen K., 1989, P391; IBBOTSON MR, 1990, J EXP BIOL, V148, P255; KELLY DH, 1979, J OPT SOC AM, V69, P1340, DOI 10.1364/JOSA.69.001340; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; MADDESS T, 1991, J EXP BIOL, V161, P171; MORGAN MJ, 1995, NATURE, V378, P380, DOI 10.1038/378380a0; REICHARDT W, 1957, Z NATURFORSCH PT B, V12, P448, DOI 10.1515/znb-1957-0707; Reichardt W., 1961, S PRINC SENS COMM, P303; SANTEN JPH, 1985, J OPT SOC AM A, V2, P300; VANSTEVENINCK RRD, 1986, BIOL CYBERN, V54, P223, DOI 10.1007/BF00318418; WILSON HR, 1985, BIOL CYBERN, V51, P213, DOI 10.1007/BF00337147; WOLFOBERHOLLENZER F, 1994, J NEUROPHYSIOL, V71, P1559, DOI 10.1152/jn.1994.71.4.1559	22	113	115	2	45	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 4	1996	382	6586					63	66		10.1038/382063a0	http://dx.doi.org/10.1038/382063a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UV473	21638927				2022-12-28	WOS:A1996UV47300053
J	Moxon, ER; Das, P; Greenwood, B; Heymann, DL; Horton, R; Levine, OS; Plotkin, S; Nossal, G				Moxon, E. Richard; Das, Pamela; Greenwood, Brian; Heymann, David L.; Horton, Richard; Levine, Orin S.; Plotkin, Stanley; Nossal, Gus			A call to action for the new decade of vaccines	LANCET			English	Editorial Material							PREVENTION		[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Das, Pamela; Horton, Richard] The Lancet, London NW1 7BY, England; [Greenwood, Brian; Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Plotkin, Stanley] Univ Penn, Philadelphia, PA 19104 USA; [Nossal, Gus] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; University of Melbourne	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk						Barnighausen T, 2011, VACCINE, V29, P2371, DOI 10.1016/j.vaccine.2010.11.090; BLOOM DE, 2010, WORLD ECON, V6, P15; Chandran A, 2010, BIOL-TARGETS THER, V4, P213; Clemens J, 2005, NAT MED, V11, pS12, DOI 10.1038/nm1225; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; *GAVI ALL, GAVI ALL STRAT BUS P; GAVI Alliance, FACTS FIG; Hargreaves JR, 2011, LANCET, V378, P1885, DOI 10.1016/S0140-6736(11)60687-9; Kersten G, 2007, EXPERT OPIN DRUG DEL, V4, P459, DOI 10.1517/17425247.4.5.459; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NOSSAL GJV, PHIL T R B IN PRESS; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; PLOTKIN SA, 2009, VACCINES, V16, P1709; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Senouci K, 2010, VACCINE, V28, pA26, DOI 10.1016/j.vaccine.2010.02.028; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; SMITH J, 2011, LANCET	21	23	23	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					298	302		10.1016/S0140-6736(11)60766-6	http://dx.doi.org/10.1016/S0140-6736(11)60766-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XL	21664682				2022-12-28	WOS:000293615800008
J	Reynolds, AJ; Temple, JA; Ou, SR; Arteaga, IA; White, BAB				Reynolds, Arthur J.; Temple, Judy A.; Ou, Suh-Ruu; Arteaga, Irma A.; White, Barry A. B.			School-Based Early Childhood Education and Age-28 Well-Being: Effects by Timing, Dosage, and Subgroups	SCIENCE			English	Article							CONFIRMATORY ANALYSIS; SOCIAL-DEVELOPMENT; PARENT CENTERS; PRESCHOOL; INTERVENTION; PROGRAMS; HEALTH; MIDLIFE; PATHS	Advances in understanding the effects of early education have benefited public policy and developmental science. Although preschool has demonstrated positive effects on life-course outcomes, limitations in knowledge on program scale, subgroup differences, and dosage levels have hindered understanding. We report the effects of the Child-Parent Center Education Program on indicators of well-being up to 25 years later for more than 1400 participants. This established, publicly funded intervention begins in preschool and provides up to 6 years of service in inner-city Chicago schools. Relative to the comparison group receiving the usual services, program participation was independently linked to higher educational attainment, income, socioeconomic status (SES), and health insurance coverage, as well as lower rates of justice-system involvement and substance abuse. Evidence of enduring effects was strongest for preschool, especially for males and children of high school dropouts. The positive influence of four or more years of service was limited primarily to education and SES. Dosage within program components was mostly unrelated to outcomes. Findings demonstrate support for the enduring effects of sustained school-based early education to the end of the third decade of life.	[Reynolds, Arthur J.; Ou, Suh-Ruu; White, Barry A. B.] Univ Minnesota, Inst Child Dev & Human Capital Res Collaborat, Minneapolis, MN 55455 USA; [Temple, Judy A.] Univ Minnesota, Dept Appl Econ, Humphrey Sch Publ Affairs, Minneapolis, MN 55455 USA; [Arteaga, Irma A.] Univ Missouri, Harry S Truman Sch Publ Affairs, Columbia, MO 65211 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Missouri System; University of Missouri Columbia	Reynolds, AJ (corresponding author), Univ Minnesota, Inst Child Dev & Human Capital Res Collaborat, 51 E River Rd, Minneapolis, MN 55455 USA.	ajr@umn.edu		Arteaga, Irma/0000-0002-4782-9081; Ou, Suh-Ruu/0000-0003-4735-3113	National Institute of Child Health and Human Development [HD034294]; McKnight Foundation; Human Capital Research Collaborative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034294] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD034294] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); McKnight Foundation; Human Capital Research Collaborative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants from the National Institute of Child Health and Human Development (HD034294), McKnight Foundation, and the Human Capital Research Collaborative (a partnership of the University of Minnesota and Federal Reserve Bank of Minneapolis). We thank the Chicago Public Schools for invaluable collaboration on the study over the years. We also are grateful to the Illinois Departments of Employment Security, Human Services, Corrections, Child and Family Services, and Public Health; Circuit and Juvenile Courts of Cook County; City Colleges of Chicago; Chapin Hall Center for Children at the University of Chicago; and the Health Survey Center at the University of Minnesota for assistance and cooperation in data collection. We also thank P. Braveman and L. Chase-Lansdale for valuable comments.	Braveman Paula, 2009, Pediatrics, V124 Suppl 3, pS163, DOI 10.1542/peds.2009-1100D; Camilli G, 2010, TEACH COLL REC, V112, P579; Chase-Lansdale PL, 2003, SCIENCE, V299, P1548, DOI 10.1126/science.1076921; Chicago Longitudinal Study, 2005, CHIC LONG STUD US GU; Cohen M.A., 2005, COSTS CRIME JUSTICE; Consortium for Longitudinal Studies, 1983, TWIG IS BENT LAST EF; Garces E, 2002, AM ECON REV, V92, P999, DOI 10.1257/00028280260344560; Gormley WT, 2008, SCIENCE, V320, P1723, DOI 10.1126/science.1156019; Hawkins JD, 2008, ARCH PEDIAT ADOL MED, V162, P1133, DOI 10.1001/archpedi.162.12.1133; Hirano K, 2003, ECONOMETRICA, V71, P1161, DOI 10.1111/1468-0262.00442; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Johnson D. L., 2004, J PRIM PREV, V25, P195; Karoly LA., 2005, EARLY CHILDHOOD INTE; Lachman ME, 2004, ANNU REV PSYCHOL, V55, P305, DOI 10.1146/annurev.psych.55.090902.141521; McCormick MC, 2006, PEDIATRICS, V117, P771, DOI 10.1542/peds.2005-1316; Melhuish EC, 2008, SCIENCE, V321, P1161, DOI 10.1126/science.1158808; Naisbitt N., 1968, CHILD PARENT ED CTR; Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Pianta RC, 2007, SCIENCE, V315, P1795, DOI 10.1126/science.1139719; Reynolds A., 2000, SUCCESS EARLY INTERV; Reynolds A. J., 2003, CHILD WELFARE J POLI, V82, P379; Reynolds AJ, 2004, CHILD DEV, V75, P1299, DOI 10.1111/j.1467-8624.2004.00742.x; REYNOLDS AJ, 1995, EARLY CHILD RES Q, V10, P1, DOI 10.1016/0885-2006(95)90024-1; Reynolds AJ, 2008, ANNU REV CLIN PSYCHO, V4, P109, DOI 10.1146/annurev.clinpsy.3.022806.091411; Reynolds AJ, 2007, ARCH PEDIAT ADOL MED, V161, P730, DOI 10.1001/archpedi.161.8.730; Reynolds AJ, 2011, CHILD DEV, V82, P555, DOI 10.1111/j.1467-8624.2010.01562.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sampson RJ, 2008, P NATL ACAD SCI USA, V105, P845, DOI 10.1073/pnas.0710189104; Schweinhart L.J., 2005, LIFETIME EFFECTS HIG; Singh-Manoux A, 2004, INT J EPIDEMIOL, V33, P1072, DOI 10.1093/ije/dyh224; Temple JA, 2007, ECON EDUC REV, V26, P126, DOI 10.1016/j.econedurev.2005.11.004; *US DEP HHS, 2010, HEAD START IMP STUD; Zigler E, 2006, VISION FOR UNIVERSAL PRESCHOOL EDUCATION, P1, DOI 10.2277/ 0521612993	34	209	210	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					360	364		10.1126/science.1203618	http://dx.doi.org/10.1126/science.1203618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	792HF	21659565	Green Accepted			2022-12-28	WOS:000292732000048
J	Shimamura, T; Shiroishi, M; Weyand, S; Tsujimoto, H; Winter, G; Katritch, V; Abagyan, R; Cherezov, V; Liu, W; Han, GW; Kobayashi, T; Stevens, RC; Iwata, S				Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Winter, Graeme; Katritch, Vsevolod; Abagyan, Ruben; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Kobayashi, Takuya; Stevens, Raymond C.; Iwata, So			Structure of the human histamine H-1 receptor complex with doxepin	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; STRUCTURE-BASED DISCOVERY; CRYSTAL-STRUCTURE; BINDING-SITE; MUTATIONAL ANALYSIS; ANTIDEPRESSANTS; PURIFICATION; MEMBRANE; AFFINITY; MODELS	The biogenic amine histamine is an important pharmacological mediator involved in pathophysiological processes such as allergies and inflammations. Histamine H-1 receptor (H1R) antagonists are very effective drugs alleviating the symptoms of allergic reactions. Here we show the crystal structure of the H1R complex with. doxepin, a first-generation H1R antagonist. Doxepin sits deep in the ligand-binding pocket and directly interacts with Trp 428(6,48), a highly conserved key residue G -protein-coupled-receptor activation. This well-conserved pocket with mostly hydrophobic nature contributes to the low selectivity of the first-generation compounds. The pocket is associated with an anion-binding region occupied by a phosphate ion. Docking of various second-generation H1R antagonists reveals that the unique carboxyl group present in this class of compounds interacts with Lys191(5.39) and/or Lys 179(ECL2), both of which form part of the anion-binding region. This region is not conserved in other aminergic receptors, demonstrating how minor differences in receptors lead to pronounced selectivity differences with small molecules. Our study sheds light on the molecular basis of H1R antagonist specificity against H1R.	[Shimamura, Tatsuro; Cherezov, Vadim; Liu, Wei; Han, Gye Won; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Weyand, Simone; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Japan Sci & Technol Agcy, ERATO, Human Receptor Crystallog Project, Sakyo Ku, Kyoto 6068501, Japan; [Shimamura, Tatsuro; Shiroishi, Mitsunori; Tsujimoto, Hirokazu; Kobayashi, Takuya; Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan; [Shiroishi, Mitsunori] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Weyand, Simone; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Weyand, Simone; Winter, Graeme; Iwata, So] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Iwata, So] RIKEN, Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Scripps Research Institute; Japan Science & Technology Agency (JST); Kyoto University; Kyushu University; Imperial College London; Diamond Light Source; University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	t-coba@mfour.med.kyoto-u.ac.jp; stevens@scripps.edu; so_iwata@me.com	soler, martha maricel m gomez/L-6025-2014; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Y-2721-2019; Liu, Wei/F-1820-2011; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLQ-8724-2022; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Q-8357-2016; Stevens, Raymond/K-7272-2015	soler, martha maricel m gomez/0000-0002-4412-8108; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Shiroishi, Mitsunori/0000-0002-3133-157X	Japan Science and Technology Agency; MEXT, Japan; NIH [P50 GM073197, R01 GM071872, GM075915]; NIH PSI [U54 GM094618]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G023425/1]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation; Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited [062164/7/00/Z]; Scripps Research Institute; National Science Foundation [HS0308078]; Science Foundation Ireland [02-IN1-B266]; Biotechnology and Biological Sciences Research Council [BB/G023425/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM089857, R01GM071872, U54GM094618] Funding Source: NIH RePORTER; BBSRC [BB/G023425/1] Funding Source: UKRI	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH PSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Wellcome Trust at the Diamond Light Source Limited(Wellcome Trust); Scripps Research Institute; National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the ERATO Human Receptor Crystallography Project from the Japan Science and Technology Agency and by the Targeted Proteins Research Program of MEXT (S.I.), Japan; the NIH Common Fund grant P50 GM073197 for technology development (R.C.S.) and NIH PSI:Biology grant U54 GM094618 (R.C.S., V.C., V.K. and R.A.); R.A. was also partly funded by NIH R01 GM071872. The work was also partly funded by the Biotechnology and Biological Sciences Research Council (BBSRC) BB/G023425/1 (SI), Grant-in-Aid for challenging Exploratory Research (T.S.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (T.S. and T.K.), Takeda Scientific Foundation (M.S.) and the Sumitomo Foundation (T K.). A part of the work was performed in the Membrane Protein Laboratory funded by the Wellcome Trust (grant 062164/7/00/Z) at the Diamond Light Source Limited and at The Scripps Research Institute. We thank D. Axford, R. Owen and G. Evans for help with data collection at 124 of the Diamond Light Source Limited, H. Wu for help with the preparation of Supplementary Fig. 1 and Q. Xu for help on validation of data processing and A. Walker for assistance with manuscript preparation. The authors acknowledge Y. Zheng (The Ohio State University) and M. Caffrey, Trinity College (Dublin, Ireland), for the loan of the in meso robot (built with support from the NIH (GM075915), the National Science Foundation (HS0308078), and Science Foundation Ireland (02-IN1-B266)). S.I. is thankful for the help of L E Johnson, a co-founder of the Diamond-MPL Project and R. Tanaka, the technical coordinator of the ERATO Human Receptor Crystallography Project.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Abagyan R., 2011, ICM MANUAL V 3 0; Aishima J, 2010, ACTA CRYSTALLOGR D, V66, P1032, DOI 10.1107/S0907444910028192; Bakker RA, 2004, MOL PHARMACOL, V65, P538, DOI 10.1124/mol.65.3.538; Bakker RA, 2000, EUR J PHARMACOL, V387, pR5, DOI 10.1016/S0014-2999(99)00803-1; Bakker RA, 2001, MOL PHARMACOL, V60, P1133, DOI 10.1124/mol.60.5.1133; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bruysters M, 2004, EUR J PHARMACOL, V487, P55, DOI 10.1016/j.ejphar.2004.01.028; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; de Graaf C, 2009, CURR PHARM DESIGN, V15, P4026, DOI 10.2174/138161209789824786; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gillard M, 2003, INFLAMM RES, V52, pS49, DOI 10.1007/s000110300050; Gillard M, 2002, MOL PHARMACOL, V61, P391, DOI 10.1124/mol.61.2.391; Hill SJ, 1997, PHARMACOL REV, V49, P253; HILL SJ, 1990, PHARMACOL REV, V42, P45; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jongejan A, 2005, ARCH PHARM, V338, P248, DOI 10.1002/ardp.200400998; Katritch V, 2011, NEUROPHARMACOLOGY, V60, P108, DOI 10.1016/j.neuropharm.2010.07.009; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kiss R, 2004, EUR J MED CHEM, V39, P959, DOI 10.1016/j.ejmech.2004.07.009; Klabunde T, 2002, CHEMBIOCHEM, V3, P929, DOI 10.1002/1439-7633(20021004)3:10<928::AID-CBIC928>3.0.CO;2-5; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; LEURS R, 1995, BIOCHEM BIOPH RES CO, V214, P110, DOI 10.1006/bbrc.1995.2263; Matsumoto Y, 2008, PHARMACOLOGY, V81, P266, DOI 10.1159/000115970; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Nonaka H, 1998, EUR J PHARMACOL, V345, P111, DOI 10.1016/S0014-2999(97)01620-8; OHTA K, 1994, BIOCHEM BIOPH RES CO, V203, P1096, DOI 10.1006/bbrc.1994.2295; Okamura N, 2000, BRIT J PHARMACOL, V129, P115, DOI 10.1038/sj.bjp.0702994; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ratnala VRP, 2004, EUR J BIOCHEM, V271, P2636, DOI 10.1111/j.1432-1033.2004.04192.x; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; Simons FER, 2004, NEW ENGL J MED, V351, P2203, DOI 10.1056/NEJMra033121; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Tashiro M, 2009, HUM PSYCHOPHARM CLIN, V24, P540, DOI 10.1002/hup.1051; Totrov M, 1997, PROTEINS, P215; Totrov M. M., 1999, P 3 ANN INT C COMP M, P312, DOI DOI 10.1145/299432.299509; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1999, J BIOL CHEM, V274, P29994, DOI 10.1074/jbc.274.42.29994; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WOOSLEY RL, 1993, JAMA-J AM MED ASSOC, V269, P1532, DOI 10.1001/jama.269.12.1532; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; YAMASHITA M, 1991, P NATL ACAD SCI USA, V88, P11515, DOI 10.1073/pnas.88.24.11515; Yap Yee Guan, 2002, Clin Allergy Immunol, V17, P389	59	597	609	6	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					65	U82		10.1038/nature10236	http://dx.doi.org/10.1038/nature10236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697825	Green Accepted, Green Published			2022-12-28	WOS:000292461300045
J	Stewart, K; Gostin, LO				Stewart, Katie; Gostin, Lawrence O.			Food and Drug Administration Regulation of Food Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stewart, Katie; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Enhancing Food Safety, 2010, ROL FOOD DRUG ADM; Johnson R, 2011, FEDERAL FOOD SAFETY; Morris JG, 2011, EMERG INFECT DIS, V17, P126, DOI [10.3201/eid1701101821, 10.3201/eid1701.101821]; U.S. GOVT ACCOUNTABILITY OFFICE, 2011, GAO11318SP; *USDA, FOOD CPI EXP	5	5	5	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 6	2011	306	1					88	89		10.1001/jama.2011.885	http://dx.doi.org/10.1001/jama.2011.885			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	787LV	21673283				2022-12-28	WOS:000292378700025
J	Hope, T; McMillan, J				Hope, Tony; McMillan, John			The art of medicine Advance decisions, chronic mental illness, and everyday care	LANCET			English	Editorial Material							DEMENTIA; CAPACITY		[Hope, Tony] Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England; [McMillan, John] Flinders Med Ctr, Sch Med, Adelaide, SA 5001, Australia	University of Oxford; Flinders Medical Centre	Hope, T (corresponding author), Univ Oxford, Ethox Ctr, Oxford OX3 7LF, England.	tonyhope@doctors.org.uk	McMillan, John/S-9660-2018	McMillan, John/0000-0002-7507-1861				Agich G, 2003, DEPENDENCE AUTONOMY; David A., 2010, BRIT MED J, V341, P587; Dresser R, 1995, HASTINGS CENT REP, V25, P32, DOI 10.2307/3527839; Dworkin R., 1993, LIFES DOMINION; Hope T, 2009, J MED ETHICS, V35, P733, DOI 10.1136/jme.2009.030783; Jaworska A, 1999, PHILOS PUBLIC AFF, V28, P105, DOI 10.1111/j.1088-4963.1999.00105.x; Nuffield Council on Bioethics, DEM ETH ISS	7	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2076	2077		10.1016/S0140-6736(11)60909-4	http://dx.doi.org/10.1016/S0140-6736(11)60909-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21692228	Bronze			2022-12-28	WOS:000292117800016
J	Maughan, TS; Adams, RA; Smith, CG; Meade, AM; Seymour, MT; Wilson, RH; Idziaszczyk, S; Harris, R; Fisher, D; Kenny, SL; Kay, E; Mitchell, JK; Madi, A; Jasani, B; James, MD; Bridgewater, J; Kennedy, MJ; Claes, B; Lambrechts, D; Kaplan, R; Cheadle, JP				Maughan, Timothy S.; Adams, Richard A.; Smith, Christopher G.; Meade, Angela M.; Seymour, Matthew T.; Wilson, Richard H.; Idziaszczyk, Shelley; Harris, Rebecca; Fisher, David; Kenny, Sarah L.; Kay, Edward; Mitchell, Jenna K.; Madi, Ayman; Jasani, Bharat; James, Michelle D.; Bridgewater, John; Kennedy, M. John; Claes, Bart; Lambrechts, Diether; Kaplan, Richard; Cheadle, Jeremy P.		MRC COIN Trial Investigators	Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial	LANCET			English	Article							GROWTH-FACTOR RECEPTOR; MUTATION STATUS; LUNG-CANCER; PANITUMUMAB; KRAS; FLUOROURACIL; BEVACIZUMAB; LEUCOVORIN; GEFITINIB; SURVIVAL	Background In the Medical Research Council (MRC) COIN trial, the epidermal growth factor receptor (EGFR)-targeted antibody cetuximab was added to standard chemotherapy in first-line treatment of advanced colorectal cancer with the aim of assessing effect on overall survival. Methods In this randomised controlled trial, patients who were fit for but had not received previous chemotherapy for advanced colorectal cancer were randomly assigned to oxaliplatin and fluoropyrimidine chemotherapy (arm A), the same combination plus cetuximab (arm B), or intermittent chemotherapy (arm C). The choice of fluoropyrimidine therapy (capecitabine or infused fluouroracil plus leucovorin) was decided before randomisation. Randomisation was done centrally (via telephone) by the MRC Clinical Trials Unit using minimisation. Treatment allocation was not masked. The comparison of arms A and C is described in a companion paper. Here, we present the comparison of arm A and B, for which the primary outcome was overall survival in patients with KRAS wild-type tumours. Analysis was by intention to treat. Further analyses with respect to NRAS, BRAF, and EGFR status were done. The trial is registered, ISRCTN27286448. Findings 1630 patients were randomly assigned to treatment groups (815 to standard therapy and 815 to addition of cetuximab). Tumour samples from 1316 (81%) patients were used for somatic molecular analyses; 565 (43%) had KRAS mutations. In patients with KRAS wild-type tumours (arm A, n=367; arm B, n=362), overall survival did not differ between treatment groups (median survival 17.9 months [IQR 10-3-29.2] in the control group vs 17.0 months [9.4-30.1] in the cetuximab group; HR 1.04, 95% CI 0.87-1.23, p=0.67). Similarly, there was no effect on progression-free survival (8.6 months [IQR 5.0-12.5] in the control group vs 8.6 months [5.1-13-8] in the cetuximab group; HR 0-96, 0.82-1.12, p=0-60). Overall response rate increased from 57% (n=209) with chemotherapy alone to 64% (n=232) with addition of cetuximab (p=0.049). Grade 3 and higher skin and gastrointestinal toxic effects were increased with cetuximab (14 vs 114 and 67 vs 97 patients in the control group vs the cetuximab group with KRAS wild-type tumours, respectively). Overall survival differs by somatic mutation status irrespective of treatment received: BRAF mutant, 8.8 months (IQR 4.5-27.4); KRAS mutant, 14.4 months (8.5-24.0); all wild-type, 20.1 months (11.5-31.7). Interpretation This trial has not confirmed a benefit of addition of cetuximab to oxaliplatin-based chemotherapy in first-line treatment of patients with advanced colorectal cancer. Cetuximab increases response rate, with no evidence of benefit in progression-free or overall survival in KRAS wild-type patients or even in patients selected by additional mutational analysis of their tumours. The use of cetuximab in combination with oxaliplatin and capecitabine in first-fine chemotherapy in patients with widespread metastases cannot be recommended.	[Meade, Angela M.; Fisher, David; Kenny, Sarah L.; Kay, Edward; Mitchell, Jenna K.; Kaplan, Richard] MRC Clin Trials Unit, London NW1 2DA, England; [Maughan, Timothy S.; Adams, Richard A.; Smith, Christopher G.; Idziaszczyk, Shelley; Harris, Rebecca; Madi, Ayman; Jasani, Bharat; James, Michelle D.; Cheadle, Jeremy P.] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Seymour, Matthew T.] St James Univ Hosp, Leeds, W Yorkshire, England; [Seymour, Matthew T.] Univ Leeds, Leeds, W Yorkshire, England; [Bridgewater, John] UCL, Inst Canc, London, England; [Kennedy, M. John] All Ireland Cooperat Oncol Res Grp, ICORG, Dublin, Ireland; [Claes, Bart; Lambrechts, Diether] Univ Louvain, VIB, Vesalius Res Ctr, Louvain, Belgium; [Wilson, Richard H.] Queens Univ Belfast, Belfast, Antrim, North Ireland	Medical Research Council Clinical Trials Unit; Cardiff University; Saint James's University Hospital; University of Leeds; University of London; University College London; All-Ireland Cooperative Oncology Research Group; Flanders Institute for Biotechnology (VIB); Queens University Belfast	Kaplan, R (corresponding author), MRC Clin Trials Unit, London NW1 2DA, England.	rk@ctu.mrc.ac.uk	Verdrengh, Evelien/H-4571-2012; Lambrechts, Diether/AAJ-3167-2020; Bridgewater, John/J-5957-2018; Kay, Elaine/D-8539-2013; Maughan, Tim/AAV-7636-2021	Lambrechts, Diether/0000-0002-3429-302X; Seymour, Matthew/0000-0002-2441-9629; Adams, Richard/0000-0003-3915-7243; Samuel, Leslie/0000-0002-8402-8670; Fisher, David/0000-0002-2512-2296; Hickish, Tamas/0000-0001-6770-7279; Azzabi, Ashraf/0000-0003-4801-9109; Sebag-Montefiore, David/0000-0002-5978-9259; Atherton, Philip/0000-0002-7286-046X; Kaplan, Richard S./0000-0002-0189-8348; Cunningham, David/0000-0001-5158-1069; McDermott, Ray/0000-0002-8952-4315; Tan, Li Tee/0000-0001-9333-9190	Cancer Research UK; Cancer Research Wales; UK Medical Research Council; Merck KGgA; UK MRC; Roche; Dako Ltd; AstraZeneca; MRC; National Cancer Research Networks; Merck; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); University College London Hospitals; University College London Comprehensive Biomedical Research Centre; Irish Health Research Board; MRC [MC_U122861325] Funding Source: UKRI; Medical Research Council [MC_U122861325] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research Wales; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Merck KGgA; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Roche(Roche Holding); Dako Ltd; AstraZeneca(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Research Networks; Merck(Merck & Company); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); University College London Hospitals; University College London Comprehensive Biomedical Research Centre; Irish Health Research Board; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding Cancer Research UK, Cancer Research Wales, UK Medical Research Council, Merck KGgA.; TSM and RAA have received travel, accommodation, and lecture fees from Roche and Merck Serono. AMM, DE, SLK, JKM, ER, and RK are employed by the UK MRC, which is also the trial sponsor. MTS has received travel expenses and an educational grant from Roche. JB has received an honorarium payment and travel expenses for attendance at educational meetings from Merck. 131 has received consultancy fees from Dako Ltd, Roche, and AstraZeneca. MJK has received travel expenses from Amgen. CGS, SI, RH, MDJ, BC, DL, RHW, AM, and JPC all declare that they have no conflicts of interest.; We thank the 2445 patients and their families who participated in COIN; Tony Lai for use of laboratory space in the Wales Heart Research Institute, Cardiff University for the somatic mutation profiling; and Natacha Lays and Gilian Peuteman for technical support. The trial was funded through the peer-reviewed Cancer Research UK Clinical Trials Advisory and Awards Committee, the MRC, and an unrestricted educational grant from Merck kGaA. Additional support in the form of discounted products was provided by Sanofi, Wyeth, and Baxter. Data collection at UK sites was supported by staff funding from the National Cancer Research Networks. The somatic profiling was co-supported by Cancer Research Wales (CGS, PhD studentship) and Merck. BC was supported by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen). B was supported in part by the University College London Hospitals and University College London Comprehensive Biomedical Research Centre. MJK has received a grant from the Irish Health Research Board. In addition to the individuals named in the list of COIN Trial Investigators, we acknowledge the contributions of a large number of clinicians, research nurses, data managers, and other clinical and support staff at the participating centres.	Adams RA, 2009, BRIT J CANCER, V100, P251, DOI 10.1038/sj.bjc.6604877; Adams RA, 2011, LANCET ONCOL, V12, P642, DOI 10.1016/S1470-2045(11)70102-4; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; BOKEMEYER C, 2008, P AM SOC CLIN ONCO S, V26; Borner M, 2008, ANN ONCOL, V19, P1288, DOI 10.1093/annonc/mdn058; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; National Cancer Institute, NAT CANC I COMM TOX; National Institute for Health and Clinical Excellence, 2009, CET 1 LIN TREATM MET; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; TVEIT K, 2011, P AM SOC CLIN ONCOL, V29; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019	24	753	796	1	58	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2103	2114		10.1016/S0140-6736(11)60613-2	http://dx.doi.org/10.1016/S0140-6736(11)60613-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21641636	Green Published			2022-12-28	WOS:000292117800032
J	Gilbert, D				Gilbert, Daniel			Buried by bad decisions	NATURE			English	Editorial Material									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Gilbert, D (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu						[Anonymous], 1899, J AM MED ASS, VXXXII, P947; Becker GS, 2006, J POLIT ECON, V114, P38, DOI 10.1086/498918; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Gray K, 2008, PSYCHOL SCI, V19, P1260, DOI 10.1111/j.1467-9280.2008.02208.x; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; JOHNSON EJ, 1993, J RISK UNCERTAINTY, V7, P35, DOI 10.1007/BF01065313; LARRICK RP, 1990, PSYCHOL SCI, V1, P362, DOI 10.1111/j.1467-9280.1990.tb00243.x; McClure T., 2006, DONT MESS TEXAS STOR; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; VISCUSI WK, 1987, RAND J ECON, V18, P465, DOI 10.2307/2555636	10	22	22	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					275	277		10.1038/474275a	http://dx.doi.org/10.1038/474275a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777TD	21677724	Green Published			2022-12-28	WOS:000291647100013
J	Kellermann, AL; Martinez, R				Kellermann, Arthur L.; Martinez, Ricardo			The ER, 50 Years On	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EMERGENCY; ROOM; CARE		[Kellermann, Arthur L.] RAND Corp, Santa Monica, CA 90406 USA; [Martinez, Ricardo] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA	RAND Corporation; Emory University	Kellermann, AL (corresponding author), RAND Corp, Santa Monica, CA 90406 USA.							Asplin BR, 2001, ANN EMERG MED, V37, P500, DOI 10.1067/mem.2001.115174; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, HOSP BAS EM CAR BREA; Niska R, 2010, 26 NAT HLTH STAT; Pitts SR, 2010, HEALTH AFFAIR, V29, P1620, DOI 10.1377/hlthaff.2009.1026; SHORTLIFFE EC, 1958, NEW ENGL J MED, V258, P20, DOI 10.1056/NEJM195801022580105	5	31	31	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2278	2279		10.1056/NEJMp1101544	http://dx.doi.org/10.1056/NEJMp1101544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675886				2022-12-28	WOS:000291643800003
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE The truth hurts	BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3650	10.1136/bmj.d3650	http://dx.doi.org/10.1136/bmj.d3650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677006				2022-12-28	WOS:000291932700005
J	Morduch, J				Morduch, Jonathan			Why Finance Matters	SCIENCE			English	Editorial Material							IMPACT		NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10012 USA	New York University	Morduch, J (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10012 USA.	jonathan.morduch@nyu.edu						[Anonymous], 1999, BANKER POOR MICROLEN; Banerjee Abhijit, 2009, MIRACLE MICROFINANCE; Chaia A., 2009, HALF WORLD IS UNBANK; Coleman BE, 1999, J DEV ECON, V60, P105, DOI 10.1016/S0304-3878(99)00038-3; Collins D., 2009, PORTFOLIOS POOR WORL, DOI DOI 10.1080/09614524.2010.491535; de Mel S, 2008, Q J ECON, V123, P1329, DOI 10.1162/qjec.2008.123.4.1329; Johnston D, 2008, WORLD BANK ECON REV, V22, P517, DOI 10.1093/wber/lhn016; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; *MIXMARKET, 2009, MIXMARKET DAT; REED LR, 2011, STATE MICROCREDIT SU, P3	10	9	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1271	1272		10.1126/science.1208113	http://dx.doi.org/10.1126/science.1208113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	775EP	21659594				2022-12-28	WOS:000291441700032
J	Gravitz, L				Gravitz, Lauren			A smouldering public-health crisis	NATURE			English	Editorial Material																		Alter MJ, 2011, HEPATOL RES CLIN DEV, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013	4	138	142	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					S2	S4		10.1038/474S2a	http://dx.doi.org/10.1038/474S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666731	Bronze			2022-12-28	WOS:000291397800003
J	Jirawatnotai, S; Hu, YD; Michowski, W; Elias, JE; Becks, L; Bienvenu, F; Zagozdzon, A; Goswami, T; Wang, YYE; Clark, AB; Kunkel, TA; van Harn, T; Xia, B; Correll, M; Quackenbush, J; Livingston, DM; Gygi, SP; Sicinski, P				Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Elias, Joshua E.; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; Goswami, Tapasree; Wang, Yaoyu E.; Clark, Alan B.; Kunkel, Thomas A.; van Harn, Tanja; Xia, Bing; Correll, Mick; Quackenbush, John; Livingston, David M.; Gygi, Steven P.; Sicinski, Piotr			A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers	NATURE			English	Article							HUMAN RAD51 PROTEIN; DOUBLE-STRAND BREAK; PHOSPHORYLATION; DAMAGE; OVEREXPRESSION; ABSENCE; CELLS	Cyclin D1 is a component of the core cell cycle machinery(1). Abnormally high levels of cyclin D1 are detected in many human cancer types(2). To elucidate the molecular functions of cyclin D1 in human cancers, we performed a proteomic screen for cyclin D1 protein partners in several types of human tumours. Analyses of cyclin D1 interactors revealed a network of DNA repair proteins, including RAD51, a recombinase that drives the homologous recombination process(3). We found that cyclin D1 directly binds RAD51, and that cyclin D1-RAD51 interaction is induced by radiation. Like RAD51, cyclin D1 is recruited to DNA damage sites in a BRCA2-dependent fashion. Reduction of cyclin D1 levels in human cancer cells impaired recruitment of RAD51 to damaged DNA, impeded the homologous recombination-mediated DNA repair, and increased sensitivity of cells to radiation in vitro and in vivo. This effect was seen in cancer cells lacking the retinoblastoma protein, which do not require D-cyclins for proliferation(4,5). These findings reveal an unexpected function of a core cell cycle protein in DNA repair and suggest that targeting cyclin D1 may be beneficial also in retinoblastoma-negative cancers which are currently thought to be unaffected by cyclin D1 inhibition.	[Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Jirawatnotai, Siwanon; Hu, Yiduo; Michowski, Wojciech; Becks, Lisa; Bienvenu, Frederic; Zagozdzon, Agnieszka; van Harn, Tanja; Livingston, David M.; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Jirawatnotai, Siwanon] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Prathom, Thailand; [Elias, Joshua E.; Goswami, Tapasree; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Becks, Lisa] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmacol, Boston, MA 02115 USA; [Wang, Yaoyu E.; Correll, Mick; Quackenbush, John] Dana Farber Canc Inst, Ctr Canc Computat Biol, Boston, MA 02215 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Mol Genet Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Xia, Bing] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ 08903 USA; [Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Quackenbush, John] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Mahidol University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.	peter_sicinski@dfci.harvard.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788; Quackenbush, John/0000-0002-2702-5879	NIH [R01 CA083688, P01 CA080111, P01 CA109901]; Thailand Research Fund [MRG5280248]; Foundation for Polish Science; CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS [Z01 ES065089]; NATIONAL CANCER INSTITUTE [P01CA109901, R01CA083688, R01CA138804, P01CA080111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065089, ZIAES065089] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund(Thailand Research Fund (TRF)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); CCCB; Dana-Farber Strategic Plan Initiative; Division of Intramural Research of the NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the members of the Sicinski lab for help and advice, N. Li for help with initial experiments, S Panyim and Y. Geng for discussions and reading the manuscript, P. Nakatani for pOZ-FH-N construct, M. Jasin for DR-GFP system, D. Bulavin and E. Appella for anti-phospho-CDC25A antibodies, A. Smogorzewska for anti-FANCI antibody, A. Venkitaraman and M. Lee for GST-BRCA2 fragments, and DFCI Confocal and Light Microscopy Core Facility for assisting with confocal microscopy. This work was supported by R01 CA083688, P01 CA080111 and P01 CA109901 grants from NIH (to P.S.). S.J. is supported by The Thailand Research Fund MRG5280248, W.M. by Foundation for Polish Science, Y.E.W. through the CCCB and the Dana-Farber Strategic Plan Initiative, A.B.C. and T.A.K. by Project Z01 ES065089 (to T.A.K.) from the Division of Intramural Research of the NIH, NIEHS.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; BARTKOVA J, 1995, CANCER RES, V55, P949; BATES S, 1994, ONCOGENE, V9, P1633; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Ek S, 2005, LEUKEMIA RES, V29, P205, DOI 10.1016/j.leukres.2004.06.009; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; Hosokawa Y, 1998, GENE CHROMOSOME CANC, V22, P66, DOI 10.1002/(SICI)1098-2264(199805)22:1<66::AID-GCC9>3.0.CO;2-5; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Li ZP, 2010, CANCER RES, V70, P8802, DOI 10.1158/0008-5472.CAN-10-0312; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; Martin JMC, 1999, CANCER RES, V59, P1134; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pontano LL, 2008, MOL CELL BIOL, V28, P7245, DOI 10.1128/MCB.01085-08; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9	29	245	250	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					230	234		10.1038/nature10155	http://dx.doi.org/10.1038/nature10155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654808	Green Accepted			2022-12-28	WOS:000291397800054
J	Maekawa, M; Yamaguchi, K; Nakamura, T; Shibukawa, R; Kodanaka, I; Ichisaka, T; Kawamura, Y; Mochizuki, H; Goshima, N; Yamanaka, S				Maekawa, Momoko; Yamaguchi, Kei; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Kawamura, Yoshifumi; Mochizuki, Hiromi; Goshima, Naoki; Yamanaka, Shinya			Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1	NATURE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; PROTEIN; MOUSE; FIBROBLASTS	Induced pluripotent stem cells (iPSCs) are generated from somatic cells by the transgenic expression of three transcription factors collectively called OSK: Oct3/4 (also called Pou5f1), Sox2 and Klf4(1). However, the conversion to iPSCs is inefficient. The protooncogene Myc enhances the efficiency of iPSC generation by OSK but it also increases the tumorigenicity of the resulting iPSCs(2). Here we show that the Gli-like transcription factor Glis1 (Glis family zinc finger 1) markedly enhances the generation of iPSCs from both mouse and human fibroblasts when it is expressed together with OSK. Mouse iPSCs generated using this combination of transcription factors can form germline-competent chimaeras. Glis1 is enriched in unfertilized oocytes and in embryos at the one-cell stage. DNA microarray analyses show that Glis1 promotes multiple pro-reprogramming pathways, including Myc, Nanog, Lin28, Wnt, Essrb and the mesenchymal-epithelial transition. These results therefore show that Glis1 effectively promotes the direct reprogramming of somatic cells during iPSC generation.	[Maekawa, Momoko; Nakamura, Tomonori; Shibukawa, Ran; Kodanaka, Ikumi; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Maekawa, Momoko; Shibukawa, Ran; Kodanaka, Ikumi; Yamanaka, Shinya] JST, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Yamaguchi, Kei; Kawamura, Yoshifumi; Mochizuki, Hiromi] Japan Biol Informat Consortium, Tokyo 1350064, Japan; [Nakamura, Tomonori; Ichisaka, Tomoko; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068507, Japan; [Goshima, Naoki] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo 1350064, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	n-goshima@aist.go.jp; yamanaka@cira.kyoto-u.ac.jp	Nakamura, Tomonori/V-8828-2019	Nakamura, Tomonori/0000-0002-0173-0780	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	We thank T. Yamamoto, Y. Yamada and the members of our laboratory for valuable scientific discussions and administrative support. We thank M. Nakagawa, H. Seki, M. Murakami, A. Okada, M. Narita, M. Inoue, H. Shiga and T. Matsumoto for technical assistance and H. Suemori (Kyoto University) for human ES cells. This work was supported in part by grants from the New Energy and Industrial Technology Development Organization (NEDO), the Leading Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of the Japanese Society for the Promotion of Science (JSPS), Grants-in-Aid for Scientific Research from JSPS and MEXT, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). S.Y. is a member of scientific advisory boards of iPearian Inc. and iPS Academia Japan.	Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Goshima N, 2008, NAT METHODS, V5, P1011, DOI 10.1038/nmeth.1273; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Hashimoto J, 2009, J BIOMOL SCREEN, V14, P970, DOI 10.1177/1087057109341406; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	277	323	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					225	U268		10.1038/nature10106	http://dx.doi.org/10.1038/nature10106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654807	Green Submitted			2022-12-28	WOS:000291397800053
J	Ofstad, TA; Zuker, CS; Reiser, MB				Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.			Visual place learning in Drosophila melanogaster	NATURE			English	Article							MUSHROOM BODIES; CENTRAL COMPLEX; SPATIAL MEMORY; FRUIT-FLY; BEHAVIOR; SYSTEM; EXPRESSION; PARADIGM; CELLS; HEAD	The ability of insects to learn and navigate to specific locations in the environment has fascinated naturalists for decades. The impressive navigational abilities of ants, bees, wasps and other insects demonstrate that insects are capable of visual place learning(1-4), but little is known about the underlying neural circuits that mediate these behaviours. Drosophila melanogaster (common fruit fly) is a powerful model organism for dissecting the neural circuitry underlying complex behaviours, from sensory perception to learning and memory. Drosophila can identify and remember visual features such as size, colour and contour orientation(5,6). However, the extent to which they use vision to recall specific locations remains unclear. Here we describe a visual place learning platform and demonstrate that Drosophila are capable of forming and retaining visual place memories to guide selective navigation. By targeted genetic silencing of small subsets of cells in the Drosophila brain, we show that neurons in the ellipsoid body, but not in the mushroom bodies, are necessary for visual place learning. Together, these studies reveal distinct neuroanatomical substrates for spatial versus non-spatial learning, and establish Drosophila as a powerful model for the study of spatial memories. [GRAPHICS] .	[Ofstad, Tyler A.; Zuker, Charles S.; Reiser, Michael B.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Ofstad, Tyler A.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci, La Jolla, CA 92093 USA; [Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurobiol, La Jolla, CA 92093 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Zuker, Charles S.] Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; Howard Hughes Medical Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Zuker, CS (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	cz2195@columbia.edu; reiserm@janelia.hhmi.org		Reiser, Michael/0000-0002-4108-4517	HHMI	HHMI(Howard Hughes Medical Institute)	We particularly thank M. Gallio for help with thermosensation and the development of temperature behavioural tests. We also thank G. Rubin for providing GAL4 lines before publication, A. Jenett for their anatomical annotation and M. Dickinson for discussions and advice. Brain images were provided by the Janelia Fly Light Project. T. Laverty and the Janelia Fly Core assisted with Drosophila maintenance. Additional support was provided by J. Osborne, C. Werner, D. Olbris and M. Bolstad. We also thank V. Jayaraman, members of the Reiser and Zuker labs, Janelia Farm colleagues and the Janelia Fly Olympiad Project. This project was supported through the HHMI Janelia Farm Research Campus visitor programmed (T.A.O. and C.S.Z., hosted by M.B.R.). C.S.Z. is a HHMI investigator and a Senior Fellow at Janelia Farm.	Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BERNSTEIN S, 1969, BRAIN RES, V16, P85, DOI 10.1016/0006-8993(69)90087-0; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Capaldi EA, 1999, J EXP BIOL, V202, P1655; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Fahrbach SE, 1995, LEARN MEMORY, V2, P199, DOI 10.1101/lm.2.5.199; Foucaud J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015231; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; MCGUIRE SE, 2004, SCI STKE, pPL6; Mizunami M, 1998, J COMP NEUROL, V402, P520; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; Reiser MB, 2008, J NEUROSCI METH, V167, P127, DOI 10.1016/j.jneumeth.2007.07.019; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Strauss R, 1997, J EXP BIOL, V200, P1281; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2001, TRENDS GENET, V17, P719, DOI 10.1016/S0168-9525(01)02526-4; WEHNER R, 1979, EXPERIENTIA, V35, P1569, DOI 10.1007/BF01953197; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; Wolf R, 1998, LEARN MEMORY, V5, P166; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Wustmann G, 1997, LEARN MEMORY, V4, P328, DOI 10.1101/lm.4.4.328; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; Zars T, 2009, J NEUROGENET, V23, P104, DOI 10.1080/01677060802441364	40	260	265	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					204	U240		10.1038/nature10131	http://dx.doi.org/10.1038/nature10131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654803	Green Accepted, Green Published			2022-12-28	WOS:000291397800048
J	Mazzulli, JR; Xu, YH; Sun, Y; Knight, AL; McLean, PJ; Caldwell, GA; Sidransky, E; Grabowski, GA; Krainc, D				Mazzulli, Joseph R.; Xu, You-Hai; Sun, Ying; Knight, Adam L.; McLean, Pamela J.; Caldwell, Guy A.; Sidransky, Ellen; Grabowski, Gregory A.; Krainc, Dimitri			Gaucher Disease Glucocerebrosidase and alpha-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies	CELL			English	Article							PARKINSONS-DISEASE; MOUSE MODELS; MUTATIONS; DEFICIENCY; MECHANISM; OLIGOMERS; CATECHOLS; ENZYME	Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is not known. Here, we show that functional loss of GD-linked glucocerebrosidase (GCase) in primary cultures or human iPS neurons compromises lysosomal protein degradation, causes accumulation of alpha-synuclein (alpha-syn), and results in neurotoxicity through aggregation-dependent mechanisms. Glucosylceramide (GlcCer), the GCase substrate, directly influenced amyloid formation of purified alpha-syn by stabilizing soluble oligomeric intermediates. We further demonstrate that alpha-syn inhibits the lysosomal activity of normal GCase in neurons and idiopathic PD brain, suggesting that GCase depletion contributes to the pathogenesis of sporadic synucleinopathies. These findings suggest that the bidirectional effect of alpha-syn and GCase forms a positive feedback loop that may lead to a self-propagating disease. Therefore, improved targeting of GCase to lysosomes may represent a specific therapeutic approach for PD and other synucleinopathies.	[Mazzulli, Joseph R.; McLean, Pamela J.; Krainc, Dimitri] Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Xu, You-Hai; Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Knight, Adam L.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA; [Caldwell, Guy A.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurobiol, Birmingham, AL 35294 USA; [Sidransky, Ellen] NHGRI, Sect Mol Neurogenet, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts General Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Tuscaloosa; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Krainc, D (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis,Dept Neurol, Charlestown, MA 02129 USA.	krainc@mgh.helix.harvard.edu	Mazzulli, joseph/AAS-4480-2020	McLean, Pamela/0000-0003-4870-5715; Caldwell, Guy/0000-0002-8283-9090	National Institutes of Health [R01NS051303, F32NS066730]; National Institute of Neurological Disorders and Stroke [R01DK36729]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070168, F32NS066730, R01NS051303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Harry Ischiropoulos for pCDNA3.1 human alpha-syn plasmids and syn303 antibody, Benoit I. Giasson for the SNL-1 antibody, and Kimberly Kegel for technical advice on liposome formation. This work was supported by National Institutes of Health grants R01NS051303 (D.K.) and F32NS066730 (J.R.M.) from the National Institute of Neurological Disorders and Stroke, R01DK36729 (G.A.G.), and the Intramural Programs of the National Human Genome Research Institute and the National Institutes of Health (E.S.).	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; BRADY RO, 1965, J BIOL CHEM, V240, P39; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Duda JE, 2002, ANN NEUROL, V52, P205, DOI 10.1002/ana.10279; ERICKSON AH, 1985, J BIOL CHEM, V260, P4319; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GOKERALPAN O, 2008, LANCET, V372, P1263; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LEE RE, 1968, P NATL ACAD SCI USA, V61, P484, DOI 10.1073/pnas.61.2.484; LILL CM, 2008, PDGENE DATABASE ALZH; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; Mazzulli JR, 2006, J NEUROSCI, V26, P10068, DOI 10.1523/JNEUROSCI.0896-06.2006; Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun Y, 2005, J LIPID RES, V46, P2102, DOI 10.1194/jlr.M500202-JLR200; Tayebi N, 2003, MOL GENET METAB, V79, P104, DOI 10.1016/S1096-7192(03)00071-4; Tayebi N, 2001, MOL GENET METAB, V73, P313, DOI 10.1006/mgme.2001.3201; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Trojanowski JQ, 2002, NEUROTOXICOLOGY, V23, P457, DOI 10.1016/S0161-813X(02)00065-7; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Zala D, 2005, NEUROBIOL DIS, V20, P785, DOI 10.1016/j.nbd.2005.05.017	38	886	915	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 8	2011	146	1					37	52		10.1016/j.cell.2011.06.001	http://dx.doi.org/10.1016/j.cell.2011.06.001			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	789TN	21700325	Green Accepted, Bronze			2022-12-28	WOS:000292539300005
J	Kulacki, G				Kulacki, Gregory			US and China need contact, not cold war	NATURE			English	Editorial Material												gkulacki@ucsusa.org							0	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					444	445		10.1038/474444a	http://dx.doi.org/10.1038/474444a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697927	Bronze			2022-12-28	WOS:000291939700024
J	Sanderson, K				Sanderson, Katharine			A chewy problem	NATURE			English	Editorial Material																		Binder JB, 2009, J AM CHEM SOC, V131, P1979, DOI 10.1021/ja808537j; Sergeev AG, 2011, SCIENCE, V332, P439, DOI 10.1126/science.1200437; Zhong SH, 2010, ENERG FUEL, V24, P2891, DOI 10.1021/ef901575a	3	251	266	4	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S12	S14		10.1038/474S012a	http://dx.doi.org/10.1038/474S012a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697834				2022-12-28	WOS:000291939700004
J	Wang, TY; Nallamothu, BK; Krumholz, HM; Li, S; Roe, MT; Jollis, JG; Jacobs, AK; Holmes, DR; Peterson, ED; Ting, HH				Wang, Tracy Y.; Nallamothu, Brahmajee K.; Krumholz, Harlan M.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Jacobs, Alice K.; Holmes, David R.; Peterson, Eric D.; Ting, Henry H.			Association of Door-In to Door-Out Time With Reperfusion Delays and Outcomes Among Patients Transferred for Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; CARDIOVASCULAR DATA REGISTRY; LONGITUDINAL DATA-ANALYSIS; TO-BALLOON TIME; ST-ELEVATION; PRIMARY ANGIOPLASTY; INTERHOSPITAL TRANSFER; THROMBOLYTIC THERAPY; AMERICAN-COLLEGE; SYMPTOM-ONSET	Context Patients with ST-elevation myocardial infarction (STEMI) requiring inter-hospital transfer for primary percutaneous coronary intervention (PCI) often have prolonged overall door-to-balloon (DTB) times from first hospital presentation to second hospital PCI. Door-in to door-out (DIDO) time, defined as the duration of time from arrival to discharge at the first or STEMI referral hospital, is a new clinical performance measure, and a DIDO time of 30 minutes or less is recommended to expedite reperfusion care. Objective To characterize time to reperfusion and patient outcomes associated with a DIDO time of 30 minutes or less. Design, Setting, and Patients Retrospective cohort of 14 821 patients with STEMI transferred to 298 STEMI receiving centers for primary PCI in the ACTION Registry-Get With the Guidelines between January 2007 and March 2010. Main Outcome Measures Factors associated with a DIDO time greater than 30 minutes, overall DTB times, and risk-adjusted in-hospital mortality. Results Median DIDO time was 68 minutes (interquartile range, 43-120 minutes), and only 1627 patients (11%) had DIDO times of 30 minutes or less. Significant factors associated with a DIDO time greater than 30 minutes included older age, female sex, off-hours presentation, and non-emergency medical services transport to the first hospital. Patients with a DIDO time of 30 minutes or less were significantly more likely to have an overall DTB time of 90 minutes or less compared with patients with DIDO times greater than 30 minutes (60% [95% confidence interval {CI}, 57%-62%] vs 13% [95% CI, 12%-13%]; P < .001). Among patients with DIDO times greater than 30 minutes, only 0.6% (95% CI, 0.5%-0.8%) had an absolute contraindication to fibrinolysis. Observed in-hospital mortality was significantly higher among patients with DIDO times greater than 30 minutes vs patients with DIDO times of 30 minutes or less (5.9% [95% CI, 5.5%-6.3%] vs 2.7% [95% CI, 1.9%-3.5%]; P < .001; adjusted odds ratio for in-hospital mortality, 1.56 [95% CI, 1.15-2.12]). Conclusion A DIDO time of 30 minutes or less was observed in only a small proportion of patients transferred for primary PCI but was associated with shorter reperfusion delays and lower in-hospital mortality. JAMA. 2011;305(24):2540-2547	[Wang, Tracy Y.; Li, Shuang; Roe, Matthew T.; Jollis, James G.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Med, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI 48104 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Jacobs, Alice K.] Boston Med Ctr, Dept Med, Cardiol Sect, Boston, MA USA; [Ting, Henry H.] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN USA; [Holmes, David R.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Duke University; University of Michigan System; University of Michigan; Yale University; Yale University; Boston Medical Center; Mayo Clinic; Mayo Clinic	Wang, TY (corresponding author), 2400 Pratt St, Durham, NC 27705 USA.	tracy.wang@duke.edu	, Harlan/AAI-2875-2020; Peterson, Eric David/ABF-5033-2021	Jacobs, Alice/0000-0002-2428-2458	Bristol-Myers Squibb/Sanofi; Schering Plough/Merck; Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance; Eli Lilly; Novartis; Merck-Schering Plough; Bristol-Myers Squibb; American College of Cardiology; American Heart Association; Glaxo Smith Kline; KAI Pharmaceuticals; Sanofi-Aventis; Orexigen; Astra Zeneca; St Jude Inc; Bayer; Pfizer; ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians; Society of Hospital Medicine	Bristol-Myers Squibb/Sanofi(Bristol-Myers Squibb); Schering Plough/Merck(Merck & CompanySchering Plough Corporation); Medicines Co; Heartscape; Canyon Pharmaceuticals; Eli Lilly/Daiichi Sankyo Alliance(Eli Lilly); Eli Lilly(Eli Lilly); Novartis(Novartis); Merck-Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); American College of Cardiology(General Electric); American Heart Association(American Heart Association); Glaxo Smith Kline(GlaxoSmithKline); KAI Pharmaceuticals; Sanofi-Aventis(Sanofi-Aventis); Orexigen; Astra Zeneca(AstraZeneca); St Jude Inc; Bayer(Bayer AG); Pfizer(Pfizer); ACC Foundation's NCDR; Society of Chest Pain Centers; American College of Emergency Physicians(General Electric); Society of Hospital Medicine	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. All conflicts of interest are listed at http://www.dcri.org. Dr Wang reports receiving research grants to the Duke Clinical Research Institute from the Bristol-Myers Squibb/Sanofi Partnership, Schering Plough/Merck, The Medicines Co, Heartscape, Canyon Pharmaceuticals, and Eli Lilly/Daiichi Sankyo Alliance, as well as consulting fees/honoraria for Medco and Astra Zeneca. Dr Krumholz reports chairing a scientific advisory board for United Healthcare. Dr Roe reports receiving research funding from Eli Lilly, Novartis, Merck-Schering Plough, Bristol-Myers Squibb, the American College of Cardiology, and the American Heart Association; and consulting fees/honoraria from Glaxo Smith Kline, KAI Pharmaceuticals, Novartis, Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, Orexigen, and Astra Zeneca. Dr Jacobs reports chairing the Mission: Lifeline Advisory Working Group. Dr Peterson reports receiving research grants from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, Schering Plough/Merck, and St Jude Inc and consultant fees from Bayer and Pfizer. No other disclosures were reported.; This research was supported by the ACC Foundation's NCDR. The ACTION Registry-GWTG is an initiative of the ACC Foundation and the AHA with partnering support from the Society of Chest Pain Centers, the American College of Emergency Physicians, and the Society of Hospital Medicine. The registry is sponsored in part by the Bristol-Myers Squibb/Sanofi Partnership.	American Hospital Association, 2005, ANN SURV HOSP DAT DO; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; [Anonymous], MEAS SUMM AC MYOC IN; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Berger PB, 1999, CIRCULATION, V100, P14, DOI 10.1161/01.CIR.100.1.14; Bohmer E, 2010, J AM COLL CARDIOL, V55, P102, DOI 10.1016/j.jacc.2009.08.007; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Chakrabarti A, 2008, J AM COLL CARDIOL, V51, P2442, DOI 10.1016/j.jacc.2008.02.071; Chin CT, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.004; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Eagle KA, 2002, LANCET, V359, P373, DOI 10.1016/S0140-6736(02)07595-5; Ellrodt G, 2007, CIRCULATION, V116, pE49, DOI 10.1161/CIRCULATIONAHA.107.184048; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Jacobs AK, 2006, CIRCULATION, V113, P1159, DOI 10.1161/CIRCULATIONAHA.105.610345; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Jollis JG, 2007, JAMA-J AM MED ASSOC, V298, P2371, DOI 10.1001/jama.298.20.joc70124; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Krumholz HM, 2011, J AM COLL CARDIOL, V57, P637, DOI 10.1016/j.jacc.2010.12.010; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; Krumholz HM, 2008, J AM COLL CARDIOL, V52, P2046, DOI 10.1016/j.jacc.2008.10.012; Kushner, 2010, CIRCULATION, V121, pE257, DOI 10.1161/CIR.0b013e3181d7a65e; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Nallamothu BK, 2009, AM J CARDIOL, V103, P1051, DOI 10.1016/j.amjcard.2008.12.030; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Wang TY, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.001; Wang TY, 2011, AM HEART J, V161, pe1; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2540	2547		10.1001/jama.2011.862	http://dx.doi.org/10.1001/jama.2011.862			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693742	Bronze			2022-12-28	WOS:000291860400021
J	Alexander, GC; O'Connor, AB; Stafford, RS				Alexander, G. Caleb; O'Connor, Alec B.; Stafford, Randall S.			Enhancing Prescription Drug Innovation and Adoption	ANNALS OF INTERNAL MEDICINE			English	Article							SURROGATE END-POINTS; CLINICAL-TRIALS; FDA; RISK; INFORMATION	The adoption and use of a new drug would ideally be guided by its innovation and cost-effectiveness. However, information about the relative efficacy and safety of a drug is typically incomplete even well after market entry, and various other forces create a marketplace in which most new drugs are little better than their older counterparts. Five proposed mechanisms are considered for promoting innovation and reducing the use of therapies ultimately found to offer poor value or have unacceptable risks. These changes range from increasing the evidence required for U. S. Food and Drug Administration approval to modifying the structure of drug reimbursement. Despite the challenges of policy implementation, the United States has a long history of successfully improving the societal value and safe use of prescription medicines.	Univ Chicago, Univ Chicago Hosp, Chicago, IL 60637 USA; Univ Illinois, Sch Pharm, Chicago, IL USA; Univ Rochester, Sch Med & Dent, Rochester, NY USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA	University of Chicago; University of Illinois System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Rochester; Stanford University	Alexander, GC (corresponding author), Univ Chicago, Med Ctr, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu	; Stafford, Randall/F-3974-2017	O'Connor, Alec/0000-0001-8181-5567; Stafford, Randall/0000-0003-1805-1271	Agency for Healthcare Research and Quality [K08 HS15699, RO1 HS0189960]; National Heart, Lung, and Blood Institute [K24 HL086703]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS015699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL086703] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By grants K08 HS15699 and RO1 HS0189960 from the Agency for Healthcare Research and Quality (Dr. Alexander) and grant K24 HL086703 from the National Heart, Lung, and Blood Institute (Dr. Stafford).	Abraham J, 2005, SOC SCI MED, V61, P881, DOI 10.1016/j.socscimed.2005.01.004; Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; *ASTRAZENECA, 2010, 4 Q FULL YEAR RES 20; BACIU A, 2007, FUTURE DRUG SAFETY P; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fretheim Atle, 2003, BMC Fam Pract, V4, P19, DOI 10.1186/1471-2296-4-19; Green JA, 2007, PRESCRIBING NUMBERS; Hamburg MA, 2010, NEW ENGL J MED, V363, P2228, DOI 10.1056/NEJMsa1007467; Kesselheim AS, 2010, NEW ENGL J MED, V363, P1855, DOI 10.1056/NEJMhle1002961; Leidl R M, 1994, Int J Technol Assess Health Care, V10, P467; Lindstrom JA, 2009, DERMATOL THER, V22, P246, DOI 10.1111/j.1529-8019.2009.01238.x; Mintzes Barbara, 2005, Can J Clin Pharmacol, V12, pe22; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; *OFF INSP GEN, OEI039400760 US DEP; Olson MK, 2008, J HEALTH ECON, V27, P175, DOI 10.1016/j.jhealeco.2007.10.007; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Polinski JM, 2007, HEALTH AFFAIR, V26, P750, DOI 10.1377/hlthaff.26.3.750; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Rogers E., 1962, DIFFUSION INNOVATION; Schiff GD, 2009, JAMA-J AM MED ASSOC, V301, P865, DOI 10.1001/jama.2009.195; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Strom BL, 2006, JAMA-J AM MED ASSOC, V295, P2072, DOI 10.1001/jama.295.17.2072; Thomas CP, 2003, NEW ENGL J MED, V349, P2186, DOI 10.1056/NEJMp038172; *US FDA, 2010, FAST TRACK ACC APPR; *US GOV ACC OFF, 2002, GAO02958 US GOV ACC; Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; WITTES J, 1989, STAT MED, V8, P415, DOI 10.1002/sim.4780080405; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; Zhang YT, 2007, HEALTH AFFAIR, V26, P880, DOI 10.1377/hlthaff.26.3.880; 2001, PRESCRIRE INT, V10, P52	37	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					833	839		10.7326/0003-4819-154-12-201106210-00012	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00012			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	779SA	21690598	Green Accepted			2022-12-28	WOS:000291800500020
J	Talley, NJ				Talley, Nicholas J.			Quadruple-drug therapy was better than triple-drug therapy for eradicating Helicobacter pylori in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INFECTION		Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Talley, NJ (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.		Talley, Nicholas J/D-5399-2013	Talley, Nicholas J/0000-0003-2537-3092				Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Luther J, 2010, AM J GASTROENTEROL, V105, P65, DOI 10.1038/ajg.2009.508; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Molina-Infante J, 2010, ALIMENT PHARM THER, V31, P1077, DOI 10.1111/j.1365-2036.2010.04274.x	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-2	10.7326/0003-4819-154-12-201106210-02002	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690580				2022-12-28	WOS:000291800500001
J	Mao, ZY; Hine, C; Tian, X; Van Meter, M; Au, M; Vaidya, A; Seluanov, A; Gorbunova, V				Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera			SIRT6 Promotes DNA Repair Under Stress by Activating PARP1	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; PROTEIN SIR2; DEACETYLASE; STABILITY; CHROMATIN; POLY(ADP-RIBOSYL)ATION; LONGEVITY; KINASE; SITES	Sirtuin 6 (SIRT6) is a mammalian homolog of the yeast Sir2 deacetylase. Mice deficient for SIRT6 exhibit genome instability. Here, we show that in mammalian cells subjected to oxidative stress SIRT6 is recruited to the sites of DNA double-strand breaks (DSBs) and stimulates DSB repair, through both nonhomologous end joining and homologous recombination. Our results indicate that SIRT6 physically associates with poly[adenosine diphosphate (ADP)-ribose] polymerase 1 (PARP1) and mono-ADP-ribosylates PARP1 on lysine residue 521, thereby stimulating PARP1 poly-ADP-ribosylase activity and enhancing DSB repair under oxidative stress.	[Mao, Zhiyong; Hine, Christopher; Tian, Xiao; Van Meter, Michael; Au, Matthew; Vaidya, Amita; Seluanov, Andrei; Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Seluanov, A (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	andrei.seluanov@rochester.edu; vera.gorbunova@rochester.edu	Tian, Xiao/E-3998-2017	Tian, Xiao/0000-0001-5300-3596; Gorbunova, Vera/0000-0001-8979-0333; Hine, Christopher/0000-0003-1926-7939; Mao, Zhiyong/0000-0002-5298-1918; Seluanov, Andrei/0000-0003-3400-538X	NIH; Ellison Medical Foundation; NATIONAL INSTITUTE ON AGING [F31AG041603, R01AG027237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (to V.G.) and the Ellison Medical Foundation (to V.G. and A.S.). Z.M. performed DNA repair assays, immunoblots, coimmunoprecipitations, in situ staining, and biochemical assays; C.H. and A.V. performed ChIP; X.T. analyzed PARP1 mutants; M.V.M. analyzed DNA damage foci; M.A. performed comet assays; and Z.M., C.H., A.S., and V.G. designed the study, analyzed data, and wrote the manuscript.	Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Audebert M, 2006, J MOL BIOL, V356, P257, DOI 10.1016/j.jmb.2005.11.028; Burkle A, 2000, BIOGERONTOLOGY, V1, P41, DOI 10.1023/A:1010089924898; di Fagagna FD, 1999, NAT GENET, V23, P76; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gorbunova V, 2005, MECH AGEING DEV, V126, P621, DOI 10.1016/j.mad.2005.02.008; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hochegger H, 2006, EMBO J, V25, P1305, DOI 10.1038/sj.emboj.7601015; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Paddock MN, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000428; Saunders LR, 2009, SCIENCE, V323, P1021, DOI 10.1126/science.1170007; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	25	557	581	4	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1443	1446		10.1126/science.1202723	http://dx.doi.org/10.1126/science.1202723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680843	Green Accepted			2022-12-28	WOS:000291689000045
J	Florence, C; Shepherd, J; Brennan, I; Simon, T				Florence, Curtis; Shepherd, Jonathan; Brennan, Iain; Simon, Thomas			Effectiveness of anonymised information sharing and use in health service, police, and local government partnership for preventing violence related injury: experimental study and time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACCIDENT	Objective To evaluate the effectiveness of anonymised information sharing to prevent injury related to violence. Design Experimental study and time series analysis of a prototype community partnership between the health service, police, and local government partners designed to prevent violence. Setting Cardiff, Wales, and 14 comparison cities designated "most similar" by the Home Office in England and Wales. Intervention After a 33 month development period, anonymised data relevant to violence prevention (precise violence location, time, days, and weapons) from patients attending emergency departments in Cardiff and reporting injury from violence were shared over 51 months with police and local authority partners and used to target resources for violence prevention. Main outcome measures Health service records of hospital admissions related to violence and police records of woundings and less serious assaults in Cardiff and other cities after adjustment for potential confounders. Results Information sharing and use were associated with a substantial and significant reduction in hospital admissions related to violence. In the intervention city (Cardiff) rates fell from seven to five a month per 100 000 population compared with an increase from five to eight in comparison cities (adjusted incidence rate ratio 0.58, 95% confidence interval 0.49 to 0.69). Average rate of woundings recorded by the police changed from 54 to 82 a month per 100 000 population in Cardiff compared with an increase from 54 to 114 in comparison cities (adjusted incidence rate ratio 0.68, 0.61 to 0.75). There was a significant increase in less serious assaults recorded by the police, from 15 to 20 a month per 100 000 population in Cardiff compared with a decrease from 42 to 33 in comparison cities (adjusted incidence rate ratio 1.38, 1.13 to 1.70). Conclusion An information sharing partnership between health services, police, and local government in Cardiff, Wales, altered policing and other strategies to prevent violence based on information collected from patients treated in emergency departments after injury sustained in violence. This intervention led to a significant reduction in violent injury and was associated with an increase in police recording of minor assaults in Cardiff compared with similar cities in England and Wales where this intervention was not implemented.	[Shepherd, Jonathan] Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales; [Florence, Curtis; Simon, Thomas] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA USA; [Brennan, Iain] Univ Hull, Dept Social Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Cardiff University; Centers for Disease Control & Prevention - USA; University of Hull	Shepherd, J (corresponding author), Cardiff Univ, Violence & Soc Res Grp, Sch Dent, Cardiff CF14 4XY, S Glam, Wales.	shepherdjp@cardiff.ac.uk		Shepherd, Jonathan/0000-0001-6466-2298; Brennan, Iain/0000-0003-2131-1599	Home Office; Wales Office for Research and Development in Health and Social Care (WORD) [R/98/037]	Home Office; Wales Office for Research and Development in Health and Social Care (WORD)	The development of the prototype partnership was funded in part by a grant from the Home Office targeted policing fund. The study was funded in part by the Wales Office for Research and Development in Health and Social Care (WORD), grant No R/98/037.	[Anonymous], PREV VIOL GUID IMPL; Braga A. A., 2007, CAMPBELL SYST REV, V3, P1, DOI DOI 10.4073/CSR.2007.1; BULLOCK S, 2007, POLICE SERVICE STREN; Christopherson O., 2004, POLICE SERVICE STREN; Clarke R.V., 1994, CRIME PREVENTION STU, V2, P165; CLARKSON C, 1994, CRIM LAW REV, P4; Clegg M., 2006, POLICE SERVICE STREN; COTTON J, 2003, POLICE SERVICE STREN; *CTR STUD PREV VIO, BLUEPR VIOL PREV; Dahlberg Linda L, 2005, Int J Inj Contr Saf Promot, V12, P93, DOI 10.1080/15660970500086239; Dubourg R, 2005, EC SOCIAL COSTS CRIM; Faergemann Christian, 2007, J Forensic Leg Med, V14, P20, DOI 10.1016/j.jcfm.2006.01.001; FARRINGTON D, 2004, CROSS NATL STUDIES C; Giacopassi D, 2000, J CRIM JUST, V28, P397, DOI 10.1016/S0047-2352(00)00054-4; Goodwin V, 2000, J ACCID EMERG MED, V17, P196; Green L., 1995, JUSTICE Q, V12, P711, DOI DOI 10.1080/07418829500096261; HAHN H, 2007, MMWR RECOMM REP, V56, P1; HARPER G, 2002, FAMILY ORIGINS DEV G; Houry D, 2002, ANN EMERG MED, V39, P56, DOI 10.1067/mem.2002.117759; Kellermann AL, 2001, ANN EMERG MED, V38, P423, DOI 10.1067/mem.2001.117273; Mercy JA, 2006, INJURY PREV, V12, P1, DOI 10.1136/ip.2006.012542; Pinto R., 2005, POLICE SERVICE STREN; Povey D., 2001, POLICE SERVICE STREN; RITTERN, 2009, NATL I JUSTICE J, V264, P20; Sachs CJ, 1998, ANN EMERG MED, V31, P488, DOI 10.1016/S0196-0644(98)70259-8; Shepherd JP, 2001, LANCET, V358, P1717, DOI 10.1016/S0140-6736(01)06716-2; SHEPHERD JP, 1990, J ROY SOC MED, V83, P75, DOI 10.1177/014107689008300206; SHEPHERD JP, 1990, INJURY, V21, P139, DOI 10.1016/0020-1383(90)90081-5; Shepherd JP, 2001, ANN EMERG MED, V38, P430, DOI 10.1067/mem.2001.114317; SHEPHERD JP, 1993, J ROY SOC MED, V86, P87; Sherman L W, 1995, JUSTICE Q, V12, P625; Simmons J., 2003, NATL CRIME RECORDING; SISSON D, 2001, POLICE SERVICE STREN; Sivarajasingam V, 2004, INJURY, V35, P467, DOI 10.1016/S0020-1383(03)00241-9; Sivarajasingam V, 2003, INJURY PREV, V9, P312, DOI 10.1136/ip.9.4.312; SMITH C, 2002, POLICE SERVICE STREN; STPIERRE TL, 1992, AM J COMMUN PSYCHOL, V20, P673; Sutherland I, 2002, INJ PREV, V8, P246, DOI 10.1136/ip.8.3.246; The Crown Prosecution Service, OFF PERS INC CHARG S; Villaveces A, 2000, JAMA-J AM MED ASSOC, V283, P1205, DOI 10.1001/jama.283.9.1205; Walker A, 2009, CRIME ENGLAND WALES; Warburton AL, 2006, EMERG MED J, V23, P12, DOI 10.1136/emj.2004.023028; Warburton AL, 2004, EMERG MED J, V21, P473, DOI 10.1136/emj.2003.004978; WHO, 2022, GLOB BURD DIS 2004 U; World Health Organization, 2002, WORLD REPORT VIOLENC	45	88	88	1	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2011	342								d3313	10.1136/bmj.d3313	http://dx.doi.org/10.1136/bmj.d3313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LF	21680632	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000291933000004
J	Shi, ML; Zhu, JH; Wang, R; Chen, X; Mi, LZ; Walz, T; Springer, TA				Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Walz, Thomas; Springer, Timothy A.			Latent TGF-beta structure and activation	NATURE			English	Article							GROWTH-FACTOR-BETA; BINDING-PROTEIN; CRYSTAL-STRUCTURE; SECRETION; MATURE; TGF-BETA-1; DOMAIN; FACTOR-BETA-1; INFLAMMATION; REQUIREMENT	Transforming growth factor (TGF)-beta is stored in the extracellular matrix as a latent complex with its prodomain. Activation of TGF-beta 1 requires the binding of alpha(v) integrin to an RGD sequence in the prodomain and exertion of force on this domain, which is held in the extracellular matrix by latent TGF-beta binding proteins. Crystals of dimeric porcine proTGF-beta 1 reveal a ring-shaped complex, a novel fold for the prodomain, and show how the prodomain shields the growth factor from recognition by receptors and alters its conformation. Complex formation between alpha(v)beta(6) integrin and the prodomain is insufficient for TGF-beta 1 release. Force-dependent activation requires unfastening of a 'straitjacket' that encircles each growth-factor monomer at a position that can be locked by a disulphide bond. Sequences of all 33 TGF-beta family members indicate a similar prodomain fold. The structure provides insights into the regulation of a family of growth and differentiation factors of fundamental importance in morphogenesis and homeostasis.	[Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Shi, Minlong; Zhu, Jianghai; Wang, Rui; Chen, Xing; Mi, Lizhi; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Walz, Thomas] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA.	springer@idi.harvard.edu	Zhu, Jianghai/B-7339-2014; Mi, Li-Zhi/B-1371-2016; shi, minlong/G-8734-2013	Mi, Li-Zhi/0000-0001-9907-5245; Walz, Thomas/0000-0003-2606-2835	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01 HL103526] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belville C, 2004, MOL ENDOCRINOL, V18, P708, DOI 10.1210/me.2003-0358; Blanchet MH, 2008, EMBO J, V27, P2580, DOI 10.1038/emboj.2008.174; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BRUNNER AM, 1992, MOL ENDOCRINOL, V6, P1691, DOI 10.1210/me.6.10.1691; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chen Y, 2005, J MOL BIOL, V345, P175, DOI 10.1016/j.jmb.2004.10.039; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cui YZ, 2001, GENE DEV, V15, P2797; DAOPIN S, 1992, SCIENCE, V257, P369, DOI 10.1126/science.1631557; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derynck Rik, 2008, P29; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; GENTRY LE, 1987, MOL CELL BIOL, V7, P3418, DOI 10.1128/MCB.7.10.3418; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Heras B, 2005, ACTA CRYSTALLOGR D, V61, P1173, DOI 10.1107/S0907444905019451; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janssens K, 2006, J MED GENET, V43, P1, DOI 10.1136/jmg.2005.033522; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Lack J, 2003, J MOL BIOL, V334, P281, DOI 10.1016/j.jmb.2003.09.053; Little SC, 2009, NAT CELL BIOL, V11, P637, DOI 10.1038/ncb1870; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; SCHLUNEGGER MP, 1992, NATURE, V358, P430, DOI 10.1038/358430a0; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Ulloa L, 2001, J BIOL CHEM, V276, P21387, DOI 10.1074/jbc.M006933200; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Walton KL, 2009, J BIOL CHEM, V284, P9311, DOI 10.1074/jbc.M808763200; WILSON CA, 1993, MOL ENDOCRINOL, V7, P247, DOI 10.1210/me.7.2.247; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105; Zou ZC, 2004, PROTEIN EXPRES PURIF, V37, P265, DOI 10.1016/j.pep.2003.06.001	46	648	673	6	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					343	U370		10.1038/nature10152	http://dx.doi.org/10.1038/nature10152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677751	Green Accepted			2022-12-28	WOS:000291647100038
J	Dolmetsch, R; Geschwind, DH				Dolmetsch, Ricardo; Geschwind, Daniel H.			The Human Brain in a Dish: The Promise of iPSC-Derived Neurons	CELL			English	Review							PLURIPOTENT STEM-CELLS; SCHIZOPHRENIA	Induced pluripotent stem cell-derived neurons from patients promise to fill an important niche between studies in humans and model organisms in deciphering mechanisms and identifying therapeutic avenues for neurologic and psychiatric diseases. Recent work begins to tap this potential and also highlights challenges that must be overcome to be fully realized.	[Dolmetsch, Ricardo] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Geschwind, Daniel H.] UCLA Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] UCLA Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] UCLA Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dolmetsch, R (corresponding author), Stanford Univ, Dept Neurobiol, Fairchild Res Bldg,Room D227, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu; dhg@mednet.ucla.edu			NIH; NIA; NIGMS; Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754, DP1MH099904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Autism Speaks; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge Giovanni Coppola for critical discussions and help with the figure and Lauren Kawaguchi and Elizabeth Nigh for editorial assistance. The authors also acknowledge support for their research from the NIH (D.H.G. and R.D.), NIA (D.H.G.), NIGMS (R.D.), Autism Speaks (D.H.G), and the Simons Foundation (D.H.G. and R.D.).	Allman JM, 2011, AM J HUM BIOL, V23, P5, DOI 10.1002/ajhb.21136; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Cheung AYL, 2011, HUM MOL GENET, V20, P2103, DOI 10.1093/hmg/ddr093; Clowry G, 2010, J ANAT, V217, P276, DOI 10.1111/j.1469-7580.2010.01281.x; Dragunow M, 2008, NAT REV DRUG DISCOV, V7, P659, DOI 10.1038/nrd2617; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2009, NATURE, V461, P908, DOI 10.1038/nature08537; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; STEFFENHAGEN C, 2011, STEM CELL R IN PRESS, DOI DOI 10.1007/S12015.011.9251.9; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Vassos E, 2010, HUM MOL GENET, V19, P3477, DOI 10.1093/hmg/ddq259; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855	20	203	208	3	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					831	834		10.1016/j.cell.2011.05.034	http://dx.doi.org/10.1016/j.cell.2011.05.034			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663789	Green Accepted, Bronze			2022-12-28	WOS:000291461600011
J	Jurkovic, D; Wilkinson, H				Jurkovic, Davor; Wilkinson, Helen			Diagnosis and management of ectopic pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE SYSTEMIC METHOTREXATE; EXPECTANT MANAGEMENT; LAPAROSCOPIC SURGERY; RANDOMIZED-TRIAL; ECONOMIC-EVALUATION; RISK-FACTORS; SONOGRAPHY		[Jurkovic, Davor] Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England; [Wilkinson, Helen] Kings Coll Hosp London, Ectop Pregnancy Trust, London, England	University of London; University College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Jurkovic, D (corresponding author), Univ Coll Hosp, Dept Obstet & Gynaecol, London NW1 2BU, England.	davor.jurkovic@uclh.nhs.uk						Agency for Healthcare Research and Quality, 2008, MED MAN ECT PREGN, P427; Ankum WM, 1996, FERTIL STERIL, V65, P1093, DOI 10.1016/S0015-0282(16)58320-4; Bouyer J, 2003, AM J EPIDEMIOL, V157, P185, DOI 10.1093/aje/kwf190; BROWN DL, 1994, J ULTRAS MED, V13, P259, DOI 10.7863/jum.1994.13.4.259; CACCIATORE B, 1989, OBSTET GYNECOL, V73, P770; Condous G, 2006, ULTRASOUND OBST GYN, V28, P121, DOI 10.1002/uog.2838; CORDINA M, 2011, BJOG; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Ehrenberg-Buchner S, 2009, CLIN OBSTET GYNECOL, V52, P372, DOI 10.1097/GRF.0b013e3181b0be24; Elson J, 2004, ULTRASOUND OBST GYN, V23, P552, DOI 10.1002/uog.1061; Hajenius PJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000324.pub2; Hajenius PJ, 1997, LANCET, V350, P774, DOI 10.1016/S0140-6736(97)05487-1; Helmy S, 2007, ULTRASOUND OBST GYN, V30, P988, DOI 10.1002/uog.5186; Huusom LD, 2011, BJOG-INT J OBSTET GY, V118, P1, DOI 10.1111/j.1471-0528.2010.02782.x; Kirk E, 2007, HUM REPROD, V22, P1744, DOI 10.1093/humrep/dem073; Kirk E, 2007, HUM REPROD, V22, P2824, DOI 10.1093/humrep/dem283; KOBAYASHI M, 1969, AM J OBSTET GYNECOL, V103, P1131, DOI 10.1016/0002-9378(69)90518-3; Korhonen J, 1996, OBSTET GYNECOL, V88, P775, DOI 10.1016/0029-7844(96)00293-1; LI TC, 1991, HUM REPROD, V6, P1002, DOI 10.1093/oxfordjournals.humrep.a137449; Lundorff P, 1991, ACTA OBSTET GYN SCAN, V70, P343, DOI 10.3109/00016349109007885; Moeller LBK, 2009, ACTA OBSTET GYN SCAN, V88, P1331, DOI 10.3109/00016340903188912; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Mol BWJ, 1999, FERTIL STERIL, V71, P155, DOI 10.1016/S0015-0282(98)00396-3; Mol F, 2008, HUM REPROD UPDATE, V14, P309, DOI 10.1093/humupd/dmn012; Murray H, 2005, CAN MED ASSOC J, V173, P905, DOI 10.1503/cmaj.050222; *ROYAL COLL OBST G, 2004, 21 ROYAL COLL OBST G; Royal College of Obstetricians and Gunecologists, 2009, UK MED EL CRIT CONTR; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P192, DOI 10.1111/j.1471-0528.2001.00038.x; Sowter MC, 2001, BRIT J OBSTET GYNAEC, V108, P204, DOI 10.1111/j.1471-0528.2001.00037.x; Stein JC, 2010, ANN EMERG MED, V56, P674, DOI 10.1016/j.annemergmed.2010.06.563; WANG R, 2011, ANN EMERG MED; Wedderburn CJ, 2010, HUM REPROD, V25, P328, DOI 10.1093/humrep/dep397	32	63	67	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2011	342								d3397	10.1136/bmj.d3397	http://dx.doi.org/10.1136/bmj.d3397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665933				2022-12-28	WOS:000291645900003
J	Eisenstein, M				Eisenstein, Michael			A moving target	NATURE			English	Editorial Material																		Brimacombe CL, 2011, J VIROL, V85, P596, DOI 10.1128/JVI.01592-10; Frey SE, 2010, VACCINE, V28, P6367, DOI 10.1016/j.vaccine.2010.06.084; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231	4	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S16	S17		10.1038/474S16a	http://dx.doi.org/10.1038/474S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666730	Bronze			2022-12-28	WOS:000291397800010
J	Overmoyer, BA; Lee, JM; Lerwill, MF				Overmoyer, Beth A.; Lee, Janie M.; Lerwill, Melinda F.			Case 17-2011: A 49-Year-Old Woman with a Mass in the Breast and Overlying Skin Changes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CANCER; EXPRESSION; CHEMOTHERAPY; CARCINOMA; IDENTIFICATION; ANGIOGENESIS; MASTECTOMY; INDUCTION; SURVIVAL; SUBTYPES		[Overmoyer, Beth A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Overmoyer, Beth A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lee, Janie M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lerwill, Melinda F.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Lee, Janie M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Overmoyer, Beth A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lerwill, Melinda F.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Overmoyer, BA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.				Harvard Medical School Department of Continuing Education; Dana-Farber/Brigham and Women's Cancer Center; Massachusetts General Hospital Cancer Center; NATIONAL CANCER INSTITUTE [K07CA128816] Funding Source: NIH RePORTER	Harvard Medical School Department of Continuing Education; Dana-Farber/Brigham and Women's Cancer Center; Massachusetts General Hospital Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This case was presented at the postgraduate course Breast Cancer: New Horizons Current Controversies (2010), Judy E. Garber, M.D., M.P.H., Barbara L. Smith, M.D., Ph.D., and Eric P. Winer, M.D., course directors; sponsored by the Harvard Medical School Department of Continuing Education, Dana-Farber/Brigham and Women's Cancer Center, and Massachusetts General Hospital Cancer Center.	Alpaugh ML, 2002, AM J PATHOL, V161, P619, DOI 10.1016/S0002-9440(10)64217-4; Anderson WF, 2003, J CLIN ONCOL, V21, P2254, DOI 10.1200/JCO.2003.07.082; Anderson William F, 2005, Breast Dis, V22, P9; Baldini Editta, 2004, Clin Breast Cancer, V5, P358, DOI 10.3816/CBC.2004.n.042; Bertucci F, 2005, CANCER RES, V65, P2170, DOI 10.1158/0008-5472.CAN-04-4115; Bertucci F, 2010, CANCER-AM CANCER SOC, V116, P2783, DOI 10.1002/cncr.25165; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Bristol IJ, 2008, INT J RADIAT ONCOL, V72, P474, DOI 10.1016/j.ijrobp.2008.01.039; Charafe-Jaufrret E, 2004, J PATHOL, V202, P265, DOI 10.1002/path.1515; Colpaert CG, 2003, BRIT J CANCER, V88, P718, DOI 10.1038/sj.bjc.6600807; Cristofanilli Massimo, 2004, Clin Breast Cancer, V4, P415, DOI 10.3816/CBC.2004.n.004; Curcio LD, 1999, ANN SURG ONCOL, V6, P249, DOI 10.1007/s10434-999-0249-3; Fleming RYD, 1997, ANN SURG ONCOL, V4, P452, DOI 10.1007/BF02303668; Gong Y, 2008, SEMIN ONCOL, V35, P33, DOI 10.1053/j.seminoncol.2007.11.014; Harris EER, 2003, INT J RADIAT ONCOL, V55, P1200, DOI 10.1016/S0360-3016(02)04201-3; Hennessy BT, 2006, CANCER-AM CANCER SOC, V106, P1000, DOI 10.1002/cncr.21726; Hidar S, 2009, INT J SURG, V7, P272, DOI 10.1016/j.ijsu.2009.04.012; Kleer CG, 2004, BREAST CANCER RES, V6, pR110, DOI 10.1186/bcr755; Kleer CG, 2001, MODERN PATHOL, V14, P458, DOI 10.1038/modpathol.3880334; Liauw SL, 2004, CANCER-AM CANCER SOC, V100, P920, DOI 10.1002/cncr.20083; Low JA, 2004, J CLIN ONCOL, V22, P4067, DOI 10.1200/JCO.2004.04.068; Panades M, 2005, J CLIN ONCOL, V23, P1941, DOI 10.1200/JCO.2005.06.233; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Van der Auwera I, 2004, CLIN CANCER RES, V10, P7965, DOI 10.1158/1078-0432.CCR-04-0063; Van Laere SJ, 2006, BREAST CANCER RES TR, V95, P243, DOI 10.1007/s10549-005-9015-9; Veyret C, 2006, CANCER, V107, P2535, DOI 10.1002/cncr.22227; Wedam SB, 2006, J CLIN ONCOL, V24, P769, DOI 10.1200/JCO.2005.03.4645	28	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2246	2254		10.1056/NEJMcpc1100922	http://dx.doi.org/10.1056/NEJMcpc1100922			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651397				2022-12-28	WOS:000291392100013
J	Buys, SS; Partridge, E; Black, A; Johnson, CC; Lamerato, L; Isaacs, C; Reding, DJ; Greenlee, RT; Yokochi, LA; Kessel, B; Crawford, ED; Church, TR; Andriole, GL; Weissfeld, JL; Fouad, MN; Chia, D; O'Brien, B; Ragard, LR; Clapp, JD; Rathmell, JM; Riley, TL; Hartge, P; Pinsky, PF; Zhu, CS; Izmirlian, G; Kramer, BS; Miller, AB; Xu, JL; Prorok, PC; Gohagan, JK; Berg, CD				Buys, Saundra S.; Partridge, Edward; Black, Amanda; Johnson, Christine C.; Lamerato, Lois; Isaacs, Claudine; Reding, Douglas J.; Greenlee, Robert T.; Yokochi, Lance A.; Kessel, Bruce; Crawford, E. David; Church, Timothy R.; Andriole, Gerald L.; Weissfeld, Joel L.; Fouad, Mona N.; Chia, David; O'Brien, Barbara; Ragard, Lawrence R.; Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.; Hartge, Patricia; Pinsky, Paul F.; Zhu, Claire S.; Izmirlian, Grant; Kramer, Barnett S.; Miller, Anthony B.; Xu, Jian-Lun; Prorok, Philip C.; Gohagan, John K.; Berg, Christine D.		PLCO Project Team	Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context Screening for ovarian cancer with cancer antigen 125 (CA-125) and transvaginal ultrasound has an unknown effect on mortality. Objective To evaluate the effect of screening for ovarian cancer on mortality in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Design, Setting, and Participants Randomized controlled trial of 78 216 women aged 55 to 74 years assigned to undergo either annual screening (n=39 105) or usual care (n=39 111) at 10 screening centers across the United States between November 1993 and July 2001. Intervention The intervention group was offered annual screening with CA-125 for 6 years and transvaginal ultrasound for 4 years. Participants and their health care practitioners received the screening test results and managed evaluation of abnormal results. The usual care group was not offered annual screening with CA-125 for 6 years or transvaginal ultrasound but received their usual medical care. Participants were followed up for a maximum of 13 years (median [range], 12.4 years [10.9-13.0 years]) for cancer diagnoses and death until February 28, 2010. Main Outcome Measures Mortality from ovarian cancer, including primary peritoneal and fallopian tube cancers. Secondary outcomes included ovarian cancer incidence and complications associated with screening examinations and diagnostic procedures. Results Ovarian cancer was diagnosed in 212 women (5.7 per 10 000 person-years) in the intervention group and 176 (4.7 per 10 000 person-years) in the usual care group (rate ratio [RR], 1.21; 95% confidence interval [CI], 0.99-1.48). There were 118 deaths caused by ovarian cancer (3.1 per 10 000 person-years) in the intervention group and 100 deaths (2.6 per 10 000 person-years) in the usual care group (mortality RR, 1.18; 95% CI, 0.82-1.71). Of 3285 women with false-positive results, 1080 underwent surgical follow-up; of whom, 163 women experienced at least 1 serious complication (15%). There were 2924 deaths due to other causes (excluding ovarian, colorectal, and lung cancer) (76.6 per 10 000 person-years) in the intervention group and 2914 deaths (76.2 per 10 000 person-years) in the usual care group (RR, 1.01; 95% CI, 0.96-1.06). Conclusions Among women in the general US population, simultaneous screening with CA-125 and transvaginal ultrasound compared with usual care did not reduce ovarian cancer mortality. Diagnostic evaluation following a false-positive screening test result was associated with complications.	[Buys, Saundra S.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, Salt Lake City, UT USA; [Partridge, Edward; Fouad, Mona N.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Black, Amanda] NCI, Epidemiol & Biostat Program, NIH, Bethesda, MD 20892 USA; [Hartge, Patricia] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Pinsky, Paul F.; Zhu, Claire S.; Izmirlian, Grant; Prorok, Philip C.; Berg, Christine D.] NCI, Early Detect Res Grp, Biometry Res Grp, Div Canc Prevent,NIH, Bethesda, MD 20892 USA; [Kramer, Barnett S.] NCI, Off Commun & Educ, NIH, Bethesda, MD 20892 USA; [Gohagan, John K.] NIH, Off Dis Prevent, Bethesda, MD 20892 USA; [Johnson, Christine C.; Lamerato, Lois] Henry Ford Hlth Syst, Detroit, MI USA; [Isaacs, Claudine] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Reding, Douglas J.; Greenlee, Robert T.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Yokochi, Lance A.; Kessel, Bruce] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; Univ Colorado, Denver, CO 80202 USA; [Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Weissfeld, Joel L.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Chia, David] Univ Calif Los Angeles, Immunogenet Ctr, Los Angeles, CA USA; [O'Brien, Barbara; Ragard, Lawrence R.] Westat Corp, Rockville, MD USA; [Clapp, Jonathan D.; Rathmell, Joshua M.; Riley, Thomas L.] Informat Management Serv Inc, Rockville, MD USA; [Miller, Anthony B.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; Henry Ford Health System; Henry Ford Hospital; Georgetown University; Pacific Health Research & Education Institute; University of Colorado System; University of Colorado Denver; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Westat; Information Management Services, Inc.; University of Toronto	Berg, CD (corresponding author), Execut Plaza N,6130 Execut Blvd,MSC 7346,Room 311, Rockville, MD 20852 USA.	bergc@mail.nih.gov	Berg, Christine/K-1047-2014; Church, Timothy/AAH-7017-2020; Purdue, Mark P/C-9228-2016; Schliep, Karen C/A-2803-2012	Church, Timothy/0000-0003-3292-5035; Purdue, Mark P/0000-0003-1177-3108; Bresalier, Robert/0000-0002-9740-281X; Clapp, Jonathan/0000-0002-8058-5808; Johnson, Christine Cole/0000-0002-6864-6604	National Cancer Institute; Division of Cancer Prevention of the National Cancer Institute; Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025518, N01CN025513, N01CN025404, N01CN025524, N01CN025511, N01CN025522, N01CN075022, N01CN025516, N01CN025512, N01CN025515, N01CN025476, N01CN025514] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [N01CA075022, N01CA025516, N01CA025522, ZIACP010207] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Prevention of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The National Cancer Institute funded the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. This research also was supported by contracts from the Division of Cancer Prevention of the National Cancer Institute and by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics National Cancer Institute, National Institutes of Health, Department of Health and Human Services.	Ahlbom A, 1993, BIOSTATISTICS EPIDEM; [Anonymous], 2010, R LANG ENV STAT COMP; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Havrilesky LJ, 2011, CANCER-AM CANCER SOC, V117, P545, DOI 10.1002/cncr.25624; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Izmirlian G, ESTIMATION RELATIVE; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kobayashi H, 2008, INT J GYNECOL CANCER, V18, P414, DOI 10.1111/j.1525-1438.2007.01035.x; Menon U, 2005, J CLIN ONCOL, V23, P7919, DOI 10.1200/JCO.2005.01.6642; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Miller AB, 2000, CONTROL CLIN TRIALS, V21, p400S, DOI 10.1016/S0197-2456(00)00095-7; Partridge E, 2009, OBSTET GYNECOL, V113, P775, DOI 10.1097/AOG.0b013e31819cda77; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Proschan MA, 2006, STAT BIOL HEALTH, P1; Simpson NK, 2000, CONTROL CLIN TRIALS, V21, p356S, DOI 10.1016/S0197-2456(00)00102-1; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Stallings FL, 2000, CONTROL CLIN TRIALS, V21, p379S, DOI 10.1016/S0197-2456(00)00093-3; Weissfeld JL, 2000, CONTROL CLIN TRIALS, V21, p390S, DOI 10.1016/S0197-2456(00)00094-5	22	805	837	0	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2295	2303		10.1001/jama.2011.766	http://dx.doi.org/10.1001/jama.2011.766			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642681	Bronze			2022-12-28	WOS:000291349100022
J	Borgonie, G; Garcia-Moyano, A; Litthauer, D; Bert, W; Bester, A; van Heerden, E; Moller, C; Erasmus, M; Onstott, TC				Borgonie, G.; Garcia-Moyano, A.; Litthauer, D.; Bert, W.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.; Onstott, T. C.			Nematoda from the terrestrial deep subsurface of South Africa	NATURE			English	Article							WITWATERSRAND BASIN; EVOLUTION; WATER	Since its discovery over two decades ago, the deep subsurface biosphere has been considered to be the realm of single-cell organisms, extending over three kilometres into the Earth's crust and comprising a significant fraction of the global biosphere(1-4). The constraints of temperature, energy, dioxygen and space seemed to preclude the possibility of more-complex, multicellular organisms from surviving at these depths. Here we report species of the phylum Nematoda that have been detected in or recovered from 0.9-3.6-kilometre-deep fracture water in the deep mines of South Africa but have not been detected in the mining water. These subsurface nematodes, including a new species, Halicephalobus mephisto, tolerate high temperature, reproduce asexually and preferentially feed upon subsurface bacteria. Carbon-14 data indicate that the fracture water in which the nematodes reside is 3,000-12,000-year-old palaeometeoric water. Our data suggest that nematodes should be found in other deep hypoxic settings where temperature permits, and that they may control the microbial population density by grazing on fracture surface biofilm patches. Our results expand the known metazoan biosphere and demonstrate that deep ecosystems are more complex than previously accepted. The discovery of multicellular life in the deep subsurface of the Earth also has important implications for the search for subsurface life on other planets in our Solar System.	[Borgonie, G.; Bert, W.] Univ Ghent, Dept Biol, Nematol Sect, B-9000 Ghent, Belgium; [Garcia-Moyano, A.; Litthauer, D.; Bester, A.; van Heerden, E.; Moeller, C.; Erasmus, M.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, ZA-9300 Bloemfontein, South Africa; [Bert, W.] Wageningen Univ, Dept Plant Sci, Nematol Lab, NL-6708 Wageningen, Netherlands; [Onstott, T. C.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Ghent University; University of the Free State; Wageningen University & Research; Princeton University	Borgonie, G (corresponding author), Univ Ghent, Dept Biol, Nematol Sect, Ledeganckstr 35, B-9000 Ghent, Belgium.	gborgonie@gmail.com; tullis@princeton.edu	Bert, Wim/D-4511-2013; Erasmus, Mariana/AAE-9823-2019; Garcia-Moyano, Antonio/O-4791-2014; Garcia-Moyano, Antonio/AAI-8647-2020	Bert, Wim/0000-0002-5864-412X; Erasmus, Mariana/0000-0003-2191-762X; Garcia-Moyano, Antonio/0000-0003-1997-8589; Garcia-Moyano, Antonio/0000-0003-1997-8589; Onstott, Tullis/0000-0002-2898-3374	FWO; BOF; UFS; National Science Foundation [EAR 0409605]; BioPAD/UFS; Directorate For Geosciences [0948659] Funding Source: National Science Foundation	FWO(FWO); BOF; UFS; National Science Foundation(National Science Foundation (NSF)); BioPAD/UFS; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	G.B. is grateful to the University of Ghent for allowing a year-long sabbatical, and for grants from the FWO, BOF and UFS. We express our recognition of the support provided by Tau Tona gold mine (AngloGold Ashanti Limited), Driefontein gold mine (Gold Fields Limited), Beatrix gold mine (Gold Fields Limited), Zondereinde mine (Northern Platinum Ltd) and Star Diamonds mine (Petra Diamonds), and by the many people without whom this work would have been impossible. In particular, we are grateful to F. Rheeder, H. Moller, T. Lineque, A. Thwala, K. Sokhela, C. Rose, R. Fynn, B. Visser, O. Holovachev, T. Moens, M. Couvreur and A. Vierstraete. We are grateful to E. Botes and K. Albertyn of the University of the Free State for their contributions to the data analysis. T.C.O. acknowledges support from a National Science Foundation Continental Dynamics Program grant (EAR 0409605). E.v.H. acknowledges support from a BioPAD/UFS Metagenomics Platform grant.	Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dorris M, 1999, PARASITOL TODAY, V15, P188, DOI 10.1016/S0169-4758(99)01439-8; Edwards KJ, 2005, TRENDS MICROBIOL, V13, P449, DOI 10.1016/j.tim.2005.07.005; Ekendahl S, 2003, MICROB ECOL, V46, P416, DOI 10.1007/s00248-003-2008-5; Engel AS, 2007, J CAVE KARST STUD, V69, P187; Ferris H, 1997, SOIL BIOL BIOCHEM, V29, P1183, DOI 10.1016/S0038-0717(97)00035-7; Foll RL, 1999, COMP BIOCHEM PHYS B, V124, P269, DOI 10.1016/S0305-0491(99)00130-3; Gihring TM, 2006, GEOMICROBIOL J, V23, P415, DOI 10.1080/01490450600875696; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; HOEPPLI R., 1932, HONG KONG NATURALIST SUPPL, V1, P15; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; JANA BB, 1973, HYDROBIOLOGIA, V41, P291, DOI 10.1007/BF00016623; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Michel RL, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P53, DOI 10.1007/1-4020-3023-1_5; Moser DP, 2005, APPL ENVIRON MICROB, V71, P8773, DOI 10.1128/AEM.71.12.8773-8783.2005; Neher D. A., 2004, ENCY SOILS ENV, V3, P1; Ocana A., 1991, Nematologia Mediterranea, V19, P25; Onstott TC, 2006, GEOMICROBIOL J, V23, P369, DOI 10.1080/01490450600875688; Onstott T. C., 1998, ENIGMATIC MICROORGAN, P487; PEDERSEN K, 1993, EARTH-SCI REV, V34, P243, DOI 10.1016/0012-8252(93)90058-F; PHELPS TJ, 1994, MICROBIAL ECOL, V28, P335, DOI 10.1007/BF00662027; SINCLAIR JL, 1989, GEOMICROBIOL J, V7, P15, DOI 10.1080/01490458909377847; Van Voorhies WA, 1999, P NATL ACAD SCI USA, V96, P11399, DOI 10.1073/pnas.96.20.11399; Van Voorhies WA, 2000, J EXP BIOL, V203, P2467; Wanger G, 2006, GEOMICROBIOL J, V23, P443, DOI 10.1080/01490450600875746; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; YEATES GW, 1993, J NEMATOL, V25, P315	29	125	135	0	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					79	82		10.1038/nature09974	http://dx.doi.org/10.1038/nature09974			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637257	Green Published			2022-12-28	WOS:000291156700041
J	De Stefani, D; Raffaello, A; Teardo, E; Szabo, I; Rizzuto, R				De Stefani, Diego; Raffaello, Anna; Teardo, Enrico; Szabo, Ildiko; Rizzuto, Rosario			A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter	NATURE			English	Article							ENDOPLASMIC-RETICULUM; INDUCED APOPTOSIS; CA2+ CHANNELS; COLOCALIZATION; PROPAGATION; ACTIVATION; DYNAMICS; CONTACTS; FEEDBACK; SIGNALS	Mitochondrial Ca(2+) homeostasis has a key role in the regulation of aerobic metabolism and cell survival(1), but the molecular identity of the Ca(2+) channel, the mitochondrial calcium uniporter(2), is still unknown. Here we have identified in silico a protein (named MCU) that shares tissue distribution with MICU1 (also known as CBARA1), a recently characterized uniporter regulator(3), is present in organisms in which mitochondrial Ca(2+) uptake was demonstrated and whose sequence includes two transmembrane domains. Short interfering RNA (siRNA) silencing of MCU in HeLa cells markedly reduced mitochondrial Ca(2+) uptake. MCU overexpression doubled the matrix Ca(2+) concentration increase evoked by inositol 1,4,5-trisphosphate-generating agonists, thus significantly buffering the cytosolic elevation. The purified MCU protein showed channel activity in planar lipid bilayers, with electrophysiological properties and inhibitor sensitivity of the uniporter. A mutant MCU, in which two negatively charged residues of the putative pore-forming region were replaced, had no channel activity and reduced agonist-dependent matrix Ca(2+) concentration transients when overexpressed in HeLa cells. Overall, these data demonstrate that the 40-kDa protein identified is the channel responsible for ruthenium-red-sensitive mitochondrial Ca(2+) uptake, thus providing a molecular basis for this process of utmost physiological and pathological relevance.	[De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [De Stefani, Diego; Raffaello, Anna; Rizzuto, Rosario] Univ Padua, Inst Neurosci, CNR, I-35121 Padua, Italy; [Teardo, Enrico; Szabo, Ildiko] Univ Padua, Dept Biol, Padua, Italy	University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Padua	Rizzuto, R (corresponding author), Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy.	rosario.rizzuto@unipd.it	Szabo, Ildiko/AAW-5972-2021; Padova, Ildiko/K-5344-2016; Raffaello, Anna/K-7052-2016; De Stefani, Diego/I-7715-2015	Szabo, Ildiko/0000-0002-3637-3947; De Stefani, Diego/0000-0003-3796-8907; Rizzuto, Rosario/0000-0001-7044-5097; RAFFAELLO, ANNA/0000-0002-8344-6459	Italian Ministry of Education, University and Research; European Commission [223576]; National Institutes of Health [1P01AG025532-01A1]; Cariparo Foundation (Padua); Italian Association for Cancer Research (AIRC); Telethon-Italy [GPP1005]; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cariparo Foundation (Padua)(Fondazione Cariparo); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy(Fondazione Telethon); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Zoratti for help in the analysis of electrophysiological data, G. Merli for carrying out some of the experiments and P. Bernardi, T. Pozzan and L. Cendron for helpful discussions and for the N33-D1cpV expression plasmid (T. Pozzan). This research was supported by grants from the Italian Ministry of Education, University and Research, European Commission (FP7 "MyoAGE", no. 223576), National Institutes of Health (Grant #1P01AG025532-01A1), Cariparo Foundation (Padua), the Italian Association for Cancer Research (AIRC) and Telethon-Italy (GPP1005).	BENAIM G, 1990, MOL BIOCHEM PARASIT, V39, P61, DOI 10.1016/0166-6851(90)90008-A; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carafoli E, 2003, TRENDS BIOCHEM SCI, V28, P175, DOI 10.1016/S0968-0004(03)00053-7; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Hajnoczky G, 1999, J BIOL CHEM, V274, P14157, DOI 10.1074/jbc.274.20.14157; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Michels G, 2009, CIRCULATION, V119, P2435, DOI 10.1161/CIRCULATIONAHA.108.835389; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Pinton P, 2007, METHOD CELL BIOL, V80, P297, DOI 10.1016/S0091-679X(06)80015-4; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szabo I, 2011, CELL DEATH DIFFER, V18, P427, DOI 10.1038/cdd.2010.112; Teardo E, 2010, CELL PHYSIOL BIOCHEM, V26, P253, DOI 10.1159/000320525; Tinel H, 1999, EMBO J, V18, P4999, DOI 10.1093/emboj/18.18.4999; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Xiong ZH, 1997, J BIOL CHEM, V272, P31022, DOI 10.1074/jbc.272.49.31022	32	1277	1291	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					336	U104		10.1038/nature10230	http://dx.doi.org/10.1038/nature10230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685888	Green Accepted			2022-12-28	WOS:000294206500039
J	van Rooij, WJ; Sluzewski, M; Peluso, JP				van Rooij, Willem Jan; Sluzewski, Menno; Peluso, Jo P.			Rupture of a giant carotid-ophthalmic aneurysm	LANCET			English	Editorial Material									[van Rooij, Willem Jan; Sluzewski, Menno; Peluso, Jo P.] St Elizabeth Hosp, Dept Radiol, NL-5062 JG Tilburg, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ)	van Rooij, WJ (corresponding author), St Elizabeth Hosp, Dept Radiol, Hilvarenbeeksewg 60, NL-5062 JG Tilburg, Netherlands.	wjjvanrooij@gmail.com		Sluzewski, Menno/0000-0002-3949-5958					0	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 2	2011	378	9785					56	56		10.1016/S0140-6736(10)61261-5	http://dx.doi.org/10.1016/S0140-6736(10)61261-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21641027				2022-12-28	WOS:000292659700034
J	Coiera, E				Coiera, Enrico			Why system inertia makes health reform so difficult	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPETING DEMANDS; CLINICAL INERTIA; PATIENT SAFETY; DIABETES CARE; IMPROVE; INTERVENTIONS; PERFORMANCE; DECISION; QUALITY; TRIALS		Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia	University of New South Wales Sydney	Coiera, E (corresponding author), Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia.	e.coiera@unsw.edu.au		Coiera, Enrico/0000-0002-6444-6584				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Albertos R, 2011, CURR OPIN GASTROEN, V27, P160, DOI 10.1097/MOG.0b013e32834373b1; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Bell CM, 2007, CAN MED ASSOC J, V176, P1717, DOI 10.1503/cmaj.070472; Braithwaite J, 2005, J ROY SOC MED, V98, P542, DOI 10.1258/jrsm.98.12.542; Braithwaite J, 2010, J ROY SOC MED, V103, P219, DOI 10.1258/jrsm.2010.100032; Coiera E, 2009, QUAL SAF HEALTH CARE, V18, P99, DOI 10.1136/qshc.2007.025833; Coiera E, 2001, MED J AUSTRALIA, V174, P467, DOI 10.5694/j.1326-5377.2001.tb143376.x; Dattee B, J HLTH SERV RES S2, V15, P19; Dunn AG, 2011, J AM MED INFORM ASSN, V18, P259, DOI 10.1136/amiajnl-2010-000075; FULLBROOK P, 2003, NURS CRIT CARE, V8, P249; Gall J, 2003, SYSTEMS BIBLE BEGINN; Genschel P, 1997, GOVERNANCE, V10, P43, DOI 10.1111/0952-1895.281996028; Grant RW, 2009, J AM BOARD FAM MED, V22, P513, DOI 10.3122/jabfm.2009.05.080232; Grimshaw JM, 2004, MED J AUSTRALIA, V180, pS50; HANNAN MT, 1984, AM SOCIOL REV, V49, P149, DOI 10.2307/2095567; Hofer TP, 2004, J GEN INTERN MED, V19, P646, DOI 10.1007/s11606-004-0058-0; JAEN CR, 1994, J FAM PRACTICE, V38, P166; Jaen CR, 2001, J FAM PRACTICE, V50, P859; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kauffman S.A., 1993, ORIGINS ORDER; Klinkman MS, 1997, GEN HOSP PSYCHIAT, V19, P98, DOI 10.1016/S0163-8343(96)00145-4; Lee SYD, 1999, HEALTH SERV RES, V34, P923; McShea D. W., 2010, BIOL 1 LAW; Nutting P A, 2001, J Am Board Fam Pract, V14, P352; O'Connor PJ, 2005, HEALTH SERV RES, V40, P1854, DOI 10.1111/j.1475-6773.2005.00437.x; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Purola T, 1972, Med Care, V10, P373, DOI 10.1097/00005650-197209000-00001; Rivkin J. W., 2002, Complexity, V7, P31, DOI 10.1002/cplx.10037; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Ruef M, 1997, STRATEGIC MANAGE J, V18, P837, DOI 10.1002/(SICI)1097-0266(199712)18:11<837::AID-SMJ917>3.0.CO;2-B; Safford MM, 2007, J GEN INTERN MED, V22, P1648, DOI 10.1007/s11606-007-0433-8; Simon H.A., 1956, PSYCHOL REV, V63, P1129; Stange KC, 2007, ANN FAM MED, V5, P371, DOI 10.1370/afm.734; van Bruggen R, 2009, FAM PRACT, V26, P428, DOI 10.1093/fampra/cmp053; [No title captured]	38	61	61	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 23	2011	342								d3693	10.1136/bmj.d3693	http://dx.doi.org/10.1136/bmj.d3693			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AU	21700652				2022-12-28	WOS:000292200600002
J	Perry, DC; Harper, AR; Bruce, CE				Perry, Daniel C.; Harper, Aenone R.; Bruce, Colin E.			A limping child	BRITISH MEDICAL JOURNAL			English	Editorial Material							CALVE-PERTHES-DISEASE		[Perry, Daniel C.; Bruce, Colin E.] Univ Liverpool, Liverpool L12 2AP, Merseyside, England; [Perry, Daniel C.; Bruce, Colin E.] Alder Hey Hosp, Liverpool L12 2AP, Merseyside, England; [Harper, Aenone R.] Mersey Deanery, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Perry, DC (corresponding author), Univ Liverpool, Liverpool L12 2AP, Merseyside, England.	danperry@doctors.org.uk						CATTERALL A, 1982, J BONE JOINT SURG BR, V64, P269, DOI 10.1302/0301-620X.64B3.6807991; Chell J, 2001, ANN ROY COLL SURG, V83, P186; HALL AJ, 1984, AM J EPIDEMIOL, V120, P531, DOI 10.1093/oxfordjournals.aje.a113913; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2103, DOI 10.2106/00004623-200410000-00001; Herring JA, 2004, J BONE JOINT SURG AM, V86A, P2121, DOI 10.2106/00004623-200410000-00002; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; PERRY D, 2010, BRIT MED J, V351, pC4250; STULBERG SD, 1981, J BONE JOINT SURG AM, V63, P1095, DOI 10.2106/00004623-198163070-00006; SUTHERLAND DH, 1980, J BONE JOINT SURG AM, V62, P336, DOI 10.2106/00004623-198062030-00004; WALDENSTROM H, 1923, ACTA CHIR SCAND, V55, P577	10	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3565	10.1136/bmj.d3565	http://dx.doi.org/10.1136/bmj.d3565			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AT	21697233				2022-12-28	WOS:000292200500002
J	Watts, G				Watts, Geoff			Profile Leonard Hayflick and the limits of ageing	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk							0	10	10	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2075	2075		10.1016/S0140-6736(11)60908-2	http://dx.doi.org/10.1016/S0140-6736(11)60908-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21684371				2022-12-28	WOS:000292117800015
J	Costello, DJ; Gonzalez, RG; Frosch, MP				Costello, Daniel J.; Gonzalez, R. Gilberto; Frosch, Matthew P.			Case 18-2011: A 35-Year-Old HIV-Positive Woman with Headache and Altered Mental Status	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNODEFICIENCY-VIRUS-INFECTION; IMMUNE RECONSTITUTION; ANTIRETROVIRAL TREATMENT; LEUKOENCEPHALOPATHY; TOXOPLASMOSIS; RESTORATION; DISORDERS; HIV/AIDS; STEROIDS		[Costello, Daniel J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Frosch, Matthew P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Costello, Daniel J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Frosch, Matthew P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Costello, DJ (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861; Costello, Daniel/0000-0001-6023-8246	Penumbra	Penumbra	Dr. Gonzalez reports receiving grant support from Penumbra. No other potential conflict of interest relevant to this article was reported. Dr. Costello's current affiliation is the Department of Neurology, Cork University Hospital, and University College Cork, Cork, Ireland.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Crum NF, 2006, AIDS, V20, P466, DOI 10.1097/01.aids.0000196173.42680.5f; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Everall IP, 1999, BRAIN PATHOL, V9, P209; Foulon G, 2004, CLIN INFECT DIS, V38, P418, DOI 10.1086/381094; FRENCH MAH, 1992, AIDS, V6, P1293, DOI 10.1097/00002030-199211000-00009; French MA, 2009, CLIN INFECT DIS, V48, P101, DOI 10.1086/595006; Gray F, 2005, J NEUROVIROL, V11, P16, DOI 10.1080/13550280500511741; Intalapaporn Poj, 2006, J Infect, V53, pe79, DOI 10.1016/j.jinf.2005.10.011; Janowicz DM, 2005, J NEUROL NEUROSUR PS, V76, P891, DOI 10.1136/jnnp.2004.058438; Johnson T, 2010, ANN NY ACAD SCI, V1184, P106, DOI 10.1111/j.1749-6632.2009.05111.x; Koralnik IJ, 1999, NEUROLOGY, V52, P253, DOI 10.1212/WNL.52.2.253; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; McCombe JA, 2009, NEUROLOGY, V72, P835, DOI 10.1212/01.wnl.0000343854.80344.69; Miller RF, 2004, ACTA NEUROPATHOL, V108, P17, DOI 10.1007/s00401-004-0852-0; Newsome SD, 2009, J NEUROVIROL, V15, P288, DOI 10.1080/13550280902913610; Pfeffer G, 2009, NEUROLOGY, V73, P321, DOI 10.1212/WNL.0b013e3181af788e; Plentz A, 2008, INFECTION, V36, P158, DOI 10.1007/s15010-007-6354-y; Rushing EJ, 2008, J NEUROPATH EXP NEUR, V67, P819, DOI 10.1097/NEN.0b013e318181b4da; Silver B, 1997, ARCH NEUROL-CHICAGO, V54, P647, DOI 10.1001/archneur.1997.00550170115023; Tan K, 2009, NEUROLOGY, V72, P1458, DOI 10.1212/01.wnl.0000343510.08643.74; Tremont-Lukats IW, 2009, ANN INTERN MED, V150, P656, DOI 10.7326/0003-4819-150-9-200905050-00025; Venkataramana A, 2006, NEUROLOGY, V67, P383, DOI 10.1212/01.wnl.0000227922.22293.93; Wendel KA, 2003, CLIN INFECT DIS, V37, P1107, DOI 10.1086/378300	25	8	8	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2343	2352		10.1056/NEJMcpc1007104	http://dx.doi.org/10.1056/NEJMcpc1007104			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675893				2022-12-28	WOS:000291643800014
J	Chambers, SM; Studer, L				Chambers, Stuart M.; Studer, Lorenz			Cell Fate Plug and Play: Direct Reprogramming and Induced Pluripotency	CELL			English	Review							EMBRYONIC STEM-CELLS; DIRECT CONVERSION; DEFINED FACTORS; IPS CELLS; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; PROGENITORS	Building on the discovery that MyoD expression reprograms fibroblasts into muscle, three papers (Vierbuchen et al., 2010; Ieda et al., 2010; Szabo et al., 2010) recently reported the reprogramming of fibroblasts into neurons, cardiomyocytes, and blood cell progenitors without first passing the cells through a pluripotent state. Here we discuss the advantages and challenges of harnessing this direct reprogramming method for regenerative medicine.	[Chambers, Stuart M.; Studer, Lorenz] Sloan Kettering Inst, Ctr Stem Cell Biol, New York, NY 10065 USA; [Chambers, Stuart M.; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Chambers, SM (corresponding author), Sloan Kettering Inst, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10065 USA.	chambers@mskcc.org; studerl@mskcc.org	Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987				Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Papapetrou EP, 2011, NAT BIOTECHNOL, V29, P73, DOI 10.1038/nbt.1717; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	18	90	91	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					827	830		10.1016/j.cell.2011.05.036	http://dx.doi.org/10.1016/j.cell.2011.05.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663788	Bronze			2022-12-28	WOS:000291461600010
J	Davis, M; Chew, MK; Hobbs, RJ; Lugo, AE; Ewel, JJ; Vermeij, GJ; Brown, JH; Rosenzweig, ML; Gardener, MR; Carroll, SP; Thompson, K; Pickett, STA; Stromberg, JC; Del Tredici, P; Suding, KN; Ehrenfeld, JG; Grime, JP; Mascaro, J; Briggs, JC				Davis, Mark; Chew, Matthew K.; Hobbs, Richard J.; Lugo, Ariel E.; Ewel, John J.; Vermeij, Geerat J.; Brown, James H.; Rosenzweig, Michael L.; Gardener, Mark R.; Carroll, Scott P.; Thompson, Ken; Pickett, Steward T. A.; Stromberg, Juliet C.; Del Tredici, Peter; Suding, Katharine N.; Ehrenfeld, Joan G.; Grime, J. Philip; Mascaro, Joseph; Briggs, John C.			Don't judge species on their origins	NATURE			English	Editorial Material							SCIENTISTS; MANAGEMENT		[Davis, Mark] Macalester Coll, St Paul, MN 55105 USA	Macalester College	Davis, M (corresponding author), Macalester Coll, St Paul, MN 55105 USA.	davis@macalester.edu	Hobbs, Richard J/F-5883-2010; Suding, Katharine/O-6290-2017	Hobbs, Richard J/0000-0003-4047-3147; Suding, Katharine/0000-0002-5357-0176; Carroll, Scott/0000-0003-2094-9398				Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Chew MK, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P35; Chew MK, 2009, J HIST BIOL, V42, P231, DOI 10.1007/s10739-009-9181-4; Davis M. A., 2009, INVASION BIOL; Fleishman E, 2011, BIOSCIENCE, V61, P290, DOI 10.1525/bio.2011.61.4.9; Gardener MR, 2010, RANGELAND J, V32, P407, DOI 10.1071/RJ10029; Gleditsch JM, 2011, DIVERS DISTRIB, V17, P244, DOI 10.1111/j.1472-4642.2010.00733.x; Stromberg JC, 2009, RESTOR ECOL, V17, P177, DOI 10.1111/j.1526-100X.2008.00514.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	10	630	654	7	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					153	154		10.1038/474153a	http://dx.doi.org/10.1038/474153a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654782				2022-12-28	WOS:000291397800026
J	Weatherall, DJ				Weatherall, D. J.			The art of medicine The quiet art revisited	LANCET			English	Editorial Material									Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Weatherall, DJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	liz.rose@imm.ox.ac.uk						Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; DEWHURST K, 1970, OXFORD MED, P23; HARVEY AM, 1989, MODEL ITS KIND CENTE, V1, P7; HORGAN J, 2007, END SCI; Horton Richard C., 2003, 2 OPINION DOCTORS DI; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Weatherall D J, 2010, Notes Rec R Soc Lond, V64 Suppl 1, pS5; WEATHERALL DJ, 1995, SCI QUIET ART ROLE R	8	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2011	377	9781					1912	1913		10.1016/S0140-6736(11)60800-3	http://dx.doi.org/10.1016/S0140-6736(11)60800-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	777LW	21648122				2022-12-28	WOS:000291623200016
J	Heath, I				Heath, Iona			LIFE AND DEATH Are policy makers really listening?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.	iona.heath22@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 2	2011	342								d3218	10.1136/bmj.d3218	http://dx.doi.org/10.1136/bmj.d3218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774MO	21636634				2022-12-28	WOS:000291390900002
J	Turner, SL; Li, N; Guda, T; Githure, J; Carde, RT; Ray, A				Turner, Stephanie Lynn; Li, Nan; Guda, Tom; Githure, John; Carde, Ring T.; Ray, Anandasankar			Ultra-prolonged activation of CO2-sensing neurons disorients mosquitoes	NATURE			English	Article							CARBON-DIOXIDE; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; MAXILLARY PALP; DROSOPHILA; INSECT; DEET; RECEPTORS; RESPONSES; DIPTERA	Carbon dioxide (CO2) present in exhaled air is the most important sensory cue for female blood-feeding mosquitoes, causing activation of long-distance host-seeking flight, navigation towards the vertebrate host(1) and, in the case of Aedes aegypti, increased sensitivity to skin odours(2). The CO2 detection machinery is therefore an ideal target to disrupt host seeking. Here we use electrophysiological assays to identify a volatile odorant that causes an unusual, ultra-prolonged activation of CO2-detecting neurons in three major disease-transmitting mosquitoes: Anopheles gambiae, Culex quinquefasciatus and A. aegypti. Importantly, ultra-prolonged activation of these neurons severely compromises their ability subsequently to detect CO2 for several minutes. We also identify odours that strongly inhibit CO2-sensitive neurons as candidates for use in disruption of host-seeking behaviour, as well as an odour that evokes CO2-like activity and thus has potential use as a lure in trapping devices. Analysis of responses to panels of structurally related odours across the three mosquitoes and Drosophila, which have related CO2-receptor proteins, reveals a pattern of inhibition that is often conserved. We use video tracking in wind-tunnel experiments to demonstrate that the novel ultra-prolonged activators can completely disrupt CO2-mediated activation as well as source-finding behaviour in Aedes mosquitoes, even after the odour is no longer present. Lastly, semi-field studies demonstrate that use of ultra-prolonged activators disrupts CO2-mediated hut entry behaviour of Culex mosquitoes. The three classes of CO2-response-modifying odours offer powerful instruments for developing new generations of insect repellents and lures, which even in small quantities can interfere with the ability of mosquitoes to seek humans.	[Turner, Stephanie Lynn; Ray, Anandasankar] Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA; [Li, Nan; Carde, Ring T.; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Guda, Tom; Githure, John] ICIPE, Human Hlth Div, Nairobi, Kenya	University of California System; University of California Riverside; University of California System; University of California Riverside; International Centre of Insect Physiology & Ecology (ICIPE)	Ray, A (corresponding author), Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH) [R01AI087785]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087785] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; NIAID (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank E. Lacey and S. McInally for help setting up behaviour experiments; the Malaria Group team members in ICIPE Mbita Point Research Station, Y. Afrane and G. Yan for logistical support; S. M. Boyle for help with Pharmacophores; K. Klingler for help with statistics; J. Perecko for building traps and excitorepellency chambers; A. Dahanukar and G. Tauxe for comments on the manuscript; W. Walton, P. Atkinson, P. Wirth and A. Khalon for mosquitoes. Part of this work was funded by a grant to A. Ray from the Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative, and part supported by a grant to A. Ray, Award Number R01AI087785, from the NIAID (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID or NIH.	Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; Carde RT, 2010, ECOL CONT VECTOR-BOR, V2, P115; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Grant AJ, 1996, CIBA F SYMP, V200, P233; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Klun JA, 2004, J MED ENTOMOL, V41, P418, DOI 10.1603/0022-2585-41.3.418; Krajick K, 2006, SCIENCE, V313, P36, DOI 10.1126/science.313.5783.36; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noosidum A, 2008, J VECTOR ECOL, V33, P305, DOI 10.3376/1081-1710-33.2.305; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rostelien T, 2000, CHEM SENSES, V25, P141, DOI 10.1093/chemse/25.2.141; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zollner GE, 2004, PHYSIOL ENTOMOL, V29, P381, DOI 10.1111/j.0307-6962.2004.00399.x; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	30	115	124	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					87	U114		10.1038/nature10081	http://dx.doi.org/10.1038/nature10081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637258	Green Accepted, Green Submitted			2022-12-28	WOS:000291156700043
J	Nielsen, SF; Hjorthoj, CR; Erlangsen, A; Nordentoft, M				Nielsen, Sandra Feodor; Hjorthoj, Carsten Rygaard; Erlangsen, Annette; Nordentoft, Merete			Psychiatric disorders and mortality among people in homeless shelters in Denmark: a nationwide register-based cohort study	LANCET			English	Article							10-YEAR FOLLOW-UP; MENTAL-DISORDERS; STREET YOUTH; RISK-FACTORS; ADULTS; DEATH; SCHIZOPHRENIA; STOCKHOLM; WOMEN; PREVALENCE	Background The increased mortality of homeless people compared with non-homeless people might be linked to psychiatric disorders. However, homeless people are, because of their insufficient accommodation, difficult to sample and monitor, which has limited previous studies. We aimed to assess registered psychiatric disorders, mortality, and predictors of mortality in the homeless shelter population in Denmark. Methods We did a nationwide, prospective, register-based cohort study of homeless people aged 16 years and older who were registered in the Danish Homeless Register between Jan 1, 1999, and Dec 31, 2009. We calculated the proportion of registered psychiatric disorders, overall and cause-specific standardised mortality ratio (SMR), and life expectancy. Hazard ratios (HRs) were used to assess predictors of death. Findings 32 711 homeless people (23 040 men and 9671 women) were included in the study population. 14 381 men (62.4%) and 5632 women (58.2%) had registered psychiatric disorders, and 11 286 men (49.0%) and 3564 women (36.9%) had a substance abuse diagnosis. During the study period, 3839 men (16.7%) and 951 women (9.8%) died. The overall SMR for men was 5.6 (95% CI 5.4-5.8) and for women was 6.7 (6.2-7.1), and external causes accounted for 1161 (27.9%) of 4161 deaths for which information on the cause was available. Remaining life expectancy at age 15-24 years was 21.6 years (95% CI 21.2-22.1) and 17.4 years (16.4-18.5) lower for homeless men and women, respectively, than the general population. Registered substance abuse disorder was associated with the highest mortality risk compared with no psychiatric contact registered (adjusted HR 1.4, 95% CI 1.3-1.5 for men; 1.7, 1.4-2.1 for women). Interpretation Health problems are extensive in the homeless shelter population and there is an urgent need for more sustained efforts to reduce the high morbidity and mortality, especially from external causes. Register data is an important resource to supplement existing knowledge on homeless people with more valid and detailed information.	[Nielsen, Sandra Feodor] Univ Copenhagen, Mental Hlth Ctr Copenhagen, Res Unit, DK-2400 Copenhagen NV, Denmark; [Nielsen, Sandra Feodor; Hjorthoj, Carsten Rygaard; Erlangsen, Annette; Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, DK-2400 Copenhagen NV, Denmark; [Erlangsen, Annette] Johns Hopkins Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA	University of Copenhagen; University of Copenhagen; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Nielsen, SF (corresponding author), Univ Copenhagen, Mental Hlth Ctr Copenhagen, Res Unit, Bispebjerg Bakke 23,Opg 13A,3rd Floor, DK-2400 Copenhagen NV, Denmark.	frkfeodor@hotmail.com	Nordentoft, Merete/AAH-3253-2019; Erlangsen, Annette/ABE-1547-2021; Erlangsen, Annette/A-7153-2017	Erlangsen, Annette/0000-0003-3475-0558; Erlangsen, Annette/0000-0003-3475-0558; Hjorthoj, Carsten/0000-0002-6943-4785; Nilsson, Sandra Feodor/0000-0002-7598-5014; Nordentoft, Merete/0000-0003-4895-7023	Danish Council for Independent Research; Danish Council for Independent Research (DFF) [10-080986]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Danish Council for Independent Research (DFF)(Det Frie Forskningsrad (DFF))	This study was funded by the Danish Council for Independent Research (DFF) (10-080986).	ALSTROM CH, 1975, BRIT J ADDICT, V70, P245; [Anonymous], 2010, DAN HOM REG; Babidge NC, 2001, ACTA PSYCHIAT SCAND, V103, P105, DOI 10.1034/j.1600-0447.2001.00192.x; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Beijer U, 2007, NORD J PSYCHIAT, V61, P363, DOI 10.1080/08039480701644637; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beijer U, 2010, EUR J PUBLIC HEALTH, V20, P511, DOI 10.1093/eurpub/ckq033; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; CHIANG CL, 1983, LIFE TABLE ITS APPL; Chiu S, 2009, J EPIDEMIOL COMMUN H, V63, P943, DOI 10.1136/jech.2009.088468; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Folsom DP, 2005, AM J PSYCHIAT, V162, P370, DOI 10.1176/appi.ajp.162.2.370; HIBBS JR, 1994, NEW ENGL J MED, V331, P304, DOI 10.1056/NEJM199408043310506; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 1997, ANN INTERN MED, V126, P625, DOI 10.7326/0003-4819-126-8-199704150-00007; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; Juel K, 1999, DAN MED BULL, V46, P354; Kasprow WJ, 2000, J NERV MENT DIS, V188, P141, DOI 10.1097/00005053-200003000-00003; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P899, DOI 10.4088/JCP.v68n0612; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nordentoft M, 2003, BRIT MED J, V327, P81, DOI 10.1136/bmj.327.7406.81; Nyamathi AM, 2000, J GEN INTERN MED, V15, P565, DOI 10.1046/j.1525-1497.2000.07007.x; Pascual JC, 2008, GEN HOSP PSYCHIAT, V30, P14, DOI 10.1016/j.genhosppsych.2007.08.006; Pedersen CB, 2006, DAN MED BULL, V53, P441; Raoult D, 2001, Lancet Infect Dis, V1, P77, DOI 10.1016/S1473-3099(01)00062-7; Roy E, 2004, JAMA-J AM MED ASSOC, V292, P569, DOI 10.1001/jama.292.5.569; Shaw M, 1998, LANCET, V352, P743, DOI 10.1016/S0140-6736(05)60868-9; Statistic Denmark, 2006, STATB DENM FOD207 DE; Statistic Denmark, 1981, STATB DENM FOD5 DEAT; Statistic Denmark, 2007, STATB DENM FOD507 DE; Statistic Denmark, 1974, DENM STATB DENM FOD2; Statistic Denmark, 1990, STATB DENM BEF5 POP; van Laere I, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-208; van Laere IR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-3; Wahlbeck K, 2011, BRIT J PSYCHIAT, V199, P453, DOI 10.1192/bjp.bp.110.085100; *WHO, 1967, MAN INT CLASS DIS IC; Wilk J, 2006, J NERV MENT DIS, V194, P454, DOI 10.1097/01.nmd.0000221289.54911.63; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	40	132	134	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2205	2214		10.1016/S0140-6736(11)60747-2	http://dx.doi.org/10.1016/S0140-6736(11)60747-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	786XI	21676456				2022-12-28	WOS:000292340800033
J	Beaglehole, R; Bonita, R; Alleyne, G; Horton, R; Li, LM; Lincoln, P; Mbanya, JC; Mckee, M; Moodie, R; Nishtar, S; Piot, P; Reddy, KS; Stuckler, D				Beaglehole, Robert; Bonita, Ruth; Alleyne, George; Horton, Richard; Li, Liming; Lincoln, Paul; Mbanya, Jean Claude; McKee, Martin; Moodie, Rob; Nishtar, Sania; Piot, Peter; Reddy, K. Srinath; Stuckler, David		Lancet NCD Action Grp	UN High-Level Meeting on Non-Communicable Diseases: addressing four questions	LANCET			English	Article							CARDIOVASCULAR-DISEASE; LOW-INCOME; HEALTH; RISK; BURDEN	Non-communicable diseases (NCDs), principally heart disease, stroke, cancer, diabetes, and chronic respiratory diseases, are a global crisis and require a global response. Despite the threat to human development, and the availability of affordable, cost-effective, and feasible interventions, most countries, development agencies, and foundations neglect the crisis. The UN High-Level Meeting (UN HLM) on NCDs in September, 2011, is an opportunity to stimulate a coordinated global response to NCDs that is commensurate with their health and economic burdens. To achieve the promise of the UN HLM, several questions must be addressed. In this report, we present the realities of the situation by answering four questions: is there really a global crisis of NCDs; how is NCD a development issue; are affordable and cost-effective interventions available; and do we really need high-level leadership and accountability? Action against NCDs will support other global health and development priorities. A successful outcome of the UN HLM depends on the heads of states and governments attending the meeting, and endorsing and implementing the commitments to action. Long-term success requires inspired and committed national and international leadership.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London NW1 7BY, England; Peking Union Med Coll, Beijing 100021, Peoples R China; [Lincoln, Paul] Natl Heart Forum, London, England; [Mbanya, Jean Claude] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sania] HeartFile, Islamabad, Pakistan; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Stuckler, David] Harvard Univ, Boston, MA 02115 USA	University of Auckland; Pan American Health Organization; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of Melbourne; Public Health Foundation of India; Harvard University	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012; Mbanya, Jean Claude N/T-5147-2018; McKee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Stuckler, David/0000-0002-1288-8401; Moodie, Alan/0000-0002-8425-7975; Reddy, K Srinath/0000-0003-3416-3548; Mbanya, Jean Claude N/0000-0001-9651-8653; McKee, Martin/0000-0002-0121-9683				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; [Anonymous], 2011, 1 GLOB MIN C HLTH LI; [Anonymous], 2010, HLTH NUTR POPUL SER; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bissell K, 2010, SMOKING CESSATION SM; Blanco F, 2010, AIDS REV, V12, P231; Burki TK, 2011, LANCET, V377, P1559, DOI 10.1016/S0140-6736(11)60626-0; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Creswell J, 2011, EUR RESPIR J, V37, P1269, DOI 10.1183/09031936.00084310; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Egeland GM, 2010, DIABETIC MED, V27, P257, DOI 10.1111/j.1464-5491.2010.02944.x; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Lee PT, 2010, LANCET, V376, P516, DOI 10.1016/S0140-6736(10)61254-8; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Manderbacka K, 2011, PHARMACOEPIDEM DR S, V20, P338, DOI 10.1002/pds.2072; MWATSAMA M, 2010, RAISING POLITICAL PR; *NCD ALL, 2010, NONC DIS PRIOR WOM H; *NCD ALL, PROP OUTC STAT UN HI; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Organization WH, 2016, GLOBAL STATUS REPORT; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rabkin M, 2011, GLOB PUBLIC HEALTH, V6, P247, DOI 10.1080/17441692.2011.552068; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Shi WX, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-16; Stahl T., 2006, HLTH ALL POLICIES PR; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; STUCKLER D, SICK SOC RE IN PRESS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Suhrcke M., 2006, CHRONIC DIS EC PERSP; Suhrcke M, 2007, EC CONSEQUENCES NONC; *UN, 2010, PREV CONTR NONC DIS; *UN, 2001, UN GEN ASS SPEC SESS; WHO, 2010, MORT BURD DIS EST WH; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Economic Forum, 2011, GLOB RISKS 2011	43	256	271	0	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					449	455		10.1016/S0140-6736(11)60879-9	http://dx.doi.org/10.1016/S0140-6736(11)60879-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21665266				2022-12-28	WOS:000293615900036
J	Guilbaud, R; Butler, IB; Ellam, RM				Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.			Abiotic Pyrite Formation Produces a Large Fe Isotope Fractionation	SCIENCE			English	Article							IRON; REDOX; CONSTRAINTS; SEDIMENTS; MINERALS; OCEAN; REDUCTION; CHEMISTRY; FE(III); OXYGEN	The iron isotope composition of sedimentary pyrite has been proposed as a potential proxy to trace microbial metabolism and the redox evolution of the oceans. We demonstrate that Fe isotope fractionation accompanies abiotic pyrite formation in the absence of Fe(II) redox change. Combined fractionation factors between Fe(II)(aq), mackinawite, and pyrite permit the generation of pyrite with Fe isotope signatures that nearly encapsulate the full range of sedimentary delta(56)Fe(pyrite) recorded in Archean to modern sediments. We propose that Archean negative Fe isotope excursions reflect partial Fe(II)(aq) utilization during abiotic pyrite formation rather than microbial dissimilatory Fe(III) reduction. Late Proterozoic to modern sediments may reflect greater Fe(II)(aq) utilization and variations in source composition.	[Guilbaud, Romain; Butler, Ian B.] Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland; [Guilbaud, Romain; Butler, Ian B.; Ellam, Rob M.] Scottish Univ Environm Res Ctr, E Kilbride G75 0QF, Lanark, Scotland; [Ellam, Rob M.] ECOSSE, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh; Scottish Universities Research & Reactor Center	Guilbaud, R (corresponding author), Univ Edinburgh, Sch Geosci, Grant Inst, Edinburgh EH9 3JW, Midlothian, Scotland.	R.Guilbaud@sms.ed.ac.uk	Ellam, Rob M/B-7878-2009; Guilbaud, Romain/R-1428-2017	Ellam, Rob M/0000-0001-8159-4864; Guilbaud, Romain/0000-0001-9701-9522	ECOSSE; Natural Environment Research Council [NE/E003958/1]; NERC [NE/E003958/1] Funding Source: UKRI	ECOSSE; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by an ECOSSE Ph.D. studentship to R.G. and Natural Environment Research Council research grant NE/E003958/1 to I.B.B. We are thankful to K. Keefe, V. Gallagher, N. Odling, B. D. Roach, S. Mowbray, and C. Fricke for technical support and B. Ngwenya, A. Matthews, D. Rickard, A. McAnena, and M. Pekala for constructive discussions.	Anbar AD, 2000, SCIENCE, V288, P126, DOI 10.1126/science.288.5463.126; Anbar AD, 2007, ANNU REV EARTH PL SC, V35, P717, DOI 10.1146/annurev.earth.34.031405.125029; Archer C, 2006, GEOLOGY, V34, P153, DOI 10.1130/G22067.1; Butler IB, 2005, EARTH PLANET SC LETT, V236, P430, DOI 10.1016/j.epsl.2005.05.022; Butler IB, 2004, EARTH PLANET SC LETT, V228, P495, DOI 10.1016/j.epsl.2004.10.005; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Czaja AD, 2010, EARTH PLANET SC LETT, V292, P170, DOI 10.1016/j.epsl.2010.01.032; Duan Y, 2010, EARTH PLANET SC LETT, V290, P244, DOI 10.1016/j.epsl.2009.11.052; Guilbaud R, 2011, GEOCHIM COSMOCHIM AC, V75, P2721, DOI 10.1016/j.gca.2011.02.023; ISLEY AE, 1995, J GEOL, V103, P169, DOI 10.1086/629734; Johnson CM, 2008, ANNU REV EARTH PL SC, V36, P457, DOI 10.1146/annurev.earth.36.031207.124139; Johnson CM, 2005, GEOCHIM COSMOCHIM AC, V69, P963, DOI 10.1016/j.gca.2004.06.043; Li C, 2010, SCIENCE, V328, P80, DOI 10.1126/science.1182369; Luther GW, 2005, J NANOPART RES, V7, P389, DOI 10.1007/s11051-005-4272-4; Matthews A, 2004, GEOCHIM COSMOCHIM AC, V68, P3107, DOI 10.1016/j.gca.2004.01.019; McAnena A, 2009, GEOCHIM COSMOCHIM AC, V73, pA854; Polyakov VB, 2007, GEOCHIM COSMOCHIM AC, V71, P3833, DOI 10.1016/j.gca.2007.05.019; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Rickard D, 1997, GEOCHIM COSMOCHIM AC, V61, P135, DOI 10.1016/S0016-7037(96)00322-5; Rickard D, 2007, CHEM REV, V107, P514, DOI 10.1021/cr0503658; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; Rouxel OJ, 2010, GEOSTAND GEOANAL RES, V34, P135, DOI 10.1111/j.1751-908X.2010.00063.x; Schauble EA, 2004, REV MINERAL GEOCHEM, V55, P65, DOI 10.2138/gsrmg.55.1.65; Severmann S, 2006, GEOCHIM COSMOCHIM AC, V70, P2006, DOI 10.1016/j.gca.2006.01.007; Severmann S, 2008, GEOLOGY, V36, P487, DOI 10.1130/G24670A.1; Skulan JL, 2002, GEOCHIM COSMOCHIM AC, V66, P2995, DOI 10.1016/S0016-7037(02)00902-X; Yamaguchi KE, 2005, CHEM GEOL, V218, P135, DOI 10.1016/j.chemgeo.2005.01.020	29	104	113	1	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1548	1551		10.1126/science.1202924	http://dx.doi.org/10.1126/science.1202924			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700871	Green Accepted			2022-12-28	WOS:000291990000042
J	Gupta, S; Luo, XF; Mohanty, B; Ritter, HG; Xu, N				Gupta, Sourendu; Luo, Xiaofeng; Mohanty, Bedangadas; Ritter, Hans Georg; Xu, Nu			Scale for the Phase Diagram of Quantum Chromodynamics	SCIENCE			English	Article							QUARK-GLUON PLASMA; TRANSITION; QCD; FLUCTUATION; PERSPECTIVE; COLLISIONS	Matter described by quantum chromodynamics (QCD), the theory of strong interactions, may undergo phase transitions when its temperature and the chemical potentials are varied. QCD at finite temperature is studied in the laboratory by colliding heavy ions at varying beam energies. We present a test of QCD in the nonperturbative domain through a comparison of thermodynamic fluctuations predicted in lattice computations with the experimental data of baryon number distributions in high-energy heavy ion collisions. This study provides evidence for thermalization in these collisions and allows us to find the crossover temperature between normal nuclear matter and a deconfined phase called the quark gluon plasma. This value allows us to set a scale for the phase diagram of QCD.	[Mohanty, Bedangadas] Ctr Variable Energy Cyclotron, Expt High Energy Phys & Applicat Grp, Kolkata 700064, India; [Gupta, Sourendu] Tata Inst Fundamental Res, Dept Theoret Phys, Mumbai 400005, Maharashtra, India; [Luo, Xiaofeng] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Luo, Xiaofeng; Ritter, Hans Georg; Xu, Nu] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Nucl Sci, Berkeley, CA 94720 USA; [Xu, Nu] Cent China Normal Univ, Coll Phys Sci & Technol, Wuhan 430079, Peoples R China	Variable Energy Cyclotron Centre; Tata Institute of Fundamental Research (TIFR); Chinese Academy of Sciences; University of Science & Technology of China, CAS; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Central China Normal University	Mohanty, B (corresponding author), Ctr Variable Energy Cyclotron, Expt High Energy Phys & Applicat Grp, 1 AF Bidhan Nagar, Kolkata 700064, India.	bedanga@vecc.gov.in		Luo, Xiaofeng/0000-0002-4919-303X; Mohanty, Bedangadas/0000-0001-9610-2914	Department of Atomic Energy-Board of Research in Nuclear Sciences [2010/21/15-BRNS/2026]; U.S. Department of Energy [DE-AC03-76SF00098]; Chinese Ministry of Education	Department of Atomic Energy-Board of Research in Nuclear Sciences(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); U.S. Department of Energy(United States Department of Energy (DOE)); Chinese Ministry of Education(Ministry of Education, China)	We thank Z. Fodor, R. V. Gavai, F. Karsch, D. Keane, V. Koch, B. Mueller, K. Rajagopal, K. Redlich, H. Satz, and M. Stephanov for enlightening discussions. We acknowledge the Indian Lattice Gauge Theory Initiative for computational support, the Department of Atomic Energy-Board of Research in Nuclear Sciences through the project sanction 2010/21/15-BRNS/2026, the U.S. Department of Energy under contract DE-AC03-76SF00098, and the Chinese Ministry of Education.	Abelev BI, 2010, PHYS REV C, V81, DOI 10.1103/PhysRevC.81.024911; Abelev BI, 2009, PHYS REV C, V79, DOI 10.1103/PhysRevC.79.034909; Adams J, 2005, NUCL PHYS A, V757, P102, DOI 10.1016/j.nuclphysa.2005.03.085; Adcox K, 2005, NUCL PHYS A, V757, P184, DOI 10.1016/j.nuclphysa.2005.03.086; Aggarwal MM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.022302; Alford M, 1998, PHYS LETT B, V422, P247, DOI 10.1016/S0370-2693(98)00051-3; Aoki Y, 2006, PHYS LETT B, V643, P46, DOI 10.1016/j.physletb.2006.10.021; Aoki Y, 2006, NATURE, V443, P675, DOI 10.1038/nature05120; Aoki Y, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/06/088; Arsene I, 2005, NUCL PHYS A, V757, P1, DOI 10.1016/j.nuclphysa.2005.02.130; Asakawa M, 2000, PHYS REV LETT, V85, P2072, DOI 10.1103/PhysRevLett.85.2072; Back BB, 2005, NUCL PHYS A, V757, P28, DOI 10.1016/j.nuclphysa.2005.03.084; Berdnikov B, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.105017; Braun-Munzinger P, 2009, REV MOD PHYS, V81, P1031, DOI 10.1103/RevModPhys.81.1031; BROWN FR, 1988, PHYS REV LETT, V61, P2058, DOI 10.1103/PhysRevLett.61.2058; Cheng M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.054507; Cleymans J, 1998, PHYS REV LETT, V81, P5284, DOI 10.1103/PhysRevLett.81.5284; Gavai RV, 2011, PHYS LETT B, V696, P459, DOI 10.1016/j.physletb.2011.01.006; Gavai RV, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.034506; Gupta S., 2010, P SCI LATTICE2010, P007; Gupta S., 2009, POS CPOD2009, VCPOD2009, P025; Hatta Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.102003; Jeon S, 2000, PHYS REV LETT, V85, P2076, DOI 10.1103/PhysRevLett.85.2076; Karsch F, 2011, PHYS LETT B, V695, P136, DOI 10.1016/j.physletb.2010.10.046; Mohanty B, 2009, NUCL PHYS A, V830, p899C, DOI 10.1016/j.nuclphysa.2009.10.132; Peardon M, 2010, AIP CONF PROC, V1257, P19, DOI 10.1063/1.3483319; PISARSKI RD, 1984, PHYS REV D, V29, P338, DOI 10.1103/PhysRevD.29.338; Schmidt C., 2010, QUARK CONF HADR SPEC; Stephanov M, 1999, PHYS REV D, V60, DOI 10.1103/PhysRevD.60.114028; STERMAN G, 1995, REV MOD PHYS, V67, P157, DOI 10.1103/RevModPhys.67.157; Wilczek F, 2000, PHYS TODAY, V53, P13, DOI 10.1063/1.882927; Wilczek F, 1999, PHYS TODAY, V52, P11, DOI 10.1063/1.882562	32	227	232	4	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1525	1528		10.1126/science.1204621	http://dx.doi.org/10.1126/science.1204621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700867	Green Submitted			2022-12-28	WOS:000291990000036
J	Lederbogen, F; Kirsch, P; Haddad, L; Streit, F; Tost, H; Schuch, P; Wust, S; Pruessner, JC; Rietschel, M; Deuschle, M; Meyer-Lindenberg, A				Lederbogen, Florian; Kirsch, Peter; Haddad, Leila; Streit, Fabian; Tost, Heike; Schuch, Philipp; Wuest, Stefan; Pruessner, Jens C.; Rietschel, Marcella; Deuschle, Michael; Meyer-Lindenberg, Andreas			City living and urban upbringing affect neural social stress processing in humans	NATURE			English	Article							EARLY-LIFE STRESS; PSYCHOSOCIAL STRESS; GENETIC RISK; LIMBIC SYSTEM; SCHIZOPHRENIA; BRAIN; MECHANISMS; AMYGDALA; CORTEX; RESPONSES	More than half of the world's population now lives in cities, making the creation of a healthy urban environment amajor policy priority(1). Cities have both health risks and benefits(1), but mental health is negatively affected: mood and anxiety disorders are more prevalent in city dwellers(2) and the incidence of schizophrenia is strongly increased in people born and raised in cities(3-6). Although these findings have been widely attributed to the urban social environment(2,3,7,8), the neural processes that could mediate such associations are unknown. Here we show, using functional magnetic resonance imaging in three independent experiments, that urban upbringing and city living have dissociable impacts on social evaluative stress processing in humans. Current city living was associated with increased amygdala activity, whereas urban upbringing affected the perigenual anterior cingulate cortex, a key region for regulation of amygdala activity, negative affect(9) and stress(10). These findings were regionally and behaviourally specific, as no other brain structures were affected and no urbanicity effect was seen during control experiments invoking cognitive processing without stress. Our results identify distinct neural mechanisms for an established environmental risk factor, link the urban environment for the first time to social stress processing, suggest that brain regions differ in vulnerability to this risk factor across the lifespan, and indicate that experimental interrogation of epidemiological associations is a promising strategy in social neuroscience.	[Lederbogen, Florian; Kirsch, Peter; Haddad, Leila; Streit, Fabian; Tost, Heike; Schuch, Philipp; Wuest, Stefan; Rietschel, Marcella; Deuschle, Michael; Meyer-Lindenberg, Andreas] Univ Heidelberg, Cent Inst Mental Hlth, Fac Med, D-68159 Mannheim, Germany; [Pruessner, Jens C.] McGill Univ, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; McGill University	Meyer-Lindenberg, A (corresponding author), Univ Heidelberg, Cent Inst Mental Hlth, Fac Med, D-68159 Mannheim, Germany.	a.meyer-lindenberg@zi-mannheim.de	Deuschle, Michael/E-4638-2012; Tost, med. Dr. phil. Heike/AAX-8305-2020; Kirsch, Peter/C-2499-2008; Meyer-Lindenberg, Andreas/H-1076-2011	Kirsch, Peter/0000-0002-0817-1248; Pruessner, Jens/0000-0002-8582-2980; Streit, Fabian/0000-0003-1080-4339; Wust, Stefan/0000-0002-2315-8949; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	European Community [HEALTH-F2-2010-241909]; German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 636-B7]; Federal Ministry of Education and Research (MooDS)	European Community(European Commission); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Federal Ministry of Education and Research (MooDS)(Federal Ministry of Education & Research (BMBF))	We thank D. Gass and C. Niemeyer for technical assistance. We also thank C. Sauer, O. Grimm, M. Plichta and A. Schafer for support on data analyses. The research leading to these results has received funding from the European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-241909 (Project EU-GEI), German Research Foundation (Deutsche Forschungsgemeinschaft SFB 636-B7) and Federal Ministry of Education and Research (MooDS) to A.M.L. EU-GEI is an acronym for the project "European network of National Schizophrenia Networks Studying Gene-Environment Interactions''. F.S. is a member of the International Research Training Group "Psychoneuroendocrinology of Stress'', Institute of Psychobiology, University of Trier, Germany, granted by the German Research Foundation.	Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; DIORIO D, 1993, J NEUROSCI, V13, P3839; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Krabbendam L, 2005, SCHIZOPHRENIA BULL, V31, P795, DOI 10.1093/schbul/sbi060; Lederbogen F, 2010, EUR J ENDOCRINOL, V163, P443, DOI 10.1530/EJE-10-0491; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Meyer-Lindenberg A, 2010, NATURE, V468, P194, DOI 10.1038/nature09569; Mortensen PB, 1999, NEW ENGL J MED, V340, P603, DOI 10.1056/NEJM199902253400803; Pedersen CB, 2001, ARCH GEN PSYCHIAT, V58, P1039, DOI 10.1001/archpsyc.58.11.1039; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; Pruessner JC, 2008, BIOL PSYCHIAT, V63, P234, DOI 10.1016/j.biopsych.2007.04.041; Rasetti R, 2009, AM J PSYCHIAT, V166, P216, DOI 10.1176/appi.ajp.2008.08020261; Selten JP, 2005, BRIT J PSYCHIAT, V187, P101, DOI 10.1192/bjp.187.2.101; Spinelli S, 2009, ARCH GEN PSYCHIAT, V66, P658, DOI 10.1001/archgenpsychiatry.2009.52; van Os J, 2004, AM J PSYCHIAT, V161, P2312, DOI 10.1176/appi.ajp.161.12.2312; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vidal CN, 2006, ARCH GEN PSYCHIAT, V63, P25, DOI 10.1001/archpsyc.63.1.25; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	30	829	856	14	452	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					498	501		10.1038/nature10190	http://dx.doi.org/10.1038/nature10190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697947				2022-12-28	WOS:000291939700046
J	Kenfield, SA; Stampfer, MJ; Chan, JM; Giovannucci, E				Kenfield, Stacey A.; Stampfer, Meir J.; Chan, June M.; Giovannucci, Edward			Smoking and Prostate Cancer Survival and Recurrence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CIGARETTE-SMOKING; RADICAL PROSTATECTOMY; UNITED-STATES; HEALTH-PROFESSIONALS; EPITHELIAL-CELLS; MEN; RISK; CADMIUM; RADIOTHERAPY	Context Studies of smoking in relation to prostate cancer mortality or recurrence in prostate cancer patients are limited, with few prostate cancer-specific outcomes. Objective To assess the relation of cigarette smoking and smoking cessation with overall, prostate cancer-specific, and cardiovascular disease (CVD) mortality and biochemical recurrence among men with prostate cancer. Design, Setting, and Participants Prospective observational study of 5366 men diagnosed with prostate cancer between 1986 and 2006 in the Health Professionals Follow-Up Study. Main Outcome Measures Hazard ratios (HRs) for overall, prostate cancer-specific, and CVD mortality, and biochemical recurrence, defined by an increase in prostate-specific antigen (PSA) levels. Results There were 1630 deaths, 524 (32%) due to prostate cancer and 416 (26%) to CVD, and 878 biochemical recurrences. Absolute crude rates for prostate cancer-specific death for never vs current smokers were 9.6 vs 15.3 per 1000 person-years; for all-cause mortality, the corresponding rates were 27.3 and 53.0 per 1000 person-years. In multi-variable analysis, current vs never smokers had an increased risk of prostate cancer mortality (HR, 1.61; 95% confidence interval [CI], 1.11-2.32), as did current smokers with clinical stage T1 through T3 (HR, 1.80; 95% CI, 1.04-3.12). Current smokers also had increased risk of biochemical recurrence (HR, 1.61; 95% CI, 1.16-2.22), total mortality (HR, 2.28; 95% CI, 1.87-2.80), and CVD mortality (HR, 2.13; 95% CI, 1.39-3.26). After adjusting for clinical stage and grade (likely intermediates of the relation of smoking with prostate cancer recurrence and survival), current smokers had increased risk of prostate cancer mortality (HR, 1.38; 95% CI, 0.94-2.03), as did current smokers with clinical stage T1 through T3 (HR, 1.41; 95% CI, 0.80-2.49); they also had an increased risk of biochemical recurrence (HR, 1.47; 95% CI, 1.06-2.04). Greater number of pack-years was associated with significantly increased risk of prostate cancer mortality but not biochemical recurrence. Current smokers of 40 or more pack-years vs never smokers had increased prostate cancer mortality (HR, 1.82; 95% CI, 1.03-3.20) and biochemical recurrence (HR, 1.48; 95% CI, 0.88-2.48). Compared with current smokers, those who had quit smoking for 10 or more years (HR, 0.60; 95% CI, 0.42-0.87) or who have quit for less than 10 years but smoked less than 20 pack-years (HR, 0.64; 95% CI, 0.28-1.45) had prostate cancer mortality risks similar to never smokers (HR, 0.61; 95% CI, 0.42-0.88). Conclusions Smoking at the time of prostate cancer diagnosis is associated with increased overall and CVD mortality and prostate cancer-specific mortality and recurrence. Men who have quit for at least 10 years have prostate cancer-specific mortality risks similar to those who have never smoked. JAMA. 2011;305(24):2548-2555	[Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Channing Labs, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Med, Boston, MA USA; [Kenfield, Stacey A.; Stampfer, Meir J.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kenfield, Stacey A.; Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chan, June M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Chan, June M.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kenfield, SA (corresponding author), Channing Labs, Dept Med, Brigham & Womens Hosp, 181 Longwood Ave,Room 452, Boston, MA 02115 USA.	skenfiel@hsph.harvard.edu		Chan, June/0000-0002-7620-569X	National Institutes of Health [CA055075, CA141298]; NATIONAL CANCER INSTITUTE [R01CA141298, T32CA009001, R25CA098566, R01CA090598, P01CA055075] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA055075 and CA141298 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achanzar WE, 2001, CANCER RES, V61, P455; Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; Benbrahim-Tallaa L, 2007, PROSTATE, V67, P135, DOI 10.1002/pros.20479; Byrne MM, 2010, CANCER EPIDEMIOL, V34, P611, DOI 10.1016/j.canep.2010.06.017; Chan JM, 1999, CANCER EPIDEM BIOMAR, V8, P893; Chan JM, 2006, CANCER CAUSE CONTROL, V17, P199, DOI 10.1007/s10552-005-0413-4; DANIELL HW, 1995, J UROLOGY, V154, P153, DOI 10.1016/S0022-5347(01)67253-7; Enokida A, 2006, CANCER, V106, P79; Freedland SJ, 2003, UROLOGY, V61, P365, DOI 10.1016/S0090-4295(02)02268-9; Giovannucci E, 1999, CANCER EPIDEM BIOMAR, V8, P277; Giovannucci E, 2007, INT J CANCER, V121, P1571, DOI 10.1002/ijc.22788; Gong ZH, 2008, CANCER CAUSE CONTROL, V19, P25, DOI 10.1007/s10552-007-9066-9; Handa K, 1997, ATHEROSCLEROSIS, V130, P37, DOI 10.1016/S0021-9150(96)06041-8; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Heinonen OP, 1998, J NATL CANCER I, V90, P440, DOI 10.1093/jnci/90.6.440; Jager T, 2007, UROLOGE, V46, P397, DOI 10.1007/s00120-006-1252-y; Jain RK, 2001, NAT MED, V7, P775, DOI 10.1038/89889; Joshu CE, 2011, JNCI-J NATL CANCER I, V103, P835, DOI 10.1093/jnci/djr124; Kuban DA, 2006, INT J RADIAT ONCOL, V65, P1487, DOI 10.1016/j.ijrobp.2006.03.027; Kupelian PA, 2002, J CLIN ONCOL, V20, P3376, DOI 10.1200/JCO.2002.01.150; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Merrick GS, 2004, INT J RADIAT ONCOL, V58, P1056, DOI 10.1016/j.ijrobp.2003.08.021; Moreira DM, 2010, UROLOGY, V76, P1218, DOI 10.1016/j.urology.2010.01.066; Nock NL, 2006, CANCER EPIDEM BIOMAR, V15, P756, DOI 10.1158/1055-9965.EPI-05-0826; Oefelein MG, 2004, J UROLOGY, V171, P2281, DOI 10.1097/01.ju.0000125123.46733.93; Pantarotto J, 2007, BJU INT, V99, P564, DOI 10.1111/j.1464-410X.2006.06656.x; Pickles T, 2004, J UROLOGY, V171, P1543, DOI 10.1097/01.ju.0000118292.25214.a4; POUR PM, 1983, CARCINOGENESIS, V4, P49, DOI 10.1093/carcin/4.1.49; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Roach M, 2006, INT J RADIAT ONCOL, V65, P965, DOI 10.1016/j.ijrobp.2006.04.029; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Svartberg J, 2007, INT J ANDROL, V30, P137, DOI 10.1111/j.1365-2605.2006.00720.x; Tamimi R, 2001, EUR J CANCER PREV, V10, P275, DOI 10.1097/00008469-200106000-00012; Villablanca AC, 1998, J APPL PHYSIOL, V84, P2089, DOI 10.1152/jappl.1998.84.6.2089; Vinceti M, 2007, SCI TOTAL ENVIRON, V373, P77, DOI 10.1016/j.scitotenv.2006.11.005; WAALKES MP, 1994, J TOXICOL ENV HEALTH, V43, P251, DOI 10.1080/15287399409531920; Wilson KM, 2011, JNCI-J NATL CANCER I, V103, P876, DOI 10.1093/jnci/djr151; Yu GP, 1997, CANCER DETECT PREV, V21, P497; Zeng XB, 2004, BIOMETALS, V17, P559, DOI 10.1023/B:BIOM.0000045739.89653.67; Zu K, 2009, CANCER CAUSE CONTROL, V20, P1799, DOI 10.1007/s10552-009-9387-y	42	177	179	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2548	2555		10.1001/jama.2011.879	http://dx.doi.org/10.1001/jama.2011.879			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693743	Green Accepted			2022-12-28	WOS:000291860400022
J	Sonnichsen, C				Soennichsen, Carsten			Detecting Intruders on the Nanoscale	SCIENCE			English	Editorial Material							DNA		Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55099 Mainz, Germany	Johannes Gutenberg University of Mainz	Sonnichsen, C (corresponding author), Johannes Gutenberg Univ Mainz, Inst Phys Chem, D-55099 Mainz, Germany.	soennichsen@uni-mainz.de	Sönnichsen, Carsten/A-5682-2009	Sönnichsen, Carsten/0000-0003-1824-7696				Arbouet A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.127401; FAIDUK A, 2010, SCIENCE, V330, P353; Hummer G, 2010, P NATL ACAD SCI USA, V107, P21441, DOI 10.1073/pnas.1015661107; Lindfors K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.037401; Liphardt J, 2002, SCIENCE, V296, P1832, DOI 10.1126/science.1071152; Liu N, 2011, SCIENCE, V332, P1407, DOI 10.1126/science.1199958; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Siedentopf H, 1902, ANN PHYS, V315, P1, DOI [10.1002/andp.19023150102, DOI 10.1002/ANDP.19023150102]; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]	13	6	6	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1389	1390		10.1126/science.1207553	http://dx.doi.org/10.1126/science.1207553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680831				2022-12-28	WOS:000291689000027
J	Weissman, JS; Hasnain-Wynia, R				Weissman, Joel S.; Hasnain-Wynia, Romana			Advancing Health Care Equity through Improved Data Collection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weissman, Joel S.] Harvard Univ, Sch Med, Mongan Inst Hlth Policy, Boston, MA 02115 USA; [Hasnain-Wynia, Romana] Northwestern Univ, Ctr Healthcare Equ, Inst Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine	Weissman, JS (corresponding author), Harvard Univ, Sch Med, Mongan Inst Hlth Policy, Boston, MA 02115 USA.			Hasnain-Wynia, Romana/0000-0001-6009-3569				Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Elliott MN, 2009, HEALTH SERV OUTCOME, V9, P69, DOI 10.1007/s10742-009-0047-1; Fremont AM, 2005, HEALTH AFFAIR, V24, P516, DOI 10.1377/hlthaff.24.2.516; HASNAINWYNIA R, 2010, MED CARE RES RE 1001; ULMER C, 2009, I MED RACE ETHICITY	5	18	18	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2276	2277		10.1056/NEJMp1103069	http://dx.doi.org/10.1056/NEJMp1103069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675885				2022-12-28	WOS:000291643800002
J	Orkin, SH; Hochedlinger, K				Orkin, Stuart H.; Hochedlinger, Konrad			Chromatin Connections to Pluripotency and Cellular Reprogramming	CELL			English	Review							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; TRANSCRIPTIONAL REGULATORY CIRCUITRY; PROTEIN-INTERACTION NETWORK; X-CHROMOSOME INACTIVATION; CXXC FINGER PROTEIN-1; REPRESSIVE COMPLEX 2; LONG NONCODING RNAS; SELF-RENEWAL; GROUND-STATE	The pluripotent state of embryonic stem cells (ESCs) provides a unique perspective on regulatory programs that govern self-renewal and differentiation and somatic cell reprogramming. Here, we review the highly connected protein and transcriptional networks that maintain pluripotency and how they are intertwined with factors that affect chromatin structure and function. The complex interrelationships between pluripotency and chromatin factors are illustrated by X chromosome inactivation, regulatory control by noncoding RNAs, and environmental influences on cell states. Manipulation of cell state through the process of transdifferentiation suggests that environmental cues may direct transcriptional programs as cells enter a transiently "plastic" state during reprogramming.	[Orkin, Stuart H.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Orkin, Stuart H.] Childrens Hosp, Boston, MA 02115 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Orkin, Stuart H.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu; khochedlinger@helix.mgh.harvard.edu	liang, yan/H-3894-2011		NIH [DP2OD003266-01, R01HD058013-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Joost Gribnau, Raul Mostoslavsky, Bernhard Payer, and members of the Orkin and Hochedlinger labs for critical reading of the manuscript. Due to space limitations, we apologize to those colleagues whose publications could not be cited. Support to K.H. is from NIH grants DP2OD003266-01 and R01HD058013-01A1.	Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Ahmed K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010531; Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Efe JA, 2011, NAT CELL BIOL, V13, P215, DOI 10.1038/ncb2164; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gaspar-Maia A, 2011, NAT REV MOL CELL BIO, V12, P36, DOI 10.1038/nrm3036; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Griffiths DS, 2011, NAT CELL BIOL, V13, P13, DOI 10.1038/ncb2135; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kane NM, 2010, MOL THER, V18, P2139, DOI 10.1038/mt.2010.231; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2011, SEMIN CELL DEV BIOL, V22, P359, DOI 10.1016/j.semcdb.2011.02.016; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kong KY, 2009, BLOOD, V114, P60, DOI 10.1182/blood-2008-08-174755; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Leitch HG, 2010, DEVELOPMENT, V137, P2279, DOI 10.1242/dev.050427; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lessard JA, 2010, ANNU REV CELL DEV BI, V26, P503, DOI 10.1146/annurev-cellbio-051809-102012; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Nagamatsu G, 2011, J BIOL CHEM, V286, P10641, DOI 10.1074/jbc.M110.216390; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2011, HUM GENET, V130, P255, DOI 10.1007/s00439-011-0998-5; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ram EVSR, 2009, GENE DEV, V23, P2793, DOI 10.1101/gad.1881609; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Seki Y, 2010, P NATL ACAD SCI USA, V107, P10926, DOI 10.1073/pnas.0907601107; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tate CM, 2009, MOL CELL BIOL, V29, P3817, DOI 10.1128/MCB.00243-09; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Ura H, 2011, EMBO J, V30, P2190, DOI 10.1038/emboj.2011.126; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Varlakhanova NV, 2010, DIFFERENTIATION, V80, P9, DOI 10.1016/j.diff.2010.05.001; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Williams LH, 2011, DEVELOPMENT, V138, P2049, DOI 10.1242/dev.061176; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhu DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007684	154	285	296	0	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					835	850		10.1016/j.cell.2011.05.019	http://dx.doi.org/10.1016/j.cell.2011.05.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663790	Green Accepted, Bronze			2022-12-28	WOS:000291461600012
J	Rice, C				Rice, Charles			Miles to go before we sleep	NATURE			English	Editorial Material									Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10021 USA	Rockefeller University	Rice, C (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA.	ricec@mail.rockefeller.edu							0	17	17	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S8	S8		10.1038/474S8a	http://dx.doi.org/10.1038/474S8a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666734	Bronze			2022-12-28	WOS:000291397800005
J	Yahia, M				Yahia, Mohammed			A uniquely Egyptian epidemic	NATURE			English	Editorial Material																		El-Zanaty F., 2009, EGYPT DEMOGRAPHIC HL, DOI DOI 10.1177/0049475514561330; Kamal SM, 2008, HEPATOLOGY, V47, P1371, DOI 10.1002/hep.22127; KAMEL MA, 1992, LANCET, V340, P427, DOI 10.1016/0140-6736(92)91508-6; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107	4	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S12	S13		10.1038/474S12a	http://dx.doi.org/10.1038/474S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666728				2022-12-28	WOS:000291397800008
J	Dowdy, DW				Dowdy, David W.			Trained to Avoid Primary Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Dowdy, David W.] Univ Calif San Francisco, Internal Med Residency Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Dowdy, DW (corresponding author), Univ Calif San Francisco, Internal Med Residency Program, 505 Parnassus Ave,M-987, San Francisco, CA 94143 USA.	david.w.dowdy@gmail.com							0	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11					CP8	CP9		10.7326/0003-4819-154-11-201106070-00012	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646562				2022-12-28	WOS:000291312300017
J	Sieradzki, K				Sieradzki, Karl			Potential Solutions for Creating Responsive Materials	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sieradzki, K (corresponding author), Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA.	karl.sieradzki@asu.edu						ANGERSTEINKOZLOWSKA H, 1986, ELECTROCHIM ACTA, V31, P1051, DOI 10.1016/0013-4686(86)80020-2; Corcoran SG, 1997, MATER RES SOC SYMP P, V451, P93; Greer JR, 2005, ACTA MATER, V53, P1821, DOI 10.1016/j.actamat.2004.12.031; Jin HJ, 2011, SCIENCE, V332, P1179, DOI 10.1126/science.1202190; NABARRO FRN, 1967, THEORY CRYSTAL DISLO, P294; Rehbinder P.A., 1972, PROGR SURFACE SCI, V3, P97, DOI DOI 10.1016/0079-6816(72)90011-1.; SIERADZKI K, 1987, J PHYS CHEM SOLIDS, V48, P1101, DOI 10.1016/0022-3697(87)90120-X; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; WESTWOOD AR, 1962, PHILOS MAG, V7, P633, DOI 10.1080/14786436208212629; Woodford WH, 2010, J ELECTROCHEM SOC, V157, pA1052, DOI 10.1149/1.3464773; Wool RP, 2008, SOFT MATTER, V4, P400, DOI 10.1039/b711716g	11	5	5	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1158	1159		10.1126/science.1206856	http://dx.doi.org/10.1126/science.1206856			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636763				2022-12-28	WOS:000291205200035
J	Sanderson, MJ; McMahon, MM; Steel, M				Sanderson, Michael J.; McMahon, Michelle M.; Steel, Mike			Terraces in Phylogenetic Tree Space	SCIENCE			English	Article							MIXED MODELS; ALGORITHMS; INFERENCE	A key step in assembling the tree of life is the construction of species-rich phylogenies from multilocus-but often incomplete-sequence data sets. We describe previously unknown structure in the landscape of solutions to the tree reconstruction problem, comprising sometimes vast "terraces" of trees with identical quality, arranged on islands of phylogenetically similar trees. Phylogenetic ambiguity within a terrace can be characterized efficiently and then ameliorated by new algorithms for obtaining a terrace's maximum-agreement subtree or by identifying the smallest set of new targets for additional sequencing. Algorithms to find optimal trees or estimate Bayesian posterior tree distributions may need to navigate strategically in the neighborhood of large terraces in tree space.	[Sanderson, Michael J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [McMahon, Michelle M.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Steel, Mike] Univ Canterbury, Allan Wilson Ctr Mol Ecol & Evolut, Christchurch 1, New Zealand	University of Arizona; University of Arizona; University of Canterbury	Sanderson, MJ (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	sanderm@email.arizona.edu		Steel, Mike/0000-0001-7015-4644	NSF [0829674]	NSF(National Science Foundation (NSF))	Thanks to C. Ane, M. Bordewich, D. Bryant, D. Fernandez-Baca, M. Nachman, B. O'Meara, and C. Semple for helpful comments. This work was supported by NSF award 0829674 (to M.J.S. and M. M. M.). All data used in this paper were obtained from GenBank or TreeBASE and are detailed in the Supporting Online Material.	AHO AV, 1981, SIAM J COMPUT, V10, P405, DOI 10.1137/0210030; Amir A, 1997, SIAM J COMPUT, V26, P1656, DOI 10.1137/S0097539794269461; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bordewich M, 2003, THESIS U OXFORD; Bouchenak-Khelladi Y, 2008, MOL PHYLOGENET EVOL, V47, P488, DOI 10.1016/j.ympev.2008.01.035; Bryant D., 2003, BIOCONSENSUS, P163; CONSTANTINESCU M, 1995, J CLASSIF, V12, P101, DOI 10.1007/BF01202270; DAY WHE, 1985, J CLASSIF, V2, P7, DOI 10.1007/BF01908061; Felsenstein J., 2004, INFERRING PHYLOGENIE; MADDISON DR, 1991, SYST ZOOL, V40, P315, DOI 10.2307/2992325; McDade LA, 2008, AM J BOT, V95, P1136, DOI 10.3732/ajb.0800096; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mossel E, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P384; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salter LA, 2001, SYST BIOL, V50, P970, DOI 10.1080/106351501753462902; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Semple C, 2003, DISCRETE APPL MATH, V127, P489, DOI 10.1016/S0166-218X(02)00250-0; Smith SA, 2011, AM J BOT, V98, P404, DOI 10.3732/ajb.1000481; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Whelan S, 2010, MOL BIOL EVOL, V27, P2674, DOI 10.1093/molbev/msq163	23	73	73	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					448	450		10.1126/science.1206357	http://dx.doi.org/10.1126/science.1206357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21680810				2022-12-28	WOS:000292959600044
J	Postberg, F; Schmidt, J; Hillier, J; Kempf, S; Srama, R				Postberg, F.; Schmidt, J.; Hillier, J.; Kempf, S.; Srama, R.			A salt-water reservoir as the source of a compositionally stratified plume on Enceladus	NATURE			English	Article							LIQUID WATER; VAPOR PLUMES; E-RING; DUST; SODIUM; ORIGIN	The discovery of a plume of water vapour and ice particles emerging from warm fractures ('tiger stripes') in Saturn's small, icy moon Enceladus(1-6) raised the question of whether the plume emerges from a subsurface liquid source(6-8) or from the decomposition of ice(9-12). Previous compositional analyses of particles injected by the plume into Saturn's diffuse E ring have already indicated the presence of liquid water(8), but the mechanisms driving the plume emission are still debated(13). Here we report an analysis of the composition of freshly ejected particles close to the sources. Salt-rich ice particles are found to dominate the total mass flux of ejected solids (more than 99 per cent) but they are depleted in the population escaping into Saturn's E ring. Ice grains containing organic compounds are found to be more abundant in dense parts of the plume. Whereas previous Cassini observations were compatible with a variety of plume formation mechanisms, these data eliminate or severely constrain non-liquid models and strongly imply that a salt-water reservoir with a large evaporating surface(7,8) provides nearly all of the matter in the plume.	[Postberg, F.] Heidelberg Univ, Inst Geowissensch, D-69120 Heidelberg, Germany; [Postberg, F.; Kempf, S.; Srama, R.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Schmidt, J.] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Hillier, J.] Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; [Kempf, S.] Tech Univ Carolo Wilhelmina Braunschweig, IGEP, D-38106 Braunschweig, Germany; [Kempf, S.] Univ Colorado, LASP, Boulder, CO 80303 USA; [Srama, R.] Univ Stuttgart, IRS, D-70569 Stuttgart, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; University of Potsdam; Open University - UK; Braunschweig University of Technology; University of Colorado System; University of Colorado Boulder; University of Stuttgart	Postberg, F (corresponding author), Heidelberg Univ, Inst Geowissensch, D-69120 Heidelberg, Germany.	Frank.Postberg@mpi-hd.mpg.de	Postberg, Frank/AAE-6295-2019	Postberg, Frank/0000-0002-5862-4276; KEMPF, SASCHA/0000-0001-5236-3004	Deutsches Zentrum fur Luft und Raumfahrt (DLR); Deutsche Forschungs Gemeinschaft (DFG); UK Science and Technology Facilities Council	Deutsches Zentrum fur Luft und Raumfahrt (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR)); Deutsche Forschungs Gemeinschaft (DFG)(German Research Foundation (DFG)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank G. Moragas-Klostermeyer and S. Helfert for their efforts in preparing the CDA plume observations. We acknowledge the work of the scientists and engineers of the Cassini Team at JPL. This work was supported by Deutsches Zentrum fur Luft und Raumfahrt (DLR) and Deutsche Forschungs Gemeinschaft (DFG programme 'The first 10 million years of the solar system'). J.H. was supported by the UK Science and Technology Facilities Council.	Dougherty MK, 2006, SCIENCE, V311, P1406, DOI 10.1126/science.1120985; Gioia G, 2007, P NATL ACAD SCI USA, V104, P13578, DOI 10.1073/pnas.0706018104; Halevy I, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034349; Hansen CJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047415; Hansen CJ, 2006, SCIENCE, V311, P1422, DOI 10.1126/science.1121254; Hedman MM, 2009, ASTROPHYS J, V693, P1749, DOI 10.1088/0004-637X/693/2/1749; Hillier JK, 2007, MON NOT R ASTRON SOC, V377, P1588, DOI 10.1111/j.1365-2966.2007.11710.x; Kempf S., 2010, AM GEOPH UN FALL M; Kieffer SW, 2006, SCIENCE, V314, P1764, DOI 10.1126/science.1133519; Kieffer SW, 2009, ICARUS, V203, P238, DOI 10.1016/j.icarus.2009.05.011; Magee B., 2011, LUN PLAN I SCI C ABS, V42, P2818; Nimmo F, 2007, NATURE, V447, P289, DOI 10.1038/nature05783; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Postberg F, 2008, ICARUS, V193, P438, DOI 10.1016/j.icarus.2007.09.001; Postberg F, 2009, NATURE, V459, P1098, DOI 10.1038/nature08046; Schmidt J, 2008, NATURE, V451, P685, DOI 10.1038/nature06491; Schneider NM, 2009, NATURE, V459, P1102, DOI 10.1038/nature08070; Spahn F, 2006, SCIENCE, V311, P1416, DOI 10.1126/science.1121375; Spencer JR, 2006, SCIENCE, V311, P1401, DOI 10.1126/science.1121661; Spitale JN, 2007, NATURE, V449, P695, DOI 10.1038/nature06217; Srama R, 2004, SPACE SCI REV, V114, P465, DOI 10.1007/s11214-004-1435-z; Sremcevic M, 2003, PLANET SPACE SCI, V51, P455, DOI 10.1016/S0032-0633(03)00050-3; Tian F, 2007, ICARUS, V188, P154, DOI 10.1016/j.icarus.2006.11.010; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Zolotov MY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031234	26	278	282	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					620	622		10.1038/nature10175	http://dx.doi.org/10.1038/nature10175			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21697830				2022-12-28	WOS:000292204300034
J	Choi, J; Wang, DY; Kundu, S; Choliy, Y; Emge, TJ; Krogh-Jespersen, K; Goldman, AS				Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.			Net Oxidative Addition of C(sp(3))-F Bonds to Iridium via Initial C-H Bond Activation	SCIENCE			English	Article							TRANSITION-METAL-COMPLEXES; REDUCTIVE ELIMINATION; FLUORINE; REACTIVITY; CHEMISTRY; MECHANISM; HYDROGEN	Carbon-fluorine bonds are the strongest known single bonds to carbon and as a consequence can prove very hard to cleave. Alhough vinyl and aryl C-F bonds can undergo oxidative addition to transition metal complexes, this reaction has appeared inoperable with aliphatic substrates. We report the addition of C(sp(3))-F bonds (including alkyl-F) to an iridium center via the initial, reversible cleavage of a C-H bond. These results suggest a distinct strategy for the development of catalysts and promoters to make and break C-F bonds, which are of strong interest in the context of both pharmaceutical and environmental chemistry.	[Choi, Jongwook; Wang, David Y.; Kundu, Sabuj; Choliy, Yuriy; Emge, Thomas J.; Krogh-Jespersen, Karsten; Goldman, Alan S.] Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Krogh-Jespersen, K (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, New Brunswick, NJ 08903 USA.	krogh@rutchem.rutgers.edu; alan.goldman@rutgers.edu	Goldman, Alan/D-9521-2011	Goldman, Alan/0000-0002-2774-710X	NSF [CHE-0719307, CHE-0650456]	NSF(National Science Foundation (NSF))	We thank the NSF (grant CHE-0719307) for support of this work. R. Kondrat (University of California, Riverside) is thanked for obtaining LIFDI spectra and for related discussion. Analytical data were obtained from the Center for Enabling New Technologies Through Catalysis Elemental Analysis Facility at the University of Rochester, funded by NSF CHE-0650456. Metrical parameters for the structure of 4b are available free of charge from the Cambridge Crystallographic Data Centre under reference CCDC-823748.	Amii H, 2009, CHEM REV, V109, P2119, DOI 10.1021/cr800388c; Bourgeois CJ, 2006, ORGANOMETALLICS, V25, P3474, DOI 10.1021/om060267s; BROTHERS PJ, 1988, CHEM REV, V88, P1293, DOI 10.1021/cr00089a014; Cho EJ, 2010, SCIENCE, V328, P1679, DOI 10.1126/science.1190524; Choi J, 2009, J AM CHEM SOC, V131, P15627, DOI 10.1021/ja906930u; COLLMAN JP, 1968, ACCOUNTS CHEM RES, V1, P136, DOI 10.1021/ar50005a002; Cooper AC, 1997, ORGANOMETALLICS, V16, P505, DOI 10.1021/om9605488; de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Douvris C, 2008, SCIENCE, V321, P1188, DOI 10.1126/science.1159979; Dransfield TA, 2010, J FLUORINE CHEM, V131, P1213, DOI 10.1016/j.jfluchem.2010.05.008; Fawcett J, 2010, DALTON T, V39, P5827, DOI 10.1039/c0dt00066c; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; Gomez-Benitez V., 2003, REV SOC QUIM MEX, V47, P124; HALPERN J, 1970, ACCOUNTS CHEM RES, V3, P386, DOI 10.1021/ar50035a004; Hartwig J. F, 2009, ORGANOTRANSITION MET; Huang DJ, 2000, J AM CHEM SOC, V122, P8916, DOI 10.1021/ja001646u; Hughes RP, 2005, J AM CHEM SOC, V127, P15020, DOI 10.1021/ja055166k; Hughes RP, 2009, EUR J INORG CHEM, P4591, DOI 10.1002/ejic.200900816; Jasim NA, 2000, J AM CHEM SOC, V122, P8685, DOI 10.1021/ja0010913; Kanzelberger M, 2000, J AM CHEM SOC, V122, P11017, DOI 10.1021/ja001626s; KIPLINGER JL, 1994, CHEM REV, V94, P373, DOI 10.1021/cr00026a005; Kraft BM, 2010, J FLUORINE CHEM, V131, P1122, DOI 10.1016/j.jfluchem.2010.05.003; McCulloch A, 2003, J FLUORINE CHEM, V123, P21, DOI 10.1016/S0022-1139(03)00105-2; MCMILLEN DF, 1982, ANNU REV PHYS CHEM, V33, P493, DOI 10.1146/annurev.pc.33.100182.002425; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Northcutt TO, 2001, J AM CHEM SOC, V123, P7257, DOI 10.1021/ja003944x; Parkin G, 2009, ACCOUNTS CHEM RES, V42, P315, DOI 10.1021/ar800156h; Perutz RN., 2007, COMPREHENSIVE ORGANO, P725; RACHIDI IE, 1990, NEW J CHEM, V14, P671; Rybtchinski B, 1996, J AM CHEM SOC, V118, P12406, DOI 10.1021/ja962253r; STILLE JK, 1977, ACCOUNTS CHEM RES, V10, P434, DOI 10.1021/ar50120a002; Torrens H, 2005, COORDIN CHEM REV, V249, P1957, DOI 10.1016/j.ccr.2005.01.025; Veltheer JE, 1995, J AM CHEM SOC, V117, P12478, DOI 10.1021/ja00155a012; Vetter AJ, 2009, J AM CHEM SOC, V131, P10742, DOI 10.1021/ja9002316; Vigalok A, 2008, CHEM-EUR J, V14, P5102, DOI 10.1002/chem.200701738; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Werkema EL, 2005, J AM CHEM SOC, V127, P7781, DOI 10.1021/ja0504800	37	133	133	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1545	1548		10.1126/science.1200514	http://dx.doi.org/10.1126/science.1200514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	782EE	21700870				2022-12-28	WOS:000291990000041
J	Brotherton, JML; Fridman, M; May, CL; Chappell, G; Saville, AM; Gertig, DM				Brotherton, Julia M. L.; Fridman, Masha; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.			Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study	LANCET			English	Article							PREDICTED IMPACT; PAPILLOMAVIRUS; LESIONS	Background Australia introduced a human papillomavirus (HPV) vaccination programme with the quadrivalent HPV vaccine for all women aged 12-26 years between 2007 and 2009. We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination programme. Methods With data from the Victorian Cervical Cytology Registry between 2003 and 2009, we compared the incidence of histopathologically defined high-grade cervical abnormalities (HGAs, lesions coded as cervical intraepithelial neoplasia of grade 2 or worse or adenocarcinoma in situ; primary outcome) and low-grade cytological abnormalities (LGAs) in five age groups before (Jan 1, 2003, to March 31, 2007) and after (April 1, 2007, to Dec 31, 2009) the vaccination programme began. Binary comparisons between the two periods were done with Fisher's exact test. Poisson piecewise regression analysis was used to compare incident rate trends. Findings After the introduction of the vaccination programme, we recorded a decrease in the incidence of HGAs by 0.38% (95% CI 0.61-0.16) in girls younger than 18 years. This decrease was progressive and significantly different to the linear trend in incidence before introduction of the vaccination (incident rate ratio 1.14, 1.00-1.30, p=0.05). No similar temporal decline was recorded for LGAs or in older age groups. Interpretation This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme. Linkage between vaccination and screening registers is needed to confirm that this ecological observation is attributable to vaccination and to monitor participation in screening among vaccinated women.	[Brotherton, Julia M. L.; May, Cathryn L.; Chappell, Genevieve; Saville, A. Marion; Gertig, Dorota M.] Victorian Cytol Serv, Victorian Cytol Serv Registries, Melbourne, Vic 8002, Australia; [Fridman, Masha] Dept Primary Ind, Biosci Res Div, Bundoora, Vic, Australia		Brotherton, JML (corresponding author), Victorian Cytol Serv, Victorian Cytol Serv Registries, POB 310, Melbourne, Vic 8002, Australia.	jbrother@vcs.org.au	Gertig, Dorota/Z-1087-2019		Australian Research Council; CSL Biotherapies; GlaxoSmithKline; Victorian Government	Australian Research Council(Australian Research Council); CSL Biotherapies; GlaxoSmithKline(GlaxoSmithKline); Victorian Government	JMLB, DMG, and MS are investigators on an Australian Research Council Linkage Grant, for which CSL Biotherapies is a partner organisation. JMLB was an investigator on a national HPV prevalence study that received partial, equal, and unrestricted funding from CSL Biotherapies and GlaxoSmithKline. GC, MF, and CLM declare that they have no conflicts of interest.; We thank Grace Zampogna (VCCR) for her assistance with variable definitions and appreciate the methodological advice received from Ian Gordon (Statistical Consulting Centre, University of Melbourne, Victoria, Australia), Karen Canfell (NSW Cancer Council, NSW, Australia), and Carolyn Nickson (University of Melbourne, Victoria, Australia). The VCCR is fully funded by the Victorian Government and operated by the Victorian Cytology Service.	Asghari S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-62; [Australian Institute of Health and Welfare Australasian Association of Cancer Registries], 2008, CANC SER AIHW; Australian Institute of Health and Welfare, 2010, CANC SER AIHW; Australian Institute of Health and Welfare, 2008, NAT CERV SCREEN PROG; Brameld KJ, 2003, INT J EPIDEMIOL, V32, P617, DOI 10.1093/ije/dyg191; Brotherton JML, WILL YOUNG WOMEN HAV; Clifford GM, 2005, CANCER EPIDEM BIOMAR, V14, P1157, DOI 10.1158/1055-9965.EPI-04-0812; Constantine R, 2008, PSYCHIAT SERV, V59, P1162, DOI 10.1176/appi.ps.59.10.1162; Cuzick J, 2010, BRIT J CANCER, V102, P933, DOI 10.1038/sj.bjc.6605528; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Frazer, 2020, GUIDELINES MANAGEMEN; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Heley S, 2009, AUST FAM PHYSICIAN, V38, P977; Immunise Australia Program, HUM PAP HPV; Kreimer AR, PROOF OF PRINCIPLE E; Kurman RJ, 1994, BETHESDA SYSTEM REPO; Levy-Bruhl D, 2009, EUR J CANCER, V45, P2709, DOI 10.1016/j.ejca.2009.07.023; Mao C, 2006, OBSTET GYNECOL, V107, P1425; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Porras C, 2009, CANCER EPIDEM BIOMAR, V18, P863, DOI 10.1158/1055-9965.EPI-08-0951; Sellors J, HPV VACCINATION DEV; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; Tota J, 2010, SEX HEALTH, V7, P376, DOI 10.1071/SH10022; [UCLA Academic Technology Services SCG], STAT FAQ CAN I RUN P; Victorian Cervical Cytology Registry, 2009, VICT CERV CYT REG ST; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; World Health Organization, 2009, M HPV VACC COV IMP M	29	358	366	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2085	2092		10.1016/S0140-6736(11)60551-5	http://dx.doi.org/10.1016/S0140-6736(11)60551-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684381				2022-12-28	WOS:000292117800030
J	Hewish, M; Cunningham, D				Hewish, Madeleine; Cunningham, David			First-line treatment of advanced colorectal cancer	LANCET			English	Editorial Material							CETUXIMAB; KRAS; CHEMOTHERAPY; MUTATION		[Cunningham, David] Royal Marsden Hosp NHS Trust, London SM2 5PT, Surrey, England; Royal Marsden Hosp NHS Trust, Sutton 5M2 5PT, Surrey, England	Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Cunningham, D (corresponding author), Royal Marsden Hosp NHS Trust, London SM2 5PT, Surrey, England.	david.cunningham@rmh.nhs.uk		Cunningham, David/0000-0001-5158-1069	MRC [G0802325] Funding Source: UKRI; Medical Research Council [G0802325] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams RA, 2011, LANCET ONCOL, V12, P642, DOI 10.1016/S1470-2045(11)70102-4; Chibaudel B, 2009, J CLIN ONCOL, V27, P5727, DOI 10.1200/JCO.2009.23.4344; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; DEWDNEY A, 2011, J CLIN ONCOL S, V29, P360; Hawkes E, 2010, J CLIN ONCOL, V28, pE529, DOI 10.1200/JCO.2010.29.5626; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Mekenkamp L, 2011, AACR ANN M ORL FLOR, P235; Oden-Gangloff A, 2009, BRIT J CANCER, V100, P1330, DOI 10.1038/sj.bjc.6605008; Pander J, 2010, EUR J CANCER, V46, P1829, DOI 10.1016/j.ejca.2010.03.017; Scartozzi M, 2011, BRIT J CANCER, V104, P1786, DOI 10.1038/bjc.2011.161; TA176, 2009, TA176 CET 1 LIN TREA; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091	15	12	12	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2060	2062		10.1016/S0140-6736(11)60788-5	http://dx.doi.org/10.1016/S0140-6736(11)60788-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21641637				2022-12-28	WOS:000292117800006
J	A'Hearn, MF; Belton, MJS; Delamere, WA; Feaga, LM; Hampton, D; Kissel, J; Klaasen, KP; McFadden, LA; Meech, KJ; Melosh, HJ; Schultz, PH; Sunshine, JM; Thomas, PC; Veverka, J; Wellnitz, DD; Yeomans, DK; Besse, S; Bodewits, D; Bowling, TJ; Carcich, BT; Collins, SM; Farnham, TL; Groussin, O; Hermalyn, B; Kelley, MS; Li, JY; Lindler, DJ; Lisse, CM; McLaughlin, SA; Merlin, F; Protopapa, S; Richardson, JE; Williams, JL				A'Hearn, Michael F.; Belton, Michael J. S.; Delamere, W. Alan; Feaga, Lori M.; Hampton, Donald; Kissel, Jochen; Klaasen, Kenneth P.; McFadden, Lucy A.; Meech, Karen J.; Melosh, H. Jay; Schultz, Peter H.; Sunshine, Jessica M.; Thomas, Peter C.; Veverka, Joseph; Wellnitz, Dennis D.; Yeomans, Donald K.; Besse, Sebastien; Bodewits, Dennis; Bowling, Timothy J.; Carcich, Brian T.; Collins, Steven M.; Farnham, Tony L.; Groussin, Olivier; Hermalyn, Brendan; Kelley, Michael S.; Li, Jian-Yang; Lindler, Don J.; Lisse, Carey M.; McLaughlin, Stephanie A.; Merlin, Frederic; Protopapa, Silvia; Richardson, James E.; Williams, Jade L.			EPOXI at Comet Hartley 2	SCIENCE			English	Article							DEEP IMPACT; ICE; PARTICLES; INSTRUMENT	Understanding how comets work-what drives their activity-is crucial to the use of comets in studying the early solar system. EPOXI (Extrasolar Planet Observation and Deep Impact Extended Investigation) flew past comet 103P/Hartley 2, one with an unusually small but very active nucleus, taking both images and spectra. Unlike large, relatively inactive nuclei, this nucleus is outgassing primarily because of CO2, which drags chunks of ice out of the nucleus. It also shows substantial differences in the relative abundance of volatiles from various parts of the nucleus.	[A'Hearn, Michael F.; Feaga, Lori M.; McFadden, Lucy A.; Sunshine, Jessica M.; Wellnitz, Dennis D.; Besse, Sebastien; Bodewits, Dennis; Farnham, Tony L.; Kelley, Michael S.; Li, Jian-Yang; McLaughlin, Stephanie A.; Merlin, Frederic; Protopapa, Silvia; Williams, Jade L.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Belton, Michael J. S.] Belton Space Explorat Initiat LLC, Tucson, AZ 85716 USA; [Delamere, W. Alan] Delamere Support Serv, Boulder, CO 80304 USA; [Hampton, Donald] Univ Alaska Fairbanks, Inst Geophys, Fairbanks, AK 99775 USA; [Kissel, Jochen] Max Planck Inst Sonnensyst Forsch, D-37191 Katlenburg Lindau, Germany; [Klaasen, Kenneth P.; Yeomans, Donald K.; Collins, Steven M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [McFadden, Lucy A.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Meech, Karen J.] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Melosh, H. Jay] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Melosh, H. Jay; Bowling, Timothy J.; Richardson, James E.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Schultz, Peter H.; Hermalyn, Brendan] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Thomas, Peter C.; Veverka, Joseph; Carcich, Brian T.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Groussin, Olivier] Univ Aix Marseille 1, Lab Astrophys Marseille, F-13013 Marseille, France; [Groussin, Olivier] CNRS, F-13013 Marseille, France; [Kelley, Michael S.] NASA Headquarters, Planetary Sci Div, Washington, DC 20546 USA; [Lindler, Don J.] Sigma Space Corp, Lanham, MD 20706 USA; [Lisse, Carey M.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Merlin, Frederic] Univ Paris 07, Observ Paris, LESIA, F-92195 Meudon, France	University System of Maryland; University of Maryland College Park; University of Alaska System; University of Alaska Fairbanks; Max Planck Society; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Hawaii System; University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Brown University; Cornell University; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); National Aeronautics & Space Administration (NASA); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite	A'Hearn, MF (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	ma@astro.umd.edu	Wellnitz, Dennis/B-4080-2012; Meech, Karen/CAH-1412-2022; Lisse, Carey M/B-7772-2016; McFadden, Lucy-Ann/I-4902-2013	Lisse, Carey M/0000-0002-9548-1526; McFadden, Lucy-Ann/0000-0002-0537-9975; Feaga, Lori/0000-0002-4230-6759; Li, Jian-Yang/0000-0003-3841-9977; Besse, Sebastien/0000-0002-1052-5439; Meech, Karen/0000-0002-2058-5670; Bodewits, Dennis/0000-0002-2668-7248; Sunshine, Jessica/0000-0002-9413-8785; Protopapa, Silvia/0000-0001-8541-8550; Kelley, Michael/0000-0002-6702-7676	NASA [NNM07AA99C, NMO711002]; University of Maryland; Centre National d'Etudes Spatiales	NASA(National Aeronautics & Space Administration (NASA)); University of Maryland; Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	Data from EPOXI will be released through NASA's Planetary Data System in 2011. Image IDs in this paper are part of the final ID in the archive. This work was supported by NASA's Discovery Program contract NNM07AA99C to the University of Maryland and task order NMO711002 to the Jet Propulsion Laboratory. The work was supported by the home institutions of several of the scientists, particularly by the University of Maryland. The contributions of O. Groussin and F. Merlin to this project were funded in part by the Centre National d'Etudes Spatiales.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2007, ICARUS, V187, P1, DOI 10.1016/j.icarus.2006.12.011; AHEARN MF, 1981, ASTROPHYS J, V248, pL147, DOI 10.1086/183644; Belton MJS, 2009, ICARUS, V200, P280, DOI 10.1016/j.icarus.2008.11.012; Bocklelee-Morvan D., 2004, COMETS, P391; Brownlee DE, 2004, SCIENCE, V304, P1764, DOI 10.1126/science.1097899; BURATTI B, 1983, ICARUS, V55, P93, DOI 10.1016/0019-1035(83)90053-2; CAMPINS H, 1983, NATURE, V301, P405, DOI 10.1038/301405a0; Colangeli L, 1999, ASTRON ASTROPHYS, V343, pL87; Combi MR, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L6; Crovisier J, 1999, ESA SP PUBL, V427, P161; Feaga LM, 2007, ICARUS, V190, P345, DOI [10.1016/j.icarus.2007.04.009, 10.1016/j.icarus.2007.04.038]; Feaga L. M., 2007, B AM ASTRON SOC, V38, P450; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Groussin O, 2004, ASTRON ASTROPHYS, V419, P375, DOI 10.1051/0004-6361:20040073; Grundy WM, 2007, SCIENCE, V318, P234, DOI 10.1126/science.1147623; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HANNER MS, 1984, ASTROPHYS J, V277, pL75, DOI 10.1086/184207; HANNER MS, 1981, ICARUS, V47, P342, DOI 10.1016/0019-1035(81)90182-2; Harmon J. K., 2010, IAU CIRC, V9179, P1; Harmon J. K., 2005, COMETS, P274; Harmon JK, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L2; KELLER HU, 1987, ASTRON ASTROPHYS, V187, P807; KISSEL J, 1986, NATURE, V321, P336, DOI 10.1038/321336a0; Klaasen KP, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2972112; Li J.-Y., 2007, ICARUS, V187, P141; LICHTENEGGER HIM, 1991, ICARUS, V90, P319, DOI 10.1016/0019-1035(91)90110-F; Lisse CM, 2009, PUBL ASTRON SOC PAC, V121, P968, DOI 10.1086/605546; MATTHEWS CN, 1992, ADV SPACE RES-SERIES, V12, P21, DOI 10.1016/0273-1177(92)90149-R; PATASHNICK H, 1977, ICARUS, V30, P402, DOI 10.1016/0019-1035(77)90174-9; Richardson JE, 2007, ICARUS, V190, P357, DOI 10.1016/j.icarus.2007.08.001; Robinson MS, 2001, NATURE, V413, P396, DOI 10.1038/35096518; Soderblom LA, 2002, SCIENCE, V296, P1087, DOI 10.1126/science.1069527; Sunshine JM, 2007, ICARUS, V190, P284, DOI 10.1016/j.icarus.2007.04.024; Thomas PC, 2007, ICARUS, V187, P4, DOI 10.1016/j.icarus.2006.12.013; Weaver HA, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L5; WEAVER HA, 1994, ASTROPHYS J, V422, P374, DOI 10.1086/173732	37	321	322	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1396	1400		10.1126/science.1204054	http://dx.doi.org/10.1126/science.1204054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680835				2022-12-28	WOS:000291689000032
J	Bell, G; Gonzalez, A				Bell, Graham; Gonzalez, Andrew			Adaptation and Evolutionary Rescue in Metapopulations Experiencing Environmental Deterioration	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; EXTINCTION; POPULATIONS; GENETICS; RANGES	It is not known whether evolution will usually be rapid enough to allow a species to adapt and persist in a deteriorating environment. We tracked the eco-evolutionary dynamics of metapopulations with a laboratory model system of yeast exposed to salt stress. Metapopulations experienced environmental deterioration at three different rates and their component populations were either unconnected or connected by local dispersal or by global dispersal. We found that adaptation was favored by gradual deterioration and local dispersal. After further abrupt deterioration, the frequency of evolutionary rescue depended on both the prior rate of deterioration and the rate of dispersal. Adaptation was surprisingly frequent and rapid in small peripheral populations. Thus, evolutionary dynamics affect both the persistence and the range of a species after environmental deterioration.	[Bell, Graham; Gonzalez, Andrew] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Gonzalez, A (corresponding author), McGill Univ, Dept Biol, 1205 Ave Docteur Penfield, Montreal, PQ H3A 1B1, Canada.	andrew.gonzalez@mcgill.ca	Gonzalez, Andrew/F-2247-2010	Gonzalez, Andrew/0000-0001-6075-8081	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; Canada Research Chair Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); Canada Research Chair Program(Canada Research Chairs)	The robot was programmed and operated by Z. M. Wang, assisted by A.-M. LeHeureux. G. B. and A. G. are supported by funding from the Natural Sciences and Engineering Research Council of Canada and by the Canadian Foundation for Innovation. A. G. is supported by the Canada Research Chair Program. We thank two anonymous reviewers for comments that improved the manuscript.	Bell G, 2008, EVOL APPL, V1, P3, DOI 10.1111/j.1752-4571.2007.00011.x; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Dhar R, 2011, J EVOLUTION BIOL, V24, P1135, DOI 10.1111/j.1420-9101.2011.02249.x; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Orr HA, 2008, AM NAT, V172, P160, DOI 10.1086/589460; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Samani P, 2010, J EVOLUTION BIOL, V23, P791, DOI 10.1111/j.1420-9101.2010.01945.x; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100	23	241	242	3	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1327	1330		10.1126/science.1203105	http://dx.doi.org/10.1126/science.1203105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659606				2022-12-28	WOS:000291441700046
J	Fujisaki, J; Wu, J; Carlson, AL; Silberstein, L; Putheti, P; Larocca, R; Gao, WD; Saito, TI; Lo Celso, C; Tsuyuzaki, H; Sato, T; Cote, D; Sykes, M; Strom, TB; Scadden, DT; Lin, CP				Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Silberstein, Lev; Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Saito, Toshiki I.; Lo Celso, Cristina; Tsuyuzaki, Hitoshi; Sato, Tatsuyuki; Cote, Daniel; Sykes, Megan; Strom, Terry B.; Scadden, David T.; Lin, Charles P.			In vivo imaging of T-reg cells providing immune privilege to the haematopoietic stem-cell niche	NATURE			English	Article							BONE-MARROW NICHE; ENGRAFTMENT	Stem cells reside in a specialized regulatory microenvironment or niche(1,2), where they receive appropriate support for maintaining self-renewal and multi-lineage differentiation capacity(1-3). The niche may also protect stem cells from environmental insults(3) including cytotoxic chemotherapy and perhaps pathogenic immunity(4). The testis, hair follicle and placenta are all sites of residence for stem cells and are immune-suppressive environments, called immune-privileged sites, where multiple mechanisms cooperate to prevent immune attack, even enabling prolonged survival of foreign allografts without immunosuppression(4). We sought to determine if somatic stem-cell niches more broadly are immune-privileged sites by examining the haematopoietic stem/progenitor cell (HSPC) niche(1,2,5-7) in the bone marrow, a site where immune reactivity exists(8,9). We observed persistence of HSPCs from allogeneic donor mice (allo-HSPCs) in non-irradiated recipient mice for 30 days without immunosuppression with the same survival frequency compared to syngeneic HSPCs. These HSPCs were lost after the depletion of FoxP3 regulatory T (T-reg) cells. High-resolutionin vivo imaging over time demonstrated marked co-localization of HSPCs with T-reg cells that accumulated on the endosteal surface in the calvarial and trabecular bone marrow. T-reg cells seem to participate in creating a localized zone where HSPCs reside and where T-reg cells are necessary for allo-HSPC persistence. In addition to processes supporting stem-cell function, the niche will provide a relative sanctuary from immune attack.	[Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Carlson, Alicia L.; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Fujisaki, Joji; Wu, Juwell; Silberstein, Lev; Lo Celso, Cristina; Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Wu, Juwell] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Silberstein, Lev; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Inst Transplantat, Boston, MA 02215 USA; [Putheti, Prabhakar; Larocca, Rafael; Gao, Wenda; Strom, Terry B.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Saito, Toshiki I.; Sykes, Megan] Massachusetts Gen Hosp E, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Bone Marrow Transplantat Sect, Boston, MA 02129 USA; [Tsuyuzaki, Hitoshi; Sato, Tatsuyuki] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Cote, Daniel] Dept Phys Genie Phys & Opt, Quebec City, PQ G1J 2G3, Canada; [Cote, Daniel] Univ Laval Robert Giffard, Ctr Rech, Quebec City, PQ G1J 2G3, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; University of Tokyo; Laval University	Fujisaki, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol,Adv Microscopy Program, CPZN 8238,185 Cambridge St, Boston, MA 02114 USA.	jfujisaki@partners.org; lin@helix.mgh.harvard.edu	Côté, Daniel/D-5185-2011; Sato, Tatsuyuki/V-8183-2019; Assumpcao Larocca, Rafael/H-1655-2015; Larocca, Rafael/J-9557-2012	Sato, Tatsuyuki/0000-0002-9229-9016; Assumpcao Larocca, Rafael/0000-0002-9995-1804; Lo Celso, Cristina/0000-0002-1163-4207	Bullock fellowship; Harvard Stem Cell Institute; DoD [W81XWH-10-1-0217]; NIH [HL097748, HL97794, CA111519, AI041521]; EMBO; HFSP; philanthropic sources; Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA111519] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097794, R01HL097748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI041521, P01AI073748] Funding Source: NIH RePORTER	Bullock fellowship; Harvard Stem Cell Institute; DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); HFSP(Human Frontier Science Program); philanthropic sources; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Bullock fellowship (to J.F.), the Harvard Stem Cell Institute and DoD W81XWH-10-1-0217 (to J.F. and C.P.L.), NIH HL097748 (to C.P.L.), HL97794 (to D.T.S.), CA111519 (to M.S.), AI041521 (to T.B.S), EMBO (to C.L.C.), HFSP (to C.L.C.), philanthropic sources (to D.T.S. and C.L.C.), and the National Institutes of Health. We acknowledge J. Zhao and D. Cao for cell sorting.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Huang YM, 2004, BLOOD, V104, P873, DOI 10.1182/blood-2003-11-3910; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	19	388	402	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					216	U256		10.1038/nature10160	http://dx.doi.org/10.1038/nature10160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654805	Green Accepted			2022-12-28	WOS:000291397800051
J	Krimsky, S				Krimsky, Sheldon			Beware of gifts that come at too great a cost	NATURE			English	Editorial Material									Tufts Univ, Medford, MA 02155 USA	Tufts University	Krimsky, S (corresponding author), Tufts Univ, Medford, MA 02155 USA.	sheldon.krimsky@tufts.edu	Krimsky, Sheldon/F-3147-2010						0	2	2	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					129	129		10.1038/474129a	http://dx.doi.org/10.1038/474129a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654761	Bronze			2022-12-28	WOS:000291397800016
J	Bell, AM; Robinson, GE				Bell, Alison M.; Robinson, Gene E.			Behavior and the Dynamic Genome	SCIENCE			English	Editorial Material							EVOLUTION; ACCOMMODATION; GENES; FOXP2; LINK		[Bell, Alison M.] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Robinson, Gene E.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Bell, Alison M.; Robinson, Gene E.] Univ Illinois, Inst Genom Biol, Program Ecol Evolutionary Biol & Conservat, Neurosci Program, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Bell, AM (corresponding author), Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA.	generobi@life.uiuc.edu			NIGMS NIH HHS [R01 GM082937, R01 GM082937-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082937] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Aubret F, 2009, CURR BIOL, V19, P1932, DOI 10.1016/j.cub.2009.09.061; Badyaev AV, 2009, PHILOS T R SOC B, V364, P1125, DOI 10.1098/rstb.2008.0285; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Baldwin J. M., 1902, DEV EVOLUTION; Bell AM, 2010, PHILOS T R SOC B, V365, P4001, DOI 10.1098/rstb.2010.0185; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Konopka G, 2010, NEURON, V68, P231, DOI 10.1016/j.neuron.2010.10.012; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; McGuigan K, 2009, TRENDS ECOL EVOL, V24, P305, DOI 10.1016/j.tree.2009.02.001; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; West-Eberhard Mary Jane, 2003, pi; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966	19	41	41	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1161	1162		10.1126/science.1203295	http://dx.doi.org/10.1126/science.1203295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636765	Green Accepted			2022-12-28	WOS:000291205200037
J	Kocsis, S; Braverman, B; Ravets, S; Stevens, MJ; Mirin, RP; Shalm, LK; Steinberg, AM				Kocsis, Sacha; Braverman, Boris; Ravets, Sylvain; Stevens, Martin J.; Mirin, Richard P.; Shalm, L. Krister; Steinberg, Aephraim M.			Observing the Average Trajectories of Single Photons in a Two-Slit Interferometer	SCIENCE			English	Article							QUANTUM MEASUREMENTS; COMPLEMENTARITY; SPIN; REALIZATION; COMPONENT; PARTICLE	A consequence of the quantum mechanical uncertainty principle is that one may not discuss the path or "trajectory" that a quantum particle takes, because any measurement of position irrevocably disturbs the momentum, and vice versa. Using weak measurements, however, it is possible to operationally define a set of trajectories for an ensemble of quantum particles. We sent single photons emitted by a quantum dot through a double-slit interferometer and reconstructed these trajectories by performing a weak measurement of the photon momentum, postselected according to the result of a strong measurement of photon position in a series of planes. The results provide an observationally grounded description of the propagation of subensembles of quantum particles in a two-slit interferometer.	[Kocsis, Sacha; Braverman, Boris; Shalm, L. Krister; Steinberg, Aephraim M.] Univ Toronto, Ctr Quantum Informat & Quantum Control, Toronto, ON M5S 1A7, Canada; [Kocsis, Sacha; Braverman, Boris; Shalm, L. Krister; Steinberg, Aephraim M.] Univ Toronto, Dept Phys, Inst Opt Sci, Toronto, ON M5S 1A7, Canada; [Kocsis, Sacha] Griffith Univ, Ctr Quantum Dynam, Brisbane, Qld 4111, Australia; [Ravets, Sylvain] Univ Paris Sud, CNRS, Inst Opt, Lab Charles Fabry, F-91127 Palaiseau, France; [Stevens, Martin J.; Mirin, Richard P.] NIST, Boulder, CO 80305 USA; [Shalm, L. Krister] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada	University of Toronto; University of Toronto; Griffith University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institute of Standards & Technology (NIST) - USA; University of Waterloo	Steinberg, AM (corresponding author), Univ Toronto, Ctr Quantum Informat & Quantum Control, 60 St George St, Toronto, ON M5S 1A7, Canada.	steinberg@physics.utoronto.ca	Steinberg, Aephraim M/C-3226-2008; Shalm, Lynden/AAC-2274-2020; Ravets, Sylvain/GRJ-9252-2022	Steinberg, Aephraim M/0000-0002-7737-8971; Ravets, Sylvain/0000-0003-1746-5245; Mirin, Richard/0000-0002-4472-4655	Natural Sciences and Engineering Research Council of Canada; Canadian Institute for Advanced Research, and QuantumWorks	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institute for Advanced Research, and QuantumWorks(Canadian Institute for Advanced Research (CIFAR))	A.M.S. conceived of the experiment and supervised the work; M.J.S. and R.P.M. designed and fabricated the single-photon sources; S.K. constructed the experiment and acquired the data with assistance from B.B. and S.R. and much guidance from L.K.S.; B.B., S.K., and S.R. carried out the data analysis and generated the figures; S.K. and L.K.S. wrote the text with input from all the other co-authors. This work was supported by the Natural Sciences and Engineering Research Council of Canada, the Canadian Institute for Advanced Research, and QuantumWorks. S.K. thanks B. Higgins and L.K.S. thanks K.J. Resch for useful discussions. The data from the experiment has been archived and is available at www.physics.utoronto.ca/similar to aephraim/data/PhotonTrajectories.	AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; AHARONOV Y, 1989, PHYS REV LETT, V62, P2327, DOI 10.1103/PhysRevLett.62.2327; BOHM D, 1952, PHYS REV, V85, P166, DOI 10.1103/PhysRev.85.166; BOHM D, 1952, PHYS REV, V85, P180, DOI 10.1103/PhysRev.85.180; Bohr N, 1928, NATURWISSENSCHAFTEN, V16, P245, DOI 10.1007/BF01504968; Bohr N., 1972, COLLECTED WORKS; Born M, 2005, PRINCIPLES OPTICS, V7th edn; Brukner C, 1999, PHYS REV LETT, V83, P3354, DOI 10.1103/PhysRevLett.83.3354; Dixon PB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.173601; Dressel J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.240401; Hadfield RH, 2005, OPT EXPRESS, V13, P10846, DOI 10.1364/OPEX.13.010846; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Jacques V, 2007, SCIENCE, V315, P966, DOI 10.1126/science.1136303; LEGGETT AJ, 1989, PHYS REV LETT, V62, P2325, DOI 10.1103/PhysRevLett.62.2325; Loudon R., 2000, QUANTUM THEORY LIGHT; Lundeen JS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020404; Matthew L.S, 1989, FEYNMAN LECT PHYS; Mir R, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/287; Mirin RP, 2004, APPL PHYS LETT, V84, P1260, DOI 10.1063/1.1650032; PERES A, 1989, PHYS REV LETT, V62, P2326, DOI 10.1103/PhysRevLett.62.2326; Pryde GJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220405; RITCHIE NWM, 1991, PHYS REV LETT, V66, P1107, DOI 10.1103/PhysRevLett.66.1107; SCULLY MO, 1991, NATURE, V351, P111, DOI 10.1038/351111a0; Wiseman HM, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/165; WOOTTERS WK, 1979, PHYS REV D, V19, P473, DOI 10.1103/PhysRevD.19.473; Yokota K, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033011	26	412	415	5	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1170	1173		10.1126/science.1202218	http://dx.doi.org/10.1126/science.1202218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636767				2022-12-28	WOS:000291205200040
J	Pergola, PE; Raskin, P; Toto, RD; Meyer, CJ; Huff, JW; Grossman, EB; Krauth, M; Ruiz, S; Audhya, P; Christ-Schmidt, H; Wittes, J; Warnock, DG				Pergola, Pablo E.; Raskin, Philip; Toto, Robert D.; Meyer, Colin J.; Huff, J. Warren; Grossman, Eric B.; Krauth, Melissa; Ruiz, Stacey; Audhya, Paul; Christ-Schmidt, Heidi; Wittes, Janet; Warnock, David G.		BEAM Study Investigators	Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RENAL OUTCOMES; DISEASE; NRF2; INFLAMMATION; MICE; INHIBITION; MECHANISMS; PATHWAYS; INDUCERS; INJURY	BACKGROUND Chronic kidney disease (CKD) associated with type 2 diabetes is the leading cause of kidney failure, with both inflammation and oxidative stress contributing to disease progression. Bardoxolone methyl, an oral antioxidant inflammation modulator, has shown efficacy in patients with CKD and type 2 diabetes in short-term studies, but longer-term effects and dose response have not been determined. METHODS In this phase 2, double-blind, randomized, placebo-controlled trial, we assigned 227 adults with CKD (defined as an estimated glomerular filtration rate [GFR] of 20 to 45 ml per minute per 1.73 m(2) of body-surface area) in a 1: 1: 1: 1 ratio to receive placebo or bardoxolone methyl at a target dose of 25, 75, or 150 mg once daily. The primary outcome was the change from baseline in the estimated GFR with bardoxolone methyl, as compared with placebo, at 24 weeks; a secondary outcome was the change at 52 weeks. RESULTS Patients receiving bardoxolone methyl had significant increases in the mean (+/- SD) estimated GFR, as compared with placebo, at 24 weeks (with between-group differences per minute per 1.73 m(2) of 8.2 +/- 1.5 ml in the 25-mg group, 11.4 +/- 1.5 ml in the 75-mg group, and 10.4 +/- 1.5 ml in the 150-mg group; P<0.001). The increases were maintained through week 52, with significant differences per minute per 1.73 m2 of 5.8 +/- 1.8 ml, 10.5 +/- 1.8 ml, and 9.3 +/- 1.9 ml, respectively. Muscle spasms, the most frequent adverse event in the bardoxolone methyl groups, were generally mild and dose-related. Hypomagnesemia, mild increases in alanine aminotransferase levels, and gastrointestinal effects were more common among patients receiving bardoxolone methyl. CONCLUSIONS Bardoxolone methyl was associated with improvement in the estimated GFR in patients with advanced CKD and type 2 diabetes at 24 weeks. The improvement persisted at 52 weeks, suggesting that bardoxolone methyl may have promise for the treatment of CKD.	[Pergola, Pablo E.] Renal Associates, San Antonio, TX 78215 USA; [Raskin, Philip; Toto, Robert D.] Univ Texas SW, Dept Med, Dallas, TX USA; [Meyer, Colin J.; Huff, J. Warren; Grossman, Eric B.; Krauth, Melissa; Ruiz, Stacey; Audhya, Paul] Reata Pharmaceut, Irving, TX USA; [Christ-Schmidt, Heidi; Wittes, Janet] Stat Collaborat, Washington, DC USA; [Warnock, David G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Pergola, PE (corresponding author), Renal Associates, 215 E Quincy,Suite 610, San Antonio, TX 78215 USA.	ppergola@raparesearch.com			Reata Pharmaceuticals	Reata Pharmaceuticals	Supported by Reata Pharmaceuticals.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barnett AH, 2005, NEW ENGL J MED, V352, P1731; Cachofeiro V, 2008, KIDNEY INT, V74, pS4, DOI 10.1038/ki.2008.516; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; DUNNETT CW, 1992, J AM STAT ASSOC, V87, P162, DOI 10.2307/2290465; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HAYASHI H, 1992, KIDNEY INT, V41, P749, DOI 10.1038/ki.1992.117; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Lemley KV, 2000, KIDNEY INT, V58, P1228, DOI 10.1046/j.1523-1755.2000.00223.x; Lemley KV, 2000, KIDNEY INT, V58, P2257; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; Li J, 2004, PHYSIOL GENOMICS, V18, P261, DOI 10.1152/physiolgenomics.00209.2003; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Marrero MB, 2005, CURR DIABETES REV, V1, P197, DOI 10.2174/1573399054022802; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Navaneethan SD, 2009, CLIN J AM SOC NEPHRO, V4, P542, DOI 10.2215/CJN.04750908; Onuigbo MAC, 2011, NEPHRON CLIN PRACT, V118, pC407, DOI 10.1159/000324164; Osburn WO, 2008, TOXICOL SCI, V104, P218, DOI 10.1093/toxsci/kfn079; Pergola PE, 2011, AM J NEPHROL, V33, P469, DOI 10.1159/000327599; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Raptis AE, 2001, EXP CLIN ENDOCR DIAB, V109, pS424, DOI 10.1055/s-2001-18600; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; WOLFINGER R, 1993, COMMUN STAT-SIMUL C, V22, P1079, DOI 10.1080/03610919308813143; Wu QQ, 2011, AM J PHYSIOL-RENAL, V300, pF1180, DOI 10.1152/ajprenal.00353.2010; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Yoh K, 2001, KIDNEY INT, V60, P1343, DOI 10.1046/j.1523-1755.2001.00939.x	41	649	686	2	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					327	336		10.1056/NEJMoa1105351	http://dx.doi.org/10.1056/NEJMoa1105351			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21699484				2022-12-28	WOS:000293172200011
J	Eskola, J; Kilpi, T				Eskola, Juhani; Kilpi, Terhi			Public-private collaboration in vaccine research	LANCET			English	Editorial Material									[Eskola, Juhani; Kilpi, Terhi] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland	Finland National Institute for Health & Welfare	Eskola, J (corresponding author), Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland.	juhani.eskola@thl.fi						Abraham J, 2002, LANCET, V360, P1498, DOI 10.1016/S0140-6736(02)11477-2; Bailey R., 2008, SCRUTINIZING IND FUN; Bion J, 2009, CURR OPIN CRIT CARE, V15, P583, DOI 10.1097/MCC.0b013e328332f53a; Fauci AS, 2005, NAT IMMUNOL, V6, P743, DOI 10.1038/ni0805-743; Folkers GK, 1998, NAT MED, V4, P491, DOI 10.1038/nm0598supp-491; French M, 2009, VACC 21 CENT TAK CAN; Gottesman MM, 2010, ACAD MED, V85, P1660, DOI 10.1097/ACM.0b013e3181fa3f91; Health Protection Agency, 2005, HLTH PROT AG RES STR; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					385	386		10.1016/S0140-6736(11)60690-9	http://dx.doi.org/10.1016/S0140-6736(11)60690-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21664686				2022-12-28	WOS:000293615900009
J	Meinema, AC; Laba, JK; Hapsari, RA; Otten, R; Mulder, FAA; Kralt, A; van den Bogaart, G; Lusk, CP; Poolman, B; Veenhoff, LM				Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; Kralt, Annemarie; van den Bogaart, Geert; Lusk, C. Patrick; Poolman, Bert; Veenhoff, Liesbeth M.			Long Unfolded Linkers Facilitate Membrane Protein Import Through the Nuclear Pore Complex	SCIENCE			English	Article							INTRACELLULAR TRAFFICKING; ARCHITECTURE; TRANSPORT; DOMAIN	Active nuclear import of soluble cargo involves transport factors that shuttle cargo through the nuclear pore complex (NPC) by binding to phenylalanine-glycine (FG) domains. How nuclear membrane proteins cross through the NPC to reach the inner membrane is presently unclear. We found that at least a 120-residue-long intrinsically disordered linker was required for the import of membrane proteins carrying a nuclear localization signal for the transport factor karyopherin-a. We propose an import mechanism for membrane proteins in which an unfolded linker slices through the NPC scaffold to enable binding between the transport factor and the FG domains in the center of the NPC.	[Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Meinema, Anne C.; Laba, Justyna K.; Hapsari, Rizqiya A.; Otten, Renee; Mulder, Frans A. A.; van den Bogaart, Geert; Poolman, Bert; Veenhoff, Liesbeth M.] Univ Groningen, Dept Biophys Chem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Kralt, Annemarie; Veenhoff, Liesbeth M.] Univ Med Ctr Groningen, European Res Inst Biol Ageing, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Lusk, C. Patrick] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06519 USA	University of Groningen; University of Groningen; University of Groningen; Yale University	Veenhoff, LM (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Zernike Inst Adv Mat,Netherlands Prote Ctr, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	l.m.veenhoff@rug.nl	Institute, Zernike/W-7033-2019; van den Bogaart, Geert/A-1089-2014; van den Bogaart, Geert/GLV-3283-2022; Poolman, Bert/D-1882-2012; Mulder, Frans AA/C-7158-2017	van den Bogaart, Geert/0000-0003-2180-6735; van den Bogaart, Geert/0000-0003-2180-6735; Mulder, Frans AA/0000-0001-9427-8406; Veenhoff, Liesbeth/0000-0002-0158-4728; Lusk, C. Patrick/0000-0003-4703-0533; Otten, Renee/0000-0001-7342-6131	Netherlands Organization for Scientific Research [700.56.302]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank M. C. King, M. P. Rout, and D. J. Slotboom for discussion; V. Krasnikov for help with confocal microscopy; and M. Graham for assistance with immunoelectron microscopy. We thank S. R. Wente, U. K. Laemmli, and M. P. Rout for reagents and strains. This work was supported by funding from the Netherlands Organization for Scientific Research (VIDI fellowship to L.M.V. and F.A.A.M.; Top-subsidy grant 700.56.302 to B.P.). L.M.V. conceived the project. Experiments were performed and analyzed by A.C.M., J.K.L., R.A.H., C.P.L., and A. K. NMR was performed by R.O. and F.A.A.M. G.v.d.B. helped with image analysis. Experiments were designed and the manuscript was written by A.C.M., C.P.L., B.P., and L.M.V.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Haruki H, 2008, MOL CELL, V31, P925, DOI 10.1016/j.molcel.2008.07.020; HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lusk CP, 2007, NAT REV MOL CELL BIO, V8, P414, DOI 10.1038/nrm2165; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ostlund C, 1999, J CELL SCI, V112, P1709; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wu W, 2002, J CELL SCI, V115, P1361; Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4; Zuleger N, 2008, BIOCHEM SOC T, V36, P1373, DOI 10.1042/BST0361373	22	94	95	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 1	2011	333	6038					90	93		10.1126/science.1205741	http://dx.doi.org/10.1126/science.1205741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785UF	21659568	Bronze			2022-12-28	WOS:000292255400056
J	Cohen, JC; Horton, JD; Hobbs, HH				Cohen, Jonathan C.; Horton, Jay D.; Hobbs, Helen H.			Human Fatty Liver Disease: Old Questions and New Insights	SCIENCE			English	Review							INSULIN-RESISTANCE; HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; ADIPOSE-TISSUE; PREVALENCE; GLUCOSE; TRANSPLANTATION; CHOLESTEROL; LIPOGENESIS; POPULATION	Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.	[Cohen, Jonathan C.; Horton, Jay D.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Horton, Jay D.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu			NIH [RL1HL092550, UL1DE109584, PO1 HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, RL1HL092550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Rodgers for the histological sections in Fig. 1 and D. Russell, J. Goldstein, M. Brown, and J. Browning for helpful discussions. The University of Texas Southwestern Medical Center has applied to patent the association between rs738409 and NAFLD. Supported by grants from the NIH (RL1HL092550, UL1DE109584, and PO1 HL20948). H.H.H. is on the Scientific Advisory Board for Pfizer. J.D.H. is a consultant for Merck, Pfizer, and Sanofi-Aventis and is on the Scientific Advisory Board of Aegerion.	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Argo CK, 2009, CLIN LIVER DIS, V13, P511, DOI 10.1016/j.cld.2009.07.005; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bandsma RHJ, 2008, PEDIATR RES, V63, P702, DOI 10.1203/PDR.0b013e31816c9013; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Bhargava R, 2004, DIABETES, V53, P1311, DOI 10.2337/diabetes.53.5.1311; Brown JM, 2010, J LIPID RES, V51, P3306, DOI 10.1194/jlr.M010256; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hooper AJ, 2011, J LIPID RES, V52, P593, DOI 10.1194/jlr.R008896; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Johnson NA, 2010, HEPATOLOGY, V52, P370, DOI 10.1002/hep.23711; Komatsu M, 2008, J HEPATOL, V49, P810, DOI 10.1016/j.jhep.2008.05.016; Kozlitina J, 2011, HEPATOLOGY, V53, P467, DOI 10.1002/hep.24072; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Malik SM, 2009, LIVER TRANSPLANT, V15, P1843, DOI 10.1002/lt.21943; Michel P. J., HEPATOLOGY, DOI [10.1002/hep.24334, DOI 10.1002/HEP.24334]; Mummadi RR, 2008, CLIN GASTROENTEROL H, V6, P1396, DOI 10.1016/j.cgh.2008.08.012; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Semple RK, 2009, J CLIN INVEST, V119, P315, DOI 10.1172/JCI37432; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Struben VMD, 2000, AM J MED, V108, P9, DOI 10.1016/S0002-9343(99)00315-0; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tanoli T, 2004, J LIPID RES, V45, P941, DOI 10.1194/jlr.M300508-JLR200; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tilg H, 2010, DIGEST DIS, V28, P179, DOI 10.1159/000282083; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	51	1499	1587	8	433	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1519	1523		10.1126/science.1204265	http://dx.doi.org/10.1126/science.1204265			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700865	Green Accepted			2022-12-28	WOS:000291990000034
J	Moraes, M				Moraes, Marcia			Lessons from Brazil	NATURE			English	Editorial Material									Univ Sao Paulo, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Moraes, M (corresponding author), Univ Sao Paulo, BR-05508 Sao Paulo, Brazil.	mafdmora@esalq.usp.br							0	15	15	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S25	S25		10.1038/474S025a	http://dx.doi.org/10.1038/474S025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697841	Green Published, Bronze			2022-12-28	WOS:000291939700010
J	Savage, N				Savage, Neil			The ideal biofuel	NATURE			English	Editorial Material																			0	117	119	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S9	S11		10.1038/474S09a	http://dx.doi.org/10.1038/474S09a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697843	Bronze			2022-12-28	WOS:000291939700003
J	Collins, GS; Mallett, S; Altman, DG				Collins, Gary S.; Mallett, Susan; Altman, Douglas G.			Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores	BRITISH MEDICAL JOURNAL			English	Article							PROGNOSTIC MODEL; SURVIVAL-DATA; WOMEN; MEN; UK	Objective To evaluate the performance of the QFractureScores for predicting the 10 year risk of osteoporotic and hip fractures in an independent UK cohort of patients from general practice records. Design Prospective cohort study. Setting 364 UK general practices contributing to The Health Improvement Network (THIN) database. Participants 2.2 million adults registered with a general practice between 27 June 1994 and 30 June 2008, aged 30-85 (13 million person years), with 25 208 osteoporotic fractures and 12 188 hip fractures. Main outcome measures First (incident) diagnosis of osteoporotic fracture (vertebra, distal radius, or hip) and incident hip fracture recorded in general practice records. Results Results from this independent and external validation of QFractureScores indicated good performance data for both osteoporotic and hip fracture end points. Discrimination and calibration statistics were comparable to those reported in the internal validation of QFractureScores. The hip fracture score had better performance data for both women and men. It explained 63% of the variation in women and 60% of the variation in men, with areas under the receiver operating characteristic curve of 0.89 and 0.86, respectively. The risk score for osteoporotic fracture explained 49% of the variation in women and 38% of the variation in men, with corresponding areas under the receiver operating characteristic curve of 0.82 and 0.74. QFractureScores were well calibrated, with predicted risks closely matching those across all 10ths of risk and for all age groups. Conclusion QFractureScores are useful tools for predicting the 10 year risk of osteoporotic and hip fractures in patients in the United Kingdom.	[Collins, Gary S.; Mallett, Susan; Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England	University of Oxford	Collins, GS (corresponding author), Univ Oxford, Ctr Stat Med, Wolfson Coll Annexe, Oxford OX2 6UD, England.	gary.collins@csm.ox.ac.uk	Collins, Gary Stephen/A-2258-2014; Altman, Douglas G/A-9714-2012; Mallett, Sue/GPS-9933-2022	Collins, Gary Stephen/0000-0002-2772-2316; Mallett, Sue/0000-0002-0596-8200				Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Burge Rt, 2001, J MED ECON, V4, P51, DOI DOI 10.3111/200104051062; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Dawson-Hughes B, 2008, J CLIN ENDOCR METAB, V93, P2463, DOI 10.1210/jc.2008-0926; Graf E, 1999, STAT MED, V18, P2529; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; *NAT OST FDN, 2011, CLIN GUID PREV TREAT; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; *R PROJ, 2011, R PROJ STAT COMP PRO; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schafer JL, 1999, STAT MED, V18, P2529; StataCorp, 2021, STATA STAT SOFTWARE; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; 1999, AM J MED, V94, P646	19	70	71	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3651	10.1136/bmj.d3651	http://dx.doi.org/10.1136/bmj.d3651			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AT	21697214	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000292200500004
J	Shafazand, S				Shafazand, Shirin			Review: Adding noninvasive ventilation to standard therapy improves outcomes in patients with some causes of acute respiratory failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Miami, Miller Sch Med, Miami, FL 33136 USA	University of Miami	Shafazand, S (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-7	10.7326/0003-4819-154-12-201106210-02007	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690585				2022-12-28	WOS:000291800500006
J	Heki, K				Heki, Kosuke			A Tale of Two Earthquakes	SCIENCE			English	Editorial Material							SUMATRA-ANDAMAN EARTHQUAKE; JAPAN		Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University	Heki, K (corresponding author), Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	heki@mail.sci.hokudai.ac.jp						Banerjee P, 2005, SCIENCE, V308, P1769, DOI 10.1126/science.1113746; Geller RJ, 2011, NATURE, V472, P407, DOI 10.1038/nature10105; Han SC, 2006, SCIENCE, V313, P658, DOI 10.1126/science.1128661; Heki K, 2004, EARTH PLANET SC LETT, V219, P13, DOI 10.1016/S0012-821X(03)00693-9; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Heki K, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045335; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132	11	19	20	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1390	1391		10.1126/science.1206643	http://dx.doi.org/10.1126/science.1206643			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680832				2022-12-28	WOS:000291689000028
J	Lam, JKY; Lam, KSL; Kung, AWC; Tan, KCB; Chow, WS; Tso, AWK				Lam, Joanne K. Y.; Lam, Karen S. L.; Kung, Annie W. C.; Tan, Kathryn C. B.; Chow, Wing-Sun; Tso, Annette W. K.			PICTURE QUIZ A woman with raised alkaline phosphatase and forearm deformity	BRITISH MEDICAL JOURNAL			English	Editorial Material							PAGETS-DISEASE; ZOLEDRONIC ACID; BONE; RISEDRONATE; MULTICENTER; ETIDRONATE; MANAGEMENT; DIAGNOSIS; TURNOVER		[Lam, Joanne K. Y.; Lam, Karen S. L.; Kung, Annie W. C.; Tan, Kathryn C. B.; Chow, Wing-Sun; Tso, Annette W. K.] Queen Mary Hosp, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lam, JKY (corresponding author), Queen Mary Hosp, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	kyjoanne414@yahoo.com.hk						ALTMAN RD, 1973, NEW ENGL J MED, V289, P1379, DOI 10.1056/NEJM197312272892601; BARKER DJP, 1984, BRIT MED BULL, V40, P396, DOI 10.1093/oxfordjournals.bmb.a072011; Eastell R, 1999, BONE, V24, p49S, DOI 10.1016/S8756-3282(99)00053-8; Hosking D, 2007, J BONE MINER RES, V22, P142, DOI 10.1359/JBMR.061001; Hsu L. F., 1998, Annals Academy of Medicine Singapore, V27, P289; Irving K., 2005, GD ROUNDS, V5, P23, DOI [10.1102/1470-5206.2005.0005, DOI 10.1102/1470-5206.2005.0005]; Josse RG, 2007, CLIN INVEST MED, V30, pE210; Kanis JA, 1998, PATHOPHYSIOLOGY TREA, P110; Paget J, 1877, T MED CHIR SOC, V60, P235; Reid IR, 2005, NEW ENGL J MED, V353, P898, DOI 10.1056/NEJMoa044241; ROUX C, 1995, ARTHRITIS RHEUM, V38, P851, DOI 10.1002/art.1780380620; Selby PL, 2002, BONE, V31, P366, DOI 10.1016/S8756-3282(02)00817-7; Shankar S, 2006, J BONE MINER RES, V21, pP22, DOI 10.1359/JBMR.06S204; SIRIS ES, 1994, J BONE MINER RES, V9, P303; Siris ES, 1998, J BONE MINER RES, V13, P1032, DOI 10.1359/jbmr.1998.13.6.1032; STEINBACH HL, 1961, AMER J ROENTGENOL RA, V86, P950; Urai J, 1962, Z ORTHOP IHRE GRENZG, V95, P362; WELLMAN HN, 1977, CLIN ORTHOP RELAT R, P55; Whyte MP, 2006, NEW ENGL J MED, V355, P593, DOI 10.1056/NEJMcp060278	19	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3435	10.1136/bmj.d3435	http://dx.doi.org/10.1136/bmj.d3435			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LC	21677018				2022-12-28	WOS:000291932700001
J	Smith, CR; Leon, MB; Mack, MJ; Miller, C; Moses, JW; Svensson, LG; Tuzcu, EM; Webb, JG; Fontana, GP; Makkar, RR; Williams, M; Dewey, T; Kapadia, S; Babaliaros, V; Thourani, VH; Corso, P; Pichard, AD; Bavaria, JE; Herrmann, HC; Akin, JJ; Anderson, WN; Wang, DL; Pocock, SJ				Smith, Craig R.; Leon, Martin B.; Mack, Michael J.; Miller, Craig; Moses, Jeffrey W.; Svensson, Lars G.; Tuzcu, E. Murat; Webb, John G.; Fontana, Gregory P.; Makkar, Raj R.; Williams, Mathew; Dewey, Todd; Kapadia, Samir; Babaliaros, Vasilis; Thourani, Vinod H.; Corso, Paul; Pichard, Augusto D.; Bavaria, Joseph E.; Herrmann, Howard C.; Akin, Jodi J.; Anderson, William N.; Wang, Duolao; Pocock, Stuart J.		PARTNER Trial Investigators	Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THORACIC SURGEONS; ELDERLY-PATIENTS; HEART-VALVE; IMPLANTATION; STENOSIS; OUTCOMES; AGE; PROSTHESIS; SOCIETY; FEASIBILITY	Background The use of transcatheter aortic-valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement. However, the two procedures have not been compared in a randomized trial involving high-risk patients who are still candidates for surgical replacement. Methods At 25 centers, we randomly assigned 699 high-risk patients with severe aortic stenosis to undergo either transcatheter aortic-valve replacement with a balloon-expandable bovine pericardial valve (either a transfemoral or a transapical approach) or surgical replacement. The primary end point was death from any cause at 1 year. The primary hypothesis was that transcatheter replacement is not inferior to surgical replacement. Results The rates of death from any cause were 3.4% in the transcatheter group and 6.5% in the surgical group at 30 days (P = 0.07) and 24.2% and 26.8%, respectively, at 1 year (P = 0.44), a reduction of 2.6 percentage points in the transcatheter group (upper limit of the 95% confidence interval, 3.0 percentage points; predefined margin, 7.5 percentage points; P = 0.001 for noninferiority). The rates of major stroke were 3.8% in the transcatheter group and 2.1% in the surgical group at 30 days (P = 0.20) and 5.1% and 2.4%, respectively, at 1 year (P = 0.07). At 30 days, major vascular complications were significantly more frequent with transcatheter replacement (11.0% vs. 3.2%, P<0.001); adverse events that were more frequent after surgical replacement included major bleeding (9.3% vs. 19.5%, P<0.001) and new-onset atrial fibrillation (8.6% vs. 16.0%, P = 0.006). More patients undergoing transcatheter replacement had an improvement in symptoms at 30 days, but by 1 year, there was not a significant between-group difference. Conclusions In high-risk patients with severe aortic stenosis, transcatheter and surgical procedures for aortic-valve replacement were associated with similar rates of survival at 1 year, although there were important differences in periprocedural risks.	[Smith, Craig R.; Leon, Martin B.; Moses, Jeffrey W.; Williams, Mathew] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10032 USA; [Mack, Michael J.] Baylor Healthcare Syst, Dallas, TX USA; [Dewey, Todd] Med City Dallas, Dallas, TX USA; Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Akin, Jodi J.; Anderson, William N.] Edwards Lifesci, Irvine, CA USA; [Svensson, Lars G.; Tuzcu, E. Murat; Kapadia, Samir] Cleveland Clin Fdn, Cleveland, OH USA; [Webb, John G.] Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada; [Fontana, Gregory P.; Makkar, Raj R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Babaliaros, Vasilis; Thourani, Vinod H.] Emory Univ, Sch Med, Atlanta, GA USA; [Corso, Paul; Pichard, Augusto D.] Washington Hosp Ctr, Washington, DC 20010 USA; [Bavaria, Joseph E.; Herrmann, Howard C.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Wang, Duolao; Pocock, Stuart J.] London Sch Hyg & Trop Med, London, England	Columbia University; NewYork-Presbyterian Hospital; Baylor Health Care System; Medical City Dallas Hospital; Stanford University; Edwards Lifesciences; Cleveland Clinic Foundation; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Cedars Sinai Medical Center; Emory University; MedStar Washington Hospital Center; University of Pennsylvania; Pennsylvania Medicine; University of London; London School of Hygiene & Tropical Medicine	Smith, CR (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, 177 Ft Washington Ave,Milstein Bldg 7-435, New York, NY 10032 USA.	crs2@columbia.edu	Miller, Craig/GWQ-5012-2022; thourani, vinod/AAP-5968-2020; Doğan, Ali/AAN-5331-2020; Asch, Federico/AAS-7653-2021; Thompson, Christopher R/F-3967-2010	Asch, Federico/0000-0002-1744-5271; Thompson, Christopher R/0000-0001-9206-376X; Miller, D. Craig/0000-0001-7619-0080; Williams, Mathew/0000-0003-2055-8741	Edwards Lifesciences	Edwards Lifesciences	Supported by Edwards Lifesciences.	Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Bakaeen FG, 2010, ANN THORAC SURG, V90, P769, DOI 10.1016/j.athoracsur.2010.04.066; Bonow Robert O, 2008, Circulation, V118, pe523, DOI 10.1161/CIRCULATIONAHA.108.190748; Bose AK, 2007, J CARDIOTHORAC SURG, V2, DOI 10.1186/1749-8090-2-33; Bouma BJ, 1999, HEART, V82, P143, DOI 10.1136/hrt.82.2.143; CHEITLIN MD, 1979, AM HEART J, V98, P689, DOI 10.1016/0002-8703(79)90465-4; Cribier A, 2004, J AM COLL CARDIOL, V43, P698, DOI 10.1016/j.jacc.2003.11.026; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Cribier A, 2006, J AM COLL CARDIOL, V47, P1214, DOI 10.1016/j.jacc.2006.01.049; Dewey TM, 2008, J THORAC CARDIOV SUR, V135, P180, DOI 10.1016/j.jtcvs.2007.09.011; Florath I, 2010, EUR J CARDIO-THORAC, V37, P1304, DOI 10.1016/j.ejcts.2009.12.025; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Grube E, 2006, CIRCULATION, V114, P1616, DOI 10.1161/CIRCULATIONAHA.106.639450; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Himbert D, 2009, J AM COLL CARDIOL, V54, P303, DOI 10.1016/j.jacc.2009.04.032; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; LUND O, 1990, CIRCULATION, V82, P124, DOI 10.1161/01.CIR.82.1.124; MURPHY ES, 1981, CIRCULATION, V64, P184; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; PETER M, 1993, CHEST, V103, P1715, DOI 10.1378/chest.103.6.1715; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P18, DOI 10.1016/j.jacc.2010.07.036; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Ross J Jr, 1968, Circulation, V38, P61; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; Shahian DM, 2009, ANN THORAC SURG, V88, pS2, DOI 10.1016/j.athoracsur.2009.05.053; Sharony R, 2003, ANN THORAC SURG, V75, P1808, DOI 10.1016/S0003-4975(03)00117-6; Shroyer ALW, 2003, ANN THORAC SURG, V75, P1856, DOI 10.1016/S0003-4975(03)00179-6; Svensson LG, 2008, ANN THORAC SURG, V86, P46, DOI 10.1016/j.athoracsur.2008.04.049; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Thourani VH, 2011, ANN THORAC SURG, V91, P49, DOI 10.1016/j.athoracsur.2010.09.040; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307; Varadarajan P, 2006, ANN THORAC SURG, V82, P2111, DOI 10.1016/j.athoracsur.2006.07.048; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807	40	4406	4551	3	162	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2187	2198		10.1056/NEJMoa1103510	http://dx.doi.org/10.1056/NEJMoa1103510			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21639811	Green Accepted			2022-12-28	WOS:000291392100005
J	Howard, DH				Howard, David H.			Realigning Incentives for Developing and Pricing New Anticancer Treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Emory University	Howard, DH (corresponding author), Emory Univ, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	david.howard@emory.edu						Centers for Medicare and Medicaid Services, PROP DEC MEM AUT CEL; CMS HHS, 2011, FED REGISTER, V76, P19528; Congressional Budget Office, LONG TERM AN BUDG PR; Elkin EB, 2010, JAMA-J AM MED ASSOC, V303, P1086, DOI 10.1001/jama.2010.283; House Committee of the Budget, PATH PROSP REST AM C; Howard DH, 2010, ARCH INTERN MED, V170, P537, DOI 10.1001/archinternmed.2010.36; Stein R., 2010, WASH POST, pA01; Zajac A, 2001, LOS ANGELES TIM 0326, pA14	8	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2347	2348		10.1001/jama.2011.793	http://dx.doi.org/10.1001/jama.2011.793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642689				2022-12-28	WOS:000291349100030
J	Kesselheim, AS; Myers, JA; Avorn, J				Kesselheim, Aaron S.; Myers, Jessica A.; Avorn, Jerry			Characteristics of Clinical Trials to Support Approval of Orphan vs Nonorphan Drugs for Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACCELERATED APPROVAL; ONCOLOGY PRODUCTS; END-POINTS; EXPERIENCE; DISEASES	Context The Orphan Drug Act incentivizes medication development for rare diseases, offering substantial financial benefits to the manufacturer. Orphan products constitute most new drug approvals in oncology, but safety and efficacy questions have emerged about some of these agents. Objectives To define characteristics of orphan cancer drugs and their pivotal clinical trials and to compare these with nonorphan drugs. Design and Setting We identified all new orphan and nonorphan drugs approved between 2004 and 2010 to treat cancer. We then collected data on key development variables from publicly available information on the US Food and Drug Administration's Web site and in the Code of Federal Regulations. Main Outcome Measures We assessed clinical testing dates, approved indications, and regulatory characteristics (regular vs accelerated review, advisory committee review, postmarketing commitments). We then compared design features (randomization, blinding, primary end point) of pivotal trials supporting approval of orphan and nonorphan drugs and rates of adverse safety outcomes (deaths not attributed to disease progression, serious adverse events, dropouts) in pivotal trials. Results Fifteen orphan and 12 nonorphan drugs were approved between January 1, 2004, and December 31, 2010. Pivotal trials of orphan drugs had smaller participant numbers (median, 96 [interquartile range {IQR}, 66-152] vs 290 [IQR, 185-394] patients exposed to the drug; P<.001) and were less likely to be randomized (30% vs 80%; P=.007). Orphan and nonorphan pivotal trials varied in their blinding (P=.04), with orphan trials less likely to be double-blind (4% vs 33%). Primary study outcomes also varied (P=.04), with orphan trials more likely to assess disease response (68% vs 27%) rather than overall survival (8% vs 27%). More treated patients had serious adverse events in trials of orphan drugs vs trials of nonorphan drugs (48% vs 36%; odds ratio, 1.72; 95% confidence interval, 1.02-2.92; P=.04). Conclusion Compared with pivotal trials used to approve nonorphan cancer drugs, pivotal trials for recently approved orphan drugs for cancer were more likely to be smaller and to use nonrandomized, unblinded trial designs and surrogate end points to assess efficacy. JAMA. 2011;305(22):2320-2326 www.jama.com	[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Agency for Healthcare Research and Quality [K08HS18465-01]; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Kesselheim is supported by career development award K08HS18465-01 from the Agency for Healthcare Research and Quality and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research.	[Anonymous], SEARCH ORPH DRUG DES; [Anonymous], NME DRUG NEW BIOL AP; Avorn J, 2005, POWERFUL MED BENEFIT; Avorn J, 2007, NEW ENGL J MED, V356, P1697, DOI 10.1056/NEJMp078041; Bross PF, 2001, CLIN CANCER RES, V7, P1490; Buckley BM, 2008, LANCET, V371, P2051, DOI 10.1016/S0140-6736(08)60876-4; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cote T, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2546-c1; Dagher R, 2004, J NATL CANCER I, V96, P1500, DOI 10.1093/jnci/djh279; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; Hirschler B, 2010, UK SAYS NOVARTIS BRI; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Johnson JR, 2003, J CLIN ONCOL, V21, P1404, DOI 10.1200/JCO.2003.08.072; Kesselheim AS. B, 2010, RARE DIS ORPHAN PROD, P291; Mckee AE, 2010, ONCOLOGIST, V15, P13, DOI 10.1634/theoncologist.2010-S1-13; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Mitsumoto J, 2009, ANN NEUROL, V66, P184, DOI 10.1002/ana.21676; National Cancer Institute, A Z LIST CANC; Office of the Inspector General, 2011, ORPH DRUG ACT IMPL I; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P793, DOI 10.1001/jama.2010.1161; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Tsimberidou AM, 2009, J CLIN ONCOL, V27, P6243, DOI 10.1200/JCO.2009.23.6018; U. S. Food Drug Adm. (FDA), 2011, DEV PROD RAR DIS CON; US Food and Drug Administration, 2011, POSTM REQ COMM; US Food and Drug Administration, 2010, MYL GEMT OZ MARK WIT; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001; Yin W, 2009, J HEALTH ECON, V28, P950, DOI 10.1016/j.jhealeco.2009.06.011	29	155	159	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2320	2326		10.1001/jama.2011.769	http://dx.doi.org/10.1001/jama.2011.769			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642684	Bronze			2022-12-28	WOS:000291349100025
J	Douma, RA; Mos, ICM; Erkens, PMG; Nizet, TAC; Durian, MF; Hovens, MM; van Houten, AA; Hofstee, HMA; Klok, FA; ten Cate, H; Ullmann, EF; Buller, HR; Kamphuisen, PW; Huisman, MV				Douma, Renee A.; Mos, Inge C. M.; Erkens, Petra M. G.; Nizet, Tessa A. C.; Durian, Marc F.; Hovens, Marcel M.; van Houten, Anja A.; Hofstee, Herman M. A.; Klok, Frederikus A.; ten Cate, Hugo; Ullmann, Erik F.; Buller, Harry R.; Kamphuisen, Pieter W.; Huisman, Menno V.		Prometheus Study Grp	Performance of 4 Clinical Decision Rules in the Diagnostic Management of Acute Pulmonary Embolism A Prospective Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							REVISED GENEVA SCORE; D-DIMER; VENOUS THROMBOEMBOLISM; PROBABILITY ASSESSMENT; COMPUTED-TOMOGRAPHY; WELLS RULE; SIMPLIFICATION; PREDICTION; EMERGENCY; UTILITY	Background: Several clinical decision rules (CDRs) are available to exclude acute pulmonary embolism (PE), but they have not been directly compared. Objective: To directly compare the performance of 4 CDRs (Wells rule, revised Geneva score, simplified Wells rule, and simplified revised Geneva score) in combination with D-dimer testing to exclude PE. Design: Prospective cohort study. Setting: 7 hospitals in the Netherlands. Patients: 807 consecutive patients with suspected acute PE. Intervention: The clinical probability of PE was assessed by using a computer program that calculated all CDRs and indicated the next diagnostic step. Results of the CDRs and D-dimer tests guided clinical care. Measurements: Results of the CDRs were compared with the prevalence of PE identified by computed tomography or venous thromboembolism at 3-month follow-up. Results: Prevalence of PE was 23%. The proportion of patients categorized as PE-unlikely ranged from 62% (simplified Wells rule) to 72% (Wells rule). Combined with a normal D-dimer result, the CDRs excluded PE in 22% to 24% of patients. The total failure rates of the CDR and D-dimer combinations were similar (1 failure, 0.5% to 0.6% [ upper-limit 95% CI, 2.9% to 3.1%]). Even though 30% of patients had discordant CDR outcomes, PE was not detected in any patient with discordant CDRs and a normal D-dimer result. Limitation: Management was based on a combination of decision rules and D-dimer testing rather than only 1 CDR combined with D-dimer testing. Conclusion: All 4 CDRs show similar performance for exclusion of acute PE in combination with a normal D-dimer result. This prospective validation indicates that the simplified scores may be used in clinical practice.	[Mos, Inge C. M.] Leiden Univ, Med Ctr, Sect Vasc Med, Dept Gen Internal Med Endocrinol, NL-2300 RC Leiden, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Maastricht Univ, Sch Publ Hlth & Primary Care, Med Ctr, Maastricht, Netherlands; Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; Rijnstate Hosp Arnhem, Arnhem, Netherlands; Erasmus Univ, Med Ctr, Rotterdam, Netherlands; Maasstad Hosp, Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Maastricht University; Maastricht University; Rijnstate Hospital; Erasmus University Rotterdam; Erasmus MC; Maasstad Hospital	Mos, ICM (corresponding author), Leiden Univ, Med Ctr, Sect Vasc Med, Dept Gen Internal Med Endocrinol, Room C4-70,POB 9600, NL-2300 RC Leiden, Netherlands.	i.c.m.mos@lumc.nl	Cate, Hugo ten/AAM-4000-2021; Bossuyt, Patrick M./B-4557-2016; Klok, Erik/U-4870-2019	Bossuyt, Patrick M./0000-0003-4427-0128; Klok, Erik/0000-0001-9961-0754; Hofstee, Herman/0000-0002-7203-3704; ten Cate, Hugo/0000-0001-7796-4463; Kamphuisen, Pieter/0000-0002-6263-0177	Academic Medical Center; VU University Medical Center; Rijnstate Hospital; Leiden University Medical Center; Maastricht University Medical Center; Erasmus Medical Center; Maasstad Hospital; The Netherlands Heart Foundation [2006B224]	Academic Medical Center; VU University Medical Center; Rijnstate Hospital; Leiden University Medical Center; Maastricht University Medical Center; Erasmus Medical Center; Maasstad Hospital; The Netherlands Heart Foundation(Netherlands Heart Foundation)	Academic Medical Center, VU University Medical Center, Rijnstate Hospital, Leiden University Medical Center, Maastricht University Medical Center, Erasmus Medical Center, and Maasstad Hospital.r Dr. Mos is supported by a grant from the Netherlands Heart Foundation (2006B224).r Dr. Mos: Grant: The Netherlands Heart Foundation. Dr. ten Cate: Consultancy: Bayer, Roche, Philips. Payment for lectures including service on speakers bureaus: Bayer, Boehringer Ingelheim, GlaxoSmithKline, Philips. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum = M10-1964.	Calisir C, 2009, EUR J EMERG MED, V16, P49, DOI 10.1097/MEJ.0b013e328304ae6d; Ceriani E, 2010, J THROMB HAEMOST, V8, P957, DOI 10.1111/j.1538-7836.2010.03801.x; Douma RA, 2009, THROMB HAEMOSTASIS, V101, P197, DOI 10.1160/TH08-07-0444; Gardner MJ, 1989, STAT CONFIDENCE, P59; Gibson NS, 2008, CHEST, V134, P789, DOI 10.1378/chest.08-0344; Gibson NS, 2008, THROMB HAEMOSTASIS, V99, P229, DOI 10.1160/TH07-05-0321; Kelly J, 2003, CHEST, V124, P1116, DOI 10.1378/chest.124.3.1116; Klok FA, 2008, J THROMB HAEMOST, V6, P40, DOI 10.1111/j.1538-7836.2007.02820.x; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Roy PM, 2009, ANN INTERN MED, V151, P677, DOI 10.7326/0003-4819-151-10-200911170-00003; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wong DD, 2011, INTERN MED J, V41, P258, DOI 10.1111/j.1445-5994.2010.02204.x	19	172	182	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00002	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00002			112	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646554				2022-12-28	WOS:000291312300001
J	Souwer, IH; Lagro-Janssen, ALM				Souwer, I. H.; Lagro-Janssen, A. L. M.			10-MINUTE CONSULTATION Chronic chilblains	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lagro-Janssen, A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, Unit Womens Studies Med, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Souwer, IH (corresponding author), Middelie 91, NL-1472 GT Middelie, Netherlands.	IHSouweri.souwer@wxs.nl	Lagro, A.L.M./H-8066-2014					GOETTE DK, 1990, J AM ACAD DERMATOL, V23, P257, DOI 10.1016/0190-9622(90)70209-Z; JACOB JR, 1986, ARCH INTERN MED, V146, P1589, DOI 10.1001/archinte.146.8.1589; Morioka N, 1991, Nihon Hifuka Gakkai Zasshi, V101, P615; RUSTIN MHA, 1989, BRIT J DERMATOL, V120, P267; Souwer IH, 2009, INT J CLIN PRACT, V63, P282, DOI 10.1111/j.1742-1241.2008.01912.x; Souwer Ibo H, 2007, Eur J Gen Pract, V13, P159, DOI 10.1080/13814780701471068; Viguier M, 2001, MEDICINE, V80, P180, DOI 10.1097/00005792-200105000-00004	7	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d2708	10.1136/bmj.d2708	http://dx.doi.org/10.1136/bmj.d2708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SL	21652748				2022-12-28	WOS:000291645200001
J	Arie, S				Arie, Sophie			DEATH PENALTY Unwilling executioners?	BRITISH MEDICAL JOURNAL			English	Editorial Material												mail@sophiearie.com							0	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 6	2011	342								d3461	10.1136/bmj.d3461	http://dx.doi.org/10.1136/bmj.d3461			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SC	21646306				2022-12-28	WOS:000291644200001
J	Copeland, SR; Sponheimer, M; de Ruiter, DJ; Lee-Thorp, JA; Codron, D; le Roux, PJ; Grimes, V; Richards, MP				Copeland, Sandi R.; Sponheimer, Matt; de Ruiter, Darryl J.; Lee-Thorp, Julia A.; Codron, Daryl; le Roux, Petrus J.; Grimes, Vaughan; Richards, Michael P.			Strontium isotope evidence for landscape use by early hominins	NATURE			English	Article							HUMAN-EVOLUTION; LIFE-HISTORY; RATIOS; BODY; AUSTRALOPITHECUS; SR-87/SR-86; PATTERNS; AFRICA; ORIGIN; HOMO	Ranging and residence patterns among early hominins have been indirectly inferred from morphology(1,2), stone-tool sourcing(3), referential models(4,5) and phylogenetic models(6-8). However, the highly uncertain nature of such reconstructions limits our understanding of early hominin ecology, biology, social structure and evolution. We investigated landscape use in Australopithecus africanus and Paranthropus robustus from the Sterkfontein and Swartkrans cave sites in South Africa using strontium isotope analysis, a method that can help to identify the geological substrate on which an animal lived during tooth mineralization. Here we show that a higher proportion of small hominins than large hominins had non-local strontium isotope compositions. Given the relatively high levels of sexual dimorphism in early hominins, the smaller teeth are likely to represent female individuals, thus indicating that females were more likely than males to disperse from their natal groups. This is similar to the dispersal pattern found in chimpanzees(9), bonobos(10) and many human groups(11), but dissimilar from that of most gorillas and other primates(12). The small proportion of demonstrably non-local large hominin individuals could indicate that male australopiths had relatively small home ranges, or that they preferred dolomitic landscapes.	[Copeland, Sandi R.; Grimes, Vaughan; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Copeland, Sandi R.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [de Ruiter, Darryl J.] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA; [Lee-Thorp, Julia A.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford OX1 3QY, England; [Lee-Thorp, Julia A.; le Roux, Petrus J.] Univ Cape Town, Dept Geol Sci, AEON EarthLAB, ZA-7701 Rondebosch, South Africa; [Codron, Daryl] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, CH-8057 Zurich, Switzerland; [Grimes, Vaughan] Mem Univ, Dept Archaeol, St John, NF A1C 5S7, Canada; [Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada	Max Planck Society; University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; University of Oxford; University of Cape Town; University of Zurich; Memorial University Newfoundland; University of British Columbia	Copeland, SR (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	sandi.copeland@colorado.edu	Grimes, Vaughan/AAG-5174-2021; le Roux, Petrus J./AAD-4755-2021; Richards, Michael/A-9374-2008; Codron, Daryl/B-8867-2008; Sponheimer, Matt/A-6075-2013; Richards, Michael/O-3717-2016	Grimes, Vaughan/0000-0002-2177-3147; le Roux, Petrus J./0000-0002-5930-4995; Richards, Michael/0000-0001-5274-8887; Codron, Daryl/0000-0001-5223-9513; Sponheimer, Matt/0000-0002-8743-1123; Richards, Michael/0000-0001-5274-8887; de Ruiter, Darryl/0000-0003-1183-0352	National Science Foundation, USA [0609963]; Max Planck Society; University of Colorado	National Science Foundation, USA(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Colorado	Funding for this project was provided by the National Science Foundation, USA (grant 0609963), the Max Planck Society, a University of Colorado LEAP Associate Professor Growth Grant and the University of Colorado Dean's Fund for Excellence. We are grateful to the Ditsong National Museum of Natural History (formerly the Transvaal Museum), including F. Thackeray, S. Potze and T. Kearny, for allowing us access to the Sterkfontein and Swartkrans fossil material and for granting permission for laser ablation MC-ICP-MS analysis. We thank S. Potze and T. Perregil for flying to Cape Town to allow laser ablation MC-ICP-MS sampling of the hominins. We also thank L. Berger, J. Brophy, J. Codron and J. Hancox for help in the field, J. Montgomery for useful discussions and J. Sealy and J. Lanham for help with plant preparation in the Archaeology Department, University of Cape Town. We thank A. Anderson, C. Campbell, B. Covert, D. Grimstead, F. Grine, J. Leichliter, O. Paine, J. Quade, P. Sandberg and P. Ungar for commenting on the manuscript. The research of A. Sillen and G. Hall inspired this study.	Ambrose SH, 2001, SCIENCE, V291, P1748, DOI 10.1126/science.1059487; Anton SC, 2002, J HUM EVOL, V43, P773, DOI 10.1006/jhev.2002.0602; BEYNON AD, 1988, NATURE, V335, P509, DOI 10.1038/335509a0; Charlier BLA, 2006, CHEM GEOL, V232, P114, DOI 10.1016/j.chemgeo.2006.02.015; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Copeland SR, 2010, J ARCHAEOL SCI, V37, P1437, DOI 10.1016/j.jas.2010.01.003; EMBER CR, 1978, ETHNOLOGY, V17, P439, DOI 10.2307/3773193; Faure G., 1972, STRONTIUM ISOTOPE GE; Foley R, 2009, PHILOS T R SOC B, V364, P3267, DOI 10.1098/rstb.2009.0136; FURUICHI T, 1989, INT J PRIMATOL, V10, P173, DOI 10.1007/BF02735199; GHIGLIERI MP, 1987, J HUM EVOL, V16, P319, DOI 10.1016/0047-2484(87)90065-0; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOSZ JR, 1983, BIOSCIENCE, V33, P23, DOI 10.2307/1309240; Graustein W. C., 1989, STABLE ISOTOPES ECOL, V68, P491; HURST RW, 1981, ENVIRON GEOL, V3, P363, DOI 10.1007/BF02473525; Lockwood CA, 2007, SCIENCE, V318, P1443, DOI 10.1126/science.1149211; Mahler P.E., 1973, METRIC VARIATION PON; McHenry HM, 1998, J HUM EVOL, V35, P1, DOI 10.1006/jhev.1997.0197; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Moore Jim, 1996, P275, DOI 10.1017/CBO9780511752414.022; Plavcan JM, 1997, J HUM EVOL, V32, P345, DOI 10.1006/jhev.1996.0096; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Robbins MM, 2004, AM J PRIMATOL, V64, P145, DOI 10.1002/ajp.20069; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Sillen A, 1998, GEOCHIM COSMOCHIM AC, V62, P2463, DOI 10.1016/S0016-7037(98)00182-3; Tooby J., 1987, P183; WHEELER PE, 1992, J HUM EVOL, V23, P351, DOI 10.1016/0047-2484(92)90071-G; William C, 1981, WOMAN GATHERER, P35; Wrangham R.W., 1987, P51	29	135	138	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					76	U100		10.1038/nature10149	http://dx.doi.org/10.1038/nature10149			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637256				2022-12-28	WOS:000291156700040
J	Baughman, JM; Perocchi, F; Girgis, HS; Plovanich, M; Belcher-Timme, CA; Sancak, Y; Bao, XR; Strittmatter, L; Goldberger, O; Bogorad, RL; Koteliansky, V; Mootha, VK				Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Bogorad, Roman L.; Koteliansky, Victor; Mootha, Vamsi K.			Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; OXIDATIVE-PHOSPHORYLATION; RNAI THERAPEUTICS; PROTEIN TOPOLOGY; TRANSPORT; DELIVERY; RESPIRATION; INHIBITION; LIBRARY; COMPLEX	Mitochondria from diverse organisms are capable of transporting large amounts of Ca(2+) via a ruthenium-red-sensitive, membrane-potential-dependent mechanism called the uniporter(1-4). Although the uniporter's biophysical properties have been studied extensively, its molecular composition remains elusive. We recently used comparative proteomics to identify MICU1 (also known as CBARA1), an EF-hand-containing protein that serves as a putative regulator of the uniporter(5). Here, we use whole-genome phylogenetic profiling, genome-wide RNA co-expression analysis and organelle-wide protein coexpression analysis to predict proteins functionally related to MICU1. All three methods converge on a novel predicted transmembrane protein, CCDC109A, that we now call 'mitochondrial calcium uniporter' (MCU). MCU forms oligomers in the mitochondrial inner membrane, physically interacts with MICU1, and resides within a large molecular weight complex. Silencing MCU in cultured cells or in vivo in mouse liver severely abrogates mitochondrial Ca(2+) uptake, whereas mitochondrial respiration and membrane potential remain fully intact. MCU has two predicted transmembrane helices, which are separated by a highly conserved linker facing the intermembrane space. Acidic residues in this linker are required for its full activity. However, an S259A point mutation retains function but confers resistance to Ru360, the most potent inhibitor of the uniporter. Our genomic, physiological, biochemical and pharmacological data firmly establish MCU as an essential component of the mitochondrial Ca(2+) uniporter.	[Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Baughman, Joshua M.; Perocchi, Fabiana; Girgis, Hany S.; Plovanich, Molly; Belcher-Timme, Casey A.; Sancak, Yasemin; Bao, X. Robert; Strittmatter, Laura; Goldberger, Olga; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Bogorad, Roman L.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Koteliansky, Victor] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Mootha, VK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu	Bogorad, Roman/G-2609-2011	perocchi, fabiana/0000-0002-1102-6500; Bao, Xiaoyan/0000-0001-7931-2944	National Science Foundation; National Institutes of Health [GM0077465, DK080261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Nilsson, J. Engreitz and S. Calvo for bioinformatics assistance; D. Root and S. Silver for assistance in lentiviral RNAi; B. R. Bettencourt, K. Charisse, S. Kuchimanchi and L. Speciner for siRNA design, synthesis and formulation; M. Blower, J. Avruch and R. Ward for advice; and members of the Mootha laboratory for valuable feedback. J. M. B. and L. S. were supported by graduate student fellowships from the National Science Foundation. This work was supported by grants from the National Institutes of Health (GM0077465, DK080261) awarded to V.K.M.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; CHANCE B, 1955, J BIOL CHEM, V217, P383; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Ryan MT, 2001, METHOD CELL BIOL, V65, P189, DOI 10.1016/S0091-679X(01)65012-X; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; YING WL, 1991, BIOCHEMISTRY-US, V30, P4949, DOI 10.1021/bi00234a016	28	1266	1290	2	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 18	2011	476	7360					341	U111		10.1038/nature10234	http://dx.doi.org/10.1038/nature10234			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811JV	21685886	Green Accepted			2022-12-28	WOS:000294206500040
J	Hirose, S; Benabentos, R; Ho, HI; Kuspa, A; Shaulsky, G				Hirose, Shigenori; Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad			Self-Recognition in Social Amoebae Is Mediated by Allelic Pairs of Tiger Genes	SCIENCE			English	Article							CELL-CELL ADHESION; DICTYOSTELIUM DEVELOPMENT; LAGC; GBF	Free-living cells of the social amoebae Dictyostelium discoideum can aggregate and develop into multicellular fruiting bodies in which many die altruistically as they become stalk cells that support the surviving spores. Dictyostelium cells exhibit kin discrimination-a potential defense against cheaters, which sporulate without contributing to the stalk. Kin discrimination depends on strain relatedness, and the polymorphic genes tgrB1 and tgrC1 are potential components of that mechanism. Here, we demonstrate a direct role for these genes in kin discrimination. We show that a matching pair of tgrB1 and tgrC1 alleles is necessary and sufficient for attractive self-recognition, which is mediated by differential cell-cell adhesion. We propose that TgrB1 and TgrC1 proteins mediate this adhesion through direct binding. This system is a genetically tractable ancient model of eukaryotic self-recognition.	[Hirose, Shigenori; Kuspa, Adam] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Benabentos, Rocio; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Cell & Mol Biol Grad Program, Houston, TX 77030 USA; [Benabentos, Rocio; Ho, Hsing-I; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kuspa, A (corresponding author), Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	akuspa@bcm.edu; gadi@bcm.edu		Shaulsky, Gad/0000-0002-0532-0551; Kuspa, Adam/0000-0002-9156-149X	NIH [R01 GM084992]; National Research Service from the NIH [F31 GM086131]; NSF [2006042535]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084992, F31GM086131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service from the NIH; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Wang and W. J. Cordill for useful discussions. This work was supported by grant no. R01 GM084992 from the NIH. R. B. was supported by National Research Service Award grant F31 GM086131 from the NIH and by an NSF fellowship 2006042535.	Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BRAR SK, 1993, J BIOL CHEM, V268, P24902; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Iranfar N, 2006, DEV BIOL, V290, P460, DOI 10.1016/j.ydbio.2005.11.035; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Rosa SFP, 2010, CURR BIOL, V20, P1122, DOI 10.1016/j.cub.2010.04.050; Rosengarten RD, 2011, MOL BIOL EVOL, V28, P933, DOI 10.1093/molbev/msq282; Shaulsky G, 2007, CURR BIOL, V17, pR684, DOI 10.1016/j.cub.2007.06.024; Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004; Sukumaran S, 1998, DEV BIOL, V200, P16, DOI 10.1006/dbio.1998.8934; Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881	16	92	95	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 22	2011	333	6041					467	470		10.1126/science.1203903	http://dx.doi.org/10.1126/science.1203903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700835	Green Accepted			2022-12-28	WOS:000292959600050
J	Block, BA; Jonsen, ID; Jorgensen, SJ; Winship, AJ; Shaffer, SA; Bograd, SJ; Hazen, EL; Foley, DG; Breed, GA; Harrison, AL; Ganong, JE; Swithenbank, A; Castleton, M; Dewar, H; Mate, BR; Shillinger, GL; Schaefer, KM; Benson, SR; Weise, MJ; Henry, RW; Costa, DP				Block, B. A.; Jonsen, I. D.; Jorgensen, S. J.; Winship, A. J.; Shaffer, S. A.; Bograd, S. J.; Hazen, E. L.; Foley, D. G.; Breed, G. A.; Harrison, A. -L.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Dewar, H.; Mate, B. R.; Shillinger, G. L.; Schaefer, K. M.; Benson, S. R.; Weise, M. J.; Henry, R. W.; Costa, D. P.			Tracking apex marine predator movements in a dynamic ocean	NATURE			English	Article							PACIFIC-OCEAN; BLUEFIN TUNA; MORTALITY; HABITAT; SHARKS; FISH; POPULATION; RESOURCES; MIGRATION; TURTLES	Pelagic marine predators face unprecedented challenges and uncertain futures. Overexploitation and climate variability impact the abundance and distribution of top predators in ocean ecosystems(1-4). Improved understanding of ecological patterns, evolutionary constraints and ecosystem function is critical for preventing extinctions, loss of biodiversity and disruption of ecosystem services. Recent advances in electronic tagging techniques have provided the capacity to observe the movements and long-distance migrations of animals in relation to ocean processes across a range of ecological scales(5,6). Tagging of Pacific Predators, a field programme of the Census of Marine Life, deployed 4,306 tags on 23 species in the North Pacific Ocean, resulting in a tracking data set of unprecedented scale and species diversity that covers 265,386 tracking days from 2000 to 2009. Here we report migration pathways, link ocean features to multispecies hotspots and illustrate niche partitioning within and among congener guilds. Our results indicate that the California Current large marine ecosystem and the North Pacific transition zone attract and retain a diverse assemblage of marine vertebrates. Within the California Current large marine ecosystem, several predator guilds seasonally undertake north-south migrations that may be driven by oceanic processes, species-specific thermal tolerances and shifts in prey distributions. We identify critical habitats across multinational boundaries and show that top predators exploit their environment in predictable ways, providing the foundation for spatial management of large marine ecosystems.	[Block, B. A.; Jorgensen, S. J.; Ganong, J. E.; Swithenbank, A.; Castleton, M.; Shillinger, G. L.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Jonsen, I. D.; Winship, A. J.; Breed, G. A.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Shaffer, S. A.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Bograd, S. J.; Hazen, E. L.; Foley, D. G.] NOAA, SW Fisheries Sci Ctr, Div Environm Res, Pacific Grove, CA 93950 USA; [Breed, G. A.; Harrison, A. -L.; Weise, M. J.; Henry, R. W.; Costa, D. P.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Long Marine Lab, Santa Cruz, CA 95060 USA; [Dewar, H.] NOAA, SW Fisheries Sci Ctr, Fisheries Res Div, La Jolla, CA 92037 USA; [Mate, B. R.] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA; [Schaefer, K. M.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Benson, S. R.] NOAA, SW Fisheries Sci Ctr, Protected Resources Div, La Jolla, CA 92037 USA	Stanford University; Dalhousie University; California State University System; San Jose State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Hazen, Elliott/G-4149-2014; Bograd, Steven/AAA-4824-2021; Shaffer, Scott A/D-5015-2009; Costa, Daniel/E-2616-2013	Hazen, Elliott/0000-0002-0412-7178; Shaffer, Scott A/0000-0002-7751-5059; Harrison, Autumn-Lynn/0000-0002-6213-1765; Jonsen, Ian/0000-0001-5423-6076; Costa, Daniel/0000-0002-0233-5782	Sloan Foundation; Packard Foundation; Moore Foundation; Office of Naval Research; NOAA; E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	Sloan Foundation(Alfred P. Sloan Foundation); Packard Foundation(The David & Lucile Packard Foundation); Moore Foundation(Gordon and Betty Moore Foundation); Office of Naval Research(Office of Naval Research); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); E&P Sound and Marine Life JIP under the OGP; Monterey Bay Aquarium Foundation	This manuscript is the culmination of a Census of Marine Life cross project synthesis between TOPP and Future of Marine Animal Populations (FMAP). Funding for this work was provided by the Sloan Foundation's Census of Marine Life programme. TOPP research was funded by the Sloan, Packard and Moore foundations. FMAP was funded by the Sloan Foundation. Electronic tagging and tracking in TOPP was also supported by the Office of Naval Research, the NOAA, the E&P Sound and Marine Life JIP under contract from the OGP, and the Monterey Bay Aquarium Foundation. We thank the TOPP scientific teams and all those who supported animal tagging efforts, R. Kochevar and D. Kohrs for their dedication and their effort on behalf of the Census of Marine Life. We are grateful to the numerous captains and crews who provided ship time and logistical support and to the US Fish and Wildlife Service in Hawaii for further logistical support. We thank the Mexican authorities and collaborating TOPP partners (O. Sosa-Nishizki) for permitting and assisting in research in their waters. All animal research was conducted in accordance with IACUC protocols from Stanford University and the University of California.	Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Berman-Kowalewski M, 2010, AQUAT MAMM, V36, P59, DOI 10.1578/AM.36.1.2010.59; Campana SE, 2002, N AM J FISH MANAGE, V22, P106, DOI 10.1577/1548-8675(2002)022<0106:PDOTPI>2.0.CO;2; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; Halpern BS, 2009, CONSERV LETT, V2, P138, DOI 10.1111/j.1755-263X.2009.00058.x; Hays GC, 2003, MAR ECOL PROG SER, V262, P305, DOI 10.3354/meps262305; Heupel MR, 2002, CAN J FISH AQUAT SCI, V59, P624, DOI 10.1139/F02-036; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; Lewison RL, 2003, ECOL APPL, V13, P743, DOI 10.1890/1051-0761(2003)013[0743:EFBAEO]2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; PICES, 2004, PICES SPEC PUBL, V1; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Robinson Robert A., 2009, Endangered Species Research, V7, P87, DOI 10.3354/esr00095; Scheffer M, 2005, TRENDS ECOL EVOL, V20, P579, DOI 10.1016/j.tree.2005.08.018; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shiels HA, 2011, P ROY SOC B-BIOL SCI, V278, P18, DOI 10.1098/rspb.2010.1274; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; STEELE JH, 1994, PHILOS T ROY SOC B, V343, P5, DOI 10.1098/rstb.1994.0001; Swain DP, 2008, CAN J FISH AQUAT SCI, V65, P2315, DOI 10.1139/F08-175; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279	30	852	868	10	587	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					86	90		10.1038/nature10082	http://dx.doi.org/10.1038/nature10082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697831				2022-12-28	WOS:000292461300050
J	Robert, C; Thomas, L; Bondarenko, I; O'Day, S; Weber, J; Garbe, C; Lebbe, C; Baurain, JF; Testori, A; Grob, JJ; Davidson, N; Richards, J; Maio, M; Hauschild, A; Miller, WH; Gascon, P; Lotem, M; Harmankaya, K; Ibrahim, R; Francis, S; Chen, TT; Humphrey, R; Hoos, A; Wolchok, JD				Robert, Caroline; Thomas, Luc; Bondarenko, Igor; O'Day, Steven; Weber, Jeffrey; Garbe, Claus; Lebbe, Celeste; Baurain, Jean-Francois; Testori, Alessandro; Grob, Jean-Jacques; Davidson, Neville; Richards, Jon; Maio, Michele; Hauschild, Axel; Miller, Wilson H., Jr.; Gascon, Pere; Lotem, Michal; Harmankaya, Kaan; Ibrahim, Ramy; Francis, Stephen; Chen, Tai-Tsang; Humphrey, Rachel; Hoos, Axel; Wolchok, Jedd D.			Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT INTERLEUKIN-2 THERAPY; COOPERATIVE-ONCOLOGY-GROUP; LONG-TERM SURVIVAL; MALIGNANT-MELANOMA; RESPONSE CRITERIA; DOUBLE-BLIND; PHASE-III; CHEMOTHERAPY; ANTIBODIES; TAMOXIFEN	BACKGROUND Ipilimumab monotherapy (at a dose of 3 mg per kilogram of body weight), as compared with glycoprotein 100, improved overall survival in a phase 3 study involving patients with previously treated metastatic melanoma. We conducted a phase 3 study of ipilimumab (10 mg per kilogram) plus dacarbazine in patients with previously untreated metastatic melanoma. METHODS We randomly assigned 502 patients with previously untreated metastatic melanoma, in a 1: 1 ratio, to ipilimumab (10 mg per kilogram) plus dacarbazine (850 mg per square meter of body-surface area) or dacarbazine (850 mg per square meter) plus placebo, given at weeks 1, 4, 7, and 10, followed by dacarbazine alone every 3 weeks through week 22. Patients with stable disease or an objective response and no dose-limiting toxic effects received ipilimumab or placebo every 12 weeks thereafter as maintenance therapy. The primary end point was overall survival. RESULTS Overall survival was significantly longer in the group receiving ipilimumab plus dacarbazine than in the group receiving dacarbazine plus placebo (11.2 months vs. 9.1 months, with higher survival rates in the ipilimumab-dacarbazine group at 1 year (47.3% vs. 36.3%), 2 years (28.5% vs. 17.9%), and 3 years (20.8% vs. 12.2%) (hazard ratio for death, 0.72; P < 0.001). Grade 3 or 4 adverse events occurred in 56.3% of patients treated with ipilimumab plus dacarbazine, as compared with 27.5% treated with dacarbazine and placebo (P < 0.001). No drug-related deaths or gastrointestinal perforations occurred in the ipilimumab-dacarbazine group. CONCLUSIONS Ipilimumab (at a dose of 10 mg per kilogram) in combination with dacarbazine, as compared with dacarbazine plus placebo, improved overall survival in patients with previously untreated metastatic melanoma. The types of adverse events were consistent with those seen in prior studies of ipilimumab; however, the rates of elevated liver-function values were higher and the rates of gastrointestinal events were lower than expected on the basis of prior studies. (Funded by Bristol-Myers Squibb; ClinicalTrials.gov number, NCT00324155.)	[Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Robert, Caroline] Inst Gustave, Villejuif, France; [Thomas, Luc] Ctr Hosp, Pierre Benite, France; [Lebbe, Celeste] Hop St Louis Univ, Paris, France; [Grob, Jean-Jacques] Hop La Timone, Marseille, France; [Bondarenko, Igor] Dnepropetrovsk State Med Ctr, Dnepropetrovsk, Ukraine; [O'Day, Steven] Angeles Clin & Res Inst, Santa Monica, CA USA; [Weber, Jeffrey] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Garbe, Claus] Univ Med Ctr, Tubingen, Germany; [Baurain, Jean-Francois] Clin Univ St Luc, B-1200 Brussels, Belgium; [Francis, Stephen] Bristol Myers Squibb, Braine Lalleud, Belgium; [Testori, Alessandro] Ist Europeo Oncol, Milan, Italy; [Maio, Michele] Univ Hosp Siena, Siena, Italy; [Richards, Jon] Oncol Specialists, Park Ridge, IL USA; [Hauschild, Axel] Univ Kiel, Kiel, Germany; [Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Gascon, Pere] Hosp Clin Barcelona, Barcelona, Spain; [Lotem, Michal] Hadassah Hebrew Univ Hosp, Sharett Inst Oncol, Jerusalem, Israel; [Harmankaya, Kaan] Med Univ Vienna, Vienna, Austria; [Ibrahim, Ramy] Medimmune, Gaithersburg, MD USA; [Chen, Tai-Tsang; Hoos, Axel] Bristol Myers Squibb, Wallingford, CT USA; [Humphrey, Rachel] Bristol Myers Squibb, Lawrenceville, NJ USA	Memorial Sloan Kettering Cancer Center; UNICANCER; Gustave Roussy; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Dnipro State Medical University; Angeles Clinic & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Bristol-Myers Squibb; IRCCS European Institute of Oncology (IEO); University of Siena; University Hospital of Siena; University of Kiel; Lady Davis Institute; McGill University; McGill University; University of Barcelona; Hospital Clinic de Barcelona; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of Vienna; AstraZeneca; Medimmune; Bristol-Myers Squibb; Bristol-Myers Squibb	Wolchok, JD (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	wolchokj@mskcc.org	Garbe, Claus/ABH-2128-2021; Robert, Caroline/G-6157-2018; Bondarenko, Igor/W-9412-2019; Bondarenko, Igor N/GQP-1497-2022; Bondarenko, Igor/U-5156-2017	Garbe, Claus/0000-0001-8530-780X; Robert, Caroline/0000-0002-9493-0238; Bondarenko, Igor/0000-0002-7071-2471; Bondarenko, Igor N/0000-0002-7071-2471; Bondarenko, Igor/0000-0002-7071-2471; TESTORI, ALESSANDRO/0000-0003-3685-0210; Weber, Jeffrey/0000-0002-4962-2957; CHEN, TAI-TSANG/0000-0003-2524-0409; coral, sandra/0000-0002-1308-3082; Grob, Jean-Jacques/0000-0002-0667-153X; Maio, Michele/0000-0002-0323-6321	Bristol-Myers Squibb; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Bristol-Myers Squibb.	Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bedikian AY, 2008, CANCER INVEST, V26, P624, DOI 10.1080/07357900802027073; DANCYGIER H, 1983, HEPATO-GASTROENTEROL, V30, P93; Falkson CI, 1998, J CLIN ONCOL, V16, P1743, DOI 10.1200/JCO.1998.16.5.1743; Fong L, 2008, J CLIN ONCOL, V26, P5275, DOI 10.1200/JCO.2008.17.8954; FROSCH PJ, 1979, J CANCER RES CLIN, V95, P281, DOI 10.1007/BF00410649; GREENSTONE MA, 1981, BRIT MED J, V282, P1744, DOI 10.1136/bmj.282.6278.1744; Hersh EM, 2011, INVEST NEW DRUG, V29, P489, DOI 10.1007/s10637-009-9376-8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoos A, 2010, JNCI-J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Julia F, 2010, ANTI-CANCER AGENT ME, V10, P661, DOI 10.2174/187152010794479834; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Mokyr MB, 1998, CANCER RES, V58, P5301; O'Day SJ, 2010, ANN ONCOL, V21, P1712, DOI 10.1093/annonc/mdq013; O'Day SJ, 2007, CANCER-AM CANCER SOC, V110, P2614, DOI 10.1002/cncr.23086; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Robert C, 2009, ONCOLOGIST, V14, P848, DOI 10.1634/theoncologist.2009-0028; Rusthoven JJ, 1996, J CLIN ONCOL, V14, P2083, DOI 10.1200/JCO.1996.14.7.2083; Schmidt H, 2009, EJC SUPPL, V7, P577, DOI 10.1016/S1359-6349(09)71948-2; Weber J, 2009, CLIN CANCER RES, V15, P5591, DOI 10.1158/1078-0432.CCR-09-1024; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	27	3248	3388	7	183	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2517	2526		10.1056/NEJMoa1104621	http://dx.doi.org/10.1056/NEJMoa1104621			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21639810	Bronze			2022-12-28	WOS:000292199800007
J	de Boer, IH; Rue, TC; Hall, YN; Heagerty, PJ; Weiss, NS; Himmelfarb, J				de Boer, Ian H.; Rue, Tessa C.; Hall, Yoshio N.; Heagerty, Patrick J.; Weiss, Noel S.; Himmelfarb, Jonathan			Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-INSUFFICIENCY; SERUM CREATININE; RISK; MICROALBUMINURIA; ALBUMINURIA; MORTALITY; NEPHROPATHY; PROTEINURIA; POPULATION; EPIDEMIOLOGY	Context Diabetes is the leading cause of kidney disease in the developed world. Over time, the prevalence of diabetic kidney disease (DKD) may increase due to the expanding size of the diabetes population or decrease due to the implementation of diabetes therapies. Objective To define temporal changes in DKD prevalence in the United States. Design, Setting, and Participants Cross-sectional analyses of the Third National Health and Nutrition Examination Survey (NHANES III) from 1988-1994 (N = 15 073), NHANES 1999-2004 (N = 13 045), and NHANES 2005-2008 (N = 9588). Participants with diabetes were defined by levels of hemoglobin A(1c) of 6.5% or greater, use of glucose-lowering medications, or both (n = 1431 in NHANES III; n = 1443 in NHANES 1999-2004; n = 1280 in NHANES 2005-2008). Main Outcome Measures Diabetic kidney disease was defined as diabetes with albuminuria (ratio of urine albumin to creatinine >= 30 mg/g), impaired glomerular filtration rate (<60 mL/min/1.73 m(2) estimated using the Chronic Kidney Disease Epidemiology Collaboration formula), or both. Prevalence of albuminuria was adjusted to estimate persistent albuminuria. Results The prevalence of DKD in the US population was 2.2% (95% confidence interval [CI], 1.8%-2.6%) in NHANES III, 2.8% (95% CI, 2.4%-3.1%) in NHANES 1999-2004, and 3.3% (95% CI, 2.8%-3.7%) in NHANES 2005-2008 (P < .001 for trend). The prevalence of DKD increased in direct proportion to the prevalence of diabetes, without a change in the prevalence of DKD among those with diabetes. Among persons with diabetes, use of glucose-lowering medications increased from 56.2% (95% CI, 52.1%-60.4%) in NHANES III to 74.2% (95% CI, 70.4%-78.0%) in NHANES 2005-2008 (P < .001); use of renin-angiotensin-aldosterone system inhibitors increased from 11.2% (95% CI, 9.0%-13.4%) to 40.6% (95% CI, 37.2%-43.9%), respectively (P < .001); the prevalence of impaired glomerular filtration rate increased from 14.9% (95% CI, 12.1%-17.8%) to 17.7% (95% CI, 15.2%-20.2%), respectively (P =. 03); and the prevalence of albuminuria decreased from 27.3% (95% CI, 22.0%-32.7%) to 23.7% (95% CI, 19.3%-28.0%), respectively, but this was not statistically significant (P =. 07). Conclusions Prevalence of DKD in the United States increased from 1988 to 2008 in proportion to the prevalence of diabetes. Among persons with diabetes, prevalence of DKD was stable despite increased use of glucose-lowering medications and renin-angiotensin-aldosterone system inhibitors. JAMA. 2011;305(24):2532-2539	[de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Kidney Res Inst, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Div Nephrol, Seattle, WA 98104 USA; [de Boer, Ian H.; Hall, Yoshio N.; Himmelfarb, Jonathan] Univ Washington, Dept Med, Seattle, WA 98104 USA; [Rue, Tessa C.; Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98104 USA; [de Boer, Ian H.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Univ Washington, Kidney Res Inst, Box 359606,325 9th Ave, Seattle, WA 98104 USA.	deboer@u.washington.edu	Hall, Yoshio/AAP-5723-2021; de Boer, Ian/GYJ-3282-2022		Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources [5KL2RR025015]; National Institutes of Health [UL1RR025014]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK087726, 1R01DK088762]; Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015, UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087726, K23DK087900, R01DK088762] Funding Source: NIH RePORTER	Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients; Nephrion/Cytopheryx Medical Advisory Board; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Satellite Healthcare; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Himmelfarb reported that all honoraria and consulting fees from serving on the Shire Scientific Advisory Board on Outcomes Studies in Hemodialysis Patients and the Nephrion/Cytopheryx Medical Advisory Board are donated to the Kidney Research Institute at the University of Washington; money is paid to his institution (University of Washington) for his consulting work for Genzyme, Lilly, and Thrasos. No other authors reported disclosures.; This publication was made possible by grant 5KL2RR025015 from the National Center for Research Resources, grant UL1RR025014 from the National Institutes of Health, grants 1R01DK087726 and 1R01DK088762 from the National Institute of Diabetes and Digestive and Kidney Diseases, and funding from the Satellite Healthcare's Norman S. Coplon Extramural Grant Program.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; BORCHJOHNSEN K, 1987, BMJ-BRIT MED J, V294, P1651, DOI 10.1136/bmj.294.6588.1651; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2007, J AM SOC NEPHROL, V18, P235, DOI 10.1681/ASN.2006040394; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; de Boer IH, 2009, DIABETES CARE, V32, P1833, DOI 10.2337/dc09-0191; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2000, LANCET, V355, P253; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; Groop PH, 2009, DIABETES, V58, P1651, DOI 10.2337/db08-1543; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Ninomiya T, 2009, J AM SOC NEPHROL, V20, P1813, DOI 10.1681/ASN.2008121270; Orchard TJ, 2010, DIABETOLOGIA, V53, P2312, DOI 10.1007/s00125-010-1860-3; PARVING HH, 1982, ACTA ENDOCRINOL-COP, V100, P550, DOI 10.1530/acta.0.1000550; Perkins BA, 2005, J AM SOC NEPHROL, V16, P1404, DOI 10.1681/ASN.2004100854; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; US Renal Data System, 2010, USRDS 2010 ANN DAT R; VIBERTI GC, 1982, LANCET, V1, P1430	41	631	641	4	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2532	2539		10.1001/jama.2011.861	http://dx.doi.org/10.1001/jama.2011.861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693741	Green Accepted			2022-12-28	WOS:000291860400020
J	Hawkes, N				Hawkes, Nigel			MEDICAL RESEARCH Dangers of research into chronic fatigue syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						[Anonymous], 2011, LANCET, V377, P1808; NICE, CHRON FAT SYNDR MYAL; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2	4	15	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3780	10.1136/bmj.d3780	http://dx.doi.org/10.1136/bmj.d3780			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697226				2022-12-28	WOS:000292200500006
J	Treister, E; Schawinski, K; Volonteri, M; Natarajan, P; Gawiser, E				Treister, Ezequiel; Schawinski, Kevin; Volonteri, Marta; Natarajan, Priyamvada; Gawiser, Eric			Black hole growth in the early Universe is self-regulated and largely hidden from view	NATURE			English	Article							ACTIVE GALACTIC NUCLEI; ULTRA DEEP FIELD; LUMINOSITY FUNCTION; REDSHIFT QUASARS; GALAXIES; DISCOVERY; DENSITY; MODELS; ORIGIN; AGN	The formation of the first massive objects in the infant Universe remains impossible to observe directly and yet it sets the stage for the subsequent evolution of galaxies(1-3). Although some black holes with masses more than 10(9) times that of the Sun have been detected in luminous quasars less than one billion years after the Big Bang(4,5), these individual extreme objects have limited utility in constraining the channels of formation of the earliest black holes; this is because the initial conditions of black hole seed properties are quickly erased during the growth process(6). Here we report a measurement of the amount of black hole growth in galaxies at redshift z = 6-8 (0.95-0.7 billion years after the Big Bang), based on optimally stacked, archival X-ray observations. Our results imply that black holes grow in tandem with their host galaxies throughout cosmic history, starting from the earliest times. We find that most copiously accreting black holes at these epochs are buried in significant amounts of gas and dust that absorb most radiation except for the highest-energy X-rays. This suggests that black holes grew significantly more during these early bursts than was previously thought, but because of the obscuration of their ultraviolet emission they did not contribute to the re-ionization of the Universe.	[Treister, Ezequiel] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; [Treister, Ezequiel] Univ Concepcion, Dept Astron, Concepcion, Chile; [Schawinski, Kevin; Natarajan, Priyamvada] Yale Ctr Astron & Astrophys, New Haven, CT 06520 USA; [Schawinski, Kevin; Natarajan, Priyamvada] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Volonteri, Marta] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Natarajan, Priyamvada] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Natarajan, Priyamvada] Harvard Univ, Inst Theory & Computat, Cambridge, MA 02138 USA; [Gawiser, Eric] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA	University of Hawaii System; Universidad de Concepcion; Yale University; Yale University; University of Michigan System; University of Michigan; Yale University; Harvard University; Rutgers State University New Brunswick	Treister, E (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	treister@ifa.hawaii.edu	Schawinski, Kevin/N-7057-2016; Natarajan, Priyamvada/AAG-2086-2021	Schawinski, Kevin/0000-0001-5464-0888; Treister, Ezequiel/0000-0001-7568-6412; Gawiser, Eric/0000-0003-1530-8713	Division Of Astronomical Sciences [0807570] Funding Source: National Science Foundation	Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; Bouwens RJ, 2006, ASTROPHYS J, V653, P53, DOI 10.1086/498733; Bouwens R. J., 2010, UV LUMINOSITY FUNCTI; Brandt WN, 2005, ANNU REV ASTRON ASTR, V43, P827, DOI 10.1146/annurev.astro.43.051804.102213; Bromm V, 2003, ASTROPHYS J, V596, P34, DOI 10.1086/377529; Fan XH, 2001, ASTRON J, V121, P54, DOI 10.1086/318033; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; King A, 2003, ASTROPHYS J, V596, pL27, DOI 10.1086/379143; Labbe I, 2006, ASTROPHYS J, V649, pL67, DOI 10.1086/508512; LAWRENCE A, 1982, ASTROPHYS J, V256, P410, DOI 10.1086/159918; Lodato G, 2006, MON NOT R ASTRON SOC, V371, P1813, DOI 10.1111/j.1365-2966.2006.10801.x; Loeb A, 2009, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2009/03/022; Madau P, 2001, ASTROPHYS J, V551, pL27, DOI 10.1086/319848; Sazonov S, 2007, ASTRON ASTROPHYS, V462, P57, DOI 10.1051/0004-6361:20066277; Shankar F, 2009, ASTROPHYS J, V690, P20, DOI 10.1088/0004-637X/690/1/20; Shemmer O, 2006, ASTROPHYS J, V644, P86, DOI 10.1086/503543; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Treister E, 2009, ASTROPHYS J, V696, P110, DOI 10.1088/0004-637X/696/1/110; Treister E, 2010, ASTROPHYS J LETT, V722, pL238, DOI 10.1088/2041-8205/722/2/L238; Treister E, 2010, SCIENCE, V328, P600, DOI 10.1126/science.1184246; Ueda Y, 2007, ASTROPHYS J, V664, pL79, DOI 10.1086/520576; Volonteri M, 2003, ASTROPHYS J, V582, P559, DOI 10.1086/344675; Volonteri M, 2006, ASTROPHYS J, V650, P669, DOI 10.1086/507444; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Willott CJ, 2007, ASTRON J, V134, P2435, DOI 10.1086/522962; Willott CJ, 2010, ASTRON J, V139, P906, DOI 10.1088/0004-6256/139/3/906; Wyithe JSB, 2003, ASTROPHYS J, V595, P614, DOI 10.1086/377475	30	59	60	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					356	358		10.1038/nature10103	http://dx.doi.org/10.1038/nature10103			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677753	Green Submitted			2022-12-28	WOS:000291647100040
J	Weiss, U				Weiss, Ulla			Intestinal networks in health and disease	NATURE			English	Editorial Material																			0	2	3	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					297	297		10.1038/474297a	http://dx.doi.org/10.1038/474297a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677745	Bronze			2022-12-28	WOS:000291647100053
J	Shetty, P				Shetty, Priya			Lunch with The Lancet Bill Roedy	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1996	1996		10.1016/S0140-6736(11)60851-9	http://dx.doi.org/10.1016/S0140-6736(11)60851-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21665024				2022-12-28	WOS:000292011700015
J	Carpenter, BK				Carpenter, Barry K.			Taking the High Road and Getting There Before You	SCIENCE			English	Editorial Material									Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales	Cardiff University	Carpenter, BK (corresponding author), Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.	carpenterb1@cardiff.ac.uk						Glowacki DR, 2009, J AM CHEM SOC, V131, P13896, DOI 10.1021/ja9043054; Schreiner PR, 2011, SCIENCE, V332, P1300, DOI 10.1126/science.1203761; Yamataka H, 2010, ADV PHYS ORG CHEM, V44, P173, DOI 10.1016/S0065-3160(08)44004-2	3	20	20	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1269	1270		10.1126/science.1206693	http://dx.doi.org/10.1126/science.1206693			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	775EP	21659592				2022-12-28	WOS:000291441700030
J	Cotta-Ramusino, C; McDonald, ER; Hurov, K; Sowa, ME; Harper, JW; Elledge, SJ				Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Sowa, Mathew E.; Harper, J. Wade; Elledge, Stephen J.			A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling	SCIENCE			English	Article							REPAIR; PARTICIPATE; CHECKPOINT; COMPLEXES	The DNA damage response (DDR) is brought about by a protein kinase cascade that orchestrates DNA repair through transcriptional and posttranslational mechanisms. Cell cycle arrest is a hallmark of the DDR. We screened for cells that lacked damage-induced cell cycle arrest and uncovered a critical role for Fanconi anemia and homologous recombination proteins in ATR (ataxia telangiectasia and Rad3-related) signaling. Three DDR candidates, the RNA processing protein INTS7, the circadian transcription factor CLOCK, and a previously uncharacterized protein RHINO, were recruited to sites of DNA damage. RHINO independently bound the Rad9-Rad1-Hus1 complex (9-1-1) and the ATR activator TopBP1. RHINO was recruited to sites of DNA damage by the 9-1-1 complex to promote Chk1 activation. We suggest that RHINO functions together with the 9-1-1 complex and TopBP1 to fully activate ATR.	[Cotta-Ramusino, Cecilia; McDonald, E. Robert, III; Hurov, Kristen; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA; [Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Div Genet,Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236	NIH; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R37GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Institute of Chemistry and Cell Biology-Longwood for screening assistance. We also thank K. Hofmann, A. Ciccia, A. Bredemeyer, B. Adamson, A. Burrows, A. Smogorzewska, and A. Brass for helpful discussions. This work was supported by NIH grants to S.J.E. and J.W.H. C. C. R. is the recipient of a long-term European Molecular Biology Organization fellowship. S.J.E. is a Howard Hughes Medical Institute investigator. W. H. is a paid consultant for Millennium Pharmaceuticals and its program in oncology.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2007, CHROMOSOMA, V116, P331, DOI 10.1007/s00412-007-0108-6; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Huang J, 2009, MOL CELL, V35, P384, DOI 10.1016/j.molcel.2009.06.011; Iyer LM, 2002, GENOME BIOL, V3; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Li YJ, 2009, J BIOL CHEM, V284, P23525, DOI 10.1074/jbc.C109.039586; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	21	145	161	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1313	1317		10.1126/science.1203430	http://dx.doi.org/10.1126/science.1203430			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659603	Green Accepted			2022-12-28	WOS:000291441700043
J	Linglart, A; Menguy, C; Couvineau, A; Auzan, C; Gunes, Y; Cancel, M; Motte, E; Pinto, G; Chanson, P; Bougneres, P; Clauser, E; Silve, C				Linglart, Agnes; Menguy, Christine; Couvineau, Alain; Auzan, Colette; Gunes, Yasemin; Cancel, Mathilde; Motte, Emmanuelle; Pinto, Graziella; Chanson, Philippe; Bougneres, Pierre; Clauser, Eric; Silve, Caroline			Recurrent PRKAR1A Mutation in Acrodysostosis with Hormone Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPENDENT PROTEIN-KINASE; GS-ALPHA BIOACTIVITY; REGULATORY SUBUNIT; CARNEY COMPLEX; PSEUDOHYPOPARATHYROIDISM; GENE; REVEALS; MUTANT; LOCUS; 1A	The skeletal dysplasia characteristic of acrodysostosis resembles the Albright's hereditary osteodystrophy seen in patients with pseudohypoparathyroidism type 1a, but defects in the a-stimulatory subunit of the G-protein (GNAS), the cause of pseudohypoparathyroidism type 1a, are not present in patients with acrodysostosis. We report a germ-line mutation in the gene encoding PRKAR1A, the cyclic AMP (cAMP)-dependent regulatory subunit of protein kinase A, in three unrelated patients with acrodysostosis and resistance to multiple hormones. The mutated subunit impairs the protein kinase A response to stimulation by cAMP; this explains our patients' hormone resistance and the similarities of their skeletal abnormalities with those observed in patients with pseudohypoparathyroidism type 1a.	[Silve, Caroline] Hop St Vincent de Paul, INSERM, Ctr Reference Malad Rares Metab Calcium & Phospho, U986, F-75674 Paris, France; [Linglart, Agnes; Auzan, Colette; Bougneres, Pierre; Clauser, Eric; Silve, Caroline] Univ Paris 05, Fac Med, Paris, France; [Couvineau, Alain] Univ Paris Denis Diderot, Ctr Rech Biomed Bichat Beaujon, INSERM, U773, Paris, France; [Auzan, Colette; Clauser, Eric] Hop Europeen Georges Pompidou, INSERM, U970, Ctr Rech Cardiovasc, Paris, France; [Pinto, Graziella] Hop Necker Enfants Malad, Assistance Publ Hopt Paris AP HP, Serv Endocrinol Pediat, Paris, France; [Clauser, Eric] Hop Cochin, AP HP, Dept Biol Hormonale & Metab, F-75674 Paris, France; [Silve, Caroline] Hop Bichat Claude Bernard, AP HP, Serv Biochim Hormonale & Genet, F-75877 Paris 18, France; [Linglart, Agnes; Bougneres, Pierre; Silve, Caroline] Hop Bicetre, AP HP, Serv Endocrinol Enfant, Le Kremlin Bicetre, France; [Linglart, Agnes; Bougneres, Pierre; Silve, Caroline] Hop Bicetre, Ctr Reference Malad Rares Metab Calcium & Phospho, Le Kremlin Bicetre, France; [Linglart, Agnes; Chanson, Philippe; Bougneres, Pierre; Silve, Caroline] Univ Paris Sud, Fac Med, F-94275 Le Kremlin Bicetre, France; [Chanson, Philippe] Hop Bicetre, AP HP, Serv Endocrinol Adulte & Malad Reprod, Le Kremlin Bicetre, France; [Chanson, Philippe] Hop Bicetre, Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Silve, C (corresponding author), Hop St Vincent de Paul, INSERM, Ctr Reference Malad Rares Metab Calcium & Phospho, U986, 82 Ave Denfert Rochere, F-75674 Paris, France.	caroline.silve@inserm.fr	couvineau, alain/T-3466-2019; Chanson, Philippe/F-8511-2013; couvineau, alain/G-3641-2013; Motte-Signoret, Emmanuelle/AAM-3230-2021; Linglart, Agnès/A-8047-2016	couvineau, alain/0000-0003-2912-5168; Chanson, Philippe/0000-0001-5096-5722; couvineau, alain/0000-0003-2912-5168; Motte-Signoret, Emmanuelle/0000-0002-0514-4420; Linglart, Agnès/0000-0003-3455-002X; DOS SANTOS MENGUY, Christine/0000-0002-6748-5183; Cancel, Mathilde/0000-0003-1162-214X				ABLOW RC, 1977, AM J ROENTGENOL, V128, P95, DOI 10.2214/ajr.128.1.95; Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Bertherat J, 2003, CANCER RES, V63, P5308; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Carney JA, 2001, AM J SURG PATHOL, V25, P164, DOI 10.1097/00000478-200102000-00004; Graham JM, 2001, PEDIATR RADIOL, V31, P2, DOI 10.1007/s002470000355; Groussin L, 2002, AM J HUM GENET, V71, P1433, DOI 10.1086/344579; Horvath A, 2008, REV ENDOCR METAB DIS, V9, P1, DOI 10.1007/s11154-007-9066-9; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; MAROTEAUX P, 2002, MALADIES OSSEUSES EN; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; SKALHEGG BS, 1992, J BIOL CHEM, V267, P15707; SPAULDING SW, 1993, ENDOCR REV, V14, P632, DOI 10.1210/er.14.5.632; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tasken K, 1997, ADV SEC MESS PHOSPH, V31, P191; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tsang KM, 2010, P NATL ACAD SCI USA, V107, P8683, DOI 10.1073/pnas.1003680107; Vlaeminck-Guillem V, 2001, J CLIN ENDOCR METAB, V86, P3091, DOI 10.1210/jc.86.7.3091; WAGAR G, 1980, ACTA ENDOCRINOL-COP, V93, P43, DOI 10.1530/acta.0.0930043; WETTERS TV, 1983, MOL CELL BIOL, V3, P250, DOI 10.1128/MCB.3.2.250; Wilson LC, 1997, J MED GENET, V34, P133, DOI 10.1136/jmg.34.2.133	25	114	119	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2218	2226		10.1056/NEJMoa1012717	http://dx.doi.org/10.1056/NEJMoa1012717			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651393				2022-12-28	WOS:000291392100008
J	Miller, FG; Joffe, S				Miller, Franklin G.; Joffe, Steven			Balancing Access and Evaluation in the Approval of New Cancer Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCELERATED APPROVAL; CLINICAL-TRIALS		[Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Miller, FG (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	fmiller@nih.gov	Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; Allison M, 2011, NAT BIOTECHNOL, V29, P13, DOI 10.1038/nbt.1746; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Chabner BA, 2011, NEW ENGL J MED, V364, P1087, DOI 10.1056/NEJMp1100548; Ellenberg SS, 2011, J NATL CANCER I, V103, P616, DOI 10.1093/jnci/djr104; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Rawls John., 1971, THEORY JUSTICE; Rettig R. A., 2007, FALSE HOPE BONE MARR	10	14	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2345	2346		10.1001/jama.2011.784	http://dx.doi.org/10.1001/jama.2011.784			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642688				2022-12-28	WOS:000291349100029
J	Brambles, OJ; Lotko, W; Zhang, B; Wiltberger, M; Lyon, J; Strangeway, RJ				Brambles, O. J.; Lotko, W.; Zhang, B.; Wiltberger, M.; Lyon, J.; Strangeway, R. J.			Magnetosphere Sawtooth Oscillations Induced by Ionospheric Outflow	SCIENCE			English	Article							ION OUTFLOW; SUBSTORMS; SATELLITE; WIND; SIMULATION; CONVECTION; DEPENDENCE; BOUNDARY; REGION; FIELD	The sawtooth mode of convection of Earth's magnetosphere is a 2- to 4-hour planetary-scale oscillation powered by the solar wind-magnetosphere-ionosphere (SW-M-I) interaction. Using global simulations of geospace, we have shown that ionospheric O+ outflows can generate sawtooth oscillations. As the outflowing ions fill the inner magnetosphere, their pressure distends the nightside magnetic field. When the outflow fluence exceeds a threshold, magnetic field tension cannot confine the accumulating fluid; an O+-rich plasmoid is ejected, and the field dipolarizes. Below the threshold, the magnetosphere undergoes quasi-steady convection. Repetition and the sawtooth period are controlled by the strength of the SW-M-I interaction, which regulates the outflow fluence.	[Brambles, O. J.; Lotko, W.; Zhang, B.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Wiltberger, M.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Lyon, J.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Strangeway, R. J.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA	Dartmouth College; National Center Atmospheric Research (NCAR) - USA; Dartmouth College; University of California System; University of California Los Angeles	Brambles, OJ (corresponding author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.	ojbrambles@dartmouth.edu	Wiltberger, Michael/B-8781-2008	Wiltberger, Michael/0000-0002-4844-3148; Zhang, Binzheng/0000-0002-1555-6023; Lotko, William/0000-0002-3859-1593	NASA [NNX08AI36G, NNX07AQ16G, NNX07AT15G]; NSF Science and Technology Centers [ATM-0120950]; National Center for Atmospheric Research under Computational Information Systems Laboratory [36761008]; NSF; Directorate For Geosciences [0929367] Funding Source: National Science Foundation	NASA(National Aeronautics & Space Administration (NASA)); NSF Science and Technology Centers; National Center for Atmospheric Research under Computational Information Systems Laboratory; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the NASA Sun-Earth Connection Theory Program (grant NNX08AI36G), the NASA Living With a Star Targeted Research and Technology Program (grants NNX07AQ16G and NNX07AT15G), and the Center for Integrated Space Weather Modeling funded by the NSF Science and Technology Centers program under cooperative agreement ATM-0120950. Computing resources for the research were provided by the National Center for Atmospheric Research under Computational Information Systems Laboratory Project 36761008. The National Center for Atmospheric Research is supported by NSF. Simulation data are available from O. Brambles. FAST satellite data are available online at http://sprg.ssl.berkeley.edu/fast/.	BANKS PM, 1968, J GEOPHYS RES, V73, P6846, DOI 10.1029/JA073i021p06846; Baumjohann W., 1996, BASIC SPACE PLASMA P; BELIAN RD, 1989, P RES I ATMOS NAGOYA, V36, P127; BOROVSKY JE, 1993, J GEOPHYS RES-SPACE, V98, P3807, DOI 10.1029/92JA02556; Bouhram M, 2004, ANN GEOPHYS-GERMANY, V22, P1787, DOI 10.5194/angeo-22-1787-2004; Brambles OJ, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2010JA015469; Cai X, 2006, ANN GEOPHYS-GERMANY, V24, P3481, DOI 10.5194/angeo-24-3481-2006; Cai X, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013764; Chaston CC, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029144; Chaston CC, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010053; Cully CM, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2001JA009200; DeJong AD, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013870; DUNGEY JW, 1961, PHYS REV LETT, V6, P47, DOI 10.1103/PhysRevLett.6.47; FELDSTEIN YI, 1970, PLANET SPACE SCI, V18, P501, DOI 10.1016/0032-0633(70)90127-3; Glocer A, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2009JA014053; Goodrich CC, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012155; Henderson MG, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011111; Huang CS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016162; Huang CS, 2003, J GEOPHYS RES-SPACE, V108, DOI 10.1029/2002JA009704; Hultqvist B., 1999, MAGNETOSPHERIC PLASM, DOI 10.1007/978-94-011-4477-3_8; Keiling A, 2003, SCIENCE, V299, P383, DOI 10.1126/science.1080073; Kitamura K, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010734; Kuznetsova MM, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012316; Lavraud B, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013192; Lotko W, 2004, J ATMOS SOL-TERR PHY, V66, P1443, DOI 10.1016/j.jastp.2004.03.027; Lyon JG, 2004, J ATMOS SOL-TERR PHY, V66, P1333, DOI 10.1016/j.jastp.2004.03.020; Mann IR, 1999, J GEOPHYS RES-SPACE, V104, P333, DOI 10.1029/1998JA900026; McPherron RL, 2005, Multiscale Coupling of Sun-Earth Processes, P113, DOI 10.1016/B978-044451881-1/50009-5; Norqvist P, 1998, J GEOPHYS RES-SPACE, V103, P23459, DOI 10.1029/98JA02076; Nose M, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010930; Paschmann G., 2003, AURORAL PLASMA PHYS, P70; Pulkkinen TI, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031011; PYTTE T, 1978, J GEOPHYS RES-SPACE, V83, P663, DOI 10.1029/JA083iA02p00663; Raeder J, 2008, SPACE SCI REV, V141, P535, DOI 10.1007/s11214-008-9421-5; Sergeev V. A., 1977, PHYS SOLARITERR POTS, V5, P39; Sergeev VA, 1996, SPACE SCI REV, V75, P551, DOI 10.1007/BF00833344; Seyler CE, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012412; SHELLEY EG, 1972, J GEOPHYS RES, V77, P6104, DOI 10.1029/JA077i031p06104; Strangeway RJ, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010829; THELIN B, 1990, J GEOPHYS RES-SPACE, V95, P5931, DOI 10.1029/JA095iA05p05931; Troshichev O, 2009, J ATMOS SOL-TERR PHY, V71, P1340, DOI 10.1016/j.jastp.2009.05.017; Tung YK, 2001, J GEOPHYS RES-SPACE, V106, P3603, DOI 10.1029/2000JA900115; Vasyliunas V.M., 1983, PHYS JOVIAN MAGNETOS, P395, DOI [10.1017/CBO9780511564574.013, DOI 10.1017/CBO9780511564574.013, 10.1017/cbo9780511564574.013]; VASYLIUNAS VM, 1982, PLANET SPACE SCI, V30, P359, DOI 10.1016/0032-0633(82)90041-1; Wiltberger M, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013108; Wiltberger M, 2000, J GEOPHYS RES-SPACE, V105, P27649, DOI 10.1029/1999JA000251; Winglee RM, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA000214; Yau AW, 1997, SPACE SCI REV, V80, P1, DOI 10.1023/A:1004947203046	48	91	92	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1183	1186		10.1126/science.1202869	http://dx.doi.org/10.1126/science.1202869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636770				2022-12-28	WOS:000291205200044
J	Gong, P				Gong, Peng			China needs no foreign help to feed itself	NATURE			English	Editorial Material									[Gong, Peng] Tsinghua Univ, Ctr Earth Syst Sci, Beijing, Peoples R China; [Gong, Peng] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Tsinghua University; University of California System; University of California Berkeley	Gong, P (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Beijing, Peoples R China.	penggong@tsinghua.edu.cn							0	21	29	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					7	7		10.1038/474007a	http://dx.doi.org/10.1038/474007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637215	Bronze			2022-12-28	WOS:000291156700008
J	Hayden, EJ; Ferrada, E; Wagner, A				Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas			Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme	NATURE			English	Article							GROUP-I RIBOZYME; PROTEIN; EVOLVABILITY; STABILITY; EPISTASIS; MECHANISM; AZOARCUS; INTRON; VITRO; CORE	Cryptic variation is caused by the robustness of phenotypes to mutations(1). Cryptic variation has no effect on phenotypes in a given genetic or environmental background, but it can have effects after mutations or environmental change(2-5). Because evolutionary adaptation by natural selection requires phenotypic variation, phenotypically revealed cryptic genetic variation may facilitate evolutionary adaptation(6-8). This is possible if the cryptic variation happens to be pre-adapted, or "exapted"(9), to a new environment, and is thus advantageous once revealed. However, this facilitating role for cryptic variation has not been proven, partly because most pertinent work focuses on complex phenotypes of whole organisms whose genetic basis is incompletely understood. Here we show that populations of RNA enzymes with accumulated cryptic variation adapt more rapidly to a new substrate than a population without cryptic variation. A detailed analysis of our evolving RNA populations in genotype space shows that cryptic variation allows a population to explore new genotypes that become adaptive only in a new environment. Our observations show that cryptic variation contains new genotypes pre-adapted to a changed environment. Our results highlight the positive role that robustness and epistasis can have in adaptive evolution(10,11).	[Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Hayden, Eric J.; Ferrada, Evandro; Wagner, Andreas] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch		Ferrada, Evandro/0000-0003-3242-1726	Swiss National Science Foundation [315200-116814, 315200-119697, 315230-129708]; SystemsX.ch; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch; University of Zurich	We thank R. Dhar and N. de la Chaux for bioinformatic support. We thank the Functional Genomics Center, Zurich, for collecting sequence data. We acknowledge support from Swiss National Science Foundation grants 315200-116814, 315200-119697 and 315230-129708, from the YeastX program of SystemsX.ch, and from the Research Priority Program in Systems Biology at the University of Zurich.	Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; BEAUDRY AA, 1992, SCIENCE, V257, P635, DOI 10.1126/science.1496376; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake RD, 1996, NUCLEIC ACIDS RES, V24, P2095, DOI 10.1093/nar/24.11.2095; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; BREAKER RR, 1994, TRENDS BIOTECHNOL, V12, P268, DOI 10.1016/0167-7799(94)90138-4; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Eckert K A, 1991, PCR Methods Appl, V1, P17; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hanczyc MM, 1998, RNA, V4, P268; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Kondrashov FA, 2001, P NATL ACAD SCI USA, V98, P12089, DOI 10.1073/pnas.211214298; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Lawrence MS, 2005, RNA, V11, P1173, DOI 10.1261/rna.2110905; Le Rouzic A, 2008, TRENDS ECOL EVOL, V23, P33, DOI 10.1016/j.tree.2007.09.014; LEHMAN N, 1993, NATURE, V361, P182, DOI 10.1038/361182a0; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Ouellet J, 2009, RNA, V15, P1822, DOI 10.1261/rna.1759009; Pan J, 1998, J MOL BIOL, V280, P597, DOI 10.1006/jmbi.1998.1901; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380; Stahley MR, 2005, SCIENCE, V309, P1587, DOI 10.1126/science.1114994; Tanner MA, 1996, RNA, V2, P74; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke CO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-3; Yu W, 2006, BIOTECHNIQUES, V40, P499, DOI 10.2144/000112124	37	158	163	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					92	U120		10.1038/nature10083	http://dx.doi.org/10.1038/nature10083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637259	Green Accepted			2022-12-28	WOS:000291156700044
J	Usherwood, JR; Stavrou, M; Lowe, JC; Roskilly, K; Wilson, AM				Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.			Flying in a flock comes at a cost in pigeons	NATURE			English	Article							VORTEX THEORY; FLIGHT; FREQUENCY; BIRDS; DRAG	Flying birds often form flocks, with social(1), navigational(2) and antipredator(3) implications. Further, flying in a flock can result in aerodynamic benefits, thus reducing power requirements(4), as demonstrated by a reduction in heart rate and wingbeat frequency in pelicans flying in a V-formation(5). But how general is an aerodynamic power reduction due to group-flight? V-formation flocks are limited to moderately steady flight in relatively large birds, and may represent a special case. What are the aerodynamic consequences of flying in the more usual 'cluster'(6,7) flock? Here we use data from innovative back-mounted Global Positioning System (GPS) and 6-degrees-of-freedom inertial sensors to show that pigeons (1) maintain powered, banked turns like aircraft, imposing dorsal accelerations of up to 2g, effectively doubling body weight and quadrupling induced power requirements; (2) increase flap frequency with increases in all conventional aerodynamic power requirements; and (3) increase flap frequency when flying near, particularly behind, other birds. Therefore, unlike V-formation pelicans, pigeons do not gain an aerodynamic advantage from flying in a flock. Indeed, the increased flap frequency, whether due to direct aerodynamic interactions or requirements for increased stability or control, suggests a considerable energetic cost to flight in a tight cluster flock.	[Usherwood, James R.; Stavrou, Marinos; Lowe, John C.; Roskilly, Kyle; Wilson, Alan M.] Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Usherwood, JR (corresponding author), Univ London, Struct & Mot Lab, Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	jusherwood@rvc.ac.uk		Wilson, Alan/0000-0001-9914-3455	Wellcome Trust; Royal Society; BBSRC; EPSRC; EPSRC [EP/H013016/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank T. Hubel, H. Chapman, V. Unt and T. Demes for practical assistance, and The Wellcome Trust (J.R.U.), The Royal Society (A.M.W.), BBSRC (K.R.) and EPSRC for funding.	Bilo D., 1984, BIONA REP, V3, P87; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P115, DOI 10.1098/rstb.1984.0053; Greene P R, 1979, Physiologist, V22, pS35; Hedrick TL, 2004, J EXP BIOL, V207, P1689, DOI 10.1242/jeb.00933; Hedrick TL, 2009, SCIENCE, V324, P252, DOI 10.1126/science.1168431; HEPPNER FH, 1974, BIRD BANDING, V45, P160, DOI 10.2307/4512025; HIGDON JJL, 1978, AM NAT, V112, P727, DOI 10.1086/283314; Lilienthal O., 2001, BIRDFLIGHT BASIS AVI; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pennycuick C.J., 1989, BIRD FLIGHT PERFORMA; Pennycuick CJ, 1996, J EXP BIOL, V199, P2757; POMEROY H, 1992, AUK, V109, P256; RAYNER JMV, 1979, J FLUID MECH, V91, P697, DOI 10.1017/S0022112079000410; Schmidt-Wellenburg CA, 2007, J COMP PHYSIOL B, V177, P327, DOI 10.1007/s00360-006-0132-5; Spedding GR, 2010, J AIRCRAFT, V47, P120, DOI 10.2514/1.44247; Tinbergen N, 1951, STUDY INSTINCT; Tobalske BW, 2003, NATURE, V421, P363, DOI 10.1038/nature01284; Usherwood JR, 2006, BIOL LETTERS, V2, P47, DOI 10.1098/rsbl.2005.0399; Usherwood JR, 2009, BIOINSPIR BIOMIM, V4, DOI 10.1088/1748-3182/4/1/015003; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	23	81	86	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					494	497		10.1038/nature10164	http://dx.doi.org/10.1038/nature10164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697946	Green Accepted, Green Published			2022-12-28	WOS:000291939700045
J	Lipchik, RJ				Lipchik, Randolph J.			Review: Current drug treatments do not reduce mortality in idiopathic pulmonary fibrosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lipchik, RJ (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.							King TE, 2005, AM J RESP CRIT CARE, V172, P268, DOI 10.1164/rccm.200503-483OE	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-8	10.7326/0003-4819-154-12-201106210-02008	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690586				2022-12-28	WOS:000291800500007
J	Santelli, JS; Galea, S				Santelli, John S.; Galea, Sandro			The global burden of disease in 10-24-year-olds	LANCET			English	Editorial Material							YOUNG-PEOPLE; MORTALITY		[Santelli, John S.] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Galea, Sandro] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	Columbia University; Columbia University	Santelli, JS (corresponding author), Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, New York, NY 10027 USA.	js2637@columbia.edu	Galea, Sandro/GLR-6066-2022; Santelli, John/AAG-3046-2021	Galea, Sandro/0000-0002-7534-0945				Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P17; McCambridge J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000413; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2	9	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2058	2060		10.1016/S0140-6736(11)60618-1	http://dx.doi.org/10.1016/S0140-6736(11)60618-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21652064				2022-12-28	WOS:000292117800005
J	O'Neill, LAJ				O'Neill, Luke A. J.			Innate Immunity in Plants Goes to the PUB	SCIENCE			English	Editorial Material							TOLL-LIKE RECEPTORS		Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; LU D, 2010, P NATL ACAD SCI USA, V104, P12217; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903	6	6	6	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1386	1387		10.1126/science.1208448	http://dx.doi.org/10.1126/science.1208448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680829				2022-12-28	WOS:000291689000025
J	Maa, J				Maa, John			The Waits That Matter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Sch Med, Div Gen Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Maa, J (corresponding author), Univ Calif San Francisco, Sch Med, Div Gen Surg, San Francisco, CA 94143 USA.							*AM COLL SURG DIV, 2006, GROW CRIS PAT ACC EM; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; *HOSP EM DEP, CROWD CONT OCC SOM P; *HOSP EM DEP, 2003, CROWD COND VAR HOSP; Institute of Medicine Committee on the Future of Emergency Care in the United States Health System, 2006, HOSP BAS EM CAR BREA	5	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2279	2281		10.1056/NEJMp1101882	http://dx.doi.org/10.1056/NEJMp1101882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675887				2022-12-28	WOS:000291643800004
J	Pearce, EN				Pearce, Elizabeth N.			Iodine nutrition in the UK: what went wrong?	LANCET			English	Editorial Material							DIETARY IODINE; DEFICIENCY; MILK		Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA	Boston University	Pearce, EN (corresponding author), Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA.	elizabeth.pearce@bmc.org		Pearce, Elizabeth/0000-0003-3799-0354				[Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Becker DV, 2006, THYROID, V16, P949, DOI 10.1089/thy.2006.16.949; Kibirige MS, 2004, ARCH DIS CHILD-FETAL, V89, pF436, DOI 10.1136/adc.2003.029306; Lazarus JH, 2008, LANCET, V372, P888, DOI 10.1016/S0140-6736(08)61390-2; Li M, 2006, MED J AUSTRALIA, V184, P307, DOI 10.5694/j.1326-5377.2006.tb00248.x; National Health and Medical Research Council (NHMRC), 2010, IOD SUPPL PREGN BREA; Pearce EN, 2010, J CLIN ENDOCR METAB, V95, P3207, DOI 10.1210/jc.2010-0014; Pearce EN, 2004, J CLIN ENDOCR METAB, V89, P3421, DOI 10.1210/jc.2003-032002; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; *UNICEF WORLD SUMM, 1990, WORLD DECL SURV PROT; Vanderpump MPJ, 2011, LANCET, V377, P2007, DOI 10.1016/S0140-6736(11)60693-4; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	13	7	7	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1979	1980		10.1016/S0140-6736(11)60741-1	http://dx.doi.org/10.1016/S0140-6736(11)60741-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21640376				2022-12-28	WOS:000292011700004
J	Medenbach, J; Seiler, M; Hentze, MW				Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.			Translational Control via Protein-Regulated Upstream Open Reading Frames	CELL			English	Article							MSL-2 MESSENGER-RNA; SEX-LETHAL; DOSAGE COMPENSATION; BINDING PROTEIN; DROSOPHILA; INITIATION; MECHANISM; GENE; RECOGNITION; REPRESSION	Analysis of the regulation of msl-2 mRNA by Sex lethal (SXL), which is critical for dosage compensation in Drosophila, has uncovered a mode of translational control based on common 50 untranslated region elements, upstream open reading frames (uORFs), and interaction sites for RNA-binding proteins. We show that SXL binding downstream of a short uORF imposes a strong negative effect on major reading frame translation. The underlying mechanism involves increasing initiation of scanning ribosomes at the uORF and augmenting its impediment to downstreamtranslation. Our analyses reveal that SXL exerts its effect controlling initiation, not elongation or termination, at the uORF. Probing the generality of the underlying mechanism, we show that the regulatorymodule that we define experimentally functions in a heterologous context, and we identify natural Drosophila mRNAs that are regulated via this module. We propose that protein-regulated uORFs constitute a systematic principle for the regulation of protein synthesis.	[Medenbach, Jan; Seiler, Markus; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Seiler, Markus/HHR-8348-2022; Medenbach, Jan/B-6877-2018; Hentze, Matthias W/V-3980-2017	Seiler, Markus/0000-0002-9600-6620; Medenbach, Jan/0000-0003-0749-7788; Hentze, Matthias W/0000-0002-4023-7876	Deutsche Forschungsgemeinschaft [FOR855 He 1442/13-1, FOR855 He 1442/13-2]; EMBO; NGFN DiGtoP	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO(European Molecular Biology Organization (EMBO)); NGFN DiGtoP	We thank Anne Ephrussi for kindly providing a Drosophila PTB plasmid, Toby Gibson for generous support, the EMBL Protein Expression and Purification Core Facility for recombinant proteases, and members of the Hentze lab for useful discussions. We also thank an anonymous reviewer for insightful comments that enlightened our mechanistic model. This work was supported by Deutsche Forschungsgemeinschaft Grants FOR855 He 1442/13-1 and /13-2 to M.W.H. J.M. acknowledges a long-term postdoctoral fellowship from EMBO. M.S. was funded by the NGFN DiGtoP grant.	Abaza I, 2006, GENE DEV, V20, P380, DOI 10.1101/gad.371906; BASHAW GJ, 1995, DEVELOPMENT, V121, P3245; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Beckmann K, 2005, CELL, V122, P529, DOI 10.1016/j.cell.2005.06.011; Besse F, 2009, GENE DEV, V23, P195, DOI 10.1101/gad.505709; Bopp D, 1996, DEVELOPMENT, V122, P971; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cuchalova L, 2010, MOL CELL BIOL, V30, P4671, DOI 10.1128/MCB.00430-10; Duncan K, 2006, GENE DEV, V20, P368, DOI 10.1101/gad.371406; Duncan KE, 2009, MOL CELL, V36, P571, DOI 10.1016/j.molcel.2009.09.042; Gebauer F, 2003, MOL CELL, V11, P1397, DOI 10.1016/S1097-2765(03)00176-X; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; GRAY NK, 1993, EUR J BIOCHEM, V218, P657, DOI 10.1111/j.1432-1033.1993.tb18420.x; Grskovic M, 2003, EMBO J, V22, P5571, DOI 10.1093/emboj/cdg539; Hayden CA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-61; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hood HM, 2009, ANNU REV MICROBIOL, V63, P385, DOI 10.1146/annurev.micro.62.081307.162835; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nanda JS, 2009, J MOL BIOL, V394, P268, DOI 10.1016/j.jmb.2009.09.017; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Seiler M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-144; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788	35	98	105	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					902	913		10.1016/j.cell.2011.05.005	http://dx.doi.org/10.1016/j.cell.2011.05.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663794	Bronze			2022-12-28	WOS:000291461600017
J	Yea, SS; Fruman, DA				Yea, Sung Su; Fruman, David A.			New mTOR Targets Grb Attention	SCIENCE			English	Editorial Material							DISRUPTION		[Yea, Sung Su] Inje Univ, Coll Med, Dept Biochem, Pusan 614735, South Korea; [Fruman, David A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Inje University; University of California System; University of California Irvine	Yea, SS (corresponding author), Inje Univ, Coll Med, Dept Biochem, Pusan 614735, South Korea.	dfruman@uci.edu						Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	6	25	26	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1270	1271		10.1126/science.1208071	http://dx.doi.org/10.1126/science.1208071			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659593				2022-12-28	WOS:000291441700031
J	Makol, A; Ytterberg, SR				Makol, Ashima; Ytterberg, Steven R.			Calcinosis Cutis in Systemic Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Makol, Ashima; Ytterberg, Steven R.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Makol, A (corresponding author), Mayo Clin, Rochester, MN 55905 USA.			Makol, Ashima/0000-0002-8748-898X					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2245	2245		10.1056/NEJMicm1011692	http://dx.doi.org/10.1056/NEJMicm1011692			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651396				2022-12-28	WOS:000291392100011
J	Schlutter, J				Schluetter, Jana			New drugs hit the target	NATURE			English	Editorial Material																			0	50	57	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S5	S7		10.1038/474S5a	http://dx.doi.org/10.1038/474S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666733	Bronze			2022-12-28	WOS:000291397800004
J	Wonderling, D; Sawyer, L; Fenu, E; Lovibond, K; Laramee, P				Wonderling, David; Sawyer, Laura; Fenu, Elisabetta; Lovibond, Kate; Laramee, Philippe			National Clinical Guideline Centre Cost-Effectiveness Assessment for the National Institute for Health and Clinical Excellence	ANNALS OF INTERNAL MEDICINE			English	Article								The National Clinical Guideline Centre (NCGC) develops evidence-based clinical guidelines on behalf of the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom. The U. K. Department of Health has commissioned NICE to make recommendations on the basis of both clinical effectiveness and cost-effectiveness. This article describes how cost-effectiveness is evaluated and accounted for in NCGC guidelines. Six recent case studies are presented, in which consideration of cost-effectiveness has informed recommendations in various ways for clinical guidelines on alcohol use disorders, chronic obstructive pulmonary disease, glaucoma, lower urinary tract symptoms, non-ST-segment elevation myocardial infarction and unstable angina, and venous thromboembolism prophylaxis. Some of the challenges faced in trying to account for cost-effectiveness in clinical guidelines are outlined, as well as some of the difficulties in adapting cost-effectiveness guidelines for other settings.	[Wonderling, David] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	Royal College of Physicians	Wonderling, D (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England.	enquiries@ncgc.ac.uk		Wonderling, David/0000-0003-0315-6273	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	By the National Institute for Health and Clinical Excellence.	[Anonymous], 2008, GUID METH TECHN APPR; [Anonymous], 2010, VEN THROMB RED RISK; Briggs A, 2006, DECISION MODELLING H; Briggs A, 2010, VALUE HEALTH, V13, pS22, DOI 10.1111/j.1524-4733.2010.00751.x; British Medical Association and the Royal Pharmaceutical Society Joint Formulary Committee, BRIT NAT FORM; Brunetti M, 2010, EVIDENCE BASED DECIS, P114; Cahen DL, 2007, NEW ENGL J MED, V356, P676, DOI 10.1056/NEJMoa060610; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Dolan P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2577; Edejer T, 2003, MAKING CHOICES HLTH; Glasziou PP, 2001, DECISION MAKING HLTH; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Henriksson M, 2008, HEART, V94, P717, DOI 10.1136/hrt.2007.127340; Hill J, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00007; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Karlsson G, 1996, PHARMACOECONOMICS, V9, P113, DOI 10.2165/00019053-199609020-00003; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Lord J., EC MODELLING DIAGNOS; MEHREZ A, 1991, MED DECIS MAKING, V11, P140, DOI 10.1177/0272989X9101100212; National Clinical Guideline Centre, 2009, GLAUC DIAGN MAN CHRO; National Clinical Guideline Centre, 2010, MAN LOW UR TRACT SYM; National Clinical Guideline Centre, 2010, CHRON HEART FAIL NAT; National Clinical Guideline Centre (UK), 2010, UNST ANG NSTEMI EARL; National Clinical Guideline Centre (UK), 2010, ALC US DIS DIAGN CLI; National Health Service Business Services Authority, NHS EL DRUG TAR; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2008, SOC VAL JUDG PRINC D, V2nd; National Institute for Health and Clinical Excellence, 2008, REP NICE CIT COUNC M; National Institute for Health and Clinical Excellence, 2007, METH REV WORKSH KEY; Nord E, 2009, VALUE HEALTH, V12, pS10, DOI 10.1111/j.1524-4733.2009.00516.x; O'Brien BJ, 1997, AM J MANAG CARE, V3, pS33; Organisation for Economic Co-operation and Development, PURCH POW PAR GDP; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; U.K. Department of Health, NHS COST COST COLL; U.K. Department of Health, 2010, NEW VAL BAS APPR PRI; UK Department of Health, 2010, EQ EXC LIB NHS	36	16	16	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00008	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00008			40	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646559				2022-12-28	WOS:000291312300007
J	Theoret, MR; Ning, YM; Zhang, JJ; Justice, R; Keegan, P; Pazdur, R				Theoret, Marc R.; Ning, Yang-Min; Zhang, Jenny J.; Justice, Robert; Keegan, Patricia; Pazdur, Richard			The Risks and Benefits of 5 alpha-Reductase Inhibitors for Prostate-Cancer Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOPREVENTION		[Theoret, Marc R.; Ning, Yang-Min; Justice, Robert; Keegan, Patricia; Pazdur, Richard] US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Zhang, Jenny J.] US FDA, Off Biostat, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Theoret, MR (corresponding author), US FDA, Off Oncol Drug Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.		Zhang, Jenny/GXV-4980-2022					Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; *FDA, 2010, DEC 1 M ONC DRUGS AD; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Walsh PC, 2010, NEW ENGL J MED, V362, P1237, DOI 10.1056/NEJMe1001045	5	114	117	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					97	99		10.1056/NEJMp1106783	http://dx.doi.org/10.1056/NEJMp1106783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791SP	21675880				2022-12-28	WOS:000292685500001
J	Izawa, Y; Pun, D; Stahl, SS				Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.			Palladium-Catalyzed Aerobic Dehydrogenation of Substituted Cyclohexanones to Phenols	SCIENCE			English	Article							MOLECULAR-OXYGEN; OXIDATIVE AROMATIZATION; HYDRIDE; TRIFLUOROACETATE; COMPLEXES; TURNOVER; STRATEGY; AMINES; LIGAND; BOND	Aromatic molecules are key constituents of many pharmaceuticals, electronic materials, and commodity plastics. The utility of these molecules directly reflects the identity and pattern of substituents on the aromatic ring. Here, we report a palladium(II) catalyst system, incorporating an unconventional ortho-dimethylaminopyridine ligand, for the conversion of substituted cyclohexanones to the corresponding phenols. The reaction proceeds via successive dehydrogenation of two saturated carbon-carbon bonds of the six-membered ring and uses molecular oxygen as the hydrogen acceptor. This reactivity demonstrates a versatile and efficient strategy for the synthesis of substituted aromatic molecules with fundamentally different selectivity constraints from the numerous known synthetic methods that rely on substitution of a preexisting aromatic ring.	[Izawa, Yusuke; Pun, Doris; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu			NIH [RC1-GM091161]; Mitsubishi Chemical Corporation; NSF [CHE-1041934]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091161] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitsubishi Chemical Corporation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the NIH (RC1-GM091161), Mitsubishi Chemical Corporation, and NSF (CHE-1041934 to D.P.) for financial support of this work.	Ahuja R, 2011, NAT CHEM, V3, P167, DOI [10.1038/nchem.946, 10.1038/NCHEM.946]; BAMFIELD P, 1984, CHEM SOC REV, V13, P441, DOI 10.1039/cs9841300441; Bercaw JE, 2008, J ORG CHEM, V73, P8654, DOI 10.1021/jo8016296; Bercaw JE, 2008, ANGEW CHEM INT EDIT, V47, P9941, DOI 10.1002/anie.200804455; Buckle D. R., 2010, ENCY REAGENTS ORGANI; Campbell AN, 2010, J AM CHEM SOC, V132, P15116, DOI 10.1021/ja105829t; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; Denney MC, 2006, J AM CHEM SOC, V128, P2508, DOI 10.1021/ja0562292; Dobereiner GE, 2010, CHEM REV, V110, P681, DOI 10.1021/cr900202j; FU PP, 1978, CHEM REV, V78, P317, DOI 10.1021/cr60314a001; Gligorich KM, 2009, CHEM COMMUN, P3854, DOI 10.1039/b902868d; Heitman LH, 2009, J MED CHEM, V52, P2036, DOI 10.1021/jm801561h; HORNING EC, 1947, J AM CHEM SOC, V69, P1359, DOI 10.1021/ja01198a035; Izawa Y, 2010, ADV SYNTH CATAL, V352, P3223, DOI 10.1002/adsc.201000771; Konnick MM, 2008, J AM CHEM SOC, V130, P5753, DOI 10.1021/ja7112504; LAROCK RC, 1993, J ORG CHEM, V58, P5298, DOI 10.1021/jo00072a004; Maleczka RE, 2003, J AM CHEM SOC, V125, P7792, DOI 10.1021/ja0349857; Moriuchi T, 2009, TETRAHEDRON LETT, V50, P7385, DOI 10.1016/j.tetlet.2009.10.070; MUZART J, 1982, J MOL CATAL, V15, P373, DOI 10.1016/0304-5102(82)80029-1; Muzart J, 2010, EUR J ORG CHEM, V2010, P3779, DOI 10.1002/ejoc.201000278; SCHUDA PF, 1987, J ORG CHEM, V52, P1972, DOI 10.1021/jo00386a014; SHELDON RA, 1991, J MOL CATAL, V68, P1, DOI 10.1016/0304-5102(91)80056-9; Stahl SS, 2004, ANGEW CHEM INT EDIT, V43, P3400, DOI 10.1002/anie.200300630; Tyman JHP., 1996, STUDIES ORGANIC CHEM; VANBENTHEM RATM, 1994, J CHEM SOC CHEM COMM, P357, DOI 10.1039/c39940000357; WENZEL TT, 1989, J CHEM SOC CHEM COMM, P932, DOI 10.1039/c39890000932; Ye XA, 2010, GREEN CHEM, V12, P1180, DOI 10.1039/c0gc00106f; Yi CS, 2009, ORGANOMETALLICS, V28, P947, DOI 10.1021/om8010883; Zhang XW, 2011, INORG CHIM ACTA, V369, P253, DOI 10.1016/j.ica.2010.11.016	30	350	354	4	183	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					209	213		10.1126/science.1204183	http://dx.doi.org/10.1126/science.1204183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21659567	Green Accepted			2022-12-28	WOS:000292502700046
J	Chapman, PB; Hauschild, A; Robert, C; Haanen, JB; Ascierto, P; Larkin, J; Dummer, R; Garbe, C; Testori, A; Maio, M; Hogg, D; Lorigan, P; Lebbe, C; Jouary, T; Schadendorf, D; Ribas, A; O'Day, SJ; Sosman, JA; Kirkwood, JM; Eggermont, AMM; Dreno, B; Nolop, K; Li, J; Nelson, B; Hou, J; Lee, RJ; Flaherty, KT; McArthur, GA				Chapman, Paul B.; Hauschild, Axel; Robert, Caroline; Haanen, John B.; Ascierto, Paolo; Larkin, James; Dummer, Reinhard; Garbe, Claus; Testori, Alessandro; Maio, Michele; Hogg, David; Lorigan, Paul; Lebbe, Celeste; Jouary, Thomas; Schadendorf, Dirk; Ribas, Antoni; O'Day, Steven J.; Sosman, Jeffrey A.; Kirkwood, John M.; Eggermont, Alexander M. M.; Dreno, Brigitte; Nolop, Keith; Li, Jiang; Nelson, Betty; Hou, Jeannie; Lee, Richard J.; Flaherty, Keith T.; McArthur, Grant A.		BRIM-3 Study Grp	Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC MELANOMA; PHASE-III; MALIGNANT-MELANOMA; RAF KINASE; DACARBAZINE; INHIBITION; RESISTANCE; SORAFENIB; PATHWAY	BACKGROUND Phase 1 and 2 clinical trials of the BRAF kinase inhibitor vemurafenib (PLX4032) have shown response rates of more than 50% in patients with metastatic melanoma with the BRAF V600E mutation. METHODS We conducted a phase 3 randomized clinical trial comparing vemurafenib with dacarbazine in 675 patients with previously untreated, metastatic melanoma with the BRAF V600E mutation. Patients were randomly assigned to receive either vemurafenib (960 mg orally twice daily) or dacarbazine (1000 mg per square meter of body-surface area intravenously every 3 weeks). Coprimary end points were rates of overall and progression-free survival. Secondary end points included the response rate, response duration, and safety. A final analysis was planned after 196 deaths and an interim analysis after 98 deaths. RESULTS At 6 months, overall survival was 84% (95% confidence interval [CI], 78 to 89) in the vemurafenib group and 64% (95% CI, 56 to 73) in the dacarbazine group. In the interim analysis for overall survival and final analysis for progression-free survival, vemurafenib was associated with a relative reduction of 63% in the risk of death and of 74% in the risk of either death or disease progression, as compared with dacarbazine (P < 0.001 for both comparisons). After review of the interim analysis by an independent data and safety monitoring board, crossover from dacarbazine to vemurafenib was recommended. Response rates were 48% for vemurafenib and 5% for dacarbazine. Common adverse events associated with vemurafenib were arthralgia, rash, fatigue, alopecia, keratoacanthoma or squamous-cell carcinoma, photosensitivity, nausea, and diarrhea; 38% of patients required dose modification because of toxic effects. CONCLUSIONS Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation. (Funded by Hoffmann-La Roche; BRIM-3 ClinicalTrials.gov number, NCT01006980.)	[Chapman, Paul B.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hauschild, Axel] Univ Kiel, Kiel, Germany; [Schadendorf, Dirk] Univ Hosp Essen, Essen, Germany; [Garbe, Claus] Univ Tubingen, Tubingen, Germany; [Robert, Caroline; Eggermont, Alexander M. M.] Inst Gustave Roussy, Paris, France; [Lebbe, Celeste] Hop St Louis, Serv Dermatol, F-75475 Paris, France; [Haanen, John B.] Netherlands Canc Inst, Amsterdam, Netherlands; [Ascierto, Paolo] Ist Nazl Tumori Fdn Pascale, Naples, Italy; [Maio, Michele] Ist Toscano Tumori, Florence, Italy; [Larkin, James] Royal Marsden Hosp, Dept Med Oncol, London, England; [Dummer, Reinhard] Univ Zurich, Dept Dermatol, Zurich, Switzerland; [Testori, Alessandro] Ist Europeo Oncol, Milan, Italy; [Hogg, David] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Hogg, David] Univ Hlth Network, Toronto, ON, Canada; [Lorigan, Paul] Univ Manchester, Manchester, Lancs, England; [Jouary, Thomas] St Andre Hosp, Bordeaux, France; [Dreno, Brigitte] Nantes Univ Hosp, Dept Dermatol, Nantes, France; [Ribas, Antoni] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [O'Day, Steven J.] Angeles Clin & Res Inst, Los Angeles, CA USA; [Sosman, Jeffrey A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Kirkwood, John M.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Nolop, Keith] Plexxikon, Berkeley, CA USA; [Li, Jiang; Lee, Richard J.] Hoffmann La Roche, Nutley, NJ USA; [Nelson, Betty; Hou, Jeannie] Genentech Inc, San Francisco, CA USA; [Flaherty, Keith T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [McArthur, Grant A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	Memorial Sloan Kettering Cancer Center; University of Kiel; University of Duisburg Essen; Eberhard Karls University of Tubingen; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Netherlands Cancer Institute; IRCCS Fondazione Pascale; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Royal Marsden NHS Foundation Trust; University of Zurich; IRCCS European Institute of Oncology (IEO); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Manchester; CHU Bordeaux; Nantes Universite; CHU de Nantes; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Angeles Clinic & Research Institute; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Plexxikon; Roche Holding; Roche Holding; Genentech; Harvard University; Massachusetts General Hospital; Peter Maccallum Cancer Center	Chapman, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA.	chapmanp@mskcc.org	Del Vecchio, Michele/K-1584-2016; Schadendorf, Dirk/AAE-8206-2019; Lorigan, Paul/J-6898-2015; Ottensmeier, Christian H/E-8131-2012; Haanen, John/AAD-8578-2022; Garbe, Claus/ABH-2128-2021; Ascierto, Paolo A/J-9106-2016; Robert, Caroline/G-6157-2018; Haanen, John/AAD-8534-2022	Del Vecchio, Michele/0000-0001-9060-2512; Lorigan, Paul/0000-0002-8875-2164; Ottensmeier, Christian H/0000-0003-3619-1657; Garbe, Claus/0000-0001-8530-780X; Ascierto, Paolo A/0000-0002-8322-475X; Robert, Caroline/0000-0002-9493-0238; Haanen, John/0000-0001-5884-7704; Larkin, James/0000-0001-5569-9523; McArthur, Grant/0000-0001-8908-6071; Maio, Michele/0000-0002-0323-6321; Melucci, Maria Teresa/0000-0002-1677-3345; coral, sandra/0000-0002-1308-3082; TESTORI, ALESSANDRO/0000-0003-3685-0210; Grob, Jean-Jacques/0000-0002-0667-153X	Hoffmann-La Roche; Roche; GlaxoSmithKline; Abraxis/Celgene; AstraZeneca; Bayer; Biovex; Bristol-Myers Squibb; Boehringer Ingleheim; Eisai; Merck; Novartis; Bayer and Merck; Schering-Plough; Plexxikon; Roche/Genentech; Millennium; Vical; Imedex; Pfizer; NATIONAL CANCER INSTITUTE [K24CA097588] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	Hoffmann-La Roche(Hoffmann-La Roche); Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Abraxis/Celgene; AstraZeneca(AstraZeneca); Bayer(Bayer AG); Biovex; Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer Ingleheim; Eisai(Eisai Co Ltd); Merck(Merck & Company); Novartis(Novartis); Bayer and Merck; Schering-Plough(Merck & CompanySchering Plough Corporation); Plexxikon; Roche/Genentech(Roche HoldingGenentech); Millennium(Takeda Pharmaceutical Company Ltd); Vical; Imedex; Pfizer(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by Hoffmann-La Roche.; Dr. Chapman reports receiving consulting fees, payment for serving on scientific advisory boards, and grant support from Roche and consulting fees from GlaxoSmithKline; Dr. Hauschild, receiving consulting fees from Abraxis/Celgene, AstraZeneca, Bayer, Biovex, Bristol-Myers Squibb, Boehringer Ingleheim, Eisai, GlaxoSmithKline, Merck, Novartis, and Roche, grant support from Bayer and Merck, and lecture fees from Abraxis/Celgene, AstraZeneca, Biovex, Bristol-Myers Squibb, Merck, Novartis, and Roche; Dr. Robert, receiving consulting fees from Roche, Bristol-Myers Squibb, GlaxoSmithKline, and Merck and travel payments from Bristol-Myers Squibb; Dr. Ascierto, serving as a board member for Bristol-Myers Squibb, GlaxoSmithKline, Schering-Plough, Merck, and Roche and lecture fees from Schering-Plough and Merck; Dr. Garbe, receiving consulting fees from Bristol-Myers Squibb, Merck, GlaxoSmithKline, and Philogen, grant support from Bristol-Myers Squibb, Philogen, and Swedish Orphan, and travel payments from Bristol- Myers Squibb, Roche, and Merck; Dr. Maio, serving on advisory boards for Bristol-Myers Squibb and Pfizer and receiving lecture fees from Bristol-Myers Squibb; Dr. Hogg, receiving consulting fees from Roche, GlaxoSmithKline, and Bristol-Myers Squibb and lecture fees from Roche; Dr. Lorigan, receiving consulting fees from Roche and an educational grant from Roche; Dr. Lebbe, serving on paid advisory boards for Roche and Bristol- Myers Squibb and receiving payments for the development of educational presentations and travel payments from Bristol-Myers Squibb; Dr. Jouary, serving on an advisory board for Bristol-Myers Squibb and receiving consulting fees from Bristol-Myers Squibb and Schering-Plough; Dr. Schadendorf, receiving consulting fees from Roche, GlaxoSmithKline, Bristol-Myers Squibb, and Merck, serving on advisory boards for Roche, GlaxoSmithKline, Bristol-Myers Squibb, Merck, and Schering-Plough, receiving grant support from Schering-Plough and Plexxikon, receiving lecture fees from Bristol-Myers Squibb, Merck, Schering-Plough, and Roche, and receiving payment for developing presentations for Bristol-Myers Squibb; Dr. Ribas, receiving consulting fees from Roche/Genentech; Dr. O'Day, receiving consulting fees from Glaxo-SmithKline, receiving consulting fees, grant support, lecture fees, and payment for the development of educational presentations from Bristol-Myers Squibb, and serving as an expert witness in a private lawsuit; Dr. Sosman, receiving grant support from Roche, Millennium, and GlaxoSmithKline and consulting fees from Roche and Millennium; Dr. Kirkwood, serving as a board member for Morphotek and receiving consulting fees from GlaxoSmithKline and Vical, lecture fees from Merck, and payment for the development of educational presentations from Imedex; Dr. Eggermont, receiving consulting fees from Bristol-Myers Squibb, Merck, and GlaxoSmithKline; Dr. Dreno, receiving consulting fees from Roche; Dr. Nolop, being an employee of and having an equity interest in Plexxikon; Mrs. Li and Dr. Lee, being employees of Roche; Miss Nelson and Dr. Hou, being employees of Genentech and having an equity interest in Roche; Dr. Flaherty, receiving consulting fees from GlaxoSmithKline; and Dr. McArthur, receiving grant support from Pfizer. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2010, GLOBOCAN 2008 CANC I; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Avril MF, 2004, J CLIN ONCOL, V22, P1118, DOI 10.1200/JCO.2004.04.165; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Kwon EJ, 2009, J AM ACAD DERMATOL, V61, P522, DOI 10.1016/j.jaad.2008.10.043; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Middleton MR, 2000, J CLIN ONCOL, V18, P158, DOI 10.1200/JCO.2000.18.1.158; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ribas A, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.8509; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Williams VL, 2011, INT J DERMATOL, V50, P396, DOI 10.1111/j.1365-4632.2010.04822.x; WOLCHOK JD, 2011, J CLIN ONCOL S, V29, pLBA5	28	5658	5844	7	560	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2507	2516		10.1056/NEJMoa1103782	http://dx.doi.org/10.1056/NEJMoa1103782			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AM	21639808	Green Accepted, Green Published			2022-12-28	WOS:000292199800006
J	Hothorn, M; Belkhadir, Y; Dreux, M; Dabi, T; Noel, JP; Wilson, IA; Chory, J				Hothorn, Michael; Belkhadir, Youssef; Dreux, Marlene; Dabi, Tsegaye; Noel, Joseph. P.; Wilson, Ian A.; Chory, Joanne			Structural basis of steroid hormone perception by the receptor kinase BRI1	NATURE			English	Article							RICH REPEAT PROTEIN; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; BRASSINOSTEROIDS; COMPLEX; BAK1; RECOGNITION; ACTIVATION; BRI1/BAK1; MUTANT	Polyhydroxylated steroids are regulators of body shape and size in higher organisms. In metazoans, intracellular receptors recognize these molecules. Plants, however, perceive steroids at membranes, using the membrane-integral receptor kinase BRASSINOSTEROID INSENSITIVE 1 (BRI1). Here we report the structure of the Arabidopsis thaliana BRI1 ligand-binding domain, determined by X-ray diffraction at 2.5 angstrom resolution. We find a superhelix of 25 twisted leucine-rich repeats (LRRs), an architecture that is strikingly different from the assembly of LRRs in animal Toll-like receptors. A 70-amino-acid island domain between LRRs 21 and 22 folds back into the interior of the superhelix to create a surface pocket for binding the plant hormone brassinolide. Known loss- and gain-of-function mutations map closely to the hormone-binding site. We propose that steroid binding to BRI1 generates a docking platform for a co-receptor that is required for receptor activation. Our findings provide insight into the activation mechanism of this highly expanded family of plant receptors that have essential roles in hormone, developmental and innate immunity signalling.	[Hothorn, Michael; Belkhadir, Youssef; Dabi, Tsegaye; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Belkhadir, Youssef; Dabi, Tsegaye; Noel, Joseph. P.; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Dreux, Marlene] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Noel, Joseph. P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute; Salk Institute; Scripps Research Institute; Scripps Research Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu	Dreux, Marlene/M-7295-2014; Belkhadir, Youssef/GXM-6743-2022; Noel, Joseph P/A-9459-2009; Hothorn, Michael/C-6807-2011	Dreux, Marlene/0000-0002-6607-4796; Belkhadir, Youssef/0000-0001-7149-7139; Hothorn, Michael/0000-0002-3597-5698	Howard Hughes Medical Institute; National Science Foundation [IOS-0649389]; European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH [AI042266]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, R01AI042266] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); European Molecular Biology Organisation; International Human Frontier Science Program Organisation; Philippe Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Vanhnasy and W. Yu for maintaining insect cell stocks, M. Jinek and B. W. Han for advice, W. Kwiatowski for maintenance of the Salk X-ray equipment, Y. Jaillais for discussion, and F.V. Chisari for encouragement and support. This work was supported by the Howard Hughes Medical Institute and a grant from the National Science Foundation (IOS-0649389) to J.C. M.H. was supported by long-term fellowships from the European Molecular Biology Organisation and the International Human Frontier Science Program Organisation. Y.B. was a Howard Hughes Medical Institute fellow of the Life Sciences Research Foundation and also received support from the Philippe Foundation. I.A.W. was supported by NIH grant AI042266 and by the Skaggs Institute for Chemical Biology.	Back TG, 2003, J PLANT GROWTH REGUL, V22, P350, DOI 10.1007/s00344-003-0057-0; Belkhadir Y, 2006, SCIENCE, V314, P1410, DOI 10.1126/science.1134040; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Dievarta A, 2006, FUNCT PLANT BIOL, V33, P723, DOI 10.1071/FP06080; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fujioka S, 1997, PLANT CELL, V9, P1951, DOI 10.1105/tpc.9.11.1951; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gruszka D, 2011, J APPL GENET, V52, P257, DOI 10.1007/s13353-011-0031-7; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Karlova R, 2006, PLANT CELL, V18, P626, DOI 10.1105/tpc.105.039412; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nishimura R, 2002, NATURE, V420, P426, DOI 10.1038/nature01231; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444	50	269	295	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					467	U90		10.1038/nature10153	http://dx.doi.org/10.1038/nature10153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666665	Green Submitted, Green Accepted			2022-12-28	WOS:000291939700039
J	Booth, RA; Ansari, MT; Loit, E; Tricco, AC; Weeks, L; Doucette, S; Skidmore, B; Sears, M; Sy, R; Karsh, J				Booth, Ronald A.; Ansari, Mohammed T.; Loit, Evelin; Tricco, Andrea C.; Weeks, Laura; Doucette, Steve; Skidmore, Becky; Sears, Margaret; Sy, Richmond; Karsh, Jacob			Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							INFLAMMATORY-BOWEL-DISEASE; INOSINE TRIPHOSPHATE PYROPHOSPHATASE; ADVERSE DRUG-REACTIONS; AZATHIOPRINE THERAPY; TPMT ACTIVITY; ETHNIC-DIFFERENCES; GENOTYPIC ANALYSIS; JAPANESE PATIENTS; KOREAN PATIENTS; TOXICITY	Background: The evidence for testing thiopurine S-methyl transferase (TPMT) enzymatic activity or genotype before starting therapy with thiopurine-based drugs is unclear. Purpose: To examine the sensitivity and specificity of TPMT genotyping for TPMT enzymatic activity, reducing harm from thiopurine by pretesting, and the association of thiopurine toxicity with TPMT status in adults and children with chronic inflammatory diseases. Data Sources: MEDLINE, EMBASE, the Cochrane Library, and Ovid HealthSTAR (from inception to December 2010) and BIOSIS and Genetics Abstracts (to May 2009). Study Selection: Two reviewers screened records and identified relevant studies in English. Data Extraction: Data on patient characteristics, outcomes, and risk for bias were extracted by one reviewer and independently identified by another. Data Synthesis: 54 observational studies and 1 randomized, controlled trial were included. Insufficient evidence addressed the effectiveness of pretesting. Genotyping sensitivity to identify patients with low and intermediate TPMT enzymatic activity ranged from 70.33% to 86.15% (lower-bound 95% CI, 54.52% to 70.88%; upper-bound CI, 78.50% to 96.33%). Sparse data precluded estimation of genotype sensitivity to identify patients with low to absent enzymatic activity. Genotyping specificity approached 100%. Compared with noncarriers, heterozygous and homozygous genotypes were both associated with leukopenia (odds ratios, 4.29 [CI, 2.67 to 6.89] and 20.84 [CI, 3.42 to 126.89], respectively). Compared with intermediate or normal activity, low TPMT enzymatic activity was significantly associated with myelotoxicity and leukopenia. Limitation: Available evidence was not rigorous and was underpowered to detect a difference in outcomes. Conclusion: Insufficient evidence addresses the effectiveness of TPMT pretesting in patients with chronic inflammatory diseases. Estimates of the sensitivity of genotyping are imprecise. Evidence confirms the known associations of leukopenia or myelotoxicity with reduced TPMT activity or variant genotype.	[Ansari, Mohammed T.] Univ Ottawa, Evidence Based Practice Ctr, Ottawa Methods Ctr, Clin Epidemiol Program,Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; St Michaels Hosp, Toronto, ON M5B 1W8, Canada; Ottawa Hosp Res Inst, Ottawa Hosp, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; Ottawa Hospital Research Institute	Ansari, MT (corresponding author), Univ Ottawa, Evidence Based Practice Ctr, Ottawa Methods Ctr, Clin Epidemiol Program,Ottawa Hosp Res Inst, Box 208,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	moansari@ohri.ca	Loit, Evelin/I-2489-2016; Tricco, Andrea/B-9920-2011	Loit, Evelin/0000-0001-6635-8740; Tricco, Andrea/0000-0002-4114-8971; Skidmore, Becky/0000-0001-8293-9238	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA290-2007-10059-I]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By contract HHSA290-2007-10059-I (EPCIII) from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.	Ameyaw MM, 1999, HUM MOL GENET, V8, P367, DOI 10.1093/hmg/8.2.367; Ansari A, 2008, ALIMENT PHARM THER, V28, P973, DOI 10.1111/j.1365-2036.2008.03788.x; Ansari A, 2002, ALIMENT PHARM THER, V16, P1743, DOI 10.1046/j.1365-2036.2002.01353.x; Anstey AV, 2004, BRIT J DERMATOL, V151, P1123, DOI 10.1111/j.1365-2133.2004.06323.x; Banerjee S, 2006, J PEDIATR GASTR NUTR, V43, P324, DOI 10.1097/01.mpg.0000228135.31793.9f; Bezier M, 2008, EUR J DERMATOL, V18, P512, DOI 10.1684/ejd.2008.0473; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Center for Drug Evaluation and Research, OV IM; Chakravarty K, 2008, RHEUMATOLOGY, V47, P924, DOI 10.1093/rheumatology/kel216a; Collie-Duguid ESR, 1999, PHARMACOGENETICS, V9, P37, DOI 10.1097/00008571-199902000-00006; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Corominas H, 2003, RHEUMATOLOGY, V42, P40, DOI 10.1093/rheumatology/keg028; Czaja AJ, 2006, DIGEST DIS SCI, V51, P968, DOI 10.1007/s10620-006-9336-5; De Ridder L, 2006, ALIMENT PHARM THER, V23, P1137, DOI 10.1111/j.1365-2036.2006.02853.x; Derijks LJJ, 2004, THER DRUG MONIT, V26, P311, DOI 10.1097/00007691-200406000-00016; Dubinsky MC, 2000, GASTROENTEROLOGY, V118, P705, DOI 10.1016/S0016-5085(00)70140-5; Dubinsky MC, 2002, GASTROENTEROLOGY, V122, P904, DOI 10.1053/gast.2002.32420; Efrati E, 2009, EUR J CLIN PHARMACOL, V65, P257, DOI 10.1007/s00228-008-0590-7; Engen RM, 2006, CURR DRUG TARGETS, V7, P1641, DOI 10.2174/138945006779025446; Firooz A, 2008, ARCH DERMATOL, V144, P1143, DOI 10.1001/archderm.144.9.1143; Ford LT, 2010, J CLIN PATHOL, V63, P288, DOI 10.1136/jcp.2009.069252; Ford L, 2009, ANN CLIN BIOCHEM, V46, P152, DOI 10.1258/acb.2008.008167; Gardiner SJ, 2008, CLIN GASTROENTEROL H, V6, P654, DOI 10.1016/j.cgh.2008.02.032; Gearry RB, 2004, PHARMACOGENETICS, V14, P779, DOI 10.1097/00008571-200411000-00010; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Gisbert JP, 2006, AM J GASTROENTEROL, V101, P2769, DOI 10.1111/j.1572-0241.2006.00843.x; Haglund S, 2004, CLIN CHEM, V50, P288, DOI 10.1373/clinchem.2003.023846; Hibi T, 2003, J GASTROENTEROL, V38, P740, DOI 10.1007/s00535-003-1139-2; Higgs JE, 2010, PHARMACOGENOMICS, V11, P177, DOI 10.2217/PGS.09.155; Hindorf U, 2006, ALIMENT PHARM THER, V24, P331, DOI 10.1111/j.1365-2036.2006.02977.x; Hindorf U, 2004, SCAND J GASTROENTERO, V39, P1105, DOI 10.1080/00365520410007980; Hindorf U, 2010, J HEPATOL, V52, P106, DOI 10.1016/j.jhep.2009.10.004; Hon YY, 1999, HUM MOL GENET, V8, P371, DOI 10.1093/hmg/8.2.371; Ishioka S, 1999, INTERNAL MED, V38, P944, DOI 10.2169/internalmedicine.38.944; Jojic N, 2003, ARCH GASTROENTEROHEP, V22, P5, DOI DOI 10.1046/J.0269-2813.2003.01690.X; Jun JB, 2005, CLIN EXP RHEUMATOL, V23, P873; Kader HA, 2000, J CLIN GASTROENTEROL, V30, P409, DOI 10.1097/00004836-200006000-00011; Kim JH, 2008, GASTROENTEROLOGY, V134, pA210; Kim JH, 2010, J CLIN GASTROENTEROL, V44, pE242, DOI 10.1097/MCG.0b013e3181d6baf5; Kolorz M, 2009, NEUROENDOCRINOL LETT, V30, P137; Kurzawski M, 2004, THER DRUG MONIT, V26, P541, DOI 10.1097/00007691-200410000-00013; Langley PG, 2002, J HEPATOL, V37, P441, DOI 10.1016/S0168-8278(02)00214-3; LENNARD L, 1989, CLIN PHARMACOL THER, V46, P149, DOI 10.1038/clpt.1989.119; Lichtenstein GR, 2006, GASTROENTEROLOGY, V130, P940, DOI 10.1053/j.gastro.2006.01.048; Lindqvist M, 2006, NUCLEOS NUCLEOT NUCL, V25, P1033, DOI 10.1080/15257770600890814; Lopez AJ, 2006, GASTROENTEROLOGY S2, V130; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marinaki AM, 2003, PHARMACOGENETICS, V13, P97, DOI 10.1097/00008571-200302000-00006; McLeod HL, 1999, PHARMACOGENETICS, V9, P773, DOI 10.1097/01213011-199912000-00012; Meggitt SJ, 2001, CLIN EXP DERMATOL, V26, P369, DOI 10.1046/j.1365-2230.2001.00837.x; Newman W, 2011, PHARMACOGEN IN PRESS; Okada Y, 2005, BIOL PHARM BULL, V28, P2117, DOI 10.1248/bpb.28.2117; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palmieri O, 2007, ALIMENT PHARM THER, V26, P737, DOI 10.1111/j.1365-2036.2007.03421.x; Payne K, 2007, RHEUMATOLOGY, V46, P727, DOI 10.1093/rheumatology/kel427; Payne K, 2009, PERS MED, V6, P103, DOI 10.2217/17410541.6.1.103; Prefontaine E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000067.pub2; Reuther LO, 2003, SCAND J GASTROENTERO, V38, P972, DOI 10.1080/00365520310005082; Sahasranaman S, 2008, EUR J CLIN PHARMACOL, V64, P753, DOI 10.1007/s00228-008-0478-6; Sanderson J, 2004, ANN CLIN BIOCHEM, V41, P294, DOI 10.1258/0004563041201455; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; Schedel J, 2006, ANN NY ACAD SCI, V1069, P477, DOI 10.1196/annals.1351.048; Schmeling H, 2007, ARTHRITIS RHEUM, V56, P4265; Schwab M, 2002, PHARMACOGENETICS, V12, P429, DOI 10.1097/00008571-200208000-00003; Seddik M, 2003, THIOPURINE S METHYLT; Shah JA, 2008, EUR J GASTROEN HEPAT, V20, P169, DOI 10.1097/MEG.0b013e3282f16d50; SNOW JL, 1995, ARCH DERMATOL, V131, P193, DOI 10.1001/archderm.131.2.193; Stassen PM, 2009, ANN RHEUM DIS, V68, P758, DOI 10.1136/ard.2008.097667; Stocco G, 2005, DIGEST LIVER DIS, V37, P940, DOI 10.1016/j.dld.2005.08.003; Stocco G, 2004, RADIOL ONCOL, V38, P101; Stocco G, 2007, INFLAMM BOWEL DIS, V13, P57, DOI 10.1002/ibd.20004; Stolk JN, 1998, ARTHRITIS RHEUM-US, V41, P1858, DOI 10.1002/1529-0131(199810)41:10<1858::AID-ART19>3.3.CO;2-#; Stuart A, 1994, KENDALLS ADV THEORY; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Tamori A, 2007, LIVER INT, V27, P95, DOI 10.1111/j.1478-3231.2006.01392.x; Tani C, 2009, CLIN EXP RHEUMATOL, V27, P321; van Dieren J, 2005, GASTROENTEROLOGY S2, V128; Vestergaard T, 2010, CLIN EXP DERMATOL, V35, P140, DOI 10.1111/j.1365-2230.2009.03446.x; von Ahsen N, 2005, CLIN CHEM, V51, P2282, DOI 10.1373/clinchem.2005.057158; Weyer N, 2001, EUR J CLIN PHARMACOL, V57, P129, DOI 10.1007/s002280100287; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Winter JW, 2007, ALIMENT PHARM THER, V25, P1069, DOI 10.1111/j.1365-2036.2007.03301.x; Zelinkova Z, 2006, CLIN GASTROENTEROL H, V4, P44, DOI 10.1016/j.cgh.2005.10.019	85	73	79	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					814	823		10.7326/0003-4819-154-12-201106210-00009	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690596				2022-12-28	WOS:000291800500017
J	Medema, JP; Vermeulen, L				Medema, Jan Paul; Vermeulen, Louis			Microenvironmental regulation of stem cells in intestinal homeostasis and cancer	NATURE			English	Review							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; SOMATIC MUTATION; PROGENITOR CELLS; INDIAN HEDGEHOG; KNOCKOUT MICE; TUMOR-GROWTH; IN-VITRO; COLON; APC	The identification of intestinal stem cells as well as their malignant counterparts, colon cancer stem cells, has undergone rapid development in recent years. Under physiological conditions, intestinal homeostasis is a carefully balanced and efficient interplay between stem cells, their progeny and the microenvironment. These interactions regulate the astonishingly rapid renewal of the intestinal epithelial layer, which consequently puts us at serious risk of developing cancer. Here we highlight the microenvironment-derived signals that regulate stem-cell fate and epithelial differentiation. As our understanding of normal intestinal crypt homeostasis grows, these developments may point towards new insights into the origin of cancer and the maintenance and regulation of cancer stem cells.	[Medema, Jan Paul; Vermeulen, Louis] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Medema, JP (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.p.medema@amc.nl	Sprick, Martin R./A-8611-2008; Vermeulen, Louis/B-7488-2008	Sprick, Martin R./0000-0001-9691-7574; Vermeulen, Louis/0000-0002-6066-789X; Medema, Jan Paul/0000-0003-3045-2924	Netherlands Organization for Scientific Research (NWO); Dutch Cancer Society [UVA2009-4416]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding)	We would like to thank the members of the laboratory and G. van den Brink for critically reading the manuscript. Our work is sponsored by grants from the Netherlands Organization for Scientific Research (NWO; VICI program) and from the Dutch Cancer Society (UVA2009-4416).	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bijlsma MF, 2004, BIOESSAYS, V26, P387, DOI 10.1002/bies.20007; Borovski T, 2009, CELL CYCLE, V8, P803, DOI 10.4161/cc.8.6.7935; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Campbell F, 1996, GUT, V39, P569, DOI 10.1136/gut.39.4.569; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Crabtree M, 2003, ONCOGENE, V22, P4257, DOI 10.1038/sj.onc.1206471; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Gould KA, 1996, GENETICS, V144, P1777; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Katajisto P, 2008, NAT GENET, V40, P455, DOI 10.1038/ng.98; Kemper K, 2010, CANCER RES, V70, P719, DOI 10.1158/0008-5472.CAN-09-1820; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Luo FJ, 2009, INT J EXP PATHOL, V90, P558, DOI 10.1111/j.1365-2613.2009.00667.x; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rubinfeld B, 1997, CANCER RES, V57, P4624; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schepers AG, 2011, EMBO J, V30, P1104, DOI 10.1038/emboj.2011.26; Shao JY, 2006, CANCER RES, V66, P846, DOI 10.1158/0008-5472.CAN-05-2606; Shen MM, 2008, COLD SH Q B, V73, P529, DOI 10.1101/sqb.2008.73.050; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takayama Tetsuji, 2005, Clin Gastroenterol Hepatol, V3, pS42, DOI 10.1016/S1542-3565(05)00257-0; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; van Dop WA, 2009, GASTROENTEROLOGY, V136, P2195, DOI 10.1053/j.gastro.2009.02.068; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2010, MECH DEVELOP, V127, P73, DOI 10.1016/j.mod.2009.10.005; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104	100	346	366	2	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					318	326		10.1038/nature10212	http://dx.doi.org/10.1038/nature10212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677748				2022-12-28	WOS:000291647100035
J	Dong, XQ; Simon, MA				Dong, XinQi; Simon, Melissa A.			Enhancing National Policy and Programs to Address Elder Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NEGLECT		[Dong, XinQi] Rush Univ, Med Ctr, Rush Inst Healthy Aging, Chicago, IL 60612 USA; [Simon, Melissa A.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Simon, Melissa A.] Northwestern Univ, Dept Obstet & Gynecol, Dept Prevent Med, Chicago, IL 60611 USA	Rush University; Northwestern University; Feinberg School of Medicine; Northwestern University	Dong, XQ (corresponding author), Rush Univ, Med Ctr, Rush Inst Healthy Aging, 1645 W Jackson Blvd,Ste 675, Chicago, IL 60612 USA.	xinqidong@gmail.com			NIA NIH HHS [K23 AG030944, RC4 AG039085, R01 AG11101] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG030944, RC4AG039085, R01AG011101] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acierno R, 2010, AM J PUBLIC HEALTH, V100, P292, DOI 10.2105/AJPH.2009.163089; Congressional Research Services, VIOL WOM ACT HIST FE; Dong XQ, 2009, JAMA-J AM MED ASSOC, V302, P517, DOI 10.1001/jama.2009.1109; Dong XQ, 2005, CLIN GERIATR MED, V21, P293, DOI 10.1016/j.cger.2004.10.006; Government Accountability Office, 2011, ELD JUST STRONG FED; National Center on Elder Abuse, ELD AB PREV INC	6	43	43	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2460	2461		10.1001/jama.2011.835	http://dx.doi.org/10.1001/jama.2011.835			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777EB	21673299				2022-12-28	WOS:000291597300028
J	Reynolds, L				Reynolds, Lucy			PERSONAL VIEW For-profit companies will strip NHS assets under proposed reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									London Sch Hyg & Trop Med, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Reynolds, L (corresponding author), London Sch Hyg & Trop Med, London WC1H 9SH, England.	lucy.reynolds@lshtm.ac.uk	Reynolds, Dr L/CAG-7830-2022						0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3760	10.1136/bmj.d3760	http://dx.doi.org/10.1136/bmj.d3760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677011	Green Accepted			2022-12-28	WOS:000291932700013
J	Bulgac, A; Luo, YL; Magierski, P; Roche, KJ; Yu, YL				Bulgac, Aurel; Luo, Yuan-Lung; Magierski, Piotr; Roche, Kenneth J.; Yu, Yongle			Real-Time Dynamics of Quantized Vortices in a Unitary Fermi Superfluid	SCIENCE			English	Article							HELIUM II; GAS; VORTEX; SYSTEMS	We introduce a comprehensive theoretical framework for the fermionic superfluid dynamics, grounded on a local extension of the time-dependent density functional theory. With this approach, we describe the generation and the real-time evolution and interaction of quantized vortices, the large-amplitude collective modes, as well as the loss of superfluidity at high flow velocities. We demonstrate the formation of vortex rings and provide a microscopic description of the crossing and reconnection of quantized vortex lines in a fermion superfluid, which provide the mechanism for the emergence of quantum turbulence at very low temperatures. We observe that superfluidity often survives when these systems are stirred with velocities far exceeding the speed of sound.	[Bulgac, Aurel; Luo, Yuan-Lung; Magierski, Piotr; Roche, Kenneth J.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Magierski, Piotr] Warsaw Univ Technol, Fac Phys, PL-00662 Warsaw, Poland; [Roche, Kenneth J.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Yu, Yongle] Wuhan Inst Phys & Math, State Key Lab Magnet Resonance Atom & Mol Phys, Wuhan 430071, Peoples R China	University of Washington; University of Washington Seattle; Warsaw University of Technology; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS	Bulgac, A (corresponding author), Univ Washington, Dept Phys, Seattle, WA 98195 USA.	bulgac@uw.edu		Roche, Kenneth/0000-0002-5675-9265; Bulgac, Aurel/0000-0003-0556-4107; Magierski, Piotr/0000-0001-8769-5017	U.S. Department of Energy (DOE) [DE-FG02-97ER41014, DE-FC02-07ER41457, DE-AC05-760RL01830]; Polish Ministry of Science [N N202 128439]; People's Republic of China [NSF-11075201, NKBRSF-2011CB921503]; NSF [PHY-0922770]; National Energy Research Scientific Computing Center, DOE [B-AC02-05CH11231]; National Center for Computational Sciences, DOE [DE-AC05-00OR22725]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Polish Ministry of Science(Ministry of Science and Higher Education, Poland); People's Republic of China; NSF(National Science Foundation (NSF)); National Energy Research Scientific Computing Center, DOE(United States Department of Energy (DOE)); National Center for Computational Sciences, DOE(United States Department of Energy (DOE))	We thank G. F. Bertsch for discussions. This work was supported by U.S. Department of Energy (DOE) grants DE-FG02-97ER41014, DE-FC02-07ER41457, DE-AC05-760RL01830; grant no. N N202 128439 from the Polish Ministry of Science; and grants NSF-11075201 and NKBRSF-2011CB921503 from the People's Republic of China. Calculations have been performed on Univ. of Washington (UW) Athena, Hyak UW (NSF Major Research Instrumentation grant PHY-0922770), Franklin (Cray XT4, National Energy Research Scientific Computing Center, DOE grant B-AC02-05CH11231), and JaguarPF (Cray XT5, National Center for Computational Sciences, DOE grant DE-AC05-00OR22725). Movies clips of the simulations are archived at www.phys.washington.edu/groups/qmbnt/UFG/ (see SOM for instructions).	ABRIKOSOV AA, 1957, SOV PHYS JETP-USSR, V5, P1174; Aranson IS, 2002, REV MOD PHYS, V74, P99, DOI 10.1103/RevModPhys.74.99; Baker GA, 1999, PHYS REV C, V60, DOI 10.1103/PhysRevC.60.054311; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bulgac A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.190404; Bulgac A, 2008, J PHYS CONF SER, V125, DOI 10.1088/1742-6596/125/1/012064; Bulgac A, 2010, J PHYS G NUCL PARTIC, V37, DOI 10.1088/0954-3899/37/6/064006; Bulgac A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.085302; Carlson J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.050401; Dreizler R.M., 1990, DENSITY FUNCTIONAL T; Feynman R. P., 1955, PROG LOW TEMP PHYS, V1, P17; Ginzburg V.L., 1950, J. Exp. Theor. Phys, V20, P1064, DOI DOI 10.1007/978-3-540-68008-6_4; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; GROSS EP, 1961, NUOVO CIMENTO, V20, P454, DOI 10.1007/BF02731494; KETTERLE W, 2007, ULTRACOLD FERMI GASE, V164; Landau L, 1941, J PHYS-USSR, V5, P71; Landau L. D., 1947, J PHYS USSR, V11, P91; Nygaard N, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.210402; O'Hara KM, 2002, SCIENCE, V298, P2179, DOI 10.1126/science.1079107; Onsager L., 1949, NUOVO CIM, V6, P279, DOI [DOI 10.1007/BF02780991, 10.1007/BF02780991]; Parker NG, 2008, SPRINGER SER ATOM OP, V45, P173; PITAEVSKII LP, 1961, SOV PHYS JETP-USSR, V13, P451; RUNGE E, 1984, PHYS REV LETT, V52, P997, DOI 10.1103/PhysRevLett.52.997; Sensarma R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090403; Tisza L, 1938, NATURE, V141, P913, DOI 10.1038/141913a0; Tonini G, 2006, EUR PHYS J D, V39, P283, DOI 10.1140/epjd/e2006-00110-7; Vinen WF, 2007, PHYS TODAY, V60, P43, DOI 10.1063/1.2731972; Yuzbashyan EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.097005; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	29	63	63	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1288	1291		10.1126/science.1201968	http://dx.doi.org/10.1126/science.1201968			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659597	Green Submitted			2022-12-28	WOS:000291441700036
J	Reinhart, PH; Kelly, JW				Reinhart, Peter H.; Kelly, Jeffery W.			Treating the Periphery to Ameliorate Neurodegenerative Diseases	CELL			English	Editorial Material								Abnormalities in the kynurenine pathway are associated with neurodegenerative disorders. Zwilling et al. (2011) show that inhibition of kynurenine 3-monooxygenase in the body's periphery leads to an increase in kyneuric acid, a neuroprotective compound, in the brain. This intervention ameliorates neurodegeneration in mouse models of Alzheimer's disease and Huntington's disease.	[Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Reinhart, Peter H.] Proteostasis Therapeut Inc, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kelly, JW (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	jkelly@scripps.edu		Reinhart, Peter/0000-0003-0123-7846				Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; Doody Rachelle S, 2011, Alzheimers Dement, V7, P197, DOI 10.1016/j.jalz.2011.01.001; Jacobsen J Steven, 2005, NeuroRx, V2, P612; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Usui K, 2009, P NATL ACAD SCI USA, V106, P18563, DOI 10.1073/pnas.0804758106; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	9	11	11	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					813	814		10.1016/j.cell.2011.05.031	http://dx.doi.org/10.1016/j.cell.2011.05.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663784	Bronze			2022-12-28	WOS:000291461600006
J	Guarente, L				Guarente, Leonard			Sirtuins, Aging, and Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SMALL-MOLECULE ACTIVATORS; FATTY-ACID OXIDATION; CALORIE RESTRICTION; SIRT1 DEACETYLASE; GENE-EXPRESSION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; METABOLIC DISEASE; PROTECTS; LONGEVITY	Populations in developed countries continue to grow older, as medical advances allow baby boomers to march inexorably onward. Many of the most important diseases that lead to disability and death occur late in life, indicating that aging itself is a key risk factor. Recent research into the science of aging has identified genes and pathways that appear to control the aging process. This review describes one such family of antiaging genes, the sirtuins, and details progress in understanding the biology that undergirds their promise as therapeutic targets.	[Guarente, Leonard] MIT, Dept Biol, Cambridge, MA 02139 USA; [Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave,68-280, Cambridge, MA 02139 USA.	leng@mit.edu						Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P283, DOI 10.1517/13543770902755111; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bell EL, 2011, ONCOGENE        0228; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Benigni A, 2009, J CLIN INVEST, V119, P524, DOI 10.1172/JCI36703; Berdichevsky A, 2010, P NATL ACAD SCI USA, V107, P18927, DOI 10.1073/pnas.1013854107; Boily G, 2009, ONCOGENE, V28, P2882, DOI 10.1038/onc.2009.147; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Dai H, 2010, J BIOL CHEM, V285, P32695, DOI 10.1074/jbc.M110.133892; Donmez G, 2010, CELL, V142, P494, DOI 10.1016/j.cell.2010.07.034; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2011, MOL CELL, V41, P139, DOI 10.1016/j.molcel.2011.01.002; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Lefevre M, 2009, ATHEROSCLEROSIS, V203, P206, DOI 10.1016/j.atherosclerosis.2008.05.036; Li L, 2011, ACTA BIOCH BIOPH SIN, V43, P103, DOI 10.1093/abbs/gmq104; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Min SW, 2010, NEURON, V68, P801, DOI 10.1016/j.neuron.2010.11.013; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Ogura M, 2010, BIOCHEM BIOPH RES CO, V393, P73, DOI 10.1016/j.bbrc.2010.01.081; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Picard F, 2004, NATURE, V430, P921, DOI 10.1038/nature02892; Planavila A, 2010, CARDIOVASC RES  1222; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ramadori G, 2010, CELL METAB, V12, P78, DOI 10.1016/j.cmet.2010.05.010; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Ruderman NB, 2010, AM J PHYSIOL-ENDOC M, V298, pE751, DOI 10.1152/ajpendo.00745.2009; Satoh A, 2010, J NEUROSCI, V30, P10220, DOI 10.1523/JNEUROSCI.1385-10.2010; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Szkudelska K, 2010, METABOLISM      0915; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2010, INT J BIOL SCI, V6, P682; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	90	410	440	6	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2235	2244		10.1056/NEJMra1100831	http://dx.doi.org/10.1056/NEJMra1100831			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651395	Green Published			2022-12-28	WOS:000291392100010
J	Donnelly, J; Gizaw, R				Donnelly, John; Gizaw, Rahel			Profile Lomita Bekele: delivering health care to an Ethiopian village	LANCET			English	Biographical-Item												donnellyglobe@gmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2011	377	9781					1911	1911		10.1016/S0140-6736(11)60799-X	http://dx.doi.org/10.1016/S0140-6736(11)60799-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777LW	21641469				2022-12-28	WOS:000291623200015
J	Reif, JH				Reif, John H.			Scaling Up DNA Computation	SCIENCE			English	Editorial Material							MOLECULES		Duke Univ, Dept Comp Sci, Durham, NC 27708 USA	Duke University	Reif, JH (corresponding author), Duke Univ, Dept Comp Sci, Durham, NC 27708 USA.	reif@cs.duke.edu			Direct For Computer & Info Scie & Enginr [0829798] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1141847] Funding Source: National Science Foundation	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Mao CD, 2000, NATURE, V407, P493, DOI 10.1038/35035038; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Qian L, 2009, LECT NOTES COMPUT SC, V5347, P70, DOI 10.1007/978-3-642-03076-5_7; Reif J, 2011, NANOFABRICATION HDB; Sakamoto K, 1999, BIOSYSTEMS, V52, P81, DOI 10.1016/S0303-2647(99)00035-0; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	9	15	17	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1156	1157		10.1126/science.1208068	http://dx.doi.org/10.1126/science.1208068			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636761				2022-12-28	WOS:000291205200033
J	Phan, G; Remaut, H; Wang, T; Allen, WJ; Pirker, KF; Lebedev, A; Henderson, NS; Geibel, S; Volkan, E; Yan, J; Kunze, MBA; Pinkner, JS; Ford, B; Kay, CWM; Li, HL; Hultgren, SJ; Thanassi, DG; Waksman, G				Phan, Gilles; Remaut, Han; Wang, Tao; Allen, William J.; Pirker, Katharina F.; Lebedev, Andrey; Henderson, Nadine S.; Geibel, Sebastian; Volkan, Ender; Yan, Jun; Kunze, Micha B. A.; Pinkner, Jerome S.; Ford, Bradley; Kay, Christopher W. M.; Li, Huilin; Hultgren, Scott J.; Thanassi, David G.; Waksman, Gabriel			Crystal structure of the FimD usher bound to its cognate FimC-FimH substrate	NATURE			English	Article							CHAPERONE-SUBUNIT COMPLEXES; BACTERIAL OUTER-MEMBRANE; PILUS BIOGENESIS; MOLECULAR REPLACEMENT; ADHESIN; RECOGNITION; DOMAIN; SITE	Type 1 pili are the archetypal representative of a widespread class of adhesive multisubunit fibres in Gram-negative bacteria. During pilus assembly, subunits dock as chaperone-bound complexes to an usher, which catalyses their polymerization and mediates pilus translocation across the outer membrane. Here we report the crystal structure of the full-length FimD usher bound to the FimC-FimH chaperone-adhesin complex and that of the unbound form of the FimD translocation domain. The FimD-FimC-FimH structure shows FimH inserted inside the FimD 24-stranded beta-barrel translocation channel. FimC-FimH is held in place through interactions with the two carboxy-terminal periplasmic domains of FimD, a binding mode confirmed in solution by electron paramagnetic resonance spectroscopy. To accommodate FimH, the usher plug domain is displaced from the barrel lumen to the periplasm, concomitant with a marked conformational change in the beta-barrel. The amino-terminal domain of FimD is observed in an ideal position to catalyse incorporation of a newly recruited chaperone-subunit complex. The FimD-FimC-FimH structure provides unique insights into the pilus subunit incorporation cycle, and captures the first view of a protein transporter in the act of secreting its cognate substrate.	[Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] UCL, Inst Struct & Mol Biol, London WC1E 7HX, England; [Phan, Gilles; Remaut, Han; Allen, William J.; Pirker, Katharina F.; Geibel, Sebastian; Yan, Jun; Kunze, Micha B. A.; Kay, Christopher W. M.; Waksman, Gabriel] Univ London Birkbeck Coll, London WC1E 7HX, England; [Remaut, Han] Vrije Univ Brussel VIB, B-1050 Brussels, Belgium; [Wang, Tao; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Lebedev, Andrey] Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Volkan, Ender; Pinkner, Jerome S.; Ford, Bradley; Hultgren, Scott J.] Washington Univ, Sch Med, Ctr Womens Infect Dis Res, St Louis, MO 63110 USA; [Ford, Bradley] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kay, Christopher W. M.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Kay, Christopher W. M.; Waksman, Gabriel] UCL, Res Dept Struct & Mol Biol, London WC1E 6BT, England; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; United States Department of Energy (DOE); Brookhaven National Laboratory; University of York - UK; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; University of London; University College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Waksman, G (corresponding author), UCL, Inst Struct & Mol Biol, Malet St, London WC1E 7HX, England.	david.thanassi@stonybrook.edu; g.waksman@ucl.ac.uk	VOLKAN, ENDER/GRF-1572-2022; Kay, Christopher William Michael/C-2467-2008; VOLKAN, ENDER/ABI-7302-2020; Geibel, Sebastian/B-5607-2015; VOLKAN, ENDER/AAJ-4583-2021	Kay, Christopher William Michael/0000-0002-5200-6004; Geibel, Sebastian/0000-0003-0068-680X; VOLKAN, ENDER/0000-0002-0071-5028; Frederiksen, Jun/0000-0003-0764-1831; Ford, Bradley/0000-0002-7871-7955; Remaut, Han/0000-0002-9775-4102; Kunze, Micha/0000-0001-8922-5510; Li, Huilin/0000-0001-8085-8928; Pinkner, Jerome/0000-0002-7389-7440	Medical Research Council [85602]; NIH [GM62987, 49950, 29549, 48689, GM74985]; BNL [10-16]; VIB; FWO-Vlaanderen; Austrian Science Fund [J 2959-N17]; Biotechnology and Biological Sciences Research Council [BB/F001134/1] Funding Source: researchfish; Medical Research Council [G0800002, G0100442] Funding Source: researchfish; BBSRC [BB/F001134/1] Funding Source: UKRI; MRC [G0800002, G0100442] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987, R01GM074985] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BNL; VIB; FWO-Vlaanderen(FWO); Austrian Science Fund(Austrian Science Fund (FWF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by Medical Research Council grant 85602 to G.W., NIH grant GM62987 to D.G.T., NIH grants 49950, 29549 and 48689 to S.J.H., and NIH grant GM74985 and BNL LDRD grant 10-16 to H.L.; H.R. is supported by a VIB Young PI project grant and the Odysseus program of the FWO-Vlaanderen. K.F.P. is supported by a Schrodinger Fellowship from the Austrian Science Fund, project J 2959-N17. We thank the staff of beamlines X25 and X29 at NSLS, the staff of beamline ID23-1 at ESRF, N. Cronin for technical assistance during data collection, and H. Saibil and E. Orlova for comments on the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barnhart MM, 2000, P NATL ACAD SCI USA, V97, P7709, DOI 10.1073/pnas.130183897; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Eidam O, 2008, FEBS LETT, V582, P651, DOI 10.1016/j.febslet.2008.01.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ford B, 2010, J BACTERIOL, V192, P1824, DOI 10.1128/JB.01677-09; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Le Trong I, 2010, CELL, V141, P645, DOI 10.1016/j.cell.2010.03.038; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li QQ, 2010, MOL MICROBIOL, V76, P159, DOI 10.1111/j.1365-2958.2010.07089.x; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Munera D, 2007, MOL MICROBIOL, V64, P333, DOI 10.1111/j.1365-2958.2007.05657.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pinkner JS, 2006, P NATL ACAD SCI USA, V103, P17897, DOI 10.1073/pnas.0606795103; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Remaut H, 2006, MOL CELL, V22, P831, DOI 10.1016/j.molcel.2006.05.033; Rose RJ, 2008, P NATL ACAD SCI USA, V105, P12873, DOI 10.1073/pnas.0802177105; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Verger D, 2008, STRUCTURE, V16, P1724, DOI 10.1016/j.str.2008.08.012; Verger D, 2006, EMBO REP, V7, P1228, DOI 10.1038/sj.embor.7400833; Vetsch M, 2004, NATURE, V431, P329, DOI 10.1038/nature02891; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	44	137	138	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					49	U71		10.1038/nature10109	http://dx.doi.org/10.1038/nature10109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637253	Green Accepted			2022-12-28	WOS:000291156700034
J	Pederson, GT; Gray, ST; Woodhouse, CA; Betancourt, JL; Fagre, DB; Littell, JS; Watson, E; Luckman, BH; Graumlich, LJ				Pederson, Gregory T.; Gray, Stephen T.; Woodhouse, Connie A.; Betancourt, Julio L.; Fagre, Daniel B.; Littell, Jeremy S.; Watson, Emma; Luckman, Brian H.; Graumlich, Lisa J.			The Unusual Nature of Recent Snowpack Declines in the North American Cordillera	SCIENCE			English	Article							TEMPERATURE VARIABILITY; CLIMATE-CHANGE; WESTERN; PRECIPITATION; EARLIER; DROUGHT	In western North America, snowpack has declined in recent decades, and further losses are projected through the 21st century. Here, we evaluate the uniqueness of recent declines using snowpack reconstructions from 66 tree-ring chronologies in key runoff-generating areas of the Colorado, Columbia, and Missouri River drainages. Over the past millennium, late 20th century snowpack reductions are almost unprecedented in magnitude across the northern Rocky Mountains and in their north-south synchrony across the cordillera. Both the snowpack declines and their synchrony result from unparalleled springtime warming that is due to positive reinforcement of the anthropogenic warming by decadal variability. The increasing role of warming on large-scale snowpack variability and trends foreshadows fundamental impacts on streamflow and water supplies across the western United States.	[Pederson, Gregory T.; Fagre, Daniel B.] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT 59715 USA; [Pederson, Gregory T.] Univ Arizona, Sch Nat Resources, Tucson, AZ 85721 USA; [Pederson, Gregory T.; Gray, Stephen T.; Woodhouse, Connie A.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA; [Gray, Stephen T.] Univ Wyoming, Dept Civil & Architectural Engn, Laramie, WY 82071 USA; [Woodhouse, Connie A.] Univ Arizona, Sch Geog & Dev, Tucson, AZ 85721 USA; [Betancourt, Julio L.] USGS, Natl Res Program, Div Water Resources, Tucson, AZ 85719 USA; [Littell, Jeremy S.] Univ Washington, Climate Impacts Grp, Seattle, WA 98195 USA; [Watson, Emma; Luckman, Brian H.] Univ Western Ontario, Dept Geog, London, ON N6A 5C2, Canada; [Graumlich, Lisa J.] Univ Washington, Coll Environm, Seattle, WA 98195 USA	United States Department of the Interior; United States Geological Survey; University of Arizona; University of Arizona; University of Wyoming; University of Arizona; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; Western University (University of Western Ontario); University of Washington; University of Washington Seattle	Pederson, GT (corresponding author), US Geol Survey, No Rocky Mt Sci Ctr, 2327 Univ Way,Suite 2, Bozeman, MT 59715 USA.	gpederson@usgs.gov	Graumlich, Lisa/A-1421-2012	Graumlich, Lisa/0000-0003-1239-1873	USGS Western Mountain Initiative; NSF [GSS-0620793, DEB-0734277, 980931, 9729571]; USGS; Denver Water Board; Joint Institute for the Study of the Atmosphere and Ocean under National Oceanic and Atmospheric Administration (NOAA) [NA17RJ1232, 1856]; NOAA [NA07OAR4310371]; Natural Sciences and Engineering Research Council of Canada [8847]	USGS Western Mountain Initiative; NSF(National Science Foundation (NSF)); USGS(United States Geological Survey); Denver Water Board; Joint Institute for the Study of the Atmosphere and Ocean under National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank S. Laursen for project assistance; G. McCabe and D. McWethey for helpful comments; and T. Chesley-Preston (USGS), L. Clampitt (USGS), S. Moore [Environmental Systems Research Institute (ESRI)], B. Ralston (ESRI), and L. Saunders (ESRI) for assistance building animations and Web-mapping tools for the snowpack database. We give a special thanks to contributors to the International Tree Ring Databank and M. Colenutt, D. Meko, and T. Knight for the invaluable tree-ring records. This research was financially supported in part by the USGS Western Mountain Initiative and NSF (grants GSS-0620793 and DEB-0734277). C. A. W. was supported by NSF (grants 980931 and 9729571), USGS Earth Surface Dynamics Program, and the Denver Water Board. J.S.L was supported by the Joint Institute for the Study of the Atmosphere and Ocean under National Oceanic and Atmospheric Administration (NOAA) Cooperative Agreement NA17RJ1232 (contribution 1856) and NOAA Climate Program Office Sector Applications Research Program (grant NA07OAR4310371). B. H. L was supported by the Natural Sciences and Engineering Research Council of Canada (grant 8847). Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U. S. government. G. T. P, S. T. G, C. A. W., and L.J.G planned the project, contributed data, and designed and participated in the data analyses and writing of the paper. G. T. P and S. T. G. conducted all the analyses. J.L.B. and D. B. F. contributed substantially to the analysis design and writing of the paper. J.S.L, E. W., and B. H. L provided critical northern cordilleran tree-ring chronologies and contributed to the writing of the paper. Reprints and permissions information is available online at www.sciencemag.org/site/about/permissions.xhtml. The authors declare no competing financial interests. All of the snowpack reconstructions and tree-ring chronologies used to generate them are available online at the World Data Center for Paleoclimatology in Boulder, Colorado, USA (www.ncdc.noaa.gov/paleo/pubs/pederson2011/pederson2011.html) and from the USGS Northern Rocky Mountain Science Center in Bozeman, Montana, USA (www.nrmsc.usgs.gov/NorthAmerSnowpack/).	Abatzoglou JT, 2011, INT J CLIMATOL, V31, P1135, DOI 10.1002/joc.2137; Ault TR, 2011, J CLIMATE, V24, P4003, DOI 10.1175/2011JCLI4069.1; Bales RC, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004387; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Brown DP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018726; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Dettinger MD, 1998, J CLIMATE, V11, P3095, DOI 10.1175/1520-0442(1998)011<3095:NSPPIW>2.0.CO;2; Flanner MG, 2011, NAT GEOSCI, V4, P151, DOI 10.1038/NGEO1062; GRAUMLICH LJ, 1987, ANN ASSOC AM GEOGR, V77, P19, DOI 10.1111/j.1467-8306.1987.tb00142.x; Hauer FR, 1997, HYDROL PROCESS, V11, P903; Kitzberger T, 2007, P NATL ACAD SCI USA, V104, P543, DOI 10.1073/pnas.0606078104; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Luckman BH, 2005, CLIM DYNAM, V24, P131, DOI 10.1007/s00382-004-0511-0; Luckman BH, 2000, GEOMORPHOLOGY, V32, P357, DOI 10.1016/S0169-555X(99)00104-X; McCabe GJ, 2008, QUATERN INT, V188, P31, DOI 10.1016/j.quaint.2007.07.001; McCabe GJ, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI283.1; Meko DM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029988; Milly PCD, 2008, SCIENCE, V319, P573, DOI 10.1126/science.1151915; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Peterson DW, 2001, ECOLOGY, V82, P3330, DOI 10.1890/0012-9658(2001)082[3330:MHGRTC]2.0.CO;2; Salzer MW, 2005, CLIMATIC CHANGE, V70, P465, DOI 10.1007/s10584-005-5922-3; Schwartz MD, 2006, GLOBAL CHANGE BIOL, V12, P343, DOI 10.1111/j.1365-2486.2005.01097.x; Solomon S., 2007, PHYS SCI BASIS WORKI; Stahle DW, 2007, CLIMATIC CHANGE, V83, P133, DOI 10.1007/s10584-006-9171-x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wilson R, 2007, CLIM DYNAM, V28, P425, DOI 10.1007/s00382-006-0194-9; Woodhouse CA, 2009, J CLIMATE, V22, P4336, DOI 10.1175/2009JCLI2705.1; Woodhouse CA, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004455; Woodhouse CA, 2003, J CLIMATE, V16, P1551, DOI 10.1175/1520-0442-16.10.1551; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	31	247	253	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					332	335		10.1126/science.1201570	http://dx.doi.org/10.1126/science.1201570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21659569				2022-12-28	WOS:000292732000040
J	Garner, EC; Bernard, R; Wang, WQ; Zhuang, XW; Rudner, DZ; Mitchison, T				Garner, Ethan C.; Bernard, Remi; Wang, Wenqin; Zhuang, Xiaowei; Rudner, David Z.; Mitchison, Tim			Coupled, Circumferential Motions of the Cell Wall Synthesis Machinery and MreB Filaments in B. subtilis	SCIENCE			English	Article							ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; CYTOSKELETON; MORPHOGENESIS; SHAPE; MBL; LOCALIZATION; SEGREGATION	Rod-shaped bacteria elongate by the action of cell wall synthesis complexes linked to underlying dynamic MreB filaments. To understand how the movements of these filaments relate to cell wall synthesis, we characterized the dynamics of MreB and the cell wall elongation machinery using high-precision particle tracking in Bacillus subtilis. We found that MreB and the elongation machinery moved circumferentially around the cell, perpendicular to its length, with nearby synthesis complexes and MreB filaments moving independently in both directions. Inhibition of cell wall synthesis by various methods blocked the movement of MreB. Thus, bacteria elongate by the uncoordinated, circumferential movements of synthetic complexes that insert radial hoops of new peptidoglycan during their transit, possibly driving the motion of the underlying MreB filaments.	[Garner, Ethan C.; Mitchison, Tim] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Bernard, Remi; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Wang, Wenqin; Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Garner, EC (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	ethan.garner@hms.harvard.edu; zhuang@chemistry.harvard.edu; rudner@hms.harvard.edu; timothy_mitchison@hms.harvard.edu	Garner, Ethan/J-4025-2014; Wang, Wenqin/E-9418-2012	Garner, Ethan/0000-0003-0141-3555; 	NIH [R01-GM073831, R01-GM096450, R01-GM39565]; Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096450, R01GM039565, R01GM073831] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Graumman, J. Errington, R. Carballido-Lopez, D. Kearns, D. Popham, and D. Scheffers for strains; D. Kahne, S. Walker, T. Bernhardt, and T. Uehara for discussions; Q. Justman for editing; S. Layer for inspiration; T. Emonet for MicrobeTracker; and the HMS Nikon Imaging Center for the use of their facilites. Funding was provided by NIH grants R01-GM073831 (D.Z.R.), R01-GM096450 (X.Z.), and R01-GM39565 (T.M.). X.Z. is a Howard Hughes Medical Investigator. E.C.G. was supported by the Helen Hay Whitney Foundation.	Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Hayhurst EJ, 2008, P NATL ACAD SCI USA, V105, P14603, DOI 10.1073/pnas.0804138105; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kawai Y, 2009, MOL MICROBIOL, V73, P719, DOI 10.1111/j.1365-2958.2009.06805.x; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Mayer JA, 2009, CELL MOTIL CYTOSKEL, V66, P109, DOI 10.1002/cm.20332; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2003, CURR BIOL, V13, P1916, DOI 10.1016/j.cub.2003.10.024; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x	19	374	379	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					222	225		10.1126/science.1203285	http://dx.doi.org/10.1126/science.1203285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636745	Green Accepted			2022-12-28	WOS:000292502700050
J	Levan, AJ; Tanvir, NR; Cenko, SB; Perley, DA; Wiersema, K; Bloom, JS; Fruchter, AS; Postigo, AD; O'Brien, PT; Butler, N; van der Horst, AJ; Leloudas, G; Morgan, AN; Misra, K; Bower, GC; Farihi, J; Tunnicliffe, RL; Modjaz, M; Silverman, JM; Hjorth, J; Thone, C; Cucchiara, A; Ceron, JMC; Castro-Tirado, AJ; Arnold, JA; Bremer, M; Brodie, JP; Carroll, T; Cooper, MC; Curran, PA; Cutri, RM; Ehle, J; Forbes, D; Fynbo, J; Gorosabel, J; Graham, J; Hoffman, DI; Guziy, S; Jakobsson, P; Kamble, A; Kerr, T; Kasliwal, MM; Kouveliotou, C; Kocevski, D; Law, NM; Nugent, PE; Ofek, EO; Poznanski, D; Quimby, RM; Rol, E; Romanowsky, AJ; Sanchez-Ramirez, R; Schulze, S; Singh, N; van Spaandonk, L; Starling, RLC; Strom, RG; Tello, JC; Vaduvescu, O; Wheatley, PJ; Wijers, RAMJ; Winters, JM; Xu, D				Levan, A. J.; Tanvir, N. R.; Cenko, S. B.; Perley, D. A.; Wiersema, K.; Bloom, J. S.; Fruchter, A. S.; Postigo, A. de Ugarte; O'Brien, P. T.; Butler, N.; van der Horst, A. J.; Leloudas, G.; Morgan, A. N.; Misra, K.; Bower, G. C.; Farihi, J.; Tunnicliffe, R. L.; Modjaz, M.; Silverman, J. M.; Hjorth, J.; Thoene, C.; Cucchiara, A.; Ceron, J. M. Castro; Castro-Tirado, A. J.; Arnold, J. A.; Bremer, M.; Brodie, J. P.; Carroll, T.; Cooper, M. C.; Curran, P. A.; Cutri, R. M.; Ehle, J.; Forbes, D.; Fynbo, J.; Gorosabel, J.; Graham, J.; Hoffman, D. I.; Guziy, S.; Jakobsson, P.; Kamble, A.; Kerr, T.; Kasliwal, M. M.; Kouveliotou, C.; Kocevski, D.; Law, N. M.; Nugent, P. E.; Ofek, E. O.; Poznanski, D.; Quimby, R. M.; Rol, E.; Romanowsky, A. J.; Sanchez-Ramirez, R.; Schulze, S.; Singh, N.; van Spaandonk, L.; Starling, R. L. C.; Strom, R. G.; Tello, J. C.; Vaduvescu, O.; Wheatley, P. J.; Wijers, R. A. M. J.; Winters, J. M.; Xu, D.			An Extremely Luminous Panchromatic Outburst from the Nucleus of a Distant Galaxy	SCIENCE			English	Article							GAMMA-RAY BURST; SWIFT-ERA	Variable x-ray and gamma-ray emission is characteristic of the most extreme physical processes in the universe. We present multiwavelength observations of a unique gamma-ray-selected transient detected by the Swift satellite, accompanied by bright emission across the electromagnetic spectrum, and whose properties are unlike any previously observed source. We pinpoint the event to the center of a small, star-forming galaxy at redshift z = 0.3534. Its high-energy emission has lasted much longer than any gamma-ray burst, whereas its peak luminosity was similar to 100 times higher than bright active galactic nuclei. The association of the outburst with the center of its host galaxy suggests that this phenomenon has its origin in a rare mechanism involving the massive black hole in the nucleus of that galaxy.	[Levan, A. J.; Tunnicliffe, R. L.; van Spaandonk, L.; Wheatley, P. J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Tanvir, N. R.; Wiersema, K.; O'Brien, P. T.; Farihi, J.; Starling, R. L. C.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Perley, D. A.; Bloom, J. S.; Butler, N.; Morgan, A. N.; Bower, G. C.; Silverman, J. M.; Cucchiara, A.; Nugent, P. E.; Poznanski, D.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Fruchter, A. S.; Misra, K.; Graham, J.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Postigo, A. de Ugarte; Leloudas, G.; Hjorth, J.; Fynbo, J.] Univ Copenhagen, Dark Cosmol Ctr, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [van der Horst, A. J.] Univ Space Res Assoc, Natl Space Sci & Technol Ctr, Huntsville, AL 35805 USA; [Modjaz, M.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10024 USA; [Thoene, C.; Castro-Tirado, A. J.; Gorosabel, J.; Guziy, S.; Sanchez-Ramirez, R.; Tello, J. C.] Consejo Super Invest Cient IAA CSIC, Inst Astrofis Andalucia, E-18008 Granada, Spain; [Ceron, J. M. Castro] European Space Agcy, European Space Astron Ctr, Herschel Sci Operat Ctr, Madrid 28691, Spain; [Arnold, J. A.; Brodie, J. P.; Kocevski, D.; Romanowsky, A. J.; Singh, N.] Univ Calif Santa Cruz, Lick Observ, Univ Calif Observ, Santa Cruz, CA 95064 USA; [Bremer, M.; Winters, J. M.] Inst RadioAstron Millimetr, F-38406 St Martin Dheres, France; [Carroll, T.; Ehle, J.; Kerr, T.] Joint Astron Ctr, Hilo, HI 96720 USA; [Cooper, M. C.] Univ Calif Irvine, Ctr Galaxy Evolut, Irvine, CA 92697 USA; [Curran, P. A.] Ctr Saclay, Irfu Serv Astrophys, Direct Sci Mat CNRS, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France; [Cutri, R. M.; Hoffman, D. I.] CALTECH, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Forbes, D.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Graham, J.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Kasliwal, M. M.; Ofek, E. O.; Quimby, R. M.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Jakobsson, P.; Schulze, S.] Univ Iceland, Inst Sci, Ctr Astrophys & Cosmol, IS-107 Reykjavik, Iceland; [Kamble, A.] Univ Wisconsin, Ctr Gravitat & Cosmol, Milwaukee, WI 53211 USA; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, Space Sci Off, Huntsville, AL 35812 USA; [Law, N. M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Nugent, P. E.; Poznanski, D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Computat Cosmol Ctr, Berkeley, CA 94720 USA; [Rol, E.; Strom, R. G.; Wijers, R. A. M. J.] Univ Amsterdam, Astron Inst, NL-1098 XH Amsterdam, Netherlands; [Singh, N.] Natl Univ Ireland, Ctr Astron, Galway, Ireland; [van Spaandonk, L.] Univ Hertfordshire, Ctr Astrophys Res, Sci & Technol Res Inst, Hatfield AL10 9AB, Herts, England; [Strom, R. G.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Vaduvescu, O.] Isaac Newton Grp Telescopes, E-38700 Santa Cruz De La Palma, Canary Islands, Spain; [Xu, D.] Weizmann Inst Sci, Fac Phys, Benoziyo Ctr Astrophys, IL-76100 Rehovot, Israel	University of Warwick; University of Leicester; University of California System; University of California Berkeley; Space Telescope Science Institute; University of Copenhagen; Niels Bohr Institute; Universities Space Research Association (USRA); Columbia University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); European Space Agency; University of California System; University of California Santa Cruz; University of California System; University of California Irvine; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); California Institute of Technology; Swinburne University of Technology; Johns Hopkins University; California Institute of Technology; University of Iceland; University of Wisconsin System; University of Wisconsin Milwaukee; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Amsterdam; Ollscoil na Gaillimhe-University of Galway; University of Hertfordshire; Isaac Newton Group of Telescopes; Weizmann Institute of Science	Levan, AJ (corresponding author), Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England.	a.j.levan@warwick.ac.uk	Bower, Geoffrey/ABC-8386-2020; Curran, Peter A/B-5293-2013; Nugent, Peter Edward/AGG-8472-2022; Jakobsson, Pall/L-9950-2015; Fynbo, Johan P. U./L-8496-2014; Guziy, Sergiy/HGC-0149-2022; Vaduvescu, Ovidiu/GYJ-3429-2022; Forbes, Duncan/AAG-8594-2019; Hjorth, Jens/M-5787-2014; Levan, Andrew/F-6179-2014; Thone, Christina/Q-3938-2017; Leloudas, Giorgos/E-4470-2015	Bower, Geoffrey/0000-0003-4056-9982; Curran, Peter A/0000-0003-3003-4626; Jakobsson, Pall/0000-0002-9404-5650; Fynbo, Johan P. U./0000-0002-8149-8298; Hjorth, Jens/0000-0002-4571-2306; Kasliwal, Tamay/0000-0001-5634-7167; Sanchez-Ramirez, Ruben/0000-0002-7158-5099; Levan, Andrew/0000-0001-7821-9369; Wijers, Ralph/0000-0002-3101-1808; Wheatley, Peter/0000-0003-1452-2240; Schulze, Steve/0000-0001-6797-1889; Fruchter, Andrew/0000-0002-6652-9279; de Ugarte Postigo, Antonio/0000-0001-7717-5085; Nugent, Peter/0000-0002-3389-0586; van der Horst, Alexander/0000-0001-9149-6707; Castro-Tirado, A. J./0000-0003-2999-3563; Poznanski, Dovi/0000-0003-1470-7173; Bloom, Joshua/0000-0002-7777-216X; Wiersema, Klaas/0000-0002-9133-7957; O'Brien, Paul/0000-0002-5128-1899; Thone, Christina/0000-0002-7978-7648; Rol, Evert/0000-0001-8357-4453; Cutri, Roc/0000-0002-0077-2305; Leloudas, Giorgos/0000-0002-8597-0756; Farihi, Jay/0000-0003-1748-602X	Science and Technology Facilities Council. Swift; NASA mission in partnership with the Italian Space Agency and the UK Space Agency; NASA/Swift [NNX10AI21G]; NASA/Fermi [NNX1OA057G]; NSF [AST-0908886, AST-0808099, AST-0909237, AST-1008353]; NASA [NNH07ZDA001-GLAST, NAS5-26555]; Carlsberg foundation; Hubble Fellowship [HST-HF-51277.01-A]; Space Telescope Science Institute (STScI); Danish National Research Foundation; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Netherlands Foundation for Scientific Research; Institut National des Sciences de l'Univers/CNRS (France); Max-Planck-Gesellschaft (Germany); Instituto Geografico Nacional (Spain); W.M. Keck Foundation; Spanish programs [AYA-2007-63677, AYA-2008-03467/ESP, AYA-2009-14000-C03-01]; Royal Society; Spanish Ministry of Science and Innovation [AYA2008-03467/ESP, AYA2009-14000-C03-01]; European Research Council [247295]; Commonwealth of Australia; STFC [ST/H001972/1, ST/I005773/1, PP/E002064/1, ST/I001719/1, ST/F002599/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I005773/1, ST/I001719/1, ST/F002599/1, PP/E002064/1, ST/H001972/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [1009991] Funding Source: National Science Foundation; Division Of Astronomical Sciences [0908886] Funding Source: National Science Foundation	Science and Technology Facilities Council. Swift; NASA mission in partnership with the Italian Space Agency and the UK Space Agency; NASA/Swift(National Aeronautics & Space Administration (NASA)); NASA/Fermi(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Carlsberg foundation(Carlsberg Foundation); Hubble Fellowship; Space Telescope Science Institute (STScI)(Space Telescope Science Institute); Danish National Research Foundation(Danmarks Grundforskningsfond); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Netherlands Foundation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Institut National des Sciences de l'Univers/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Max-Planck-Gesellschaft (Germany)(Max Planck Society); Instituto Geografico Nacional (Spain); W.M. Keck Foundation(W.M. Keck Foundation); Spanish programs; Royal Society(Royal Society of London); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Council(European Research Council (ERC)European Commission); Commonwealth of Australia(Australian Government); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We gratefully acknowledge the efforts of the many observatories whose data are presented here. We particularly thank D. Malesani for assistance in the calibration of the optical photometry, M. Irwin for assistance with processing the UKIRT data, D. Fox for help with the PTF data, and K. Hurley and J. Prochaska for assistance in obtaining the Keck data. A.J.L. and N.R.T. acknowledge support from the Science and Technology Facilities Council. Swift, launched in November 2004, is a NASA mission in partnership with the Italian Space Agency and the UK Space Agency. Swift is managed by NASA Goddard. Pennsylvania State University controls science and flight operations from the Mission Operations Center in University Park, Pennsylvania. Los Alamos National Laboratory provides gamma-ray imaging analysis. S.B.C. acknowledges generous support from G. Bengier and C. Bengier, the Richard and Rhoda Goldman Fund, NASA/Swift grant NNX10AI21G, NASA/Fermi grant NNX1OA057G, and NSF grant AST-0908886. A.J.vdH. was supported by NASA grant NNH07ZDA001-GLAST. G.L. is supported by a grant from the Carlsberg foundation. M.M. is supported by the Hubble Fellowship grant HST-HF-51277.01-A, awarded by the The Space Telescope Science Institute (STScI), which is operated by AURA under NASA contract NAS5-26555. The Dark Cosmology Centre is funded by the Danish National Research Foundation. This work makes use of data obtained by the Chandra X-ray Observatory (OBSID = 12920). This work is based on observations made with the NASA/ESA Hubble Space Telescope (program ID 12447), obtained from the data archive at the Space Telescope Institute. STScI is operated by the association of Universities for Research in Astronomy under the NASA contract NAS 5-26555. This work is also based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (United States), the Science and Technology Facilities Council (UK), the National Research Council (Canada), Consejo Nacional de Investigaciones Cientificas y Tecnicas (Chile), the Australian Research Council (Australia), Ministerio da Ciencia e Tecnologia (Brazil), and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina). The UK Infrared Telescope is operated by the Joint Astronomy Centre on behalf of the Science and Technology Facilities Council of the UK. UKIRT data were processed by the Cambridge Astronomical Survey Unit. This work is also based on observations made with the Nordic Optical Telescope, operated on the island of La Palma jointly by Denmark, Finland, Iceland, Norway, and Sweden, in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. This work is also based on observations made with the GTC and on observations obtained with the Samuel Oschin Telescope at the Palomar Observatory as part of the Palomar Transient Factory project. The National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231, provided staff, computational resources, and data storage for this project. The WHT is operated on the island of La Palma by the Isaac Newton Group in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias.; This work is also based on observations made with the Italian Telescopio Nazionale Galileo operated on the island of La Palma by the Fundacion Glileo Galilei of the INAF (Istituto Nazionale di Astrofisica) at the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias. The WSRT is operated by ASTRON, with support from the Netherlands Foundation for Scientific Research. This work is also based on observations carried out with the IRAM Plateau de Bure Interferometer. IRAM is supported by Institut National des Sciences de l'Univers/CNRS (France), Max-Planck-Gesellschaft (Germany), and Instituto Geografico Nacional (Spain). Some of the data presented here were obtained at the W.M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California, and NASA. The Observatory was made possible by the generous financial support of the W.M. Keck Foundation. J.G., A.J.C.T., R.S.R., and S.G. are partially supported by the Spanish programs AYA-2007-63677, AYA-2008-03467/ESP, and AYA-2009-14000-C03-01. R.L.C.S. is supported by a Royal Society Fellowship. We acknowledge support by the Spanish Ministry of Science and Innovation under project grants AYA2008-03467/ESP and AYA2009-14000-C03-01 (including Feder funds). J.P.B. and A.J.R. were supported by the NSF through grants AST-0808099 and AST-0909237. A.N.M. gratefully acknowledges support from a NSF Graduate Research Fellowship. A.P.K. is partially supported by NSF award AST-1008353. R.A.M.J.W. acknowledges support from the European Research Council via Advanced Investigator grant 247295. We acknowledge access to the major research facilities program supported by the Commonwealth of Australia under the International Science Linkages program. N.B. and C.P. are NASA Einstein Fellows. M.C.C. is a Hubble Fellow. Data used in this paper are presented in the SOM or taken from the literature as cited.	Aharonian F, 2005, SCIENCE, V309, P746, DOI 10.1126/science.1113764; BARTHELMY SD, 2011, GRB COORD NETWORK, P1; Bennert VN, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/2/59; BLOOM J, 2011, SCIENCE, V333; BRUNTHALER A, 2011, GRB COORD NETWORK, P1; CENKO SB, 2011, GRB COORD NETWORK, P1; CUMMINGS JC, 2011, GRB COORD NETWORK, P1; Donnarumma I, 2009, ASTROPHYS J LETT, V691, pL13, DOI 10.1088/0004-637X/691/1/L13; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; Gehrels N, 2009, ANNU REV ASTRON ASTR, V47, P567, DOI 10.1146/annurev.astro.46.060407.145147; Hjorth J, 2003, NATURE, V423, P847, DOI 10.1038/nature01750; Ho LC, 2009, ASTROPHYS J, V699, P626, DOI 10.1088/0004-637X/699/1/626; Just DW, 2007, ASTROPHYS J, V665, P1004, DOI 10.1086/519990; Kann DA, 2010, ASTROPHYS J, V720, P1513, DOI 10.1088/0004-637X/720/2/1513; Komossa S, 2004, ASTROPHYS J, V603, pL17, DOI 10.1086/382046; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; Kouveliotou C, 2004, ASTROPHYS J, V608, P872, DOI 10.1086/420878; Krimm H. A., 2011, GRB COORDINATES NETW, V350, P1; LELOUDAS G, 2011, GRB COORD NETWORK, P1; Levan A. J., 2011, GCN, V11886, P1; Nousek JA, 2006, ASTROPHYS J, V642, P389, DOI 10.1086/500724; Pineau FX, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015141; PREDEHL P, 1995, ASTRON ASTROPHYS, V293, P889; Sakamoto T., 2011, GCN, V12561, P1; THOENE C, 2011, GRB COORD NETWORK, P1; Ueda Y, 2003, ASTROPHYS J, V598, P886, DOI 10.1086/378940; Woosley SE, 2006, ANNU REV ASTRON ASTR, V44, P507, DOI 10.1146/annurev.astro.43.072103.150558; ZAUDERER A, 2011, GRB COORD NETWORK, P1	28	256	258	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					199	202		10.1126/science.1207143	http://dx.doi.org/10.1126/science.1207143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21680811	Green Submitted, Green Accepted			2022-12-28	WOS:000292502700043
J	Sherman, RB; Woodcock, J; Norden, J; Grandinetti, C; Temple, RJ				Sherman, Rachel Behrman; Woodcock, Janet; Norden, Janet; Grandinetti, Cheryl; Temple, Robert J.			New FDA Regulation to Improve Safety Reporting in Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sherman, Rachel Behrman; Norden, Janet; Grandinetti, Cheryl] US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Sherman, RB (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Med Policy, Silver Spring, MD USA.							[Anonymous], 1995, E2A ICH; Crowe BJ, 2009, CLIN TRIALS, V6, P430, DOI 10.1177/1740774509344101; *CTR DRUG EV RES, GUID IND INV SAF REP; Food and Drug Administration HHS, 2010, Fed Regist, V75, P59935	4	33	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	2011	365	1					3	5		10.1056/NEJMp1103464	http://dx.doi.org/10.1056/NEJMp1103464			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	788QL	21651388				2022-12-28	WOS:000292459400002
J	Chow, BY; Boyden, ES				Chow, Brian Y.; Boyden, Edward S.			Synthetic Physiology	SCIENCE			English	Editorial Material							PROTEIN INTERACTIONS; LIGHT; INDUCTION		[Chow, Brian Y.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; MIT, Media Lab, McGovern Inst, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	University of Pennsylvania; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Chow, BY (corresponding author), Univ Penn, Dept Bioengn, 210 S 33rd St, Philadelphia, PA 19104 USA.	esb@media.mit.edu		Klapoetke, Nathan/0000-0002-3270-1966	NINDS NIH HHS [R01 NS075421] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075421] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Boyden E. S., 2011, F1000 BIOL REP, V3; Endy D, 2001, NATURE, V409, P391, DOI 10.1038/35053181; Han X, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00018; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Moglich A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1286, DOI 10.1039/c0pp00167h; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535	14	6	6	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1508	1509		10.1126/science.1208555	http://dx.doi.org/10.1126/science.1208555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700858	Green Submitted, Green Accepted			2022-12-28	WOS:000291990000027
J	Siomi, H; Siomi, MC				Siomi, Haruhiko; Siomi, Mikiko C.			Stress Signaling Etches Heritable Marks on Chromatin	CELL			English	Editorial Material							GENOME	Transgenerational inheritance of epigenetic states allows organisms to pass on adaptive responses to the environment to their offspring. Seong et al. (2011) now reveal how stress- induced signaling through dATF-2 disrupts heterochromatin and leaves heritable marks that influence patterns of gene expression in subsequent generations.	[Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan	Keio University	Siomi, H (corresponding author), Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	awa403@z2.keio.jp	Siomi, Haruhiko/A-7020-2015	Siomi, Haruhiko/0000-0001-8690-3822				Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Koonin EV, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-42; Martienssen R, 2008, NEW PHYTOL, V179, P570, DOI 10.1111/j.1469-8137.2008.02567.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	10	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1005	1007		10.1016/j.cell.2011.06.009	http://dx.doi.org/10.1016/j.cell.2011.06.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703443	Bronze			2022-12-28	WOS:000292025700006
J	Elley, CR; Kerse, N				Elley, C. Raina; Kerse, Ngaire			The Cardiovascular Health Awareness Program reduced CV hospitalizations but not mortality in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Elley, C. Raina; Kerse, Ngaire] Univ Auckland, Auckland 1, New Zealand	University of Auckland	Elley, CR (corresponding author), Univ Auckland, Auckland 1, New Zealand.		Kerse, Ngaire/AFF-8119-2022					Cole JA, 2010, CARDIOL RES PRACT, V2011; Ebrahim S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Ploeg Jenny, 2005, Can Fam Physician, V51, P1244	3	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-3	10.7326/0003-4819-154-12-201106210-02003	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690581				2022-12-28	WOS:000291800500002
J	Singh, S; Loke, YK; Enright, PL; Furberg, CD				Singh, Sonal; Loke, Yoon K.; Enright, Paul L.; Furberg, Curt D.			Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CARDIOVASCULAR-DISEASE; COPD; IPRATROPIUM; DEATH; RISK	Objective To systematically review the risk of mortality associated with long term use of tiotropium delivered using a mist inhaler for symptomatic improvement in chronic obstructive pulmonary disease. Data sources Medline, Embase, the pharmaceutical company clinical trials register, the US Food and Drug Administration website, and ClinicalTrials.gov for randomised controlled trials from inception to July 2010. Study selection Trials were selected for inclusion if they were parallel group randomised controlled trials of tiotropium solution using a mist inhaler (Respimat Soft Mist Inhaler, Boehringer Ingelheim) versus placebo for chronic obstructive pulmonary disease; the treatment duration was more than 30 days, and they reported data on mortality. Relative risks of all cause mortality were estimated using a fixed effect meta-analysis, and heterogeneity was assessed with the I-2 statistic. Results Five randomised controlled trials were eligible for inclusion. Tiotropium mist inhaler was associated with a significantly increased risk of mortality (90/3686 v 47/2836; relative risk 1.52, 95% confidence interval, 1.06 to 2.16; P=0.02; I-2=0%). Both 10 mu g (2.15, 1.03 to 4.51; P=0.04; I-2=9%) and 5 mu g (1.46, 1.01 to 2.10; P=0.04; I-2=0%) doses of tiotropium mist inhaler were associated with an increased risk of mortality. The overall estimates were not substantially changed by sensitivity analysis of the fixed effect analysis of the five trials combined using the random effects model (1.45, 1.02 to 2.07; P=0.04), limiting the analysis to three trials of one year's duration each (1.50, 1.05 to 2.15), or the inclusion of additional data on tiotropium mist inhaler from another investigational drug programme (1.42, 1.01 to 2.00). The number needed to treat for a year with the 5 mu g dose to see one additional death was estimated to be 124 (95% confidence interval 52 to 5682) based on the average control event rate from the long term trials. Conclusions This meta-analysis explains safety concerns by regulatory agencies and indicates a 52% increased risk of mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease.	[Singh, Sonal] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21287 USA; [Loke, Yoon K.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Enright, Paul L.] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA; [Furberg, Curt D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27109 USA	Johns Hopkins University; University of East Anglia; University of Arizona; Wake Forest University	Singh, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 1830 E Monument St, Baltimore, MD 21287 USA.	ssingh31@jhu.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X	National Center for Research Resources, National Institutes of Health [1KL2RR025006-03]; National Institutes of health Roadmap for Medical Research; Pfizer; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SS is supported by a grant from the National Center for Research Resources, a component of the National Institutes of Health (No 1KL2RR025006-03), and National Institutes of health Roadmap for Medical Research. The contents of this study are solely the responsibility of the authors and do not necessarily represent the official view of National Center for Research Resources or the National Institutes of Health. The design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript was independent of any sources of funding. Competing interests. All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any companies for the submitted work; PE has received about $30 000 (18 pound 000; (sic)21 000) from Pfizer to review the quality of spirometry tests done for an international study of varenicline for smoking cessation in patients with chronic obstructive pulmonary disease; no author has non-financial interests that may be relevant to the submitted work; no other relationships or activities that could appear to have influenced the submitted work.	Alzayer Reem, 2010, Qual Prim Care, V18, P189; [Anonymous], 2011, NCT01126437; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Bateman ED, 2010, RESP MED, V104, P1460, DOI 10.1016/j.rmed.2010.06.004; Bateman Eric, 2010, Int J Chron Obstruct Pulmon Dis, V5, P197; Boehringer Ingelheim, 2009, BRIEF DOC; Boehringer Ingelheim, 2010, DAT SHEET SPIR RESP; Boehringer Ingelheim International, 2010, TIOTR SPIR RESP EV F; Boehringer Ingelheim International, 2011, TRIAL RES; Boehringer Ingelheim International, 2009, RETR COLL VIT STAT P; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Caillaud Denis, 2007, Int J Chron Obstruct Pulmon Dis, V2, P559; Cates Christopher J, 2002, BMC Med Res Methodol, V2, P1, DOI 10.1186/1471-2288-2-1; Celli B, 2010, CHEST, V137, P20, DOI 10.1378/chest.09-0011; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; ClinicalTrials.gov, 2010, NCT00240435 CLINICAL; ClinicalTrials.gov, 2010, NCT00168844 CLINICAL; ClinicalTrials.gov, 2010, NCT00528996 CLINICAL; ClinicalTrials.gov, 2010, NCT00239473 CLINICAL; ClinicalTrials.gov, 2010, NCT00387088 CLINICAL; ClinicalTrials.gov, 2010, NCT00168831 CLINICAL; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; Division of Pulmonary-Allergy Drugs Advisory Committee and Office of Surveillance and Epidemiology US Food and Drug Administration, 2009, DIV PULM ALL DURGS A; Electronic Medicines Compendium, 2011, SPIR RESP SUMM PROD; Guite HF, 1999, THORAX, V54, P301, DOI 10.1136/thx.54.4.301; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Information Centre for Health and Social Care, 2009, PRESCR COST AN ENGL; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Loke Y., 2008, COCHRANE HDB SYSTEMA; Macie Christine, 2008, Int J Chron Obstruct Pulmon Dis, V3, P163; McIvor RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c833; Medicines and Healthcare Products Regulatory Agency, 2010, DRUG SAF UPD; NHS National Services Scotland, 2009, PRESCR COST AN SCOTL; Ogale SS, 2010, CHEST, V137, P13, DOI 10.1378/chest.08-2367; Ringbaek T, 2003, RESP MED, V97, P264, DOI 10.1053/rmed.2003.1423; Rodrigo GJ, 2009, RESP MED, V103, P1421, DOI 10.1016/j.rmed.2009.05.020; Scottish Medicines Consortium, 2011, 41107 SMC; Singh S, 2009, JAMA-J AM MED ASSOC, V301, P1227; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Van den Bruel A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-50; van Noord JA, 2009, RESP MED, V103, P22, DOI 10.1016/j.rmed.2008.10.002; Voshaar T, 2008, RESP MED, V102, P32, DOI 10.1016/j.rmed.2007.08.009; World Health Organization, 2008, GLOB BURD DIS 2004 U	45	160	165	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3215	10.1136/bmj.d3215	http://dx.doi.org/10.1136/bmj.d3215			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21672999	hybrid, Green Published			2022-12-28	WOS:000291932100003
J	Stacey, T; Thompson, JMD; Mitchell, EA; Ekeroma, AJ; Zuccollo, JM; McCowan, LME				Stacey, Tomasina; Thompson, John M. D.; Mitchell, Ed A.; Ekeroma, Alec J.; Zuccollo, Jane M.; McCowan, Lesley M. E.			Association between maternal sleep practices and risk of late stillbirth: a case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFANT-DEATH; DAYTIME SLEEPINESS; FETAL-DEATH; PREGNANCY; OBESITY; ANTEPARTUM; POSITION; APNEA	Objectives To determine whether snoring, sleep position, and other sleep practices in pregnant women are associated with risk of late stillbirth. Design Prospective population based case-control study. Setting Auckland, New Zealand Participants Cases: 155 women with a singleton late stillbirth (>= 28 weeks' gestation) without congenital abnormality born between July 2006 and June 2009 and booked to deliver in Auckland. Controls: 310 women with single ongoing pregnancies and gestation matched to that at which the stillbirth occurred. Multivariable logistic regression adjusted for known confounding factors. Main outcome measure Maternal snoring, daytime sleepiness (measured with the Epworth sleepiness scale), and sleep position at the time of going to sleep and on waking (left side, right side, back, and other). Results The prevalence of late stillbirth in this study was 3.09/1000 births. No relation was found between snoring or daytime sleepiness and risk of late stillbirth. However, women who slept on their back or on their right side on the previous night (before stillbirth or interview) were more likely to experience a late stillbirth compared with women who slept on their left side (adjusted odds ratio for back sleeping 2.54 (95% CI 1.04 to 6.18), and for right side sleeping 1.74 (0.98 to 3.01)). The absolute risk of late stillbirth for women who went to sleep on their left was 1.96/1000 and was 3.93/1000 for women who did not go to sleep on their left. Women who got up to go to the toilet once or less on the last night were more likely to experience a late stillbirth compared with women who got up more frequently (adjusted odds ratio 2.28 (1.40 to 3.71)). Women who regularly slept during the day in the previous month were also more likely to experience a late stillbirth than those who did not (2.04 (1.26 to 3.27)). Conclusions This is the first study to report maternal sleep related practices as risk factors for stillbirth, and these findings require urgent confirmation in further studies.	[Stacey, Tomasina; Ekeroma, Alec J.; McCowan, Lesley M. E.] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1142, New Zealand; [Thompson, John M. D.; Mitchell, Ed A.] Univ Auckland, Dept Paediat, Auckland 1142, New Zealand; [Zuccollo, Jane M.] Wellington Sch Med, Dept Obstet & Gynaecol, Wellington 6021, New Zealand	University of Auckland; University of Auckland; University of Otago	Stacey, T (corresponding author), Univ Auckland, Dept Obstet & Gynaecol, Private Bag 92019, Auckland 1142, New Zealand.	t.stacey@auckland.ac.nz	Ekeroma, Alec/H-4938-2019; Ekeroma, Alec/Y-3211-2019; McCowan, Lesley/C-2215-2009	Ekeroma, Alec/0000-0002-7581-8275; Stacey, Tomasina/0000-0003-2002-6200; McCowan, Lesley/0000-0001-9915-7873	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Cure Kids; Nurture Foundation; Auckland District Health Board Trust	Funding received from: Cure Kids, the Nurture Foundation, and the Auckland District Health Board Trust fund. EAM, JMDT, and TS are supported in part by Cure Kids. The authors were independent of the funders in all aspects of study design, data analysis, and writing of the manuscript.	AUSTIN H, 1994, EPIDEMIOL REV, V16, P65, DOI 10.1093/oxfordjournals.epirev.a036146; Brain KA, 2001, BRIT J OBSTET GYNAEC, V108, P543, DOI 10.1016/S0306-5456(00)00106-6; Carbonne B, 1996, OBSTET GYNECOL, V88, P797, DOI 10.1016/0029-7844(96)00298-0; Centre for Maternal and Child Enquiries (CMACE), 2011, PER MORT 2009 UK; Chen MY, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-59; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; DREWS CD, 1990, INT J EPIDEMIOL, V19, P405, DOI 10.1093/ije/19.2.405; GIBBONS LE, 1993, AM J EPIDEMIOL, V137, P654, DOI 10.1093/oxfordjournals.aje.a116723; Gray R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3754; Haberman S, 2011, AM J OBSTET GYNECOL, V204, pS278; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; Izci B, 2005, SLEEP MED, V6, P163, DOI 10.1016/j.sleep.2004.12.007; Jeffreys RM, 2006, BJOG-INT J OBSTET GY, V113, P1239, DOI 10.1111/j.1471-0528.2006.01056.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KINSELLA SM, 1994, OBSTET GYNECOL, V83, P774; Kuo CD, 1997, ANAESTHESIA, V52, P1161, DOI 10.1111/j.1365-2044.1997.254-az0387.x; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; Maasilta P, 2001, CHEST, V120, P1448, DOI 10.1378/chest.120.5.1448; Mador MJ, 2005, CHEST, V128, P2130, DOI 10.1378/chest.128.4.2130; MILSOM I, 1984, AM J OBSTET GYNECOL, V148, P764, DOI 10.1016/0002-9378(84)90563-5; New Zealand Ministry of Health, 2004, ETHN DAT PROT HLTH D; Nohr EA, 2005, OBSTET GYNECOL, V106, P250, DOI 10.1097/01.AOG.0000172422.81496.57; Olivarez SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.008; *PER SOC AUSTR NZ, 2009, PSANZ CLIN PRACT GUI; PMMRC, 2009, PER MAT MORT NZ 2006; Reddy UM, 2010, OBSTET GYNECOL, V116, P1119, DOI 10.1097/AOG.0b013e3181f903f8; Salihu HM, 2008, J OBSTET GYNAECOL RE, V34, P843, DOI 10.1111/j.1447-0756.2008.00855.x; Salihu HM, 2007, OBSTET GYNECOL, V110, P552, DOI 10.1097/01.AOG.0000270159.80607.10; Salmond C., 2007, NZDEP2006 INDEX DEPR; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Stacey T, 2011, AUST NZ J OBSTET GYN, V51, P3, DOI 10.1111/j.1479-828X.2010.01254.x; Stacey T, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-3; Venkata C, 2009, J AM BOARD FAM MED, V22, P158, DOI 10.3122/jabfm.2009.02.080057; Willinger M, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.057; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002; [No title captured]	36	78	77	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3403	10.1136/bmj.d3403	http://dx.doi.org/10.1136/bmj.d3403			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21673002	Green Published			2022-12-28	WOS:000291932100007
J	Barnes, TRE; Paton, C				Barnes, Thomas R. E.; Paton, Carol			UNCERTAINTIES PAGE Do antidepressants improve negative symptoms in schizophrenia?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; COGNITIVE-BEHAVIOR THERAPY; ADD-ON THERAPY; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; MIRTAZAPINE ADD; METAANALYSIS; CLOZAPINE; ANTIPSYCHOTICS; AUGMENTATION		[Barnes, Thomas R. E.; Paton, Carol] Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England	Imperial College London	Barnes, TRE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mental Hlth, London W6 8RP, England.	t.r.barnes@imperial.ac.uk			Department of Health [07/83/01] Funding Source: Medline; National Institute for Health Research [07/83/01] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Abbasi SH, 2010, SCHIZOPHR RES, V116, P101, DOI 10.1016/j.schres.2009.11.008; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Berk M, 2009, HUM PSYCHOPHARM CLIN, V24, P233, DOI 10.1002/hup.1017; Bobes J, 2010, J CLIN PSYCHIAT, V71, P280, DOI 10.4088/JCP.08m04250yel; Buchanan RW, 2007, SCHIZOPHRENIA BULL, V33, P1013, DOI 10.1093/schbul/sbl057; Buckley PF, 2007, ACTA PSYCHIAT SCAND, V115, P93, DOI 10.1111/j.1600-0447.2007.00992.x; CARPENTER WT, 1985, SCHIZOPHRENIA BULL, V11, P440, DOI 10.1093/schbul/11.3.440; Chang JS, 2008, J CLIN PSYCHIAT, V69, P720, DOI 10.4088/JCP.v69n0505; Cho SJ, 2011, PROG NEURO-PSYCHOPH, V35, P208, DOI 10.1016/j.pnpbp.2010.11.006; Erhart SM, 2006, SCHIZOPHRENIA BULL, V32, P234, DOI 10.1093/schbul/sbj055; Hofer A, 2005, EUR PSYCHIAT, V20, P386, DOI 10.1016/j.eurpsy.2005.02.005; Iancu I, 2010, PSYCHIAT RES, V179, P19, DOI 10.1016/j.psychres.2010.04.035; Lecrubier Y, 2007, EVID-BASED MENT HEAL, V10, DOI 10.1136/ebmh.10.4.113; Melle I, 2008, ARCH GEN PSYCHIAT, V65, P634, DOI 10.1001/archpsyc.65.6.634; Mulholland C, 2003, J PSYCHOPHARMACOL, V17, P107, DOI 10.1177/0269881103017001713; Paton C, 2007, J CLIN PSYCHOPHARM, V27, P198, DOI 10.1097/JCP.0b013e318036bfbb; Rosenheck R, 2006, AM J PSYCHIAT, V163, P411, DOI 10.1176/appi.ajp.163.3.411; RUMMEL C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005581.PUB2; Sepehry AA, 2007, J CLIN PSYCHIAT, V68, P604, DOI 10.4088/JCP.v68n0417; Silver H, 2000, INT CLIN PSYCHOPHARM, V15, P257, DOI 10.1097/00004850-200015050-00002; Singh SP, 2010, BRIT J PSYCHIAT, V197, P174, DOI 10.1192/bjp.bp.109.067710; Tiihonen J, 2009, SCHIZOPHR RES, V109, P10, DOI 10.1016/j.schres.2009.01.002; Turkington D, 2008, SCHIZOPHR RES, V98, P1, DOI 10.1016/j.schres.2007.09.026; Turkington D, 2006, BRIT J PSYCHIAT, V189, P36, DOI 10.1192/bjp.bp.105.010884; Weiner E, 2010, NEUROPSYCHOPHARMACOL, V35, P2274, DOI 10.1038/npp.2010.101; Wykes T, 2008, SCHIZOPHRENIA BULL, V34, P523, DOI 10.1093/schbul/sbm114	26	8	8	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2011	342								d3371	10.1136/bmj.d3371	http://dx.doi.org/10.1136/bmj.d3371			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SS	21665932				2022-12-28	WOS:000291645900002
J	DeWeerdt, S				DeWeerdt, Sarah			A testing journey	NATURE			English	Editorial Material																		Duarte CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012822; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Shawky SM, 2010, CLIN BIOCHEM, V43, P1163, DOI 10.1016/j.clinbiochem.2010.07.001; Zuure F, 2010, EUROSURVEILLANCE, V15, P5; Zuure FR, 2011, AM J PREV MED, V40, P345, DOI 10.1016/j.amepre.2010.11.019	5	4	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S20	S21		10.1038/474S20a	http://dx.doi.org/10.1038/474S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666732	Bronze			2022-12-28	WOS:000291397800012
J	Maxmen, A				Maxmen, Amy			Playing the odds	NATURE			English	Editorial Material							CHRONIC HEPATITIS-C; IL28B											Casrouge A, 2011, J CLIN INVEST, V121, P308, DOI 10.1172/JCI40594; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hitomi Y, 2011, GASTROENTEROLOGY, V140, P1314, DOI 10.1053/j.gastro.2010.12.038; Kelly C, 2011, GUT; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S9	S10		10.1038/474S9a	http://dx.doi.org/10.1038/474S9a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666735				2022-12-28	WOS:000291397800006
J	Kryazhimskiy, S; Draghi, JA; Plotkin, JB				Kryazhimskiy, Sergey; Draghi, Jeremy A.; Plotkin, Joshua B.			In Evolution, the Sum Is Less than Its Parts	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; EVOLVABILITY; POPULATION; ADAPTATION; MUTATIONS; DYNAMICS		[Kryazhimskiy, Sergey; Draghi, Jeremy A.; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19103 USA; [Kryazhimskiy, Sergey] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	University of Pennsylvania; Harvard University	Kryazhimskiy, S (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19103 USA.	jplotkin@sas.upenn.edu	Plotkin, Joshua B/E-6947-2013; Kryazhimskiy, Sergey/AAV-1258-2020	Kryazhimskiy, Sergey/0000-0001-9128-8705				Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Trindade S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000578; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	13	8	8	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1160	1161		10.1126/science.1208072	http://dx.doi.org/10.1126/science.1208072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636764				2022-12-28	WOS:000291205200036
J	Mukherjee, D				Mukherjee, Debabrata			Antithrombotics and stent type for primary PCI	LANCET			English	Editorial Material							ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; BARE-METAL STENT; FOLLOW-UP; TRIAL; ANGIOPLASTY		Texas Tech Univ, Hlth Sci Ctr, Div Cardiovasc Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Mukherjee, D (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Div Cardiovasc Med, El Paso, TX 79905 USA.	debabrata.mukherjee@ttuhsc.edu	Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Aasa M, 2010, AM HEART J, V160, P322, DOI 10.1016/j.ahj.2010.05.008; Atary JZ, 2010, AM J CARDIOL, V106, P4, DOI 10.1016/j.amjcard.2010.02.005; Kaltoft A, 2010, J AM COLL CARDIOL, V56, P641, DOI 10.1016/j.jacc.2010.05.009; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Martinez AW, 2011, WIRES NANOMED NANOBI, V3, P256, DOI 10.1002/wnan.123; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mukherjee D, 2011, JAMA-J AM MED ASSOC, V305, P1710, DOI 10.1001/jama.2011.521; Spaulding C, 2011, JACC-CARDIOVASC INTE, V4, P14, DOI 10.1016/j.jcin.2010.10.007; Stone GW, 2011, LANCET, V377, P2193, DOI 10.1016/S0140-6736(11)60764-2; Vink MA, 2011, JACC-CARDIOVASC INTE, V4, P24, DOI 10.1016/j.jcin.2010.11.003; World Health Organization, 2011, CARD DIS	11	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2154	2156		10.1016/S0140-6736(11)60707-1	http://dx.doi.org/10.1016/S0140-6736(11)60707-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21665264				2022-12-28	WOS:000292340800005
J	Okma, KGH; Marmor, TR; Oberlander, J				Okma, Kieke G. H.; Marmor, Theodore R.; Oberlander, Jonathan			Managed Competition for Medicare? Sobering Lessons from the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Okma, Kieke G. H.] NYU, New York, NY 10012 USA; [Marmor, Theodore R.] Yale Univ, New Haven, CT USA; [Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC USA	New York University; Yale University; University of North Carolina; University of North Carolina Chapel Hill	Okma, KGH (corresponding author), NYU, New York, NY 10012 USA.							Enthoven AC, 2007, NEW ENGL J MED, V357, P2421, DOI 10.1056/NEJMp078199; Maarse H, 2011, MARKTHERVORMING ZORG; Marmor TR., 2009, COMP STUDIES POLITIC; Okma K., 2010, 6 COUNTRIES 6 REFORM; SALTMAN RB, 2011, WASHINGTON POST 0507	5	21	22	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					287	289		10.1056/NEJMp1106090	http://dx.doi.org/10.1056/NEJMp1106090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798AJ	21675914				2022-12-28	WOS:000293172200002
J	Cohen, T; Corbett, EL				Cohen, Ted; Corbett, Elizabeth L.			Test and treat in HIV: success could depend on rapid detection	LANCET			English	Editorial Material							INFECTION		[Cohen, Ted] Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Cohen, Ted] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Cohen, Ted] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Corbett, Elizabeth L.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine	Cohen, T (corresponding author), Harvard Univ, Sch Publ Hlth, Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA.	tcohen@hsph.harvard.edu	Cohen, Ted/G-8101-2011	Corbett, Elizabeth/0000-0002-3552-3181; Cohen, Ted/0000-0002-8091-7198				Anglemyer A, 2011, COCHRANE DATABASE SY; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; *NAT I ALL INF DIS, TREAT HIV INF PEOPL; Pilcher Christopher D, 2006, Curr HIV/AIDS Rep, V3, P160, DOI 10.1007/s11904-006-0011-4; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Quinn TC, 2000, AIDS, V14, P2751, DOI 10.1097/00002030-200012010-00015; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556	13	16	17	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 16	2011	378	9787					204	206		10.1016/S0140-6736(11)60896-9	http://dx.doi.org/10.1016/S0140-6736(11)60896-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	798JD	21684592				2022-12-28	WOS:000293201100006
J	Powers, KA; Ghani, AC; Miller, WC; Hoffman, IF; Pettifor, AE; Kamanga, G; Martinson, FEA; Cohen, MS				Powers, Kimberly A.; Ghani, Azra C.; Miller, William C.; Hoffman, Irving F.; Pettifor, Audrey E.; Kamanga, Gift; Martinson, Francis E. A.; Cohen, Myron S.			The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study	LANCET			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HETEROSEXUAL TRANSMISSION; SEXUAL TRANSMISSION; PROSPECTIVE COHORT; UNITED-STATES; VIRAL LOAD; STAGE; RISK; PARTNERSHIPS	Background HIV transmission risk is higher during acute and early HIV infection than it is during chronic infection, but the contribution of early infection to the spread of HIV is controversial. We estimated the contribution of early infection to HIV incidence in Lilongwe, Malawi, and predict the future effect of hypothetical prevention interventions targeted at early infection only, chronic infection only, or both stages. Methods We developed a deterministic mathematical model describing heterosexual HIV transmission, informed by detailed behavioural and viral-load data collected in Lilongwe. We included sexual contact within and outside of steady pairs and divided the infectious period into intervals to allow for changes in transmissibility by infection stage. We used a Bayesian melding approach to fit the model to HIV prevalence data collected between 1987 and 2005 at Lilongwe antenatal clinics. We assessed interventions that reduced the per-contact transmission probability to 0.00003 in people receiving them, and varied the proportion of individuals receiving the intervention in each stage. Findings We estimated that 38.4% (95% credible interval 18-6-52.3) of HIV transmissions in Lilongwe are attributable to sexual contact with individuals with early infection. Interventions targeted at only early infection substantially reduced HIV prevalence, but did not lead to elimination, even with 100% coverage. Interventions targeted at only chronic infections also reduced HIV prevalence, but coverage levels of 95-99% were needed for the elimination of HIV. In scenarios with less than 95% coverage of interventions targeted at chronic infections, additional interventions reaching 25-75% of individuals with early infection reduced HIV prevalence substantially. Interpretation Our results suggest that early infection plays an important part in HIV transmission in this sub-Saharan African setting. Without near-complete coverage, interventions during chronic infection will probably have incomplete effectiveness unless complemented by strategies targeting individuals with early HIV infection.	[Powers, Kimberly A.; Miller, William C.; Hoffman, Irving F.; Cohen, Myron S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Powers, Kimberly A.; Miller, William C.; Pettifor, Audrey E.; Cohen, Myron S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Cohen, Myron S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Ghani, Azra C.] Univ London Imperial Coll Sci Technol & Med, MRC Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London SW7 2AZ, England; [Kamanga, Gift; Martinson, Francis E. A.] UNC Project Malawi, Lilongwe, Malawi	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London	Powers, KA (corresponding author), Ctr Infect Dis, CB 7030,Bioinformat 2nd Floor, Chapel Hill, NC 27599 USA.	powersk@email.unc.edu	Miller, William C/H-4800-2014; Ghani, Azra/B-8560-2009; Pettifor, Audrey/H-6793-2019	Miller, William C/0000-0002-1934-7827; Pettifor, Audrey/0000-0002-3387-0817; Ghani, Azra/0000-0002-0007-4910	National Institutes of Health (NIH) [R01 MH068686, R37 DK049381, R01 AI083059, 5T32AI070114, P30 AI50410]; University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council [G0600719B] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083059, P30AI050410, T32AI070114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH068686] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina Center for AIDS Research; University of North Carolina at Chapel Hill Center for AIDS Research (CFAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health, University of North Carolina Center for AIDS Research.; We thank Christophe Fraser for suggestions on the mathematical modelling methods, and Ward Cates, Jim Shelton, and David Burns for providing helpful comments on an earlier draft of this paper. We also thank four anonymous reviewers, whose comments on our work substantially improved this Article. This research was supported by the National Institutes of Health (NIH; grant numbers R01 MH068686, R37 DK049381, R01 AI083059, and 5T32AI070114) and the University of North Carolina at Chapel Hill Center for AIDS Research (CFAR), an NIH funded programme (grant number P30 AI50410).	Abu-Raddad LJ, 2008, AIDS, V22, P1055, DOI 10.1097/QAD.0b013e3282f8af84; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Assefa Y, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60647-4; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Cates W, 1997, AM J PUBLIC HEALTH, V87, P1928, DOI 10.2105/AJPH.87.12.1928; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Cohen MS, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60640-1; Del Romero J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2205; Dodd PJ, 2010, AIDS, V24, P729, DOI 10.1097/QAD.0b013e32833433fe; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Epstein H, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60643-7; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fiscus SA, 2007, J INFECT DIS, V195, P416, DOI 10.1086/510755; Garnett GP, 2009, LANCET, V373, P9, DOI 10.1016/S0140-6736(08)61698-0; Glynn JR, 2008, SEX TRANSM INFECT, V84, P356, DOI 10.1136/sti.2008.030056; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001; Hallett TB, 2008, PLOS MED, V5, P403, DOI 10.1371/journal.pmed.0050053; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 2010, INT J CLIN PRACT, V64, P678, DOI 10.1111/j.1742-1241.2010.02381.x; HOSSEINIPOUR M, 2004, 11 C RETR OPP INF; Hsieh YH, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60645-0; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jaffe H, 2009, LANCET, V373, P1080, DOI 10.1016/S0140-6736(09)60646-2; Jurgens R, 2009, LANCET, V373, P1079, DOI 10.1016/S0140-6736(09)60644-9; Kim JH, 2010, EPIDEMIOLOGY, V21, P676, DOI 10.1097/EDE.0b013e3181e6639f; Koopman JS, 1997, J ACQ IMMUN DEF SYND, V14, P249, DOI 10.1097/00042560-199703010-00009; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lurie M, 2009, LANCET, V374, P1420, DOI 10.1016/S0140-6736(09)61860-2; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; Miller WC, 2010, CURR OPIN HIV AIDS, V5, P277, DOI 10.1097/COH.0b013e32833a0d3a; Miller WC, 2009, AIDS, V23, P835, DOI 10.1097/QAD.0b013e328326f55e; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; *NSO MAL, 2008, MAL POP HOUS CENS; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Pilcher CD, 2001, JAMA-J AM MED ASSOC, V286, P1713, DOI 10.1001/jama.286.14.1713; Pilcher CD, 2004, AIDS, V18, P517, DOI 10.1097/00002030-200402200-00019; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pinkerton SD, 1996, EVALUATION REV, V20, P516, DOI 10.1177/0193841X9602000502; PINKERTON SD, 2007, AIDS BEHAV, V7, P7; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Ruark A, 2009, LANCET, V373, P1078, DOI 10.1016/S0140-6736(09)60642-5; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; Taylor MM, 2007, CLIN INFECT DIS, V44, P301, DOI 10.1086/510487; *US BUR CENS, HIV AIDS SURV DAT; Vaidya NK, 2010, J VIROL, V84, P4302, DOI 10.1128/JVI.02284-09; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Wakabi W, 2008, LANCET INFECT DIS, V8, P285, DOI 10.1016/S1473-3099(08)70090-2; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, LANCET, V373, P1077, DOI 10.1016/S0140-6736(09)60641-3; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; 2004, MALAWI DEMOGRAPHIC H	74	246	252	1	33	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2011	378	9787					256	268		10.1016/S0140-6736(11)60842-8	http://dx.doi.org/10.1016/S0140-6736(11)60842-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798JD	21684591	Green Accepted			2022-12-28	WOS:000293201100033
J	Das, SK; Eder, S; Schauer, S; Diwoky, C; Temmel, H; Guertl, B; Gorkiewicz, G; Tamilarasan, KP; Kumari, P; Trauner, M; Zimmermann, R; Vesely, P; Haemmerle, G; Zechner, R; Hoefler, G				Das, Suman K.; Eder, Sandra; Schauer, Silvia; Diwoky, Clemens; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Trauner, Michael; Zimmermann, Robert; Vesely, Paul; Haemmerle, Guenter; Zechner, Rudolf; Hoefler, Gerald			Adipose Triglyceride Lipase Contributes to Cancer-Associated Cachexia	SCIENCE			English	Article							WHOLE-BODY LIPOLYSIS; ENERGY-METABOLISM; SKELETAL-MUSCLE; WEIGHT-LOSS; FATTY-ACID; MICE; TISSUE; INFLAMMATION; DEFINITION; MECHANISMS	Cachexia is a multifactorial wasting syndrome most common in patients with cancer that is characterized by the uncontrolled loss of adipose and muscle mass. We show that the inhibition of lipolysis through genetic ablation of adipose triglyceride lipase (Atgl) or hormone-sensitive lipase (Hsl) ameliorates certain features of cancer-associated cachexia (CAC). In wild-type C57BL/6 mice, the injection of Lewis lung carcinoma or B16 melanoma cells causes tumor growth, loss of white adipose tissue (WAT), and a marked reduction of gastrocnemius muscle. In contrast, Atgl-deficient mice with tumors resisted increased WAT lipolysis, myocyte apoptosis, and proteasomal muscle degradation and maintained normal adipose and gastrocnemius muscle mass. Hsl-deficient mice with tumors were also protected although to a lesser degree. Thus, functional lipolysis is essential in the pathogenesis of CAC. Pharmacological inhibition of metabolic lipases may help prevent cachexia.	[Eder, Sandra; Zimmermann, Robert; Haemmerle, Guenter; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Das, Suman K.; Schauer, Silvia; Temmel, Hannes; Guertl, Barbara; Gorkiewicz, Gregor; Tamilarasan, Kuppusamy P.; Kumari, Pooja; Vesely, Paul; Hoefler, Gerald] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria; [Diwoky, Clemens] Graz Univ Technol, Inst Med Engn, A-8010 Graz, Austria; [Kumari, Pooja; Trauner, Michael] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, A-8036 Graz, Austria	University of Graz; Medical University of Graz; Graz University of Technology; Medical University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; gerald.hoefler@medunigraz.at	Gorkiewicz, Gregor/ABF-1602-2021; Vesely, Paul/AAO-1286-2020; Hoefler, Gerald/B-7006-2008; Das, Suman kumar/E-1270-2015; Hoefler, Gerald/H-1796-2016	Gorkiewicz, Gregor/0000-0003-1149-4782; Das, Suman kumar/0000-0002-0539-5174; Green, Tami/0000-0002-4070-6214; Jha, Pooja/0000-0002-0293-9287; Zimmermann, Robert/0000-0002-7354-870X; Vesely, Paul Willibald/0000-0003-3608-1060; Trauner, Michael/0000-0002-1275-6425; Green, Tami/0000-0003-0485-0363; Zechner, Rudolf/0000-0001-5483-1182; Haemmerle, Guenter/0000-0001-9900-5896; Hoefler, Gerald/0000-0002-9056-3063	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX [F30]; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [Z136]; Austrian Science Fund (FWF) [F 3002, F 3008, Z 136] Funding Source: researchfish	Medical University of Graz; Forschungsforderungsgesellschaft; Bundesministerium fur Wissenschaft und Forschung; SFB LIPOTOX(German Research Foundation (DFG)); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank E. Zechner and C. Schober-Trummler for reviewing the manuscript. The research was supported by the doctoral program Molecular Medicine of the Medical University of Graz (S. D.); GOLD, Genomics of Lipid-Associated Disorders as part of the Austrian Genome Project GEN-AU funded by Forschungsforderungsgesellschaft and Bundesministerium fur Wissenschaft und Forschung (Ru.Ze.); SFB LIPOTOX grant no. F30 (Ru.Ze., G. H.), the Wittgenstein Award 2007 grant no. Z136 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (Ru.Ze.). S. K. D., Ro.Zi., G. H., and Ru.Ze. hold a patent related to the modulation of ATGL for prevention and treatment of cachexia.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Belizario JE, 2001, BRIT J CANCER, V84, P1135, DOI 10.1054/bjoc.2001.1700; Bing C, 2004, P NATL ACAD SCI USA, V101, P2500, DOI 10.1073/pnas.0308647100; Busquets S, 2007, CLIN NUTR, V26, P239, DOI 10.1016/j.clnu.2006.12.001; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; FEARON KCH, 1992, P NUTR SOC, V51, P251, DOI 10.1079/PNS19920036; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hyltander A, 2000, EUR J CANCER, V36, P330, DOI 10.1016/S0959-8049(99)00273-7; JEEVANANDAM M, 1986, METABOLISM, V35, P304, DOI 10.1016/0026-0495(86)90145-9; Kawamura I, 1999, ANTICANCER RES, V19, P341; Khal J, 2005, INT J BIOCHEM CELL B, V37, P2196, DOI 10.1016/j.biocel.2004.10.017; KLEIN S, 1990, J CLIN INVEST, V86, P1403, DOI 10.1172/JCI114854; Lainscak M, 2008, AM J CARDIOL, V101, p8E, DOI 10.1016/j.amjcard.2008.02.065; Laurencikiene J, 2008, CANCER RES, V68, P9247, DOI 10.1158/0008-5472.CAN-08-1343; LEGASPI A, 1987, METABOLISM, V36, P958, DOI 10.1016/0026-0495(87)90132-6; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; RENNIE MJ, 1983, CLIN PHYSIOL, V3, P387, DOI 10.1111/j.1475-097X.1983.tb00847.x; Ryden M, 2008, CANCER-AM CANCER SOC, V113, P1695, DOI 10.1002/cncr.23802; SHAW JHF, 1987, ANN SURG, V205, P368, DOI 10.1097/00000658-198704000-00005; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; van Royen M, 2000, BIOCHEM BIOPH RES CO, V270, P533, DOI 10.1006/bbrc.2000.2462; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	30	365	381	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					233	238		10.1126/science.1198973	http://dx.doi.org/10.1126/science.1198973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21680814				2022-12-28	WOS:000292502700053
J	Klassen, T; Davis, C; Goldman, A; Burgess, D; Chen, T; Wheeler, D; McPherson, J; Bourquin, T; Lewis, L; Villasana, D; Morgan, M; Muzny, D; Gibbs, R; Noebels, J				Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard; Noebels, Jeffrey			Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy	CELL			English	Article							SEVERE MYOCLONIC EPILEPSY; ORGANIZATION; MUTATIONS; MODELS; CHANNELOPATHIES; SUSCEPTIBILITY; PREVALENCE; MECHANISMS; EVOLUTION; ALIGNMENT	Ion channel mutations are an important cause of rare Mendelian disorders affecting brain, heart, and other tissues. We performed parallel exome sequencing of 237 channel genes in a well-characterized human sample, comparing variant profiles of unaffected individuals to those with the most common neuronal excitability disorder, sporadic idiopathic epilepsy. Rare missense variation in known Mendelian disease genes is prevalent in both groups at similar complexity, revealing that even deleterious ion channel mutations confer uncertain risk to an individual depending on the other variants with which they are combined. Our findings indicate that variant discovery via large scale sequencing efforts is only a first step in illuminating the complex allelic architecture underlying personal disease risk. We propose that in silico modeling of channel variation in realistic cell and network models will be crucial to future strategies assessing mutation profile pathogenicity and drug response in individuals with a broad spectrum of excitability disorders.	[Klassen, Tara; Davis, Caleb; Goldman, Alica; Burgess, Dan; Chen, Tim; Noebels, Jeffrey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Noebels, Jeffrey] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [McPherson, John; Gibbs, Richard; Noebels, Jeffrey] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Wheeler, David; McPherson, John; Bourquin, Traci; Lewis, Lora; Villasana, Donna; Morgan, Margaret; Muzny, Donna; Gibbs, Richard] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Noebels, J (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.	jnoebels@bcm.edu	McPherson, John D/D-2633-2017; Resource Center, NINDS Human Genetics/AGF-2474-2022; Wheeler, David A/M-9740-2018; Sander-Effron, Samuel/AAX-2231-2020	McPherson, John D/0000-0001-8049-9347; Wheeler, David A/0000-0002-9056-6299; Davis, Caleb/0000-0002-5125-0494; Noebels, Jeffrey/0000-0002-2887-0839	NIH [NS 049130]; National Human Genome Research Institute; Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047304, R01NS049130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Gillson Longenbaugh Foundation; Blue Bird Circle Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Melissa Lambeth and Marsha Hill for assistance with clinical recruitment, the Human Genome Sequencing Center sequencing team, and Colleen Clancy and Luay Nakhleh for valuable discussion. The authors acknowledge the support NIH NS 049130 (J.N.), the National Human Genome Research Institute (R. G.), the Gillson Longenbaugh Foundation (J.N. and R. G.), and the Blue Bird Circle Foundation.	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bayes A, 2009, NAT REV NEUROSCI, V10, P635, DOI 10.1038/nrn2701; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bower James M, 2007, Methods Mol Biol, V401, P103, DOI 10.1007/978-1-59745-520-6_7; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Demolombe S, 2005, CARDIOVASC RES, V67, P438, DOI 10.1016/j.cardiores.2005.04.021; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Drolet B, 2005, J CLIN INVEST, V115, P2209, DOI 10.1172/JCI23741; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; Gargus JJ, 2003, AM J HUM GENET, V72, P785, DOI 10.1086/374317; Glasscock E, 2007, NAT NEUROSCI, V10, P1554, DOI 10.1038/nn1999; Goaillard JM, 2009, NAT NEUROSCI, V12, P1424, DOI 10.1038/nn.2404; Grashow R, 2009, P NATL ACAD SCI USA, V106, P11742, DOI 10.1073/pnas.0905614106; Gurkiewicz M, 2007, PLOS COMPUT BIOL, V3, P1633, DOI 10.1371/journal.pcbi.0030169; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hawkins NA, 2011, NEUROBIOL DIS, V41, P655, DOI 10.1016/j.nbd.2010.11.016; Hiriart M, 2008, AM J PHYSIOL-ENDOC M, V295, pE1298, DOI 10.1152/ajpendo.90493.2008; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Kaczmarek LK, 2006, NAT REV NEUROSCI, V7, P761, DOI 10.1038/nrn1988; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kellems AR, 2009, J COMPUT NEUROSCI, V27, P161, DOI 10.1007/s10827-008-0134-2; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; Liu G, 2003, NEUROPHARMACOLOGY, V44, P413, DOI 10.1016/S0028-3908(02)00400-8; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marder E, 2010, NEURON, V66, P161, DOI 10.1016/j.neuron.2010.04.022; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Matzke AJM, 2010, MOL PLANT, V3, P642, DOI 10.1093/mp/ssq013; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Nusser Z, 2009, TRENDS NEUROSCI, V32, P267, DOI 10.1016/j.tins.2009.01.003; Ohmori I, 2006, EPILEPSIA, V47, P1636, DOI 10.1111/j.1528-1167.2006.00643.x; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Scheffer IE, 2007, BRAIN, V130, P100, DOI 10.1093/brain/awl272; Sheets MF, 2010, TRENDS CARDIOVAS MED, V20, P16, DOI 10.1016/j.tcm.2010.03.002; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thomas EA, 2009, ARCH NEUROL-CHICAGO, V66, P1225, DOI 10.1001/archneurol.2009.219; Tobin AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006742; Toledo-Rodriguez M, 2005, TRENDS NEUROSCI, V28, P534, DOI 10.1016/j.tins.2005.08.001; Tomaselli GF, 2010, HEART RHYTHM, V7, P206, DOI 10.1016/j.hrthm.2009.10.029; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Tsuji K, 2007, J MOL CELL CARDIOL, V42, P662, DOI 10.1016/j.yjmcc.2006.12.015; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wray NR, 2010, GENOME MED, V2, DOI 10.1186/gm131; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002056; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	75	227	231	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1036	1048		10.1016/j.cell.2011.05.025	http://dx.doi.org/10.1016/j.cell.2011.05.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703448	Green Accepted, Bronze			2022-12-28	WOS:000292025700011
J	Muller, B				Mueller, Berndt			The Limits of Ordinary Matter	SCIENCE			English	Editorial Material									[Mueller, Berndt] Duke Univ, Dept Phys, Durham, NC 27708 USA	Duke University	Muller, B (corresponding author), Duke Univ, Dept Phys, Durham, NC 27708 USA.	muller@phy.duke.edu						Aggarwal MM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.022302; Aoki Y, 2006, NATURE, V443, P675, DOI 10.1038/nature05120; Asakawa M, 2000, PHYS REV LETT, V85, P2072, DOI 10.1103/PhysRevLett.85.2072; Athanasiou C, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074008; Gupta S., 2009, POS CPOD2009, VCPOD2009, P025; Gupta S, 2011, SCIENCE, V332, P1525, DOI 10.1126/science.1204621; Karsch F, 2011, PHYS LETT B, V695, P136, DOI 10.1016/j.physletb.2010.10.046; Koch V, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.182301; Muller B, 2006, ANNU REV NUCL PART S, V56, P93, DOI 10.1146/annurev.nucl.56.080805.140556	9	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1513	1514		10.1126/science.1207995	http://dx.doi.org/10.1126/science.1207995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700862				2022-12-28	WOS:000291990000031
J	Seong, KH; Li, D; Shimizu, H; Nakamura, R; Ishii, S				Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke			Inheritance of Stress-Induced, ATF-2-Dependent Epigenetic Change	CELL			English	Article							POSITION-EFFECT VARIEGATION; DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; RNA-POLYMERASE; GENE; P38; PARAMUTATION; ACTIVATION; EXPRESSION; RESPONSES	Atf1, the fission yeast homolog of activation transcription factor-2 (ATF-2), contributes to heterochromatin formation. However, the role of ATF-2 in chromatin assembly in higher organisms remains unknown. This study reveals that Drosophila ATF-2 (dATF-2) is required for heterochromatin assembly, whereas the stress-induced phosphorylation of dATF-2, via Mekk1-p38, disrupts heterochromatin. The dATF-2 protein colocalized with HP1, not only on heterochromatin but also at specific loci in euchromatin. Heat shock or osmotic stress induced phosphorylation of dATF-2 and resulted in its release from heterochromatin. This heterochromatic disruption was an epigenetic event that was transmitted to the next generation in a non-Mendelian fashion. When embryos were exposed to heat stress over multiple generations, the defective chromatin state was maintained over multiple successive generations, though it gradually returned to the normal state. The results suggest a mechanism by which the effects of stress are inherited epigenetically via the regulation of a tight chromatin structure.	[Seong, Ki-Hyeon; Li, Dong; Shimizu, Hideyuki; Nakamura, Ryoichi; Ishii, Shunsuke] RIKEN Tsukuba Inst, Mol Genet Lab, Tsukuba, Ibaraki 3050074, Japan	RIKEN	Ishii, S (corresponding author), RIKEN Tsukuba Inst, Mol Genet Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.	sishii@rtc.riken.jp	Ishii, Shunsuke/A-5271-2016	Ishii, Shunsuke/0000-0002-6530-2478; Seong, Ki-Hyeon/0000-0002-0606-8896; Li, Dong/0000-0002-7268-657X	Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [23370079] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Y. Iijima and T. Nomura for technical assistance, the staff of the Research Resources Center of the RIKEN Brain Science Institute for microarray analysis, L. L. Wallrath, the Exelixis collection at Harvard Medical School, T. Ide, T. Adachi-Yamada, and J. Eissenberg, and the Bloomington Stock Center for Drosophila strains. This work was supported in part by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology.	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; Gowen JW, 1933, SCIENCE, V77, P312, DOI 10.1126/science.77.1995.312; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Khurana JS, 2010, J CELL BIOL, V191, P905, DOI 10.1083/jcb.201006034; Lloyd VK, 2003, GENOME, V46, P1104, DOI 10.1139/G03-070; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Maekawa T, 2010, EMBO J, V29, P184, DOI 10.1038/emboj.2009.318; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; RABINOW L, 1991, GENETICS, V129, P463; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sano Y, 2005, MOL BIOL CELL, V16, P2934, DOI 10.1091/mbc.E04-11-1008; Shimizu H, 2008, MOL CELL BIOL, V28, P6278, DOI 10.1128/MCB.02242-07; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wagschal A, 2007, CSH PROTOC; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	37	214	221	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1049	1061		10.1016/j.cell.2011.05.029	http://dx.doi.org/10.1016/j.cell.2011.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703449	Bronze			2022-12-28	WOS:000292025700012
J	Quimby, RM; Kulkarni, SR; Kasliwal, MM; Gal-Yam, A; Arcavi, I; Sullivan, M; Nugent, P; Thomas, R; Howell, DA; Nakar, E; Bildsten, L; Theissen, C; Law, NM; Dekany, R; Rahmer, G; Hale, D; Smith, R; Ofek, EO; Zolkower, J; Velur, V; Walters, R; Henning, J; Bui, K; McKenna, D; Poznanski, D; Cenko, SB; Levitan, D				Quimby, R. M.; Kulkarni, S. R.; Kasliwal, M. M.; Gal-Yam, A.; Arcavi, I.; Sullivan, M.; Nugent, P.; Thomas, R.; Howell, D. A.; Nakar, E.; Bildsten, L.; Theissen, C.; Law, N. M.; Dekany, R.; Rahmer, G.; Hale, D.; Smith, R.; Ofek, E. O.; Zolkower, J.; Velur, V.; Walters, R.; Henning, J.; Bui, K.; McKenna, D.; Poznanski, D.; Cenko, S. B.; Levitan, D.			Hydrogen-poor superluminous stellar explosions	NATURE			English	Article							LUMINOUS SUPERNOVAE; PAIR-INSTABILITY; LIGHT CURVES; STARS	Supernovae are stellar explosions driven by gravitational or thermonuclear energy that is observed as electromagnetic radiation emitted over weeks or more(1). In all known supernovae, this radiation comes from internal energy deposited in the outflowing ejecta by one or more of the following processes: radioactive decay of freshly synthesized elements(2) (typically Ni-56), the explosion shock in the envelope of a supergiant star(3), and interaction between the debris and slowly moving, hydrogen-rich circumstellar material(4). Here we report observations of a class of luminous supernovae whose properties cannot be explained by any of these processes. The class includes four new supernovae that we have discovered and two previously unexplained events(5,6) (SN 2005ap and SCP 06F6) that we can now identify as members of the same class. These supernovae are all about ten times brighter than most type Ia supernova, do not show any trace of hydrogen, emit significant ultraviolet flux for extended periods of time and have late-time decay rates that are inconsistent with radioactivity. Our data require that the observed radiation be emitted by hydrogen-free material distributed over a large radius (similar to 10(15) centimetres) and expanding at high speeds (>10(4) kilometres per second). These long-lived, ultraviolet-luminous events can be observed out to redshifts z>4.	[Quimby, R. M.; Kulkarni, S. R.; Kasliwal, M. M.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Gal-Yam, A.; Arcavi, I.] Weizmann Inst Sci, Benoziyo Ctr Astrophys, Fac Phys, IL-76100 Rehovot, Israel; [Sullivan, M.] Univ Oxford, Dept Phys Astrophys, Oxford OX1 3RH, England; [Nugent, P.; Thomas, R.; Poznanski, D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Howell, D. A.; Bildsten, L.] Las Cumbres Observ Global Telescope Network, Goleta, CA 93117 USA; [Howell, D. A.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Nakar, E.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys Astron, IL-69978 Tel Aviv, Israel; [Bildsten, L.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Theissen, C.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Law, N. M.] Univ Toronto, Dunlap Inst Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Dekany, R.; Rahmer, G.; Hale, D.; Smith, R.; Ofek, E. O.; Zolkower, J.; Velur, V.; Walters, R.; Henning, J.; Bui, K.; McKenna, D.] CALTECH, Caltech Opt Observ, Pasadena, CA 91125 USA; [Poznanski, D.; Cenko, S. B.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Levitan, D.] CALTECH, Dept Phys, Pasadena, CA 91125 USA	California Institute of Technology; Weizmann Institute of Science; University of Oxford; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; Tel Aviv University; University of California System; University of California Santa Barbara; University of California System; University of California San Diego; University of Toronto; California Institute of Technology; University of California System; University of California Berkeley; California Institute of Technology	Quimby, RM (corresponding author), CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA.	quimby@astro.caltech.edu	Howell, Andy/ABE-6446-2020; San Diego, University of California/M-1048-2019; Nugent, Peter Edward/AGG-8472-2022	San Diego, University of California/0000-0002-9807-5435; Sullivan, Mark/0000-0001-9053-4820; Nakar, Ehud/0000-0002-4534-7089; Gal-Yam, Avishay/0000-0002-3653-5598; Kasliwal, Tamay/0000-0001-5634-7167; Nugent, Peter/0000-0002-3389-0586; Poznanski, Dovi/0000-0003-1470-7173	Office of Science of the US Department of Energy; Israel Science Foundation; US-Israel Binational Science Foundation; US Department of Energy; Gordon and Betty Moore foundation; Bengier Foundation; Richard and Rhoda Goldman Fund; Royal Society; Division Of Astronomical Sciences [1009987] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); US Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore foundation(Gordon and Betty Moore Foundation); Bengier Foundation; Richard and Rhoda Goldman Fund; Royal Society(Royal Society of London); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Observations were obtained with the Samuel Oschin Telescope and the 60-inch telescope at Palomar Observatory as part of the PTF project, a scientific collaboration between the California Institute of Technology, Columbia University, Las Cumbres Observatory, the Lawrence Berkeley National Laboratory, the National Energy Research Scientific Computing Center, the University of Oxford and the Weizmann Institute of Science. Some of the data presented here were obtained at the W.M. Keck Observatory and the William Herschel Telescope. The National Energy Research Scientific Computing Center, which is supported by the Office of Science of the US Department of Energy, provided staff, computational resources and data storage for this project. Observations by the Weizmann PTF partnership and from the Wise Observatory are supported by grants from the Israel Science Foundation and the US-Israel Binational Science Foundation. We acknowledge support from the US Department of Energy Scientific Discovery through Advanced Computing programme, the Hale Fellowship from the Gordon and Betty Moore foundation, the Bengier Foundation, the Richard and Rhoda Goldman Fund, and the Royal Society.	ARNETT WD, 1982, ASTROPHYS J, V253, P785, DOI 10.1086/159681; Barbary K, 2009, ASTROPHYS J, V690, P1358, DOI 10.1088/0004-637X/690/2/1358; CHEVALIER RA, 1982, ASTROPHYS J, V258, P790, DOI 10.1086/160126; Chevalier RA, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/1/L6; Drake A. J., 1958, CENTR BUR ELECT TELE; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; GRASSBERG EK, 1971, ASTROPHYS SPACE SCI, V10, P28, DOI 10.1007/BF00654604; Hogg D. W., 2002, K CORRECTION; JEFFERY DJ, 1990, JER WIN SCH, V6, P149; Kasen D, 2010, ASTROPHYS J, V717, P245, DOI 10.1088/0004-637X/717/1/245; Law NM, 2009, PUBL ASTRON SOC PAC, V121, P1395, DOI 10.1086/648598; Mahabal A. A., 2010, ASTRONOMERS TELEGR; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Pastorello A, 2010, ASTROPHYS J LETT, V724, pL16, DOI 10.1088/2041-8205/724/1/L16; Pastorello A., 2010, ASTRONOMERS TELEGR, V2504; Quimby R. M., 2010, ASTRONOMERS TELEGR; Quimby RM, 2007, ASTROPHYS J, V668, pL99, DOI 10.1086/522862; Rau A, 2009, PUBL ASTRON SOC PAC, V121, P1334, DOI 10.1086/605911; Umeda H, 2008, ASTROPHYS J, V673, P1014, DOI 10.1086/524767; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333; Woosley SE, 2010, ASTROPHYS J LETT, V719, pL204, DOI 10.1088/2041-8205/719/2/L204; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225	22	381	381	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					487	489		10.1038/nature10095	http://dx.doi.org/10.1038/nature10095			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21654747	Green Submitted			2022-12-28	WOS:000291939700043
J	Dalrymple, T				Dalrymple, Theodore			PERSONAL VIEW The demise of cultured doctors is bad for everyone	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3649	10.1136/bmj.d3649	http://dx.doi.org/10.1136/bmj.d3649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697224				2022-12-28	WOS:000292200500003
J	Preiss, D; Seshasai, SRK; Welsh, P; Murphy, SA; Ho, JE; Waters, DD; DeMicco, DA; Barter, P; Cannon, CP; Sabatine, MS; Braunwald, E; Kastelein, JJP; de Lemos, JA; Blazing, MA; Pedersen, TR; Tikkanen, MJ; Sattar, N; Ray, KK				Preiss, David; Seshasai, Sreenivasa Rao Kondapally; Welsh, Paul; Murphy, Sabina A.; Ho, Jennifer E.; Waters, David D.; DeMicco, David A.; Barter, Philip; Cannon, Christopher P.; Sabatine, Marc S.; Braunwald, Eugene; Kastelein, John J. P.; de Lemos, James A.; Blazing, Michael A.; Pedersen, Terje R.; Tikkanen, Matti J.; Sattar, Naveed; Ray, Kausik K.			Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE CORONARY SYNDROMES; LIPID-LOWERING THERAPY; 14 RANDOMIZED-TRIALS; MYOCARDIAL-INFARCTION; LDL CHOLESTEROL; HEART-DISEASE; ATORVASTATIN; EFFICACY; SIMVASTATIN; PROGRESSION	Context A recent meta-analysis demonstrated that statin therapy is associated with excess risk of developing diabetes mellitus. Objective To investigate whether intensive-dose statin therapy is associated with increased risk of new-onset diabetes compared with moderate-dose statin therapy. Data Sources We identified relevant trials in a literature search of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (January 1, 1996, through March 31, 2011). Unpublished data were obtained from investigators. Study Selection We included randomized controlled end-point trials that compared intensive-dose statin therapy with moderate-dose statin therapy and included more than 1000 participants who were followed up for more than 1 year. Data Extraction Tabular data provided for each trial described baseline characteristics and numbers of participants developing diabetes and experiencing major cardiovascular events (cardiovascular death, nonfatal myocardial infarction or stroke, coronary revascularization). We calculated trial-specific odds ratios (ORs) for new-onset diabetes and major cardiovascular events and combined these using random-effects model meta-analysis. Between-study heterogeneity was assessed using the I-2 statistic. Results In 5 statin trials with 32 752 participants without diabetes at baseline, 2749 developed diabetes (1449 assigned intensive-dose therapy, 1300 assigned moderate-dose therapy, representing 2.0 additional cases in the intensive-dose group per 1000 patient years) and 6684 experienced cardiovascular events(3134 and 3550, respectively, representing 6.5 fewer cases in the intensive-dose group per 1000 patient-years) over a weighted mean (SD) follow-up of 4.9 (1.9) years. Odds ratios were 1.12 (95% confidence interval [CI], 1.04-1.22; I-2 = 0%) for new-onset diabetes and 0.84(95% CI, 0.75-0.94; I-2 = 74%) for cardiovascular events for participants receiving intensive therapy compared with moderate-dose therapy. As compared with moderate-dose statin therapy, the number needed to harm per year for intensive-dose statin therapy was 498 for new-onset diabetes while the number needed to treat per year for intensive-dose statin therapy was 155 for cardiovascular events. Conclusion In a pooled analysis of data from 5 statin trials, intensive-dose statin therapy was associated with an increased risk of new-onset diabetes compared with moderate dose statin therapy. JAMA. 2011;305(24):2556-2564	[Preiss, David; Welsh, Paul; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Seshasai, Sreenivasa Rao Kondapally] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Murphy, Sabina A.; Cannon, Christopher P.; Sabatine, Marc S.; Braunwald, Eugene] Harvard Univ, Sch Med, Div Cardiovasc, TIMI Study Grp, Boston, MA USA; [Ho, Jennifer E.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Waters, David D.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [DeMicco, David A.] Pfizer, Global Pharmaceut, New York, NY USA; [Barter, Philip] Heart Res Inst, Sydney, NSW, Australia; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA; [Blazing, Michael A.] Duke Clin Res Inst, Durham, NC USA; [Pedersen, Terje R.] Univ Oslo, Oslo, Norway; [Pedersen, Terje R.] Oslo Univ Hosp, Ctr Preventat Med, Oslo, Norway; [Tikkanen, Matti J.] Univ Helsinki, Helsinki, Finland; [Tikkanen, Matti J.] Helsinki Univ Hosp, Div Cardiol, Helsinki, Finland; [Tikkanen, Matti J.] Folkhalsan Res Ctr, Helsinki, Finland; [Ray, Kausik K.] St Georges Univ London, Div Cardiac & Vasc Sci, London, England	University of Glasgow; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; Pfizer; University of Sydney; Heart Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Texas System; University of Texas Southwestern Medical Center Dallas; Duke University; University of Oslo; University of Oslo; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; St Georges University London	Preiss, D (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	david.preiss@glasgow.ac.uk; kray@sgul.ac.uk	Hug, Balthasar L./G-1568-2010; Sabatine, Marc/AAJ-6751-2020; Cannon, Christopher P/AAY-7644-2020; Kastelein, John/AAF-7950-2020; Welsh, Paul/H-5249-2019; Ray, Kausik/Z-2055-2019; de Lemos, James/ABD-6669-2021	Sabatine, Marc/0000-0002-0691-3359; Cannon, Christopher P/0000-0003-4596-2791; Welsh, Paul/0000-0002-7970-3643; Ho, Jennifer/0000-0002-7987-4768; Preiss, David/0000-0003-3139-1836	Bristol-Myers Squibb through the TIMI Study Group; Merck; Pfizer; Bristol-Myers Squibb; AstraZeneca; Roche; Accumetrics; GlaxoSmithKline; Intekrin Therapeutics; Takeda; AstraZeneca through Brigham and Women's Hospital; Bristol-Myers Squibb/sanofi-aventis; Schering Plough; Amgen; Eli Lilly; sanofi-aventis; Novartis; Boehringer Ingelheim; Isis; Genzyme; Kowa; Schering-Plough; Novo Nordisk	Bristol-Myers Squibb through the TIMI Study Group; Merck(Merck & Company); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Roche(Roche Holding); Accumetrics; GlaxoSmithKline(GlaxoSmithKline); Intekrin Therapeutics; Takeda(Takeda Pharmaceutical Company Ltd); AstraZeneca through Brigham and Women's Hospital; Bristol-Myers Squibb/sanofi-aventis(Sanofi-AventisBristol-Myers Squibb); Schering Plough(Merck & CompanySchering Plough Corporation); Amgen(Amgen); Eli Lilly(Eli Lilly); sanofi-aventis(Sanofi-Aventis); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Isis; Genzyme(Sanofi-AventisGenzyme Corporation); Kowa; Schering-Plough(Merck & CompanySchering Plough Corporation); Novo Nordisk(Novo Nordisk)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Murphy reported receiving research grant support through the TIMI Study Group from Bristol-Myers Squibb and Merck. Dr Ho reported receiving consulting fees from Pfizer. Dr Waters reported receiving honoraria for lectures from Bristol-Myers Squibb and Pfizer and consulting for Merck Schering Plough and Pfizer for participation in clinical trial committees. Dr DeMicco reported being an employee of Pfizer. Dr Barter reported acting as member on advisory boards for AstraZeneca, CSL, Merck, Novartis, Pfizer, and Roche; receiving honoraria from Abbott, AstraZeneca, Merck, Novartis, Pfizer, and Roche; and participating in clinical trials sponsored by AstraZeneca, Merck, Pfizer, and Roche. Dr Cannon reported receiving research grants or support from Accumetrics, AstraZeneca, GlaxoSmithKline, Intekrin Therapeutics, Merck, and Takeda; acting on advisory boards (funds donated to charity) for Alnylam, Bristol-Myers Squibb/sanofi, and Novartis; receiving honoraria for independent educational symposia from AstraZeneca and Pfizer; and acting as a clinical advisor with equity for Automedics Medical Systems. Dr Sabatine reported receiving research grant support through Brigham and Women's Hospital from AstraZeneca, Bristol-Myers Squibb/sanofi-aventis, Schering Plough, and Amgen; consulting for AstraZeneca and Bristol-Myers Squibb/sanofi-aventis; and lecturing for Bristol-Myers Squibb/sanofi-aventis. Dr Braunwald reported receiving research support for the TIMI Study Group from Merck, AstraZeneca, and Pfizer. Dr Kastelein reported having participated in clinical trials sponsored by Pfizer, AstraZeneca, Merck, Eli Lilly, sanofi-aventis, Roche, Novartis, Boehringer Ingelheim, Isis, and Genzyme and receiving lecturing and consulting fees from Pfizer, AstraZeneca, Merck, Eli Lilly, sanofi-aventis, Roche, Novartis, Isis, Genzyme, and Kowa. Dr de Lemos reported consulting for AstraZeneca and receiving honoraria from Merck/Schering and Pfizer for lectures (>2 years ago). Dr Blazing reported receiving speaking or consulting fees from Merck and being the principal investigator on a research grant from Schering-Plough administered through the Duke Clinical Research Institute. Dr Pedersen reported receiving speakers' honoraria from and consulting for Pfizer and Merck-Schering Plough and receiving speakers' honoraria from AstraZeneca. Dr Tikkanen reported participating in clinical trials sponsored by Pfizer and Takeda, acting as member of a steering committee for a trial sponsored by Pfizer, and being a member of an advisory board of MSD Finland. Dr Sattar reported consulting for and receiving lecture fees from Merck, Pfizer, and AstraZeneca and having received research grant support from Pfizer. Dr Ray reported consulting/lecturing at symposia funded by Novo Nordisk, Roche, Pfizer, Merck, sanofi-aventis, and AstraZeneca. No other disclosures were reported.	Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Campeau L, 1997, NEW ENGL J MED, V336, P153; Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Deedwania P, 2007, CIRCULATION, V115, P700, DOI 10.1161/CIRCULATIONAHA.106.654756; Freeman DJ, 2001, CIRCULATION, V103, P357; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Koh KK, 2010, J AM COLL CARDIOL, V55, P1209, DOI 10.1016/j.jacc.2009.10.053; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LaRosa JC, 2010, AM J CARDIOL, V105, P283, DOI 10.1016/j.amjcard.2009.09.025; Mallinson JE, 2009, J PHYSIOL-LONDON, V587, P219, DOI 10.1113/jphysiol.2008.164699; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murphy SA, 2009, J AM COLL CARDIOL, V54, P2358, DOI 10.1016/j.jacc.2009.10.005; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Sabatine MS, 2004, CIRCULATION, V110, P834; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Tikkanen MJ, 2009, J AM COLL CARDIOL, V54, P2353, DOI 10.1016/j.jacc.2009.08.035; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wannamethee SG, 2011, ARCH INTERN MED, V171, P404, DOI 10.1001/archinternmed.2011.2; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047	31	984	1046	1	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2556	2564		10.1001/jama.2011.860	http://dx.doi.org/10.1001/jama.2011.860			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693744	Bronze, Green Published			2022-12-28	WOS:000291860400023
J	Duong, HA; Robles, MS; Knutti, D; Weitz, CJ				Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.			A Molecular Mechanism for Circadian Clock Negative Feedback	SCIENCE			English	Article							HISTONE ACETYLATION; TRANSCRIPTION; BINDING; PSF; COMPONENTS; REVEALS; FBXL3; MPER1; LOOP; LIMB	Circadian rhythms in mammals are generated by a feedback loop in which the three PERIOD (PER) proteins, acting in a large complex, inhibit the transcriptional activity of the CLOCK-BMAL1 dimer, which represses their own expression. Although fundamental, the mechanism of negative feedback in the mammalian clock, or any eukaryotic clock, is unknown. We analyzed protein constituents of PER complexes purified from mouse tissues and identified PSF (polypyrimidine tract-binding protein-associated splicing factor). Our analysis indicates that PSF within the PER complex recruits SIN3A, a scaffold for assembly of transcriptional inhibitory complexes and that the PER complex thereby rhythmically delivers histone deacetylases to the Per1 promoter, which repress Per1 transcription. These findings provide a function for the PER complex and a molecular mechanism for circadian clock negative feedback.	[Duong, Hao A.; Robles, Maria S.; Knutti, Darko; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Robles, Maria S/D-6307-2015	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761	G. Harold and Leila Y. Mathers Charitable Foundation; NIH; Edward R. and Anne G. Lefler Center; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward R. and Anne G. Lefler Center; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Liu for technical assistance, P. Nakatani (Dana Farber Cancer Institute) for the FH tag, D. Weaver and S. Reppert (University of Massachusetts) for Per1<SUP>-/-</SUP>;Per2<SUP>-/-</SUP> mice, N. Copeland (Institute of Molecular and Cell Biology, Singapore) for reagents, and Y. Kurihara (Yokohama National University) for PSF plasmid. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation (C.J.W.), NIH Training Grant in Fundamental Neurobiology fellowship (H.A.D.), an Edward R. and Anne G. Lefler Center fellowship (M.S.R.), and a Swiss National Science Foundation fellowship (D.K.).	Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Padmanabhan K., UNPUB; Perales M, 2007, PLANT CELL, V19, P2111, DOI 10.1105/tpc.107.050807; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07	29	194	202	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1436	1439		10.1126/science.1196766	http://dx.doi.org/10.1126/science.1196766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680841	Green Accepted			2022-12-28	WOS:000291689000043
J	Patel, MM; Lopez-Collada, VR; Bulhoes, MM; De Oliveira, LH; Marquez, AB; Flannery, B; Esparza-Aguilar, M; Renoiner, EIM; Luna-Cruz, ME; Sato, HK; Hernandez-Hernandez, LD; Toledo-Cortina, G; Ceron-Rodriguez, M; Osnaya-Romero, N; Martinez-Alcazar, M; Aguinaga-Villasenor, RG; Plascencia-Hernandez, A; Fojaco-Gonzalez, F; Rezk, GHP; Gutierrez-Ramirez, SF; Dorame-Castillo, R; Tinajero-Pizano, R; Mercado-Villegas, B; Barbosa, MR; Maluf, EMC; Ferreira, LB; de Carvalho, FM; dos Santos, AR; Cesar, ED; de Oliveira, MEP; Silva, CLO; Cortes, MD; Matus, CR; Tate, J; Gargiullo, P; Parashar, UD				Patel, Manish M.; Richardson Lopez-Collada, Vesta; Bulhoes, Marilia Mattos; Helena De Oliveira, Lucia; Bautista Marquez, Aurora; Flannery, Brendan; Esparza-Aguilar, Marcelino; Montenegro Renoiner, Ernesto Isaac; Edilia Luna-Cruz, Maria; Sato, Helena Keico; del Carmen Hernandez-Hernandez, Luz; Toledo-Cortina, Gerardo; Ceron-Rodriguez, Magdalena; Osnaya-Romero, Neydi; Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio; Plascencia-Hernandez, Arturo; Fojaco-Gonzalez, Francisco; Hernandez-Peredo Rezk, Guillermo; Fortino Gutierrez-Ramirez, Sixto; Dorame-Castillo, Roberto; Tinajero-Pizano, Rogelio; Mercado-Villegas, Bernice; Barbosa, Marilia Reichelt; Cesario Maluf, Eliane Mara; Ferreira, Lucimar Bozza; de Carvalho, Francisca Maria; dos Santos, Ana Rosa; Cesar, Eduardo Dolabella; Paula de Oliveira, Maria Elisa; Osterno Silva, Carmem Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.			Intussusception Risk and Health Benefits of Rotavirus Vaccination in Mexico and Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD DIARRHEA; CASE SERIES; SAFETY; INFANTS; EFFICACY; CHILDREN; GASTROENTERITIS; IMMUNIZATION; VACCINES	Background Because postlicensure surveillance determined that a previous rotavirus vaccine, RotaShield, caused intussusception in 1 of every 10,000 recipients, we assessed the association of the new monovalent rotavirus vaccine (RV1) with intussusception after routine immunization of infants in Mexico and Brazil. Methods We used case-series and case-control methods to assess the association between RV1 and intussusception. Infants with intussusception were identified through active surveillance at 69 hospitals (16 in Mexico and 53 in Brazil), and age-matched infants from the same neighborhood were enrolled as controls. Vaccination dates were verified by a review of vaccination cards or clinic records. Results We enrolled 615 case patients (285 in Mexico and 330 in Brazil) and 2050 controls. An increased risk of intussusception 1 to 7 days after the first dose of RV1 was identified among infants in Mexico with the use of both the case-series method (incidence ratio, 5.3; 95% confidence interval [CI], 3.0 to 9.3) and the case-control method (odds ratio, 5.8; 95% CI, 2.6 to 13.0). No significant risk was found after the first dose among infants in Brazil, but an increased risk, albeit smaller than that seen after the first dose in Mexico - an increase by a factor of 1.9 to 2.6 - was seen 1 to 7 days after the second dose. A combined annual excess of 96 cases of intussusception in Mexico (approximately 1 per 51,000 infants) and in Brazil (approximately 1 per 68,000 infants) and of 5 deaths due to intussusception was attributable to RV1. However, RV1 prevented approximately 80,000 hospitalizations and 1300 deaths from diarrhea each year in these two countries. Conclusions RV1 was associated with a short-term risk of intussusception in approximately 1 of every 51,000 to 68,000 vaccinated infants. The absolute number of deaths and hospitalizations averted because of vaccination far exceeded the number of intussusception cases that may have been associated with vaccination. (Funded in part by the GAVI Alliance and the U. S. Department of Health and Human Services.)	[Patel, Manish M.; Tate, Jacqueline; Gargiullo, Paul; Parashar, Umesh D.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Richardson Lopez-Collada, Vesta; Bautista Marquez, Aurora; Esparza-Aguilar, Marcelino; Edilia Luna-Cruz, Maria; del Carmen Hernandez-Hernandez, Luz] Minist Hlth, Natl Ctr Child & Adolescent Hlth, Mexico City, DF, Mexico; [Toledo-Cortina, Gerardo] Hosp Pediat Moctezuma, Mexico City, DF, Mexico; [Ceron-Rodriguez, Magdalena] Hosp Infantil Mexico Dr Federico Gomez, Mexico City, DF, Mexico; [Osnaya-Romero, Neydi] Inst Nacl Pediat, Mexico City, DF, Mexico; [Bulhoes, Marilia Mattos; Montenegro Renoiner, Ernesto Isaac; dos Santos, Ana Rosa] Minist Hlth, Secretariat Hlth Surveillance, Brasilia, DF, Brazil; [Montenegro Renoiner, Ernesto Isaac] Univ Brasilia, Nucleo Med Trop, Brasilia, DF, Brazil; [Flannery, Brendan] Pan Amer Hlth Org, Brasilia, DF, Brazil; [Sato, Helena Keico] Secretaria Estado Saude Sao Paulo, Sao Paulo, Brazil; [Ferreira, Lucimar Bozza] Secretaria Municipal Saude Curitiba, Curitiba, Parana, Brazil; [de Carvalho, Francisca Maria] Secretaria Estado Saude Rio de Janeiro, Rio De Janeiro, Brazil; [Cesar, Eduardo Dolabella] Secretaria Estado Saude Minas Gerais, Belo Horizonte, MG, Brazil; [Osterno Silva, Carmem Lucia] Secretaria Estado Saude Curitiba, Ceara, Brazil; [Helena De Oliveira, Lucia; de los Angeles Cortes, Maria; Ruiz Matus, Cuauhtemoc] Pan Amer Hlth Org, Washington, DC USA; [Osnaya-Romero, Neydi] Hosp Nino Morelense, Cuernavaca, Morelos, Mexico; [Martinez-Alcazar, Mario; Gabriela Aguinaga-Villasenor, Rocio] Hosp Infantil Morelia Eva Samano de Lopez Mateos, Morelia, Michoacan, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Reg Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; [Plascencia-Hernandez, Arturo] Hosp Civil Nuevo Guadalajara Juan I Menchaca, Guadalajara, Jalisco, Mexico; [Fojaco-Gonzalez, Francisco] Hosp Alta Especialidad Nino Dr Rodolfo Nieto Padr, Villahermosa, Tabasco, Mexico; [Hernandez-Peredo Rezk, Guillermo] Ctr Especialidades Med Veracruz, Xalapa, Veracruz, Mexico; [Fortino Gutierrez-Ramirez, Sixto] Hosp Metropolitano Dr Bernardo Sepulveda, Monterrey, Nuevo Leon, Mexico; [Dorame-Castillo, Roberto] Hosp Infantil Estado Sonora, Hermosillo, Sonora, Mexico; [Tinajero-Pizano, Rogelio] Hosp Gen Reg Leon, Guanajuato, Mexico; [Mercado-Villegas, Bernice] Hosp Civil Tepic Dr Antonio Gonzalez Guevara, Tepic, Nayarit, Mexico	Centers for Disease Control & Prevention - USA; Hospital Infantil de Mexico Federico Gomez; Universidade de Brasilia; Pan American Health Organization; Pan American Health Organization	Patel, MM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	mpatel@cdc.gov	Hernandez, Arturo Plascencia/K-9659-2017; Osnaya-Romero, Neydi/AAI-2458-2020	Hernandez, Arturo Plascencia/0000-0002-7950-3019; /0000-0003-1486-3651	GAVI Alliance; U.S. Department of Health and Human Services	GAVI Alliance; U.S. Department of Health and Human Services	Funded in part by the GAVI Alliance under a collaborative agreement with the Program for Appropriate Technology in Health (PATH) and in part by the U.S. Department of Health and Human Services.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P533; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P38; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P325; [Anonymous], 45 INT C ANT AG CHEM; Araujo EC, 2007, J PEDIAT-BRAZIL, V83, P217, DOI [10.2223/JPED.1600, 10.1590/S0021-75572007000400006]; Bines JE, 2004, VACCINE, V22, P569, DOI 10.1016/j.vaccine.2003.09.016; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Cortese M, ESTIMATES BENEFITS P; Cortese Margaret M., 2010, Morbidity and Mortality Weekly Report, V59, P1074; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; de Palma O, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2825; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Moser CA, 2001, J INFECT DIS, V183, P1108, DOI 10.1086/319294; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Musonda P, 2006, STAT MED, V25, P2618, DOI 10.1002/sim.2477; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Patel MM, 2009, VACCINE, V27, P2916, DOI 10.1016/j.vaccine.2009.03.016; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Salinas M, 2005, PEDIATR INFECT DIS J, V24, P807, DOI 10.1097/01.inf.0000178294.13954.a1; Simonsen L, 2001, LANCET, V358, P1224, DOI 10.1016/S0140-6736(01)06346-2; Steele AD, 2010, VACCINE, V28, P6542, DOI 10.1016/j.vaccine.2008.08.034; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285	30	272	288	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2283	2292		10.1056/NEJMoa1012952	http://dx.doi.org/10.1056/NEJMoa1012952			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675888	Bronze			2022-12-28	WOS:000291643800006
J	Bishop, TF; Ryan, AK; Casalino, LP				Bishop, Tara F.; Ryan, Andrew K.; Casalino, Lawrence P.			Paid Malpractice Claims for Adverse Events in Inpatient and Outpatient Settings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT SAFETY; DIAGNOSTIC ERROR; PRIMARY-CARE; AMBULATORY-CARE; EPIDEMIOLOGY; NEGLIGENCE; LITIGATION; MEDICINE; QUALITY	Context An analysis of paid malpractice claims may provide insight into the prevalence and seriousness of adverse medical events in the outpatient setting. Objective To report and compare the number, magnitude, and type of paid malpractice claims for events in inpatient and outpatient settings. Design and Setting Retrospective analysis of malpractice claims paid on behalf of physicians in outpatient and inpatient settings using data from the National Practitioner Data Bank from 2005 through 2009. We evaluated trends in claims paid by setting, characteristics of paid claims, and factors associated with payment amount. Main Outcome Measures Number of paid claims, mean and median payment amounts, types of errors, and outcomes of errors. Results In 2009, there were 10 739 malpractice claims paid on behalf of physicians. Of these paid claims, 4910 (47.6%; 95% confidence interval [CI], 46.6%-48.5%) were for events in the inpatient setting, 4448 (43.1%; 95% CI, 42.1%-44.0%) were for events in the outpatient setting, and 966 (9.4%; 95% CI, 8.8%-9.9%) involved events in both settings. The proportion of payments for events in the outpatient setting increased by a small but statistically significant amount, from 41.7% (95% CI, 40.9%-42.6%) in 2005 to 43.1% (95% CI, 42.1%-44.0%) in 2009 (P<.001 for trend across years). In the outpatient setting, the most common reason for a paid claim was diagnostic (45.9%; 95% CI, 44.4%-47.4%), whereas in the inpatient setting the most common reason was surgical (34.1%; 95% CI, 32.8%-35.4%). Major injury and death were the 2 most common outcomes in both settings. Mean payment amount for events in the inpatient setting was significantly higher than in the outpatient setting ($362 965; 95% CI, $348 192-$377 738 vs $290 111; 95% CI, $278 289-$301 934; P<.001). Conclusion In 2009, the number of paid malpractice claims reported to the National Practitioner Data Bank for events in the outpatient setting was similar to the number in the inpatient setting. JAMA. 2011;305(23):2427-2431 www.jama.com	[Bishop, Tara F.; Ryan, Andrew K.; Casalino, Lawrence P.] Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, New York, NY 10021 USA; [Bishop, Tara F.] Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA	Cornell University; Cornell University	Bishop, TF (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Div Outcomes & Effectiveness, 402 E 67th St,Room LA-218, New York, NY 10021 USA.	tlfernan@med.cornell.edu	Casalino, Lawrence/ABE-1245-2020	Casalino, Lawrence/0000-0002-7927-7859	Agency for Healthcare Research and Quality [K01 HS018546-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018546] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Bishop is supported in part by funds provided to her as a Nanette Laitman Clinical Scholar in Public Health at Weill Cornell Medical College. Dr Ryan is supported by grant K01 HS018546-01 from the Agency for Healthcare Research and Quality.	Berner ES, 2007, ANN INTERN MED, V146, P470, DOI 10.7326/0003-4819-146-6-200703200-00022; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Carroll AE, 2007, PEDIATRICS, V120, P10, DOI 10.1542/peds.2006-3618; Casalino LP, 2009, ARCH INTERN MED, V169, P1123, DOI 10.1001/archinternmed.2009.130; Casalino LP, 1999, NEW ENGL J MED, V341, P1147, DOI 10.1056/NEJM199910073411511; CHANDRA A, 2005, HLTH AFF MILLWOOD S; Department of Health and Human Services, DAT BANK NAT PRACT H; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gandhi TK, 2006, ANN INTERN MED, V145, P488, DOI 10.7326/0003-4819-145-7-200610030-00006; Gandhi TK, 2010, NEW ENGL J MED, V363, P1001, DOI 10.1056/NEJMp1003294; Gandhi TK, 2000, J GEN INTERN MED, V15, P626, DOI 10.1046/j.1525-1497.2000.91119.x; Gandhi TK, 2000, J GEN INTERN MED, V15, P149, DOI 10.1046/j.1525-1497.2000.04199.x; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; General Accounting Office, 2000, PUBL GEN ACC OFF; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Kistler CE, 2010, ARCH INTERN MED, V170, P1480, DOI 10.1001/archinternmed.2010.288; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; KRAVITZ RL, 1991, JAMA-J AM MED ASSOC, V266, P2087, DOI 10.1001/jama.266.15.2087; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; McKinsey and Company Global Institute, 2008, ACC COST US HEALTHC; National Center for Health Statistics, AMB CAR US PHYS VIS; Newman-Toker DE, 2009, JAMA-J AM MED ASSOC, V301, P1060, DOI 10.1001/jama.2009.249; Pagano M., 2000, PRINCIPLES BIOSTATIS, V2nd edition; Phillips RL, 2004, QUAL SAF HEALTH CARE, V13, P121, DOI 10.1136/qshc.2003.008029; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Schiff GD, 2009, ARCH INTERN MED, V169, P1881, DOI 10.1001/archinternmed.2009.333; Singh H, 2007, ARCH INTERN MED, V167, P302, DOI 10.1001/archinte.167.3.302; Singh H, 2010, JAMA-J AM MED ASSOC, V304, P463, DOI 10.1001/jama.2010.1035; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; United States Department of Labor, CPI INFL CALC; Wachter RM, 2006, ANN INTERN MED, V145, P547, DOI 10.7326/0003-4819-145-7-200610030-00014; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	34	99	109	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2427	2431		10.1001/jama.2011.813	http://dx.doi.org/10.1001/jama.2011.813			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673294				2022-12-28	WOS:000291597300022
J	Kickbusch, I				Kickbusch, Ilona			Global health diplomacy: how foreign policy can influence health	BRITISH MEDICAL JOURNAL			English	Editorial Material								Ilona Kickbusch argues that public health experts need to work with diplomats in order to achieve global health goals	Grad Inst Int Studies, Global Hlth Programme, CH-1211 Geneva, Switzerland		Kickbusch, I (corresponding author), Grad Inst Int Studies, Global Hlth Programme, CH-1211 Geneva, Switzerland.	kickbusch@bluewin.ch						Alvarez C., 2009, VENEZUELAS OIL BASED; Aviel JoannF., 2005, MULTILATERAL DIPLOMA, P159; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Brandt AM., 2007, CIGARETTE CENTURY RI; Clinton Hillary Rodham, 2010, COMMUNICATION   0816; *COUNC EUR UN, 2010, N966410 COUNC EUR UN; *FED DEP HOM AFF, SWISS HLTH FOR POL 2; Feinsilver J., 2006, CUBAN MED DIPLOMACY; Foreign Ministers of Brazil France Indonesia Norway Senegal South Africa and Thailand (Oslo), 2007, LANCET, V369, P1373; GOMEZ EJ, 2009, FOREIGN POLICY  0722; *GOV JAP, 2010, JAP GLOB HLTH POL 20; *HM GOV, HLTH GLOB OUTC FRAM; HM Government, 2008, HLTH GLOB UK GOV STR; Kaufmann JR, 2009, HEALTH AFFAIR, V28, P1091, DOI 10.1377/hlthaff.28.4.1091; Khanna P, 2011, RUN WORLD CHARTING C; Norwegian Ministry of Health and Care Services and Norwegian Ministry of Foreign Services, 2010, NORW WHO STRAT NORW; *UK SECR GEN, 2009, NOT SECR GEN A 64 36	17	36	36	0	25	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2011	342								d3154	10.1136/bmj.d3154	http://dx.doi.org/10.1136/bmj.d3154			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SS	21665931				2022-12-28	WOS:000291645900001
J	Yu, YH; Yoon, SO; Poulogiannis, G; Yang, Q; Ma, XJM; Villen, J; Kubica, N; Hoffman, GR; Cantley, LC; Gygi, SP; Blenis, J				Yu, Yonghao; Yoon, Sang-Oh; Poulogiannis, George; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Cantley, Lewis C.; Gygi, Steven P.; Blenis, John			Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling	SCIENCE			English	Article							INHIBITION; DISRUPTION; RESISTANCE; ACTIVATION; KINASE; LEADS	The evolutionarily conserved serine-threonine kinase mammalian target of rapamycin (mTOR) plays a critical role in regulating many pathophysiological processes. Functional characterization of the mTOR signaling pathways, however, has been hampered by the paucity of known substrates. We used large-scale quantitative phosphoproteomics experiments to define the signaling networks downstream of mTORC1 and mTORC2. Characterization of one mTORC1 substrate, the growth factor receptor-bound protein 10 (Grb10), showed that mTORC1-mediated phosphorylation stabilized Grb10, leading to feedback inhibition of the phosphatidylinositol 3-kinase (PI3K) and extracellular signal-regulated, mitogen-activated protein kinase (ERK-MAPK) pathways. Grb10 expression is frequently down-regulated in various cancers, and loss of Grb10 and loss of the well-established tumor suppressor phosphatase PTEN appear to be mutually exclusive events, suggesting that Grb10 might be a tumor suppressor regulated by mTORC1.	[Yu, Yonghao; Yoon, Sang-Oh; Yang, Qian; Ma, Xiaoju Max; Villen, Judit; Kubica, Neil; Hoffman, Gregory R.; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA; [Yang, Qian] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard School of Dental Medicine	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Steven_gygi@hms.harvard.edu; john_blenis@hms.harvard.edu	Poulogiannis, George/AAE-1966-2019; Poulogiannis, George/AAY-2210-2021; Cantley, Lewis C/D-1800-2014	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; Villen, Judit/0000-0002-1005-1739	Tuberous Sclerosis Alliance [ID-146]; NIH [GM051405, CA46595, HG3456, R00CA140789]; NATIONAL CANCER INSTITUTE [R37CA046595, R00CA140789, R01CA046595] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, R01GM051405, R01GM041890] Funding Source: NIH RePORTER	Tuberous Sclerosis Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Blenis and Gygi laboratories for critical discussion. This work was supported by a postdoctoral fellowship from the Tuberous Sclerosis Alliance (grant ID-146 to Y.Y.), and NIH grants GM051405 and CA46595 (J.B.), HG3456 (S. P. G.), and R00CA140789 (J.V.). J.B. is an Established Investigator of the LAM Foundation. A provisional patent on the phosphorylation sites identified and the participation of Grb10 in the feedback loop was filed on 9/23/2010 (no. 61/403, 932 to J.B., S. P. G. and Y.Y.).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Langlais P, 2005, BIOCHEMISTRY-US, V44, P8890, DOI 10.1021/bi050413i; Lim MA, 2004, FRONT BIOSCI-LANDMRK, V9, P387, DOI 10.2741/1226; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07	16	628	645	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1322	1326		10.1126/science.1199484	http://dx.doi.org/10.1126/science.1199484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659605	Green Accepted			2022-12-28	WOS:000291441700045
J	Nelson, J; Maroon, M				Nelson, Jenny; Maroon, Michele			Pseudoverrucous Papules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nelson, Jenny; Maroon, Michele] Geisinger Med Ctr, Danville, PA 17822 USA	Geisinger Medical Center	Nelson, J (corresponding author), Geisinger Med Ctr, Danville, PA 17822 USA.								0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					E50	E50		10.1056/NEJMicm1007893	http://dx.doi.org/10.1056/NEJMicm1007893			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651389				2022-12-28	WOS:000291392100012
J	Sylvestre, D				Sylvestre, Diana			Recognizing resistance	NATURE			English	Editorial Material							ADHERENCE; MUTATIONS		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sylvestre, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	diana.sylvestre@ucsf.edu						Ferrando SJ, 1996, AM J DRUG ALCOHOL AB, V22, P475, DOI 10.3109/00952999609001674; Foretier N, 2008, HEPATOLOGY, V48, p760A; Singh N, 1999, CLIN INFECT DIS, V29, P824, DOI 10.1086/520443; Tong X, 2008, ANTIVIR RES, V77, P177, DOI 10.1016/j.antiviral.2007.11.010; Tulsky JP, 2000, ARCH INTERN MED, V160, P697, DOI 10.1001/archinte.160.5.697; Yi MK, 2006, J BIOL CHEM, V281, P8205, DOI 10.1074/jbc.M510246200	6	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S11	S11		10.1038/474S11a	http://dx.doi.org/10.1038/474S11a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666727	Bronze			2022-12-28	WOS:000291397800007
J	Van den Bruel, A; Thompson, MJ; Haj-Hassan, T; Stevens, R; Moll, H; Lakhanpaul, M; Mant, D				Van den Bruel, Ann; Thompson, Matthew J.; Haj-Hassan, Tanya; Stevens, Richard; Moll, Henriette; Lakhanpaul, Monica; Mant, David			Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; LOWER RESPIRATORY-TRACT; BACTERIAL-INFECTION; OUTPATIENT MANAGEMENT; SERUM PROCALCITONIN; FEVER; RISK; METAANALYSIS; INFANTS; POINT	Objective To collate all available evidence on the diagnostic value of laboratory tests for the diagnosis of serious infections in febrile children in ambulatory settings. Design Systematic review. Data sources Electronic databases, reference tracking, and consultation with experts. Study selection Studies were selected on six criteria: design (studies of diagnostic accuracy or deriving prediction rules), participants (otherwise healthy children and adolescents aged 1 month to 18 years), setting (first contact ambulatory care), outcome (serious infection), features assessed (in first contact care), and data reported (sufficient to construct a 2x2 table). Data extraction Quality assessment was based on the quality assessment tool of diagnostic accuracy studies (QUADAS) criteria. Meta-analyses were done using the bivariate random effects method and hierarchical summary receiver operating characteristic curves for studies with multiple thresholds. Data synthesis None of the 14 studies identified were of high methodological quality and all were carried out in an emergency department or paediatric assessment unit. The prevalence of serious infections ranged from 4.5% to 29.3%. Tests were carried out for C reactive protein (five studies), procalcitonin (three), erythrocyte sedimentation rate (one), interleukins (two), white blood cell count (seven), absolute neutrophil count (two), band count (three), and left shift (one). The tests providing most diagnostic value were C reactive protein and procalcitonin. Bivariate random effects meta-analysis (five studies, 1379 children) for C reactive protein yielded a pooled positive likelihood ratio of 3.15 (95% confidence interval 2.67 to 3.71) and a pooled negative likelihood ratio of 0.33 (0.22 to 0.49). To rule in serious infection, cut-off levels of 2 ng/mL for procalcitonin (two studies, positive likelihood ratio 13.7, 7.4 to 25.3 and 3.6, 1.4 to 8.9) and 80 mg/L for C reactive protein (one study, positive likelihood ratio 8.4, 5.1 to 14.1) are recommended; lower cut-off values of 0.5 ng/mL for procalcitonin or 20 mg/L for C reactive protein are necessary to rule out serious infection. White blood cell indicators are less valuable than inflammatory markers for ruling in serious infection (positive likelihood ratio 0.87-2.43), and have no value for ruling out serious infection (negative likelihood ratio 0.61-1.14). The best performing clinical decision rule (recently validated in an independent dataset) combines testing for C reactive protein, procalcitonin, and urinalysis and has a positive likelihood ratio of 4.92 (3.26 to 7.43) and a negative likelihood ratio of 0.07 (0.02 to 0.27). Conclusion Measuring inflammatory markers in an emergency department setting can be diagnostically useful, but clinicians should apply different cut-off values depending on whether they are trying to rule in or rule out serious infection. Measuring white blood cell count is less useful for ruling in serious infection and not useful for ruling out serious infection. More rigorous studies are needed, including studies in primary care, to assess the value of laboratory tests alongside clinical diagnostic measurements, including vital signs.	[Van den Bruel, Ann; Thompson, Matthew J.; Stevens, Richard; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England; [Thompson, Matthew J.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Moll, Henriette] Sophia Childrens Univ Hosp, Erasmus MC, Rotterdam, Netherlands; [Lakhanpaul, Monica] Univ Leicester, Dept Med & Social Care Educ, Hlth Educ Res & Dev Unit, Leicester LE1 7RH, Leics, England	University of Oxford; Oregon Health & Science University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Leicester	Van den Bruel, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX1 2JD, England.	ann.vandenbruel@dphpc.ox.ac.uk	Van den Bruel, Ann/AAC-2442-2020	Van den Bruel, Ann/0000-0001-9012-2009; Lakhanpaul, Monica/0000-0002-9855-2043; Stevens, Richard/0000-0002-9258-4060	Health Technology Assessment project [07/37/05]; National Institute for Health Research's National School for Primary Care Research; Health Technology Assessment; National Institute for Health Research [CL-2009-13-007] Funding Source: researchfish	Health Technology Assessment project; National Institute for Health Research's National School for Primary Care Research; Health Technology Assessment; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Technology Assessment project 07/37/05 (Systematic review and validation of clinical prediction rules for identifying children with serious infections in emergency departments and urgent-access primary care) and the National Institute for Health Research's National School for Primary Care Research.; This work was funded by the Health Technology Assessment and is therefore subject to standard arrangements for use of Crown copyright material by other organisations.	Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Andreola B, 2007, PEDIATR INFECT DIS J, V26, P672, DOI 10.1097/INF.0b013e31806215e3; Baker MD, 1999, PEDIATRICS, V103, P627, DOI 10.1542/peds.103.3.627; BAKER MD, 1993, NEW ENGL J MED, V329, P1437, DOI 10.1056/NEJM199311113292001; Berger RMF, 1996, EUR J PEDIATR, V155, P468, DOI 10.1007/BF01955183; Bleeker SE, 2007, ACTA PAEDIATR, V96, P100, DOI 10.1111/j.1651-2227.2006.00033.x; BONADIO WA, 1993, CLIN PEDIATR, V32, P401, DOI 10.1177/000992289303200703; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; de Jong J, 2009, ACTA PAEDIATR, V98, P1142, DOI 10.1111/j.1651-2227.2009.01309.x; Dukic V, 2003, BIOMETRICS, V59, P936, DOI 10.1111/j.0006-341X.2003.00108.x; Esposito S, 2005, CLIN CHEM LAB MED, V43, P438, DOI 10.1515/CCLM.2005.077; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Galetto-Lacour A, 2003, PEDIATRICS, V112, P1054, DOI 10.1542/peds.112.5.1054; Galetto-Lacour A, 2010, ARCH DIS CHILD, V95, P968, DOI 10.1136/adc.2009.176800; Garra G, 2005, ACAD EMERG MED, V12, P921, DOI 10.1197/j.aem.2005.06.006; Hsiao AL, 2006, PEDIATRICS, V117, P1695, DOI 10.1542/peds.2005-1673; Jones AE, 2007, ANN EMERG MED, V50, P34, DOI 10.1016/j.annemergmed.2006.10.020; Lacour AG, 2001, EUR J PEDIATR, V160, P95, DOI 10.1007/s004310000681; Lacour AG, 2008, PEDIATR INFECT DIS J, V27, P654, DOI 10.1097/INF.0b013e318168d2b4; Mantadakis E, 2009, J PEDIAT, V155, pe1; Mantadakis E, 2009, J PEDIATR-US, V155, P875, DOI 10.1016/j.jpeds.2009.06.037; Monteny M, 2006, CLIN CHEM LAB MED, V44, P1428, DOI 10.1515/CCLM.2006.270; Nademi Z, 2001, J INFECTION, V43, P221, DOI 10.1053/jinf.2001.0920; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Sanders S, 2008, J PEDIATR, V153, P570, DOI 10.1016/j.jpeds.2008.04.023; Saxena S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007484; Seamark DA, 2003, ANN CLIN BIOCHEM, V40, P178, DOI 10.1258/000456303763046139; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; StataCorp, 2005, STAT STAT SOFTW PROG; Thayyil S, 2005, ACTA PAEDIATR, V94, P155, DOI 10.1080/08035250410025140; Thompson M, 2009, ARCH DIS CHILD, V94, P888, DOI 10.1136/adc.2009.159095; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Thompson PL, 2009, ARCH DIS CHILD, V94, P337, DOI 10.1136/adc.2008.147579; Trautner BW, 2006, PEDIATRICS, V118, P34, DOI 10.1542/peds.2005-2823; Urinary tract infection in children, 2007, UR TRACT INF CHILDR; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538; Van den Bruel Ann, 2006, BMC Fam Pract, V7, P23, DOI 10.1186/1471-2296-7-23; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB	41	192	192	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2011	342								d3082	10.1136/bmj.d3082	http://dx.doi.org/10.1136/bmj.d3082			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SO	21653621	hybrid			2022-12-28	WOS:000291645500004
J	Keating, NL; Landrum, MB; Lamont, EB; Bozeman, SR; Krasnow, SH; Shulman, LN; Brown, JR; Earle, CC; Oh, WK; Rabin, M; McNeil, BJ				Keating, Nancy L.; Landrum, Mary Beth; Lamont, Elizabeth B.; Bozeman, Samuel R.; Krasnow, Steven H.; Shulman, Lawrence N.; Brown, Jennifer R.; Earle, Craig C.; Oh, William K.; Rabin, Michael; McNeil, Barbara J.			Quality of Care for Older Patients With Cancer in the Veterans Health Administration Versus the Private Sector A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CELL LUNG-CANCER; III COLON-CANCER; PROSTATE-CANCER; ADJUVANT CHEMOTHERAPY; MYOCARDIAL-INFARCTION; PROPENSITY SCORE; ADVERSE EVENTS; SENSITIVITY; MEDICARE; SYSTEM	Background: The Veterans Health Administration (VHA) is the largest integrated health care system in the United States. Studies suggest that the VHA provides better preventive care and care for some chronic illnesses than does the private sector. Objective: To assess the quality of cancer care for older patients provided by the VHA versus fee-for-service Medicare. Design: Observational study of patients with cancer that was diagnosed between 2001 and 2004 who were followed through 2005. Setting: VHA and non-VHA hospitals and office-based practices. Patients: Men older than 65 years with incident colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Measurements: Rates of processes of care for colorectal, lung, or prostate cancer; lymphoma; or multiple myeloma. Rates were adjusted by using propensity score weighting. Results: Compared with the fee-for-service Medicare population, the VHA population received diagnoses of colon (P < 0.001) and rectal (P = 0.007) cancer at earlier stages and had higher adjusted rates of curative surgery for colon cancer (92.7% vs. 90.5%; P < 0.010), standard chemotherapy for diffuse large B-cell non-Hodgkin lymphoma (71.1% vs. 59.3%; P < 0.001), and bisphosphonate therapy for multiple myeloma (62.1% vs. 50.4%; P < 0.001). The VHA population had lower adjusted rates of 3-dimensional conformal or intensity-modulated radiation therapy for prostate cancer treated with external-beam radiation therapy (61.6% vs. 86.0%; P < 0.001). Adjusted rates were similar for 9 other measures. Sensitivity analyses suggest that if patients with cancer in the VHA system have more severe comorbid illness than other patients, rates for most indicators would be higher in the VHA population than in the fee-for-service Medicare population. Limitation: This study included only older men and did not include information about performance status, severity of comorbid illness, or patient preferences. Conclusion: Care for older men with cancer in the VHA system was generally similar to or better than care for fee-for-service Medicare beneficiaries, although adoption of some expensive new technologies may be delayed in the VHA system.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Massachusetts Gen Hosp,Ctr Canc, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Abt Associates Inc, Cambridge, MA USA; Vet Affairs Med Ctr, Washington, DC 20422 USA; Inst Clin Evaluat Sci, Toronto, ON, Canada; Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; ABT Associates; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Icahn School of Medicine at Mount Sinai	Keating, NL (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	keating@hcp.med.harvard.edu	Keating, Nancy L/I-9968-2019; Oh, William K/B-9163-2012	Keating, Nancy L/0000-0002-8274-4681; Oh, William K/0000-0001-5113-8147; Lamont, Elizabeth/0000-0001-6604-678X	Department of Veterans Affairs; Department of Veterans Affairs through the Office of Policy and Planning [101-35-04]	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs through the Office of Policy and Planning(US Department of Veterans Affairs)	Department of Veterans Affairs.r By contract 101-35-04 from the Department of Veterans Affairs through the Office of Policy and Planning.	Adib RS, 1997, BRIT J UROL, V79, P235; Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Baker LH, 2000, ONCOLOGY-NY, V14, P111; Berenson JR, 1996, NEW ENGL J MED, V334, P488, DOI 10.1056/NEJM199602223340802; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chrischilles EA, 2010, J CLIN ONCOL, V28, P620, DOI 10.1200/JCO.2009.23.8485; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kahn KL, 2010, JAMA-J AM MED ASSOC, V303, P1037, DOI 10.1001/jama.2010.272; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Kizer KW, 2009, ANNU REV PUBL HEALTH, V30, P313, DOI 10.1146/annurev.publhealth.29.020907.090940; Kizer KW, 2000, MED CARE, V38, pS7; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; Ladapo Pearson SJ., 2007, INTENSITY MODULATED; Lamont E, 2011, J GERIATRI IN PRESS; Lamont EB, 2003, JNCI-J NATL CANCER I, V95, P1370, DOI 10.1093/jnci/djg035; Lamont EB, 2010, J CLIN ONCOL, V28, P215, DOI 10.1200/JCO.2008.21.3652; Landrum MB, 2004, HEALTH SERV RES, V39, P1773, DOI 10.1111/j.1475-6773.2004.00317.x; Laurie SA, 2004, LUNG CANCER, V43, P223, DOI 10.1016/j.lungcan.2003.09.002; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; National Cancer Institute, SURV EP END RES OV S; National Comprehensive Cancer Network, 2001, CLIN PRACT GUID ONC; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Petersen LA, 2000, NEW ENGL J MED, V343, P1934, DOI 10.1056/NEJM200012283432606; Pisansky TM, 2006, NEW ENGL J MED, V355, P1583, DOI 10.1056/NEJMct055263; POTOSKY AL, 1993, MED CARE, V31, P732; Rogers SO, 2010, ANN SURG ONCOL, V17, P1581, DOI 10.1245/s10434-010-0946-y; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P42, DOI 10.1097/EDE.0b013e3181f74493; Wilson NJ, 1998, CANCER, V82, P2003, DOI 10.1002/(SICI)1097-0142(19980515)82:10+<2003::AID-CNCR5>3.3.CO;2-U; Wilt TJ, 2008, COMP EFFECTIVENESS R, V13	40	72	72	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00004	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00004			90	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646556				2022-12-28	WOS:000291312300003
J	Powell, K				Powell, Kendall			Back to the bench	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					115	117		10.1038/nj7349-115a	http://dx.doi.org/10.1038/nj7349-115a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21644267	Bronze			2022-12-28	WOS:000291156700050
J	Chand, S				Chand, Sudeep			Is health still global? A new approach from the UK Government	LANCET			English	Editorial Material									Royal Inst Int Affairs, Ctr Global Hlth Secur, London SW1Y 4LE, England		Chand, S (corresponding author), Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.	schand@chathamhouse.org.uk						Chan LH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000266; Daulaire N, 2010, COMMUNICATION    JUN; Department for International Development, 2011, UK AID CHANG LIV DEL; Feldbaum H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000226; HM Government, WHO UK I STRAT 2008; HM Government, HLTH IS GLOB OUTC FR; Horton R, 2007, LANCET, V369, P806, DOI 10.1016/S0140-6736(07)60378-X; Labonte R, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-14; Lee K, 2011, EUROPEAN BUSINESS RE; [Mott MacDonald Department of Health], 2010, ANN IND REV UK GOV G; Silberschmidt G, 2009, EUROPEAN APPROACH GL	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2011	378	9808					E19	E20		10.1016/S0140-6736(11)60552-7	http://dx.doi.org/10.1016/S0140-6736(11)60552-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863DY	21663951				2022-12-28	WOS:000298144200001
J	Egan, A; Colman, E				Egan, Amy; Colman, Eric			Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Egan, Amy; Colman, Eric] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Egan, A (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Metab & Endocrinol Prod, Silver Spring, MD USA.		Hug, Balthasar L./G-1568-2010					Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Smith MEB., 2009, DRUG CLASS REV HMG C	5	78	83	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 28	2011	365	4					285	287		10.1056/NEJMp1106689	http://dx.doi.org/10.1056/NEJMp1106689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	798AJ	21675881	Bronze			2022-12-28	WOS:000293172200001
J	Qian, BZ; Li, JF; Zhang, H; Kitamura, T; Zhang, JH; Campion, LR; Kaiser, EA; Snyder, LA; Pollard, JW				Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Zhang, Jinghang; Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.; Pollard, Jeffrey W.			CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis	NATURE			English	Article							CHEMOATTRACTANT PROTEIN-1; BLOOD MONOCYTES; EXPRESSION; MODEL; PROGRESSION; SURVIVAL; SUBSETS; CELLS	Macrophages, which are abundant in the tumour microenvironment, enhance malignancy(1). At metastatic sites, a distinct population of metastasis-associated macrophages promotes the extravasation, seeding and persistent growth of tumour cells(2). Here we define the origin of these macrophages by showing that Gr1-positive inflammatory monocytes are preferentially recruited to pulmonary metastases but not to primary mammary tumours in mice. This process also occurs for human inflammatory monocytes in pulmonary metastases of human breast cancer cells. The recruitment of these inflammatory monocytes, which express CCR2 (the receptor for chemokine CCL2), as well as the subsequent recruitment of metastasis-associated macrophages and their interaction with metastasizing tumour cells, is dependent on CCL2 synthesized by both the tumour and the stroma. Inhibition of CCL2-CCR2 signalling blocks the recruitment of inflammatory monocytes, inhibits metastasis in vivo and prolongs the survival of tumour-bearing mice. Depletion of tumour-cell-derived CCL2 also inhibits metastatic seeding. Inflammatory monocytes promote the extravasation of tumour cells in a process that requires monocyte-derived vascular endothelial growth factor. CCL2 expression and macrophage infiltration are correlated with poor prognosis and metastatic disease in human breast cancer(3-6). Our data provide the mechanistic link between these two clinical associations and indicate new therapeutic targets for treating metastatic breast cancer.	[Qian, Bin-Zhi; Li, Jiufeng; Zhang, Hui; Kitamura, Takanori; Pollard, Jeffrey W.] Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhang, Jinghang] Albert Einstein Coll Med, Flow Cytometry Core Facil, Bronx, NY 10461 USA; [Campion, Liam R.; Kaiser, Elizabeth A.; Snyder, Linda A.] Ortho Biotech Oncol R&D, Radnor, PA 19087 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Johnson & Johnson; Johnson & Johnson USA	Pollard, JW (corresponding author), Albert Einstein Coll Med, Ctr Study Reprod Biol & Womens Hlth, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	pollard@aecom.yu.edu		Kitamura, Takanori/0000-0003-2032-3918	NIH [NIH PO1 CA100324, RO1 CA131270]; Albert Einstein Cancer Center Core [P30 CA 13330]; MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA100324, P30CA013330, R01CA131270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center Core; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the NIH to J.W.P.(NIH PO1 CA100324 and RO1 CA131270) and to the Albert Einstein Cancer Center Core (P30 CA 13330). We thank J. Massague for 4173 cells and N. Ferrara for the Vegfa<SUP>flox/flox</SUP> mice. We also thank P. Marsters for statistical analyses and M. Thompson, F. Shi, C. Ferrante, F. McCabe, H. Millar-Quinn and D. Wiley for discussions and technical assistance.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Brandt B, 2005, SEMIN CANCER BIOL, V15, P387, DOI 10.1016/j.semcancer.2005.06.006; Carton JM, 2007, PROTEIN EXPRES PURIF, V55, P279, DOI 10.1016/j.pep.2007.05.017; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Ma Chaoyu, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5034; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Saji H, 2001, CANCER, V92, P1085, DOI 10.1002/1097-0142(20010901)92:5<1085::AID-CNCR1424>3.0.CO;2-K; Stern P, 2008, P NATL ACAD SCI USA, V105, P13895, DOI 10.1073/pnas.0806907105; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tsui Ping, 2007, Human Antibodies, V16, P117; Ueno T, 2000, CLIN CANCER RES, V6, P3282; Valkovic T, 1998, PATHOL RES PRACT, V194, P335, DOI 10.1016/S0344-0338(98)80057-5	26	1785	1851	11	335	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					222	U129		10.1038/nature10138	http://dx.doi.org/10.1038/nature10138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21654748	Green Accepted			2022-12-28	WOS:000292690500049
J	Puente, XS; Pinyol, M; Quesada, V; Conde, L; Ordonez, GR; Villamor, N; Escaramis, G; Jares, P; Bea, S; Gonzalez-Diaz, M; Bassaganyas, L; Baumann, T; Juan, M; Lopez-Guerra, M; Colomer, D; Tubio, JMC; Lopez, C; Navarro, A; Tornador, C; Aymerich, M; Rozman, M; Hernandez, JM; Puente, DA; Freije, JMP; Velasco, G; Gutierrez-Fernandez, A; Costa, D; Carrio, A; Guijarro, S; Enjuanes, A; Hernandez, L; Yague, J; Nicolas, P; Romeo-Casabona, CM; Himmelbauer, H; Castillo, E; Dohm, JC; de Sanjose, S; Piris, MA; de Alava, E; Miguel, JS; Royo, R; Gelpi, JL; Torrents, D; Orozco, M; Pisano, DG; Valencia, A; Guigo, R; Bayes, M; Heath, S; Gut, M; Klatt, P; Marshall, J; Raine, K; Stebbings, LA; Futreal, PA; Stratton, MR; Campbell, PJ; Gut, I; Lopez-Guillermo, A; Estivill, X; Montserrat, E; Lopez-Otin, C; Campo, E				Puente, Xose S.; Pinyol, Magda; Quesada, Victor; Conde, Laura; Ordonez, Gonzalo R.; Villamor, Neus; Escaramis, Georgia; Jares, Pedro; Bea, Silvia; Gonzalez-Diaz, Marcos; Bassaganyas, Laia; Baumann, Tycho; Juan, Manel; Lopez-Guerra, Monica; Colomer, Dolors; Tubio, Jose M. C.; Lopez, Cristina; Navarro, Alba; Tornador, Cristian; Aymerich, Marta; Rozman, Maria; Hernandez, Jesus M.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Yaguee, Jordi; Nicolas, Pilar; Romeo-Casabona, Carlos M.; Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.; de Sanjose, Silvia; Piris, Miguel A.; de Alava, Enrique; Miguel, Jesus San; Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto; Pisano, David G.; Valencia, Alfonso; Guigo, Roderic; Bayes, Monica; Heath, Simon; Gut, Marta; Klatt, Peter; Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.; Gut, Ivo; Lopez-Guillermo, Armando; Estivill, Xavier; Montserrat, Emili; Lopez-Otin, Carlos; Campo, Elias			Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia	NATURE			English	Article							CANCER GENOME; B-CLL; EXPRESSION; NOTCH1; CELLS; HYPERMUTATION; NETWORK	Chronic lymphocytic leukaemia (CLL), the most frequent leukaemia in adults in Western countries, is a heterogeneous disease with variable clinical presentation and evolution(1,2). Two major molecular subtypes can be distinguished, characterized respectively by a high or low number of somatic hypermutations in the variable region of immunoglobulin genes(3,4). The molecular changes leading to the pathogenesis of the disease are still poorly understood. Here we performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid differentiation primary response gene 88 (MYD88) and kelch-like 6 (KLHL6). Mutations in MYD88 and KLHL6 are predominant in cases of CLL with mutated immunoglobulin genes, whereas NOTCH1 and XPO1 mutations are mainly detected in patients with unmutated immunoglobulins. The patterns of somatic mutation, supported by functional and clinical analyses, strongly indicate that the recurrent NOTCH1, MYD88 and XPO1 mutations are oncogenic changes that contribute to the clinical evolution of the disease. To our knowledge, this is the first comprehensive analysis of CLL combining whole-genome sequencing with clinical characteristics and clinical outcomes. It highlights the usefulness of this approach for the identification of clinically relevant mutations in cancer.	[Conde, Laura; Villamor, Neus; Jares, Pedro; Bea, Silvia; Lopez-Guerra, Monica; Colomer, Dolors; Lopez, Cristina; Navarro, Alba; Aymerich, Marta; Rozman, Maria; Costa, Dolors; Carrio, Anna; Guijarro, Sara; Enjuanes, Anna; Hernandez, Lluis; Campo, Elias] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain; [Puente, Xose S.; Quesada, Victor; Ordonez, Gonzalo R.; Puente, Diana A.; Freije, Jose M. P.; Velasco, Gloria; Gutierrez-Fernandez, Ana; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Pinyol, Magda] IDIBAPS, Unidad Genom, Barcelona 08036, Spain; [Escaramis, Georgia; Bassaganyas, Laia; Tubio, Jose M. C.; Tornador, Cristian; Estivill, Xavier] Pompeu Fabra Univ, Ctr Genom Regulat, Genes & Dis Programme, Barcelona 08003, Spain; [Gonzalez-Diaz, Marcos; Hernandez, Jesus M.; de Alava, Enrique; Miguel, Jesus San] Univ Salamanca, Ctr Invest Canc IBMCC USAL CSIC, Univ Hosp, Serv Hematol, Salamanca 37007, Spain; [Baumann, Tycho; Lopez-Guillermo, Armando; Montserrat, Emili] Univ Barcelona, IDIBAPS, Hosp Clin, Serv Hematol, E-08036 Barcelona, Spain; [Juan, Manel; Yaguee, Jordi] IDIBAPS, Hosp Clin, Serv Inmunol, Barcelona 08036, Spain; [Tubio, Jose M. C.] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela 15706, Spain; [Nicolas, Pilar; Romeo-Casabona, Carlos M.] Univ Basque Country, Univ Deusto, Catedra Interuniv Derechoy Genoma Humano, Bilbao 48007, Spain; [Himmelbauer, Heinz; Castillo, Ester; Dohm, Juliane C.] Pompeii Fabra Univ, Ctr Genom Regulat, Ultrasequencing Unit, Barcelona 08003, Spain; [de Sanjose, Silvia] IDIBELL, Inst Catala Oncol, Unidad Infecc & Canc, Lhospitalet De Llobregat 08907, Spain; [Piris, Miguel A.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid 28029, Spain; [Royo, Romina; Gelpi, Josep L.; Torrents, David; Orozco, Modesto] Univ Barcelona, Spanish Natl Bioinformat Inst, IRB, Programa Conjunto Biol Computac,BSC, E-08028 Barcelona, Spain; [Pisano, David G.; Valencia, Alfonso] Spanish Natl Bioinformat Inst, Spanish Natl Canc Res Ctr CNIO, Struct Biol & Biocomp Programme, Madrid 28029, Spain; [Guigo, Roderic] Pompeu Fabra Univ, Ctr Genom Regulat, Spanish Natl Bioinformat Inst, Genom Bioinformat Programme, Barcelona 08003, Spain; [Bayes, Monica; Heath, Simon; Gut, Marta; Gut, Ivo] Ctr Nacl Anal Genom, Barcelona 08028, Spain; [Klatt, Peter] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Marshall, John; Raine, Keiran; Stebbings, Lucy A.; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Complexo Hospitalario Universitario de Santiago de Compostela; University of Basque Country; University of Deusto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Wellcome Trust Sanger Institute	Campo, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, Serv Anat Patol,Unidad Hematopatol, E-08036 Barcelona, Spain.	clo@uniovi.es; ecampo@clinic.ub.es	Lopez-Guillermo, Armando/Z-5684-2019; Hernandez, Luis/D-4684-2018; Juan, Manel/Q-2931-2019; Gutierrez-Fernandez, Ana/AAS-9954-2021; López, Cristina/W-4621-2017; Estivill, Xavier/E-2957-2012; de Sanjosé Llongueras, Silvia/H-6339-2014; IBIS, SARCOMAS/O-1893-2015; Velasco, Gloria/AAS-5842-2021; Tornador, Cristian/S-2197-2018; López-Otín, Carlos/AAB-2106-2020; Campo, Elias/AAC-5593-2019; Pisano, David/N-5817-2014; Gelpí, Josep Ll./M-6401-2013; Tubio, Jose M.C./H-5076-2015; Heath, Simon C/J-4138-2012; de Alava, Enrique/GOH-0368-2022; COLOMER, DOLORS/ABG-6894-2020; Piris, Miguel A/AAP-1445-2020; Gutierrez-Fernandez, Ana/ABG-6678-2020; Hernández, Jesus M/B-5459-2017; bea, silvia/K-7699-2014; Freije, José M.P./A-6535-2008; Navarro, Alba/H-2611-2015; San-Miguel, Jesús F./V-8977-2018; Piris, Miguel A/B-7067-2008; López, Cristina/ABB-3519-2020; Quesada, Víctor/B-6557-2014; Escaramis, Georgia/B-2997-2015; Jares, Pedro/T-3778-2019; Puente, Xosé S./ADB-0672-2022; Valencia, Alfonso/I-3127-2015; Gut, Ivo/ABF-3188-2020; Guigo, Roderic/D-1303-2010; Estivill, Xavier/A-3125-2013; Escaramis, Georgia/AAR-5586-2020; Tubio, Jose/AAG-7345-2019; ENJUANES, Anna/H-3245-2015; Torrents, David/G-5785-2015	Hernandez, Luis/0000-0002-4854-3069; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; López, Cristina/0000-0001-6644-1659; Velasco, Gloria/0000-0001-8032-5056; Tornador, Cristian/0000-0002-6437-9270; López-Otín, Carlos/0000-0001-6964-1904; Campo, Elias/0000-0001-9850-9793; Pisano, David/0000-0002-4895-4124; Gelpí, Josep Ll./0000-0002-0566-7723; Tubio, Jose M.C./0000-0003-3540-2459; Heath, Simon C/0000-0002-9550-0897; de Alava, Enrique/0000-0001-8400-046X; Piris, Miguel A/0000-0001-5839-3634; Hernández, Jesus M/0000-0002-9661-9371; bea, silvia/0000-0001-7192-2385; Freije, José M.P./0000-0002-4688-8266; Navarro, Alba/0000-0002-4041-0974; San-Miguel, Jesús F./0000-0002-9183-4857; Piris, Miguel A/0000-0001-5839-3634; López, Cristina/0000-0001-6644-1659; Quesada, Víctor/0000-0002-8398-3457; Escaramis, Georgia/0000-0002-5416-3177; Puente, Xosé S./0000-0001-9525-1483; Valencia, Alfonso/0000-0002-8937-6789; Gut, Ivo/0000-0001-7219-632X; Guigo, Roderic/0000-0002-5738-4477; Estivill, Xavier/0000-0002-0723-2256; Tubio, Jose/0000-0003-3540-2459; ENJUANES, Anna/0000-0002-4679-6687; Royo, Romina/0000-0003-3493-0874; Carrio, Ana/0000-0002-8394-2321; Baumann, Tycho Stephan/0000-0003-4421-0088; Raine, Keiran/0000-0002-5634-1539; BASSAGANYAS, LAIA/0000-0002-4575-0214; COLOMER, DOLORS/0000-0001-7486-8484; Rozman, Maria/0000-0002-2641-1110; Juan, Manel/0000-0002-3064-1648; JARES, PEDRO/0000-0002-8401-579X; Gonzalez Diaz, Marcos/0000-0001-6637-1072; Torrents, David/0000-0002-6086-9037; Orozco Lopez, Modesto/0000-0002-8608-3278; Himmelbauer, Heinz/0000-0001-8897-2928; NICOLAS JIMENEZ, MARIA PILAR/0000-0003-4166-5941	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Red Tematica de Investigacion del Cancer (RTICC) del ISCIII	This work was funded by the Spanish Ministry of Science and Innovation (MICINN) through the Institut de Salud Carlos III (ISCIII) and Red Tematica de Investigacion del Cancer (RTICC) del ISCIII. C.L.-O. is an Investigator of the Botin Foundation and D.T., of the ICREA program. We thank E Santos for his support of this project, A. Carracedo and J. Benitez for genotyping studies, C. Fortuny for the supply of samples and N. Villahoz and M. C. Muro for their work in the coordination of the CLL-ICGC Consortium. We are also grateful to all patients with CLL who participated in this study.	Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Coste I, 2010, J CLIN INVEST, V120, P3663, DOI 10.1172/JCI42771; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Moreno-Bueno G, 2003, ONCOGENE, V22, P6115, DOI 10.1038/sj.onc.1206868; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rosati E, 2009, BLOOD, V113, P856, DOI 10.1182/blood-2008-02-139725; ROZMAN C, 1995, NEW ENGL J MED, V333, P1052, DOI 10.1056/NEJM199510193331606; Spencer J, 2005, J IMMUNOL, V175, P5170, DOI 10.4049/jimmunol.175.8.5170; Sportoletti P, 2010, BRIT J HAEMATOL, V151, P404, DOI 10.1111/j.1365-2141.2010.08368.x; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764	26	1131	1170	3	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					101	105		10.1038/nature10113	http://dx.doi.org/10.1038/nature10113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21642962	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000292461300053
J	Fairley, P				Fairley, Peter			Next generation biofuels	NATURE			English	Editorial Material																			0	128	134	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S2	S5		10.1038/474S02a	http://dx.doi.org/10.1038/474S02a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697838	Bronze			2022-12-28	WOS:000291939700001
J	Jones, DR; Salgo, P; Meltzer, J				Jones, Dean R.; Salgo, Peter; Meltzer, Joseph			Conscious Sedation for Minor Procedures in Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRACTICE GUIDELINES; ANALGESIA; CARE		[Jones, Dean R.] Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA; New York Presbyterian Hosp, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital	Jones, DR (corresponding author), Columbia Univ, Dept Anesthesiol, 622 W 168th St PH5, New York, NY 10032 USA.	dean.jones@fraserhealth.ca						Bhananker SM, 2006, ANESTHESIOLOGY, V104, P228, DOI 10.1097/00000542-200602000-00005; Brown TB, 2005, AM FAM PHYSICIAN, V71, P85; Godwin SA, 2005, ANN EMERG MED, V45, P177, DOI 10.1016/j.annemergmed.2004.11.002; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; 1999, ANESTHESIOLOGY, V90, P896	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					E54	U113		10.1056/NEJMvcm0800732	http://dx.doi.org/10.1056/NEJMvcm0800732			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696303				2022-12-28	WOS:000291936100010
J	Savage, N				Savage, Neil			The scum solution	NATURE			English	Editorial Material																			0	43	45	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S15	S16		10.1038/474S015a	http://dx.doi.org/10.1038/474S015a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697835	Bronze			2022-12-28	WOS:000291939700005
J	Cornes, O				Cornes, Ollie			Commentary: Living with CFS/ME	BRITISH MEDICAL JOURNAL			English	Editorial Material												ollie@cornes.org						ALTER HJ, 2010, BLOOD PRODUCTS ADVIS; 2009, NY TIMES        1015	2	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3836	10.1136/bmj.d3836	http://dx.doi.org/10.1136/bmj.d3836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697227				2022-12-28	WOS:000292200500009
J	Iorio, A				Iorio, Alfonso			The Wells rule and a primary care rule were useful for ruling out deep venous thrombosis in primary care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Iorio, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Iorio, Alfonso/B-9478-2013	Iorio, Alfonso/0000-0002-3331-8766				Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Stevens SM, 2006, ACP J CLUB, V144, P46	2	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-13	10.7326/0003-4819-154-12-201106210-02013	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690591				2022-12-28	WOS:000291800500012
J	Powers, BJ; Olsen, MK; Smith, VA; Woolson, RF; Bosworth, HB; Oddone, EZ				Powers, Benjamin J.; Olsen, Maren K.; Smith, Valerie A.; Woolson, Robert F.; Bosworth, Hayden B.; Oddone, Eugene Z.			Measuring Blood Pressure for Decision Making and Quality Reporting: Where and How Many Measures?	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; HYPERTENSIVE PATIENTS; PROGNOSTIC VALUE; SELF-MEASUREMENT; HOME; VARIABILITY; STROKE; TRIALS; SOCIETY; DRUGS	Background: The optimal setting and number of blood pressure (BP) measurements that should be used for clinical decision making and quality reporting are uncertain. Objective: To compare strategies for home or clinic BP measurement and their effect on classifying patients as having BP that was in or out of control. Design: Secondary analysis of a randomized, controlled trial of strategies to improve hypertension management. (ClinicalTrials.gov registration number: NCT00237692) Setting: Primary care clinics affiliated with the Durham Veterans Affairs Medical Center. Patients: 444 veterans with hypertension followed for 18 months. Measurements: Blood pressure was measured repeatedly by using 3 methods: standardized research BP measurements at 6-month intervals; clinic BP measurements obtained during outpatient visits; and home BP measurements using a monitor that transmitted measurements electronically. Results: Patients provided 111 181 systolic BP (SBP) measurements (3218 research, 7121 clinic, and 100 842 home measurements) over 18 months. Systolic BP control rates at baseline (mean SBP <140 mm Hg for clinic or research measurement; <135 mm Hg for home measurement) varied substantially, with 28% classified as in control by clinic measurement, 47% by home measurement, and 68% by research measurement. Short-term variability was large and similar across all 3 methods of measurement, with a mean within-patient coefficient of variation of 10% (range, 1% to 24%). Patients could not be classified as having BP that was in or out of control with 80% certainty on the basis of a single clinic SBP measurement from 120 mm Hg to 157 mm Hg. The effect of within-patient variability could be greatly reduced by averaging several measurements, with most benefit accrued at 5 to 6 measurements. Limitation: The sample was mostly men with a long-standing history of hypertension and was selected on the basis of previous poor BP control. Conclusion: Physicians who want to have 80% or more certainty that they are correctly classifying patients' BP control should use the average of several measurements. Hypertension quality metrics based on a single clinic measurement potentially misclassify a large proportion of patients.	[Powers, Benjamin J.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; Duke Univ, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Powers, BJ (corresponding author), Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Hlth Serv Res & Dev 152,508 Fulton St, Durham, NC 27705 USA.	ben.powers@duke.edu; olsen008@mc.duke.edu		Smith, Valerie/0000-0001-5170-9819	U.S. Department of Veterans Affairs Health Services Research and Development Service [IIR 04-426, 08-027]; U.S. Department of Veterans Affairs [CDA 09-212]; American Heart Association	U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association)	Grant Support: By a grant from the U.S. Department of Veterans Affairs Health Services Research and Development Service (IIR 04-426). Dr. Powers is supported by a U.S. Department of Veterans Affairs Career Development Award (CDA 09-212). Dr. Bosworth is supported by an Established Investigator Award from the American Heart Association and a U.S. Department of Veterans Affairs Health Services Research and Development Service Career Scientist Award (08-027).	[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Bancej Christina M, 2010, Can J Cardiol, V26, pe152; Bobrie G, 2004, JAMA-J AM MED ASSOC, V291, P1342, DOI 10.1001/jama.291.11.1342; Bosworth HB, 2007, AM HEART J, V153, P918, DOI 10.1016/j.ahj.2007.03.004; Brueren MM, 1998, BRIT J GEN PRACT, V48, P1585; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; CHATELLIER G, 1995, HYPERTENSION, V25, P294, DOI 10.1161/01.HYP.25.2.294; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Head GA, 2010, BMJ-BRIT MED J, V340, pc1104; Hing Esther, 2010, Natl Health Stat Report, P1; Imai Y, 2001, J HYPERTENS, V19, P179, DOI 10.1097/00004872-200102000-00003; Ishikawa J, 2008, HYPERTENSION, V52, P856, DOI 10.1161/HYPERTENSIONAHA.108.115600; Johnson KA, 1999, ARCH INTERN MED, V159, P2689, DOI 10.1001/archinte.159.22.2689; Jones DW, 2003, JAMA-J AM MED ASSOC, V289, P1027, DOI 10.1001/jama.289.8.1027; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Kim JW, 2005, J GEN INTERN MED, V20, P647, DOI 10.1007/s11606-005-0112-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li Y, 2010, HYPERTENSION, V55, P1040, DOI 10.1161/HYPERTENSIONAHA.109.137273; Macaskill P, 2008, EVIDENCE BASED MED M; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Marshall T, 2006, MED DECIS MAKING, V26, P624, DOI 10.1177/0272989X06295356; National Committee for Quality Assurance, 2011, MEAS QUAL IMPR HLTH; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Persell SD, 2009, MED CARE, V47, P388, DOI 10.1097/MLR.0b013e31818b070c; PICKERING TG, 1994, LANCET, V344, P31; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Pickering Thomas G., 2002, Cardiology Clinics, V20, P207, DOI 10.1016/S0733-8651(01)00009-1; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Stergiou GS, 2002, AM J HYPERTENS, V15, P101, DOI 10.1016/S0895-7061(01)02324-X; Turnbull F, 2003, LANCET, V362, P1527; Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25; Verberk WJ, 2007, HYPERTENSION, V50, P1019, DOI 10.1161/HYPERTENSIONAHA.107.094193; Verberk WJ, 2005, J AM COLL CARDIOL, V46, P743, DOI 10.1016/j.jacc.2005.05.058; Verdecchia P, 2006, HYPERTENSION, V47, P820, DOI 10.1161/01.HYP.0000215364.56025.b9; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4; Viera AJ, 2008, J CLIN HYPERTENS, V10, P280, DOI 10.1111/j.1751-7176.2008.07530.x; VILLEGAS I, 1995, HYPERTENSION, V26, P1204, DOI 10.1161/01.HYP.26.6.1204; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; WRIGHT BM, 1970, LANCET, V1, P337	48	135	140	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					781	788		10.7326/0003-4819-154-12-201106210-00005	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690592				2022-12-28	WOS:000291800500013
J	Lu, DP; Lin, WW; Gao, XQ; Wu, SJ; Cheng, C; Avila, J; Heese, A; Devarenne, TP; He, P; Shan, LB				Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; Avila, Julian; Heese, Antje; Devarenne, Timothy P.; He, Ping; Shan, Libo			Direct Ubiquitination of Pattern Recognition Receptor FLS2 Attenuates Plant Innate Immunity	SCIENCE			English	Article							LIGASE ACTIVITY; CELL-DEATH; KINASE; ARABIDOPSIS; DEFENSE; FLAGELLIN; BAK1; PHOSPHORYLATION; PERCEPTION; RESISTANCE	Innate immune responses are triggered by the activation of pattern-recognition receptors (PRRs). The Arabidopsis PRR FLAGELLIN-SENSING 2 (FLS2) senses bacterial flagellin and initiates immune signaling through association with BAK1. The molecular mechanisms underlying the attenuation of FLS2 activation are largely unknown. We report that flagellin induces recruitment of two closely related U-box E3 ubiquitin ligases, PUB12 and PUB13, to FLS2 receptor complex in Arabidopsis. BAK1 phosphorylates PUB12 and PUB13 and is required for FLS2-PUB12/13 association. PUB12 and PUB13 polyubiquitinate FLS2 and promote flagellin-induced FLS2 degradation, and the pub12 and pub13 mutants displayed elevated immune responses to flagellin treatment. Our study has revealed a unique regulatory circuit of direct ubiquitination and turnover of FLS2 by BAK1-mediated phosphorylation and recruitment of specific E3 ligases for attenuation of immune signaling.	[Lu, Dongping; Gao, Xiquan; Cheng, Cheng; Avila, Julian; Devarenne, Timothy P.; He, Ping] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Lin, Wenwei; Wu, Shujing; Shan, Libo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Lu, Dongping; Lin, Wenwei; Gao, Xiquan; Wu, Shujing; Cheng, Cheng; He, Ping; Shan, Libo] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; [Lin, Wenwei] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou 350002, Peoples R China; [Heese, Antje] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Fujian Agriculture & Forestry University; University of Missouri System; University of Missouri Columbia	He, P (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pinghe@tamu.edu; lshan@tamu.edu	Lu, Dongping/GGB-4016-2022	Lu, Dongping/0000-0002-4888-0532; Avila, Julian/0000-0001-9388-3946; wu, shujing/0000-0002-1912-7699; He, Ping/0000-0002-5926-8349; Devarenne, Timothy/0000-0001-6032-8049; LIN, WENWEI/0000-0003-0098-6386	NSF [IOS-1030250]; NIH [R01GM092893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092893, R01GM097247] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Ausubel, J. Alfano, M. Dickman, and H. Scholthof for critical reading of the manuscript and F. Rolland for the yeast two-hybrid vectors. We also thank the Salk Institute and Arabidopsis Biological Resource Center for the Arabidopsis T-DNA insertion lines. This work was supported by NSF (IOS-1030250) to L.S. and NIH (R01GM092893) to P.H.	Azevedo C, 2001, TRENDS PLANT SCI, V6, P354, DOI 10.1016/S1360-1385(01)01960-4; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gonzalez-Lamothe R, 2006, PLANT CELL, V18, P1067, DOI 10.1105/tpc.106.040998; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Trujillo M, 2008, CURR BIOL, V18, P1396, DOI 10.1016/j.cub.2008.07.085; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	26	400	427	18	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1439	1442		10.1126/science.1204903	http://dx.doi.org/10.1126/science.1204903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680842	Green Accepted			2022-12-28	WOS:000291689000044
J	Maloy, KJ; Powrie, F				Maloy, Kevin J.; Powrie, Fiona			Intestinal homeostasis and its breakdown in inflammatory bowel disease	NATURE			English	Review							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; DENDRITIC CELLS; TRANSCRIPTION FACTOR; MAINTAIN HOMEOSTASIS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; GUT MICROBIOTA; GENE ATG16L1; MOUSE MODELS	Intestinal homeostasis depends on complex interactions between the microbiota, the intestinal epithelium and the host immune system. Diverse regulatory mechanisms cooperate to maintain intestinal homeostasis, and a breakdown in these pathways may precipitate the chronic inflammatory pathology found in inflammatory bowel disease. It is now evident that immune effector modules that drive intestinal inflammation are conserved across innate and adaptive leukocytes and can be controlled by host regulatory cells. Recent evidence suggests that several factors may tip the balance between homeostasis and intestinal inflammation, presenting future challenges for the development of new therapies for inflammatory bowel disease.	[Maloy, Kevin J.; Powrie, Fiona] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Powrie, Fiona] Univ Oxford, John Radcliffe Hosp, Expt Med Div NDM, Translat Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Maloy, KJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk; fiona.powrie@path.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688	Wellcome Trust; Cancer Research UK; European Union	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); European Union(European Commission)	We thank M. Asquith, H. Uhlig, P. Ahern and M. Barnes for review and G. Song-Zhao and O. Harrison for help with the figures. We apologize to those whose work was not cited owing to space constraints. K.J.M. and F. P. are supported by grants from the Wellcome Trust, Cancer Research UK and the European Union (FP7, INFLAMMACARE).	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Asquith M, 2010, J EXP MED, V207, P1573, DOI 10.1084/jem.20101330; Asquith MJ, 2010, GASTROENTEROLOGY, V139, P519, DOI 10.1053/j.gastro.2010.04.045; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Fantini MC, 2009, GASTROENTEROLOGY, V136, P1308, DOI 10.1053/j.gastro.2008.12.053; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Griseri T, 2010, J EXP MED, V207, P699, DOI 10.1084/jem.20091618; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Koslowski MJ, 2010, INT J MED MICROBIOL, V300, P34, DOI 10.1016/j.ijmm.2009.08.011; Laffont S, 2010, EUR J IMMUNOL, V40, P1877, DOI 10.1002/eji.200939957; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Melmed GY, 2010, NAT REV GASTRO HEPAT, V7, P110, DOI 10.1038/nrgastro.2009.218; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Saleh M, 2011, NAT REV IMMUNOL, V11, P9, DOI 10.1038/nri2891; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Siegmund B, 2010, IMMUNITY, V32, P300, DOI 10.1016/j.immuni.2010.03.010; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	100	1211	1250	10	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					298	306		10.1038/nature10208	http://dx.doi.org/10.1038/nature10208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677746				2022-12-28	WOS:000291647100033
J	Sow, SO; Okoko, BJ; Diallo, A; Viviani, S; Borrow, R; Carlone, G; Tapia, M; Akinsola, AK; Arduin, P; Findlow, H; Elie, C; Haidara, FC; Adegbola, RA; Diop, D; Parulekar, V; Chaumont, J; Martellet, L; Diallo, F; Idoko, OT; Tang, YX; Plikaytis, BD; Kulkarni, PS; Marchetti, E; LaForce, FM; Preziosi, MP				Sow, Samba O.; Okoko, Brown J.; Diallo, Aldiouma; Viviani, Simonetta; Borrow, Ray; Carlone, George; Tapia, Milagritos; Akinsola, Adebayo K.; Arduin, Pascal; Findlow, Helen; Elie, Cheryl; Haidara, Fadima Cheick; Adegbola, Richard A.; Diop, Doudou; Parulekar, Varsha; Chaumont, Julie; Martellet, Lionel; Diallo, Fatoumata; Idoko, Olubukola T.; Tang, Yuxiao; Plikaytis, Brian D.; Kulkarni, Prasad S.; Marchetti, Elisa; LaForce, F. Marc; Preziosi, Marie-Pierre			Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEISSERIA-MENINGITIDIS GROUP; POLYSACCHARIDE VACCINE; EPIDEMIC MENINGITIS; SEROGROUP-A; ANTIBODY; MEMORY; TRIAL; BELT; RISK; QUADRIVALENT	Background Group A meningococci are the source of major epidemics of meningitis in Africa. An affordable, highly immunogenic meningococcal A conjugate vaccine is needed. Methods We conducted two studies in Africa to evaluate a new MenA conjugate vaccine (PsA-TT). In study A, 601 children, 12 to 23 months of age, were randomly assigned to receive PsA-TT, a quadrivalent polysaccharide reference vaccine (PsACWY), or a control vaccine (Haemophilus influenzae type b conjugate vaccine [Hib-TT]). Ten months later, these children underwent another round of randomization within each group to receive a full dose of PsA-TT, a one-fifth dose of PsACWY, or a full dose of Hib-TT, with 589 of the original participants receiving a booster dose. In study B, 900 subjects between 2 and 29 years of age were randomly assigned to receive PsA-TT or PsACWY. Safety and reactogenicity were evaluated, and immunogenicity was assessed by measuring the activity of group A serum bactericidal antibody (SBA) with rabbit complement and performing an IgG group A-specific enzyme-linked immunosorbent assay. Results In study A, 96.0% of the subjects in the PsA-TT group and 63.7% of those in the PsACWY group had SBA titers that were at least four times as high as those at baseline; in study B, 78.2% of the subjects in the PsA-TT group and 46.2% of those in the PsACWY group had SBA titers that were at least four times as high as those at baseline. The geometric mean SBA titers in the PsA-TT groups in studies A and B were greater by factors of 16 and 3, respectively, than they were in the PsACWY groups (P<0.001). In study A, the PsA-TT group had higher antibody titers at week 40 than the PsACWY group and had obvious immunologic memory after receiving a polysaccharide booster vaccine. Safety profiles were similar across vaccine groups, although PsA-TT recipients were more likely than PsACWY recipients to have tenderness and induration at the vaccination site. Adverse events were consistent with age-specific morbidity in the study areas; no serious vaccine-related adverse events were reported. Conclusions The PsA-TT vaccine elicited a stronger response to group A antibody than the PsACWY vaccine. (Funded by the Meningitis Vaccine Project through a grant from the Bill and Melinda Gates Foundation; Controlled-Trials.com numbers, ISRCTN78147026 and ISRCTN87739946.)	[Sow, Samba O.; Tapia, Milagritos; Haidara, Fadima Cheick; Diallo, Fatoumata] Ctr Dev Vaccins, Bamako, Mali; [Okoko, Brown J.; Akinsola, Adebayo K.; Adegbola, Richard A.; Idoko, Olubukola T.] MRC Labs, Basse, Gambia; [Diallo, Aldiouma; Arduin, Pascal; Diop, Doudou] Inst Rech Dev, Dakar, Senegal; [Viviani, Simonetta; Chaumont, Julie; Martellet, Lionel; Tang, Yuxiao; Marchetti, Elisa; LaForce, F. Marc] Program Appropriate Technol Hlth, Meningitis Vaccine Project, Ferney Voltaire, France; [Borrow, Ray; Findlow, Helen] Hlth Protect Agcy NW, Vaccine Evaluat Unit, Manchester, Lancs, England; [Carlone, George; Elie, Cheryl; Plikaytis, Brian D.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Parulekar, Varsha] DiagnoSearch Life Sci, Bombay, Maharashtra, India; [Kulkarni, Prasad S.] Serum Inst India, Pune, Maharashtra, India; [Preziosi, Marie-Pierre] WHO, Initiat Vaccine Res, Meningitis Vaccine Project, CH-1211 Geneva 27, Switzerland	MRC Laboratory Molecular Biology; Institut de Recherche pour le Developpement (IRD); Centers for Disease Control & Prevention - USA; Serum Institute of India; World Health Organization	Preziosi, MP (corresponding author), WHO, Initiat Vaccine Res, Meningitis Vaccine Project, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	preziosim@who.int	Viviani, Simonetta/AAE-7966-2019	Viviani, Simonetta/0000-0002-3652-5082	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by the Meningitis Vaccine Project (MVP) through a grant from the Bill and Melinda Gates Foundation.	Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Auckland C, 2006, J INFECT DIS, V194, P1745, DOI 10.1086/509619; Baxendale HE, 2010, VACCINE, V28, P4763, DOI 10.1016/j.vaccine.2010.04.103; Black S, 2010, VACCINE, V28, P657, DOI 10.1016/j.vaccine.2009.10.104; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2000, VACCINE, V19, P1129, DOI 10.1016/S0264-410X(00)00317-0; Campagne G, 1999, B WORLD HEALTH ORGAN, V77, P499; CARLONE GM, 1992, J CLIN MICROBIOL, V30, P154, DOI 10.1128/JCM.30.1.154-159.1992; EMEA, 2000, CPMPEWP48299 EMEA; ERWA HH, 1973, B WORLD HEALTH ORGAN, V49, P301; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; *FOOD DRUG ADM, 2009, MEN VACC BLOOD BIOL; *FOOD DRUG ADM, 2011, VACC MENV VACC BLOOD; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Greenwood B, 2006, TROP MED INT HEALTH, V11, P773, DOI 10.1111/j.1365-3156.2006.01639.x; Guerin PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000342; HASSANKING MKA, 1988, J INFECTION, V16, P55, DOI 10.1016/S0163-4453(88)96117-8; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Keyserling H, 2005, ARCH PEDIAT ADOL MED, V159, P907, DOI 10.1001/archpedi.159.10.907; Knuf M, 2010, VACCINE, V28, P744, DOI 10.1016/j.vaccine.2009.10.064; Kshirsagar N, 2007, VACCINE, V25, pA101, DOI 10.1016/j.vaccine.2007.04.050; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; LAPEYSSONNIE L, 1963, Bull World Health Organ, V28 Suppl, P1; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Pichichero M, 2005, PEDIATR INFECT DIS J, V24, P57, DOI 10.1097/01.inf.0000148928.10057.86; Richmond P, 2001, J INFECT DIS, V183, P160, DOI 10.1086/317646; Ruben FL, 2001, CLIN INFECT DIS, V32, P170, DOI 10.1086/317553; Saliou P, 1978, Dev Biol Stand, V41, P97; Teyssou R, 2007, VACCINE, V25, pA3, DOI 10.1016/j.vaccine.2007.04.032; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; WAHDAN MH, 1973, B WORLD HEALTH ORGAN, V48, P667; *WHO, 1998, WHOEMCBAC983; 2009, WKLY EPIDEMIOL REC, V84, P117; 2005, WKLY EPIDEMIOL REC, V80, P313	37	134	134	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2293	2304		10.1056/NEJMoa1003812	http://dx.doi.org/10.1056/NEJMoa1003812			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675889				2022-12-28	WOS:000291643800007
J	McKhann, GM				McKhann, Guy M.			Changing Concepts of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA	Johns Hopkins University	McKhann, GM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 338 Krieger Hall,3400 N Charles St, Baltimore, MD 21218 USA.	guy.mckhann@jhu.edu						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P257, DOI 10.1016/j.jalz.2011.03.004; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jagust William, 2006, Alzheimers Dement, V2, P36, DOI 10.1016/j.jalz.2005.11.002; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003	9	67	67	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2458	2459		10.1001/jama.2011.810	http://dx.doi.org/10.1001/jama.2011.810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673298				2022-12-28	WOS:000291597300027
J	Bednarek, PH; Creinin, MD; Reeves, MF; Cwiak, C; Espey, E; Jensen, JT				Bednarek, Paula H.; Creinin, Mitchell D.; Reeves, Matthew F.; Cwiak, Carrie; Espey, Eve; Jensen, Jeffrey T.		Post-Aspiration IUD Randomization	Immediate versus Delayed IUD Insertion after Uterine Aspiration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAUTERINE; ABORTION; DEVICE; ACCEPTABILITY; FAILURE	BACKGROUND Intrauterine devices (IUDs) provide highly effective, reversible, long-term contraception that is appropriate for many women after first-trimester uterine aspiration. However, the effects of immediate versus delayed IUD insertion after uterine aspiration on rates of complications and IUD use are uncertain. METHODS We performed a randomized noninferiority trial involving women undergoing uterine aspiration for induced or spontaneous abortion at 5 to 12 weeks of gestation who desired an IUD. Subjects were randomly assigned (in a 5:6 ratio) to IUD insertion immediately after the procedure or 2 to 6 weeks afterward (delayed insertion). The primary outcome was the rate of IUD expulsion 6 months after IUD insertion; an expulsion rate 8 percentage points higher in the immediate-insertion group was defined as inferior. RESULTS Among 575 women who underwent randomization, an IUD was inserted in 100% (258 of 258) of the women in the immediate-insertion group and in 71.3% (226 of 317) of those in the delayed-insertion group (difference, 28.7 percentage points; 95% confidence interval [CI], 23.7 to 33.7). The 6-month expulsion risk was 5.0% (13 of 258 women) after immediate insertion and 2.7% (6 of 226) after delayed insertion (difference, 2.3 percentage points; 95% CI, -1.0 to 5.8), which was consistent with the predefined criterion for noninferiority. Six-month rates of IUD use were higher in the immediate-insertion group (92.3%, vs. 76.6% after delayed insertion; P<0.001). Adverse events were rare and did not differ significantly between groups. No pregnancies occurred in the immediate-insertion group; five occurred in the delayed-insertion group (P = 0.07), all in women who never received an IUD. CONCLUSIONS The 6-month rate of expulsion of an IUD after immediate insertion was higher than but not inferior to that after delayed insertion. Immediate insertion resulted in higher rates of IUD use at 6 months, without an increased risk of complications.	[Bednarek, Paula H.; Jensen, Jeffrey T.] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97239 USA; [Creinin, Mitchell D.; Reeves, Matthew F.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Creinin, Mitchell D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Cwiak, Carrie] Emory Univ, Dept Gynecol & Obstetr, Atlanta, GA 30322 USA; [Espey, Eve] Univ New Mexico, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Emory University; University of New Mexico	Bednarek, PH (corresponding author), Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, 3181 SW Sam Jackson Pk Rd,UHN 50, Portland, OR 97239 USA.	bednarek@ohsu.edu	Creinin, Mitchell/AAH-3488-2020; Jensen, Jeffrey T/C-7421-2014	Creinin, Mitchell/0000-0001-5967-8180; Jensen, Jeffrey T/0000-0002-4733-1224; Reeves, Matthew/0000-0001-7749-7447	Susan Thompson Buffett Foundation	Susan Thompson Buffett Foundation	Supported by a grant from the Susan Thompson Buffett Foundation.	ANDERSSON K, 1994, CONTRACEPTION, V49, P56, DOI 10.1016/0010-7824(94)90109-0; [Anonymous], 1983, STUD FAMILY PLANN, V14, P99; [Anonymous], 1983, STUD FAMILY PLANN, V14, P109; Backman T, 2004, AM J OBSTET GYNECOL, V190, P50, DOI 10.1016/j.ajog.2003.07.021; DAGOSTINO RB, 1988, AM STAT, V42, P198, DOI 10.2307/2685002; Drey EA, 2009, CONTRACEPTION, V79, P397, DOI 10.1016/j.contraception.2008.11.019; El-Tagy A, 2003, CONTRACEPTION, V67, P229, DOI 10.1016/S0010-7824(02)00518-8; GILLETT PG, 1980, FERTIL STERIL, V34, P121; Goodman S, 2008, CONTRACEPTION, V78, P143, DOI 10.1016/j.contraception.2008.03.003; Grimes DA, 2010, COCHRANE DB SYST REV, V6; Heikinheimo O, 2008, CONTRACEPTION, V78, P149, DOI 10.1016/j.contraception.2008.03.013; Hubacher D, 2004, CONTRACEPTION, V69, P437, DOI 10.1016/j.contraception.2004.01.009; Jones RK, 2008, PERSPECT SEX REPRO H, V40, P6, DOI 10.1363/4000608; MARRS RP, 1979, AM J OBSTET GYNECOL, V135, P731, DOI 10.1016/0002-9378(79)90383-1; Pakarinen P, 2003, CONTRACEPTION, V68, P31, DOI 10.1016/S0010-7824(03)00104-5; Reeves MF, 2007, OBSTET GYNECOL, V110, P936; Rose SB, 2010, CONTRACEPTION, V82, P345, DOI 10.1016/j.contraception.2010.04.021; Stanek AM, 2009, CONTRACEPTION, V79, P216, DOI 10.1016/j.contraception.2008.09.003; Stanwood NL, 2001, BRIT J OBSTET GYNAEC, V108, P1168, DOI 10.1016/S0306-5456(01)00264-9; Trussell J, 2004, CONTRACEPTION, V70, P89, DOI 10.1016/j.contraception.2004.03.009; UPTON GJG, 1982, J ROY STAT SOC A STA, V145, P86, DOI 10.2307/2981423	21	118	120	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2208	2217		10.1056/NEJMoa1011600	http://dx.doi.org/10.1056/NEJMoa1011600			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774NA	21651392	Bronze			2022-12-28	WOS:000291392100007
J	Jomelli, V; Khodri, M; Favier, V; Brunstein, D; Ledru, MP; Wagnon, P; Blard, PH; Sicart, JE; Braucher, R; Grancher, D; Bourles, DL; Braconnot, P; Vuille, M				Jomelli, Vincent; Khodri, Myriam; Favier, Vincent; Brunstein, Daniel; Ledru, Marie-Pierre; Wagnon, Patrick; Blard, Pierre-Henri; Sicart, Jean-Emmanuel; Braucher, Regis; Grancher, Delphine; Bourles, Didier Louis; Braconnot, Pascale; Vuille, Mathias			Irregular tropical glacier retreat over the Holocene epoch driven by progressive warming	NATURE			English	Article							CENTRAL ANDES; OVERTURNING CIRCULATION; CLIMATE-CHANGE; GLACIATION; BOLIVIA; FLUCTUATIONS; 16-DEGREES-S; HISTORY	The causes and timing of tropical glacier fluctuations during the Holocene epoch (10,000 years ago to present) are poorly understood. Yet constraining their sensitivity to changes in climate(1) is important, as these glaciers are both sensitive indicators of climate change and serve as water reservoirs for highland regions(2). Studies have so far documented extra-tropical glacier fluctuations(3,4), but in the tropics, glacier-climate relationships are insufficiently understood. Here we present a Be-10 chronology for the past 11,000 years (11 kyr), using 57 moraines from the Bolivian Telata glacier (in the Cordillera Real mountain range). This chronology indicates that Telata glacier retreated irregularly. Arapid and strong melting from the maximum extent occurred from 10.8 +/- 0.9 to 8.5 +/- 0.4 kyr ago, followed by a slower retreat until the Little Ice Age, about 200 years ago. A dramatic increase in the rate of retreat occurred over the twentieth century. A glacier-climate model indicates that, relative to modern climate, annual mean temperature for the Telata glacier region was -3.3 +/- 0.8 degrees C cooler at 11 kyr ago and remained -2.1 +/- 0.8 degrees C cooler until the end of the Little Ice Age. We suggest that long-term warming of the eastern tropical Pacific and increased atmospheric temperature in response to enhanced austral summer insolation were the main drivers for the long-term Holocene retreat of glaciers in the southern tropics.	[Jomelli, Vincent; Brunstein, Daniel; Grancher, Delphine] Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France; [Khodri, Myriam] IRD, IPSL, LOCEAN, F-75252 Paris 05, France; [Favier, Vincent] UJF, CNRS, LGGE, F-38402 St Martin Dheres, France; [Ledru, Marie-Pierre] UM2 CNRS IRD, ISEM, IRD UMR 226, F-34095 Montpellier, France; [Wagnon, Patrick; Sicart, Jean-Emmanuel] UJF Grenoble 1, CNRS, UMR 5183, IRD,G INP,LGGE,LTHE,UMR 5564, F-38402 Grenoble, France; [Blard, Pierre-Henri] Univ Lorraine, CNRS, UPR2300, CRPG, F-54501 Vandoeuvre Les Nancy, France; [Braucher, Regis; Bourles, Didier Louis] Aix Marseille Univ, CNRS, UMR 6635, CEREGE, F-13545 Aix En Provence, France; [Braconnot, Pascale] CEA Saclay, UVSQ, CNRS, CEA,Unite Mixte,Lab Sci Climat & Environm,IPSL, F-91191 Gif Sur Yvette, France; [Vuille, Mathias] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	Centre National de la Recherche Scientifique (CNRS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); State University of New York (SUNY) System; State University of New York (SUNY) Albany	Jomelli, V (corresponding author), Univ Paris 01, CNRS, Lab Geog Phys, F-92195 Meudon, France.	jomelli@cnrs-bellevue.fr	Favier, Vincent/T-1936-2017; Sicart, Jean Emmanuel/GLT-0451-2022; Vuille, Mathias/O-8128-2019; Vuille, Mathias/S-3906-2019; jomelli, vincent/AAO-9488-2020; Khodri, Myriam/K-1399-2016; , Braucher/Q-5971-2017; BLARD, Pierre-Henri/ABB-9401-2021	Favier, Vincent/0000-0001-6024-9498; Vuille, Mathias/0000-0002-9736-4518; jomelli, vincent/0000-0002-4512-5216; Khodri, Myriam/0000-0003-1941-1646; , Braucher/0000-0002-4637-4302; Blard, Pierre-Henri/0000-0002-8455-8014; Bourles, Didier/0000-0001-5991-6126; brunstein, daniel/0000-0001-5496-8349; Ledru, Marie-Pierre/0000-0002-8079-9320	French INSU; French ANR [06-Vuln-010, 10-Blan-608-01]; INSU/CNRS; French Ministry of Research and Higher Education; IRD and CEA; CNRS; EU [EVK2-CT-2002-00153]; Programme National d'Etude de la Dynamique du Climate (PNEDC)	French INSU; French ANR(French National Research Agency (ANR)); INSU/CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research and Higher Education; IRD and CEA; CNRS(Centre National de la Recherche Scientifique (CNRS)); EU(European Commission); Programme National d'Etude de la Dynamique du Climate (PNEDC)	Financial support was provided by the French INSU programme 'LEVE', the French ANR Escarcel programme no. 06-Vuln-010, UR Great Ice at IRD, and the French ANR El Paso programme no. 10-Blan-608-01. We thank P. Ginot, E. Perroy, E. Ramirez and the Bolivian authorities for facilitating our field work in the Zongo valley. The <SUP>10</SUP>Be measurements were performed at the ASTER AMS national facility (CEREGE, Aix en Provence), which is supported by INSU/CNRS, the French Ministry of Research and Higher Education, IRD and CEA. We are grateful to L. Leanni for handling the necessary physical and chemical preparations before the <SUP>10</SUP>Be measurements, and to M. Arnold, G. Aumaitre and K. Keddadouche for help during the <SUP>10</SUP>Be AMS measurements. We acknowledge the international modelling groups for providing their data for analysis. The PMIP2/MOTIF Data Archive is supported by CEA and CNRS, and was funded by the EU project MOTIF (EVK2-CT-2002-00153) and the Programme National d'Etude de la Dynamique du Climate (PNEDC). The analyses were performed using model versions available on 23 May 2009 (http://pmip2.lsce.ipsl.fr/). Computing time to run the IPSL model was provided by CEA. We are grateful for the assistance received from IHH (Instituto de Hidraulica e Hidrologia) and UMSA (Universidad Mayor de San Andres, La Paz).	Abbott MB, 2003, PALAEOGEOGR PALAEOCL, V194, P123, DOI 10.1016/S0031-0182(03)00274-8; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Blard PH, 2007, NATURE, V449, P591, DOI 10.1038/nature06142; Braconnot P, 2008, CLIM PAST, V4, P281, DOI 10.5194/cp-4-281-2008; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Buffen AM, 2009, QUATERNARY RES, V72, P157, DOI 10.1016/j.yqres.2009.02.007; Condom T, 2004, HYDROL PROCESS, V18, P2395, DOI 10.1002/hyp.1470; Cruz FW, 2009, NAT GEOSCI, V2, P210, DOI 10.1038/NGEO444; Favier V, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020654; Francou B, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002959; Garreaud R, 2003, PALAEOGEOGR PALAEOCL, V194, P5, DOI 10.1016/S0031-0182(03)00269-4; Glasser NF, 2009, QUATERNARY SCI REV, V28, P3448, DOI 10.1016/j.quascirev.2009.10.006; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Jomelli V, 2009, PALAEOGEOGR PALAEOCL, V281, P269, DOI 10.1016/j.palaeo.2008.10.033; Kageyama M, 2009, CLIM PAST, V5, P551, DOI 10.5194/cp-5-551-2009; Kaser G., 2002, TROPICAL GLACIERS; Kienast M, 2006, NATURE, V443, P846, DOI 10.1038/nature05222; Kull C, 2008, GLOBAL PLANET CHANGE, V60, P148, DOI 10.1016/j.gloplacha.2007.03.011; Licciardi JM, 2009, SCIENCE, V325, P1677, DOI 10.1126/science.1175010; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Rabatel A, 2008, QUATERNARY RES, V70, P198, DOI 10.1016/j.yqres.2008.02.012; Rodbell DT, 2008, QUATERNARY SCI REV, V27, P1612, DOI 10.1016/j.quascirev.2008.06.004; Rodbell DT, 2009, QUATERNARY SCI REV, V28, P2165, DOI 10.1016/j.quascirev.2009.03.012; Schaefer JM, 2009, SCIENCE, V324, P622, DOI 10.1126/science.1169312; Sicart JE, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010406; Smith CA, 2011, QUATERNARY RES, V75, P1, DOI 10.1016/j.yqres.2010.07.001; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002; Wagnon P, 2001, J GLACIOL, V47, P21, DOI 10.3189/172756501781832593	29	64	69	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					196	199		10.1038/nature10150	http://dx.doi.org/10.1038/nature10150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654802				2022-12-28	WOS:000291397800046
J	Goldblatt, C; Zahnle, KJ				Goldblatt, Colin; Zahnle, Kevin J.			Faint young Sun paradox remains	NATURE			English	Letter							DIMETHYL-SULFIDE; ORGANIC HAZE; AEROSOL; EVOLUTION; EARTH		[Goldblatt, Colin; Zahnle, Kevin J.] NASA, Ames Res Ctr, Space Sci & Astrobiol Div, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Goldblatt, C (corresponding author), Univ Washington, Dept Astron, Box 351580, Seattle, WA 98195 USA.	cgoldbla@uw.edu						Breon FM, 2002, SCIENCE, V295, P834, DOI 10.1126/science.1066434; Clough SA, 2005, J QUANT SPECTROSC RA, V91, P233, DOI 10.1016/j.jqsrt.2004.05.058; Domagal-Goldman SD, 2008, EARTH PLANET SC LETT, V269, P29, DOI 10.1016/j.epsl.2008.01.040; Goldblatt C, 2011, CLIM PAST, V7, P203, DOI 10.5194/cp-7-203-2011; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Kump LR, 2008, SCIENCE, V320, P195, DOI 10.1126/science.1153883; Leck C, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023651; Lin YS, 2010, BIOGEOSCIENCES, V7, P2433, DOI 10.5194/bg-7-2433-2010; MCKAY CP, 1991, ICARUS, V91, P93, DOI 10.1016/0019-1035(91)90128-G; Penner JE, 2006, ATMOS CHEM PHYS, V6, P3391, DOI 10.5194/acp-6-3391-2006; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Trainer MG, 2006, P NATL ACAD SCI USA, V103, P18035, DOI 10.1073/pnas.0608561103; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Woodhouse MT, 2010, ATMOS CHEM PHYS, V10, P7545, DOI 10.5194/acp-10-7545-2010	15	36	38	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					E3	E4		10.1038/nature09961	http://dx.doi.org/10.1038/nature09961			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637210	Bronze, Green Submitted			2022-12-28	WOS:000291156700003
J	Hachet, O; Berthelot-Grosjean, M; Kokkoris, K; Vincenzetti, V; Moosbrugger, J; Martin, SG				Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.			A Phosphorylation Cycle Shapes Gradients of the DYRK Family Kinase Pom1 at the Plasma Membrane	CELL			English	Article							FISSION YEAST; CELL POLARITY; PROTEIN-KINASES; DIVISION PLANE; GROWTH; TEA1; DETERMINANTS; CYTOSKELETON; ACTIVATION; MITOSIS	Concentration gradients regulate many cell biological and developmental processes. In rod-shaped fission yeast cells, polar cortical gradients of the DYRK family kinase Pom1 couple cell length with mitotic commitment by inhibiting a mitotic inducer positioned at midcell. However, how Pom1 gradients are established is unknown. Here, we show that Tea4, which is normally deposited at cell tips by microtubules, is both necessary and, upon ectopic cortical localization, sufficient to recruit Pom1 to the cell cortex. Pom1 then moves laterally at the plasma membrane, which it binds through a basic region exhibiting direct lipid interaction. Pom1 autophosphorylates in this region to lower lipid affinity and promote membrane release. Tea4 triggers Pom1 plasma membrane association by promoting its dephosphorylation through the protein phosphatase 1 Dis2. We propose that local dephosphorylation induces Pom1 membrane association and nucleates a gradient shaped by the opposing actions of lateral diffusion and autophosphorylation-dependent membrane detachment.	[Hachet, Olivier; Berthelot-Grosjean, Martine; Kokkoris, Kyriakos; Vincenzetti, Vincent; Moosbrugger, Josselin; Martin, Sophie G.] Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland	University of Lausanne	Martin, SG (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Fundamental Microbiol, CH-1015 Lausanne, Switzerland.	sophie.martin@unil.ch		Berthelot-Grosjean, Martine/0000-0002-7168-2622; Martin, Sophie/0000-0002-5317-2557	Human Frontiers Science Program (HFSP) long-term fellowship [LT00595/2005-L]; Roche [67-2008]; Swiss National Science Foundation [PP00A-114936]; HFSP Career Development Award [CDA0016/2008]; European Research Council [260493]	Human Frontiers Science Program (HFSP) long-term fellowship(Human Frontier Science Program); Roche(Roche Holding); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HFSP Career Development Award; European Research Council(European Research Council (ERC)European Commission)	We would like to thank Patrice Waridel and Manfredo Quadroni at the Protein Analysis Facility for the mass spectrometry, Philippe Kircher for technical help, Jurg Bahler, Iain Hagan, and Stuart MacNeill for strains and reagents, Yves Barral, Felipe Bendezu, and Richard Benton for comments on the manuscript, and all members of the lab for advice and discussion. O.H. was supported by a Human Frontiers Science Program (HFSP) long-term fellowship (LT00595/2005-L) and K. K. by a Roche research fellowship (67-2008). Research in S. G. M.'s laboratory is supported by a Swiss National Science Foundation Professorship grant (PP00A-114936), an HFSP Career Development Award (CDA0016/2008), and a European Research Council Starting Grant (260493). We also extend our thanks to the Center for Integrative Genomics at the University of Lausanne, where a large part of this work was conducted, for generous support.	Almonacid M, 2009, CURR BIOL, V19, P961, DOI 10.1016/j.cub.2009.04.024; Alvarez-Tabares I, 2007, J CELL SCI, V120, P3589, DOI 10.1242/jcs.007567; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bicho CC, 2010, CURR BIOL, V20, P1752, DOI 10.1016/j.cub.2010.08.035; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; CHANG F, 2009, PERSPECT BIOL, V1; Fuller BG, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-5; GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Knaus M, 2005, EMBO J, V24, P3000, DOI 10.1038/sj.emboj.7600783; KOUKOU AI, 1990, J GEN MICROBIOL, V136, P1271, DOI 10.1099/00221287-136-7-1271; Lochhead PA, 2005, CELL, V121, P925, DOI 10.1016/j.cell.2005.03.034; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Martin SG, 2005, DEV CELL, V8, P479, DOI 10.1016/j.devcel.2005.02.008; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Morrell JL, 2004, J CELL SCI, V117, P5293, DOI 10.1242/jcs.01409; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Tatebe H, 2005, CURR BIOL, V15, P1006, DOI 10.1016/j.cub.2005.04.061; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; WARTLICK O, 2009, PERSPECT BIOL, V1	30	90	91	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1116	1128		10.1016/j.cell.2011.05.014	http://dx.doi.org/10.1016/j.cell.2011.05.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703453	Green Published, Bronze			2022-12-28	WOS:000292025700017
J	Harris, JB; Ivers, LC; Ferraro, MJ				Harris, Jason B.; Ivers, Louise C.; Ferraro, Mary Jane			A Boy with Vomiting and Diarrhea Vibrio cholerae O1 (toxigenic), serotype Ogawa (testing performed at the CDC).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEVELOPING-COUNTRIES; GLOBAL BURDEN; BANGLADESH; MORTALITY; CHILDREN		[Harris, Jason B.] Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA; [Ferraro, Mary Jane] Massachusetts Gen Hosp, Dept Pathol & Microbiol, Boston, MA 02114 USA; [Ivers, Louise C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Harris, Jason B.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Ivers, Louise C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Ferraro, Mary Jane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harris, JB (corresponding author), Massachusetts Gen Hosp, Dept Infect Dis, Boston, MA 02114 USA.		Harris, Jason/ABF-2684-2020; Ivers, Louise C/Q-4164-2018	Harris, Jason/0000-0003-3642-5126; Ivers, Louise C/0000-0003-2314-9230				[Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1473; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; BUTLER T, 1987, B WORLD HEALTH ORGAN, V65, P317; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; HUILAN S, 1991, B WORLD HEALTH ORGAN, V69, P549; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; MAHALANABIS D, 1970, PEDIATRICS, V45, P374; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization, 2005, TREAT DIARRH MAN PHY; World Health Organization, 1999, MAN SEV MALN MAN PHY; 2010, MMWR MORB MORTAL WKL, V59, P1586; 2010, MMWR MORB MORTAL WKL, V59, P1556; CHOLERA OUTBREAK TRA	21	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2452	2461		10.1056/NEJMcpc1100927	http://dx.doi.org/10.1056/NEJMcpc1100927			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696312				2022-12-28	WOS:000291936100013
J	She, J; Han, ZF; Kim, TW; Wang, JJ; Cheng, W; Chang, JB; Shi, SA; Wang, JW; Yang, MJ; Wang, ZY; Chai, JJ				She, Ji; Han, Zhifu; Kim, Tae-Wuk; Wang, Jinjing; Cheng, Wei; Chang, Junbiao; Shi, Shuai; Wang, Jiawei; Yang, Maojun; Wang, Zhi-Yong; Chai, Jijie			Structural insight into brassinosteroid perception by BRI1	NATURE			English	Article							RECEPTOR KINASE BRI1; SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTORS; ARABIDOPSIS-THALIANA; EXTRACELLULAR DOMAIN; PLANT-GROWTH; COMPLEX; PHOSPHORYLATION; ACTIVATION; BRI1/BAK1	Brassinosteroids are essential phytohormones that have crucial roles in plant growth and development. Perception of brassinosteroids requires an active complex of BRASSINOSTEROID-INSENSITIVE 1 (BRI1) and BRI1-ASSOCIATED KINASE 1 (BAK1). Recognized by the extracellular leucine-rich repeat (LRR) domain of BRI1, brassinosteroids induce a phosphorylation-mediated cascade to regulate gene expression. Here we present the crystal structures of BRI1(LRR) in free and brassinolide-bound forms. BRI1(LRR) exists as a monomer in crystals and solution independent of brassinolide. It comprises a helical solenoid structure that accommodates a separate insertion domain at its concave surface. Sandwiched between them, brassinolide binds to a hydrophobicity-dominating surface groove on BRI1(LRR). Brassinolide recognition by BRI1(LRR) is through an induced-fit mechanism involving stabilization of two interdomain loops that creates a pronounced non-polar surface groove for the hormone binding. Together, our results define the molecular mechanisms by which BRI1 recognizes brassinosteroids and provide insight into brassinosteroid-induced BRI1 activation.	[She, Ji; Han, Zhifu; Wang, Jiawei; Yang, Maojun; Chai, Jijie] Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [She, Ji] Peking Univ, Coll Biol Sci, Beijing 100084, Peoples R China; [She, Ji; Wang, Jinjing; Cheng, Wei; Chai, Jijie] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kim, Tae-Wuk; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Chang, Junbiao; Shi, Shuai] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China	Tsinghua University; Peking University; National Institute of Biological Sciences, Beijing; Carnegie Institution for Science; Zhengzhou University	Chai, JJ (corresponding author), Tsinghua Univ, Key Lab Prot Sci, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China.	chaijj@mail.tsinghua.edu.cn	chang, junbiao/P-1095-2014; She, Ji/AAW-6150-2021; Wang, Jiawei/D-1144-2010; Wang, Zhi-Yong/E-3810-2012	chang, junbiao/0000-0001-6236-1256; Wang, Jiawei/0000-0001-9893-8539; Wang, Zhi-Yong/0000-0003-4602-3390; Yang, Maojun/0000-0002-6798-3094; Chai, Jijie/0000-0001-7591-3873	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China [20101331722]; NIH [R01GM066258]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258] Funding Source: NIH RePORTER	National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Huang and J. He at Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection; J. Chory from the Salk Institute for providing the tritium-labelled brassinolide. This research was funded by the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China grant no. 20101331722 to J. Chai and NIH R01GM066258 to Z.-Y.W.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; DeLano WL, 2002, PYMOL MOL; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hink MA, 2008, BIOPHYS J, V94, P1052, DOI 10.1529/biophysj.107.112003; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li J, 2001, P NATL ACAD SCI USA, V98, P5916, DOI 10.1073/pnas.091065998; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2005, CURR OPIN PLANT BIOL, V8, P526, DOI 10.1016/j.pbi.2005.07.009; Li JM, 2002, SCIENCE, V295, P1299; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Sheard LB, 2009, NATURE, V462, P575, DOI 10.1038/462575a; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Whippo CW, 2005, PLANT PHYSIOL, V139, P448, DOI 10.1104/pp.105.064444; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zullo Marco António Teixeira, 2002, Braz. J. Plant Physiol., V14, P143, DOI 10.1590/S1677-04202002000300001	36	268	297	5	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					472	U96		10.1038/nature10178	http://dx.doi.org/10.1038/nature10178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21666666	Green Accepted			2022-12-28	WOS:000291939700040
J	Leistikow, IP; Kalkman, CJ; de Bruijn, H				Leistikow, Ian P.; Kalkman, Cor J.; de Bruijn, Hans			Why patient safety is such a tough nut to crack	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ADVERSE EVENTS; ERRORS		[Leistikow, Ian P.; Kalkman, Cor J.] Univ Med Ctr Utrecht, Patient Safety Ctr, Utrecht, Netherlands; [de Bruijn, Hans] Delft Univ Technol, Fac Technol Policy & Management, Policy Org Law & Gaming Grp, Delft, Netherlands	Utrecht University; Utrecht University Medical Center; Delft University of Technology	Leistikow, IP (corresponding author), Dutch Healthcare Inspectorate, POB 90137, NL-5200 MA Den Bosch, Netherlands.	ianleistikow@gmail.com	Kalkman, Cor/O-3215-2019	Kalkman, Cor/0000-0002-8372-6960				Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; Berwick DM, 2003, NEW ENGL J MED, V348, P2570, DOI 10.1056/NEJMe030044; Blendon RJ, 2002, NEW ENGL J MED, V347, P1933, DOI 10.1056/NEJMsa022151; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; DeBruijn H, 2010, PROCESS MANAGEMENT: WHY PROJECT MANAGEMENT FAILS IN COMPLEX DECISION MAKING PROCESS, SECOND EDITION, P1; DEBRUIJN H, 2010, MANAGING PROFESSIONA, pCH3; Evans Robert G, 2006, Healthc Policy, V1, P12; Gawande A., 2009, CHECKLIST MANIFESTO; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LEAPE LL, 2003, HAL S HLTH SAF HAL N; McFadden KL, 2006, J HEALTHC MANAG, V51, P123, DOI 10.1097/00115514-200603000-00011; Neily J, 2010, QUAL SAF HEALTH CARE, V19, P360, DOI 10.1136/qshc.2008.031005; Pierluissi E, 2003, JAMA-J AM MED ASSOC, V290, P2838, DOI 10.1001/jama.290.21.2838; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	20	25	27	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 21	2011	342								d3447	10.1136/bmj.d3447	http://dx.doi.org/10.1136/bmj.d3447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AO	21693533				2022-12-28	WOS:000292200000003
J	Masoodi, NA				Masoodi, Nasseer A.			Compared with warfarin, high-dose dabigatran was cost-effective for preventing stroke in older patients with nonvalvular AF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ATRIAL-FIBRILLATION		Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Masoodi, NA (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.							Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Gafni A, 2006, SOC SCI MED, V62, P2091, DOI 10.1016/j.socscimed.2005.10.023; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4	4	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-12	10.7326/0003-4819-154-12-201106210-02012	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690590				2022-12-28	WOS:000291800500011
J	Saraiya, M; Hariri, S				Saraiya, Mona; Hariri, Susan			HPV vaccine effect: is the glass half full or half empty?	LANCET			English	Editorial Material							SURVEILLANCE; AUSTRALIA; IMPACT		[Saraiya, Mona; Hariri, Susan] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Saraiya, M (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30341 USA.	msaraiya@cdc.gov						*AM COLL OBST GYN, 2009, OBSTET GYNECOL, V114, P1409; *AUSTR GOV DEP HLT, 2011, NAT HPV VACC PROGR R; Bonanni P, 2010, VACCINE, V28, P4719, DOI 10.1016/j.vaccine.2010.04.070; Brotherton J, 2010, VACCINE, V28, P7453, DOI 10.1016/j.vaccine.2010.09.015; Brotherton JML, 2011, LANCET, V377, P2085, DOI 10.1016/S0140-6736(11)60551-5; Budd AC, 2010, SEX HEALTH, V7, P328, DOI 10.1071/SH09133; Creighton P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-734; Cuzick J, 2010, BRIT J CANCER, V102, P933, DOI 10.1038/sj.bjc.6605528; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Wong CA, 2011, VACCINE, V29, P878, DOI 10.1016/j.vaccine.2010.10.018; World Health Organization, 2010, MMWR WKLY EPIDEMIOL, V85, P237	11	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2057	2058		10.1016/S0140-6736(11)60650-8	http://dx.doi.org/10.1016/S0140-6736(11)60650-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21684367				2022-12-28	WOS:000292117800004
J	Aylward, B; Yamada, T				Aylward, Bruce; Yamada, Tadataka			The Polio Endgame	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE; ERADICATION; TRIAL		[Aylward, Bruce] WHO, Geneva, Switzerland; [Yamada, Tadataka] Bill & Melinda Gates Fdn, Seattle, WA USA	World Health Organization; Bill & Melinda Gates Foundation	Aylward, B (corresponding author), WHO, Geneva, Switzerland.							Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7	5	35	36	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2273	2275		10.1056/NEJMp1104329	http://dx.doi.org/10.1056/NEJMp1104329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675884	Bronze			2022-12-28	WOS:000291643800001
J	Reynolds, T				Reynolds, Toby			MEDICAL RESEARCH Clinical trials: can technology solve the problem of low recruitment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ONLINE		Barts & London NHS Trust, London, England	Barts Health NHS Trust	Reynolds, T (corresponding author), Barts & London NHS Trust, London, England.	toby.reynolds@gmail.com						Academy of Medical Sciences, 2011, NEW PATHW REG GOV HL; Campbell M K, 2007, Health Technol Assess, V11, pix; Embi PJ, 2005, ARCH INTERN MED, V165, P2272, DOI 10.1001/archinte.165.19.2272; Mackenzie IS, 2010, BRIT J CLIN PHARMACO, V69, P128, DOI 10.1111/j.1365-2125.2009.03561.x; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; McAlindon T, 2003, BMJ-BRIT MED J, V327, P484, DOI 10.1136/bmj.327.7413.484; Murray E, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1052; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; Treweek Shaun, 2010, Inform Prim Care, V18, P51; Wicks P, 2011, NAT BIOTECHNOL, V29, P411, DOI 10.1038/nbt.1837	10	15	15	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3662	10.1136/bmj.d3662	http://dx.doi.org/10.1136/bmj.d3662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781KY	21672994				2022-12-28	WOS:000291932100011
J	Kushner, HI				Kushner, Howard I.			The art of medicine Retraining the King's left hand	LANCET			English	Editorial Material							HANDEDNESS		[Kushner, Howard I.] Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Kushner, Howard I.] Program Neurosci & Behav Biol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health	Kushner, HI (corresponding author), Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	hkushne@emory.edu						Blau A., 1946, MASTER HAND STUDY OR; Bryngelson B, 1933, J HERED, V24, P387; Harris L. J., 1990, LEFT HANDEDNESS BEHA, P195; Orton ST., 1937, READING WRITING SPEE; Terman Lewis M., 1914, HYGIENE SCH CHILD; Travis LE, 1934, PSYCHOL REV, V41, P534, DOI 10.1037/h0075471	6	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1998	1999		10.1016/S0140-6736(11)60854-4	http://dx.doi.org/10.1016/S0140-6736(11)60854-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21671515				2022-12-28	WOS:000292011700018
J	Hsu, PP; Kang, SA; Rameseder, J; Zhang, Y; Ottina, KA; Lim, D; Peterson, TR; Choi, YM; Gray, NS; Yaffe, MB; Marto, JA; Sabatini, DM				Hsu, Peggy P.; Kang, Seong A.; Rameseder, Jonathan; Zhang, Yi; Ottina, Kathleen A.; Lim, Daniel; Peterson, Timothy R.; Choi, Yongmun; Gray, Nathanael S.; Yaffe, Michael B.; Marto, Jarrod A.; Sabatini, David M.			The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling	SCIENCE			English	Article							MESSENGER-RNA TRANSLATION; P-BODIES; PROTEIN; KINASE; GRB10; DISRUPTION; AUTOPHAGY; SPECIFICITY; ACTIVATION; REPRESSION	The mammalian target of rapamycin (mTOR) protein kinase is a master growth promoter that nucleates two complexes, mTORC1 and mTORC2. Despite the diverse processes controlled by mTOR, few substrates are known. We defined the mTOR-regulated phosphoproteome by quantitative mass spectrometry and characterized the primary sequence motif specificity of mTOR using positional scanning peptide libraries. We found that the phosphorylation response to insulin is largely mTOR dependent and that mTOR exhibits a unique preference for proline, hydrophobic, and aromatic residues at the +1 position. The adaptor protein Grb10 was identified as an mTORC1 substrate that mediates the inhibition of phosphoinositide 3-kinase typical of cells lacking tuberous sclerosis complex 2 (TSC2), a tumor suppressor and negative regulator of mTORC1. Our work clarifies how mTORC1 inhibits growth factor signaling and opens new areas of investigation in mTOR biology.	[Hsu, Peggy P.; Kang, Seong A.; Ottina, Kathleen A.; Peterson, Timothy R.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Peterson, Timothy R.; Yaffe, Michael B.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rameseder, Jonathan] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Rameseder, Jonathan; Lim, Daniel; Yaffe, Michael B.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zhang, Yi; Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Yi; Marto, Jarrod A.] DFCI, Blais Prote Ctr, Boston, MA 02115 USA; [Ottina, Kathleen A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Choi, Yongmun; Gray, Nathanael S.; Marto, Jarrod A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	National Institutes of Health [CA103866, AI47389, ES015339, GM68762, CA112967]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society; NATIONAL CANCER INSTITUTE [U54CA112967, R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Dana-Farber Cancer Institute; International Fulbright Science and Technology Award; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini Lab for helpful discussion, especially B. Joughin, G. Bell, H. Keys, K. Birsoy, N. Kory, C. Thoreen, J. Claessen, and D. Wagner for assistance with technical or conceptual aspects of this project. This work was supported by the National Institutes of Health (grants CA103866 and AI47389 to D. M. S.; ES015339, GM68762, and CA112967 to M.B.Y.), Department of Defense (W81XWH-07-0448 to D. M. S.), the W.M. Keck Foundation (D. M. S.), LAM Foundation (D. M. S.), Dana-Farber Cancer Institute (N. S. G, J. M), the International Fulbright Science and Technology Award (J. R.), and American Cancer Society (S. A. K.). D. M. S. is an investigator of the Howard Hughes Medical Institute. Torin1, the drug used in this paper, is part of a Whitehead-DFCI patent application on which N. S. G. and D. M. S. are inventors. Shared reagents are subject to a Materials Transfer Agreement.	Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Mok J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000482; Morrione A, 1999, J BIOL CHEM, V274, P24094, DOI 10.1074/jbc.274.34.24094; Nykamp K, 2008, RNA, V14, P1378, DOI 10.1261/rna.1066008; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	31	769	796	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1317	1322		10.1126/science.1199498	http://dx.doi.org/10.1126/science.1199498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659604	Green Accepted, Green Submitted			2022-12-28	WOS:000291441700044
J	Karlan, D; Zinman, J				Karlan, Dean; Zinman, Jonathan			Microcredit in Theory and Practice: Using Randomized Credit Scoring for Impact Evaluation	SCIENCE			English	Article							PROGRAMS; MICROFINANCE; BANGLADESH; MATTER; POOR	Microcredit institutions spend billions of dollars fighting poverty by making small loans primarily to female entrepreneurs. Proponents argue that microcredit mitigates market failures, spurs micro-enterprise growth, and boosts borrowers' well-being. We tested these hypotheses with the use of an innovative, replicable experimental design that randomly assigned individual liability microloans (of $225 on average) to 1601 individuals in the Philippines through credit scoring. After 11 to 22 months, we found evidence consistent with unmet demand at the current price (a roughly 60% annualized interest rate): Net borrowing increased in the treatment group relative to controls. However, the number of business activities and employees in the treatment group decreased relative to controls, and subjective well-being declined slightly. We also found little evidence that treatment effects were more pronounced for women. However, we did find that microloans increase ability to cope with risk, strengthen community ties, and increase access to informal credit. Thus, microcredit here may work, but through channels different from those often hypothesized by its proponents.	[Karlan, Dean] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Karlan, Dean; Zinman, Jonathan] Innovat Poverty Act, New Haven, CT 06510 USA; [Karlan, Dean; Zinman, Jonathan] MIT, Jameel Poverty Act Lab, Cambridge, MA 02142 USA; [Zinman, Jonathan] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Yale University; Innovations for Poverty Action (IPA); Massachusetts Institute of Technology (MIT); Dartmouth College	Karlan, D (corresponding author), Yale Univ, Dept Econ, New Haven, CT 06520 USA.	dean.karlan@yale.edu; jzinman@dartmouth.edu	de Groot, M/A-2025-2012	karlan, dean/0000-0003-0164-1398	Bill and Melinda Gates Foundation; National Science Foundation; USAID	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF)); USAID(United States Agency for International Development (USAID))	We thank J. Bauchet, L. Crowley, D. Duthie, M. Duthie, E. Ganir, K. Haggag, T. Harigaya, J. Soriano, M. Startz, and R. Zarsuelo for outstanding project management and research assistance; N. Hite, D. McKenzie, D. Roodman, and seminar participants at the Center for Global Development and many academic seminars and conferences for helpful comments; Bill and Melinda Gates Foundation and the National Science Foundation for funding; and especially J. Owens and his team at the USAID-funded MABS program for help with the project. Any views expressed are those of the authors and do not necessarily represent those of the funders, MABS, or USAID. Above all we thank First Macro Bank for generously providing the data from its credit-scoring experiment.	ARMENDARIZ B, 2007, EC MICROFINANCE, P199; ARMENDARIZ B, 2010, EC MICROFINANCE, P179; Banerjee Abhijit, 2010, MIRACLE MICROFINANCE; Cleary MR, 2006, DEMOCRACY CULTURE SK; Coleman BE, 1999, J DEV ECON, V60, P105, DOI 10.1016/S0304-3878(99)00038-3; Conning J., 2005, HDB DEV EC, V3, P2857; Cull R, 2007, ECON J, V117, pF107, DOI 10.1111/j.1468-0297.2007.02017.x; Cull R, 2009, J ECON PERSPECT, V23, P167, DOI 10.1257/jep.23.1.167; DEAGHION BA, 2010, EC MICROFINANCE, P1; FERNALD L, 2010, BMC PUBLIC HEALTH, V8, P409; GINE X, 2010, J DEV EC; Kaboski Joseph, 2009, IMPACTS CREDIT VILLA; Kaboski JP, 2005, J EUR ECON ASSOC, V3, P1, DOI 10.1162/1542476053295331; Karlan D., 2009, HDB DEV EC, V5; Karlan D, 2008, J EUR ECON ASSOC, V6, P510, DOI 10.1162/JEEA.2008.6.2-3.510; Karlan D, 2010, REV FINANC STUD, V23, P433, DOI 10.1093/rfs/hhp092; McKernan SM, 2002, REV ECON STAT, V84, P93, DOI 10.1162/003465302317331946; Morduch J., 1998, RES PROGRAM DEV STUD; Oswald AJ, 2010, SCIENCE, V327, P576, DOI 10.1126/science.1180606; Pitt MM, 1998, J POLIT ECON, V106, P958, DOI 10.1086/250037; Pitt MM, 2003, INT ECON REV, V44, P87, DOI 10.1111/1468-2354.t01-1-00063; ROODMAN D, 2010, IMPACT MICROCREDIT P; Zinman J, 2010, J BANK FINANC, V34, P546, DOI 10.1016/j.jbankfin.2009.08.024; BENCHMARKING ASIAN M	24	173	177	6	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1278	1284		10.1126/science.1200138	http://dx.doi.org/10.1126/science.1200138			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	775EP	21659596				2022-12-28	WOS:000291441700034
J	Scheel, C; Eaton, EN; Li, SHJ; Chaffer, CL; Reinhardt, F; Kah, KJ; Bell, G; Guo, W; Rubin, J; Richardson, AL; Weinberg, RA				Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Rubin, Jeffrey; Richardson, Andrea L.; Weinberg, Robert A.			Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast	CELL			English	Article							STEM/PROGENITOR CELLS; CANCER-CELLS; IN-VITRO; TRANSITION; METASTASIS; PROPAGATION; EXPRESSION; PATHWAYS; DISEASE; LINES	The epithelial-mesenchymal transition (EMT) has been associated with the acquisition of motility, invasiveness, and self-renewal traits. During both normal development and tumor pathogenesis, this change in cell phenotype is induced by contextual signals that epithelial cells receive from their microenvironment. The signals that are responsible for inducing an EMT and maintaining the resulting cellular state have been unclear. We describe three signaling pathways, involving transforming growth factor (TGF)-beta and canonical and noncanonical Wnt signaling, that collaborate to induce activation of the EMT program and thereafter function in an autocrine fashion to maintain the resulting mesenchymal state. Downregulation of endogenously synthesized inhibitors of autocrine signals in epithelial cells enables the induction of the EMT program. Conversely, disruption of autocrine signaling by added inhibitors of these pathways inhibits migration and self-renewal in primary mammary epithelial cells and reduces tumorigenicity and metastasis by their transformed derivatives.	[Scheel, Christina; Eaton, Elinor Ng; Li, Sophia Hsin-Jung; Chaffer, Christine L.; Reinhardt, Ferenc; Kah, Kong-Jie; Bell, George; Guo, Wenjun; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Li, Sophia Hsin-Jung; Kah, Kong-Jie; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Weinberg, Robert A.] MIT Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Rubin, Jeffrey] NCI, Bethesda, MD 20892 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Scheel, C (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	scheel@wi.mit.edu; weinberg@wi.mit.edu		Li, Sophia Hsin-Jung/0000-0001-8972-6921	National Institutes of Health/National Cancer Institute [CA12515, DE020817]; Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense; Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE [U54CA126515, F32CA144404, ZIABC010251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020817] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Massachusetts Institute of Technology Ludwig Center for Molecular Oncology; Ludwig Fellowship for Metastasis Research; Breast Cancer Research Foundation; Harvard Breast Cancer SPORE; Department of Defense(United States Department of Defense); Samuel Waxman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Brian Bierie, Thijn Brummelkamp, Sunny Gupta, Katharina Leuchte, Julia Rastelli, Andreas Scheel, Scott Valastyan, and Irene Wuethrich for critical reading of the manuscript, members of the Weinberg lab for discussion, John Stingl for protocols, the Whitehead Microarray and Flow Cytometry Cores, and the W.M. Keck Microscopy Facility for technical support. This research was supported by the National Institutes of Health/National Cancer Institute (R.A.W.; CA12515 and DE020817), Massachusetts Institute of Technology Ludwig Center for Molecular Oncology (R.A.W.), Ludwig Fellowship for Metastasis Research (C.S.), Breast Cancer Research Foundation (A.L.R. and R.A.W.), Harvard Breast Cancer SPORE (A.L.R. and R.A.W.), Department of Defense Breast Cancer Research Program Idea Award (R.A.W.), and Samuel Waxman Foundation (R.A.W.). C.S. and R.A.W. are inventors on a patent application in part based on findings detailed in this manuscript.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; CHAFFER CL, 2011, P NATL ACAD IN PRESS; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	29	661	691	6	129	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					926	940		10.1016/j.cell.2011.04.029	http://dx.doi.org/10.1016/j.cell.2011.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663795	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000291461600019
J	Aliyu, F; Esegbona, G				Aliyu, Fatima; Esegbona, G.			A PATIENT'S JOURNEY Living with obstetric fistula	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Esegbona, G.] Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria		Esegbona, G (corresponding author), Specialist Hosp, Laure Fistula Ctr, Kano, Nigeria.	gesegbona@aim.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2011	342								d2881	10.1136/bmj.d2881	http://dx.doi.org/10.1136/bmj.d2881			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SR	21659374	Bronze			2022-12-28	WOS:000291645800001
J	Dauphas, N; Kasting, JF				Dauphas, N.; Kasting, J. F.			Low p(CO2) in the pore water, not in the Archean air	NATURE			English	Letter							IRON-FORMATION; ZIRCON AGES		[Dauphas, N.] Univ Chicago, Dept Geophys Sci, Origins Lab, Chicago, IL 60637 USA; [Dauphas, N.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Kasting, J. F.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dauphas, N (corresponding author), Univ Chicago, Dept Geophys Sci, Origins Lab, Chicago, IL 60637 USA.	dauphas@uchicago.edu	Dauphas, Nicolas/E-4568-2011; Kasting, James/AAF-6851-2020					BECKER RH, 1972, GEOCHIM COSMOCHIM AC, V36, P577, DOI 10.1016/0016-7037(72)90077-4; Craddock PR, 2011, EARTH PLANET SC LETT, V303, P121, DOI 10.1016/j.epsl.2010.12.045; Fischer WW, 2009, GEOL SOC AM BULL, V121, P222, DOI 10.1130/B26328.1; Heimann A, 2010, EARTH PLANET SC LETT, V294, P8, DOI 10.1016/j.epsl.2010.02.015; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Konhauser KO, 2002, GEOLOGY, V30, P1079, DOI 10.1130/0091-7613(2002)030<1079:CBHFTP>2.0.CO;2; OWEN T, 1979, NATURE, V277, P640, DOI 10.1038/277640a0; Pickard AL, 2003, PRECAMBRIAN RES, V125, P275, DOI 10.1016/S0301-9268(03)00113-X; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Trendall AF, 2004, AUST J EARTH SCI, V51, P621, DOI 10.1111/j.1400-0952.2004.01082.x; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WALKER JCG, 1984, NATURE, V309, P340, DOI 10.1038/309340a0	13	34	34	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					E2	E3		10.1038/nature09960	http://dx.doi.org/10.1038/nature09960			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637211				2022-12-28	WOS:000291156700002
J	Reinhard, CT; Planavsky, NJ				Reinhard, Christopher T.; Planavsky, Noah J.			Mineralogical constraints on Precambrian p(CO2)	NATURE			English	Letter							BANDED IRON-FORMATION; WESTERN-AUSTRALIA; BIOMINERALIZATION; MAGNETITE; SEDIMENTS		[Reinhard, Christopher T.; Planavsky, Noah J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Reinhard, CT (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	crein003@ucr.edu						Behrends T, 2007, GEOMICROBIOL J, V24, P403, DOI 10.1080/01490450701436497; Goodwin AM, 1964, ECON GEOL, V59, P684; Han T. M., 1988, P 7 QUADR IAGOD S, P641; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Hofmann A, 2005, PRECAMBRIAN RES, V143, P23, DOI 10.1016/j.precamres.2005.09.005; Johnson CM, 2008, GEOCHIM COSMOCHIM AC, V72, P151, DOI 10.1016/j.gca.2007.10.013; Krapez B, 2003, SEDIMENTOLOGY, V50, P979, DOI 10.1046/j.1365-3091.2003.00594.x; LOVLEY DR, 1988, GEOCHIM COSMOCHIM AC, V52, P2993, DOI 10.1016/0016-7037(88)90163-9; Murakami T, 2004, EARTH PLANET SC LETT, V224, P117, DOI 10.1016/j.epsl.2004.04.040; Roh Y, 2003, CLAY CLAY MINER, V51, P83, DOI 10.1346/CCMN.2003.510110; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Steinhoefel G, 2009, GEOCHIM COSMOCHIM AC, V73, P5343, DOI 10.1016/j.gca.2009.05.037; Tompkins LA, 2001, AUST J EARTH SCI, V48, P427, DOI 10.1046/j.1440-0952.2001.00869.x; Zachara JM, 2002, GEOMICROBIOL J, V19, P179, DOI 10.1080/01490450252864271	14	32	32	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					E1	E2		10.1038/nature09959	http://dx.doi.org/10.1038/nature09959			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637209	Bronze			2022-12-28	WOS:000291156700001
J	Duke, T				Duke, Trevor			What the African fluid-bolus trial means	LANCET			English	Editorial Material							SEPTIC SHOCK; MENINGITIS; SECRETION; PNEUMONIA; CHILDREN; HORMONE		[Duke, Trevor] Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia; [Duke, Trevor] Royal Childrens Hosp, Intens Care Unit, Melbourne, Vic 3079, Australia; [Duke, Trevor] Univ Papua New Guinea, Sch Med & Hlth Sci, Port Moresby, Papua N Guinea	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Papua New Guinea	Duke, T (corresponding author), Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic 3079, Australia.	trevor.duke@rch.org.au						[Anonymous], 2005, HOSP CAR CHILDR GUID; CARCILLO JA, 1991, JAMA-J AM MED ASSOC, V266, P1242, DOI 10.1001/jama.266.9.1242; Carcillo JA, 2002, CRIT CARE MED, V30, P1365, DOI 10.1097/00003246-200206000-00040; DHAWAN A, 1992, ANN TROP PAEDIATR, V12, P455, DOI 10.1080/02724936.1992.11747614; DIXON BS, 1988, AM REV RESPIR DIS, V138, P512, DOI 10.1164/ajrccm/138.3.512; Duke T, 2002, ANN TROP PAEDIATR, V22, P145, DOI 10.1179/027249302125000878; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; JALAC SLR, 2010, PHILIPPINE J MICROBI, V39, P14; KAPLAN SL, 1978, J PEDIATR-US, V92, P758, DOI 10.1016/S0022-3476(78)80144-9; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Tibballs J, 2009, RESUSCITATION, V80, P61, DOI 10.1016/j.resuscitation.2008.10.002; [No title captured]	12	30	30	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 12	2011	378	9804					1685	1687		10.1016/S0140-6736(11)60881-7	http://dx.doi.org/10.1016/S0140-6736(11)60881-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	21683436				2022-12-28	WOS:000296899800011
J	Scharmer, GB; Henriques, VMJ; Kiselman, D; Rodriguez, JD				Scharmer, G. B.; Henriques, V. M. J.; Kiselman, D.; Rodriguez, J. de la Cruz			Detection of Convective Downflows in a Sunspot Penumbra	SCIENCE			English	Article							FINE-STRUCTURE; SIMULATED SUNSPOTS; MHD SIMULATIONS; FILAMENTS; RESOLUTION; CONTRAST; MODELS; FLOWS; FIELD	The fine structure and dynamics of sunspots and the strong outflow in their outer filamentary part-the penumbra-have puzzled astronomers for more than a century. Recent theoretical models and three-dimensional numerical simulations explain the penumbral filaments and their radiative energy output as the result of overturning convection. Here, we describe the detection of ubiquitous, relatively dark downward flows of up to 1 kilometer per second (km/s) in the interior penumbra, using imaging spectropolarimetric data from the Swedish 1-meter Solar Telescope. The dark downflows are omnipresent in the interior penumbra, distinguishing them from flows in arched flux tubes, and are associated with strong (3 to 3.5 km/s) radial outflows. They are thus part of a penumbral convective flow pattern, with the Evershed flow representing the horizontal component of that convection.	[Scharmer, G. B.; Henriques, V. M. J.; Kiselman, D.] Stockholm Univ, Royal Swedish Acad Sci, Inst Solar Phys, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden; [Scharmer, G. B.; Henriques, V. M. J.; Kiselman, D.] Stockholm Univ, AlbaNova Univ Ctr, Dept Astron, SE-10691 Stockholm, Sweden; [Rodriguez, J. de la Cruz] Univ Oslo, Inst Theoret Astrophys, N-0315 Oslo, Norway	Royal Swedish Academy of Sciences; Stockholm University; Stockholm University; University of Oslo	Scharmer, GB (corresponding author), Stockholm Univ, Royal Swedish Acad Sci, Inst Solar Phys, AlbaNova Univ Ctr, SE-10691 Stockholm, Sweden.	scharmer@astro.su.se		de la Cruz Rodriguez, Jaime/0000-0002-4640-5658	European Commission through the SOLAIRE Network [MTRN-CT-2006-035484]; Marianne and Marcus Wallenberg Foundation	European Commission through the SOLAIRE Network(European CommissionEuropean Commission Joint Research Centre); Marianne and Marcus Wallenberg Foundation	P. Sutterlin provided valuable support during the observations and data analysis, and B. Edvardsson provided advice concerning line blends. J.d.l.C.R. gratefully acknowledges financial support by the European Commission through the SOLAIRE Network (MTRN-CT-2006-035484). CRISP was funded by the Marianne and Marcus Wallenberg Foundation. The Swedish 1-meter Solar Telescope is operated on the island of La Palma by the Institute for Solar Physics of the Royal Swedish Academy of Sciences in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias.	Danilovic S, 2008, ASTRON ASTROPHYS, V484, pL17, DOI 10.1051/0004-6361:200809857; Evershed J., 1909, MNRAS, V69, P454, DOI [10.1093/mnras/69.5.454, DOI 10.1093/MNRAS/69.5.454]; Franz M, 2009, ASTRON ASTROPHYS, V508, P1453, DOI 10.1051/0004-6361/200913074; Heinemann T, 2007, ASTROPHYS J, V669, P1390, DOI 10.1086/520827; Ichimoto K, 2007, SCIENCE, V318, P1597, DOI 10.1126/science.1146046; LITES BW, 1993, ASTROPHYS J, V418, P928, DOI 10.1086/173450; Lofdahl MG, 2002, P SOC PHOTO-OPT INS, V4792, P146, DOI 10.1117/12.451791; Mathew SK, 2009, ASTRON ASTROPHYS, V501, pL19, DOI 10.1051/0004-6361/200911975; Rempel M, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/5; Rempel M, 2009, SCIENCE, V325, P171, DOI 10.1126/science.1173798; Rempel M, 2009, ASTROPHYS J, V691, P640, DOI 10.1088/0004-637X/691/1/640; Rodriguez JD, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015664; Rubio LRB, 2010, ASTROPHYS J, V725, P11, DOI 10.1088/0004-637X/725/1/11; Almeida JS, 2007, ASTROPHYS J, V658, P1357, DOI 10.1086/511254; Scharmer GB, 2008, ASTROPHYS J LETT, V677, pL149, DOI 10.1086/587982; Scharmer GB, 2006, ASTRON ASTROPHYS, V460, P605, DOI 10.1051/0004-6361:20066019; Scharmer GB, 2008, ASTROPHYS J LETT, V689, pL69, DOI 10.1086/595744; Scharmer GB, 2003, P SOC PHOTO-OPT INS, V4853, P341, DOI 10.1117/12.460377; Scharmer GB, 2009, SPACE SCI REV, V144, P229, DOI 10.1007/s11214-008-9483-4; Scharmer GRB, 2002, NATURE, V420, P151, DOI 10.1038/nature01173; Schlichenmaier R, 1998, ASTROPHYS J, V493, pL121, DOI 10.1086/311137; Schlichenmaier R, 1999, ASTRON ASTROPHYS, V349, pL37; Schlichenmaier R, 2003, ASTRON ASTROPHYS, V411, P257, DOI 10.1051/0004-6361:20031120; Spruit HC, 2010, ASTRON ASTROPHYS, V521, DOI 10.1051/0004-6361/200912519; Spruit HC, 2006, ASTRON ASTROPHYS, V447, P343, DOI 10.1051/0004-6361:20054000; Van Noort M, 2005, SOL PHYS, V228, P191, DOI 10.1007/s11207-005-5782-z; Wedemeyer-Bohm S, 2009, ASTRON ASTROPHYS, V503, P225, DOI 10.1051/0004-6361/200911983; Zakharov V, 2008, ASTRON ASTROPHYS, V488, pL17, DOI 10.1051/0004-6361:200810266	28	59	60	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					316	319		10.1126/science.1206429	http://dx.doi.org/10.1126/science.1206429			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21636742				2022-12-28	WOS:000292732000035
J	van Dijk, EL; Chen, CL; d'Aubenton-Carafa, Y; Gourvennec, S; Kwapisz, M; Roche, V; Bertrand, C; Silvain, M; Legoix-Ne, P; Loeillet, S; Nicolas, A; Thermes, C; Morillon, A				van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Silvain, M.; Legoix-Ne, P.; Loeillet, S.; Nicolas, A.; Thermes, C.; Morillon, A.			XUTs are a class of Xrn1-sensitive antisense regulatory non-coding RNA in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PERVASIVE TRANSCRIPTION; BIDIRECTIONAL PROMOTERS; EUKARYOTIC GENOME; S. CEREVISIAE; METHYLATION; POLYMERASE; CHROMATIN; DECAY; XRN1	Non-coding (nc)RNAs are key players in numerous biological processes such as gene regulation, chromatin domain formation and genome stability(1,2). Large ncRNAs interact with histone modifiers' and are involved in cancer development(6), X-chromosome inactivation(7) and autosomal gene imprinting(8). However, despite recent evidence showing that pervasive transcription is more widespread than previously thought(9), only a few examples mediating gene regulation in eukaryotes have been described(10). In Saccharomyces cerevisiae, the bona-fide regulatory ncRNAs are destabilized by the Xrn1 5'-3' RNA exonudease(11,12) (also known as Kem1), but the genome-wide characterization of the entire regulatory ncRNA family remains elusive. Here, using strand-specific RNA sequencing (RNA-seq), we identify a novel class of 1,658 Xrn1-sensitive unstable transcripts (XUTs) in which 66% are antisense to open reading frames. These transcripts are polyadenylated and RNA polymerase II (RNAPII)-dependent. The majority of XUTs strongly accumulate in lithium-containing media, indicating that they might have a role in adaptive responses to changes in growth conditions. Notably, RNAP II chromatin immunoprecipitation followed by DNA sequencing (ChIP-seq) analysis of Xrn1-deficient strains revealed a significant decrease of RNAPII occupancy over 273 genes with antisense XUTs. These genes show an unusual bias for H3K4me3 marks and require the Set1 histone H3 lysine 4 methyl-transferase for silencing. Furthermore, abolishing H3K4me3 triggers the silencing of other genes with antisense XUTs, supporting a model in which H3K4me3 antagonizes antisense ncRNA repressive activity. Our results demonstrate that antisense ncRNA-mediated regulation is a general regulatory pathway for gene expression in S. cerevisiae.	[van Dijk, E. L.; Chen, C. L.; d'Aubenton-Carafa, Y.; Silvain, M.; Thermes, C.; Morillon, A.] CNRS, Ctr Genet Mol, UPR 3404, F-91198 Gif Sur Yvette, France; [Gourvennec, S.; Kwapisz, M.; Roche, V.; Bertrand, C.; Morillon, A.] Univ Paris 06, CNRS, UMR3244, Inst Curie,ncRNA,Ctr Rech, F-75248 Paris 05, France; [Legoix-Ne, P.] Inst Curie, NGS Platform, F-75248 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Morillon, A (corresponding author), CNRS, Ctr Genet Mol, UPR 3404, Ave Terrasse, F-91198 Gif Sur Yvette, France.	thermes@cgm.cnrs-gif.fr; antonin.morillon@curie.fr	Thermes, Claude/GNP-6416-2022; CHEN, Chunlong/D-7096-2011; Morillon, Antonin/M-4751-2017	Thermes, Claude/0000-0002-0023-5294; CHEN, Chunlong/0000-0002-4795-0295; Morillon, Antonin/0000-0002-0575-5264; Roche, Veronique/0000-0001-8064-0507	Canceropole Ile de France; ANR "REGULncRNA"; ERC "EPIncRNA"; FRM fellowship	Canceropole Ile de France(Region Ile-de-France); ANR "REGULncRNA"(French National Research Agency (ANR)); ERC "EPIncRNA"; FRM fellowship(Fondation pour la Recherche Medicale)	We thank B. Seraphin, L. Benard and J. O'Sullivan for support and advice; B. Dichtl for insights into lithium treatment data normalization; M. Wery and A. Taddei for helpful discussions: A. Johnson, T. Kouzarides and V. Geli for generous gift of plasmids and strains. Special thanks to M. Descrimes, C. Jubin and S. Lair for technical assistance. We thank L. Steinmetz and M. Chodder for sharing unpublished results. E.L.V.D. benefits from an FRM fellowship. This work has benefited from facilities and expertise of the IMAGIF sequencing platform (Centre de Recherche de Gif). This work was financially supported by the Canceropole Ile de France, the ANR "REGULncRNA" and ERC "EPIncRNA" starting grant.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104; Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Jacquier A, 2009, NAT REV GENET, V10, P833, DOI 10.1038/nrg2683; Johnson AW, 1997, MOL CELL BIOL, V17, P6122, DOI 10.1128/MCB.17.10.6122; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Long RM, 2003, MOL CELL, V11, P1126, DOI 10.1016/S1097-2765(03)00198-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Matsuda E, 2009, P NATL ACAD SCI USA, V106, P15657, DOI 10.1073/pnas.0908305106; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Pinskaya M, 2009, EPIGENETICS-US, V4, P302, DOI 10.4161/epi.4.5.9369; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	35	258	260	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					114	U139		10.1038/nature10118	http://dx.doi.org/10.1038/nature10118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21697827				2022-12-28	WOS:000292461300056
J	Cerritelli, SM; Chon, HG; Crouch, RJ				Cerritelli, Susana M.; Chon, Hyongi; Crouch, Robert J.			A New Twist for Topoisomerase	SCIENCE			English	Editorial Material							RIBONUCLEOTIDE INCORPORATION; TRANSCRIPTION ELONGATION; GENOME STABILITY; DNA; INSTABILITY; REPAIR		[Cerritelli, Susana M.; Chon, Hyongi; Crouch, Robert J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Dev, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Cerritelli, SM (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Dev, NIH, Bethesda, MD 20892 USA.	crouchr@mail.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HD999999] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Rossi ML, 2006, CHEM REV, V106, P453, DOI 10.1021/cr040497l; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108	15	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1510	1511		10.1126/science.1208450	http://dx.doi.org/10.1126/science.1208450			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700860	Green Accepted			2022-12-28	WOS:000291990000029
J	Kysar, D				Kysar, Douglas			Supreme Court ruling is good, bad and ugly	NATURE			English	Editorial Material									Yale Law Sch, New Haven, CT USA	Yale University	Kysar, D (corresponding author), Yale Law Sch, New Haven, CT USA.	douglas.kysar@yale.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					421	421		10.1038/474421a	http://dx.doi.org/10.1038/474421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697906	Bronze			2022-12-28	WOS:000291939700014
J	Carpenter, CR				Carpenter, Christopher R.			Review: Insufficient evidence exists about which drugs are associated with delirium; benzodiazepines may increase risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CONTROLLED-TRIAL		Washington Univ, St Louis, MO 63130 USA	Washington University (WUSTL)	Carpenter, CR (corresponding author), Washington Univ, St Louis, MO 63130 USA.			Clegg, Andrew/0000-0001-5972-1097	NATIONAL CANCER INSTITUTE [KM1CA156708] Funding Source: NIH RePORTER; NCI NIH HHS [KM1 CA156708, KM1 CA156708-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Al-Aama T, 2011, INT J GERIATR PSYCH, V26, P687, DOI 10.1002/gps.2582; Burkhart CS, 2010, J CARDIOTHOR VASC AN, V24, P555, DOI 10.1053/j.jvca.2010.01.003; CALLAHAN CM, 1995, ANN INTERN MED, V122, P422, DOI 10.7326/0003-4819-122-6-199503150-00004; Larsen KA, 2010, PSYCHOSOMATICS, V51, P409, DOI 10.1176/appi.psy.51.5.409; Laurila JV, 2002, INT J GERIATR PSYCH, V17, P1112, DOI 10.1002/gps.753	5	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-10	10.7326/0003-4819-154-12-201106210-02010	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690588	Green Accepted			2022-12-28	WOS:000291800500009
J	Connell, KA				Connell, Kathleen A.			Elastogenesis in the Vaginal Wall and Pelvic-Organ Prolapse	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA	Yale University	Connell, KA (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, Div Urogynecol & Reconstruct Pelv Surg, New Haven, CT 06520 USA.							Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; Takacs P, 2009, INT UROGYNECOL J, V20, P207, DOI 10.1007/s00192-008-0757-x; Yanagisawa H, 2009, J CELL COMMUN SIGNAL, V3, P337, DOI 10.1007/s12079-009-0065-3	5	13	15	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2356	2358		10.1056/NEJMcibr1104976	http://dx.doi.org/10.1056/NEJMcibr1104976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675895				2022-12-28	WOS:000291643800016
J	Khor, B; Gardet, A; Xavier, RJ				Khor, Bernard; Gardet, Agnes; Xavier, Ramnik J.			Genetics and pathogenesis of inflammatory bowel disease	NATURE			English	Review							GENOME-WIDE ASSOCIATION; REGULATORY T-CELLS; INTESTINAL HOMEOSTASIS; TRANSCRIPTION FACTOR; SUSCEPTIBILITY LOCI; INDUCED COLITIS; GUT MICROBIOTA; CROHN-DISEASE; KEY ROLE; PROTEIN	Recent advances have provided substantial insight into the maintenance of mucosal immunity and the pathogenesis of inflammatory bowel disease. Cellular programs responsible for intestinal homeostasis use diverse intracellular and intercellular networks to promote immune tolerance, inflammation or epithelial restitution. Complex interfaces integrate local host and microbial signals to activate appropriate effector programs selectively and even drive plasticity between these programs. In addition, genetic studies and mouse models have emphasized the role of genetic predispositions and how they affect interactions with microbial and environmental factors, leading to pro-colitogenic perturbations of the host-commensal relationship.	[Khor, Bernard; Gardet, Agnes; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Khor, Bernard; Gardet, Agnes; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Khor, Bernard; Gardet, Agnes; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Khor, Bernard] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Xavier, RJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.	xavier@molbio.mgh.harvard.edu		Khor, Bernard/0000-0003-4689-5092	National Institutes of Health; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK083756, P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	R.J.X., A.G. and B.K. are supported by grants from the National Institutes of Health and the Crohn's and Colitis Foundation of America. We apologize to those whose work is not cited owing to space constraints.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Boasberg P, 2010, SEMIN ONCOL, V37, P440, DOI 10.1053/j.seminoncol.2010.09.004; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Campbell EL, 2010, P NATL ACAD SCI USA, V107, P14298, DOI 10.1073/pnas.0914730107; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cox JH, 2011, J EXP MED, V208, P115, DOI 10.1084/jem.20100410; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Darmoise A, 2010, IMMUNITY, V33, P216, DOI 10.1016/j.immuni.2010.08.003; Darsigny M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007609; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Do JS, 2011, J IMMUNOL, V186, P4546, DOI 10.4049/jimmunol.1004021; Dolowschiak T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001194; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hassan SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008868; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Janse M, 2011, HEPATOLOGY, V53, P1977, DOI 10.1002/hep.24307; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Konkel JE, 2011, NAT IMMUNOL, V12, P312, DOI 10.1038/ni.1997; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Monick MM, 2010, J IMMUNOL, V185, P5425, DOI 10.4049/jimmunol.1001603; Muise AM, 2009, GUT, V58, P1121, DOI 10.1136/gut.2008.175117; Pabst O, 1999, DEVELOPMENT, V126, P2215; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramon HE, 2011, MUCOSAL IMMUNOL, V4, P314, DOI 10.1038/mi.2010.69; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sasawatari S, 2011, GASTROENTEROLOGY, V140, P1513, DOI 10.1053/j.gastro.2011.01.041; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scharl M, 2009, GASTROENTEROLOGY, V137, P2030, DOI 10.1053/j.gastro.2009.07.078; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shaw MH, 2011, TRENDS IMMUNOL, V32, P73, DOI 10.1016/j.it.2010.12.007; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spehlmann ME, 2008, INFLAMM BOWEL DIS, V14, P968, DOI 10.1002/ibd.20380; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Waisberg M, 2011, P NATL ACAD SCI USA, V108, P1122, DOI 10.1073/pnas.1017996108; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Yazdanyar S, 2010, CAN MED ASSOC J, V182, P661, DOI 10.1503/cmaj.090684; Yu RY, 2010, J IMMUNOL, V185, P7302, DOI 10.4049/jimmunol.1002410; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	100	1568	1624	13	331	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					307	317		10.1038/nature10209	http://dx.doi.org/10.1038/nature10209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677747	Green Accepted			2022-12-28	WOS:000291647100034
J	Muirhead, TT; Eide, MJ				Muirhead, Trevor T.; Eide, Melody J.			Toxic Effects of Levamisole in a Cocaine User	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Muirhead, Trevor T.; Eide, Melody J.] Henry Ford Hosp, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Muirhead, TT (corresponding author), Henry Ford Hosp, Detroit, MI 48202 USA.	meide1@hfhs.org							0	25	25	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					E52	E52		10.1056/NEJMicm1008722	http://dx.doi.org/10.1056/NEJMicm1008722			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675882				2022-12-28	WOS:000291643800013
J	Spink, MJ; Menz, HB; Fotoohabadi, MR; Wee, E; Landorf, KB; Hill, KD; Lord, SR				Spink, Martin J.; Menz, Hylton B.; Fotoohabadi, Mohammad R.; Wee, Elin; Landorf, Karl B.; Hill, Keith D.; Lord, Stephen R.			Effectiveness of a multifaceted podiatry intervention to prevent falls in community dwelling older people with disabling foot pain: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIFACTORIAL INTERVENTION; EXERCISE PROGRAM; RISK-FACTORS; OUTDOOR FALLS; ANKLE; WOMEN; PREVALENCE; BALANCE; TESTS; CARE	Objective To determine the effectiveness of a multifaceted podiatry intervention in preventing falls in community dwelling older people with disabling foot pain. Design Parallel group randomised controlled trial. Setting University health sciences clinic in Melbourne, Australia. Participants 305 community dwelling men and women (mean age 74 (SD 6) years) with disabling foot pain and an increased risk of falling. 153 were allocated to a multifaceted podiatry intervention and 152 to routine podiatry care, with 12 months' follow-up. Interventions Multifaceted podiatry intervention consisting of foot orthoses, advice on footwear, subsidy for footwear ($A100 voucher; 65; pound (sic)74), a home based programme of foot and ankle exercises, a falls prevention education booklet, and routine podiatry care for 12 months. The control group received routine podiatry care for 12 months. Main outcome measures Proportion of fallers and multiple fallers, falling rate, and injuries resulting from falls during follow-up. Results Overall, 264 falls occurred during the study. 296 participants returned all 12 calendars: 147 (96%) in the intervention group and 149 (98%) in the control group. Adherence was good, with 52% of the participants completing 75% or more of the requested three exercise sessions weekly, and 55% of those issued orthoses reporting wearing them most of the time. Participants in the intervention group (n=153) experienced 36% fewer falls than participants in the control group (incidence rate ratio 0.64, 95% confidence interval 0.45 to 0.91, P=0.01). The proportion of fallers and multiple fallers did not differ significantly between the groups (relative risk 0.85, 0.66 to 1.08, P=0.19 and 0.63, 0.38 to 1.04, P=0.07). One fracture occurred in the intervention group and seven in the control group (0.14, 0.02 to 1.15, P=0.07). Significant improvements in the intervention group compared with the control group were found for the domains of strength (ankle eversion), range of motion (ankle dorsiflexion and inversion/eversion), and balance (postural sway on the floor when barefoot and maximum balance range wearing shoes). Conclusions A multifaceted podiatry intervention reduced the rate of falls in community dwelling older people with disabling foot pain. The components of the intervention are inexpensive and relatively simple to implement, suggesting that the programme could be incorporated into routine podiatry practice or multidisciplinary falls prevention clinics.	[Spink, Martin J.; Menz, Hylton B.; Fotoohabadi, Mohammad R.; Wee, Elin; Landorf, Karl B.; Hill, Keith D.] La Trobe Univ, Fac Hlth Sci, Musculoskeletal Res Ctr, Bundoora, Vic, Australia; [Spink, Martin J.; Landorf, Karl B.] La Trobe Univ, Fac Hlth Sci, Dept Podiatry, Bundoora, Vic, Australia; [Hill, Keith D.] No Hlth, Div Allied Hlth, Epping, NSW, Australia; [Hill, Keith D.] Natl Ageing Res Inst, Prevent & Publ Hlth Div, Parkville, Vic, Australia; [Lord, Stephen R.] UNSW, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Lord, Stephen R.] Neurosci Res Australia, Sydney, NSW, Australia	La Trobe University; La Trobe University; National Ageing Research Institute; University of New South Wales Sydney; Neuroscience Research Australia	Menz, HB (corresponding author), La Trobe Univ, Fac Hlth Sci, Musculoskeletal Res Ctr, Bundoora, Vic, Australia.	h.menz@latrobe.edu.au	Hill, Keith D/L-6398-2017; Landorf, Karl B/H-2829-2014; Menz, Hylton B/B-4508-2013; Lord, Stephen R/C-9612-2011	Hill, Keith D/0000-0002-2191-0308; Landorf, Karl B/0000-0002-3882-5206; Menz, Hylton B/0000-0002-2045-3846; Lord, Stephen R/0000-0002-7111-8802; Spink, Martin/0000-0002-4959-7448	National Health and Medical Research Council of Australia; La Trobe University; National Health and Medical Research Council [433049]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); La Trobe University; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council of Australia and the La Trobe University central large grant scheme. HBM is currently a National Health and Medical Research Council fellow (clinical career development award, 433049). The foot orthoses in this study were provided by Foot Science International, Christchurch, New Zealand.	*AUSTR COMM SAF QU, 2009, PREV FALLS HARM FRAM; BASSEY EJ, 1988, CLIN SCI, V74, P85, DOI 10.1042/cs0740085; Commonwealth of Australia, 2007, DONT FALL IT FALLS C; Cumming RG, 2008, BMJ-BRIT MED J, V336, P758, DOI 10.1136/bmj.39499.546030.BE; Davison J, 2005, AGE AGEING, V34, P162, DOI 10.1093/ageing/afi053; Dunn JE, 2004, AM J EPIDEMIOL, V159, P491, DOI 10.1093/aje/kwh071; Fortinsky RH, 2004, J AM GERIATR SOC, V52, P1522, DOI 10.1111/j.1532-5415.2004.52416.x; Garrow AP, 2000, PAIN, V85, P107, DOI 10.1016/S0304-3959(99)00263-8; Garrow AP, 2004, PAIN, V110, P378, DOI 10.1016/j.pain.2004.04.019; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Haran MJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2265; Hartmann A, 2009, DISABIL REHABIL, V31, P2101, DOI [10.3109/09638280902927010a, 10.3109/09638280902927010]; Harwood RH, 2005, BRIT J OPHTHALMOL, V89, P53, DOI 10.1136/bjo.2004.049478; *HELP AG, 2007, STAYING STEAD; Hernandez ME, 2010, PHYS THER, V90, P67, DOI 10.2522/ptj.20090035; Hijmans JM, 2007, GAIT POSTURE, V25, P316, DOI 10.1016/j.gaitpost.2006.03.010; Hill CL, 2008, J FOOT ANKLE RES, V1, DOI 10.1186/1757-1146-1-2; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Howe TE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004963.pub2; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Knowles EA, 1996, DIABETIC MED, V13, P1064, DOI 10.1002/(SICI)1096-9136(199612)13:12<1064::AID-DIA253>3.0.CO;2-#; Koepsell TD, 2004, J AM GERIATR SOC, V52, P1495, DOI 10.1111/j.1532-5415.2004.52412.x; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Larsen ER, 2004, PREV MED, V39, P389, DOI 10.1016/j.ypmed.2004.02.001; Lightbody E, 2002, AGE AGEING, V31, P203, DOI 10.1093/ageing/31.3.203; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; LORD SR, 1993, AUST J PUBLIC HEALTH, V17, P240, DOI 10.1111/j.1753-6405.1993.tb00143.x; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; Mahoney JE, 2007, J AM GERIATR SOC, V55, P489, DOI 10.1111/j.1532-5415.2007.01144.x; McKiernan FE, 2005, J AM GERIATR SOC, V53, P943, DOI 10.1111/j.1532-5415.2005.53302.x; Menz HB, 2006, RHEUMATOLOGY, V45, P863, DOI 10.1093/rheumatology/kel002; Menz HB, 2000, CLIN REHABIL, V14, P657, DOI 10.1191/0269215500cr375oa; Menz HB, 2006, GERONTOLOGY, V52, P174, DOI 10.1159/000091827; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Menz HB, 2006, J GERONTOL A-BIOL, V61, P866, DOI 10.1093/gerona/61.8.866; Menz HB, 2010, RHEUMATOLOGY, V49, P1391, DOI 10.1093/rheumatology/keq092; Mickle KJ, 2010, J AM GERIATR SOC, V58, P1936, DOI 10.1111/j.1532-5415.2010.03061.x; Mickle KJ, 2009, CLIN BIOMECH, V24, P787, DOI 10.1016/j.clinbiomech.2009.08.011; Munro BJ, 1999, J AM PODIAT MED ASSN, V89, P506, DOI 10.7547/87507315-89-10-506; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Robertson MC, 2005, J GERONTOL A-BIOL, V60, P530, DOI 10.1093/gerona/60.4.530; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Schulz KF, 2002, LANCET, V359, P781, DOI 10.1016/S0140-6736(02)07882-0; Sherrington C, 2003, AGE AGEING, V32, P310, DOI 10.1093/ageing/32.3.310; Shumway-Cook A, 2007, J GERONTOL A-BIOL, V62, P1420, DOI 10.1093/gerona/62.12.1420; Sohng KY, 2003, YONSEI MED J, V44, P883, DOI 10.3349/ymj.2003.44.5.883; Spink Martin J, 2008, BMC Geriatr, V8, P30, DOI 10.1186/1471-2318-8-30; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tencer AF, 2004, J AM GERIATR SOC, V52, P1840, DOI 10.1111/j.1532-5415.2004.52507.x; Tiedemann A, 2005, GERONTOLOGY, V51, P390, DOI 10.1159/000088703; Tiedemann A, 2008, AGE AGEING, V37, P430, DOI 10.1093/ageing/afn100; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Twisk J, 2004, J CLIN EPIDEMIOL, V57, P223, DOI 10.1016/j.jclinepi.2003.07.009; VANDERVOORT AA, 1989, EUR J APPL PHYSIOL O, V58, P389, DOI 10.1007/BF00643514; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams AE, 2007, RHEUMATOLOGY, V46, P302, DOI 10.1093/rheumatology/kel234; Williams AE, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-23	61	90	91	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2011	342								d3411	10.1136/bmj.d3411	http://dx.doi.org/10.1136/bmj.d3411			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LF	21680622	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000291933000005
J	Pierce, M; Kurinczuk, JJ; Spark, P; Brocklehurst, P; Knight, M				Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian		UKOSS	Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							2009 H1N1 INFLUENZA; PREGNANT-WOMEN; HOSPITALIZATIONS; STILLBIRTH; INTERVAL; ILLNESS; RISK	Objectives To follow up a UK national cohort of women admitted to hospital with confirmed 2009/H1N1 influenza in pregnancy in order to obtain a complete picture of pregnancy outcomes and estimate the risks of adverse fetal and infant outcomes. Design National cohort study. Setting 221 hospitals with obstetrician led maternity units in the UK. Participants 256 women admitted to hospital with confirmed 2009/H1N1 in pregnancy during the second wave of pandemic infection between September 2009 and January 2010; 1220 pregnant women for comparison. Main outcome measures Rates of stillbirth, perinatal mortality, and neonatal mortality; odds ratios for infected versus comparison women. Results Perinatal mortality was higher in infants born to infected women (10 deaths among 256 infants; rate 39 (95% confidence interval 19 to 71) per 1000 total births) than in infants of uninfected women (9 deaths among 1233 infants; rate 7 (3 to 13) per 1000 total births) (P<0.001). This was principally explained by an increase in the rate of stillbirth (27 per 1000 total births v 6 per 1000 total births; P=0.001). Infants of infected women were also more likely to be born prematurely than were infants of comparison women (adjusted odds ratio 4.0, 95% confidence interval 2.7 to 5.9). Infected women who delivered preterm were more likely to be infected in their third trimester (P=0.046), to have been admitted to an intensive care unit (P<0.001), and to have a secondary pneumonia (P=0.001) than were those who delivered at term. Conclusions This study suggests an increase in the risk of poor outcomes of pregnancy in women infected with 2009/H1N1, which reinforces the message from studies of maternal risk alone. The health of pregnant women is an important public health priority in future waves of this and other influenza pandemics.	[Pierce, Matthias; Kurinczuk, Jennifer J.; Spark, Patsy; Brocklehurst, Peter; Knight, Marian; UKOSS] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England	University of Oxford	Knight, M (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	marian.knight@npeu.ox.ac.uk	Knight, Marian/B-6225-2009; Pierce, Matthias/D-8561-2011	Knight, Marian/0000-0002-1984-4575; Pierce, Matthias/0000-0003-2182-0369	National Institute for Health Research [09/84/47]; NIHR National Coordinating Centre for Research Capacity Development	National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR National Coordinating Centre for Research Capacity Development	The research presented here was funded by a grant from the National Institute for Health Research Health Technology Assessment Programme, grant reference 09/84/47. MK was funded by a personal award from the NIHR National Coordinating Centre for Research Capacity Development. All researchers are independent of the funders.	Australian and New Zealand Intensive Care Influenza Investigators, 2010, BRIT MED J, V340, pc1279; Centre for Maternal and Child Enquiries, 2010, PER MORT 2008 UK; Centre for Maternal and Child Enquiries (CMACE), 2010, PER MORT 2008 UK; COFFEY VP, 1959, LANCET, V2, P935; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Department of Health, 2010, CLIN MAN GUID PREGN; DOLL R, 1960, Br J Prev Soc Med, V14, P167; Dubar G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013112; Edwards MJ, 2006, BIRTH DEFECTS RES A, V76, P507, DOI 10.1002/bdra.20277; Goldenberg RL, 2007, ACTA OBSTET GYN SCAN, V86, P1303, DOI 10.1080/00016340701644876; GRIFFITH GW, 1972, BMJ-BRIT MED J, V3, P553, DOI 10.1136/bmj.3.5826.553; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; Information Services Division Scotland, 2010, BIRTHS SCOTT HOSP; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P263, DOI 10.1111/j.1471-0528.2005.00609.x; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Laibl VR, 2005, CLIN PERINATOL, V32, P727, DOI 10.1016/j.clp.2005.04.009; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; NHS Information Centre, 2010, HOSP EP STAT MAT DAT; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Office for National Statistics, 2008, STAT REV NOT CONG AN; Office for National Statistics, 2010, BIRTH STAT 2008 SER, V37; Rogers VL, 2010, OBSTET GYNECOL, V115, P924, DOI 10.1097/AOG.0b013e3181da0c5e; Royal College of Obstetricians and Gynaecologists, UPD INFL H1N1 2009 P; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	35	177	180	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3214	10.1136/bmj.d3214	http://dx.doi.org/10.1136/bmj.d3214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781KY	21672992	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000291932100002
J	Johnston, RJ; Otake, Y; Sood, P; Vogt, N; Behnia, R; Vasiliauskas, D; McDonald, E; Xie, BT; Koenig, S; Wolf, R; Cook, T; Gebelein, B; Kussell, E; Nakagoshi, H; Desplan, C				Johnston, Robert J., Jr.; Otake, Yoshiaki; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; McDonald, Elizabeth; Xie, Baotong; Koenig, Sebastian; Wolf, Reinhard; Cook, Tiffany; Gebelein, Brian; Kussell, Edo; Nakagoshi, Hideki; Desplan, Claude			Interlocked Feedforward Loops Control Cell-Type-Specific Rhodopsin Expression in the Drosophila Eye	CELL			English	Article							DEFECTIVE-PROVENTRICULUS; PHOTORECEPTOR CELLS; FATE SPECIFICATION; MOLECULAR SWITCH; ORTHODENTICLE; MORPHOGENESIS; PREFERENCE; OMMATIDIA; BEHAVIOR; SUBTYPES	How complex networks of activators and repressors lead to exquisitely specific cell-type determination during development is poorly understood. In the Drosophila eye, expression patterns of Rhodopsins define at least eight functionally distinct though related subtypes of photoreceptors. Here, we describe a role for the transcription factor gene defective proventriculus (dve) as a critical node in the network regulating Rhodopsin expression. dve is a shared component of two opposing, interlocked feedforward loops (FFLs). Orthodenticle and Dve interact in an incoherent FFL to repress Rhodopsin expression throughout the eye. In R7 and R8 photoreceptors, a coherent FFL relieves repression by Dve while activating Rhodopsin expression. Therefore, this network uses repression to restrict and combinatorial activation to induce cell-type-specific expression. Furthermore, Dve levels are finely tuned to yield cell-type-and region-specific repression or activation outcomes. This interlocked FFL motif may be a general mechanism to control terminal cell-fate specification.	[Otake, Yoshiaki; Nakagoshi, Hideki] Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan; [Johnston, Robert J., Jr.; Sood, Pranidhi; Vogt, Nina; Behnia, Rudy; Vasiliauskas, Daniel; Kussell, Edo; Desplan, Claude] NYU, Dept Biol, New York, NY 10003 USA; [McDonald, Elizabeth; Xie, Baotong; Cook, Tiffany; Gebelein, Brian] Cincinnati Childrens Hosp, Div Dev Biol, Cincinnati, OH 45229 USA; [Koenig, Sebastian; Wolf, Reinhard] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, D-97080 Wurzburg, Germany	Okayama University; New York University; Cincinnati Children's Hospital Medical Center; University of Wurzburg	Nakagoshi, H (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	goshi@cc.okayama-u.ac.jp; cd38@nyu.edu	NAKAGOSHI, Hideki/B-2145-2011; Vasiliauskas, Daniel/AAV-1981-2020	NAKAGOSHI, Hideki/0000-0003-0850-1814; Vasiliauskas, Daniel/0000-0002-0570-2322; Cook, Tiffany/0000-0002-3100-5248; Vogt, Nina/0000-0002-2658-9138; Desplan, Claude/0000-0002-6914-1413	Deutsche Forschungsgemeinschaft; European Molecular Biology Organization; Human Frontier Science Program; NIH [5F32EY016309-03, T32 HD046387, GM079428]; University of Cincinnati Research Council; Research to Prevent Blindness; Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface; National Eye Institute/NIH [R01 13010]; NCRR, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046387] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY016309, R01EY013010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079428] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23570006] Funding Source: KAKEN	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Cincinnati Research Council; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ziegler Foundation for the Blind; Burroughs Wellcome Fund Career Award at the Scientific Interface(Burroughs Wellcome Fund); National Eye Institute/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are very grateful to S. Britt, Y.N. Jan, C. Zuker, and the Bloomington Stock Center for reagents. We thank U. Alon, R. Carthew, O. Hobert, H. Johnston, P. O'Farrell, F. Payre, and E. Siggia for helpful comments on the manuscript. We thank all members of the Desplan laboratory for suggestions throughout the project. R.J.J. was supported by a Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship. N.V. was supported by Deutsche Forschungsgemeinschaft. R.B. was supported by the European Molecular Biology Organization and Human Frontier Science Program. D.V. was supported by NIH Grant 5F32EY016309-03. B.X. was supported by the University of Cincinnati Research Council. T.C. was supported by NIH Grant T32 HD046387 (ECM), Research to Prevent Blindness, and the Ziegler Foundation for the Blind. B.G. was supported by an NIH grant (GM079428). E.K. was supported by a Burroughs Wellcome Fund Career Award at the Scientific Interface. This work was funded by a grant from the National Eye Institute/NIH R01 13010 to C.D. and conducted in a facility constructed with the support of a Research Facilities Improvement Grant from the NCRR, NIH.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Carr M, 2005, DEV GENES EVOL, V215, P402, DOI 10.1007/s00427-005-0488-7; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; Hornstein EP, 2000, P ROY SOC B-BIOL SCI, V267, P2111, DOI 10.1098/rspb.2000.1257; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; Hu XB, 2009, J COMP NEUROL, V516, P334, DOI 10.1002/cne.22114; Johnston RJ, 2010, ANNU REV CELL DEV BI, V26, P689, DOI 10.1146/annurev-cellbio-100109-104113; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Kim D, 2008, BIOESSAYS, V30, P1204, DOI 10.1002/bies.20839; Li-Kroeger D, 2008, DEV CELL, V15, P298, DOI 10.1016/j.devcel.2008.06.001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Mollereau B, 2001, NATURE, V412, P911, DOI 10.1038/35091076; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Nakagoshi H, 2002, DEV BIOL, V249, P44, DOI 10.1006/dbio.2002.0746; Nakagoshi H, 1998, GENE DEV, V12, P2724, DOI 10.1101/gad.12.17.2724; ROSSEL S, 1982, P NATL ACAD SCI-BIOL, V79, P4451, DOI 10.1073/pnas.79.14.4451; Shirai T, 2007, DEV BIOL, V312, P147, DOI 10.1016/j.ydbio.2007.09.003; Stowers RS, 1999, GENETICS, V152, P1631; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Terriente J, 2008, DEV BIOL, V320, P102, DOI 10.1016/j.ydbio.2008.04.028; TREISMAN J, 1989, CELL, V59, P553; Vandendries ER, 1996, DEV BIOL, V173, P243, DOI 10.1006/dbio.1996.0020; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wolff Tanya, 1993, P1277; Xie B, 2007, DEVELOPMENT, V134, P4243, DOI 10.1242/dev.012781; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107; Zelhof AC, 2003, DEVELOPMENT, V130, P4383, DOI 10.1242/dev.00651	38	51	51	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					956	968		10.1016/j.cell.2011.05.003	http://dx.doi.org/10.1016/j.cell.2011.05.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663797	Bronze, Green Accepted			2022-12-28	WOS:000291461600021
J	Haak, DC; HilleRisLambers, J; Pitre, E; Freeman, S				Haak, David C.; HilleRisLambers, Janneke; Pitre, Emile; Freeman, Scott			Increased Structure and Active Learning Reduce the Achievement Gap in Introductory Biology	SCIENCE			English	Article							BLOOMS TAXONOMY; SCIENCE; DIVERSITY; PEER; PERFORMANCE; COURSES	Science, technology, engineering, and mathematics instructors have been charged with improving the performance and retention of students from diverse backgrounds. To date, programs that close the achievement gap between students from disadvantaged versus nondisadvantaged educational backgrounds have required extensive extramural funding. We show that a highly structured course design, based on daily and weekly practice with problem-solving, data analysis, and other higher-order cognitive skills, improved the performance of all students in a college-level introductory biology class and reduced the achievement gap between disadvantaged and nondisadvantaged students-without increased expenditures. These results support the Carnegie Hall hypothesis: Intensive practice, via active-learning exercises, has a disproportionate benefit for capable but poorly prepared students.	[Haak, David C.; HilleRisLambers, Janneke; Freeman, Scott] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Pitre, Emile] Univ Washington, Off Minor Affairs & Divers, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Freeman, S (corresponding author), Univ Washington, Dept Biol, Box 351800, Seattle, WA 98195 USA.	srf991@uw.edu		Haak, David/0000-0002-3692-3152	University of Washington's College of Arts and Sciences; University of Washington-Howard Hughes Medical Institute [52003841]; NSF	University of Washington's College of Arts and Sciences; University of Washington-Howard Hughes Medical Institute; NSF(National Science Foundation (NSF))	We thank the University of Washington Biology Education Research Group, Bio-Grads Organizing Opportunities for Diversity and Development, and P. Haak for helpful discussion and A. Arquiza, R. Moreno, and S. Fernandes for assembling the achievement gap data across introductory STEM courses from the Office of Minority Affairs and Diversity. Data are archived with the study authors and may be obtained by contacting S.F. The work was funded by grants from the University of Washington's College of Arts and Sciences as part of the Foundations Course program, the University of Washington-Howard Hughes Medical Institute Undergraduate Science Education Programs (grant 52003841), and an NSF predoctoral fellowship to D.C.H. The research was conducted under Human Subjects Review no. 07-8483-J01.	Alexander C, 2009, ACAD MED, V84, P797, DOI 10.1097/ACM.0b013e3181a3d948; Bainbridge WL, 2002, EDUC URBAN SOC, V34, P422, DOI 10.1177/00124502034004002; Beichner R.J., 2007, RES BASED REFORM U P, P1; BLOOM BENJAMIN S., 1956, HDB 1 COGNITIVE DOMA; Bloom BS, 1984, EDUC RES, V13, P4, DOI DOI 10.3102/0013189X013006004; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Dirks Clarissa, 2006, CBE Life Sci Educ, V5, P218, DOI 10.1187/cbe.05-10-0121; Eberlein T, 2008, BIOCHEM MOL BIOL EDU, V36, P262, DOI 10.1002/bmb.20204; Farrell JJ, 1999, J CHEM EDUC, V76, P570, DOI 10.1021/ed076p570; Freeman Scott, 2007, CBE Life Sci Educ, V6, P132, DOI 10.1187/cbe.06-09-0194; Freeman S, 2011, CBE-LIFE SCI EDUC, V10, P175, DOI 10.1187/cbe.10-08-0105; FULLILOVE RE, 1990, J NEGRO EDUC, V59, P463, DOI 10.2307/2295577; G?ndara P., 1999, PRIMING PUMP STRATEG; Guskey TR, 2007, J ADV ACAD, V19, P8, DOI 10.4219/jaa-2007-704; Hrabowski FA, 2011, SCIENCE, V331, P125, DOI 10.1126/science.1202388; Krathwohl DR, 2002, THEOR PRACT, V41, P212, DOI 10.1207/s15430421tip4104_2; Larsen DP, 2009, MED EDUC, V43, P1174, DOI 10.1111/j.1365-2923.2009.03518.x; Lord T. R., 1997, INNOV HIGH EDUC, V21, P197, DOI [DOI 10.1007/BF01243716, 10.1007/BF01243716]; Malcom SM, 1996, SCIENCE, V271, P1817, DOI 10.1126/science.271.5257.1817; Matsui John, 2003, Cell Biol Educ, V2, P117, DOI 10.1187/cbe.02-10-0050; Mervis J, 2010, SCIENCE, V330, P306, DOI 10.1126/science.330.6002.306; Novak G. M., 1999, JUST IN TIME TEACHIN; Oakes J., 2006, LEARNING POWER ORG E; Piaget J., 1926, LANGUAGE THOUGHT CHI; Preszler RW, 2009, CBE-LIFE SCI EDUC, V8, P182, DOI 10.1187/cbe.09-01-0002; Rath Kenneth A, 2007, CBE Life Sci Educ, V6, P203, DOI 10.1187/cbe.06-10-0198; Slavin R.E., 2009, 2 MILLION CHILDREN S; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919; Stockdale S.L., 2004, J BEHAV EDUC, V13, P37, DOI [10.1023/B:JOBE.0000011259.97014.94, DOI 10.1023/B:JOBE.0000011259.97014.94]; Summers MF, 2006, SCIENCE, V311, P1870, DOI 10.1126/science.1125257; Tekian A, 2004, TEACH LEARN MED, V16, P28, DOI 10.1207/s15328015tlm1601_7; Vygotsky L.., 1978, MIND SOC	33	438	446	7	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1213	1216		10.1126/science.1204820	http://dx.doi.org/10.1126/science.1204820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636776				2022-12-28	WOS:000291205200052
J	Cluver, L				Cluver, Lucie			Children of the AIDS pandemic	NATURE			English	Editorial Material							DISTRESS; ORPHANS; AFRICA		Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England	University of Oxford	Cluver, L (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford OX1 2ER, England.	lucie.cluver@spi.ox.ac.uk		Cluver, Lucie/0000-0002-0418-835X	Economic and Social Research Council [ES/H001743/1] Funding Source: researchfish; ESRC [ES/H001743/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Case A, 2004, DEMOGRAPHY, V41, P483, DOI 10.1353/dem.2004.0019; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; CLUVER L, 2011, 5 S AFR AIDS C DURB; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Kumakech E, 2009, SOC SCI MED, V68, P1038, DOI 10.1016/j.socscimed.2008.10.033; Nyamukapa CA, 2008, AM J PUBLIC HEALTH, V98, P133, DOI 10.2105/AJPH.2007.116038; RICHTER L, 2006, HEART IS; Zivin JG, 2009, J PUBLIC ECON, V93, P1008, DOI 10.1016/j.jpubeco.2009.03.003	10	18	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					27	29		10.1038/474027a	http://dx.doi.org/10.1038/474027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	771KV	21637236	Bronze			2022-12-28	WOS:000291156700018
J	Baytekin, HT; Patashinski, AZ; Branicki, M; Baytekin, B; Soh, S; Grzybowski, BA				Baytekin, H. T.; Patashinski, A. Z.; Branicki, M.; Baytekin, B.; Soh, S.; Grzybowski, B. A.			The Mosaic of Surface Charge in Contact Electrification	SCIENCE			English	Article							IONIC ELECTRETS; POLYMERS; INSULATORS; GENERATION; SEPARATION; MONOLAYER; METALS	When dielectric materials are brought into contact and then separated, they develop static electricity. For centuries, it has been assumed that such contact charging derives from the spatially homogeneous material properties (along the material's surface) and that within a given pair of materials, one charges uniformly positively and the other negatively. We demonstrate that this picture of contact charging is incorrect. Whereas each contact-electrified piece develops a net charge of either positive or negative polarity, each surface supports a random "mosaic" of oppositely charged regions of nanoscopic dimensions. These mosaics of surface charge have the same topological characteristics for different types of electrified dielectrics and accommodate significantly more charge per unit area than previously thought.	[Grzybowski, B. A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Grzybowski, BA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	grzybor@northwestern.edu	Baytekin, Bilge/O-1823-2019; Soh, Siowling/T-1872-2019; Grzybowski, Bartosz A/H-5741-2017; Baytekin, Bilge/K-4719-2014	Baytekin, Bilge/0000-0002-3867-3863; Baytekin, Bilge/0000-0002-3867-3863; Branicki, Michal/0000-0001-6955-6208; Grzybowski, Bartosz/0000-0001-6613-4261	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000989]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the Non-Equilibrium Energy Research Center (NERC), which is an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under award DE-SC0000989.	Albrecht V, 2009, J ELECTROSTAT, V67, P7, DOI 10.1016/j.elstat.2008.10.002; Apodaca MM, 2010, ANGEW CHEM INT EDIT, V49, P946, DOI 10.1002/anie.200905281; Camara CG, 2008, NATURE, V455, P1089, DOI 10.1038/nature07378; Castle GSP, 1997, J ELECTROSTAT, V40-1, P13, DOI 10.1016/S0304-3886(97)00009-0; Chenery DH, 1997, BIOMATERIALS, V18, P415, DOI 10.1016/S0142-9612(96)00149-4; Cole JJ, 2010, ACS NANO, V4, P7492, DOI 10.1021/nn1016692; DAVIES DK, 1969, J PHYS D APPL PHYS, V2, P1533, DOI 10.1088/0022-3727/2/11/307; DERJAGUIN V, 1960, PHYS SOLID STATE ENG, V1, P1393; Diaz AF, 2004, J ELECTROSTAT, V62, P277, DOI 10.1016/j.elstat.2004.05.005; DIAZ AF, 1993, IBM J RES DEV, V37, P249, DOI 10.1147/rd.372.0249; DUKE CB, 1978, J APPL PHYS, V49, P315, DOI 10.1063/1.324388; ELSDON R, 1976, J PHYS D APPL PHYS, V9, P1445, DOI 10.1088/0022-3727/9/10/010; GREASON WD, 1999, 21 ANN INT EL OV EL; Grzybowski BA, 2005, J PHYS CHEM B, V109, P20511, DOI 10.1021/jp053532g; Grzybowski BA, 2003, NAT MATER, V2, P241, DOI 10.1038/nmat860; Harper W.F., 1967, CONTACT FRICTIONAL E; HORN RG, 1992, SCIENCE, V256, P362, DOI 10.1126/science.256.5055.362; HORN RG, 1993, NATURE, V366, P442, DOI 10.1038/366442a0; ISRAELI Y, 1993, POLYM DEGRAD STABIL, V42, P267, DOI 10.1016/0141-3910(93)90223-6; Iuga A, 2005, J ELECTROSTAT, V63, P937, DOI 10.1016/j.elstat.2005.03.064; KITTAKA S, 1959, J PHYS SOC JPN, V14, P532, DOI 10.1143/JPSJ.14.532; Kok JF, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051304; Kwetkus BA, 1998, PARTICUL SCI TECHNOL, V16, P55, DOI 10.1080/02726359808906784; LABIB ME, 1984, J COLLOID INTERF SCI, V97, P356, DOI 10.1016/0021-9797(84)90306-0; Liu CY, 2009, J AM CHEM SOC, V131, P6397, DOI 10.1021/ja806785x; Liu CY, 2008, NAT MATER, V7, P505, DOI 10.1038/nmat2160; LOWELL J, 1988, J PHYS D APPL PHYS, V21, P125, DOI 10.1088/0022-3727/21/1/018; LOWELL J, 1980, ADV PHYS, V29, P947, DOI 10.1080/00018738000101466; LOWELL J, 1977, J PHYS D APPL PHYS, V10, pL233, DOI 10.1088/0022-3727/10/17/001; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; McCarty LS, 2008, ANGEW CHEM INT EDIT, V47, P2188, DOI 10.1002/anie.200701812; McCarty LS, 2007, J AM CHEM SOC, V129, P4075, DOI 10.1021/ja067301e; OGRADY P, 2002, THALES MILETUS BEGIN; PAI DM, 1993, REV MOD PHYS, V65, P163, DOI 10.1103/RevModPhys.65.163; SALANECK WR, 1976, J APPL PHYS, V47, P144, DOI 10.1063/1.322306; SCHEIN LB, 1996, ELECTROPHOTOGRAPHY D; SESSLER GM, 1982, ELECTRONIC PROPERTIE, P59; Socrates G., 1980, INFRARED RAMAN CHARA, V3; TERRIS BD, 1989, PHYS REV LETT, V63, P2669, DOI 10.1103/PhysRevLett.63.2669; Wiles JA, 2003, ANAL CHEM, V75, P4859, DOI 10.1021/ac034275j; WILLIAMS R, 1982, J COLLOID INTERF SCI, V88, P530, DOI 10.1016/0021-9797(82)90281-8; Xia YN, 1996, ADV MATER, V8, P1015, DOI 10.1002/adma.19960081217; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; YU ZZ, 1990, J PHYS D APPL PHYS, V23, P1207, DOI 10.1088/0022-3727/23/9/011	44	539	546	19	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					308	312		10.1126/science.1201512	http://dx.doi.org/10.1126/science.1201512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21700838	Green Accepted			2022-12-28	WOS:000292732000033
J	Sommers, BD; Epstein, AM				Sommers, Benjamin D.; Epstein, Arnold M.			Why States Are So Miffed about Medicaid - Economics, Politics, and the "Woodwork Effect"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REFORM		[Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 665 Huntington Ave, Boston, MA 02115 USA.							Dorn S., 2010, NET EFFECTS AFFORDAB; *NAT STAT BUDG OFF, 2010, STAT EXP REP FISC YE; RAMSHAW E, 2010, NY TIMES        1112, pA21; Sommers BD, 2011, HEALTH AFFAIR, V30, P228, DOI 10.1377/hlthaff.2010.1000; Sommers BD, 2010, NEW ENGL J MED, V363, P2085, DOI 10.1056/NEJMp1010866	5	32	32	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					100	102		10.1056/NEJMp1104948	http://dx.doi.org/10.1056/NEJMp1104948			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21675913	Green Submitted, Green Published			2022-12-28	WOS:000292685500002
J	Clayton, RN				Clayton, Robert N.			The Earth and the Sun	SCIENCE			English	Editorial Material									[Clayton, Robert N.] Univ Chicago, Enrico Fermi Inst, Dept Chem, Chicago, IL 60637 USA; [Clayton, Robert N.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Clayton, RN (corresponding author), Univ Chicago, Enrico Fermi Inst, Dept Chem, 5640 S Ellis Ave, Chicago, IL 60637 USA.	r-clayton@uchicago.edu						Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; EPSTEIN S, 1970, SCIENCE, V167, P533, DOI 10.1126/science.167.3918.533; Herbst E, 2003, SPACE SCI REV, V106, P293, DOI 10.1023/A:1024654108167; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; McKeegan KD, 2011, SCIENCE, V332, P1528, DOI 10.1126/science.1204636; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877	6	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1509	1510		10.1126/science.1206965	http://dx.doi.org/10.1126/science.1206965			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700859				2022-12-28	WOS:000291990000028
J	Ridley, AJ				Ridley, Anne J.			Life at the Leading Edge	CELL			English	Review							COLLECTIVE CELL-MIGRATION; PROTEIN-KINASE-C; ARP2/3 COMPLEX; PLASMA-MEMBRANE; MYOSIN-X; INVADOPODIA FORMATION; ACTIN NUCLEATION; TUMOR-CELLS; LIM KINASES; N-WASP	Cell migration requires sustained forward movement of the plasma membrane at the cell's front or "leading edge.'' To date, researchers have uncovered four distinct ways of extending the membrane at the leading edge. In lamellipodia and filopodia, actin polymerization directly pushes the plasma membrane forward, whereas in invadopodia, actin polymerization couples with the extracellular delivery of matrix-degrading metalloproteases to clear a path for cells through the extracellular matrix. Membrane blebs drive the plasma membrane forward using a combination of actomyosin-based contractility and reversible detachment of the membrane from the cortical actin cytoskeleton. Each protrusion type requires the coordination of a wide spectrum of signaling molecules and regulators of cytoskeletal dynamics. In addition, these different protrusion methods likely act in concert to move cells through complex environments in vivo.	Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of London; King's College London	Ridley, AJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	anne.ridley@kcl.ac.uk		Ridley, Anne/0000-0001-8186-5708	Cancer Research UK; Bettencourt-Schueller Foundation; King's College London BHF Centre of Excellence	Cancer Research UK(Cancer Research UK); Bettencourt-Schueller Foundation; King's College London BHF Centre of Excellence	I am grateful to Cancer Research UK, Bettencourt-Schueller Foundation, and King's College London BHF Centre of Excellence for grant support.	ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4; ABERCROMBIE M, 1970, EXP CELL RES, V60, P437, DOI 10.1016/0014-4827(70)90537-9; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Abraham S, 2009, CURR BIOL, V19, P668, DOI 10.1016/j.cub.2009.02.057; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Ayala I, 2009, CANCER RES, V69, P747, DOI 10.1158/0008-5472.CAN-08-1980; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Bovellan M, 2010, FEBS J, V277, P58, DOI 10.1111/j.1742-4658.2009.07412.x; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522; CARMONAFONTAINE C, 2008, NAT REV MOL CELL BIO, V9, P730; CHEN WT, 1989, J EXP ZOOL, V251, P167, DOI 10.1002/jez.1402510206; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Derivery E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002462; Derivery E, 2010, BIOESSAYS, V32, P119, DOI 10.1002/bies.200900123; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Dubin-Thaler BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003735; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Etienne-Manneville S, 2009, ADV EXP MED BIOL, V656, P30, DOI 10.1007/978-1-4419-1145-2_3; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Groeger G, 2007, BIOCHEM J, V404, P23, DOI 10.1042/BJ20070146; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Han YY, 2009, J BIOL CHEM, V284, P33409, DOI 10.1074/jbc.M109.060699; Hannemann S, 2008, J BIOL CHEM, V283, P27891, DOI 10.1074/jbc.M801800200; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; Hashimoto Y, 2007, MOL BIOL CELL, V18, P4591, DOI 10.1091/mbc.E07-02-0157; Heasman SJ, 2010, J CELL BIOL, V190, P553, DOI 10.1083/jcb.201002067; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Huang C, 2010, CELL ADHES MIGR, V4, P10, DOI 10.4161/cam.4.1.9834; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Kardash E, 2010, NAT CELL BIOL, V12, P47, DOI 10.1038/ncb2003; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; LeClaire LL, 2008, J CELL BIOL, V182, P647, DOI 10.1083/jcb.200802145; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Mellor H, 2010, BBA-MOL CELL RES, V1803, P191, DOI 10.1016/j.bbamcr.2008.12.018; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagy S, 2010, J BIOL CHEM, V285, P26608, DOI 10.1074/jbc.M110.104661; Nalbant P, 2009, MOL BIOL CELL, V20, P4070, DOI 10.1091/mbc.E09-01-0041; Neubueser D, 2010, MOL BIOL CELL, V21, P2869, DOI 10.1091/mbc.E10-04-0328; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Norman LL, 2010, BIOPHYS J, V99, P1726, DOI 10.1016/j.bpj.2010.07.031; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons M, 2008, J CELL SCI, V121, P2805, DOI 10.1242/jcs.022509; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Roy BC, 2009, J CELL BIOL, V184, P253, DOI 10.1083/jcb.200805147; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schoumacher M, 2011, EUR J CELL BIOL, V90, P93, DOI 10.1016/j.ejcb.2010.05.010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Scott RW, 2010, J CELL BIOL, V191, P169, DOI 10.1083/jcb.201002041; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sousa AD, 2005, TRENDS CELL BIOL, V15, P533, DOI 10.1016/j.tcb.2005.08.006; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takahashi K, 2009, CELL SIGNAL, V21, P695, DOI 10.1016/j.cellsig.2009.01.007; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Tokuo H, 2007, J CELL BIOL, V179, P229, DOI 10.1083/jcb.200703178; Toomre D, 2010, ANNU REV CELL DEV BI, V26, P285, DOI 10.1146/annurev-cellbio-100109-104048; Urban E, 2010, NAT CELL BIOL, V12, P429, DOI 10.1038/ncb2044; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Weaver AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.288pe56; Weijer CJ, 2009, J CELL SCI, V122, P3215, DOI 10.1242/jcs.036517; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yoshida K, 2006, J CELL SCI, V119, P3833, DOI 10.1242/jcs.03152; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921; Zhang LJ, 2011, DEVELOPMENT, V138, P455, DOI 10.1242/dev.046870; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005; Zhuravlev PI, 2010, BIOPHYS J, V98, P1439, DOI 10.1016/j.bpj.2009.12.4325; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	120	665	677	4	222	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1012	1022		10.1016/j.cell.2011.06.010	http://dx.doi.org/10.1016/j.cell.2011.06.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703446	Bronze			2022-12-28	WOS:000292025700009
J	Graham-Rowe, D				Graham-Rowe, Duncan			Beyond food versus fuel	NATURE			English	Editorial Material																			0	155	159	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S6	S8		10.1038/474S06a	http://dx.doi.org/10.1038/474S06a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697842	Bronze			2022-12-28	WOS:000291939700002
J	Lapkiewicz, R; Li, PZ; Schaeff, C; Langford, NK; Ramelow, S; Wiesniak, M; Zeilinger, A				Lapkiewicz, Radek; Li, Peizhe; Schaeff, Christoph; Langford, Nathan K.; Ramelow, Sven; Wiesniak, Marcin; Zeilinger, Anton			Experimental non-classicality of an indivisible quantum system	NATURE			English	Article							KOCHEN-SPECKER THEOREM; HIDDEN-VARIABLES; MECHANICS	In contrast to classical physics, quantum theory demands that not all properties can be simultaneously well defined; the Heisenberg uncertainty principle is a manifestation of this fact(1). Alternatives have been explored-notably theories relying on joint probability distributions or non-contextual hidden-variable models, in which the properties of a system are defined independently of their own measurement and any other measurements that are made. Various deep theoretical results(2-5) imply that such theories are in conflict with quantum mechanics. Simpler cases demonstrating this conflict have been found(6-10) and tested experimentally(11,12) with pairs of quantum bits (qubits). Recently, an inequality satisfied by non-contextual hidden-variable models and violated by quantum mechanics for all states of two qubits was introduced(13) and tested experimentally(14-16). A single three-state system (a qutrit) is the simplest system in which such a contradiction is possible; moreover, the contradiction cannot result from entanglement between subsystems, because such a three-state system is indivisible. Here we report an experiment with single photonic qutrits(17,18) which provides evidence that no joint probability distribution describing the outcomes of all possible measurements-and, therefore, no non-contextual theory-can exist. Specifically, we observe a violation of the Bell-type inequality found by Klyachko, Can, Binicioglu and Shumovsky(19). Our results illustrate a deep incompatibility between quantum mechanics and classical physics that cannot in any way result from entanglement.	[Lapkiewicz, Radek; Li, Peizhe; Schaeff, Christoph; Langford, Nathan K.; Ramelow, Sven; Wiesniak, Marcin; Zeilinger, Anton] Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, A-1090 Vienna, Austria; [Lapkiewicz, Radek; Schaeff, Christoph; Langford, Nathan K.; Ramelow, Sven; Zeilinger, Anton] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria	University of Vienna; Austrian Academy of Sciences	Zeilinger, A (corresponding author), Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	anton.zeilinger@univie.ac.at	Zeilinger, Anton/A-1170-2011; Ramelow, Sven/H-6798-2012; Lapkiewicz, Radek/B-5786-2015; Langford, Nathan K/A-5699-2012	Ramelow, Sven/0000-0002-7801-4440; Langford, Nathan K/0000-0003-4338-3059; Lapkiewicz, Radek/0000-0002-7026-7275; Wiesniak, Marcin/0000-0002-1873-3945	ERC [QIT4QAD]; Austrian Science Fund [F4007]; EC (Marie Curie Research Training Network EMALI); Vienna Doctoral Program on Complex Quantum Systems; John Templeton Foundation	ERC(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); EC (Marie Curie Research Training Network EMALI)(European CommissionEuropean Commission Joint Research Centre); Vienna Doctoral Program on Complex Quantum Systems; John Templeton Foundation	This work was supported by the ERC (Advanced Grant QIT4QAD), the Austrian Science Fund (Grant F4007), the EC (Marie Curie Research Training Network EMALI), the Vienna Doctoral Program on Complex Quantum Systems and the John Templeton Foundation. We acknowledge A. A. Klyachko for discussion of the proposal made in ref. 19; M. Hentschel, M. Kacprowicz and G. J. Pryde for discussions of technical issues; A. Cabello, S. Osnaghi, H. M. Wiseman and M. Zukowski, with whom we discussed the conceptual issues; and M. Nespoli for help during the early stages of the experiment.	Amselem E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.160405; BELL JS, 1966, REV MOD PHYS, V38, P447, DOI 10.1103/RevModPhys.38.447; Cabello A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.210401; CLIFTON R, 1993, AM J PHYS, V61, P443, DOI 10.1119/1.17239; GLEASON AM, 1957, J MATH MECH, V6, P885; Guhne O, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.022121; Heisenberg W, 1930, PHYSICAL PRINCIPLES, P13; Huang YF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.250401; Kirchmair G, 2009, NATURE, V460, P494, DOI 10.1038/nature08172; Klyachko AA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.020403; Lapkiewicz R, 2010, 13 WORKSH QUANT INF; Lapkiewicz R, 2010, 41 ANN M DIV AT MOL; Moussa O, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160501; PERES A, 1991, J PHYS A-MATH GEN, V24, pL175, DOI 10.1088/0305-4470/24/4/003; Peres A, 1993, QUANTUM THEORY CONCE; Specker EP., 1960, DIALECTICA, V14, P239, DOI [DOI 10.1111/J.1746-8361.1960.TB00422.X, 10.1111/j.1746-8361.1960.tb00422.x]	20	178	178	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					490	493		10.1038/nature10119	http://dx.doi.org/10.1038/nature10119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697945	Green Submitted			2022-12-28	WOS:000291939700044
J	Ftouh, S; Morga, A; Swift, C				Ftouh, Saoussen; Morga, Antonia; Swift, Cameron			GUIDELINES Management of hip fracture in adults: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Swift, Cameron] Kings Coll London, Univ London Kings Coll Hosp, Sch Med, Clin Age Res Unit, London SE5 9RS, England; [Ftouh, Saoussen; Morga, Antonia] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Royal College of Physicians	Swift, C (corresponding author), Kings Coll London, Univ London Kings Coll Hosp, Sch Med, Clin Age Res Unit, Denmark Hill, London SE5 9RS, England.	cameron.swift@kcl.ac.uk		Lamb, Sarah/0000-0003-4349-7195; Sahota, Opinder/0000-0003-0055-7637; Johansen, Antony/0000-0003-4726-9106				British Orthopedic Association and British Geriatrics Society, 2007, CAR PAT FRAG FRACT; Cameron ID, 2005, DISABIL REHABIL, V27, P1081, DOI 10.1080/09638280500061261; *DEP HLTH, 2010, PAYM RES BEST PRACT; *NAT I CLIN EXC, 2004, 21 NAT I CLIN EXC; National Hip Fracture Database, 2010, NAT HIP FRACT DAT NA; *NHS SUPPL CHAIN, 2010, ODEP DAT ORTH DAT EV; *NIH CLIN EXC, GUID MAN 2009; *NIH CLIN EXC, 2011, CG124 NIH CLIN EXC; *NIH CLIN EXC, 2011, NICE QUAL STAND; *NIH CLIN EXC, 2010, 204 NIH CLIN EXC; *NIH CLIN EXC, 2011, 161 NIH CLIN EXC; Parker M, 2006, BMJ-BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27	12	71	83	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2011	342								d3304	10.1136/bmj.d3304	http://dx.doi.org/10.1136/bmj.d3304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AO	21693526				2022-12-28	WOS:000292200000001
J	Pickhardt, PJ; Lawrence, EM; Pooler, BD; Bruce, RJ				Pickhardt, Perry J.; Lawrence, Edward M.; Pooler, B. Dustin; Bruce, Richard J.			Diagnostic Performance of Multidetector Computed Tomography for Suspected Acute Appendicitis	ANNALS OF INTERNAL MEDICINE			English	Article							LOWER-QUADRANT PAIN; NEGATIVE APPENDECTOMY RATE; HELICAL CT; ORAL CONTRAST; ADULTS; IMPACT; US; ULTRASONOGRAPHY; ACCURACY; SCAN	Background: Use of preoperative computed tomography for suspected acute appendicitis has dramatically increased since the introduction of multidetector CT (MDCT) scanners. Objective: To evaluate the diagnostic performance of MDCT for suspected acute appendicitis in adults. Design: Analysis of MDCT findings and clinical outcomes of consecutive adults referred for MDCT for suspected appendicitis from January 2000 to December 2009. Setting: Single academic medical center in the United States. Patients: 2871 adults. Measurements: Interpretation of nonfocused abdominopelvic MDCT scans by radiologists who were aware of the study indication. Posttest assessment of diagnostic performance of MDCT for acute appendicitis, according to the reference standard of final combined clinical, surgical, and pathology findings. Results: 675 of 2871 patients (23.5%) had confirmed acute appendicitis. The sensitivity, specificity, and negative and positive predictive values of MDCT were 98.5% (95% CI, 97.3% to 99.2%) (665 of 675 patients), 98.0% (CI, 97.4% to 98.6%) (2153 of 2196 patients), 99.5% (CI, 99.2% to 99.8%) (2153 of 2163 patients), and 93.9% (CI, 91.9% to 95.5%) (665 of 708 patients), respectively. Positive and negative likelihood ratios were 51.3 (CI, 38.1 to 69.0) and 0.015 (CI, 0.008 to 0.028), respectively. The overall rate of negative findings at appendectomy was 7.5% (CI, 5.8% to 9.7%) (54 of 716 patients), but would have decreased to 4.1% (28 of 690 patients) had surgery been avoided in 26 cases with true-negative findings on MDCT. The overall perforation rate was 17.8% (120 of 675 patients) but progressively decreased from 28.9% in 2000 to 11.5% in 2009. Multidetector computed tomography provided or suggested an alternative diagnosis in 893 of 2122 patients (42.1%) without appendicitis or appendectomy. Limitation: Possible referral bias, because some patients whose appendicitis was difficult to diagnose on clinical grounds may not have been referred for MDCT for evaluation of suspected appendicitis. Conclusion: Multidetector computed tomography is a useful test for routine evaluation of suspected appendicitis in adults.	[Pickhardt, Perry J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Pickhardt, PJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Radiol, Clin Sci Ctr E3 311, 600 Highland Ave, Madison, WI 53792 USA.	ppickhardt2@uwhealth.org						ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Anderson BA, 2005, AM J SURG, V190, P474, DOI 10.1016/j.amjsurg.2005.03.037; [Anonymous], 1996, RAD RISK PERSPECTIVE; BALTHAZAR EJ, 1986, AM J ROENTGENOL, V147, P705, DOI 10.2214/ajr.147.4.705; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Coursey CA, 2010, RADIOLOGY, V254, P460, DOI 10.1148/radiol.09082298; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Flum DR, 2001, JAMA-J AM MED ASSOC, V286, P1748, DOI 10.1001/jama.286.14.1748; GALE ME, 1985, J COMPUT ASSIST TOMO, V9, P34, DOI 10.1097/00004728-198501000-00007; Ganguli S, 2006, RADIOLOGY, V241, P175, DOI 10.1148/radiol.2411050191; Hara AK, 2009, AM J ROENTGENOL, V193, P764, DOI 10.2214/AJR.09.2397; Hlibczuk V, 2010, ANN EMERG MED, V55, P51, DOI 10.1016/j.annemergmed.2009.06.509; Hu H, 1999, MED PHYS, V26, P5, DOI 10.1118/1.598470; Jacobs JE, 2001, RADIOLOGY, V220, P683, DOI 10.1148/radiol.2202001557; Johnson PT, 2009, AM J ROENTGENOL, V192, P893, DOI 10.2214/AJR.08.1685; KALENDER WA, 1990, RADIOLOGY, V176, P181, DOI 10.1148/radiology.176.1.2353088; Keyzer C, 2004, RADIOLOGY, V232, P164, DOI 10.1148/radiol.2321031115; Keyzer C, 2009, AM J ROENTGENOL, V193, P1272, DOI 10.2214/AJR.08.1959; Klingenbeck-Regn K, 1999, EUR J RADIOL, V31, P110, DOI 10.1016/S0720-048X(99)00086-8; Lane MJ, 1999, RADIOLOGY, V213, P341, DOI 10.1148/radiology.213.2.r99nv44341; Lee CC, 2007, ACAD EMERG MED, V14, P117, DOI 10.1197/j.aem.2006.08.007; Lubner MG, 2011, RADIOLOGY; McCollough CH, 2009, RADIOL CLIN N AM, V47, P27, DOI 10.1016/j.rcl.2008.10.006; Mun S, 2006, EMERG RADIOL, V12, P99, DOI 10.1007/s10140-005-0456-6; Nathan RO, 2008, AM J ROENTGENOL, V191, P1102, DOI 10.2214/AJR.07.3466; Nikolaidis P, 2004, AM J ROENTGENOL, V183, P889, DOI 10.2214/ajr.183.4.1830889; Oto A, 2005, RADIOLOGY, V234, P445, DOI 10.1148/radiol.2341032002; Paulson EK, 2005, RADIOLOGY, V235, P879, DOI 10.1148/radiol.2353041231; Paulson EK, 2009, AM J ROENTGENOL, V193, P1268, DOI 10.2214/AJR.09.3313; Pedrosa I, 2006, RADIOLOGY, V238, P891, DOI 10.1148/radiol.2383050146; Raja AS, 2010, RADIOLOGY, V256, P460, DOI 10.1148/radiol.10091570; Raman SS, 2008, NEW ENGL J MED, V358, P972, DOI 10.1056/NEJMc0707000; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rao PM, 1997, J COMPUT ASSIST TOMO, V21, P686, DOI 10.1097/00004728-199709000-00002; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rybkin AV, 2007, RADIOL CLIN N AM, V45, P411, DOI 10.1016/j.rcl.2007.04.003; Seo H, 2009, AM J ROENTGENOL, V193, P96, DOI 10.2214/AJR.08.1237; Stengel JW, 2010, RADIOLOGY, V256, P119, DOI 10.1148/radiol.10091229; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; van Randen A, 2010, EUR RADIOL, V20, P1657, DOI 10.1007/s00330-009-1706-x; van Randen A, 2008, RADIOLOGY, V249, P97, DOI 10.1148/radiol.2483071652; Wagner PL, 2008, SURGERY, V144, P276, DOI 10.1016/j.surg.2008.03.040; Weston AR, 2005, INT J TECHNOL ASSESS, V21, P368, DOI 10.1017/S0266462305050488; Wijetunga R, 2001, RADIOLOGY, V221, P747, DOI 10.1148/radiol.2213001581; WOLVERSON MK, 1979, AM J ROENTGENOL, V133, P1089, DOI 10.2214/ajr.133.6.1089	47	128	129	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					789	796		10.7326/0003-4819-154-12-201106210-00006	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690593				2022-12-28	WOS:000291800500014
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA An early warning for Alzheimer's disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3732	10.1136/bmj.d3732	http://dx.doi.org/10.1136/bmj.d3732			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677015				2022-12-28	WOS:000291932700010
J	Dupont, S; Morsut, L; Aragona, M; Enzo, E; Giulitti, S; Cordenonsi, M; Zanconato, F; Le Digabel, J; Forcato, M; Bicciato, S; Elvassore, N; Piccolo, S				Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Giulitti, Stefano; Cordenonsi, Michelangelo; Zanconato, Francesca; Le Digabel, Jimmy; Forcato, Mattia; Bicciato, Silvio; Elvassore, Nicola; Piccolo, Stefano			Role of YAP/TAZ in mechanotransduction	NATURE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL SELF-RENEWAL; CONTACT INHIBITION; ACTIN DYNAMICS; GROWTH-CONTROL; BREAST-CANCER; HIPPO PATHWAY; METASTASIS; TAZ; FORCE	Cells perceive their microenvironment not only through soluble signals but also through physical and mechanical cues, such as extracellular matrix (ECM) stiffness or confined adhesiveness. By mechanotransduction systems, cells translate these stimuli into biochemical signals controlling multiple aspects of cell behaviour, including growth, differentiation and cancer malignant progression, but how rigidity mechanosensing is ultimately linked to activity of nuclear transcription factors remains poorly understood. Here we report the identification of the Yorkie-homologues YAP (Yes-associated protein) and TAZ (transcriptional coactivator with PDZ-binding motif, also known as WWTR1) as nuclear relays of mechanical signals exerted by ECM rigidity and cell shape. This regulation requires Rho GTPase activity and tension of the actomyosin cytoskeleton, but is independent of the Hippo/LATS cascade. Crucially, YAP/TAZ are functionally required for differentiation of mesenchymal stem cells induced by ECM stiffness and for survival of endothelial cells regulated by cell geometry; conversely, expression of activated YAP overrules physical constraints in dictating cell behaviour. These findings identify YAP/TAZ as sensors and mediators of mechanical cues instructed by the cellular microenvironment.	[Dupont, Sirio; Morsut, Leonardo; Aragona, Mariaceleste; Enzo, Elena; Cordenonsi, Michelangelo; Zanconato, Francesca; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35131 Padua, Italy; [Giulitti, Stefano; Elvassore, Nicola] Univ Padua, Dept Chem Engn DIPIC, I-35131 Padua, Italy; [Le Digabel, Jimmy] Univ Paris Diderot, Lab MSC, F-75205 Paris, France; [Le Digabel, Jimmy] CNRS, UMR 7057, F-75205 Paris, France; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy	University of Padua; University of Padua; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Universita di Modena e Reggio Emilia	Dupont, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35131 Padua, Italy.	dupont@bio.unipd.it; piccolo@bio.unipd.it	Aragona, Mariaceleste/AAB-7307-2021; Dupont, Sirio/AAP-8133-2021; Bicciato, Silvio/C-9825-2009; Forcato, Mattia/B-7733-2015; BICCIATO, Silvio/J-4466-2019; CORDENONSI, MICHELANGELO/K-7692-2016	Aragona, Mariaceleste/0000-0002-2239-3541; Bicciato, Silvio/0000-0002-1944-7078; Forcato, Mattia/0000-0002-7383-6576; BICCIATO, Silvio/0000-0002-1944-7078; Dupont, Sirio/0000-0002-6869-1966; CORDENONSI, MICHELANGELO/0000-0002-8253-5724; Enzo, Elena/0000-0001-9768-6368; PICCOLO, STEFANO/0000-0002-2037-0004	Telethon and Progetti di Eccellenza; AIRC (Italian Association for Cancer Research); University of Padua; IIT; Telethon; MIUR (Italian Minister of University)	Telethon and Progetti di Eccellenza(Fondazione Telethon); AIRC (Italian Association for Cancer Research)(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); MIUR (Italian Minister of University)(Ministry of Education, Universities and Research (MIUR))	We thank G. Scita for advice and gift of reagents; X. Yang for 5SA-YAP1 plasmid; I. Farrance for 4xGTIIC-lux plasmid; H. Miyoshi for pCSII-EF-MCS vector; L. Naldini for pMD2-VSVG vector; R. Treisman for Delta N1+C mDIA, R26D and V159N Actin plasmids; G. Posern for SRF-lux reporter; mouse TAZ and psPAX2 were Addgene plasmid 19025 and 12260. This work was supported by: Telethon and Progetti di Eccellenza CARIPARO grants to N.E.; AIRC (Italian Association for Cancer Research) PI and AIRC Special Program Molecular Clinical Oncology "5 per mille'', University of Padua Strategic grant, IIT Excellence grant and Telethon to S.P.; AIRC PI and MIUR (Italian Minister of University) grants to S.D.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Descot A, 2009, MOL CELL, V35, P291, DOI 10.1016/j.molcel.2009.07.015; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Mackay A, 2003, ONCOGENE, V22, P2680, DOI 10.1038/sj.onc.1206349; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Morsut L, 2010, DEVELOPMENT, V137, P2571, DOI 10.1242/dev.053801; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Selvaraj A, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-13; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Tse J.R., 2010, CURR PROTOC CELL BIO, V47; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	44	3150	3225	40	926	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					179	U212		10.1038/nature10137	http://dx.doi.org/10.1038/nature10137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654799				2022-12-28	WOS:000291397800042
J	Lundeen, JS; Sutherland, B; Patel, A; Stewart, C; Bamber, C				Lundeen, Jeff S.; Sutherland, Brandon; Patel, Aabid; Stewart, Corey; Bamber, Charles			Direct measurement of the quantum wavefunction	NATURE			English	Article							LINEAR OPTICS; STATES; LIGHT; REALIZATION; SPIN	The wavefunction is the complex distribution used to completely describe a quantum system, and is central to quantum theory. But despite its fundamental role, it is typically introduced as an abstract element of the theory with no explicit definition(1,2). Rather, physicists come to a working understanding of the wavefunction through its use to calculate measurement outcome probabilities by way of the Born rule(3). At present, the wavefunction is determined through tomographic methods(4-8), which estimate the wavefunction most consistent with a diverse collection of measurements. The indirectness of these methods compounds the problem of defining the wavefunction. Here we show that the wavefunction can be measured directly by the sequential measurement of two complementary variables of the system. The crux of our method is that the first measurement is performed in a gentle way through weak measurement(9-18), so as not to invalidate the second. The result is that the real and imaginary components of the wavefunction appear directly on our measurement apparatus. We give an experimental example by directly measuring the transverse spatial wavefunction of a single photon, a task not previously realized by any method. We show that the concept is universal, being applicable to other degrees of freedom of the photon, such as polarization or frequency, and to other quantum systems-for example, electron spins, SQUIDs (superconducting quantum interference devices) and trapped ions. Consequently, this method gives the wavefunction a straightforward and general definition in terms of a specific set of experimental operations(19). We expect it to expand the range of quantum systems that can be characterized and to initiate new avenues in fundamental quantum theory.	[Lundeen, Jeff S.; Sutherland, Brandon; Patel, Aabid; Stewart, Corey; Bamber, Charles] CNR, Inst Natl Measurement Stand, Ottawa, ON K1A 0R6, Canada	National Research Council Canada	Lundeen, JS (corresponding author), CNR, Inst Natl Measurement Stand, 1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.	jeff.lundeen@nrc-cnrc.gc.ca	Lundeen, Jeffrey S./E-8512-2012	Lundeen, Jeffrey S./0000-0002-0978-2913	Natural Sciences and Engineering Research Council; Business Development Bank of Canada	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Business Development Bank of Canada	This work was supported by the Natural Sciences and Engineering Research Council and the Business Development Bank of Canada.	AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; AHARONOV Y, 1990, PHYS REV A, V41, P11, DOI 10.1103/PhysRevA.41.11; Aharonov Y, 2010, PHYS TODAY, V63, P27, DOI 10.1063/1.3518209; Breitenbach G, 1997, NATURE, V387, P471, DOI 10.1038/387471a0; Bridgman P. W., 1927, LOGIC MODERN PHYS; Cohen-Tannoudji C., 2006, QUANTUM MECH, V1, P19; Dixon PB, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.173601; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Dudovich N, 2006, NAT PHYS, V2, P781, DOI 10.1038/nphys434; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Jozsa R, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.044103; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Landau L. D., 1989, COURSE THEORETICAL P, V3, P6; Lundeen JS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020404; Lundeen JS, 2005, PHYS LETT A, V334, P337, DOI 10.1016/j.physleta.2004.11.037; Mermin ND, 2009, PHYS TODAY, V62, P8, DOI 10.1063/1.3141952; Mir R, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/287; Mukamel E, 2003, OPT LETT, V28, P1317, DOI 10.1364/OL.28.001317; Pryde GJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220405; Resch KJ, 2004, PHYS LETT A, V324, P125, DOI 10.1016/j.physleta.2004.02.042; RITCHIE NWM, 1991, PHYS REV LETT, V66, P1107, DOI 10.1103/PhysRevLett.66.1107; Smith BJ, 2005, OPT LETT, V30, P3365, DOI 10.1364/OL.30.003365; Smith GA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163602; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; Trebino R., 2002, FREQUENCY RESOLVED O; VOGEL K, 1989, PHYS REV A, V40, P2847, DOI 10.1103/PhysRevA.40.2847; White AG, 1999, PHYS REV LETT, V83, P3103, DOI 10.1103/PhysRevLett.83.3103; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0	30	420	425	4	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					188	191		10.1038/nature10120	http://dx.doi.org/10.1038/nature10120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654800	Green Submitted			2022-12-28	WOS:000291397800044
J	Stone, GW; Witzenbichler, B; Guagliumi, G; Peruga, JZ; Brodie, BR; Dudek, D; Kornowski, R; Hartmann, F; Gersh, BJ; Pocock, SJ; Dangas, G; Wong, SC; Fahy, M; Parise, H; Mehran, R				Stone, Gregg W.; Witzenbichler, Bernhard; Guagliumi, Giulio; Peruga, Jan Z.; Brodie, Bruce R.; Dudek, Dariusz; Kornowski, Ran; Hartmann, Franz; Gersh, Bernard J.; Pocock, Stuart J.; Dangas, George; Wong, S. Chiu; Fahy, Martin; Parise, Helen; Mehran, Roxana		HORIZONS-AMI Trial Investigators	Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; FOLLOW-UP; PREMATURE DISCONTINUATION; HARMONIZING OUTCOMES; ANTIPLATELET THERAPY; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; DOUBLE-BLIND; INTERVENTION	Background Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes. Methods HORIZONS-AMI was a prospective, open-label, randomised trial undertaken at 123 institutions in 11 countries. Patients aged 18 years or older were eligible for enrolment if they had ST-segment elevation myocardial infarction (STEM!), presented within 12 h after onset of symptoms, and were undergoing primary percutaneous coronary intervention. By use of a computerised interactive voice response system, we randomly allocated patients 1:1 to receive bivalirudin or heparin plus a glycoprotein IIb/IIIa inhibitor (GPI; pharmacological randomisation; stratified by previous and expected drug use and study site) and, if eligible, randomly allocated 3:1 to receive a paclitaxel-eluting stent or a bare metal stent (stent randomisation; stratified by pharmacological group assignment, diabetes mellitus status, lesion length, and study site). We produced Kaplan-Meier estimates of major adverse cardiovascular events at 3 years by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00433966. Findings Compared with 1802 patients allocated to receive heparin plus a GPI, 1800 patients allocated to bivalirudin monotherapy had lower rates of all-cause mortality (5.9% vs 7.7%, difference -1.9% [-3.5 to 0.2], HR 0.75 [0.58-0.97]; p=0.03), cardiac mortality (2.9% vs 5.1%, -2.2% [-3.5 to -0.9], 0.56 [0.40-0.80]; p=0.001), reinfarction (6.2% vs 8.2%, 1.9% [-3.7 to -0.2], 0.76 [0.59-0.99]; p=0.04), and major bleeding not related to bypass graft surgery (6.9% vs 10.5%, -3.6% [-5.5 to -1.7], 0.64 [0.51-0.80]; p=0.0001) at 3 years, with no significant differences in ischaemia-driven target vessel revascularisation, stent thrombosis, or composite adverse events. Compared with 749 patients who received a bare-metal stent, 2257 patients who received a paclitaxel-eluting stent had lower rates of ischaemia-driven target lesion revascularisation (9.4% vs 15.1%, -5.7% [-8.6 to -2.7], 0.60 [0.48-0.76]; p<0.0001) after 3 years, with no significant differences in the rates of death, reinfarction, stroke or stent thrombosis. Stent thrombosis was high (>= 4.5%) in both groups. Interpretation The effectiveness and safety of bivalirudin monotherapy and paclitaxel-eluting stenting are sustained at 3 years for patients with STEMI undergoing primary percutaneous coronary intervention.	[Stone, Gregg W.; Fahy, Martin; Parise, Helen] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10022 USA; [Witzenbichler, Bernhard] Charite Campus Benjamin Franklin, Berlin, Germany; [Guagliumi, Giulio] Osped Riuniti Bergamo, I-24100 Bergamo, Italy; [Peruga, Jan Z.] Silesian Ctr Heart Dis, Lodz, Poland; [Brodie, Bruce R.] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; [Brodie, Bruce R.] Moses Cone Hosp, Greensboro, NC USA; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland; [Kornowski, Ran] Rabin Med Ctr, Petah Tiqwa, Israel; [Hartmann, Franz] Univ Klinikum Schleswig Holstein, D-23538 Lubeck, Germany; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Pocock, Stuart J.] London Sch Hyg & Trop Med, London WC1, England; [Dangas, George; Mehran, Roxana] Mt Sinai Med Ctr, New York, NY 10029 USA; [Dangas, George; Mehran, Roxana] Cardiovasc Res Fdn, New York, NY USA; [Wong, S. Chiu] New York Presbyterian Hosp, New York, NY USA; [Wong, S. Chiu] Weill Cornell Med Ctr, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ospedali Riuniti di Bergamo; Silesian Center for Heart Diseases; LeBauer-Brodie Center for Cardiovascular Research & Education; Moses Cone Memorial Hospital; Jagiellonian University; Rabin Medical Center; University of Kiel; Schleswig Holstein University Hospital; Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine; Icahn School of Medicine at Mount Sinai; Cardiovascular Research Foundation (CRF); NewYork-Presbyterian Hospital; Cornell University	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 111 E 59th St,11th Floor, New York, NY 10022 USA.	gs2184@columbia.edu	Mehran, Roxana/ABF-4160-2021; Witzenbichler, Bernhard/ABC-2525-2021; Guagliumi, Giulio/K-8006-2016	Witzenbichler, Bernhard/0000-0001-9322-1926; Parise, Helen/0000-0001-7761-4973	Boston Scientific and The Medicines Company; TherOx; Medicines Company; Abbott Vascular; Atrium; Boston Scientific; Wean; Infra ReDx; Medtronic; LightLab Imaging; Accumetrics; Bristol-Myers Squibb; Sanofi	Boston Scientific and The Medicines Company; TherOx; Medicines Company; Abbott Vascular(Abbott Laboratories); Atrium; Boston Scientific(Boston Scientific); Wean; Infra ReDx; Medtronic(Medtronic); LightLab Imaging; Accumetrics; Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi	Funding Boston Scientific and The Medicines Company.; GWS has been a consultant for Osprey, Reva, Merck, CoreValve, Boston Scientific, Abbott Vascular, Xtent, Edwards. BTI, Asters Biopharma, ATI, SB Medical, Evalve, AstraZeneca, Prescient, Eli Lilly, Bristol-Myers-Squibb, Biosensors, Otsuka, The Medicines Company, Ortho-McNeil, and Gilead; received research grants from TherOx, The Medicines Company, Abbott Vascular, Atrium, Boston Scientific, Wean, and Infra ReDx; received honoraria from Edwards and Vascular Solutions; and has equity in CoreValve, Savacor, Biostar I and II funds, Caliber, FlowCardia, MedFocus I, II, and Accelerator funds, Ovalum, MediGuide, Guided Delivery Systems, Arstasis, Micardia, and AccessClosure. BW has received lecture honoraria from The Medicines Company and Boston Scientific and travel expenses from Abbott Vascular. GG has served on a board for Boston Scientific and as a consultant for Boston Scientific and Volcano; received research grants from Medtronic, Boston Scientific, Abbott Vascular, and LightLab Imaging; and received speaking honoraria from The Medicines Company. BRB has received lecture honoraria from The Medicines Company. DD has received research grants or served as consultant or advisory board member for Abbott, Adamed, Biotronik, Balton, Bayer, BBraun, BioMatrix, Boston Scientific, Boehringer Ingleheim Bristol-Myers Squibb, Cordis, Cook, Eli Lilly, EuroCor, GlaxoSmithKline, Invatec, Medtronic, The Medicines Company, Merck, Nycomed, Orbus-Neich, Pfizer, Possis, Promed, Sanofi-Aventis, Siemens, Solvay, Terumo, and Tyco. FH reports that his institution received research grants from The Medicines Company and Boston Scientific, and that he received travel expenses from Nycomed, lecture honoraria from AstraZeneca, Merck, Sharpe and Dohme, Novartis, Daiichi-Sankyo, and Berlin Chemie, and that he has received manuscript preparation fees and royalties for serving as a co-editor and author from Elsevier, Urban, and Fischer. BJG has served as a consultant for Ortho-McNeil Janssen Scientific Affairs, Amorcyte, Merck Sharp & Dohme, GE Healthcare, St Jude Medical Center, Medispec, Merck, and Boston Scientific. SJP has served as a consultant to Boston Scientific and The Medicines Company, and that his institution has received research grants from Boston Scientific and The Medicines Company. GD has served as a consultant to AstraZeneca, Datascope, Gilead, Guerbet, St Jude, Cordis; has provided expert legal testimony; and has received a research grant from Accumetrics. MF and HF are full-time employees of The Cardiovascular Research Foundation. RM has served as a consultant for Abbott, Cardiva, Cordis, The Medicines Company, AstraZeneca, Ortho-McNeil, Regado, Abiomed, Accumetrics, Daichii-Sankyo, Eli Lilly, Gilead, Guerbet, and TherOx, and has received research grants from Bristol-Myers Squibb and Sanofi. JZP, RK, and SW declare no conflicts of interest.	Atary JZ, 2010, AM J CARDIOL, V106, P4, DOI 10.1016/j.amjcard.2010.02.005; Biedler AE, 2002, ANESTHESIOLOGY, V97, P1102, DOI 10.1097/00000542-200211000-00011; Brar SS, 2009, J AM COLL CARDIOL, V53, P1677, DOI 10.1016/j.jacc.2009.03.013; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Dauerman HL, 2007, CORONARY ARTERY DIS, V18, P141, DOI 10.1097/MCA.0b013e328010a4b2; De Luca G, 2007, INT J CARDIOL, V119, P306, DOI 10.1016/j.ijcard.2006.07.143; Di Lorenzo E, 2009, CIRCULATION, V120, P964, DOI 10.1161/CIRCULATIONAHA.108.830372; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; Fransen E, 1999, CHEST, V116, P1233, DOI 10.1378/chest.116.5.1233; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; KAHN RC, 1986, INTENS CARE MED, V12, P22, DOI 10.1007/BF00315364; Kaltoft A, 2010, J AM COLL CARDIOL, V56, P641, DOI 10.1016/j.jacc.2010.05.009; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mehran R, 2008, AM HEART J, V156, P44, DOI 10.1016/j.ahj.2008.02.008; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Montalescot G, 2005, EUR HEART J, V26, P2520, DOI 10.1093/eurheartj/ehi620; Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Ndrepepa G, 2004, EUR HEART J, V25, P1635, DOI 10.1016/j.ehj.2004.04.031; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437; Spaulding C, 2011, JACC-CARDIOVASC INTE, V4, P14, DOI 10.1016/j.jcin.2010.10.007; Spertus JA, 2006, CIRCULATION, V113, P2803, DOI 10.1161/CIRCULATIONAHA.106.618066; Steg PG, 2010, CIRCULATION, V122, P2131, DOI 10.1161/CIRCULATIONAHA.109.927582; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2010, J AM COLL CARDIOL, V56, P1597, DOI 10.1016/j.jacc.2010.08.608; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; Twomley KM, 2006, J THROMB THROMBOLYS, V21, P167, DOI 10.1007/s11239-006-5206-4; Valgimigli M, 2008, JAMA-J AM MED ASSOC, V299, P1788, DOI 10.1001/jama.299.15.joc80026; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Vin MA, 2011, JACC-CARDIOVASC INTE, V4, P24; Violini R, 2010, J AM COLL CARDIOL, V55, P810, DOI 10.1016/j.jacc.2009.09.046; Wang TY, 2008, CIRCULATION, V118, P2139, DOI 10.1161/CIRCULATIONAHA.108.787143; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, NUTR AN REP WHO SCI; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Zallen G, 2000, SHOCK, V13, P29, DOI 10.1097/00024382-200013010-00006	45	338	374	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2193	2204		10.1016/S0140-6736(11)60764-2	http://dx.doi.org/10.1016/S0140-6736(11)60764-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21665265				2022-12-28	WOS:000292340800032
J	Bhutta, ZA				Bhutta, Zulfiqar A.			The last mile in global poliomyelitis eradication	LANCET			English	Editorial Material							VACCINE-DERIVED POLIOVIRUS		Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan	Aga Khan University	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu		Mouw, Jolien/0000-0002-9336-6022				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; El-Sayed N, 2007, VACCINE, V25, P5062, DOI 10.1016/j.vaccine.2007.04.022; Global Polio Eradication Initiative, 2010, PROGRESS; Global Polio Eradication Initiative, 2011, POL THIS WEEK WEDN 1; Grassly NC, 2010, J INFECT DIS, V201, P1535, DOI 10.1086/651952; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Hasan Azra S, 2004, Indian Pediatr, V41, P1040; Independent Monitoring Board of the Global Polio Eradication Initiative, 2011, REP GLOB POL ER IN; Jenkins HE, 2010, NEW ENGL J MED, V362, P2360, DOI 10.1056/NEJMoa0910074; McKenna MAJ, 2002, ATLANTA J CONST 1027; Mohammed AJ, 2010, NEW ENGL J MED, V362, P2351, DOI 10.1056/NEJMoa0909383; National Toxicology Program, 2011, Natl Toxicol Program Tech Rep Ser, P1; SABIN AB, 1979, PEDIATR RES, V13, P674, DOI 10.1203/00006450-197905001-00004; SALK D, 1980, REV INFECT DIS, V2, P243; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Wassilak S, 2011, J INFECT DIS, V203, P898, DOI 10.1093/infdis/jiq140; World Health Assembly, 1993, GLOB ER POL YEAR 200	18	25	25	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2011	378	9791					549	552		10.1016/S0140-6736(11)60744-7	http://dx.doi.org/10.1016/S0140-6736(11)60744-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	812UX	21664681				2022-12-28	WOS:000294319500008
J	Alley, JB				Alley, Joshua B.			Sleepless	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alley, Joshua B.] Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA; [Alley, Joshua B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX USA; [Alley, Joshua B.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Def, Bethesda, MD 20814 USA	United States Department of Defense; United States Air Force; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Alley, JB (corresponding author), Wilford Hall USAF Med Ctr, Dept Surg, Lackland Air Force Base, San Antonio, TX 78236 USA.	joshalleymd@hotmail.com						[Anonymous], TIME	1	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2501	2502		10.1001/jama.2011.863	http://dx.doi.org/10.1001/jama.2011.863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693732				2022-12-28	WOS:000291860400001
J	Spence, D				Spence, Des			FROM THE FRONTLINE Assisted dying: are doctors in denial?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3891	10.1136/bmj.d3891	http://dx.doi.org/10.1136/bmj.d3891			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697230				2022-12-28	WOS:000292200500012
J	Zeytinoglu, M				Zeytinoglu, Meltem			Talking It Out: Helping Our Patients Live Better While Dying	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PALLIATIVE CARE; LIFE; ASSOCIATIONS; CANCER; HEALTH; COSTS; DEATH	Although dying is an inevitable part of the life cycle, there has been extensive political debate over end-of-life care. Participating in end-of-life care conversations can be emotionally challenging for everyone involved. Messages about serious or terminal illnesses can be very hard for patients and their families to hear, and physicians frequently struggle with the burden of delivering these messages. Still, evidence shows that conversations about end-of-life care options between physicians and patients can improve the quality of life of dying patients and help to relieve the emotional burden on surviving loved ones. Legislation to support these discussions by consistently reimbursing physicians for their time spent performing this service has been blocked on multiple occasions. More research on how to improve end-of-life care will enable health care providers to optimize treatment of their patients. Overcoming political divides to support end-of-life care conversations is needed to promote care that is consistent with patients' values and needs and is a key step in encouraging better quality of life for dying patients.	[Zeytinoglu, Meltem] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zeytinoglu, M (corresponding author), Univ Chicago, NorthShore Programs, Dept Internal Med, 2650 Ridge Ave,Room 5319, Evanston, IL 60201 USA.	meltemz@gmail.com			American Cancer Society	American Cancer Society(American Cancer Society)	Grant Support: By the American Cancer Society Physician Training Award in Cancer Prevention and Control.	Billings ME, 2010, J PALLIAT MED, V13, P319, DOI 10.1089/jpm.2009.0293; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Field MJ, 1997, APPROACHING DEATH IM; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Meier DE, 2009, J PALLIAT MED, V12, P291, DOI 10.1089/jpm.2009.9648; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Pear R., 2010, NY TIMES        1225; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	13	3	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					830	832		10.7326/0003-4819-154-12-201106210-00011	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690597				2022-12-28	WOS:000291800500019
J	Bijlsma, JWJ; Berenbaum, F; Lafeber, FPJG				Bijlsma, Johannes W. J.; Berenbaum, Francis; Lafeber, Foris P. J. G.			Osteoarthritis: an update with relevance for clinical practice	LANCET			English	Article							JOINT-SPACE WIDTH; INDIVIDUAL RADIOGRAPHIC FEATURES; EVIDENCE BASED RECOMMENDATIONS; HUMAN ARTICULAR-CARTILAGE; EULAR-STANDING-COMMITTEE; GLYCATION END-PRODUCTS; KNEE OSTEOARTHRITIS; SUBCHONDRAL BONE; HAND OSTEOARTHRITIS; MATRIX METALLOPROTEINASES	Osteoarthritis is thought to be the most prevalent chronic joint disease. The incidence of osteoarthritis is rising because of the ageing population and the epidemic of obesity. Pain and loss of function are the main clinical features that lead to treatment, including non-pharmacological, pharmacological, and surgical approaches. Clinicians recognise that the diagnosis of osteoarthritis is established late in the disease process, maybe too late to expect much help from disease-modifying drugs. Despite efforts over the past decades to develop markers of disease, still-imaging procedures and biochemical marker analyses need to be improved and possibly extended with more specific and sensitive methods to reliably describe disease processes, to diagnose the disease at an early stage, to classify patients according to their prognosis, and to follow the course of disease and treatment effectiveness. In the coming years, a better definition of osteoarthritis is expected by delineating different phenotypes of the disease. Treatment targeted more specifically at these phenotypes might lead to improved outcomes.	[Bijlsma, Johannes W. J.; Lafeber, Foris P. J. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands; [Berenbaum, Francis] Univ Paris 06, Hosp St Antoine, Dept Rheumatol, Paris, France	Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Bijlsma, JWJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, POB 85-500, NL-3508 GA Utrecht, Netherlands.	j.w.j.bijlsma@umcutrecht.nl	Berenbaum, Francis/AAO-5690-2020	Berenbaum, Francis/0000-0001-8252-7815				Abadie E, 2004, OSTEOARTHR CARTILAGE, V12, P263, DOI 10.1016/j.joca.2004.01.006; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; ALTMAN RD, 1991, J RHEUMATOL, V18, P10; Amin AR, 1997, J CLIN INVEST, V99, P1231, DOI 10.1172/JCI119280; Anandacoomarasamy AL, 2010, EULAR 2010 ROM IT JU; Andersson MLE, 2006, ANN RHEUM DIS, V65, P1490, DOI 10.1136/ard.2005.051292; Aula AS, 2009, OSTEOARTHR CARTILAGE, V17, P1583, DOI 10.1016/j.joca.2009.06.010; Aurich M, 2005, ARTHRITIS RHEUM-US, V52, P112, DOI 10.1002/art.20740; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Bailey AJ, 2004, BIORHEOLOGY, V41, P349; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bansal PN, 2010, OSTEOARTHR CARTILAGE, V18, P184, DOI 10.1016/j.joca.2009.09.003; Bekkers JEJ, 2010, CARTILAGE, V1, P157, DOI 10.1177/1947603510364539; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bellamy N, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD005328; Bijl JWJ, 2008, ANN INTERN MED, V148, P315, DOI 10.7326/0003-4819-148-4-200802190-00012; Bingham CO, 2006, ARTHRITIS RHEUM-US, V54, P3494, DOI 10.1002/art.22160; Bjordal JM, 2003, AUST J PHYSIOTHER, V49, P107, DOI 10.1016/S0004-9514(14)60127-6; Boegard TL, 2003, OSTEOARTHR CARTILAGE, V11, P370, DOI 10.1016/S1063-4584(03)00030-X; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Borthakur A, 2006, NMR BIOMED, V19, P781, DOI 10.1002/nbm.1102; Brosseau L, 2003, COCHRANE DB SYST REV, V2003, DOI DOI 10.1002/14651858.CD004522; Brouwer RW, 2005, COCHRANE DB SYST REV, V1; Brown MT, 2010, EULAR 2010 ROM IT JU; Bruyere O, 2008, OSTEOARTHR CARTILAGE, V16, P254, DOI 10.1016/j.joca.2007.06.011; Buck RJ, 2010, MAGN RESON MED, V63, P680, DOI 10.1002/mrm.22207; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Burstein D, 2001, MAGNET RESON MED, V45, P36, DOI 10.1002/1522-2594(200101)45:1<36::AID-MRM1006>3.0.CO;2-W; Chan FKL, 2010, LANCET, V376, P173, DOI 10.1016/S0140-6736(10)60673-3; Chappell AS, 2009, PAIN, V146, P253, DOI 10.1016/j.pain.2009.06.024; Chevalier X, 2010, ANN RHEUM DIS, V69, P113, DOI 10.1136/ard.2008.094623; Christensen R, 2005, OSTEOARTHR CARTILAGE, V13, P20, DOI 10.1016/j.joca.2004.10.008; Christensen R, 2008, OSTEOARTHR CARTILAGE, V16, P399, DOI 10.1016/j.joca.2007.10.003; Conaghan PG, 2006, OSTEOARTHR CARTILAGE, V14, pA87, DOI 10.1016/j.joca.2006.02.028; CONROZIER T, 1995, OSTEOARTHR CARTILAGE, V3, P81; Dahaghin S, 2005, ANN RHEUM DIS, V64, P682, DOI 10.1136/ard.2004.023564; deCraen AJM, 1996, BRIT MED J, V313, P321, DOI 10.1136/bmj.313.7053.321; DeGroot J, 2004, ARTHRITIS RHEUM, V50, P1207, DOI 10.1002/art.20170; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Dunn TC, 2004, RADIOLOGY, V232, P592, DOI 10.1148/radiol.2322030976; Eckstein F, 2005, ARTHRITIS RHEUM-US, V52, P3132, DOI 10.1002/art.21348; Eckstein F, 2006, NMR BIOMED, V19, P822, DOI 10.1002/nbm.1063; Eyre DR, 2009, OSTEOARTHR CARTILAGE, V17, P423, DOI 10.1016/j.joca.2009.02.005; Felson DT, 2009, OSTEOARTHR CARTILAGE, V17, P419, DOI 10.1016/j.joca.2009.02.004; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Gabay O, 2009, CURR RHEUMATOL REV, V5, P226, DOI 10.2174/157339709790192440; Geenen R, 2010, OSTEOARTHR CARTILAGE, V18, P873, DOI 10.1016/j.joca.2010.03.002; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; Goldring MB, 2004, CLIN ORTHOP RELAT R, pS37, DOI 10.1097/01.blo.0000144484.69656.e4; Gordon CD, 2008, CLIN CHIM ACTA, V398, P21, DOI 10.1016/j.cca.2008.07.031; Grainger AJ, 2007, SKELETAL RADIOL, V36, P737, DOI 10.1007/s00256-007-0287-5; Gray ML, 2008, J ORTHOP RES, V26, P281, DOI 10.1002/jor.20482; Guermazi A, 2008, RHEUM DIS CLIN N AM, V34, P645, DOI 10.1016/j.rdc.2008.04.006; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; HOCHBERG MC, 1989, SEMIN ARTHRITIS RHEU, V18, P4, DOI 10.1016/0049-0172(89)90008-5; Homandberg GA, 1998, OSTEOARTHR CARTILAGE, V6, P231, DOI 10.1053/joca.1998.0116; Hulejova H, 2007, CYTOKINE, V38, P151, DOI 10.1016/j.cyto.2007.06.001; Hunter DJ, 2008, ANN RHEUM DIS, V67, P206, DOI 10.1136/ard.2006.066183; Hwang J, 2008, ARTHRITIS RHEUM-US, V58, P3831, DOI 10.1002/art.24069; Intema F, 2011, OSTEOARTHR CARTILAGE, V19, P668, DOI 10.1016/j.joca.2011.02.005; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; Intema F, 2010, J BONE MINER RES, V25, P1650, DOI 10.1002/jbmr.39; Iversen MD, 2010, ANN RHEUM DIS, V69, P955, DOI 10.1136/ard.2010.129270; Jahangier ZN, 2005, ARTHRITIS RHEUM, V52, P3391, DOI 10.1002/art.21376; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kahan A, 2009, ARTHRITIS RHEUM-US, V60, P524, DOI 10.1002/art.24255; Karsdal MA, 2010, OSTEOARTHR CARTILAGE, V18, P150, DOI 10.1016/j.joca.2009.08.004; Karsenty G, 2005, NEW ENGL J MED, V353, P522, DOI 10.1056/NEJMcibr051399; Keen HI, 2008, ANN RHEUM DIS, V67, P1116, DOI 10.1136/ard.2007.079483; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kong SY, 2006, ARTHRITIS RHEUM-US, V54, P2496, DOI 10.1002/art.21977; Kornaat PR, 2005, SKELETAL RADIOL, V34, P95, DOI 10.1007/s00256-004-0828-0; Kortekaas MC, 2010, ANN RHEUM DIS, V69, P1367, DOI 10.1136/ard.2009.124875; Lachance L, 2001, OSTEOARTHR CARTILAGE, V9, P527, DOI 10.1053/joca.2000.0429; Lafeber FPJG, 2006, CURR OPIN RHEUMATOL, V18, P519, DOI 10.1097/01.bor.0000240366.54960.a1; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; Laupaffarakasem W, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005118.pub2; Lequesne MG, 1998, ANN RHEUM DIS, V57, P676, DOI 10.1136/ard.57.11.676; Lin FY, 2004, BMJ-BRIT MED J, V329, P324, DOI 10.1136/bmj.38159.639028.7C; Loeser RF, 2009, OSTEOARTHR CARTILAGE, V17, P971, DOI 10.1016/j.joca.2009.03.002; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; Lohmander LS, 2005, ANN RHEUM DIS, V64, P449, DOI 10.1136/ard.2004.023572; Mancarella L, 2010, OSTEOARTHR CARTILAGE, V18, P1263, DOI 10.1016/j.joca.2010.06.006; Manheimer E., 2010, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001977.PUB2.THIS; Marijnissen ACA, 2008, OSTEOARTHR CARTILAGE, V16, P234, DOI 10.1016/j.joca.2007.06.009; May S, 2010, NAT REV RHEUMATOL, V6, P199, DOI 10.1038/nrrheum.2010.26; Mazzuca SA, 2006, ANN RHEUM DIS, V65, P64, DOI 10.1136/ard.2005.037069; Mazzuca SA, 2004, ARTHRITIS RHEUM, V50, P2508, DOI 10.1002/art.20363; MCALINDON TE, 1992, ANN RHEUM DIS, V51, P844, DOI 10.1136/ard.51.7.844; McCarthy CJ, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-51; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; Menezes NM, 2004, MAGN RESON MED, V51, P503, DOI 10.1002/mrm.10710; Merle-Vincent F, 2007, ANN RHEUM DIS, V66, P747, DOI 10.1136/ard.2006.056481; Moller B, 2009, ARTHRIT RHEUM-ARTHR, V61, P435, DOI 10.1002/art.24424; Multanen J, 2009, OSTEOARTHR CARTILAGE, V17, P559, DOI 10.1016/j.joca.2008.12.001; Naredo E, 2005, OSTEOARTHR CARTILAGE, V13, P568, DOI 10.1016/j.joca.2005.02.008; Oakley SP, 2005, OSTEOARTHR CARTILAGE, V13, P368, DOI 10.1016/j.joca.2004.12.005; Oka H, 2008, OSTEOARTHR CARTILAGE, V16, P1300, DOI 10.1016/j.joca.2008.03.011; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Osiri M., 2000, COCHRANE DB SYST REV, pCD002823, DOI [10.1002/14651858.CD002823, DOI 10.1002/14651858.CD002823, 10.1002/14651858.cd002823]; Otterness IG, 2007, ARTHRITIS RHEUM-US, V56, P3644, DOI 10.1002/art.23025; Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883; Peterfy C, 2003, SKELETAL RADIOL, V32, P128, DOI 10.1007/s00256-002-0603-z; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Potter HG, 2010, J MAGN RESON IMAGING, V31, P268, DOI 10.1002/jmri.22025; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Regatte RR, 2006, J MAGN RESON IMAGING, V23, P547, DOI 10.1002/jmri.20536; Reginster JY, 2001, LANCET, V357, P251, DOI 10.1016/S0140-6736(00)03610-2; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Roddy E, 2005, ANN RHEUM DIS, V64, P544, DOI 10.1136/ard.2004.028746; Schnitzer TJ, 2010, ARTHRIT CARE RES, V62, P1174, DOI 10.1002/acr.20260; SELLAM J, 2008, KELLEYS TXB RHEUMATO, P1547; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shakibaei M, 2008, ADV ANAT EMBRYOL CEL, V197, P1, DOI 10.1007/978-3-540-78771-6; Shapiro EM, 2002, MAGNET RESON MED, V47, P284, DOI 10.1002/mrm.10054; Sharp JT, 2007, J RHEUMATOL, V34, P874; Shibakawa A, 2005, OSTEOARTHR CARTILAGE, V13, P679, DOI 10.1016/j.joca.2005.04.010; Suri S, 2007, ANN RHEUM DIS, V66, P1423, DOI 10.1136/ard.2006.063354; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Tiderius C, 2006, OSTEOARTHR CARTILAGE, V14, P1091, DOI 10.1016/j.joca.2006.05.007; Torres L, 2006, OSTEOARTHR CARTILAGE, V14, P1033, DOI 10.1016/j.joca.2006.03.015; van Spil WE, 2010, OSTEOARTHR CARTILAGE, V18, P605, DOI 10.1016/j.joca.2010.01.012; van't Klooster R, 2008, OSTEOARTHR CARTILAGE, V16, P18, DOI 10.1016/j.joca.2007.05.015; Vignon E, 2005, J RHEUMATOL, V32, P1143; Vos PAJM, 2010, OSTEOARTHR CARTILAGE, V18, P1329, DOI 10.1016/j.joca.2010.07.006; Wakefield RJ, 1999, RHEUMATOLOGY, V38, P195, DOI 10.1093/rheumatology/38.3.195; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Walsh DA, 2007, OSTEOARTHR CARTILAGE, V15, P743, DOI 10.1016/j.joca.2007.01.020; Welch V., 2001, COCHRANE DB SYST REV; Wesseling J, 2009, ANN RHEUM DIS, V68, P1413, DOI 10.1136/ard.2008.096164; Westacott CI, 1997, ARTHRITIS RHEUM, V40, P1282, DOI 10.1002/art.1780400713; Wise BL, 2010, OSTEOARTHR CARTILAGE, V18, P883, DOI 10.1016/j.joca.2009.11.016; Young AA, 2005, J BONE JOINT SURG AM, V87A, P2763, DOI 10.2106/JBJS.D.02923; Yusuf E, 2010, ANN RHEUM DIS, V69, P761, DOI 10.1136/ard.2008.106930; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2005, ANN RHEUM DIS, V64, P669, DOI 10.1136/ard.2004.028886; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	138	1301	1413	9	238	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2115	2126		10.1016/S0140-6736(11)60243-2	http://dx.doi.org/10.1016/S0140-6736(11)60243-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684382				2022-12-28	WOS:000292117800033
J	Velasquez, SM; Ricardi, MM; Dorosz, JG; Fernandez, PV; Nadra, AD; Pol-Fachin, L; Egelund, J; Gille, S; Harholt, J; Ciancia, M; Verli, H; Pauly, M; Bacic, A; Olsen, CE; Ulvskov, P; Petersen, BL; Somerville, C; Iusem, ND; Estevez, JM				Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Fernandez, Paula V.; Nadra, Alejandro D.; Pol-Fachin, Laercio; Egelund, Jack; Gille, Sascha; Harholt, Jesper; Ciancia, Marina; Verli, Hugo; Pauly, Markus; Bacic, Antony; Olsen, Carl Erik; Ulvskov, Peter; Petersen, Bent Larsen; Somerville, Chris; Iusem, Norberto D.; Estevez, Jose M.			O-Glycosylated Cell Wall Proteins Are Essential in Root Hair Growth	SCIENCE			English	Article							MOLECULAR CHARACTERIZATION; PROLYL 4-HYDROXYLASE; ARABIDOPSIS; EXTENSIN; GENES; CODES; IDENTIFICATION; REQUIRES; MUTANTS; TOBACCO	Root hairs are single cells that develop by tip growth and are specialized in the absorption of nutrients. Their cell walls are composed of polysaccharides and hydroxyproline-rich glycoproteins (HRGPs) that include extensins (EXTs) and arabinogalactan-proteins (AGPs). Proline hydroxylation, an early posttranslational modification of HRGPs that is catalyzed by prolyl 4-hydroxylases (P4Hs), defines the subsequent O-glycosylation sites in EXTs (which are mainly arabinosylated) and AGPs (which are mainly arabinogalactosylated). We explored the biological function of P4Hs, arabinosyltransferases, and EXTs in root hair cell growth. Biochemical inhibition or genetic disruption resulted in the blockage of polarized growth in root hairs and reduced arabinosylation of EXTs. Our results demonstrate that correct O-glycosylation on EXTs is essential for cell-wall self-assembly and, hence, root hair elongation in Arabidopsis thaliana.	[Velasquez, Silvia M.; Ricardi, Martiniano M.; Dorosz, Javier Gloazzo; Iusem, Norberto D.; Estevez, Jose M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, Buenos Aires, DF, Argentina; [Fernandez, Paula V.; Ciancia, Marina] Univ Buenos Aires, Fac Agron, Ctr Invest Hidratos Carbono CONICET, Dept Biol Aplicada & Alimentos,Catedra Quim Biomo, Buenos Aires, DF, Argentina; [Nadra, Alejandro D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Pol-Fachin, Laercio; Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil; [Egelund, Jack; Harholt, Jesper; Ulvskov, Peter; Petersen, Bent Larsen] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, DK-1871 Copenhagen, Denmark; [Gille, Sascha; Pauly, Markus; Somerville, Chris] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Bacic, Antony] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Melbourne, Vic 3010, Australia; [Olsen, Carl Erik] Univ Copenhagen, Fac Life Sci, Dept Nat Sci, DK-1871 Copenhagen, Denmark; [Iusem, Norberto D.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, LFBM, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Universidade Federal do Rio Grande do Sul; University of Copenhagen; University of California System; University of California Berkeley; University of Melbourne; University of Copenhagen; University of Buenos Aires	Estevez, JM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cient & Tecn IFIByNE CONICET, Inst Fisiol Biol Mol & Neurociencias, C1428EGA, Buenos Aires, DF, Argentina.	jestevez@fbmc.fcen.uba.ar	Estevez, Jose Manuel/AAZ-9261-2020; Harholt, Jesper/F-3760-2011; Pauly, Markus/B-5895-2008; Estevez, Jose Manuel/C-2915-2018; Olsen, Carl E/H-3031-2014; Harholt, Jesper/F-6865-2014; Verli, Hugo/AAZ-2148-2021; Nadra, Alejandro/A-5668-2009; Ulvskov, Peter/I-1228-2014; Petersen, Bent/H-9437-2014; Verli, Hugo/G-8703-2012; Somerville, Christopher R/A-4048-2009	Estevez, Jose Manuel/0000-0001-6332-7738; Pauly, Markus/0000-0002-3116-2198; Estevez, Jose Manuel/0000-0001-6332-7738; Olsen, Carl E/0000-0002-2275-0596; Harholt, Jesper/0000-0002-7984-0066; Nadra, Alejandro/0000-0002-7860-3245; Ulvskov, Peter/0000-0003-3776-818X; Petersen, Bent/0000-0002-2004-9077; Verli, Hugo/0000-0002-4796-8620; Somerville, Christopher R/0000-0003-4647-0094; Ricardi, Martiniano/0000-0002-7904-6305; Iusem, Norberto/0000-0002-3052-2489; Bacic, Tony/0000-0001-7483-8605	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT2007-732, PICT2006-983]; CONICET [PIP2812, PIP0890, PIP0071]; Danish Agency for Science Technology and Innovation [274-09-0082, 2101-07-0071]; Australian Research Council; Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); U.S. Department of Energy [DOE-FG02-03ER20133]; Energy Biosciences Institute; Villum Fonden [00007173] Funding Source: researchfish	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Danish Agency for Science Technology and Innovation; Australian Research Council(Australian Research Council); Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute; Villum Fonden(Villum Fonden)	We thank R. A. Fernandez for his assistance in confocal microscopy, S. Maldonado and S. Petrucelli for providing the access to a stereoscope, and A. Nebenfuhr for providing vectors of the ER and Golgi markers. This work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (PICT2007-732 and PICT2006-983) and CONICET (PIP2812, PIP0890, and PIP0071) to A.D.N., N.D.I., and J.M.E.; from the Danish Agency for Science Technology and Innovation from the Danish Agency for Science Technology and Innovation (274-09-0082, 2101-07-0071) to J.E, P.U., and B.L.P; from the Australian Research Council to A.B.; and Conselho Nacional de Desinvolvimento Cientific e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to L.F. and H.V. We thank Arabidopsis Biological Resource Center (Ohio University) for providing T-DNA lines seed lines. Thanks to K. Kobayashi and M. Otegui for critical reading of the manuscript. This work was partially supported by a grant from the U.S. Department of Energy (DOE-FG02-03ER20133) and funding from the Energy Biosciences Institute to C.S. S.M.V. performed most of the experiments. M.M.R. analyzed and performed some of the experiments and analyzed the data. J.G.D. performed some of the experiments. P.V.F and M.C. quantified Hyp in mutants and transgenic lines. S.G. and M.P. provided the XEG113-GFP data and xeg113-2 mutant. A.D.N. performed molecular modeling of P4Hs. L.F. and H.V. measured the molecular dynamics of EXT peptides. J.E. and A.B. assessed the Golgi localization of RRAs proteins. C.E.O., P.U., and B.L.P. characterized rra3 and xeg113 EXTs using ESI-MS, and P.U. and B.L.P. isolated rra1-3 RNAi and rra3 mutants. C.S. analyzed the data. N.D.I. analyzed the data and wrote the paper. J.M.E. designed research, performed most of the experiments, analyzed the data, supervised the project, and wrote the paper. The authors declare no competing financial interests.	BARNETT NM, 1970, PLANT PHYSIOL, V45, P188, DOI 10.1104/pp.45.2.188; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Baumberger N, 2003, PLANT J, V35, P71, DOI 10.1046/j.1365-313X.2003.01784.x; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; Immerzeel P, 2006, PHYSIOL PLANTARUM, V128, P18, DOI 10.1111/j.1399-3054.2006.00712.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2; Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; Owens NW, 2010, J AM CHEM SOC, V132, P5036, DOI 10.1021/ja905724d; Petersen B. L., 2011, ANN PLANT REV, V41, P305; Price NJ, 2003, J BIOL CHEM, V278, P41389, DOI 10.1074/jbc.M304519200; Ringli C, 2010, PLANT J, V63, P662, DOI 10.1111/j.1365-313X.2010.04270.x; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STAFSTROM JP, 1986, PLANT PHYSIOL, V81, P242, DOI 10.1104/pp.81.1.242; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Valentin R, 2010, LANGMUIR, V26, P9891, DOI 10.1021/la100265d; Won SK, 2009, PLANT PHYSIOL, V150, P1459, DOI 10.1104/pp.109.140905; Xu JF, 2008, PHYTOCHEMISTRY, V69, P1631, DOI 10.1016/j.phytochem.2008.02.006; Yi K, 2010, NAT GENET, V42, P264, DOI 10.1038/ng.529; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x	31	202	219	6	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1401	1403		10.1126/science.1206657	http://dx.doi.org/10.1126/science.1206657			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680836				2022-12-28	WOS:000291689000033
J	Kavanagh, R; Smith, D				Kavanagh, Richard; Smith, Diarmuid			Bilateral Hilar and Mediastinal Lymphadenopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kavanagh, Richard; Smith, Diarmuid] Beaumont Hosp, Dublin 9, Ireland		Kavanagh, R (corresponding author), Beaumont Hosp, Dublin 9, Ireland.	diarmuidsmith@beaumont.ie		Kavanagh, Richard/0000-0002-7483-0926					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2342	2342		10.1056/NEJMicm1006314	http://dx.doi.org/10.1056/NEJMicm1006314			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675892				2022-12-28	WOS:000291643800012
J	Sadri-Ardekani, H; Akhondi, MA; van der Veen, F; Repping, S; van Pelt, AMM				Sadri-Ardekani, Hooman; Akhondi, Mohammad A.; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.			In Vitro Propagation of Human Prepubertal Spermatogonial Stem Cells	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Sadri-Ardekani, Hooman; van der Veen, Fulco; Repping, Sjoerd; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Akhondi, Mohammad A.] Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran	University of Amsterdam; Academic Medical Center Amsterdam	Sadri-Ardekani, H (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.repping@amc.uva.nl		van Pelt, Ans/0000-0001-9155-548X; Repping, Sjoerd/0000-0002-6959-149X; Akhondi, Mohammad mehdi/0000-0003-1707-3874				Brinster RL, 2007, SCIENCE, V316, P404, DOI 10.1126/science.1137741; He ZP, 2010, BIOL REPROD, V82, P363, DOI 10.1095/biolreprod.109.078550; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Mizrak SC, 2010, HUM REPROD, V25, P158, DOI 10.1093/humrep/dep354; Sadri-Ardekani H, 2009, JAMA-J AM MED ASSOC, V302, P2127, DOI 10.1001/jama.2009.1689; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106	6	141	149	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2416	2418		10.1001/jama.2011.791	http://dx.doi.org/10.1001/jama.2011.791			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673293	Bronze			2022-12-28	WOS:000291597300018
J	Jia, HJ; Wang, XY; Liu, F; Guenther, UP; Srinivasan, S; Anderson, JT; Jankowsky, E				Jia, Huijue; Wang, Xuying; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Anderson, James T.; Jankowsky, Eckhard			The RNA Helicase Mtr4p Modulates Polyadenylation in the TRAMP Complex	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RIBOSOMAL-RNA; NUCLEAR; SURVEILLANCE; DEGRADATION; EXOSOME; END; SUFFICIENT; TURNOVER; REVEALS	Many steps in nuclear RNA processing, surveillance, and degradation require TRAMP, a complex containing the poly(A) polymerase Trf4p, the Zn-knuckle protein Air2p, and the RNA helicase Mtr4p. TRAMP polyadenylates RNAs designated for decay or trimming by the nuclear exosome. It has been unclear how polyadenylation by TRAMP differs from polyadenylation by conventional poly(A) polymerase, which produces poly(A) tails that stabilize RNAs. Using reconstituted S. cerevisiae TRAMP, we show that TRAMP inherently suppresses poly(A) addition after only 3-4 adenosines. This poly(A) tail length restriction is controlled by Mtr4p. The helicase detects the number of 3'-terminal adenosines and, over several adenylation steps, elicits precisely tuned adjustments of ATP affinities and rate constants for adenylation and TRAMP dissociation. Our data establish Mtr4p as a critical regulator of polyadenylation by TRAMP and reveal that an RNA helicase can control the activity of another enzyme in a highly complex fashion and in response to features in RNA.	[Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Jia, Huijue; Liu, Fei; Guenther, Ulf-Peter; Srinivasan, Sukanya; Jankowsky, Eckhard] Case Western Reserve Univ, Dept Biochem, Sch Med, Cleveland, OH 44106 USA; [Wang, Xuying; Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53201 USA	Case Western Reserve University; Case Western Reserve University; Marquette University	Jankowsky, E (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	exj13@case.edu	Wang, Xuying/C-8053-2011; Jia, Huijue/M-3991-2015	Jia, Huijue/0000-0002-3592-126X; Jankowsky, Eckhard/0000-0001-7677-7412	NIH [GM067700, GM069949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067700, R01GM069949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Jankowsky and Anderson labs and Dr. Mike Harris (Case Western) for helpful discussions and Drs. Timothy Nilsen and Pat Maroney (Case Western) for advice on the determination of the poly(A) tail length of pre-tRNA<INF>i</INF><SUP>Met</SUP> in vivo. This work was supported by grants from the NIH to E.J. (GM067700) and J.T.A. (GM069949).	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bernstein J, 2010, BIOCHEMISTRY-US, V49, P10357, DOI 10.1021/bi101518x; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; KELLER W, 1995, CELL, V81, P829, DOI 10.1016/0092-8674(95)90001-2; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Piccininni S, 2002, J BIOL CHEM, V277, P45670, DOI 10.1074/jbc.M204124200; SACHS AB, 1987, MOL CELL BIOL, V7, P3268, DOI 10.1128/MCB.7.9.3268; Scorilas A, 2002, CRIT REV CL LAB SCI, V39, P193, DOI 10.1080/10408360290795510; SENGER B, 1992, P NATL ACAD SCI USA, V89, P10768, DOI 10.1073/pnas.89.22.10768; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946	36	77	78	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					890	901		10.1016/j.cell.2011.05.010	http://dx.doi.org/10.1016/j.cell.2011.05.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663793	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000291461600016
J	Clements, WK; Kim, AD; Ong, KG; Moore, JC; Lawson, ND; Traver, D				Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Moore, John C.; Lawson, Nathan D.; Traver, David			A somitic Wnt16/Notch pathway specifies haematopoietic stem cells	NATURE			English	Article							AORTIC ENDOTHELIUM; DEFINITIVE HEMATOPOIESIS; EMBRYONIC HEMATOPOIESIS; GENE-EXPRESSION; ZEBRAFISH; NOTCH; FATE; DIFFERENTIATION; PROLIFERATION; LEUKEMIA	Haematopoietic stem cells (HSCs) are a self-renewing population of cells that continuously replenish all blood and immune cells during the lifetime of an individual(1,2). HSCs are used clinically to treat a wide array of diseases, including acute leukaemias and congenital blood disorders, but obtaining suitable numbers of cells and finding immune-compatible donors remain serious problems. These difficulties have led to an interest in the conversion of embryonic stem cells or induced pluripotent stem cells into HSCs, which is not possible using current methodologies. To accomplish this goal, it is critical to understand the native mechanisms involved in the specification of HSCs during embryonic development. Here we demonstrate in zebrafish that Wnt16 controls a novel genetic regulatory network required for HSC specification. Non-canonical signalling by Wnt16 is required for somitic expression of the Notch ligands deltaC (dlc) and deltaD (dld), and these ligands are, in turn, required for the establishment of definitive haematopoiesis. Notch signalling downstream of Dlc and Dld is earlier than, and distinct from, known cell-autonomous requirements for Notch, strongly suggesting that novel Notch-dependent relay signal(s) induce the first HSCs in parallel to other established pathways. Our results demonstrate that somite-specific gene expression is required for the production of haemogenic endothelium.	[Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Clements, Wilson K.; Kim, Albert D.; Ong, Karen G.; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Moore, John C.; Lawson, Nathan D.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Massachusetts System; University of Massachusetts Worcester	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dtraver@ucsd.edu	Clements, Wilson/C-9617-2015; Clements, Wilson/D-4153-2011	Clements, Wilson/0000-0003-4365-9553; Lawson, Nathan/0000-0001-7788-9619	AHA [0725086Y, 0815732D]; NIH [R01-HL093467, R01-DK074482]; CIRM; March of Dimes [6-FY09-508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors wish to thank L. Zon, K. Poss, D. Kimelman, M. Lardelli, B. Appel, C. Burns, J. Campos-Ortega, D. Ransom, N. Trede, J. Lewis, M. Pack, S. Holley, C. Moens, B. Paw, R. Karlstrom and J. Waxman for probe constructs. L. Zon, R. Dorsky, S. Lin and S. Holley provided transgenic and mutant zebrafish lines. C. Weaver, K. Willert, K. J. P. Griffin, J. Bertrand, D. Stachura and Y. Lee provided critical evaluation of the manuscript. This research was funded by an AHA Postdoctoral Fellowship 0725086Y to W.K.C., an AHA Predoctoral Founders Affiliate Fellowship 0815732D to J.C.M., NIH R01-HL093467 to N.L. and NIH R01-DK074482, CIRM New Investigator Award, and March of Dimes 6-FY09-508 to D.T.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cirone P, 2008, ANGIOGENESIS, V11, P347, DOI 10.1007/s10456-008-9116-2; Clements WK, 2009, DEV DYNAM, V238, P1788, DOI 10.1002/dvdy.21977; Clements WK, 2005, DEV BIOL, V283, P322, DOI 10.1016/j.ydbio.2005.04.026; Corrigan PM, 2009, STEM CELLS DEV, V18, P759, DOI 10.1089/scd.2008.0270; Gering M, 2010, J CELL PHYSIOL, V222, P11, DOI 10.1002/jcp.21905; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Holley SA, 2002, DEVELOPMENT, V129, P1175; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Nusslein-Volhard C, 2002, ZEBRAFISH; Nygren MK, 2009, EXP HEMATOL, V37, P225, DOI 10.1016/j.exphem.2008.10.007; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Robert-Moreno A, 2008, EMBO J, V27, P1886, DOI 10.1038/emboj.2008.113; Scheer N, 2001, DEVELOPMENT, V128, P1099; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Westerfield M, 2004, ZEBRAFISH BOOK GUIDE; Yokota T, 2006, DEVELOPMENT, V133, P2041, DOI 10.1242/dev.02349	36	166	173	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					220	U262		10.1038/nature10107	http://dx.doi.org/10.1038/nature10107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654806	Green Accepted			2022-12-28	WOS:000291397800052
J	Konstantinopoulos, PA; Papavassiliou, AG				Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.			Seeing the Future of Cancer-Associated Transcription Factor Drug Targets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIOLOGY		[Konstantinopoulos, Panagiotis A.; Papavassiliou, Athanasios G.] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece; [Konstantinopoulos, Panagiotis A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA	Athens Medical School; National & Kapodistrian University of Athens; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Papavassiliou, AG (corresponding author), Univ Athens, Sch Med, Dept Biol Chem, 75 M Asias St, GR-11527 Athens, Greece.	papavas@med.uoa.gr	Karamouzis, Michalis/AAD-2860-2020					Friend SH, 2006, CANCER CELL, V10, P349, DOI 10.1016/j.ccr.2006.10.011; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Kaelin WG, 2009, GENOME MED, V1, DOI 10.1186/gm99; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; PAPAVASSILIOU AG, 1995, NEW ENGL J MED, V332, P45, DOI 10.1056/NEJM199501053320108; Papavassiliou AG, 2001, EMBO REP, V2, P80, DOI 10.1093/embo-reports/kve033; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; van Montfort RLM, 2009, TRENDS BIOTECHNOL, V27, P315, DOI 10.1016/j.tibtech.2009.02.003	10	26	27	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2349	2350		10.1001/jama.2011.727	http://dx.doi.org/10.1001/jama.2011.727			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642690				2022-12-28	WOS:000291349100031
J	Amo, A; Pigeon, S; Sanvitto, D; Sala, VG; Hivet, R; Carusotto, I; Pisanello, F; Lemenager, G; Houdre, R; Giacobino, E; Ciuti, C; Bramati, A				Amo, A.; Pigeon, S.; Sanvitto, D.; Sala, V. G.; Hivet, R.; Carusotto, I.; Pisanello, F.; Lemenager, G.; Houdre, R.; Giacobino, E.; Ciuti, C.; Bramati, A.			Polariton Superfluids Reveal Quantum Hydrodynamic Solitons	SCIENCE			English	Article							EINSTEIN CONDENSED GAS; QUANTIZED VORTICES	A quantum fluid passing an obstacle behaves differently from a classical one. When the flow is slow enough, the quantum gas enters a superfluid regime, and neither whirlpools nor waves form around the obstacle. For higher flow velocities, it has been predicted that the perturbation induced by the defect gives rise to the turbulent emission of quantized vortices and to the nucleation of solitons. Using an interacting Bose gas of exciton-polaritons in a semiconductor microcavity, we report the transition from superfluidity to the hydrodynamic formation of oblique dark solitons and vortex streets in the wake of a potential barrier. The direct observation of these topological excitations provides key information on the mechanisms of superflow and shows the potential of polariton condensates for quantum turbulence studies.	[Amo, A.; Sala, V. G.; Hivet, R.; Pisanello, F.; Lemenager, G.; Giacobino, E.; Bramati, A.] Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, F-75005 Paris, France; [Amo, A.; Sala, V. G.; Hivet, R.; Pisanello, F.; Lemenager, G.; Giacobino, E.; Bramati, A.] UPMC, CNRS, F-75005 Paris, France; [Amo, A.] CNRS, Lab Photon & Nanostruct, F-91460 Marcoussis, France; [Pigeon, S.; Ciuti, C.] Univ Paris 07, UMR 7162, Lab Mat & Phenomenes Quant, F-75013 Paris, France; [Pigeon, S.; Ciuti, C.] CNRS, F-75013 Paris, France; [Sanvitto, D.; Pisanello, F.] CNR, Ist Nanosci, NNL, I-73100 Lecce, Italy; [Carusotto, I.] Univ Trent, BEC Ctr, CNR, INO, I-38123 Povo, Italy; [Carusotto, I.] Univ Trent, Dipartimento Fis, I-38123 Povo, Italy; [Pisanello, F.] Univ Salento, Scuola Super ISUFI, I-73100 Lecce, Italy; [Houdre, R.] Ecole Polytech Fed Lausanne, Fac Sci Base, Inst Phys Mat Condensee, CH-1015 Lausanne, Switzerland	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); University of Trento; University of Trento; University of Salento; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Amo, A (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Kastler Brossel, Case 74,4 Pl Jussieu, F-75005 Paris, France.	alberto.amo@lpn.cnrs.fr; bramati@spectro.jussieu.fr	Houdre, Romuald/R-6817-2018; carusotto, iacopo/P-8327-2018; Leménager, Godefroy/P-5135-2019; Amo, Alberto/M-3722-2017; Pigeon, Simon/V-9514-2017; Ciuti, Cristiano/GYR-1378-2022; Hivet, Romain/F-4133-2012; Leménager, Godefroy/H-3392-2014; Pisanello, Ferruccio/D-3342-2009; Sala, Vera Giulia/M-2760-2014; Ciuti, Cristiano/K-7248-2012; Ciuti, Cristiano/GYR-1331-2022; Sanvitto, Daniele/B-5785-2013	Houdre, Romuald/0000-0003-3348-506X; carusotto, iacopo/0000-0002-9838-0149; Leménager, Godefroy/0000-0001-9121-3885; Amo, Alberto/0000-0002-2508-8315; Pigeon, Simon/0000-0002-9570-3379; Ciuti, Cristiano/0000-0002-1134-7013; Leménager, Godefroy/0000-0001-9121-3885; Sala, Vera Giulia/0000-0002-0301-6847; Ciuti, Cristiano/0000-0002-1134-7013; Pisanello, Ferruccio/0000-0002-1489-7758; Sanvitto, Daniele/0000-0002-3831-8829	IFRAF; Agence Nationale de la Recherche	IFRAF(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	We thank S. Barbay, J. Bloch, R. Kuszelewicz, W. D. Phillips, L. P. Pitaevskii, and M. Wouters for useful discussions, and L. Martiradonna for the confocal masks. This work was supported by the IFRAF, CLERMONT4, and the Agence Nationale de la Recherche. A.B. and C.C. are members of the Institut Universitaire de France.	Amo A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081301; Amo A, 2009, NATURE, V457, P291, DOI 10.1038/nature07640; Amo A, 2009, NAT PHYS, V5, P805, DOI 10.1038/NPHYS1364; BERLOFF NG, TURBULENCE EXCITON P; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Carusotto I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.260403; Carusotto I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166401; Chang JJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.170404; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Daley AJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.110404; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; El GA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180405; Engels P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.160405; FRISCH T, 1992, PHYS REV LETT, V69, P1644, DOI 10.1103/PhysRevLett.69.1644; Inouye S, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080402; Jackson AD, 1998, PHYS REV A, V58, P2417, DOI 10.1103/PhysRevA.58.2417; Kamchatnov AM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160402; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Lagoudakis KG, 2008, NAT PHYS, V4, P706, DOI 10.1038/nphys1051; Lai CW, 2007, NATURE, V450, P529, DOI 10.1038/nature06334; Larionova Y, 2008, OPT LETT, V33, P321, DOI 10.1364/OL.33.000321; Leggett AJ, 1999, REV MOD PHYS, V71, pS318, DOI 10.1103/RevModPhys.71.S318; Neely TW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160401; Onofrio R, 2000, PHYS REV LETT, V85, P2228, DOI 10.1103/PhysRevLett.85.2228; Pigeon S, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144513; Raman C, 1999, PHYS REV LETT, V83, P2502, DOI 10.1103/PhysRevLett.83.2502; Sanvitto D, 2010, NAT PHYS, V6, P527, DOI 10.1038/NPHYS1668; Wertz E, 2010, NAT PHYS, V6, P860, DOI [10.1038/NPHYS1750, 10.1038/nphys1750]; Winiecki T, 2000, J PHYS B-AT MOL OPT, V33, P4069, DOI 10.1088/0953-4075/33/19/317; Yulin AV, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.061801	30	326	330	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1167	1170		10.1126/science.1202307	http://dx.doi.org/10.1126/science.1202307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636766	Green Submitted			2022-12-28	WOS:000291205200039
J	O'Brien, S; Rapkin, A; Dennerstein, L; Nevatte, T				O'Brien, Shaughn; Rapkin, Andrea; Dennerstein, Lorraine; Nevatte, Tracy			Diagnosis and management of premenstrual disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DYSPHORIC DISORDER; DOUBLE-BLIND; PLACEBO; PROGESTERONE; DROSPIRENONE; EFFICACY; THERAPY; TRIAL		[Nevatte, Tracy] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Stoke On Trent ST4 7QB, Staffs, England; [O'Brien, Shaughn] Univ Hosp N Staffordshire, Stoke On Trent, Staffs, England; [Rapkin, Andrea] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Dennerstein, Lorraine] Univ Melbourne, Dept Psychiat, Natl Aging Res Inst, Melbourne, Vic 3010, Australia	Keele University; Keele University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Melbourne	Nevatte, T (corresponding author), Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Stoke On Trent ST4 7QB, Staffs, England.	t.nevatte@pmed.keele.ac.uk						[Anonymous], 2000, DIAGN STAT MAN MENT, P771; Brown J, 2009, COCHRANE DB SYST REV, V2; Bulletins ACP., 2001, INT J GYAECOL OBSTET, V73, P183; Case AM, 1998, ARCH INTERN MED, V158, P1405, DOI 10.1001/archinte.158.13.1405; Dennerstein Lorraine, 2010, Menopause Int, V16, P139, DOI 10.1258/mi.2010.010034; Ford O, 2009, COCHRANE DB SYST REV, V2, DOI CD003415; FREEMAN EW, 1995, JAMA-J AM MED ASSOC, V274, P51, DOI 10.1001/jama.274.1.51; Girman Andrea, 2003, Am J Obstet Gynecol, V188, pS56, DOI 10.1067/mob.2003.403; HAHN PM, 1995, PSYCHONEUROENDOCRINO, V20, P193, DOI 10.1016/0306-4530(94)00053-D; Halbreich U, 2003, PSYCHONEUROENDOCRINO, V28, P1, DOI 10.1016/S0306-4530(03)00098-2; Hunter MS, 2002, J PSYCHOSOM RES, V53, P811, DOI 10.1016/S0022-3999(02)00338-0; Landen M, 2001, PSYCHOPHARMACOLOGY, V155, P292, DOI 10.1007/s002130100718; Lopez LM, 2009, COCHRANE DB SYST REV, V2; MAGOS AL, 1986, BMJ-BRIT MED J, V292, P1629, DOI 10.1136/bmj.292.6536.1629; O'Brien PMS, 2011, ARCH WOMEN MENT HLTH, V14, P13, DOI 10.1007/s00737-010-0201-3; O'Brien S, 2007, INFORM HEALTHCARE; Pearlstein TB, 2005, CONTRACEPTION, V72, P414, DOI 10.1016/j.contraception.2005.08.021; RAPKIN AJ, 1988, PSYCHOL REP, V62, P55, DOI 10.2466/pr0.1988.62.1.55; Rapkin AJ, 2008, EXPERT OPIN PHARMACO, V9, P429, DOI [10.1517/14656566.9.3.429, 10.1517/14656566.9.3.429 ]; Royal College of Obstetricians and Gynaecologists, 2007, MAN GREEN TOP GUID; Steiner M, 2006, J WOMENS HEALTH, V15, P57, DOI 10.1089/jwh.2006.15.57; Steiner M, 2003, Arch Womens Ment Health, V6, P203, DOI 10.1007/s00737-003-0018-4; Tuccori M, 2009, CLIN THER, V31, P1426, DOI 10.1016/j.clinthera.2009.07.009; Wang MD, 1995, ACTA OBSTET GYN SCAN, V74, P803, DOI 10.3109/00016349509021201; WATSON NR, 1989, LANCET, V2, P730, DOI 10.1016/S0140-6736(89)90784-8; Wyatt K, 2001, BMJ-BRIT MED J, V323, P776, DOI 10.1136/bmj.323.7316.776; Wyatt KM, 2004, BJOG-INT J OBSTET GY, V111, P585, DOI 10.1111/j.1471-0528.2004.00135.x; Yonkers KA, 2005, OBSTET GYNECOL, V106, P492, DOI 10.1097/01.AOG.0000175834.77215.2e	28	23	24	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2011	342								d2994	10.1136/bmj.d2994	http://dx.doi.org/10.1136/bmj.d2994			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	774MS	21642323	Green Submitted			2022-12-28	WOS:000291391300001
J	Stevens, KK; Jardine, AG				Stevens, Kathryn K.; Jardine, Alan G.			SHARP: a stab in the right direction in chronic kidney disease	LANCET			English	Editorial Material							CARDIOVASCULAR EVENTS; HEMODIALYSIS; METAANALYSIS; TRIALS		[Stevens, Kathryn K.; Jardine, Alan G.] Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Renal Res Grp, Glasgow G12 8TA, Lanark, Scotland	University of Glasgow	Jardine, AG (corresponding author), Univ Glasgow, British Heart Fdn, Cardiovasc Res Ctr, Renal Res Grp, Glasgow G12 8TA, Lanark, Scotland.	alan.jardine@glasgow.ac.uk	Jardine, Alan/L-5770-2019	Stevens, Kate/0000-0003-2291-1692; Jardine, Alan/0000-0001-5815-9370				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; Szummer K, 2011, KIDNEY INT, V79, P997, DOI 10.1038/ki.2010.524; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	8	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2153	2154		10.1016/S0140-6736(11)60822-2	http://dx.doi.org/10.1016/S0140-6736(11)60822-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21663950				2022-12-28	WOS:000292340800004
J	Rosenbaum, S				Rosenbaum, Sara			Medicaid and Access to Health Care - A Proposal for Continued Inaction?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20037 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC 20037 USA.							Medicaid and CHIP Payment Access Commission, 2011, REP C MED CHIP; Rosenbaum S, 2009, MEDICAID PAYMENT RAT; 2011, FED REG, V76, P26342	3	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	2011	365	2					102	104		10.1056/NEJMp1106046	http://dx.doi.org/10.1056/NEJMp1106046			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	791SP	21651387				2022-12-28	WOS:000292685500003
J	Levine, OS; Bloom, DE; Cherian, T; de Quadros, C; Sow, S; Wecker, J; Duclos, P; Greenwood, B				Levine, Orin S.; Bloom, David E.; Cherian, Thomas; de Quadros, Ciro; Sow, Samba; Wecker, John; Duclos, Philippe; Greenwood, Brian			New Decade of Vaccines 4 The future of immunisation policy, implementation, and financing	LANCET			English	Article							INFLUENZAE TYPE-B; BACTERIAL-MENINGITIS; CONJUGATE VACCINES; ROTAVIRUS VACCINES; CHILDREN YOUNGER; DISEASE; SURVEILLANCE; VACCINATION; SEQUELAE; BURDEN	Vaccines have already saved many lives and they have the potential to save many more as increasingly elaborate technologies deliver new and effective vaccines against both infectious diseases for which there are currently no effective licensed vaccines such as malaria, tuberculosis, and HIV and non-infectious diseases such as hypertension and diabetes. However, these new vaccines are likely to be more complex and expensive than those that have been used so effectively in the past, and they could have a multifaceted effect on the disease that they are designed to prevent, as has already been seen with pneumococcal conjugate vaccines. Deciding which new vaccines a country should invest in requires not only sound advice from international organisations such as WHO but also a well informed national immunisation advisory committee with access to appropriate data for local disease burden. Introduction of vaccines might need modification of immunisation schedules and delivery procedures. Novel methods are needed to finance the increasing number of new vaccines that have the potential to save lives in countries that are too poor to afford them. Here, we discuss some options.	[Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Bloom, David E.] Harvard Univ, Harvard Sch Publ Hlth, Cambridge, MA 02138 USA; [Cherian, Thomas; Duclos, Philippe] WHO Headquarters, Immunizat Vaccines & Biol, Geneva, Switzerland; [de Quadros, Ciro] Sabin Inst, Washington, DC USA; [Sow, Samba] Ctr Vaccine Dev, Bamako, Mali; [Wecker, John] PATH, Seattle, WA USA; [Greenwood, Brian] London Sch Hyg & Trop Med, London WC1, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Levine, OS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, 855 N Wolfe St,Suite 600, Baltimore, MD 21205 USA.	olevine@jhsph.edu			GAVI Alliance; Bill & Melinda Gates Foundation	GAVI Alliance; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	TC and PD are employees of WHO. JW and OSL are supported by grants from the GAVI Alliance and the Bill & Melinda Gates Foundation. JW has received travel expenses from GlaxoSmithKline. All other authors declare that they have no conflicts of interest.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P1367; Barnighausen T, 2009, BEST PRACTICE PAPER; Barnighausen T, 2008, SAMJ S AFR MED J, V98, P842; Bill & Melinda Gates Foundation. Global health leaders launch Decade of Vaccines collaboration, 2010, GLOB HLTH LEAD LAUNC; Bilous J, 2006, LANCET, V367, P1464, DOI 10.1016/S0140-6736(06)68625-X; Bines JE, 2009, J INFECT DIS, V200, pS282, DOI 10.1086/605051; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Brenzel L, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P389; Bryson M, 2010, VACCINE, V28, pA13, DOI 10.1016/j.vaccine.2009.07.089; Centers for Disease Control and prevention, CDC VACC PRIC LIST; Clemens J, 2010, NAT IMMUNOL, V11, P1069, DOI 10.1038/ni1210-1069; Cohen D, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2912; Edmond K, 2010, PEDIATR INFECT DIS J, V29, P1023, DOI 10.1097/INF.0b013e3181e598ea; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hajjeh RA, 2010, VACCINE, V28, P7123, DOI 10.1016/j.vaccine.2010.07.028; International AIDS Vaccine Initiative, 2008, PROC PRIC NEW VACC D; Knoll MD, 2009, CLIN INFECT DIS, V48, pS37, DOI 10.1086/596480; Lee GM, 2007, JAMA-J AM MED ASSOC, V298, P638, DOI 10.1001/jama.298.6.638; Levine OS, 2010, HUM VACCINES, V6, P1021, DOI 10.4161/hv.6.12.13076; Levine OS, 2010, CURR OPIN INFECT DIS, V23, P236, DOI 10.1097/QCO.0b013e328338c135; Levine OS, 2004, J HEALTH POPUL NUTR, V22, P268; Lindley Megan C, 2009, Pediatrics, V124 Suppl 5, pS548, DOI 10.1542/peds.2009-1542O; Loevinsohn B, 2002, AM J PUBLIC HEALTH, V92, P19, DOI 10.2105/AJPH.92.1.19; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pan American Health Organization, 2010, PAHO REV FUND VACC S; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Scott JAG, 2008, PLOS MED, V5, P548, DOI 10.1371/journal.pmed.0050086; Senouci K, 2010, VACCINE, V28, pA26, DOI 10.1016/j.vaccine.2010.02.028; Shearer JC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000249; UNICEF, 2010, PROD MEN VACC SUPPL; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; Watt JP, 2003, J PEDIATR-US, V143, pS163, DOI 10.1067/S0022-3476(03)00576-6; Wecker JR, 2009, VACCINE, V27, pF4, DOI 10.1016/j.vaccine.2009.08.066; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8; WHO, 2010, REV NEW MEN VACC SET; WHO, 2009, WKLY EPIDEMIOL REC, V84, P517; Widdowson MA, 2009, J INFECT DIS, V200, pS1, DOI 10.1086/605061	41	61	63	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2011	378	9789					439	448		10.1016/S0140-6736(11)60406-6	http://dx.doi.org/10.1016/S0140-6736(11)60406-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XM	21664676				2022-12-28	WOS:000293615900035
J	Harper, JW; King, RW				Harper, J. Wade; King, Randall W.			Stuck in the Middle: Drugging the Ubiquitin System at the E2 Step	CELL			English	Editorial Material							INHIBITOR; LIGASE	The discovery of a small-molecule allosteric inhibitor of the CDC34 ubiquitin-conjugating enzyme (E2) by Ceccarelli et al. raises the possibility that it will be generally feasible to selectively inhibit ubiquitin transfer at this central step in the ubiquitin pathway.	[Harper, J. Wade; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; randy_king@hms.harvard.edu		Harper, Jeffrey/0000-0002-6944-7236; King, Randall/0000-0001-7882-8180	NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Ceccarelli DF, 2011, CELL, V145, P1075, DOI 10.1016/j.cell.2011.05.039; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Orlicky S, 2010, NAT BIOTECHNOL, V28, P733, DOI 10.1038/nbt.1646; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Verma R, 2004, SCIENCE, V306, P117, DOI 10.1126/science.1100946; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010	10	8	8	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1007	1009		10.1016/j.cell.2011.06.002	http://dx.doi.org/10.1016/j.cell.2011.06.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703444	Bronze			2022-12-28	WOS:000292025700007
J	Newman, AV				Newman, Andrew V.			Hidden depths	NATURE			English	Editorial Material							EARTHQUAKE; SLIP		Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Newman, AV (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, 311 Ferst Dr, Atlanta, GA 30332 USA.	anewman@gatech.edu			Directorate For Geosciences [0847382] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Gagnon K, 2005, NATURE, V434, P205, DOI 10.1038/nature03412; Lorito S, 2011, NAT GEOSCI, V4, P173, DOI [10.1038/ngeo1073, 10.1038/NGEO1073]; Murray J, 2006, B SEISMOL SOC AM, V96, pS283, DOI 10.1785/0120050820; Newman AV, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046498; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Sato M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045689; Spiess FN, 1998, PHYS EARTH PLANET IN, V108, P101, DOI 10.1016/S0031-9201(98)00089-2	7	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					441	443		10.1038/474441a	http://dx.doi.org/10.1038/474441a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697926	Bronze			2022-12-28	WOS:000291939700023
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY Of swords, ploughshares, and climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3806	10.1136/bmj.d3806	http://dx.doi.org/10.1136/bmj.d3806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697215				2022-12-28	WOS:000292200500007
J	Prakken, B; Albani, S; Martini, A				Prakken, Berent; Albani, Salvatore; Martini, Alberto			Juvenile idiopathic arthritis	LANCET			English	Article							REGULATORY T-CELLS; MACROPHAGE ACTIVATION SYNDROME; IMMUNOLOGICAL SELF-TOLERANCE; INFLIXIMAB PLUS METHOTREXATE; GENE-EXPRESSION PROFILES; PLACEBO-CONTROLLED TRIAL; 2 DISTINCT POPULATIONS; LONG-TERM SAFETY; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID	Juvenile idiopathic arthritis is a heterogeneous group of diseases characterised by arthritis of unknown origin with onset before age of 16 years. Pivotal studies in the past 5 years have led to substantial progress in various areas, ranging from disease classification to new treatments. Gene expression profiling studies have identified different immune mechanisms in distinct subtypes of the disease, and can help to redefine disease classification criteria. Moreover, immunological studies have shown that systemic juvenile idiopathic arthritis is an acquired autoinflammatory disease, and have led to successful studies of both interleukin-1 and interleukin-6 blockade. In other forms of the disease, synovial inflammation is the consequence of a disturbed balance between proinflammatory effector cells (such as T-helper-17 cells), and anti-inflammatory regulatory cells (such as FOXP3-positive regulatory T cells). Moreover, specific soluble biomarkers (S100 proteins) can guide individual treatment. Altogether these new developments in genetics, immunology, and imaging are instrumental to better define, classify, and treat patients with juvenile idiopathic arthritis.	[Martini, Alberto] Univ Genoa, Dept Paediat, I-16147 Genoa, Italy; [Martini, Alberto] Inst G Gaslini, Genoa, Italy; [Prakken, Berent] Univ Med Ctr, Ctr Mol & Cellular Intervent, Dept Paediat, Utrecht, Netherlands; [Albani, Salvatore] Sanford Burnham Med Res Inst, Inflammatory & Infect Dis Ctr, Translat Res Lab, La Jolla, CA USA	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Utrecht University; Utrecht University Medical Center; Sanford Burnham Prebys Medical Discovery Institute	Martini, A (corresponding author), Univ Genoa, Dept Paediat, Largo G Gaslini 5, I-16147 Genoa, Italy.	albertomartini@ospedale-gaslini.ge.it		MARTINI, Alberto/0000-0001-7642-1459				Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Babyn P, 2007, RHEUM DIS CLIN N AM, V33, P403, DOI 10.1016/j.rdc.2007.07.011; Barnes MG, 2010, ARTHRITIS RHEUM-US, V62, P3249, DOI 10.1002/art.27657; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Colbert RA, 2010, NAT REV RHEUMATOL, V6, P477, DOI 10.1038/nrrheum.2010.103; Damasio MB, 2010, PEDIATR RADIOL, V40, P985, DOI 10.1007/s00247-010-1612-z; De Benedetti F, 1998, J RHEUMATOL, V25, P203; De Benedetti F, 2010, ANN RHEUM DIS, V69, P146; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; de Jager W, 2009, ARTHRITIS RHEUM-US, V60, P2782, DOI 10.1002/art.24750; de Kleer I, 2006, BLOOD, V107, P1696, DOI 10.1182/blood-2005-07-2800; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; de Kleer I, 2010, J IMMUNOL, V185, P2071, DOI 10.4049/jimmunol.0901901; DEBENEDETTI F, 1994, J CLIN INVEST, V93, P2114, DOI 10.1172/JCI117206; Diak P, 2010, ARTHRITIS RHEUM-US, V62, P2517, DOI 10.1002/art.27511; Faber C, 2006, ANN RHEUM DIS, V65, P1351, DOI 10.1136/ard.2005.047878; Fall N, 2007, ARTHRITIS RHEUM-US, V56, P3793, DOI 10.1002/art.22981; Fife MS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2041; Flores-Borja F, 2008, P NATL ACAD SCI USA, V105, P19396, DOI 10.1073/pnas.0806855105; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P1286, DOI 10.1002/art.20125; Foell D, 2004, ANN RHEUM DIS, V63, P206, DOI 10.1136/ard.2003.005686; Foell D, 2010, JAMA-J AM MED ASSOC, V303, P1266, DOI 10.1001/jama.2010.375; Frosch M, 2008, RHEUMATOLOGY, V47, P121, DOI 10.1093/rheumatology/kem271; Frosch M, 2009, ARTHRITIS RHEUM-US, V60, P883, DOI 10.1002/art.24349; Gare BA, 1999, CLIN EXP RHEUMATOL, V17, P367; Gattorno M, 2005, ARTHRITIS RES THER, V7, pR256, DOI 10.1186/ar1485; Gattorno M, 2004, RHEUMATOLOGY, V43, P1091, DOI 10.1093/rheumatology/keh250; Gattorno M, 1997, CLIN EXP IMMUNOL, V109, P4, DOI 10.1046/j.1365-2249.1997.4331330.x; Gattorno M, 2008, ARTHRITIS RHEUM, V58, P1505, DOI 10.1002/art.23437; Giannini EH, 1997, ARTHRITIS RHEUM, V40, P1202; Glass DN, 1999, ARTHRITIS RHEUM-US, V42, P2261, DOI 10.1002/1529-0131(199911)42:11<2261::AID-ANR1>3.0.CO;2-P; Graham TB, 2005, J RHEUMATOL, V32, P1811; Gregorio A, 2007, RHEUMATOLOGY, V46, P308, DOI 10.1093/rheumatology/kel225; Griffin TA, 2009, ARTHRITIS RHEUM-US, V60, P2113, DOI 10.1002/art.24534; Grom AA, 2010, CURR OPIN RHEUMATOL, V22, P561, DOI 10.1097/01.bor.0000381996.69261.71; Hashkes PJ, 2010, NAT REV RHEUMATOL, V6, P561, DOI 10.1038/nrrheum.2010.142; Heijstek MW, 2007, ANN RHEUM DIS, V66, P1384, DOI 10.1136/ard.2006.063586; Hollenbach JA, 2010, ARTHRITIS RHEUM-US, V62, P1781, DOI 10.1002/art.27424; Hori S, 2003, ADV IMMUNOL, V81, P331, DOI 10.1016/S0065-2776(03)81008-8; Horneff G, 2009, ANN RHEUM DIS, V68, P519, DOI 10.1136/ard.2007.087593; Horneff G, 2009, RHEUMATOLOGY, V48, P916, DOI 10.1093/rheumatology/kep122; Hunter PJ, 2010, ARTHRITIS RHEUM-US, V62, P896, DOI 10.1002/art.27284; Jarvis JN, 2009, ARTHRITIS RHEUM-US, V60, P1488, DOI 10.1002/art.24450; JARVIS JN, 1995, CLIN EXP IMMUNOL, V100, P514; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kamphuis S, 2006, EXPERT OPIN BIOL TH, V6, P579, DOI 10.1517/14712598.6.6.579; Keen HI, 2011, J RHEUMATOL, V38, P142, DOI 10.3899/jrheum.100377; Klassen TP, 2009, LANCET, V374, P1310, DOI 10.1016/S0140-6736(09)61803-1; Klassen TP, 2008, PLOS MED, V5, P1180, DOI 10.1371/journal.pmed.0050172; Knowlton N, 2009, ARTHRITIS RHEUM-US, V60, P892, DOI 10.1002/art.24298; Lehman Thomas J A, 2007, Arthritis Rheum, V56, P2815, DOI 10.1002/art.22837; Lovell DJ, 2008, NEW ENGL J MED, V359, P810, DOI 10.1056/NEJMoa0706290; Lovell DJ, 2008, ARTHRITIS RHEUM-US, V58, P1496, DOI 10.1002/art.23427; Lovell DJ, 2000, NEW ENGL J MED, V342, P763, DOI 10.1056/NEJM200003163421103; Magni-Manzoni S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1120, DOI 10.1002/art.23916; Magni-Manzoni S, 2009, ARTHRIT RHEUM-ARTHR, V61, P1497, DOI 10.1002/art.24823; Malattia C, 2010, RHEUMATOLOGY, V49, P178, DOI 10.1093/rheumatology/kep343; Malattia C, 2008, ARTHRIT RHEUM-ARTHR, V59, P1764, DOI 10.1002/art.24313; Martini A, 2003, J RHEUMATOL, V30, P1900; Martini A, 2010, ANN RHEUM DIS, V69, P1260, DOI 10.1136/ard.2010.133033; Massa M, 2007, ARTHRITIS RHEUM, V56, P1648, DOI 10.1002/art.22567; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McGonagle D, 2009, J RHEUMATOL, V36, P1573, DOI 10.3899/jrheum.090599; Miese FR, 2010, RADIOLOGY, V257, P441, DOI 10.1148/radiol.10100459; Minden K, 2009, CLIN EXP RHEUMATOL, V27, P863; Moncrieffe H, 2010, J IMMUNOL, V185, P134, DOI 10.4049/jimmunol.0803474; Moorthy LN, 2010, PEDIATR RHEUMATOL, V8, DOI 10.1186/1546-0096-8-20; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Ogilvie EM, 2007, ARTHRITIS RHEUM-US, V56, P1954, DOI 10.1002/art.22644; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Pascual V, 2008, IMMUNOL REV, V223, P39, DOI 10.1111/j.1600-065X.2008.00643.x; Petty RE, 2004, J RHEUMATOL, V31, P390; Pharoah DS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1913; Prahalad S, 2000, ARTHRITIS RHEUM, V43, P2611, DOI 10.1002/1529-0131(200011)43:11<2611::AID-ANR33>3.0.CO;2-T; Prahalad S, 2000, ARTHRITIS RHEUM, V43, P2335; Prahalad S, 2004, CURR OPIN RHEUMATOL, V16, P588, DOI 10.1097/01.bor.0000134407.48586.b0; Prahalad Sampath, 2008, Pediatr Rheumatol Online J, V6, P11, DOI 10.1186/1546-0096-6-11; Prakken BJ, 2009, BEST PRACT RES CL RH, V23, P599, DOI 10.1016/j.berh.2009.07.003; Prince FHM, 2009, ANN RHEUM DIS, V68, P635, DOI 10.1136/ard.2007.087411; Quartier P, 2011, ANN RHEUM DIS, V70, P747, DOI 10.1136/ard.2010.134254; Ravelli A, 2011, ARTHRITIS RHEUM, V63, P8; Ravelli A, 2007, ARTHRITIS RHEUM-US, V56, P3087, DOI 10.1002/art.22835; Ravelli A, 2007, LANCET, V369, P767, DOI 10.1016/S0140-6736(07)60363-8; Ravelli A, 2005, ARTHRITIS RHEUM, V52, P826, DOI 10.1002/art.20945; Ronaghy A, ANN RHEUM D IN PRESS; Rooney ME, 2009, J RHEUMATOL, V36, P1725, DOI 10.3899/jrheum.080508; Rosen P, 2003, CLIN EXP RHEUMATOL, V21, P650; Ruperto N, 2004, CURR OPIN RHEUMATOL, V16, P566, DOI 10.1097/01.bor.0000130286.54383.ea; Ruperto N, 2004, ARTHRITIS RHEUM-US, V50, P2191, DOI 10.1002/art.20288; Ruperto N, 2000, BRIT MED J, V320, P1210; Ruperto N, 2008, LANCET, V372, P383, DOI 10.1016/S0140-6736(08)60998-8; Ruperto N, 2007, ARTHRITIS RHEUM-US, V56, P3096, DOI 10.1002/art.22838; Ruperto N, 2011, NAT REV RHEUMATOL, V7, P6, DOI 10.1038/nrrheum.2010.199; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P3131, DOI 10.1002/art.27670; Ruperto N, 2010, ARTHRITIS RHEUM-US, V62, P1792, DOI 10.1002/art.27431; Ruperto N, 2010, ANN RHEUM DIS, V69, P718, DOI 10.1136/ard.2009.100354; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Saurenmann RK, 2007, ARTHRITIS RHEUM, V56, P647, DOI 10.1002/art.22381; Saurenmann RK, 2006, J PEDIATR-US, V149, P833, DOI 10.1016/j.jpeds.2006.08.044; Saurenmann RK, 2010, ARTHRITIS RHEUM-US, V62, P1824, DOI 10.1002/art.27416; Silverman E, 2005, NEW ENGL J MED, V352, P1655, DOI 10.1056/NEJMoa041810; Silverman E, 2005, ARTHRITIS RHEUM-US, V52, P554, DOI 10.1002/art.20861; Simard JF, 2010, ARTHRITIS RHEUM-US, V62, P3776, DOI 10.1002/art.27741; Simonini G, 2010, AUTOIMMUN REV, V9, P674, DOI 10.1016/j.autrev.2010.05.017; Smith MY, 2010, ARTHRIT CARE RES, V62, P800, DOI 10.1002/acr.20128; SOUTHWOOD TR, 1989, ARTHRITIS RHEUM, V32, P1007, DOI 10.1002/anr.1780320810; Stoll ML, 2008, ARTHRIT RHEUM-ARTHR, V59, P51, DOI 10.1002/art.23240; Stoll ML, 2006, ARTHRITIS RHEUM, V54, P3564, DOI 10.1002/art.22173; Thompson SD, 2004, ARTHRITIS RHEUM-US, V50, P2920, DOI 10.1002/art.20425; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P2611, DOI 10.1002/art.27561; van den Ham HJ, 2009, RHEUMATOLOGY, V48, P899, DOI 10.1093/rheumatology/kep125; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; van Rossum M, 2003, J RHEUMATOL, V30, P825; van Rossum MAJ, 2005, ARTHRITIS RHEUM, V52, P2865, DOI 10.1002/art.21247; van Rossum MAJ, 2003, ARTHRITIS RHEUM, V48, P507, DOI 10.1002/art.10783; Vastert SJ, 2010, RHEUMATOLOGY, V49, P441, DOI 10.1093/rheumatology/kep418; Vastert SJ, 2009, BEST PRACT RES CL RH, V23, P655, DOI 10.1016/j.berh.2009.08.003; Vercoulen Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007183; Vercoulen Y, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2674; Wallace CA, 2004, J RHEUMATOL, V31, P2290; Wedderburn LR, 2000, ARTHRITIS RHEUM-US, V43, P765, DOI 10.1002/1529-0131(200004)43:4<765::AID-ANR7>3.0.CO;2-B; Wedderburn LR, 2001, INT IMMUNOL, V13, P1541, DOI 10.1093/intimm/13.12.1541; Wehrens EJ, 2010, RHEUMATOLOGY, V49, P1632, DOI 10.1093/rheumatology/keq130; Woo P, 2005, ARTHRITIS RES THER, V7, pR1281, DOI 10.1186/ar1826; Woo P, 2009, BEST PRACT RES CL RH, V23, P589, DOI 10.1016/j.berh.2009.08.001; Wulffraat NM, 2003, RHEUMATOLOGY, V42, P375, DOI 10.1093/rheumatology/keg074; Yokota S, 2008, LANCET, V371, P998, DOI 10.1016/S0140-6736(08)60454-7; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Zhang K, 2008, ARTHRITIS RHEUM, V58, P2892, DOI 10.1002/art.23734; Zonneveld-Huijssoon E, 2007, ARTHRITIS RHEUM-US, V56, P639, DOI 10.1002/art.22399	137	504	533	4	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2138	2149		10.1016/S0140-6736(11)60244-4	http://dx.doi.org/10.1016/S0140-6736(11)60244-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684384				2022-12-28	WOS:000292117800035
J	Bland, ML; Birnbaum, MJ				Bland, Michelle L.; Birnbaum, Morris J.			ADaPting to Energetic Stress	SCIENCE			English	Editorial Material							SKELETAL-MUSCLE; KINASE; AMPK		[Bland, Michelle L.; Birnbaum, Morris J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA	University of Pennsylvania	Bland, ML (corresponding author), Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu		Birnbaum, Morris/0000-0001-9972-8680; Bland, Michelle/0000-0003-0113-1152	NIDDK NIH HHS [P01 DK049210] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bland ML, 2010, DEV BIOL, V344, P293, DOI 10.1016/j.ydbio.2010.05.010; Dzeja PP, 2003, J EXP BIOL, V206, P2039, DOI 10.1242/jeb.00426; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Williams T, 2008, TRENDS CELL BIOL, V18, P193, DOI 10.1016/j.tcb.2008.01.008; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; ZELEZNIKAR RJ, 1990, J BIOL CHEM, V265, P300; ZELEZNIKAR RJ, 1995, J BIOL CHEM, V270, P7311, DOI 10.1074/jbc.270.13.7311; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	13	10	11	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1387	1388		10.1126/science.1208444	http://dx.doi.org/10.1126/science.1208444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680830				2022-12-28	WOS:000291689000026
J	Jones, JTA; Hasell, T; Wu, XF; Bacsa, J; Jelfs, KE; Schmidtmann, M; Chong, SY; Adams, DJ; Trewin, A; Schiffman, F; Cora, F; Slater, B; Steiner, A; Day, GM; Cooper, AI				Jones, James T. A.; Hasell, Tom; Wu, Xiaofeng; Bacsa, John; Jelfs, Kim E.; Schmidtmann, Marc; Chong, Samantha Y.; Adams, Dave J.; Trewin, Abbie; Schiffman, Florian; Cora, Furio; Slater, Ben; Steiner, Alexander; Day, Graeme M.; Cooper, Andrew I.			Modular and predictable assembly of porous organic molecular crystals	NATURE			English	Article							FRAMEWORK; CHEMISTRY; HYDROGEN; METHANE; DESIGN	Nanoporous molecular frameworks(1-7) are important in applications such as separation, storage and catalysis. Empirical rules exist for their assembly but it is still challenging to place and segregate functionality in three-dimensional porous solids in a predictable way. Indeed, recent studies of mixed crystalline frameworks suggest a preference for the statistical distribution of functionalities throughout the pores(7) rather than, for example, the functional group localization found in the reactive sites of enzymes(8). This is a potential limitation for 'one-pot' chemical syntheses of porous frameworks from simple starting materials. An alternative strategy is to prepare porous solids from synthetically preorganized molecular pores(9-15). In principle, functional organic pore modules could be covalently prefabricated and then assembled to produce materials with specific properties. However, this vision of mix-and-match assembly is far from being realized, not least because of the challenge in reliably predicting three-dimensional structures for molecular crystals, which lack the strong directional bonding found in networks. Here we show that highly porous crystalline solids can be produced by mixing different organic cage modules that self-assemble by means of chiral recognition. The structures of the resulting materials can be predicted computationally(16,17), allowing in silico materials design strategies(18). The constituent pore modules are synthesized in high yields on gram scales in a one-step reaction. Assembly of the porous co-crystals is as simple as combining the modules in solution and removing the solvent. In some cases, the chiral recognition between modules can be exploited to produce porous organic nanoparticles. We show that the method is valid for four different cage modules and can in principle be generalized in a computationally predictable manner based on a lock-and-key assembly between modules.	[Jones, James T. A.; Hasell, Tom; Wu, Xiaofeng; Bacsa, John; Jelfs, Kim E.; Schmidtmann, Marc; Chong, Samantha Y.; Adams, Dave J.; Trewin, Abbie; Steiner, Alexander; Cooper, Andrew I.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Jones, James T. A.; Hasell, Tom; Wu, Xiaofeng; Bacsa, John; Jelfs, Kim E.; Schmidtmann, Marc; Chong, Samantha Y.; Adams, Dave J.; Trewin, Abbie; Steiner, Alexander; Cooper, Andrew I.] Univ Liverpool, Ctr Mat Discovery, Liverpool L69 7ZD, Merseyside, England; [Schiffman, Florian; Cora, Furio; Slater, Ben] UCL, Dept Chem, London WC1H 0AJ, England; [Day, Graeme M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Liverpool; University of Liverpool; University of London; University College London; University of Cambridge	Cooper, AI (corresponding author), Univ Liverpool, Dept Chem, Crown St, Liverpool L69 7ZD, Merseyside, England.	aicooper@liv.ac.uk	Trewin, Abbie E/B-2432-2010; Chong, Samantha Y/B-4031-2009; Wu, Xiaofeng/F-2883-2011; BACSA, JOHN/L-8501-2016; Day, Graeme/B-9437-2008; Schiffmann, Florian/D-6379-2014; Cooper, Andrew/ABE-7766-2020; Cooper, Andrew I/D-9662-2011; Steiner, Alexander/L-8519-2019; Jones, James/A-6823-2010; Steiner, Alexander/I-2228-2018; Adams, Dave/F-4073-2010; Wu, Xiaofeng/B-3311-2010; Jelfs, Kim/E-1802-2011; Hasell, Tom/G-3588-2011; Slater, Ben/D-4127-2013	Chong, Samantha Y/0000-0002-3095-875X; Day, Graeme/0000-0001-8396-2771; Steiner, Alexander/0000-0002-4315-6123; Steiner, Alexander/0000-0002-4315-6123; Adams, Dave/0000-0002-3176-1350; Wu, Xiaofeng/0000-0001-5549-8836; Jelfs, Kim/0000-0001-7683-7630; Hasell, Tom/0000-0003-4736-0604; Trewin, Abbie/0000-0002-1217-3254; Slater, Ben/0000-0001-9738-5848	EPSRC [EP/F067496/1, EP/H000925/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F067496/1, EP/H000925/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Atwood JL, 2002, SCIENCE, V296, P2367, DOI 10.1126/science.1072252; Barbour LJ, 2006, CHEM COMMUN, P1163, DOI 10.1039/b515612m; Bezzu CG, 2010, SCIENCE, V327, P1627, DOI 10.1126/science.1184228; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Dance I, 1998, J CHEM SOC DALTON, P1341, DOI 10.1039/a707237f; Day GM, 2005, CRYST GROWTH DES, V5, P1023, DOI 10.1021/cg049651n; Day GM, 2009, ACTA CRYSTALLOGR B, V65, P107, DOI 10.1107/S0108768109004066; Deng HX, 2010, SCIENCE, V327, P846, DOI 10.1126/science.1181761; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Gorbitz CH, 2010, PHYS CHEM CHEM PHYS, V12, P8466, DOI 10.1039/c004055j; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hof F, 2002, ANGEW CHEM INT EDIT, V41, P1488, DOI 10.1002/1521-3773(20020503)41:9<1488::AID-ANIE1488>3.0.CO;2-G; Ingleson MJ, 2008, CHEM COMMUN, P2680, DOI 10.1039/b718367d; Jansen M, 2010, ACTA CRYSTALLOGR A, V66, P518, DOI 10.1107/S0108767310026371; Jones JTA, 2011, ANGEW CHEM INT EDIT, V50, P749, DOI 10.1002/anie.201006030; Karamertzanis PG, 2007, MOL PHYS, V105, P273, DOI 10.1080/00268970601143317; Kondo M, 1997, ANGEW CHEM INT EDIT, V36, P1725, DOI 10.1002/anie.199717251; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Mastalerz M, 2011, ANGEW CHEM INT EDIT, V50, P1046, DOI 10.1002/anie.201005301; McKeown NB, 2010, J MATER CHEM, V20, P10588, DOI 10.1039/c0jm01867h; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Price SL, 2010, PHYS CHEM CHEM PHYS, V12, P8478, DOI 10.1039/c004164e; Price SL, 2009, ACCOUNTS CHEM RES, V42, P117, DOI 10.1021/ar800147t; SIMARD M, 1991, J AM CHEM SOC, V113, P4696, DOI 10.1021/ja00012a057; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Tranchemontagne DJL, 2008, ANGEW CHEM INT EDIT, V47, P5136, DOI 10.1002/anie.200705008; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; Wheeler KA, 2008, ANGEW CHEM INT EDIT, V47, P78, DOI 10.1002/anie.200704007; Wuest JD, 2005, CHEM COMMUN, P5830, DOI 10.1039/b512641j; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	32	382	385	16	653	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					367	371		10.1038/nature10125	http://dx.doi.org/10.1038/nature10125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677756	Green Accepted			2022-12-28	WOS:000291647100043
J	Tiacci, E; Trifonov, V; Schiavoni, G; Holmes, A; Kern, W; Martelli, MP; Pucciarini, A; Bigerna, B; Pacini, R; Wells, VA; Sportoletti, P; Pettirossi, V; Mannucci, R; Elliott, O; Liso, A; Ambrosetti, A; Pulsoni, A; Forconi, F; Trentin, L; Semenzato, G; Inghirami, G; Capponi, M; Di Raimondo, F; Patti, C; Arcaini, L; Musto, P; Pileri, S; Haferlach, C; Schnittger, S; Pizzolo, G; Foa, R; Farinelli, L; Haferlach, T; Pasqualucci, L; Rabadan, R; Falini, B				Tiacci, Enrico; Trifonov, Vladimir; Schiavoni, Gianluca; Holmes, Antony; Kern, Wolfgang; Martelli, Maria Paola; Pucciarini, Alessandra; Bigerna, Barbara; Pacini, Roberta; Wells, Victoria A.; Sportoletti, Paolo; Pettirossi, Valentina; Mannucci, Roberta; Elliott, Oliver; Liso, Arcangelo; Ambrosetti, Achille; Pulsoni, Alessandro; Forconi, Francesco; Trentin, Livio; Semenzato, Gianpietro; Inghirami, Giorgio; Capponi, Monia; Di Raimondo, Francesco; Patti, Caterina; Arcaini, Luca; Musto, Pellegrino; Pileri, Stefano; Haferlach, Claudia; Schnittger, Susanne; Pizzolo, Giovanni; Foa, Robin; Farinelli, Laurent; Haferlach, Torsten; Pasqualucci, Laura; Rabadan, Raul; Falini, Brunangelo			BRAF Mutations in Hairy-Cell Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYCLIN D1; CONSTITUTIVE ACTIVATION; GENE-EXPRESSION; KINASE; RAS; MELANOMA; CANCER; ERK; P27(KIP1); REVEALS	Background Hairy-cell leukemia (HCL) is a well-defined clinicopathological entity whose underlying genetic lesion is still obscure. Methods We searched for HCL-associated mutations by performing massively parallel sequencing of the whole exome of leukemic and matched normal cells purified from the peripheral blood of an index patient with HCL. Findings were validated by Sanger sequencing in 47 additional patients with HCL. Results Whole-exome sequencing identified five missense somatic clonal mutations that were confirmed on Sanger sequencing, including a heterozygous mutation in BRAF that results in the BRAF V600E variant protein. Since BRAF V600E is oncogenic in other tumors, further analyses were focused on this genetic lesion. The same BRAF mutation was noted in all the other 47 patients with HCL who were evaluated by means of Sanger sequencing. None of the 195 patients with other peripheral B-cell lymphomas or leukemias who were evaluated carried the BRAF V600E variant, including 38 patients with splenic marginal-zone lymphomas or unclassifiable splenic lymphomas or leukemias. In immunohistologic and Western blot studies, HCL cells expressed phosphorylated MEK and ERK (the downstream targets of the BRAF kinase), indicating a constitutive activation of the RAF-MEK-ERK mitogen-activated protein kinase pathway in HCL. In vitro incubation of BRAF-mutated primary leukemic hairy cells from 5 patients with PLX-4720, a specific inhibitor of active BRAF, led to a marked decrease in phosphorylated ERK and MEK. Conclusions The BRAF V600E mutation was present in all patients with HCL who were evaluated. This finding may have implications for the pathogenesis, diagnosis, and targeted therapy of HCL. (Funded by Associazione Italiana per la Ricerca sul Cancro and others.)	[Tiacci, Enrico; Schiavoni, Gianluca; Martelli, Maria Paola; Pucciarini, Alessandra; Bigerna, Barbara; Pacini, Roberta; Sportoletti, Paolo; Pettirossi, Valentina; Capponi, Monia; Pasqualucci, Laura; Falini, Brunangelo] Univ Perugia, Inst Hematol, I-06132 Perugia, Italy; [Mannucci, Roberta] Univ Perugia, Inst Internal Med & Oncol Sci, I-06132 Perugia, Italy; [Liso, Arcangelo] Univ Foggia, Inst Hematol, Foggia, Italy; [Ambrosetti, Achille; Pizzolo, Giovanni] Univ Verona, Dept Med, Hematol Sect, I-37100 Verona, Italy; [Pucciarini, Alessandra; Foa, Robin] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Div Hematol, Rome, Italy; [Forconi, Francesco] Univ Siena, Div Hematol, I-53100 Siena, Italy; [Forconi, Francesco] Univ Hosp, Siena, Italy; [Trentin, Livio; Semenzato, Gianpietro] Univ Padua, Hematol & Clin Immunol Sect, Dept Clin & Expt Med, Padua, Italy; [Inghirami, Giorgio] Univ Turin, Dept Pathol, Ctr Expt Res & Med Studies, Turin, Italy; [Di Raimondo, Francesco] Univ Catania, Ferrarotto Hosp, Dept Biomed Sci, Sect Hematol, Catania, Italy; [Patti, Caterina] Cervello Hosp, Dept Hematol, Palermo, Italy; [Arcaini, Luca] Univ Pavia, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Div Hematol,Dept Oncohematol,Med Sch, Policlin S Matteo, I-27100 Pavia, Italy; [Musto, Pellegrino] IRCCS, Ctr Riferimento Oncol Basilicata, Dept Oncohematol, Rionero In Vulture, Italy; [Pileri, Stefano] Univ Bologna, Dept Hematol & Oncol Sci Seragnoli, Sect Hemopathol, Bologna, Italy; [Trifonov, Vladimir; Holmes, Antony; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Holmes, Antony; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Wells, Victoria A.; Pasqualucci, Laura] Columbia Univ, Inst Canc Genet, New York, NY USA; [Kern, Wolfgang; Haferlach, Claudia; Schnittger, Susanne; Haferlach, Torsten] Munich Leukemia Lab, Munich, Germany; [Farinelli, Laurent] Fasteris, Plan les Ouates, Geneva, Switzerland	University of Perugia; University of Perugia; University of Foggia; University of Verona; Sapienza University Rome; University of Siena; University of Siena; University Hospital of Siena; University of Padua; University of Turin; University of Catania; IRCCS Fondazione San Matteo; University of Pavia; IRCCS CROB; University of Bologna; Columbia University; Columbia University; Columbia University; MLL Munich Leukemia Laboratory	Falini, B (corresponding author), Univ Perugia, Inst Hematol, Osped S Maria della Misericordia, I-06132 Perugia, Italy.	faliniem@unipg.it	Di Raimondo, Francesco/K-7965-2016; Liso, Arcangelo/AAL-2183-2020; Martelli, Maria Paola/I-5618-2012; Arcaini, Luca/P-8913-2015; TRENTIN, LIVIO/J-7676-2016; mannucci, roberta/AAE-6662-2020; Forconi, Francesco/AAO-2694-2021; SEMENZATO, GIANPIETRO C/J-7727-2016; Pileri, Stefano/AAP-6337-2020; Martelli, Maria Paola/ABH-3300-2021; Rabadan, Raul/AAZ-7367-2020; TRENTIN, LIVIO/L-6678-2019; Sportoletti, Paolo/AAE-5907-2020; SPORTOLETTI, PAOLO/K-6013-2016	Di Raimondo, Francesco/0000-0002-7749-0293; Liso, Arcangelo/0000-0001-5638-227X; Arcaini, Luca/0000-0002-9504-991X; TRENTIN, LIVIO/0000-0003-1222-6149; Forconi, Francesco/0000-0002-2211-1831; SEMENZATO, GIANPIETRO C/0000-0002-6061-4595; Martelli, Maria Paola/0000-0001-9139-1729; TRENTIN, LIVIO/0000-0003-1222-6149; Rabadan, Raul/0000-0001-7946-9255; SPORTOLETTI, PAOLO/0000-0002-5630-9862; Musto, Pellegrino/0000-0003-3277-6594; FALINI, Brunangelo/0000-0002-7198-5965; SCHIAVONI, GIANLUCA/0000-0002-2693-2514	Associazione Italiana per la Ricerca sul Cancro; Associazione Umbra contro le Leucemie e i Linfomi; Fondazione CARIVERONA; Hairy Cell Leukemia Research Foundation; European Hematology Association [2008/14]; Northeast Biodefense Center [U54-AI057158]; National Institutes of Health [U54-CA121852-05]; National Library of Medicine [1R01LM010140-01]; Associazione Italiana contro le Leucemie-Linfomi e Mieloma; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Umbra contro le Leucemie e i Linfomi; Fondazione CARIVERONA(Fondazione Cariverona); Hairy Cell Leukemia Research Foundation; European Hematology Association; Northeast Biodefense Center; National Institutes of Health; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Associazione Italiana contro le Leucemie-Linfomi e Mieloma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Supported by Associazione Italiana per la Ricerca sul Cancro (investigator grant to Dr. Falini and Molecular Clinical Oncology 5 per Mille grant), Associazione Umbra contro le Leucemie e i Linfomi, the Fondazione CARIVERONA, and the Hairy Cell Leukemia Research Foundation; a fellowship (2008/14, to Dr. Tiacci) from the European Hematology Association; a grant (U54-AI057158) from the Northeast Biodefense Center; a grant (U54-CA121852-05) from the National Institutes of Health; a grant (1R01LM010140-01) from the National Library of Medicine (to Dr. Rabadan); and a grant from Associazione Italiana contro le Leucemie-Linfomi e Mieloma (to Dr. Liso).	Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Basso K, 2004, J EXP MED, V199, P59, DOI 10.1084/jem.20031175; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; BOSCH F, 1995, BRIT J HAEMATOL, V91, P1025, DOI 10.1111/j.1365-2141.1995.tb05429.x; Brose MS, 2002, CANCER RES, V62, P6997; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Case M, 2008, CANCER RES, V68, P6803, DOI 10.1158/0008-5472.CAN-08-0101; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chilosi M, 2000, BRIT J HAEMATOL, V111, P263, DOI 10.1046/j.1365-2141.2000.02210.x; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davidsson J, 2008, LEUKEMIA, V22, P1619, DOI 10.1038/leu.2008.14; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Falini B, 2004, LANCET, V363, P1869, DOI 10.1016/S0140-6736(04)16356-3; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Forconi F, 2008, BRIT J HAEMATOL, V141, P622, DOI 10.1111/j.1365-2141.2008.07106.x; Foucar K, 2008, WHO CLASSIFICATION T, P188; Grever MR, 2010, BLOOD, V115, P21, DOI 10.1182/blood-2009-06-195370; Gustafsson B, 2005, LEUKEMIA, V19, P310, DOI 10.1038/sj.leu.2403589; Harris, 2008, WHO CLASSIFICATION T, P191; Kamiguti AS, 2003, ONCOGENE, V22, P2272, DOI 10.1038/sj.onc.1206398; Lee JW, 2003, BRIT J CANCER, V89, P1958, DOI 10.1038/sj.bjc.6601371; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li YQ, 2009, ONCOL REP, V22, P671, DOI 10.3892/or_00000487; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Niault TS, 2010, CARCINOGENESIS, V31, P1165, DOI 10.1093/carcin/bgp337; Nicolaou F, 2003, BLOOD, V101, P4033, DOI 10.1182/blood-2002-01-0324; Puxeddu E, 2004, J CLIN ENDOCR METAB, V89, P2414, DOI 10.1210/jc.2003-031425; Roovers K, 1999, MOL BIOL CELL, V10, P3197, DOI 10.1091/mbc.10.10.3197; Sala E, 2008, MOL CANCER RES, V6, P751, DOI 10.1158/1541-7786.MCR-07-2001; Slupsky JR, 2007, AM J PATHOL, V170, P745, DOI 10.2353/ajpath.2007.060557; Tiacci E, 2006, NAT REV CANCER, V6, P437, DOI 10.1038/nrc1888; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2010, BIOCHEM PHARMACOL, V80, P561, DOI 10.1016/j.bcp.2010.03.019; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	41	724	754	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2305	2315		10.1056/NEJMoa1014209	http://dx.doi.org/10.1056/NEJMoa1014209			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21663470	Green Accepted			2022-12-28	WOS:000291643800008
J	Das, P				Das, Pamela			Profile Helen Rees on the quest for global equity	LANCET			English	Biographical-Item												pamela.das@lancet.com							0	0	0	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					1997	1997		10.1016/S0140-6736(11)60853-2	http://dx.doi.org/10.1016/S0140-6736(11)60853-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	782LR	21665026				2022-12-28	WOS:000292011700017
J	Herd, CDK; Blinova, A; Simkus, DN; Huang, YS; Tarozo, R; Alexander, CMO; Gyngard, F; Nittler, LR; Cody, GD; Fogel, ML; Kebukawa, Y; Kilcoyne, ALD; Hilts, RW; Slater, GF; Glavin, DP; Dworkin, JP; Callahan, MP; Elsila, JE; De Gregorio, BT; Stroud, RM				Herd, Christopher D. K.; Blinova, Alexandra; Simkus, Danielle N.; Huang, Yongsong; Tarozo, Rafael; Alexander, Conel M. O'D.; Gyngard, Frank; Nittler, Larry R.; Cody, George D.; Fogel, Marilyn L.; Kebukawa, Yoko; Kilcoyne, A. L. David; Hilts, Robert W.; Slater, Greg F.; Glavin, Daniel P.; Dworkin, Jason P.; Callahan, Michael P.; Elsila, Jamie E.; De Gregorio, Bradley T.; Stroud, Rhonda M.			Origin and Evolution of Prebiotic Organic Matter As Inferred from the Tagish Lake Meteorite	SCIENCE			English	Article							MONOCARBOXYLIC ACIDS; HYDROUS PYROLYSIS; AMINO-ACIDS; CHONDRITES; ISOVALINE	The complex suite of organic materials in carbonaceous chondrite meteorites probably originally formed in the interstellar medium and/or the solar protoplanetary disk, but was subsequently modified in the meteorites' asteroidal parent bodies. The mechanisms of formation and modification are still very poorly understood. We carried out a systematic study of variations in the mineralogy, petrology, and soluble and insoluble organic matter in distinct fragments of the Tagish Lake meteorite. The variations correlate with indicators of parent body aqueous alteration. At least some molecules of prebiotic importance formed during the alteration.	[Herd, Christopher D. K.; Blinova, Alexandra; Simkus, Danielle N.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Huang, Yongsong; Tarozo, Rafael] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Alexander, Conel M. O'D.; Gyngard, Frank; Nittler, Larry R.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Cody, George D.; Fogel, Marilyn L.; Kebukawa, Yoko] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Kilcoyne, A. L. David] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [Hilts, Robert W.] Grant MacEwan Univ, Dept Phys Sci, Edmonton, AB T5J 4S2, Canada; [Slater, Greg F.] McMaster Univ, Sch Geog & Earth Sci, Hamilton, ON L8S 4K1, Canada; [Glavin, Daniel P.; Dworkin, Jason P.; Callahan, Michael P.; Elsila, Jamie E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [De Gregorio, Bradley T.] NASA, Lyndon B Johnson Space Ctr, Engn & Sci Contract Grp, Houston, TX 77058 USA; [De Gregorio, Bradley T.; Stroud, Rhonda M.] USN, Res Lab, Washington, DC 20375 USA	University of Alberta; Brown University; Carnegie Institution for Science; Carnegie Institution for Science; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; McMaster University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; United States Department of Defense; United States Navy; Naval Research Laboratory	Herd, CDK (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	herd@ualberta.ca	Fogel, Marilyn L/M-2395-2015; Dworkin, Jason P./C-9417-2012; Callahan, Michael/D-3630-2012; Stroud, Rhonda M./C-5503-2008; Glavin, Daniel P/D-6194-2012; Kilcoyne, Arthur A L/I-1465-2013; Stroud, Rhonda M/S-4584-2018; Stroud, Rhonda/GQZ-0151-2022; Alexander, Conel M. O'D./N-7533-2013; Slater, Greg/B-5163-2013; Elsila, Jamie/AAM-2654-2020; De Gregorio, Bradley/B-8465-2008; Elsila, Jamie E/C-9952-2012; Kebukawa, Yoko/A-7315-2010	Fogel, Marilyn L/0000-0002-1176-3818; Dworkin, Jason P./0000-0002-3961-8997; Stroud, Rhonda M./0000-0001-5242-8015; Glavin, Daniel P/0000-0001-7779-7765; Kilcoyne, Arthur A L/0000-0002-8805-8690; Stroud, Rhonda M/0000-0001-5242-8015; Stroud, Rhonda/0000-0001-5242-8015; Alexander, Conel M. O'D./0000-0002-8558-1427; Slater, Greg/0000-0001-7418-7566; De Gregorio, Bradley/0000-0001-9096-3545; Herd, Christopher/0000-0001-5210-4002; Kebukawa, Yoko/0000-0001-8430-3612; Elsila, Jamie/0000-0002-0008-2590; Simkus, Danielle/0000-0002-8272-623X	Natural Sciences and Engineering Research Council of Canada; Alberta Innovates; NASA; U.S. Office of Naval Research; CIW; Grant MacEwan University; Carnegie Institution of Canada; U.S. Department of Energy [DE-AC02-05CH11231]; W.M. Keck Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates; NASA(National Aeronautics & Space Administration (NASA)); U.S. Office of Naval Research(Office of Naval Research); CIW; Grant MacEwan University; Carnegie Institution of Canada; U.S. Department of Energy(United States Department of Energy (DOE)); W.M. Keck Foundation(W.M. Keck Foundation)	Funding for this study was provided by the Natural Sciences and Engineering Research Council of Canada, Alberta Innovates, NASA (Astrobiology, including Carnegie Institution Astrobiology and the Goddard Center for Astrobiology; Origins of Solar Systems; Cosmochemistry and Postdoctoral Programs), the U.S. Office of Naval Research, the CIW, Grant MacEwan University, and the Carnegie Institution of Canada. The Canadian Institute for Advanced Research is thanked for hosting workshops that facilitated work on the MCAs. J. Kirby assisted with MCA analysis. R. Bowden carried out bulk IOM analyses. XANES data were acquired on the Scanning Transmission X-ray Microscope at beamline 5.3.2.2 of the Advanced Light Source, which is supported by the Director of the Office of Science, U.S. Department of Energy, under contract no. DE-AC02-05CH11231, and by a W.M. Keck Foundation grant to the CIW. Three anonymous reviewers are thanked for constructive comments that improved the manuscript.	Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; Botta O, 2002, SURV GEOPHYS, V23, P411, DOI 10.1023/A:1020139302770; Bowen R., 1988, ISOTOPES EARTH SCI, P452; Brearley AJ, 2005, TREATISE GEOCHEM, V1, P247; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; Busemann H, 2006, SCIENCE, V312, P727, DOI 10.1126/science.1123878; CHYBA CF, 1990, SCIENCE, V249, P366, DOI 10.1126/science.11538074; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; CRONIN JR, 1993, GEOCHIM COSMOCHIM AC, V57, P4745, DOI 10.1016/0016-7037(93)90197-5; Cronin JR., 1988, ORGANIC MATTER CARBO, P819; Deamer D, 2002, ASTROBIOLOGY, V2, P371, DOI 10.1089/153110702762470482; Dias RF, 2002, GEOCHIM COSMOCHIM AC, V66, P2755, DOI 10.1016/S0016-7037(02)00871-2; Duprat J, 2010, SCIENCE, V328, P742, DOI 10.1126/science.1184832; Gilmour I, 2005, TREATISE GEOCHEM, V1, P269; Glavin DP, 2010, METEORIT PLANET SCI, V45, P1948, DOI 10.1111/j.1945-5100.2010.01132.x; Glavin DP, 2009, P NATL ACAD SCI USA, V106, P5487, DOI 10.1073/pnas.0811618106; Grady MM, 2002, METEORIT PLANET SCI, V37, P713, DOI 10.1111/j.1945-5100.2002.tb00851.x; Herd R. K., 2007, LUNAR PLANET SCI, VXXXVIII; Hiroi T, 2001, SCIENCE, V293, P2234, DOI 10.1126/science.1063734; Huang YS, 2007, EARTH PLANET SC LETT, V259, P517, DOI 10.1016/j.epsl.2007.05.012; Huang YS, 2005, GEOCHIM COSMOCHIM AC, V69, P1073, DOI 10.1016/j.gca.2004.07.030; Kilcoyne ALD, 2003, J SYNCHROTRON RADIAT, V10, P125, DOI 10.1107/S0909049502017739; Kminek G, 2002, METEORIT PLANET SCI, V37, P697, DOI 10.1111/j.1945-5100.2002.tb00849.x; Nakamura-Messenger K, 2006, SCIENCE, V314, P1439, DOI 10.1126/science.1132175; Oba Y, 2006, METEORIT PLANET SCI, V41, P1175, DOI 10.1111/j.1945-5100.2006.tb00514.x; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; PELTZER ET, 1978, NATURE, V272, P443, DOI 10.1038/272443a0; Pizzarello S, 2003, GEOCHIM COSMOCHIM AC, V67, P1589, DOI 10.1016/S0016-7037(02)01283-8; Remusat L, 2005, GEOCHIM COSMOCHIM AC, V69, P3919, DOI 10.1016/j.gca.2005.02.032; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Scott E.R.D., 2007, TREATISE GEOCHEMISTR, V1, P1, DOI [DOI 10.1016/B0-08-043751-6/01145-2, 10.1016/B0-08-043751-6/01145-2]; SMITH GK, 1982, BIOCHEMISTRY-US, V21, P2870, DOI 10.1021/bi00541a010; Yabuta H, 2007, METEORIT PLANET SCI, V42, P37, DOI 10.1111/j.1945-5100.2007.tb00216.x; YUEN G, 1984, NATURE, V307, P252, DOI 10.1038/307252a0; Zolensky ME, 2002, METEORIT PLANET SCI, V37, P737, DOI 10.1111/j.1945-5100.2002.tb00852.x	37	173	174	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1304	1307		10.1126/science.1203290	http://dx.doi.org/10.1126/science.1203290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659601	Green Submitted			2022-12-28	WOS:000291441700041
J	Reeder-Hayes, KE				Reeder-Hayes, Katherine E.			Way Back When	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Reeder-Hayes, KE (corresponding author), Univ N Carolina, Div Hematol Oncol, Chapel Hill, NC 27515 USA.	kreeder@unch.unc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2266	2267		10.1001/jama.2011.419	http://dx.doi.org/10.1001/jama.2011.419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642667				2022-12-28	WOS:000291349100001
J	Conen, D; Everett, BM; Kurth, T; Creager, MA; Buring, JE; Ridker, PM; Pradhan, AD				Conen, David; Everett, Brendan M.; Kurth, Tobias; Creager, Mark A.; Buring, Julie E.; Ridker, Paul M.; Pradhan, Aruna D.			Smoking, Smoking Status, and Risk for Symptomatic Peripheral Artery Disease in Women A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTERMITTENT CLAUDICATION; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; MORTALITY; CHOLESTEROL; POPULATION; PREVALENCE	Background: Smoking has a well-documented detrimental effect on risk for myocardial infarction and stroke, but less information is available regarding peripheral artery disease (PAD), particularly among women. Objective: To prospectively assess the association of current smoking status, cumulative smoking exposure, and smoking cessation with incident symptomatic PAD in women. Design: Prospective cohort study. Setting: U. S. female health care professionals in the Women's Health Study. Participants: 39 825 women with no cardiovascular disease who were prospectively followed for a median of 12.7 years. Measurements: Incidence of symptomatic PAD. Cox proportional hazards models were used to compare PAD risk across smoking categories. Results: 178 confirmed PAD events occurred. Across the 4 smoking categories (never, former, < 15 cigarettes/d, and >= 15 cigarettes/d), age-adjusted incidence rates were 0.12, 0.34, 0.95, and 1.63 per 1000 person-years of follow-up, respectively. Multivariate adjustment had little effect on this relationship (adjusted hazard ratios [HRs], 3.14 [95% CI, 2.01 to 4.90], 8.93 [CI, 5.02 to 15.89], and 16.95 [CI, 10.77 to 26.67], respectively, vs. women who never smoked). Additional adjustment for high-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 levels among women with available blood samples (28 314 participants, 117 events) attenuated risk estimates (HR, 5.58 [CI, 2.61 to 11.93] for smoking < 15 cigarettes/d and 9.52 [CI, 5.17 to 17.53] for smoking >= 15 cigarettes/d). Lifetime exposure showed a strong dose-response relationship; fully adjusted HRs for smoking abstinence of fewer than 10, 10 to 29, and 30 or more pack-years were 2.52 (CI, 1.49 to 4.25), 6.75 (CI, 4.33 to 10.52), and 11.09 (CI, 6.94 to 17.72), respectively. Compared with current smokers, the adjusted HRs for fewer than 10 years, 10 to 20 years, more than 20 years, or lifelong abstinence were 0.39 (CI, 0.24 to 0.66), 0.28 (CI, 0.17 to 0.46), 0.16 (CI, 0.10 to 0.26), and 0.08 (CI, 0.05 to 0.12), respectively. Limitation: The use of symptomatic PAD as the a priori primary end point excludes asymptomatic disease. Conclusion: Among initially healthy women, smoking is a potent risk factor for symptomatic PAD and was associated with subclinical inflammation. Smoking cessation substantially reduces risk for PAD, but an increased occurrence of PAD persists even among former smokers who maintain abstinence.	[Pradhan, Aruna D.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, Boston, MA 02215 USA; Univ Basel Hosp, CH-4031 Basel, Switzerland; Vet Affairs Boston Med Ctr, Boston, MA USA; INSERM, Neuroepidemiol U708, Paris, France; Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard T.H. Chan School of Public Health; University of Basel; Boston Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pradhan, AD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Med Sch,Sch Publ Hlth, 900 Commonwealth Ave E, Boston, MA 02215 USA.	apradhan@partners.org	Kurth, Tobias/A-9243-2012	Kurth, Tobias/0000-0001-7169-2620	The National Heart, Lung, and Blood Institute [HL-043851, HL-080467, HL-082740, HL-075771]; National Cancer Institute [CA-047988]; Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL082740, R01HL080467, RC1HL099355, R01HL043851, R01HL075771] Funding Source: NIH RePORTER	The National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The National Heart, Lung, and Blood Institute and National Cancer Institute.r By the National Heart, Lung, and Blood Institute (grants HL-043851, HL-080467, HL-082740, and HL-075771), National Cancer Institute (grant CA-047988), and Donald W. Reynolds Foundation.	Aboyans V, 2007, J VASC SURG, V45, P319, DOI 10.1016/j.jvs.2006.10.032; CANTIN B, 1995, AM J CARDIOL, V75, P1224, DOI 10.1016/S0002-9149(99)80767-X; Conen D, 2009, CIRCULATION, V120, P1041, DOI 10.1161/CIRCULATIONAHA.109.863092; COX DR, 1972, J R STAT SOC B, V34, P187; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; He Y, 2008, CIRCULATION, V118, P1535, DOI 10.1161/CIRCULATIONAHA.108.784801; Heyman KM, 2009, EARLY RELEASE SELECT; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hooi JD, 2001, AM J EPIDEMIOL, V153, P666, DOI 10.1093/aje/153.7.666; INGOLFSSON IO, 1994, J CLIN EPIDEMIOL, V47, P1237, DOI 10.1016/0895-4356(94)90128-7; Kenfield SA, 2008, JAMA-J AM MED ASSOC, V299, P2037, DOI 10.1001/jama.299.17.2037; Kollerits B, 2008, ATHEROSCLEROSIS, V198, P214, DOI 10.1016/j.atherosclerosis.2007.09.012; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; LENG GC, 1992, J CLIN EPIDEMIOL, V45, P1101, DOI 10.1016/0895-4356(92)90150-L; McDermott MM, 1999, ARCH INTERN MED, V159, P387; MCKINLAY SM, 1985, ANN INTERN MED, V103, P350, DOI 10.7326/0003-4819-103-3-350; Murabito JM, 1997, CIRCULATION, V96, P44; Pradhan AD, 2008, CIRCULATION, V117, P823, DOI 10.1161/CIRCULATIONAHA.107.719369; Price JF, 1999, EUR HEART J, V20, P344, DOI 10.1053/euhj.1998.1194; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Tapp RJ, 2007, ATHEROSCLEROSIS, V190, P84, DOI 10.1016/j.atherosclerosis.2006.02.017; Teo KK, 2006, LANCET, V368, P647, DOI 10.1016/S0140-6736(06)69249-0; Vavra AK, 2009, WOMENS HEALTH, V5, P669, DOI 10.2217/WHE.09.60; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization Regional Office for Europe, 2010, TOB CONTR DAT	30	59	64	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00003	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00003			104	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646555	Green Accepted			2022-12-28	WOS:000291312300002
J	Wisman, R; Heller, J; Clark, P				Wisman, Rosann; Heller, John; Clark, Peggy			A blueprint for country-driven development	LANCET			English	Editorial Material									[Wisman, Rosann] Aspen Inst, Ministerial Leadership Initiat Global Hlth Aspen, Washington, DC 20036 USA; [Heller, John] Synergos Inst, New York, NY USA	Aspen Institute	Wisman, R (corresponding author), Aspen Inst, Ministerial Leadership Initiat Global Hlth Aspen, Washington, DC 20036 USA.	Rosann.Wisman@aspeninst.org						[Anonymous], 2005, PAR DECL AID EFF ACC; DONNELLY J, 2010, MLIS TRAINING NEGOTI; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Ghebreyesus TA, 2010, LANCET, V376, P1127, DOI 10.1016/S0140-6736(10)61465-1; *INT HLTH COMP, 2007, GLOB COMP ACH MILL D; *MIN LEAD IN, 2010, NEP MED TRAIN; *MIN LEAD IN, 2009, MAL SEN JOINT STUD T; *SYN, AFR PUBL HLTH LEAD S	8	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1902	1903		10.1016/S0140-6736(11)60778-2	http://dx.doi.org/10.1016/S0140-6736(11)60778-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21641465				2022-12-28	WOS:000291623200009
J	Khan, AI; Dinh, DM; Schneider, D; Lenski, RE; Cooper, TF				Khan, Aisha I.; Dinh, Duy M.; Schneider, Dominique; Lenski, Richard E.; Cooper, Tim F.			Negative Epistasis Between Beneficial Mutations in an Evolving Bacterial Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; FITNESS LANDSCAPES; RNA VIRUS; ADAPTATION; YEAST; SEX; EVOLVABILITY; GENERATIONS; SELECTION	Epistatic interactions between mutations play a prominent role in evolutionary theories. Many studies have found that epistasis is widespread, but they have rarely considered beneficial mutations. We analyzed the effects of epistasis on fitness for the first five mutations to fix in an experimental population of Escherichia coli. Epistasis depended on the effects of the combined mutations-the larger the expected benefit, the more negative the epistatic effect. Epistasis thus tended to produce diminishing returns with genotype fitness, although interactions involving one particular mutation had the opposite effect. These data support models in which negative epistasis contributes to declining rates of adaptation over time. Sign epistasis was rare in this genome-wide study, in contrast to its prevalence in an earlier study of mutations in a single gene.	[Khan, Aisha I.; Dinh, Duy M.; Cooper, Tim F.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Schneider, Dominique] Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France; [Schneider, Dominique] CNRS, UMR5163, F-38041 Grenoble, France; [Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	University of Houston System; University of Houston; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Michigan State University	Cooper, TF (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	tfcooper@uh.edu	Schneider, Dominique/M-6019-2014	Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375	NSF [DEB-1019989, DEB-0844355]; James S. McDonnell Foundation [220020174]; Agence Nationale de la Recherche [ANR-08-GENM-023-001]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by grants from the NSF (DEB-1019989 to R.E.L. and DEB-0844355 to T.F.C.), the James S. McDonnell Foundation (220020174 to T.F.C.), the Agence Nationale de la Recherche (Program Genomique, Grant ANR-08-GENM-023-001 to D.S.) and the Defense Advanced Research Projects Agency "Fun Bio" Program (HR0011-09-1-0055 to R.E.L. and T.F.C.). We thank R. Azevedo, T. Paixao, and D. Stoebel for valuable discussions and helpful comments on the manuscript. R. E. L. will make the ancestral and evolved strains used in this study available to qualified recipients, subject to completion of a material transfer agreement that can be found at http://technologies.msu.edu/forms.html. T.F.C. will make the strains constructed in this study available to qualified recipients. Competition experiment counts, summary input data, and analysis scripts that pertain to the experiments and analyses reported in this paper have been deposited at http://dx.doi.org/10.5061/dryad.5rv40.	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; Chou HH, 2011, SCIENCE, V332, P1190, DOI 10.1126/science.1203799; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; de Visser JAGM, 2009, AM NAT, V174, pS15, DOI 10.1086/599081; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Jasnos L, 2008, GENETICS, V178, P2105, DOI 10.1534/genetics.107.084533; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; KONDRASHOV AS, 1994, NATURE, V369, P99, DOI 10.1038/369099a0; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Montville R, 2005, PLOS BIOL, V3, P1939, DOI 10.1371/journal.pbio.0030381; Moore FBG, 2000, P ROY SOC B-BIOL SCI, V267, P515, DOI 10.1098/rspb.2000.1030; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2001, EVOLUTION, V55, P1085; Pepin KM, 2007, EVOLUTION, V61, P1710, DOI 10.1111/j.1558-5646.2007.00143.x; Sanjuan R, 2005, GENETICS, V170, P1001, DOI 10.1534/genetics.105.040741; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Silander OK, 2007, PLOS BIOL, V5, P922, DOI 10.1371/journal.pbio.0050094; TRAVISANO M, 1995, EVOLUTION, V49, P189, DOI 10.2307/2410304; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914	36	338	338	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1193	1196		10.1126/science.1203801	http://dx.doi.org/10.1126/science.1203801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636772				2022-12-28	WOS:000291205200047
J	Young, DA; Wright, AP; Roberts, JL; Warner, RC; Young, NW; Greenbaum, JS; Schroeder, DM; Holt, JW; Sugden, DE; Blankenship, DD; van Ommen, TD; Siegert, MJ				Young, Duncan A.; Wright, Andrew P.; Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Sugden, David E.; Blankenship, Donald D.; van Ommen, Tas D.; Siegert, Martin J.			A dynamic early East Antarctic Ice Sheet suggested by ice-covered fjord landscapes	NATURE			English	Article							SOUTHERN VICTORIA LAND; EXOBIOLOGICAL IMPLICATIONS; ALTERNATIVE ORIGIN; NUMERICAL-MODEL; LAKE VOSTOK; MIOCENE; MOUNTAINS; EVOLUTION; ROUGHNESS; EROSION	The first Cenozoic ice sheets initiated in Antarctica from the Gamburtsev Subglacial Mountains(1) and other highlands as a result of rapid global cooling similar to 34 million years ago(2). In the subsequent 20 million years, at a time of declining atmospheric carbon dioxide concentrations(2) and an evolving Antarctic circumpolar current(2), sedimentary sequence interpretation(3) and numerical modelling(4) suggest that cyclical periods of ice-sheet expansion to the continental margin, followed by retreat to the subglacial highlands, occurred up to thirty times. These fluctuations were paced by orbital changes and were a major influence on global sea levels(5). Ice-sheet models show that the nature of such oscillations is critically dependent on the pattern and extent of Antarctic topographic lowlands. Here we show that the basal topography of the Aurora Subglacial Basin of East Antarctica, at present overlain by 2-4.5 km of ice, is characterized by a series of well-defined topographic channels within a mountain block landscape. The identification of this fjord landscape, based on new data from ice-penetrating radar, provides an improved understanding of the topography of the Aurora Subglacial Basin and its surroundings, and reveals a complex surface sculpted by a succession of ice-sheet configurations substantially different from today's. At different stages during its fluctuations, the edge of the East Antarctic Ice Sheet lay pinned along the margins of the Aurora Subglacial Basin, the upland boundaries of which are currently above sea level and the deepest parts of which are more than 1 km below sea level. Although the timing of the channel incision remains uncertain, our results suggest that the fjord landscape was carved by at least two ice-flow regimes of different scales and directions, each of which would have over-deepened existing topographic depressions, reversing valley floor slopes.	[Young, Duncan A.; Greenbaum, Jamin S.; Schroeder, Dustin M.; Holt, John W.; Blankenship, Donald D.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA; [Wright, Andrew P.; Sugden, David E.; Siegert, Martin J.] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Australian Antarctic Div, Kingston, Tas 7050, Australia; [Roberts, Jason L.; Warner, Roland C.; Young, Neal W.; van Ommen, Tas D.] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas 7001, Australia	University of Texas System; University of Texas Austin; University of Edinburgh; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC)	Young, DA (corresponding author), Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA.	duncan@utig.ig.utexas.edu; m.j.siegert@ed.ac.uk	Siegert, Martin/M-9939-2019; Wright, Andrew/HDM-9615-2022; Roberts, Jason L/B-2235-2012; Siegert, Martin J/A-3826-2008; Holt, John/C-4896-2009; van Ommen, Tas D/B-5020-2012; Young, Duncan A./G-6256-2010	Siegert, Martin/0000-0002-0090-4806; Roberts, Jason L/0000-0002-3477-4069; Siegert, Martin J/0000-0002-0090-4806; van Ommen, Tas D/0000-0002-2463-1718; Young, Duncan A./0000-0002-6866-8176; Warner, Roland/0000-0002-9778-3544; Schroeder, Dustin/0000-0003-1916-3929	NSF [ANT-0733025]; NASA [NNX09AR52G]; NERC [NE/D003733/1]; Australian Antarctic Division [3103]; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre; Natural Environment Research Council [NE/F016646/1, NE/E018254/1] Funding Source: researchfish; NERC [NE/F016646/1, NE/E018254/1] Funding Source: UKRI	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Antarctic Division; Jackson School of Geoscience; Jet Propulsion Laboratory; G. Unger Vetlesen Foundation; Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NSF grant ANT-0733025 and NASA grant NNX09AR52G to the University of Texas at Austin, NERC grant NE/D003733/1 to the University of Edinburgh, Australian Antarctic Division project 3103, the Jackson School of Geoscience, and the Jet Propulsion Laboratory, and the G. Unger Vetlesen Foundation. This research was also supported by the Antarctic Climate and Ecosystems Cooperative Research Centre. This is UTIG contribution 2344.	Alley RB, 2003, NATURE, V424, P758, DOI 10.1038/nature01839; Bo S, 2009, NATURE, V459, P690, DOI 10.1038/nature08024; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DREWRY DJ, 1976, TECTONOPHYSICS, V36, P301, DOI 10.1016/0040-1951(76)90023-8; Duxbury NS, 2001, J GEOPHYS RES-PLANET, V106, P1453, DOI 10.1029/2000JE001254; Harwood DM, 2000, ANTARCT SCI, V12, P443; Holtedahl H., 1967, GEOGRAFISKA ANN A, V49, P188, DOI DOI 10.2307/520887; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Jamieson S. S. R., 2007, ANTARCTICA KEYSTONE, P39; Jamieson SSR, 2008, GEOMORPHOLOGY, V97, P91, DOI 10.1016/j.geomorph.2007.02.047; Kessler MA, 2008, NAT GEOSCI, V1, P365, DOI 10.1038/ngeo201; Kleman J, 2008, GEOMORPHOLOGY, V97, P73, DOI 10.1016/j.geomorph.2007.02.049; Le Brocq A. M., 2010, EARTH SYST SCI DATA, V2, P247, DOI [10.5194/essd-2-247-2010, DOI 10.5194/essd-2-247-2010, DOI 10.5194/ESSD-2-247-2010]; Lewis AR, 2007, GEOL SOC AM BULL, V119, P1449, DOI 10.1130/B26134; LOKEN OH, 1971, CAN J EARTH SCI, V8, P185, DOI 10.1139/e71-020; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Marchant DR, 2002, GEOL SOC AM BULL, V114, P718, DOI 10.1130/0016-7606(2002)114<0718:FOPGAS>2.0.CO;2; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Pekar SF, 2006, PALAEOGEOGR PALAEOCL, V231, P101, DOI 10.1016/j.palaeo.2005.07.027; Peters ME, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003222; Roberts J. L., 2011, CRYOSPHERE DISCUSSIO, V5, P655; Shepard MK, 2001, J GEOPHYS RES-PLANET, V106, P32777, DOI 10.1029/2000JE001429; Sieger MJ, 2005, GLOBAL PLANET CHANGE, V45, P249, DOI 10.1016/j.gloplacha.2004.09.008; Siegert M. J., 2001, ICE SHEETS LATE QUAT, P131; Siegert MJ, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002176; Sugden D.E., 1974, I BRIT GEOGRAPHERS S, V7, P177; Summerfield MA, 1999, GEOL SOC SPEC PUBL, V162, P255, DOI 10.1144/GSL.SP.1999.162.01.20; Watson D., 1992, CONTOURING GUIDE ANA, P67; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	131	131	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					72	75		10.1038/nature10114	http://dx.doi.org/10.1038/nature10114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637255				2022-12-28	WOS:000291156700039
J	Wood, AJ; Lo, TW; Zeitler, B; Pickle, CS; Ralston, EJ; Lee, AH; Amora, R; Miller, JC; Leung, E; Meng, XD; Zhang, L; Rebar, EJ; Gregory, PD; Urnov, FD; Meyer, BJ				Wood, Andrew J.; Lo, Te-Wen; Zeitler, Bryan; Pickle, Catherine S.; Ralston, Edward J.; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.; Meyer, Barbara J.			Targeted Genome Editing Across Species Using ZFNs and TALENs	SCIENCE			English	Article									[Wood, Andrew J.; Lo, Te-Wen; Pickle, Catherine S.; Ralston, Edward J.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zeitler, Bryan; Lee, Andrew H.; Amora, Rainier; Miller, Jeffrey C.; Leung, Elo; Meng, Xiangdong; Zhang, Lei; Rebar, Edward J.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA 94804 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Sangamo Therapeutics, Inc.	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Wood, Andrew/0000-0002-0653-2070; Meyer, Barbara/0000-0002-6530-4588; Gregory, Philip/0000-0001-9249-2468	NIH [GM30702]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030702, R01GM030702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.J.W. is a Sir Henry Wellcome Post-Doctoral Fellow. NIH (GM30702) and HHMI funded these studies.	Bogdanove AJ, 2010, CURR OPIN PLANT BIOL, V13, P394, DOI 10.1016/j.pbi.2010.04.010; Meyer BJ, 2010, CURR OPIN GENET DEV, V20, P179, DOI 10.1016/j.gde.2010.03.008; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	5	441	613	4	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 15	2011	333	6040					307	307		10.1126/science.1207773	http://dx.doi.org/10.1126/science.1207773			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21700836	Green Accepted			2022-12-28	WOS:000292732000032
J	Karakas, E; Simorowski, N; Furukawa, H				Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro			Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors	NATURE			English	Article							AMINO-TERMINAL DOMAIN; D-ASPARTATE RECEPTOR; NR2B SUBUNIT; GLUTAMATE RECEPTORS; CRYSTAL-STRUCTURE; IFENPRODIL; MECHANISMS; SOFTWARE; PROTEIN; MODELS	Since it was discovered that the anti-hypertensive agent ifenprodil has neuroprotective activity through its effects on NMDA (N-methyl-D-aspartate) receptors(1), a determined effort has been made to understand the mechanism of action and to develop improved therapeutic compounds on the basis of this knowledge(2-4). Neurotransmission mediated by NMDA receptors is essential for basic brain development and function(5). These receptors form heteromeric ion channels and become activated after concurrent binding of glycine and glutamate to the GluN1 and GluN2 subunits, respectively. A functional hallmark of NMDA receptors is that their ion-channel activity is allosterically regulated by binding of small compounds to the amino-terminal domain (ATD) in a subtype-specific manner. Ifenprodil and related phenylethanolamine compounds, which specifically inhibit GluN1 and GluN2B NMDA receptors(6,7), have been intensely studied for their potential use in the treatment of various neurological disorders and diseases, including depression, Alzheimer's disease and Parkinson's disease(2,4). Despite considerable enthusiasm, mechanisms underlying the recognition of phenylethanolamines and ATD-mediated allosteric inhibition remain limited owing to a lack of structural information. Here we report that the GluN1 and GluN2B ATDs forma heterodimer and that phenylethanolamine binds at the interface between GluN1 and GluN2B, rather than within the GluN2B cleft. The crystal structure of the heterodimer formed between the GluN1b ATD from Xenopus laevis and the GluN2B ATD from Rattus norvegicus shows a highly distinct pattern of subunit arrangement that is different from the arrangements observed in homodimeric non-NMDA receptors and reveals the molecular determinants for phenylethanolamine binding. Restriction of domain movement in the bi-lobed structure of the GluN2B ATD, by engineering of an inter-subunit disulphide bond, markedly decreases sensitivity to ifenprodil, indicating that conformational freedom in the GluN2B ATD is essential for ifenprodil-mediated allosteric inhibition of NMDA receptors. These findings pave the way for improving the design of subtype-specific compounds with therapeutic value for neurological disorders and diseases.	[Karakas, Erkan; Simorowski, Noriko; Furukawa, Hiro] WM Keck Struct Biol Lab, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Furukawa, H (corresponding author), WM Keck Struct Biol Lab, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	furukawa@cshl.edu			NIH [MH085926]; Alzheimer's Association; Fox family; NARSAD; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Fox family; NARSAD(NARSAD); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the staff at X25 and X29 at the National Synchrotron Light Source for beamline support. M. Mayer is thanked for comments on this work. We also thank D. Raleigh for the use of analytical ultracentrifugation. GluN1 clones from Xenopus laevis were gifts from M. Hollmann and H. Cline. This work was supported by NIH MH085926, the Alzheimer's Association and a donation from the Fox family (to H.F.). H.F. was also funded by a scientist development grant from the American Heart Association. E.K. is supported by a NARSAD Lieber Young Investigator Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewald RC, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.004.2009; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gallagher MJ, 1996, J BIOL CHEM, V271, P9603, DOI 10.1074/jbc.271.16.9603; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Koller M, 2010, EXPERT OPIN THER PAT, V20, P1683, DOI 10.1517/13543776.2010.533656; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Lee C. H., 2011, PLOS ONE, V6, pe19181; Malherbe P, 2003, J PHARMACOL EXP THER, V307, P897, DOI 10.1124/jpet.103.056291; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Schmidt C, 2009, MOL CELL NEUROSCI, V42, P116, DOI 10.1016/j.mcn.2009.06.004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851	29	247	255	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					249	U170		10.1038/nature10180	http://dx.doi.org/10.1038/nature10180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21677647	Green Accepted			2022-12-28	WOS:000292690500055
J	Autry, AE; Adachi, M; Nosyreva, E; Na, ES; Los, MF; Cheng, PF; Kavalali, ET; Monteggia, LM				Autry, Anita E.; Adachi, Megunai; Nosyreva, Elena; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Kavalali, Ege T.; Monteggia, Lisa M.			NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses	NATURE			English	Article							NEUROTROPHIC FACTOR; PROTEIN-SYNTHESIS; PRESYNAPTIC FUNCTION; DEPRESSION; KETAMINE; BDNF; NEUROTRANSMISSION; MODELS; PHARMACOKINETICS; ANTAGONIST	Clinical studies consistently demonstrate that a single sub-psychomimetic dose of ketamine, an ionotropic glutamatergic NMDAR (N-methyl-D-aspartate receptor) antagonist, produces fast-acting antidepressant responses in patients suffering from major depressive disorder, although the underlying mechanism is unclear(1-3). Depressed patients report the alleviation of major depressive disorder symptoms within two hours of a single, low-dose intravenous infusion of ketamine, with effects lasting up to two weeks(1-3), unlike traditional antidepressants (serotonin re-uptake inhibitors), which take weeks to reach efficacy. This delay is a major drawback to current therapies for major depressive disorder and faster-acting antidepressants are needed, particularly for suicide-risk patients'. The ability of ketamine to produce rapidly acting, long-lasting antidepressant responses in depressed patients provides a unique opportunity to investigate underlying cellular mechanisms. Here we show that ketamine and other NMDAR antagonists produce fast-acting behavioural antidepressant-like effects in mouse models, and that these effects depend on the rapid synthesis of brain-derived neurotrophic factor. We find that the ketamine-mediated blockade of NMDAR at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase (also called CaMKIII), resulting in reduced eEF2 phosphorylation and de-suppression of translation of brain-derived neurotrophic factor. Furthermore, we find that inhibitors of eEF2 kinase induce fast-acting behavioural antidepressant-like effects. Our findings indicate that the regulation of protein synthesis by spontaneous neurotransmission may serve as a viable therapeutic target for the development of fast-acting antidepressants.	[Autry, Anita E.; Adachi, Megunai; Na, Elisa S.; Los, Maarten F.; Cheng, Peng-fei; Monteggia, Lisa M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Nosyreva, Elena; Kavalali, Ege T.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kavalali, ET (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	ege.kavalali@utsouthwestern.edu	Adachi, Megumi/M-7746-2017; Autry, Anita/ABF-9006-2021; Ferrua, Camila/F-5439-2015	Adachi, Megumi/0000-0003-3404-6640; Ferrua, Camila/0000-0001-8071-377X; Na, Elisa/0000-0001-7236-9868	UT Southwestern Medical Center;  [MH070727];  [MH066198];  [T32 MH 76690-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066198, T32MH076690, R01MH070727] Funding Source: NIH RePORTER	UT Southwestern Medical Center; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. A. Mahgoub for assistance with the animal experiments, S. Birnbaum and A Pettersen for assistance with the behavioural testing and members of the Monteggia and Kavalali laboratories for discussions and cornments on the manuscript. This work was supported by grant MH070727 (L.M.M.), grant MH066198 (E.T.K.) and the Division of Basic Sciences Training Program at UT Southwestern Medical Center, T32 MH 76690-02 (A.E.A.). E.T.K. is an Established Investigator of the American Heart Association.	Adachi M, 2008, BIOL PSYCHIAT, V63, P642, DOI 10.1016/j.biopsych.2007.09.019; Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Atasoy D, 2008, J NEUROSCI, V28, P10151, DOI 10.1523/JNEUROSCI.2432-08.2008; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Capasso A, 1996, GEN PHARMACOL, V27, P707, DOI 10.1016/0306-3623(95)02077-2; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Cleary C, 2008, BRAIN RES BULL, V76, P469, DOI 10.1016/j.brainresbull.2008.03.005; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Espinosa F, 2009, J NEUROPHYSIOL, V101, P2290, DOI 10.1152/jn.90754.2008; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Hoshaw BA, 2005, BRAIN RES, V1037, P204, DOI 10.1016/j.brainres.2005.01.007; Jakawich SK, 2010, NEURON, V68, P1143, DOI 10.1016/j.neuron.2010.11.034; Kavalali ET, 2011, PHYSIOLOGY, V26, P45, DOI 10.1152/physiol.00040.2010; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; KRISTENSEN JD, 1995, BRIT J ANAESTH, V74, P193, DOI 10.1093/bja/74.2.193; Lattal KM, 2001, J NEUROSCI, V21, P5773, DOI 10.1523/JNEUROSCI.21-15-05773.2001; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lindskog M, 2010, P NATL ACAD SCI USA, V107, P21806, DOI 10.1073/pnas.1016399107; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Poleszak E, 2007, PHARMACOL BIOCHEM BE, V88, P158, DOI 10.1016/j.pbb.2007.07.018; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; SCHWARTZ PH, 1991, RES COMMUN CHEM PATH, V73, P181; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Sutton MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.265pe19; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	33	1233	1296	9	307	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 7	2011	475	7354					91	U109		10.1038/nature10130	http://dx.doi.org/10.1038/nature10130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677641	Green Accepted			2022-12-28	WOS:000292461300051
J	de Jager, M; Weissing, FJ; Herman, PMJ; Nolet, BA; van de Koppel, J				de Jager, Monique; Weissing, Franz J.; Herman, Peter M. J.; Nolet, Bart A.; van de Koppel, Johan			Levy Walks Evolve Through Interaction Between Movement and Environmental Complexity	SCIENCE			English	Article							RANDOM SEARCHES; PATTERNS; ANIMALS; STRATEGIES; FLIGHTS; SUCCESS	Ecological theory predicts that animal movement is shaped by its efficiency of resource acquisition. Focusing solely on efficiency, however, ignores the fact that animal activity can affect resource availability and distribution. Here, we show that feedback between individual behavior and environmental complexity can explain movement strategies in mussels. Specifically, experiments show that mussels use a Levy walk during the formation of spatially patterned beds, and models reveal that this Levy movement accelerates pattern formation. The emergent patterning in mussel beds, in turn, improves individual fitness. These results suggest that Levy walks evolved as a result of the selective advantage conferred by autonomously generated, emergent spatial patterns in mussel beds. Our results emphasize that an interaction between individual selection and habitat complexity shapes animal movement in natural systems.	[de Jager, Monique; Herman, Peter M. J.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, NL-4400 AC Yerseke, Netherlands; [Weissing, Franz J.] Univ Groningen, Theoret Biol Grp, Ctr Ecol & Evolutionary Studies, NL-9747 AG Groningen, Netherlands; [Nolet, Bart A.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Nolet, Bart A.; van de Koppel, Johan] Netherlands Inst Ecol NIOO KNAW, Project Grp Movement Ecol, NL-6700 AB Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	de Jager, M (corresponding author), Netherlands Inst Ecol NIOO KNAW, Spatial Ecol Dept, POB 140, NL-4400 AC Yerseke, Netherlands.	m.dejager@nioo.knaw.nl	Van de Koppel, Johan/E-7266-2010; Nolet, Bart A/C-1416-2008; de Jager, Monique/ABC-8594-2020; Herman, Peter M.J./A-9018-2011	Nolet, Bart A/0000-0002-7437-4879; Herman, Peter M.J./0000-0003-2188-6341; de Jager, Monique/0000-0001-5271-6957; Weissing, Franz J./0000-0003-3281-663X	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW); KNAW	Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); KNAW	For assistance, we thank S. Benhamou, A. Kolzsch, J. Powell, G. Theraulaz, W. Mooij, A. van den Berg, and J. van Soelen. We thank S. Kefi, F. Bartumeus, B. Silliman, and M. Rietkerk for comments on manuscript drafts. M.d.J. and J.v.d.K. designed the study. Experimental data were collected by M.d.J. and J.v.d.K. B.A.N. introduced the topic of Levy walks, and F.J.W. suggested the evolutionary invasion analysis. All analyses and modeling were done by M.d.J., assisted by J.v.d.K., P.M.J.H., and F.J.W. The paper was written by M.d.J. and J.v.d.K., and all authors contributed to the subsequent drafts. The authors declare no competing financial interests. M.d.J. is supported by a grant from the Netherlands Organization of Scientific Research-Earth and Life Sciences (NWO-ALW), and Project Group Movement Ecology by the KNAW Strategic Fund. This is publication 5033 of the Netherlands Institute of Ecology (NIOO-KNAW).	Adler PB, 2001, OECOLOGIA, V128, P465, DOI 10.1007/s004420100737; Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2009, OIKOS, V118, P488, DOI 10.1111/j.1600-0706.2009.17313.x; Benhamou S, 2008, ECOLOGY, V89, P2351, DOI 10.1890/08-0313.1; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434014; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dercole F, 2008, PRINC SER THEOR COMP, P1; Geesteranus R. A. M., 1942, Archives Neerlandaises de Zoologie, V6, P283; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Hauert C, 2006, ADV COMPLEX SYST, V9, P315, DOI 10.1142/S0219525906000847; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Nolet BA, 2002, J ANIM ECOL, V71, P451, DOI 10.1046/j.1365-2656.2002.00610.x; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; van de Koppel J, 2005, AM NAT, V165, pE66; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6	25	194	195	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1551	1553		10.1126/science.1201187	http://dx.doi.org/10.1126/science.1201187			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700872	Green Published, Green Submitted			2022-12-28	WOS:000291990000043
J	Grunbaum, D				Gruenbaum, Daniel			Why Did You Levy?	SCIENCE			English	Editorial Material							MOVEMENT		[Gruenbaum, Daniel] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Grunbaum, D (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	grunbaum@ocean.washington.edu						Carrington E, 2008, TRENDS BIOTECHNOL, V26, P55, DOI 10.1016/j.tibtech.2007.11.003; Carrington E, 2008, INTEGR COMP BIOL, V48, P801, DOI 10.1093/icb/icn078; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Giuggioli L, 2010, J ANIM ECOL, V79, P906, DOI 10.1111/j.1365-2656.2010.01682.x; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Ritchie M.E., 2010, SCALE HETEROGENEITY; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952	7	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1514	1515		10.1126/science.1208445	http://dx.doi.org/10.1126/science.1208445			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700863				2022-12-28	WOS:000291990000032
J	Xie, C; Tinker, R; Tinker, B; Pallant, A; Damelin, D; Berenfeld, B				Xie, Charles; Tinker, Robert; Tinker, Barbara; Pallant, Amy; Damelin, Daniel; Berenfeld, Boris			Computational Experiments for Science Education	SCIENCE			English	Editorial Material									[Xie, Charles; Tinker, Robert; Tinker, Barbara; Pallant, Amy; Damelin, Daniel; Berenfeld, Boris] Concord Consortium, Concord, MA 01742 USA		Xie, C (corresponding author), Concord Consortium, Concord, MA 01742 USA.	qxie@concord.org		Xie, Charles/0000-0002-1178-8361				Bridson R, 2010, SCIENCE, V330, P1756, DOI 10.1126/science.1198769; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; Finkelstein ND, 2005, PHYS REV SPEC TOP-PH, V1, DOI 10.1103/PhysRevSTPER.1.010101; Kafai YB., 2006, GAMES CULT, V1, P36, DOI [10.1177/1555412005281767, DOI 10.1177/1555412005281767]; Klahr D, 2007, J RES SCI TEACH, V44, P183, DOI 10.1002/tea.20152; Leach A., 2001, MOL MODELLING PRINCI; National Research Council, CONC FRAM NEW SCI ED; Pryor R.W., 2009, MULTIPHYSICS MODELIN; RAPPAPORT DC, 1997, ART MOL DYNAMICS SIM; Schmidt W., 1997, SPLINTERED VISION IN; Watanabe N, 2000, PHYS REV E, V62, P2914, DOI 10.1103/PhysRevE.62.2914	11	25	26	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1516	1517		10.1126/science.1197314	http://dx.doi.org/10.1126/science.1197314			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782EE	21700864				2022-12-28	WOS:000291990000033
J	Patel, MJ; Newby, LK				Patel, Mahesh J.; Newby, L. Kristin			Review: Counseling and educational methods that target multiple CV risk factors do not reduce mortality in adults without CHD	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Patel, Mahesh J.; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27710 USA	Duke University	Patel, MJ (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.							Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; ROSE G, 1986, LANCET, V1, P869	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-4	10.7326/0003-4819-154-12-201106210-02004	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690582				2022-12-28	WOS:000291800500003
J	James, SK; Roe, MT; Cannon, CP; Cornel, JH; Horrow, J; Husted, S; Katus, H; Morais, J; Steg, PG; Storey, RF; Stevens, S; Wallentin, L; Harrington, RA				James, Stefan K.; Roe, Matthew T.; Cannon, Christopher P.; Cornel, Jan H.; Horrow, Jay; Husted, Steen; Katus, Hugo; Morais, Joao; Steg, Ph Gabriel; Storey, Robert F.; Stevens, Susanna; Wallentin, Lars; Harrington, Robert A.			Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ST-SEGMENT ELEVATION; MEDICAL-MANAGEMENT; INVASIVE STRATEGY; REVASCULARIZATION; ABCIXIMAB	Objective To evaluate efficacy and safety outcomes in patients in the PLATelet inhibition and patient Outcomes (PLATO) trial who at randomisation were planned for a non-invasive treatment strategy. Design Pre-specified analysis of pre-randomisation defined subgroup of prospective randomised clinical trial. Setting 862 centres in 43 countries. Participants 5216 (28%) of 18 624 patients admitted to hospital for acute coronary syndrome who were specified as planned for non-invasive management. Interventions Randomised treatment with ticagrelor (n=2601) versus clopidogrel (2615). Main outcome measurements Primary composite end point of cardiovascular death, myocardial infarction, and stroke; their individual components; and PLATO defined major bleeding during one year. Results 2183 (41.9%) patients had coronary angiography during their initial hospital admission, 1065 (20.4%) had percutaneous coronary intervention, and 208 (4.0%) had coronary artery bypass surgery. Cumulatively, 3143 (60.3%) patients had been managed non-invasively by the end of follow-up. The incidence of the primary end point was lower with ticagrelor than with clopidogrel (12.0% (n=295) v 14.3% (346); hazard ratio 0.85, 95% confidence interval 0.73 to 1.00; P=0.04). Overall mortality was also lower (6.1% (147) v 8.2% (195); 0.75, 0.61 to 0.93; P=0.01). The incidence of total major bleeding (11.9% (272) v 10.3% (238); 1.17, 0.98 to 1.39; P=0.08) and non-coronary artery bypass grafting related major bleeding (4.0% (90) v 3.1% (71); 1.30, 0.95 to 1.77; P=0.10) was numerically higher with ticagrelor than with clopidogrel. Conclusions In patients with acute coronary syndrome initially intended for non-invasive management, the benefits of ticagrelor over clopidogrel were consistent with those from the overall PLATO results, indicating the broad benefits of P2Y12 inhibition with ticagrelor regardless of intended management strategy.	[James, Stefan K.; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [Roe, Matthew T.; Stevens, Susanna; Harrington, Robert A.] Duke Clin Res Inst, Durham, NC USA; [Cannon, Christopher P.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Cornel, Jan H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Horrow, Jay] AstraZeneca R&D, Global Med Dev, Wilmington, DE USA; [Husted, Steen] Arhus Univ Hosp, Dept Cardiol, Thrombosis Unit, Aarhus, Denmark; [Katus, Hugo] Univ Klinikum Heidelberg, Med Klin, Dept Internal Med, Heidelberg, Germany; [Morais, Joao] Santo Andres Hosp, Leiria, Portugal; [Steg, Ph Gabriel] INSERM, U698, Paris, France; [Steg, Ph Gabriel] Univ Paris 07, Paris, France; [Steg, Ph Gabriel] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England	Uppsala University; Duke University; Harvard University; Brigham & Women's Hospital; Medical Center Of Alkmaar; AstraZeneca; Aarhus University; Ruprecht Karls University Heidelberg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sheffield	James, SK (corresponding author), Uppsala Univ, Uppsala Clin Res Ctr, Dag Hammarskjolds Vag 50A,MTC Huset,Sci Pk,Box 63, S-75185 Uppsala, Sweden.	Stefan.James@ucr.uu.se	James, Stefan K/J-4554-2014; cornel, jan hein/Y-7065-2019; Storey, Robert/AAA-6853-2019; STEG, Philippe Gabriel/Z-1567-2019; Cannon, Christopher P/AAY-7644-2020	cornel, jan hein/0000-0002-1006-2112; Cannon, Christopher P/0000-0003-4596-2791; Morais, Joao/0000-0003-3406-2878; STEG, Philippe Gabriel/0000-0001-6896-2941; Storey, Robert/0000-0002-6677-6229	AstraZeneca; Eli Lilly; Bristol-Myers Squibb; Sanofi-Aventis; Merck/Schering-Plough; GlaxoSmithKline; Novartis; Accumetrics; Intekrin Therapeutics; Merck; Takeda; Pfizer; Bayer; Daiichi; Sankoy; Roche; Daiichi Sankyo; MSD/Schering-Plough; Servier; Astellas; Daiichi/Sankyo/Eli Lilly alliance; Medtronic; Otsuka Pharmaceutical; Medicines Company; Dynabyte; Eli Lilly/Daiichi Sankyo alliance; Sanofi-Aventis/Bristol-Myers Squibb; Regado Biotechnologies; Athera Biotechnologies; Portola Pharmaceutical; Portola	AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis); Merck/Schering-Plough(Merck & CompanySchering Plough Corporation); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Accumetrics; Intekrin Therapeutics; Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); Pfizer(Pfizer); Bayer(Bayer AG); Daiichi(Daiichi Sankyo Company Limited); Sankoy; Roche(Roche Holding); Daiichi Sankyo(Daiichi Sankyo Company Limited); MSD/Schering-Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); Astellas(Astellas Pharmaceuticals); Daiichi/Sankyo/Eli Lilly alliance(Daiichi Sankyo Company Limited); Medtronic(Medtronic); Otsuka Pharmaceutical(Otsuka Pharmaceutical); Medicines Company; Dynabyte; Eli Lilly/Daiichi Sankyo alliance(Eli Lilly); Sanofi-Aventis/Bristol-Myers Squibb(Sanofi-AventisBristol-Myers Squibb); Regado Biotechnologies; Athera Biotechnologies; Portola Pharmaceutical; Portola	This work was supported by AstraZeneca, who funded the PLATO trial. Representatives of the sponsor were involved in study design; data gathering, analysis, and interpretation; and revision of the report. Support for the analysis and interpretation of results and preparation of the manuscript was provided through funds to the Uppsala Clinical Research Center and Duke Clinical Research Institute as part of the clinical study agreement.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author). SKJ declares research grants and advisory board fees from AstraZeneca and honorariums from AstraZeneca, Bristol-Myers Squibb, Schering-Plough, Merck, and Eli-Lilly. MTR declares research grants from Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, and Merck/Schering-Plough; consulting fees or honorariums from GlaxoSmithKline, Novartis, Eli Lilly, Bristol-Myers Squibb, Sanofi-Aventis, Merck/Schering-Plough, and AstraZeneca. CPC receives research grants/support from Accumetrics, AstraZeneca, Glaxo-SmithKline, Intekrin Therapeutics, Merck, and Takeda; has served on advisory boards for Bristol-Myers Squibb/Sanofi-Aventis, Novartis, and Alnyam (but donates funds to charity); receives honorariums for development of independent educational symposiums from Pfizer and AstraZeneca; and is a clinical adviser for and holds equity in Automedics Medical Systems. JHC declares consulting fees from Eli Lilly and Pfizer. JH is an employee of AstraZeneca and has equity ownership in AstraZeneca. SH declares research grants from AstraZeneca, Bristol-Myers Squibb, Pfizer, and Bayer and consultant fees from Sanofi-Aventis, Pfizer, and AstraZeneca. HK declares consulting and lecture fees from AstraZeneca., Bayer, Daiichi, Sankoy, and Roche. JM declares research grants from AstraZeneca, Bayer, Daiichi Sankyo, MSD/Schering-Plough, and Eli Lilly. PGS declares research grants from Servier; consultant fees from/advisory board membership for Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi/Sankyo/Eli Lilly alliance, GlaxoSmithKline, Medtronic, Merck, Otsuka Pharmaceutical, Roche, Sanofi-Aventis, Servier, and the Medicines Company; and having equity ownership in Aterovax. RFS declares institutional grants from AstraZeneca, Dynabyte, Eli Lilly/Daiichi Sankyo alliance, Merck/Schering-Plough, and Accumetrics; honorariums from AstraZeneca, Eli Lilly/Daiichi Sankyo alliance, Novartis, Medscape, GlaxoSmithKline, and Merck/Schering-Plough; consultant fees from AstraZeneca, Eli Lilly/Daiichi Sankyo alliance, Merck/Schering-Plough, Novartis, Sanofi-Aventis/Bristol-Myers Squibb, the Medicines Company, and Accumetrics; travel support from AstraZeneca, Eli Lilly/Daiichi Sankyo alliance, and Merck/Schering-Plough. LW reports research grants from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, and Schering-Plough; honorariums from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Schering-Plough, and Eli Lilly; consultant fees from Regado Biotechnologies, Athera Biotechnologies, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, and Eli Lilly; and lecture fees from AstraZeneca, Boehringer Ingelheim, and Eli Lilly. RAH reports advisory board fees from Novartis, Portola Pharmaceutical, and Merck; consulting fees from AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Portola, and Sanofi-Aventis; honorariums/lecture fees from Eli Lilly, Merck, and AstraZeneca; grant support from AstraZeneca, Bristol-Myers Squibb, Portola Pharmaceutical, and Merck; travel support from AstraZeneca, Novartis, and Merck; and potential grant support from the Medicines Company.	Amsterdam EA, 2009, AM HEART J, V158, P748, DOI 10.1016/j.ahj.2009.09.008; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Araujo JODF, 2004, AM HEART J, V148, P937, DOI 10.1016/j.ahj/2004.05.047; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Budaj A, 2002, CIRCULATION, V106, P1622, DOI 10.1161/01.CIR.0000029926.71825.E2; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Chan MY, 2008, AM HEART J, V155, P397, DOI 10.1016/j.ahj.2007.11.014; Chan MY, 2008, JACC-CARDIOVASC INTE, V1, P369, DOI 10.1016/j.jcin.2008.03.019; Cohen MG, 2009, AM HEART J, V158, P263, DOI 10.1016/j.ahj.2009.05.016; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Hirsch A, 2009, EUR HEART J, V30, P645, DOI 10.1093/eurheartj/ehn438; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Ottervanger JP, 2004, EUR HEART J, V25, P1494, DOI 10.1016/j.ehj.2004.07.004; Simoons ML, 2001, LANCET, V357, P1915; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Yusuf S, 2003, CIRCULATION, V107, P966, DOI 10.1161/01.CIR.0000051362.96946.15	17	192	206	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2011	342								d3527	10.1136/bmj.d3527	http://dx.doi.org/10.1136/bmj.d3527			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LH	21685437	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000291933200003
J	Liu, N; Hentschel, M; Weiss, T; Alivisatos, AP; Giessen, H				Liu, Na; Hentschel, Mario; Weiss, Thomas; Alivisatos, A. Paul; Giessen, Harald			Three-Dimensional Plasmon Rulers	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; GOLD NANOPARTICLES; MOLECULAR RULER; DNA; ANALOG; METAMATERIALS; DESIGN	Plasmon rulers can be used to determine nanoscale distances within chemical or biological species. They are based on the spectral shift of the scattering spectrum when two plasmonic nanoparticles approach one another. However, the one-dimensionality of current plasmon rulers hampers the comprehensive understanding of many intriguing processes in soft matter, which take place in three dimensions. We demonstrated a three-dimensional plasmon ruler that is based on coupled plasmonic oligomers in combination with high-resolution plasmon spectroscopy. This enables retrieval of the complete spatial configuration of complex macromolecular and biological processes as well as their dynamic evolution.	[Liu, Na; Alivisatos, A. Paul] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Liu, Na; Alivisatos, A. Paul] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Inst Phys 4, D-70569 Stuttgart, Germany; [Hentschel, Mario; Weiss, Thomas; Giessen, Harald] Univ Stuttgart, Res Ctr Scope, D-70569 Stuttgart, Germany; [Weiss, Thomas] Univ Clermont Ferrand, LASMEA, F-63177 Clermont Ferrand, France	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Stuttgart; University of Stuttgart	Liu, N (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	nliu@lbl.gov	Alivisatos, Paul/N-8863-2015; Liu, Na/C-8190-2014; Weiss, Thomas/AAS-9946-2021; Hentschel, Mario/N-2093-2015; Giessen, Harald/AAG-7586-2019	Alivisatos, Paul/0000-0001-6895-9048; Liu, Na/0000-0001-5831-3382; Weiss, Thomas/0000-0002-4991-6779; Giessen, Harald/0000-0002-4270-3850; Hentschel, Mario/0000-0002-6882-4183	NIH [NIH NOT-OD-09-056]; Deutsche Forschungsgemeinschaft (DFG) [SPP1391, FOR557, GI 269/11-1]; German Ministry of Science [13N9048, 13N10146]; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Science; Landesstiftung B; Deutsch-Franzosische Hochschule-Universite franco-allemande	We thank T. Pfau and M. Dressel for useful discussions and comments and S. Hein for his material visualizations. N.L. and A.P.A. were supported by the NIH Plasmon Rulers Project, grant NIH NOT-OD-09-056. M.H., T.W., and H.G. were financially supported by the Deutsche Forschungsgemeinschaft (DFG) (grants SPP1391 and FOR557), by The German Ministry of Science (grants 13N9048 and 13N10146), and by Landesstiftung B. W.T.W. were also supported by the DFG (grant GI 269/11-1) and by Deutsch-Franzosische Hochschule-Universite franco-allemande.	Alzar CLG, 2002, AM J PHYS, V70, P37, DOI 10.1119/1.1412644; Cigler P, 2010, NAT MATER, V9, P918, DOI [10.1038/NMAT2877, 10.1038/nmat2877]; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Granet G, 2002, J OPT A-PURE APPL OP, V4, pS145, DOI 10.1088/1464-4258/4/5/362; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hentschel M, 2010, NANO LETT, V10, P2721, DOI 10.1021/nl101938p; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Jun YW, 2009, P NATL ACAD SCI USA, V106, P17735, DOI 10.1073/pnas.0907367106; Lassiter JB, 2010, NANO LETT, V10, P3184, DOI 10.1021/nl102108u; Liu GL, 2006, NAT NANOTECHNOL, V1, P47, DOI 10.1038/nnano.2006.51; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Liu N, 2010, NANO LETT, V10, P1103, DOI 10.1021/nl902621d; Liu N, 2009, NAT MATER, V8, P758, DOI [10.1038/NMAT2495, 10.1038/nmat2495]; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Mastroianni AJ, 2009, J AM CHEM SOC, V131, P8455, DOI 10.1021/ja808570g; ORDAL MA, 1983, APPL OPTICS, V22, P1099, DOI 10.1364/AO.22.001099; Papasimakis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253903; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Sonnichsen C, 2005, NANO LETT, V5, P301, DOI 10.1021/nl048089k; Sonnichsen C, 2005, NAT BIOTECHNOL, V23, P741, DOI 10.1038/nbt1100; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Tan SJ, 2011, NAT NANOTECHNOL, V6, P268, DOI [10.1038/nnano.2011.49, 10.1038/NNANO.2011.49]; Tassin P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.053901; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Xu H, 2010, OPT EXPRESS, V18, P17736, DOI 10.1364/OE.18.017736; Zhang S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047401; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	29	484	490	15	431	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1407	1410		10.1126/science.1199958	http://dx.doi.org/10.1126/science.1199958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680838				2022-12-28	WOS:000291689000035
J	Song, CL; Wang, YL; Cheng, P; Jiang, YP; Li, W; Zhang, T; Li, Z; He, K; Wang, LL; Jia, JF; Hung, HH; Wu, CJ; Ma, XC; Chen, X; Xue, QK				Song, Can-Li; Wang, Yi-Lin; Cheng, Peng; Jiang, Ye-Ping; Li, Wei; Zhang, Tong; Li, Zhi; He, Ke; Wang, Lili; Jia, Jin-Feng; Hung, Hsiang-Hsuan; Wu, Congjun; Ma, Xucun; Chen, Xi; Xue, Qi-Kun			Direct Observation of Nodes and Twofold Symmetry in FeSe Superconductor	SCIENCE			English	Article							VORTEX-CORE; DENSITY; STATES	We investigated the electron-pairing mechanism in an iron-based superconductor, iron selenide (FeSe), using scanning tunneling microscopy and spectroscopy. Tunneling conductance spectra of stoichiometric FeSe crystalline films in their superconducting state revealed evidence for a gap function with nodal lines. Electron pairing with twofold symmetry was demonstrated by direct imaging of quasiparticle excitations in the vicinity of magnetic vortex cores, Fe adatoms, and Se vacancies. The twofold pairing symmetry was further supported by the observation of striped electronic nanostructures in the slightly Se-doped samples. The anisotropy can be explained in terms of the orbital-dependent reconstruction of electronic structure in FeSe.	[Song, Can-Li; Wang, Yi-Lin; Jiang, Ye-Ping; Zhang, Tong; Li, Zhi; He, Ke; Wang, Lili; Ma, Xucun; Xue, Qi-Kun] Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China; [Song, Can-Li; Cheng, Peng; Jiang, Ye-Ping; Li, Wei; Zhang, Tong; Jia, Jin-Feng; Chen, Xi; Xue, Qi-Kun] Tsinghua Univ, Dept Phys, State Key Lab Low Dimens Quantum Phys, Beijing 100084, Peoples R China; [Hung, Hsiang-Hsuan; Wu, Congjun] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA	Chinese Academy of Sciences; Institute of Physics, CAS; Tsinghua University; University of California System; University of California San Diego	Ma, XC (corresponding author), Chinese Acad Sci, Inst Phys, Beijing 100190, Peoples R China.	xcma@aphy.iphy.ac.cn; xc@mail.tsinghua.edu.cn	Wang, Lili/C-4156-2014; Wang, Yilin/B-5845-2014; Jia, Jinfeng/O-2356-2015; Song, Can-Li/L-9337-2013; Zhang, Tong/A-7122-2019; Li, zhi/L-3081-2017; Wu, Congjun/L-1750-2015; HE, KE/G-7538-2011	Wang, Lili/0000-0001-6035-1660; Jia, Jinfeng/0000-0002-9900-281X; Song, Can-Li/0000-0003-3482-6161; Li, zhi/0000-0002-2211-2092; Song, Can-Li/0000-0002-4985-0968	National Science Foundation; Ministry of Science and Technology of China; U.S. Army Research Office [W911NF0810291]	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); U.S. Army Research Office	We thank J. P. Hu, T. Xiang, and X. Dai for helpful discussions. The work was financially supported by National Science Foundation and Ministry of Science and Technology of China. C.J.W. and H.-H.H. are supported by U.S. Army Research Office under award W911NF0810291.	Bang Y, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054529; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Chen CT, 2010, NAT PHYS, V6, P260, DOI 10.1038/NPHYS1531; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Dong JK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.087005; Fischer O, 2007, REV MOD PHYS, V79, P353, DOI 10.1103/RevModPhys.79.353; Fletcher JD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147001; Graser S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025016; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hayashi N, 1996, PHYS REV LETT, V77, P4074, DOI 10.1103/PhysRevLett.77.4074; HESS HF, 1990, PHYS REV LETT, V64, P2711, DOI 10.1103/PhysRevLett.64.2711; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Johnston DC, 2010, ADV PHYS, V59, P803, DOI 10.1080/00018732.2010.513480; Kuroki K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224511; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; McQueen TM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057002; Medvedev S, 2009, NAT MATER, V8, P630, DOI [10.1038/NMAT2491, 10.1038/nmat2491]; Michioka C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064506; Reid JP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064501; Shimojima T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057002; SHORE JD, 1989, PHYS REV LETT, V62, P3089, DOI 10.1103/PhysRevLett.62.3089; Subedi A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134514; Yin Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.097002; Zhang XH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147002	28	330	340	17	443	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1410	1413		10.1126/science.1202226	http://dx.doi.org/10.1126/science.1202226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680839	Green Submitted			2022-12-28	WOS:000291689000036
J	Dorner, M; Horwitz, JA; Robbins, JB; Barry, WT; Feng, Q; Mu, K; Jones, CT; Schoggins, JW; Catanese, MT; Burton, DR; Law, M; Rice, CM; Ploss, A				Dorner, Marcus; Horwitz, Joshua A.; Robbins, Justin B.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Burton, Dennis R.; Law, Mansun; Rice, Charles M.; Ploss, Alexander			A genetically humanized mouse model for hepatitis C virus infection	NATURE			English	Article							B TYPE-I; HUMAN LIVER; REPLICATION; RECEPTOR; ANTIBODIES; FIBROBLASTS; REVEALS; VITRO; MICE; CD81	Hepatitis C virus (HCV) remains a major medical problem. Antiviral treatment is only partially effective and a vaccine does not exist. Development of more effective therapies has been hampered by the lack of a suitable small animal model. Although xenotransplantation of immunodeficient mice with human hepatocytes has shown promise, these models are subject to important challenges. Building on the previous observation that CD81 and occludin comprise the minimal human factors required to render mouse cells permissive to HCV entry in vitro(4), we attempted murine humanization via a genetic approach. Here we show that expression of two human genes is sufficient to allow HCV infection of fully immunocompetent inbred mice. We establish a precedent for applying mouse genetics to dissect viral entry and validate the role of scavenger receptor type B class I for HCV uptake. We demonstrate that HCV can be blocked by passive immunization, as well as showing that a recombinant vaccinia virus vector induces humoral immunity and confers partial protection against heterologous challenge. This system recapitulates a portion of the HCV life cycle in an immunocompetent rodent for the first time, opening opportunities for studying viral pathogenesis and immunity and comprising an effective platform for testing HCV entry inhibitors in vivo.	[Dorner, Marcus; Horwitz, Joshua A.; Barry, Walter T.; Feng, Qian; Mu, Kathy; Jones, Christopher T.; Schoggins, John W.; Catanese, Maria Teresa; Rice, Charles M.; Ploss, Alexander] Rockefeller Univ, Ctr Study Hepatitis C, New York, NY 10021 USA; [Robbins, Justin B.; Burton, Dennis R.; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Boston, MA 02129 USA	Rockefeller University; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Ploss, A (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10021 USA.	aploss@rockefeller.edu	Feng, Qian/AAL-4323-2020; Ploss, Alexander/ABG-2330-2020	Ploss, Alexander/0000-0001-9322-7252; Law, Mansun/0000-0002-8934-9756; Dorner, Marcus/0000-0003-0321-4226; Dorner, Marcus/0000-0001-7936-1527	National Institute of Diabetes and Digestive and Kidney Diseases [RC1DK087193]; National Institute for Allergy and Infectious Disease [R01AI072613, R01AI079031, R01AI071084]; Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft); Rockefeller University; National Institute of Health [F32DK082155, F32DK081193]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079031, R01AI071084, R01AI072613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK081193, R01DK085713, RC1DK087193, F32DK082155] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute for Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Starr Foundation; Greenberg Medical Institute; German Research Foundation (Deutsche Forschungsgesellschaft)(German Research Foundation (DFG)); Rockefeller University; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Sable, E. Castillo, A. Forrest, M. Panis, S. Pouzol, S. Shirley, A. Webson and E. Giang for laboratory support, L. Chiriboga and H. Yee for technical assistance, J. Bukh and Apath, LLC for providing the prototype intergenotypic HCV chimaeras and C. Murray for editing the manuscript. This study was supported in part by award number RC1DK087193 (to C.M.R. and A.P.) from the National Institute of Diabetes and Digestive and Kidney Diseases, R01AI072613 (to C.M.R.), R01AI079031 (to M.L.) and R01AI071084 (to D.R.B.) from the National Institute for Allergy and Infectious Disease, The Starr Foundation and the Greenberg Medical Institute. M.D. was supported by a postdoctoral fellowship from the German Research Foundation (Deutsche Forschungsgesellschaft) and M.T.C. by funds from The Rockefeller University's Women & Science Fellowship Program. J.W.S. and C.T.J are recipients of Ruth L. Kirschstein National Research Service Awards from the National Institute of Health (F32DK082155 to J.W.S., F32DK081193 to C.T.J.).	Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Catanese MT, 2007, J VIROL, V81, P8063, DOI 10.1128/JVI.00193-07; Chang KS, 2006, J VIROL, V80, P7364, DOI 10.1128/JVI.00586-06; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; de Jong YP, 2010, J CLIN INVEST, V120, P650, DOI 10.1172/JCI42338; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Higginbottom A, 2000, J VIROL, V74, P3642, DOI 10.1128/JVI.74.8.3642-3649.2000; Jones CT, 2010, NAT BIOTECHNOL, V28, P167, DOI 10.1038/nbt.1604; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Law Mansun, 2004, Methods Mol Biol, V269, P187; Liang YQ, 2009, GASTROENTEROLOGY, V137, P1448, DOI 10.1053/j.gastro.2009.07.050; Lin LT, 2010, J VIROL, V84, P9170, DOI 10.1128/JVI.00559-10; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Marukian S, 2008, HEPATOLOGY, V48, P1843, DOI 10.1002/hep.22550; McCaffrey AP, 2002, MOL THER, V5, P676, DOI 10.1006/mthe.2002.0600; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; RALSTON R, 1993, J VIROL, V67, P6753, DOI 10.1128/JVI.67.11.6753-6761.1993; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schoggins JW, 2003, J VIROL, V77, P1039, DOI 10.1128/JVI.77.2.1039-1048.2003; Selby M, 1999, J IMMUNOL, V162, P669; Stoller JZ, 2008, GENESIS, V46, P200, DOI 10.1002/dvg.20384; Uprichard SL, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-89; Youn JW, 2008, J VIROL, V82, P10896, DOI 10.1128/JVI.01179-08; Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003	35	283	305	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 9	2011	474	7350					208	U246		10.1038/nature10168	http://dx.doi.org/10.1038/nature10168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654804	Green Accepted, Green Submitted			2022-12-28	WOS:000291397800049
J	Biagi, JJ; Raphael, MJ; Mackillop, WJ; Kong, WD; King, WD; Booth, CM				Biagi, James J.; Raphael, Michael J.; Mackillop, William J.; Kong, Weidong; King, Will D.; Booth, Christopher M.			Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							III COLON-CANCER; STAGE-II; PUBLICATION BIAS; RECTAL-CANCER; FLUOROURACIL; LEUCOVORIN; THERAPY; ANGIOGENESIS; RADIOTHERAPY; OXALIPLATIN	Context Adjuvant chemotherapy (AC) improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. Objective To determine the relationship between time to AC and survival outcomes via a systematic review and meta-analysis. Data Sources MEDLINE (1975 through January 2011), EMBASE, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched to identify studies that described the relationship between time to AC and survival. Study Selection Studies were only included if the relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. Data Extraction Hazard ratios (HRs) for overall survival and disease-free survival from each study were converted to a regression coefficient (beta) and standard error corresponding to a continuous representation per 4 weeks of time to AC. The adjusted beta from individual studies were combined using a fixed-effects model. Inverse variance (1/SE2) was used to weight individual studies. Publication bias was investigated using the trim and fill approach. Results We identified 10 eligible studies involving 15 410 patients (7 published articles, 3 abstracts). Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy. Six studies reported time to AC as a binary variable and 4 as 3 or more categories. Meta-analysis demonstrated that a 4-week increase in time to AC was associated with a significant decrease in both overall survival (HR, 1.14; 95% confidence interval [CI], 1.10-1.17) and disease-free survival (HR, 1.14; 95% CI, 1.10-1.18). There was no significant heterogeneity among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight. Conclusion In a meta-analysis of the available literature on time to AC, longer time to AC was associated with worse survival among patients with resected colorectal cancer.	[Biagi, James J.; Mackillop, William J.; Booth, Christopher M.] Queens Univ, Dept Oncol, Kingston, ON K7L 5P9, Canada; [Raphael, Michael J.; Mackillop, William J.; Kong, Weidong; Booth, Christopher M.] Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON K7L 5P9, Canada; [Mackillop, William J.; King, Will D.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 5P9, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Biagi, JJ (corresponding author), Queens Univ, Dept Oncol, 25 King St W, Kingston, ON K7L 5P9, Canada.	jim.biagi@krcc.on.ca			Canadian Institutes of Health Research; Cancer Care Ontario Chair in Health Services Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Care Ontario Chair in Health Services Research	This work was supported in part by a grant from the Canadian Institutes of Health Research (W.J.M.). Dr Booth is supported as a Cancer Care Ontario Chair in Health Services Research.	Ahmed S, 2010, DIS COLON RECTUM, V53, P1432, DOI 10.1007/DCR.0b013e3181e78815; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2007, J CLIN ONCOL, V25, P3732, DOI 10.1200/JCO.2007.12.2234; [Anonymous], DEC MAK TOOLS HLTH C; [Anonymous], SYST TREATM WAIT TIM; Bayraktar UD, CANCER, DOI [10.1002/cncr.25720, DOI 10.1002/CNCR.25720]; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Berglund A, 2008, ANN ONCOL, V19, P400, DOI 10.1093/annonc/mdm582; Biagi JJ, 2007, 2007 AM SOC CLIN ONC; Chau I, 2005, ANN ONCOL, V16, P549, DOI 10.1093/annonc/mdi116; Chen Z, 2008, RADIOTHER ONCOL, V87, P3, DOI 10.1016/j.radonc.2007.11.016; Cheung WY, 2009, DIS COLON RECTUM, V52, P1054, DOI 10.1007/DCR.0b013e3181a51173; Czaykowski P, 2007, 2007 AM SOC CLIN ONC; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Des Guetz G, 2010, EUR J CANCER, V46, P1049, DOI 10.1016/j.ejca.2010.01.020; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EGGERMONT AMM, 1987, SURGERY, V102, P71; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P643; GUNDUZ N, 1979, CANCER RES, V39, P3861; Hershman D, 2006, CANCER-AM CANCER SOC, V107, P2581, DOI 10.1002/cncr.22316; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Lima ISF, 2011, CANCER-AM CANCER SOC, V117, P3833, DOI 10.1002/cncr.25954; Mackillop WJ, 2007, RADIOTHER ONCOL, V84, P1, DOI 10.1016/j.radonc.2007.05.006; MCCULLOCH P, 1994, LANCET, V344, P402; National Institutes of Health, 1990, ADJ THER PAT COL REC, V8, P1; Ng CSH, 2005, WORLD J SURG, V29, P975, DOI 10.1007/s00268-005-0029-6; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; ONO I, 1994, SCAND J PLAST RECONS, V28, P269, DOI 10.3109/02844319409022010; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Taal BG, 2001, BRIT J CANCER, V85, P1437, DOI 10.1054/bjoc.2001.2117; Wadd N, 2008, ANN ONCOL, V19, P24; Zeig-Owens Rachel, 2009, J Registry Manag, V36, P30	45	434	454	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2335	2342		10.1001/jama.2011.749	http://dx.doi.org/10.1001/jama.2011.749			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642686				2022-12-28	WOS:000291349100027
J	Jenkins, M				Jenkins, Michael			PERSONAL VIEW We need cooperation rather than competition	BRITISH MEDICAL JOURNAL			English	Editorial Material												mrjmjenkins@yahoo.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2011	342								d3589	10.1136/bmj.d3589	http://dx.doi.org/10.1136/bmj.d3589			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SO	21653624				2022-12-28	WOS:000291645500019
J	Cockayne, S; Hewitt, C; Hicks, K; Jayakody, S; Kang'ombe, AR; Stamuli, E; Turner, G; Thomas, K; Curran, M; Denby, G; Hashmi, F; McIntosh, C; McLarnon, N; Torgerson, D; Watt, I				Cockayne, Sarah; Hewitt, Catherine; Hicks, Kate; Jayakody, Shalmini; Kang'ombe, Arthur Ricky; Stamuli, Eugena; Turner, Gwen; Thomas, Kim; Curran, Mike; Denby, Gary; Hashmi, Farina; McIntosh, Caroline; McLarnon, Nichola; Torgerson, David; Watt, Ian		EVerT Team	Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To compare the clinical effectiveness of cryotherapy versus salicylic acid for the treatment of plantar warts. Design A multicentre, open, two arm randomised controlled trial. Setting University podiatry school clinics, NHS podiatry clinics, and primary care in England, Scotland, and Ireland. Participants 240 patients aged 12 years and over, with a plantar wart that in the opinion of the healthcare professional was suitable for treatment with both cryotherapy and salicylic acid. Interventions Cryotherapy with liquid nitrogen delivered by a healthcare professional, up to four treatments two to three weeks apart. Patient self treatment with 50% salicylic acid (Verrugon) daily up to a maximum of eight weeks. Main outcome measures Complete clearance of all plantar warts at 12 weeks. Secondary outcomes were (a) complete clearance of all plantar warts at 12 weeks controlling for age, whether the wart had been treated previously, and type of wart, (b) patient self reported clearance of plantar warts at six months, (c) time to clearance of plantar wart, (d) number of plantar warts at 12 weeks, and (e) patient satisfaction with the treatment. Results There was no evidence of a difference between the salicylic acid and cryotherapy groups in the proportions of participants with complete clearance of all plantar warts at 12 weeks (17/119 (14%) v 15/110 (14%), difference 0.65% (95% CI -8.33 to 9.63), P=0.89). The results did not change when the analysis was repeated but with adjustment for age, whether the wart had been treated previously, and type of plantar wart or for patients' preferences at baseline. There was no evidence of a difference between the salicylic acid and cryotherapy groups in self reported clearance of plantar warts at six months (29/95 (31%) v 33/98 (34%), difference -3.15% (-16.31 to 10.02), P=0.64) or in time to clearance (hazard ratio 0.80 (95% CI 0.51 to 1.25), P=0.33). There was also no evidence of a difference in the number of plantar warts at 12 weeks (incident rate ratio 1.08 (0.81 to 1.43), P=0.62). Conclusions Salicylic acid and the cryotherapy were equally effective for clearance of plantar warts.	[Cockayne, Sarah; Hewitt, Catherine; Hicks, Kate; Jayakody, Shalmini; Kang'ombe, Arthur Ricky; Stamuli, Eugena; Turner, Gwen; Torgerson, David; Watt, Ian] Univ York, York Trials Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Thomas, Kim] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Curran, Mike; Denby, Gary] Univ Northampton, Sch Hlth, Northampton, England; [Hashmi, Farina] Univ Brighton, Sch Hlth Profess, Brighton BN2 4AT, E Sussex, England; [McIntosh, Caroline] Natl Univ Ireland, Discipline Podiatry, Galway, Ireland; [McLarnon, Nichola] Glasgow Caledonian Univ, Sch Hlth & Social Care, Glasgow G4 0BA, Lanark, Scotland; [Watt, Ian] Hull York Med Sch, York, N Yorkshire, England	University of York - UK; University of Nottingham; University of Northampton; University of Brighton; Ollscoil na Gaillimhe-University of Galway; Glasgow Caledonian University; University of Hull; University of York - UK	Cockayne, S (corresponding author), Univ York, York Trials Unit, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	sarah.cockayne@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275; Cockayne, Sarah/0000-0002-1288-5497; Hashmi, Farina/0000-0002-6257-2165; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; Thomas, Kim/0000-0001-7785-7465	UK National Institute for Health Research [05/513/02]	UK National Institute for Health Research(National Institute for Health Research (NIHR))	This project was funded by the UK National Institute for Health Research, Health Technology Assessment Programme (project No 05/513/02) and will be published in full in the journal Health Technology Assessment. The views and opinions expressed are those of the authors and do not necessarily reflect those of the Department of Health. William Ransom and Son supplied the 50% salicylic acid (Verrugon) at no cost, and BOC provided one site with liquid nitrogen storage equipment at reduced cost. These manufacturers had no role in the design of the trial or in the collection, analysis, and interpretation of data.	Bruggink SC, 2008, J INVEST DERMATOL, V128, P2549; BUNNEY MH, 1976, BRIT J DERMATOL, V94, P667, DOI 10.1111/j.1365-2133.1976.tb05167.x; Gibbs S, 2006, COCHRANE DB SYST REV, V3; Johnston M. R., 1978, Special Report, New York State Agricultural Experiment Station, P1; Keogh-Brown MR., 2006, HEALTH TECHNOL ASSES, V10, piii, ix; Kilkenny M, 1998, BRIT J DERMATOL, V138, P840; MASSING AM, 1963, ARCH DERMATOL, V87, P306, DOI 10.1001/archderm.1963.01590150022004; REA JN, 1976, BRIT J PREV SOC MED, V30, P107; Schofield J., 2009, SKIN CONDITIONS UK H; STEELE K, 1988, J ROY COLL GEN PRACT, V38, P256; Thomas KS, 2006, HEALTH TECHNOL ASSES, V10, P1; WILLIAMS HC, 1993, BRIT J DERMATOL, V128, P504, DOI 10.1111/j.1365-2133.1993.tb00226.x	12	43	46	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 7	2011	342								d3271	10.1136/bmj.d3271	http://dx.doi.org/10.1136/bmj.d3271			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SL	21652750	Green Published, Green Submitted, hybrid, Green Accepted			2022-12-28	WOS:000291645200003
J	Hill, J; Bullock, I; Alderson, P				Hill, Jennifer; Bullock, Ian; Alderson, Phil			A Summary of the Methods That the National Clinical Guideline Centre Uses to Produce Clinical Guidelines for the National Institute for Health and Clinical Excellence	ANNALS OF INTERNAL MEDICINE			English	Article							GRADE; QUALITY	The National Clinical Guideline Centre develops evidence-based clinical guidelines on behalf of the National Institute for Health and Clinical Excellence in the United Kingdom. These guidelines are developed for the National Health Service in England, Wales, and Northern Ireland and establish recommendations on best practice. The authors summarize the main methods used in development, how evidence from systematic reviews is interpreted to form recommendations, who is involved in the process, and the main outputs that are published.	[Bullock, Ian] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; Natl Inst Hlth & Clin Excellence, Manchester, Lancs, England	Royal College of Physicians; National Institute for Health & Care Excellence	Bullock, I (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, 11 St Andrews Pl,Regents Pk, London NW1 4LE, England.	enquiries@ncgc.ac.uk			National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	By the National Institute for Health and Clinical Excellence.	AGREE Next Steps Consortium, 2009, APPR GUID RES EV 2 A; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, COCHRANE HDB SYSTEMA, P4; *NAT I HLTH CLIN E, GUID MAN 2007; National Institute for Health and Clinical Excellence, GUID MAN 2009; National Institute for Health and Clinical Excellence, GUID TOP CHOS; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE	11	24	25	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00007	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00007			44	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773MV	21646558				2022-12-28	WOS:000291312300006
J	O'Mahony, R; Murthy, L; Akunne, A; Young, J				O'Mahony, Rachel; Murthy, Lakshmi; Akunne, Anayo; Young, John		Guideline Dev Grp	Synopsis of the National Institute for Health and Clinical Excellence Guideline for Prevention of Delirium	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIAL; OLDER PATIENTS; HIP FRACTURE; INTERVENTION; PROGRAM; CARE	Description: Delirium is common, is often underrecognized, and is associated with poor outcomes and high costs. In July 2010, the National Institute for Health and Clinical Excellence released a guideline that addressed diagnosis, prevention, and management of delirium. This synopsis focuses on the main recommendations about prevention of delirium. Methods: The National Clinical Guideline Centre developed these guidelines by using standard methodology of the National Institute for Health and Clinical Excellence. A multidisciplinary guideline development group posed review questions, discussed evidence, and formulated the recommendations. To underpin the guideline, a technical team from the National Clinical Guideline Centre systematically reviewed and graded pertinent evidence identified from literature searches of studies published in English to August 2009 and performed health economic modeling. Stakeholder and public comment informed guideline development and modifications. Recommendations: Considering prevention a feasible and cost-effective health strategy, the guideline development group made 13 specific recommendations that addressed the stability of the care environment (both the care team and location) and the provision of a multicomponent intervention package tailored for persons at risk for delirium. The multicomponent intervention package included assessment and modification of key clinical factors that may precipitate delirium, including cognitive impairment or disorientation, dehydration or constipation, hypoxia, infection, immobility or limited mobility, several medications, pain, poor nutrition, sensory impairment, and sleep disturbance.	[O'Mahony, Rachel] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England; UK Cochrane Ctr & KSG Trans, Oxford, England; Bradford Inst Hlth Res, Bradford, W Yorkshire, England	Royal College of Physicians	O'Mahony, R (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr, 11 St Andrews Pl,Regents Pk, London NW1 4LE, England.	ra-chel.omahony@rcplondon.ac.uk		young, john/0000-0003-4085-9306	The National Institute for Health and Clinical Excellence	The National Institute for Health and Clinical Excellence	The National Institute for Health and Clinical Excellence commissioned the National Clinical Guideline Centre to write this summary.	GUSTAFSON Y, 1991, J AM GERIATR SOC, V39, P655, DOI 10.1111/j.1532-5415.1991.tb03618.x; Harari D, 2007, AGE AGEING, V36, P190, DOI 10.1093/ageing/afl163; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Lundstrom M, 2005, J AM GERIATR SOC, V53, P622, DOI 10.1111/j.1532-5415.2005.53210.x; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN F; National Collaborating Centre for Acute Care, NUTR SUPP AD OR NUTR; National Collaborating Centre for Chronic Conditions, 2006, NAT CLIN GUID; National Collaborating Centre for Nursing and Supportive Care, INF CONTR PREV HEALT; National Institute for Health and Clinical Excellence, 2007, GUID MAN 2007; National Institute for Health and Clinical Excellence, DEL DIAGN PREV MAN; National Institute for Health and Clinical Excellence, 2010, CLIN GUID; Niam DMWT, 2005, AUSTRALAS J AGEING, V24, P174, DOI 10.1111/j.1741-6612.2005.00108.x; U.S. Department of Health and Human Services, 2004, CMS PUBL; Wanich C K, 1992, Image J Nurs Sch, V24, P201	16	145	149	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 7	2011	154	11								10.7326/0003-4819-154-11-201106070-00006	http://dx.doi.org/10.7326/0003-4819-154-11-201106070-00006			49	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	773MV	21646557				2022-12-28	WOS:000291312300005
J	Aouragh, M; Inglis, R; Inglis, A; Mainwaring, C; Tibbs, G; Paulson, S				Aouragh, Miriyam; Inglis, Russell; Inglis, Ashley; Mainwaring, Cetta; Tibbs, Geoff; Paulson, Shawn			Oxford University should stop investing in arms companies	LANCET			English	Editorial Material									[Aouragh, Miriyam; Inglis, Russell; Inglis, Ashley; Mainwaring, Cetta; Tibbs, Geoff; Paulson, Shawn] Univ Oxford Wadham Coll, Divestment Comm Oxford Antiwar Act, Oxford OX1 3PN, England	University of Oxford	Inglis, R (corresponding author), Univ Oxford Wadham Coll, Divestment Comm Oxford Antiwar Act, Oxford OX1 3PN, England.	oxfordantiwaraction@gmail.com						Aitken M, 1999, BRIT MED J, V319, P401, DOI 10.1136/bmj.319.7207.401a; Alaani S, 2011, INT J ENV RES PUB HE, V8, P89, DOI 10.3390/ijerph8010089; Bertell R, 2006, INT J HEALTH SERV, V36, P503, DOI 10.2190/13JL-9LHM-FMR4-0V7B; BOER R, 2010, WORLDWIDE INVESTMENT, P29; Busby C, 2010, INT J ENV RES PUB HE, V7, P2828, DOI 10.3390/ijerph7072828; *CAMP ARM TRAD, 2008, CLEAN INV U OXF U CO; *CAMP ARMS TRAD, 2008, SHAR DAT DOES YOUR U; Fetter S., 1999, SCI GLOB SECURITY, V8, P125, DOI DOI 10.1080/08929880008426473; HONG X, 2010, CHEM RES TOXICOL, V23, P373; *INT COAL BAN UR W, PROBL PROD GEN DYN; MADSLIEN J, 2009, BBC NEWS        0608; MANKELOW N, 2010, FT MANDATE       MAY; MARTIN L, 2005, HELLFIRE THERMOBARIC; Miller AC, 2003, J ENVIRON RADIOACTIV, V64, P247, DOI 10.1016/S0265-931X(02)00053-X; *SOC RESP INV REV, 2010, REC COUNC DIV ARMS M; *UN GEN ASS, 2010, ARES6555 UN GEM ASS; 2008, FRIENDLY FIRE BLUE W; 2010, EXTR VIC REP M COUNC; 2007, SMALL UNIT ACTIONS C; 2005, SCALATION FORCE 1 5; 2011, GUARDIAN LONDON 0328	21	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1900	1902		10.1016/S0140-6736(11)60746-0	http://dx.doi.org/10.1016/S0140-6736(11)60746-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21641464				2022-12-28	WOS:000291623200008
J	Mukherjee, T; Kim, WS; Mandal, L; Banerjee, U				Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal			Interaction Between Notch and Hif-alpha in Development and Survival of Drosophila Blood Cells	SCIENCE			English	Article							HYPOXIA; HIF-1-ALPHA; SPECIFICATION; REQUIRES; PATHWAY; LINEAGE	A blood cell type termed crystal cell in Drosophila functions in clotting and wound healing and requires Notch for specification and maintenance. We report that crystal cells express elevated levels of Sima protein orthologous to mammalian hypoxia-inducible factor-alpha (Hif-alpha) even under conditions of normal oxygen availability. In these platelet-like crystal cells, Sima activates full-length Notch receptor signaling via a noncanonical, ligand-independent mechanism that promotes hemocyte survival during both normal hematopoietic development and hypoxic stress. This interaction initiates in early endosomes, is independent of Hif-beta (Tango in Drosophila), and does not activate hypoxia response targets. Studies in vertebrate myeloid cells have shown a similar up-regulation of Hif-alpha protein in well-oxygenated environments. This study provides a mechanistic paradigm for Hif-alpha/Notch interaction that may be conserved in mammals.	[Mukherjee, Tina; Kim, William Sang; Mandal, Lolitika; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			NIH [R01HL067395]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank H. Bellen, C. Frei, S. Artavanis-Tsakonas, C. Delidakis, M. Guo, M. Regulski, B. Shilo, G. Struhl, P. Wappner, National Institute of Genetics, Vienna Drosophila RNAi Center, Flybase, and Bloomington for reagents and D. Walker, G. Weinmaster, and C. Evans for helpful discussion. Supported by NIH grant R01HL067395.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bacon NCM, 1998, BIOCHEM BIOPH RES CO, V249, P811, DOI 10.1006/bbrc.1998.9234; Bidla G, 2007, J CELL SCI, V120, P1209, DOI 10.1242/jcs.03420; Centanin L, 2005, EMBO REP, V6, P1070, DOI 10.1038/sj.embor.7400528; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Duvic B, 2002, CURR BIOL, V12, P1923, DOI 10.1016/S0960-9822(02)01297-6; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kasivisvanathan V, 2011, CURR VASC PHARMACOL, V9, P333, DOI 10.2174/157016111795495602; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Nakamura H, 2005, J IMMUNOL, V174, P7592, DOI 10.4049/jimmunol.174.12.7592; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Rizki R. R., 1981, GENETICS, V97, ps90; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Schofield CJ, 2005, BIOCHEM BIOPH RES CO, V338, P617, DOI 10.1016/j.bbrc.2005.08.111; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860	32	128	129	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1210	1213		10.1126/science.1199643	http://dx.doi.org/10.1126/science.1199643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636775	Green Accepted			2022-12-28	WOS:000291205200051
J	Merali, Z				Merali, Zeeya			THE POWER OF DISCORD	NATURE			English	News Item							QUANTUM; INFORMATION							Waldrop, M Mitchell/0000-0002-8063-1472				Braunstein SL, 1999, PHYS REV LETT, V83, P1054, DOI 10.1103/PhysRevLett.83.1054; Datta A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050502; Du JF, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.042306; Ferraro A, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.052318; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Henderson L, 2001, J PHYS A-MATH GEN, V34, P6899, DOI 10.1088/0305-4470/34/35/315; Knill E, 1998, PHYS REV LETT, V81, P5672, DOI 10.1103/PhysRevLett.81.5672; Lanyon BP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200501; Monz T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130506; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Zurek WH, 2000, ANN PHYS-BERLIN, V9, P855, DOI 10.1002/1521-3889(200011)9:11/12<855::AID-ANDP855>3.0.CO;2-K	12	72	73	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					24	26		10.1038/474024a	http://dx.doi.org/10.1038/474024a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637235	Bronze			2022-12-28	WOS:000291156700017
J	Geddes, JR; Fazel, S				Geddes, John R.; Fazel, Seena			Extreme health inequalities: mortality in homeless people	LANCET			English	Editorial Material							ASSERTIVE COMMUNITY TREATMENT; MENTAL-DISORDERS; FOLLOW-UP; INTERVENTIONS; STOCKHOLM; ILLNESS		[Geddes, John R.; Fazel, Seena] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England	University of Oxford	Geddes, JR (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.	john.geddes@psych.ox.ac.uk	Fazel, Seena/B-5307-2008; Geddes, John/B-8240-2011	Fazel, Seena/0000-0002-5383-5365; Geddes, John/0000-0002-5281-5960				Altena AM, 2010, AM J PREV MED, V38, P637, DOI 10.1016/j.amepre.2010.02.017; Beijer U, 2007, NORD J PSYCHIAT, V61, P363, DOI 10.1080/08039480701644637; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; *BROADW, 2010, STREET HOM ANN REP L; Coldwell CM, 2007, AM J PSYCHIAT, V164, P393, DOI 10.1176/appi.ajp.164.3.393; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Hwang SW, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4036; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; Nelson G, 2007, AM J ORTHOPSYCHIAT, V77, P350, DOI 10.1037/0002-9432.77.3.350; NEWTON JR, 1994, BRIT J PSYCHIAT, V165, P537, DOI 10.1192/bjp.165.4.537; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; US Department of Housing and Urban Development, 2010, 2009 ANN HOM ASS REP	14	33	34	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2011	377	9784					2156	2157		10.1016/S0140-6736(11)60885-4	http://dx.doi.org/10.1016/S0140-6736(11)60885-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	786XI	21676455				2022-12-28	WOS:000292340800006
J	Deutsch, C; Brix, H; Ito, T; Frenzel, H; Thompson, L				Deutsch, Curtis; Brix, Holger; Ito, Taka; Frenzel, Hartmut; Thompson, LuAnne			Climate-Forced Variability of Ocean Hypoxia	SCIENCE			English	Article							NORTH PACIFIC; ARABIAN SEA; DENITRIFICATION; NITROGEN; RATIOS; WATERS	Oxygen (O-2) is a critical constraint on marine ecosystems. As oceanic O-2 falls to hypoxic concentrations, habitability for aerobic organisms decreases rapidly. We show that the spatial extent of hypoxia is highly sensitive to small changes in the ocean's O-2 content, with maximum responses at suboxic concentrations where anaerobic metabolisms predominate. In model-based reconstructions of historical oxygen changes, the world's largest suboxic zone, in the Pacific Ocean, varies in size by a factor of 2. This is attributable to climate-driven changes in the depth of the tropical and subtropical thermocline that have multiplicative effects on respiration rates in low-O-2 water. The same mechanism yields even larger fluctuations in the rate of nitrogen removal by denitrification, creating a link between decadal climate oscillations and the nutrient limitation of marine photosynthesis.	[Deutsch, Curtis; Brix, Holger; Frenzel, Hartmut] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Ito, Taka] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Thompson, LuAnne] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of California System; University of California Los Angeles; Colorado State University; University of Washington; University of Washington Seattle	Deutsch, C (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	cdeutsch@atmos.ucla.edu	Thompson, LuAnne/AAA-1000-2020; Ito, Takamitsu/F-3856-2010	Thompson, LuAnne/0000-0001-8295-0533; Ito, Takamitsu/0000-0001-9873-099X; Brix, Holger/0000-0003-4229-6164	Gordon and Betty Moore Foundation; NSF [OCE-0851483, OCE-0851497]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF))	Supported by a grant from the Gordon and Betty Moore Foundation (C. D.) and NSF grants OCE-0851483 (C. D.) and OCE-0851497 (T.I.).	ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Bograd SJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034185; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Emerson S, 2004, J OCEANOGR, V60, P139, DOI 10.1023/B:JOCE.0000038323.62130.a0; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Garcia H., 2006, NOAA ATLAS NESDROS I, V63; Hallberg R, 2006, J PHYS OCEANOGR, V36, P2232, DOI 10.1175/JPO2980.1; Ito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041595; Karstensen J, 2008, PROG OCEANOGR, V77, P331, DOI 10.1016/j.pocean.2007.05.009; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Mecking S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003101; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007	27	234	239	3	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 15	2011	333	6040					336	339		10.1126/science.1202422	http://dx.doi.org/10.1126/science.1202422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	792HF	21659566				2022-12-28	WOS:000292732000041
J	Wei, W; Akkersdijk, GP				Wei, Wu; Akkersdijk, George P.			Spontaneous aneurysm of the superficial temporal artery	LANCET			English	Editorial Material									[Wei, Wu; Akkersdijk, George P.] Maasstad Hosp Rotterdam, Dept Vasc Surg, NL-3007 AC Rotterdam, Netherlands	Maasstad Hospital	Akkersdijk, GP (corresponding author), Maasstad Hosp Rotterdam, Dept Vasc Surg, Postbus 9100, NL-3007 AC Rotterdam, Netherlands.	akkersdijkg@maasstadziekenhuis.nl		Wei, Wu/0000-0003-2406-225X					0	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 9	2011	378	9786					168	168		10.1016/S0140-6736(10)61341-4	http://dx.doi.org/10.1016/S0140-6736(10)61341-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	795CJ	21683996				2022-12-28	WOS:000292948800033
J	Smart, N; Bollini, S; Dube, KN; Vieira, JM; Zhou, B; Davidson, S; Yellon, D; Riegler, J; Price, AN; Lythgoe, MF; Pu, WT; Riley, PR				Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Zhou, Bin; Davidson, Sean; Yellon, Derek; Riegler, Johannes; Price, Anthony N.; Lythgoe, Mark F.; Pu, William T.; Riley, Paul R.			De novo cardiomyocytes from within the activated adult heart after injury	NATURE			English	Article							EPICARDIAL PROGENITORS; SMOOTH-MUSCLE; NEOVASCULARIZATION; LINEAGE; CELLS; TBX18	A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction(1). A therapeutic ideal-relative to cell transplantation-would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm's tumour 1 (Wt1), through priming by thymosin beta 4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells(2) with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards resident-cell-based therapy in human ischaemic heart disease.	[Smart, Nicola; Bollini, Sveva; Dube, Karina N.; Vieira, Joaquim M.; Riley, Paul R.] UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Zhou, Bin; Pu, William T.] Childrens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Zhou, Bin; Pu, William T.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Beijing 20031, Peoples R China; [Davidson, Sean; Yellon, Derek] UCL, Hatter Cardiovasc Inst, London WC1E 6HX, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Dept Med, Ctr Adv Biomed Imaging CABI, London WC1E 6DD, England; [Riegler, Johannes; Lythgoe, Mark F.] UCL, Inst Child Hlth, London WC1E 6DD, England; [Riegler, Johannes] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England; [Price, Anthony N.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Fac Med, London W12 0NN, England	University of London; University College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Imperial College London	Riley, PR (corresponding author), UCL Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England.	p.riley@ich.ucl.ac.uk	Pu, William/AAJ-8301-2020; Smart, Nicola/AAN-4011-2020; Bollini, Sveva/J-6004-2016; Smart, Nicola/AAD-3874-2020; Yellon, Derek M/ABD-5110-2021; Davidson, Sean M/F-5275-2010	Pu, William/0000-0002-4551-8079; Bollini, Sveva/0000-0003-1076-0823; Smart, Nicola/0000-0002-3501-7254; Davidson, Sean M/0000-0001-5182-4980; Yellon, Derek/0000-0001-7791-9320; Vieira, Joaquim/0000-0003-2023-6304; Zhou, Bin/0000-0001-5278-5522; Price, Anthony/0000-0002-6907-7554; Lythgoe, Mark/0000-0002-4945-0171	British Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100401] Funding Source: NIH RePORTER; EPSRC [EP/I014667/1] Funding Source: UKRI; MRC [G0700933] Funding Source: UKRI; British Heart Foundation [PG/10/005/28175, RG/08/015/26411, FS/08/004/23625, RG/08/003/25264] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; Medical Research Council [G0700933] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the British Heart Foundation. We are grateful to F. Costantini and S. Srinivas for providing the R26R-EYFP mouse strain, to B. Vernay for assistance with confocal microscopy and A. Eddaoudi, P. Chana and A. Angheluta for assistance in flow cytometry. We thank A. Taylor and V. Muthurangu for functional interpretation of MRI data and RegeneRx Biopharmaceuticals for provision of clinical grade T beta 4.	Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chen J, 1998, DEVELOPMENT, V125, P1943; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Heiberg E, 2005, COMPUT CARDIOL, V32, P599; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahtab EAF, 2008, DEV DYNAM, V237, P847, DOI 10.1002/dvdy.21463; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Price A., 2010, J CARDIOVASC MAGN S1, V12, pP98; Rubart M, 2003, AM J PHYSIOL-CELL PH, V284, pC1654, DOI 10.1152/ajpcell.00469.2002; Smart N., 2009, CURR PROTOC STEM CEL; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2010, ANN NY ACAD SCI, V1194, P97, DOI 10.1111/j.1749-6632.2010.05478.x; Wagner KD, 2002, FASEB J, V16, P1117, DOI 10.1096/fj.01-0986fje; Willems E, 2009, PEDIATR CARDIOL, V30, P635, DOI 10.1007/s00246-009-9409-2; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	24	480	501	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					640	U117		10.1038/nature10188	http://dx.doi.org/10.1038/nature10188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654746	Green Accepted, Bronze			2022-12-28	WOS:000292204300039
J	Keck, JM; Jones, MH; Wong, CCL; Binkley, J; Chen, DC; Jaspersen, SL; Holinger, EP; Xu, T; Niepel, M; Rout, MP; Vogel, J; Sidow, A; Yates, JR; Winey, M				Keck, Jamie M.; Jones, Michele H.; Wong, Catherine C. L.; Binkley, Jonathan; Chen, Daici; Jaspersen, Sue L.; Holinger, Eric P.; Xu, Tao; Niepel, Mario; Rout, Michael P.; Vogel, Jackie; Sidow, Arend; Yates, John R., III; Winey, Mark			A Cell Cycle Phosphoproteome of the Yeast Centrosome	SCIENCE			English	Article							SPINDLE POLE BODY; BUDDING YEAST; PHOSPHORYLATION SITES; PROTEIN; DUPLICATION; KINASE; COMPLEX; CDK1	Centrosomes organize the bipolar mitotic spindle, and centrosomal defects cause chromosome instability. Protein phosphorylation modulates centrosome function, and we provide a comprehensive map of phosphorylation on intact yeast centrosomes (18 proteins). Mass spectrometry was used to identify 297 phosphorylation sites on centrosomes from different cell cycle stages. We observed different modes of phosphoregulation via specific protein kinases, phosphorylation site clustering, and conserved phosphorylated residues. Mutating all eight cyclin-dependent kinase (Cdk)-directed sites within the core component, Spc42, resulted in lethality and reduced centrosomal assembly. Alternatively, mutation of one conserved Cdk site within gamma-tubulin (Tub4-S360D) caused mitotic delay and aberrant anaphase spindle elongation. Our work establishes the extent and complexity of this prominent posttranslational modification in centrosome biology and provides specific examples of phosphorylation control in centrosome function.	[Keck, Jamie M.; Jones, Michele H.; Holinger, Eric P.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wong, Catherine C. L.; Xu, Tao; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Binkley, Jonathan; Sidow, Arend] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Chen, Daici; Vogel, Jackie] McGill Univ, Dept Biol, Montreal, PQ H3G 0B1, Canada; [Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Jaspersen, Sue L.] Univ Kansas, Dept Mol & Integrat Physiol, Med Ctr, Kansas City, KS 66160 USA; [Niepel, Mario] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA	University of Colorado System; University of Colorado Boulder; Scripps Research Institute; Stanford University; Stanford University; McGill University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Harvard University; Harvard Medical School; Rockefeller University	Winey, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, UCB 347, Boulder, CO 80309 USA.	mark.winey@colorado.edu	Rout, Michael/Y-7090-2018; Chen, Daici/AAI-7285-2020; Niepel, Mario/G-5443-2011	Chen, Daici/0000-0002-8872-0592; Niepel, Mario/0000-0003-1415-6295; Wong, Catherine CL/0000-0001-7270-980X; Rout, Michael/0000-0003-2010-706X	NIH [U54 RR022220, R01 GM062427, R01 HG003039, P41 RR011823, GM51312, F32 GM086038, T32 GM008759]; CIHR [MOP-64404]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823, U54RR022220] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051312, T32GM008759, R01GM062427, F32GM086038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Pearson, A. Stemm-Wolf, and T. Su for comments on the manuscript; T. Davis and the Winey lab for helpful discussions; E. O'Toole for the electron micrograph; E. Nazarova for assisting with spindle dynamics analysis; M. Riffle for Yeast Resource Center assistance; and D. D'amours for the Cdc28 purification protocol. This work was supported by NIH U54 RR022220 and R01 GM062427 (M.P.R.), NIH R01 HG003039 (A.S.), NIH P41 RR011823 (J.R.Y. III, T.N. Davis, principal investigator), CIHR MOP-64404 (J.V.), and NIH GM51312 (M. W.). J.M.K. was supported by NIH F32 GM086038, and E.P.H. was supported by NIH T32 GM008759. Mass spectrometry data are provided at the Yeast Resource Center (www.yeastrc.org/pdr/pages/front.jsp).	Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Ba ANN, 2010, MOL BIOL EVOL, V27, P2027, DOI 10.1093/molbev/msq090; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Binkley J, 2010, GENOME RES, V20, P142, DOI 10.1101/gr.097121.109; Crasta K, 2008, NAT CELL BIOL, V10, P665, DOI 10.1038/ncb1729; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Holinger EP, 2009, J BIOL CHEM, V284, P12949, DOI 10.1074/jbc.M900088200; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; KAHANA JA, 1995, P NATL ACAD SCI USA, V92, P9707, DOI 10.1073/pnas.92.21.9707; Kimura M., 1983, NEUTRAL THEORY MOL E; Kollman JM, 2010, NATURE, V466, P879, DOI 10.1038/nature09207; Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; Snead JL, 2007, CHEM BIOL, V14, P1261, DOI 10.1016/j.chembiol.2007.09.011; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Visintin R, 2001, MOL BIOL CELL, V12, P2961, DOI 10.1091/mbc.12.10.2961; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Winey M, 2001, NAT CELL BIOL, V3, pE23, DOI 10.1038/35050663	23	77	81	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1557	1561		10.1126/science.1205193	http://dx.doi.org/10.1126/science.1205193			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700874	Green Accepted			2022-12-28	WOS:000291990000045
J	Wang, X; Ouyang, H; Yamamoto, Y; Kumar, PA; Wei, TS; Dagher, R; Vincent, M; Lu, X; Bellizzi, AM; Ho, KY; Crum, CP; Xian, W; McKeon, F				Wang, Xia; Ouyang, Hong; Yamamoto, Yusuke; Kumar, Pooja Ashok; Wei, Tay Seok; Dagher, Rania; Vincent, Matthew; Lu, Xin; Bellizzi, Andrew M.; Ho, Khek Yu; Crum, Christopher P.; Xian, Wa; McKeon, Frank			Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; ESOPHAGEAL ADENOCARCINOMA; INTESTINAL METAPLASIA; SQUAMOUS EPITHELIUM; COLUMNAR EPITHELIUM; GENE-EXPRESSION; GASTRIC-CANCER; STEM-CELLS; DYSPLASIA; P63	Barrett's esophagus is an intestine-like metaplasia and precursor of esophageal adenocarcinoma. Triggered by gastroesophageal reflux disease, the origin of this metaplasia remains unknown. p63-deficient mice, which lack squamous epithelia, may model acid-reflux damage. We show here that p63 null embryos rapidly develop intestine-like metaplasia with gene expression profiles similar to Barrett's metaplasia. We track its source to a unique embryonic epithelium that is normally undermined and replaced by p63-expressing cells. Significantly, we show that a discrete population of these embryonic cells persists in adult mice and humans at the squamocolumnar junction, the source of Barrett's metaplasia. We show that upon programmed damage to the squamous epithelium, these embryonic cells migrate toward adjacent, specialized squamous cells in a process that may recapitulate early Barrett's. Our findings suggest that certain precancerous lesions, such as Barrett's, initiate not from genetic alterations but from competitive interactions between cell lineages driven by opportunity.	[Wei, Tay Seok; Xian, Wa] ASTAR, Inst Med Biol, Singapore 138648, Singapore; [Wang, Xia; Ouyang, Hong; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Yamamoto, Yusuke; Kumar, Pooja Ashok; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Dagher, Rania] Univ Strasbourg, Inst Sci & Ingn Supramol, F-67081 Strasbourg, France; [Vincent, Matthew] Multiclonal Therapeut Inc, Newburyport, MA 01833 USA; [Lu, Xin] Univ Oxford, Ludwig Canc Inst, Oxford OX3 7DQ, England; [Bellizzi, Andrew M.; Crum, Christopher P.; Xian, Wa] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Ho, Khek Yu] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Harvard University; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ludwig Institute for Cancer Research; University of Oxford; Harvard University; Brigham & Women's Hospital; National University of Singapore	Xian, W (corresponding author), ASTAR, Inst Med Biol, Singapore 138648, Singapore.	wa.xian@imb.a-star.edu.sg; mckeonf@gis.a-star.edu.sg	Kumar, Pooja Ashok/K-6762-2019	Lu, Xin/0000-0002-6587-1152; Bellizzi, Andrew/0000-0002-8264-6379; Kumar, Pooja/0000-0002-6589-2447; Ouyang, Hong/0000-0002-7622-7733	National Institutes of Health [RO1-GM083348, R21CA124688]; European Research Council; Agence de Nationale; Biomedical Research Council; National Medical Research Council, Singapore; Institute of Medical Biology; Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE [R21CA124688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Research Council(European Research Council (ERC)European Commission); Agence de Nationale; Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Rod Bronson and the Rodent Pathology Core at Harvard Medical School for help with histology, the staff of the Nikon Imaging Center of the Harvard Medical School for their help with imaging, and Prof. Ed Cox of the Dana Farber Cancer Institute Microarray Facility. We thank Da-Kai Mu for assistance with genotyping. We thank Profs. Birgit Lane of the Institute of Medical Biology, Bernard Dallemagne of the IRCAD, University of Strasbourg, and Teh Ming of the National University of Singapore for helpful discussions. We thank all the members in the Xian-McKeon laboratory for helpful discussions and support and Profs. Edison Liu and Barbara Knowles for their critical review of the manuscript. This work was supported by grants from the National Institutes of Health (RO1-GM083348 and R21CA124688), the European Research Council, the Agence de Nationale, and the Biomedical Research Council and the National Medical Research Council, Singapore and intramural grants from the Institute of Medical Biology and the Genome Institute of Singapore of the Agency for Science, Technology, and Research, Singapore.	Antonioli DA, 1997, GASTROENTEROL CLIN N, V26, P495, DOI 10.1016/S0889-8553(05)70309-5; Badreddine RJ, 2010, NAT REV GASTRO HEPAT, V7, P369, DOI 10.1038/nrgastro.2010.78; Barr H, 1996, LANCET, V348, P584, DOI 10.1016/S0140-6736(96)03054-1; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; Botelho NK, 2010, CANCER BIOL THER, V10, P172, DOI 10.4161/cbt.10.2.12166; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; Coad RA, 2005, J PATHOL, V206, P388, DOI 10.1002/path.1804; CORREA P, 1994, CANCER SURV, V20, P55; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Dixon J, 2001, AM J GASTROENTEROL, V96, P2575, DOI 10.1111/j.1572-0241.2001.04159.x; Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.037, 10.1053/j.gastro.2009.12.035]; Glickman JN, 2001, AM J SURG PATHOL, V25, P569, DOI 10.1097/00000478-200105000-00002; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jankowski JA, 1999, AM J PATHOL, V154, P965, DOI 10.1016/S0002-9440(10)65346-1; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kiran RP, 2010, ANN SURG, V252, P330, DOI 10.1097/SLA.0b013e3181e61e69; Leedham SJ, 2008, GUT, V57, P1041, DOI 10.1136/gut.2007.143339; LEVINE DS, 1989, LAB INVEST, V60, P418; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mutoh H, 2002, BIOCHEM BIOPH RES CO, V294, P470, DOI 10.1016/S0006-291X(02)00480-1; NAEF AP, 1975, J THORAC CARDIOV SUR, V70, P826; Piazuelo MB, 2004, MODERN PATHOL, V17, P62, DOI 10.1038/modpathol.3800016; RASKIND WH, 1992, CANCER RES, V52, P2946; REID BJ, 1991, GASTROENTEROL CLIN N, V20, P817; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; SAGAR PM, 1995, BRIT J SURG, V82, P806, DOI 10.1002/bjs.1800820628; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Souza RF, 2008, AM J PHYSIOL-GASTR L, V295, pG211, DOI 10.1152/ajpgi.90250.2008; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stairs DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003534; Strobel O, 2010, GASTROENTEROLOGY, V138, P1166, DOI 10.1053/j.gastro.2009.12.005; Suh E, 1996, MOL CELL BIOL, V16, P619; Tobey NA, 2007, AM J PHYSIOL-GASTR L, V293, pG264, DOI 10.1152/ajpgi.00047.2007; van Baal JWPM, 2008, SCAND J GASTROENTERO, V43, P132, DOI 10.1080/00365520701676575; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang J, 2009, J GASTROENTEROL, V44, P897, DOI 10.1007/s00535-009-0082-2; Weimann A, 2010, VIRCHOWS ARCH, V457, P537, DOI 10.1007/s00428-010-0972-y; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	45	245	252	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1023	1035		10.1016/j.cell.2011.05.026	http://dx.doi.org/10.1016/j.cell.2011.05.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703447	Green Accepted, Bronze			2022-12-28	WOS:000292025700010
J	Martin, J				Martin, Jeremy			Don't foul the water	NATURE			English	Editorial Material									[Martin, Jeremy] Union Concerned Scientists, Cambridge, MA USA		Martin, J (corresponding author), Union Concerned Scientists, Cambridge, MA USA.	JMartin@ucsusa.org						EPA, 2008, TECH REP; *USDA, 2010, FEEDGR YB	2	11	13	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S17	S17		10.1038/474S017a	http://dx.doi.org/10.1038/474S017a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697836	Bronze			2022-12-28	WOS:000291939700006
J	Rosen, HR				Rosen, Hugo R.			Chronic Hepatitis C Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; FIBROSIS PROGRESSION; COMBINATION THERAPY; NATURAL-HISTORY; PLUS RIBAVIRIN; LIVER FIBROSIS; UNITED-STATES; TELAPREVIR	A 45-year-old man undergoing a routine examination for life insurance is noted to have an aspartate aminotransferase level of 80 U per milliliter (normal range, 9 to 40) and an alanine aminotransferase level of 110 U per milliliter (normal range, 7 to 52). He reports a remote history of intravenous drug use. Tests for hepatitis C antibody and hepatitis B surface antibody are positive, and tests for hepatitis A and human immunodeficiency virus (HIV) antibodies are negative. Genotyping of the hepatitis C virus (HCV) reveals genotype 1b; the viral load is 2,460,000 IU per milliliter. The complete blood count is normal; the platelet count is 220x10(9) per liter. An abdominal ultrasonogram is normal. How should this patient's case be managed?	[Rosen, Hugo R.] Univ Colorado, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Aurora, CO USA; [Rosen, Hugo R.] Eastern Colorado Vet Affairs Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Rosen, HR (corresponding author), Univ Colorado Denver, Div Gastroenterol & Hepatol, B-158 Acad Off Bldg 1,12631 E 17th Ave,Rm 7614, Aurora, CO 80045 USA.	hugo.rosen@ucdenver.edu	Hug, Balthasar L./G-1568-2010					Afdhal NH, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-832922; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Becker L, 2009, CLIN GASTROENTEROL H, V7, P696, DOI 10.1016/j.cgh.2009.01.010; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Craxi A, 2011, J HEPATOL       0228; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Dienstag JL, 2006, GASTROENTEROLOGY, V131, P979; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P1018; Dienstag JL, 2006, GASTROENTEROLOGY, V130, P225, DOI 10.1053/j.gastro.2005.11.011; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Ferenci P, 2004, SEMIN LIVER DIS, V24, P25, DOI 10.1055/s-2004-832925; Foster GR, 2007, SCAND J GASTROENTERO, V42, P247, DOI 10.1080/00365520600955526; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gelman MA, 2010, TRENDS MOL MED  1122; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Golden-Mason L, 2008, J IMMUNOL, V180, P3637, DOI 10.4049/jimmunol.180.6.3637; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Hoofnagle JH, 2009, NEW ENGL J MED, V360, P1899, DOI 10.1056/NEJMe0901869; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; McMahan RH, 2011, J CLIN INVEST, V121, P821, DOI 10.1172/JCI46311; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Moreno C, 2010, J HEPATOL, V52, P25, DOI 10.1016/j.jhep.2009.10.003; Pawlotsky Jean-Michel, 2011, Gastroenterology, V140, P746, DOI 10.1053/j.gastro.2011.01.028; Pinzani M, 2006, GUT, V55, P310, DOI 10.1136/gut.2005.068585; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rosen HR, 2007, HEPATOLOGY, V46, P350, DOI 10.1002/hep.21714; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thio CL, 2010, GASTROENTEROLOGY, V138, P1240, DOI 10.1053/j.gastro.2010.02.033; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	54	322	347	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2429	2438		10.1056/NEJMcp1006613	http://dx.doi.org/10.1056/NEJMcp1006613			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696309				2022-12-28	WOS:000291936100008
J	Taveira-DaSilva, AM; Hathaway, O; Stylianou, M; Moss, J				Taveira-DaSilva, Angelo M.; Hathaway, Olanda; Stylianou, Mario; Moss, Joel			Changes in Lung Function and Chylous Effusions in Patients With Lymphangioleiomyomatosis Treated With Sirolimus	ANNALS OF INTERNAL MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; GENE-PRODUCTS; MOUSE MODELS; IFN-GAMMA; RAPAMYCIN; LAM; CHYLOTHORAX; DISEASE; WOMEN	Background: Lymphangioleiomyomatosis (LAM) is a disorder that affects women and is characterized by cystic lung destruction, chylous effusions, lymphangioleiomyomas, and angiomyolipomas. It is caused by proliferation of abnormal smooth muscle-like cells. Sirolimus is a mammalian target of rapamycin inhibitor that has been reported to decrease the size of neoplastic growths in animal models of tuberous sclerosis complex and to reduce the size of angiomyolipomas and stabilize lung function in humans. Objective: To assess whether sirolimus therapy is associated with improvement in lung function and a decrease in the size of chylous effusions and lymphangioleiomyomas in patients with LAM. Design: Observational study. Setting: The National Institutes of Health Clinical Center. Patients: 19 patients with rapidly progressing LAM or chylous effusions. Intervention: Treatment with sirolimus. Measurements: Lung function and the size of chylous effusions and lymphangioleiomyomas before and during sirolimus therapy. Results: Over a mean of 2.5 years before beginning sirolimus therapy, the mean (+/- SE) FEV1 decreased by 2.8% +/- 0.8% predicted and diffusing capacity of the lung for carbon monoxide (DLCO) decreased by 4.8% +/- 0.9% predicted per year. In contrast, over a mean of 2.6 years of sirolimus therapy, the mean (+/- SE) FEV1 increased by 1.8% +/- 0.5% predicted and DLCO increased by 0.8% +/- 0.5% predicted per year (P < 0.001). After beginning sirolimus therapy, 12 patients with chylous effusions and 11 patients with lymphangioleiomyomas experienced almost complete resolution of these conditions. In 2 of the 12 patients, sirolimus therapy enabled discontinuation of pleural fluid drainage. Limitations: This was an observational study. The resolution of effusions may have affected improvements in lung function. Conclusion: Sirolimus therapy is associated with improvement or stabilization of lung function and reduction in the size of chylous effusions and lymphangioleiomyomas in patients with LAM.	[Taveira-DaSilva, Angelo M.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Taveira-DaSilva, AM (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, Bldg 10,Room 6D05,MSC 1590, Bethesda, MD 20892 USA.	dasilvaa@nhlbi.nih.gov			NHLBI, NIH [95-H-0186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: By the Intramural Research Program, NHLBI, NIH (protocol 95-H-0186).	Almoosa KF, 2006, CLIN CHEST MED, V27, P355, DOI 10.1016/j.ccm.2006.01.005; Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Cohen MM, 2005, THORAX, V60, P875, DOI 10.1136/thx.2004.035154; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Glasgow Connie G., 2009, Lymphatic Research and Biology, V7, P221, DOI 10.1089/lrb.2009.0017; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Goncharova EA, 2008, J CELL BIOCHEM, V103, P369, DOI 10.1002/jcb.21419; Gupta Dipin, 2004, Ann Thorac Surg, V78, pe9, DOI 10.1016/j.athoracsur.2003.12.069; Hayashida M, 2007, RESPIROLOGY, V12, P523, DOI 10.1111/j.1440-1843.2007.01101.x; Jaiswal VR, 2003, ARCH PATHOL LAB MED, V127, P879; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Kenerson H, 2005, PEDIATR RES, V57, P67, DOI 10.1203/01.PDR.0000147727.78571.07; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Krymskaya VP, 2009, CELL CYCLE, V8, P403, DOI 10.4161/cc.8.3.7555; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Lazor R, 2004, RESP MED, V98, P536, DOI 10.1016/j.rmed.2003.11.013; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lu HC, 2003, CLIN IMAG, V27, P166, DOI 10.1016/S0899-7071(01)00349-7; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Makrilakis K, 2004, ANN INTERN MED, V141, P246, DOI 10.7326/0003-4819-141-3-200408030-00028; Matsui K, 2000, HUM PATHOL, V31, P1242, DOI 10.1053/hupa.2000.18500; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Mikroulis D, 2002, CHEST, V121, P2079, DOI 10.1378/chest.121.6.2079; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; NELLIST M, 1993, CELL, V75, P1305; Ohara T, 2008, ANN THORAC SURG, V86, pE7, DOI 10.1016/j.athoracsur.2008.07.062; OSBORNE JP, 1991, ANN NY ACAD SCI, V615, P125; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Ryu JH, 2003, CHEST, V123, P623, DOI 10.1378/chest.123.2.623; Smolarek TA, 1998, AM J HUM GENET, V62, P810, DOI 10.1086/301804; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Sugimoto R, 2008, J HEART LUNG TRANSPL, V27, P921, DOI 10.1016/j.healun.2008.05.012; Taille C, 2007, ANN INTERN MED, V146, P687, DOI 10.7326/0003-4819-146-9-200705010-00022; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Wong YY, 2003, AM J ROENTGENOL, V181, P284, DOI 10.2214/ajr.181.1.1810284	45	138	142	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					797	805		10.7326/0003-4819-154-12-201106210-00007	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690594	Green Accepted			2022-12-28	WOS:000291800500015
J	Windrim, R				Windrim, Rory			PPI use in the first trimester was not associated with increased risk for birth defects; PPI use 1 to 4 weeks before conception was	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Windrim, Rory] Univ Toronto, Maternal Fetal Med, Toronto, ON, Canada	University of Toronto	Windrim, R (corresponding author), Univ Toronto, Maternal Fetal Med, Toronto, ON, Canada.		Windrim, Rory/AAC-6038-2020; Windrim, Rory/ABD-6799-2021; Windrim, Rory/B-7617-2016					Richter JE, 2003, GASTROENTEROL CLIN N, V32, P235, DOI 10.1016/S0889-8553(02)00065-1	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-11	10.7326/0003-4819-154-12-201106210-02011	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690589				2022-12-28	WOS:000291800500010
J	Smith, DL; Cohen, JM; Moonen, B; Tatem, AJ; Sabot, OJ; Ali, A; Mugheiry, SM				Smith, David L.; Cohen, Justin M.; Moonen, Bruno; Tatem, Andrew J.; Sabot, Oliver J.; Ali, Abdullah; Mugheiry, Sultan M.			Solving the Sisyphean Problem of Malaria in Zanzibar	SCIENCE			English	Editorial Material							ELIMINATION		[Smith, David L.; Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Smith, David L.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Cohen, Justin M.; Moonen, Bruno; Sabot, Oliver J.] Clinton Hlth Access Initiat, Boston, MA 02127 USA; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Ali, Abdullah] Zanzibar Malaria Control Programme, Zanzibar, Tanzania; [Mugheiry, Sultan M.] Hlth & Social Welf, Zanzibar, Tanzania	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Smith, DL (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	smitdave@gmail.com	Smith, David L/L-8850-2013	Smith, David L/0000-0003-4367-3849; Cohen, Justin/0000-0003-4481-6784; Tatem, Andrew/0000-0002-7270-941X				Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Feachem RGA, 2009, SHRINKING MALARIA MA; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; MATOLA YG, 1984, CENT AFR J MED, V30, P95; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; OAKES A, 1900, BRIT FOREIGN STATE P; RBMP, 2008, GLOB MAL ACT PLAN MA; Sabot O, 2010, LANCET, V376, P1604, DOI 10.1016/S0140-6736(10)61355-4; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zanzibar Malaria Control Programme (ZMCP), 2008, ROLL BACK MAL IND SU; *ZMCP, 2009, MAL EL ZANZ FEAS ASS; *ZMCP, 2011, ROLL BACK MAL IND SU	15	27	28	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1384	1385		10.1126/science.1201398	http://dx.doi.org/10.1126/science.1201398			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778FT	21680828				2022-12-28	WOS:000291689000024
J	Grontved, A; Hu, FB				Grontved, Anders; Hu, Frank B.			Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED-CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIORS; EPIC-NORFOLK; TIME; OBESITY; WOMEN; MEN; EPIDEMIOLOGY; EXPENDITURE	Context Prolonged television (TV) viewing is the most prevalent and pervasive sedentary behavior in industrialized countries and has been associated with morbidity and mortality. However, a systematic and quantitative assessment of published studies is not available. Objective To perform a meta-analysis of all prospective cohort studies to determine the association between TV viewing and risk of type 2 diabetes, fatal or nonfatal cardiovascular disease, and all-cause mortality. Data Sources and Study Selection Relevant studies were identified by searches of the MEDLINE database from 1970 to March 2011 and the EMBASE database from 1974 to March 2011 without restrictions and by reviewing reference lists from retrieved articles. Cohort studies that reported relative risk estimates with 95% confidence intervals (CIs) for the associations of interest were included. Data Extraction Data were extracted independently by each author and summary estimates of association were obtained using a random-effects model. Data Synthesis Of the 8 studies included, 4 reported results on type 2 diabetes (175 938 individuals; 6428 incident cases during 1.1 million person-years of follow-up), 4 reported on fatal or nonfatal cardiovascular disease (34 253 individuals; 1052 incident cases), and 3 reported on all-cause mortality (26 509 individuals; 1879 deaths during 202 353 person-years of follow-up). The pooled relative risks per 2 hours of TV viewing per day were 1.20 (95% CI, 1.14-1.27) for type 2 diabetes, 1.15 (95% CI, 1.06-1.23) for fatal or nonfatal cardiovascular disease, and 1.13 (95% CI, 1.07-1.18) for all-cause mortality. While the associations between time spent viewing TV and risk of type 2 diabetes and cardiovascular disease were linear, the risk of all-cause mortality appeared to increase with TV viewing duration of greater than 3 hours per day. The estimated absolute risk differences per every 2 hours of TV viewing per day were 176 cases of type 2 diabetes per 100 000 individuals per year, 38 cases of fatal cardiovascular disease per 100 000 individuals per year, and 104 deaths for all-cause mortality per 100 000 individuals per year. Conclusion Prolonged TV viewing was associated with increased risk of type 2 diabetes, cardiovascular disease, and all-cause mortality. JAMA. 2011;305(23):2448-2455 www.jama.com	[Grontved, Anders; Hu, Frank B.] Harvard Univ, Sch Med, Channing Lab, Sch Publ Hlth,Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Med, Channing Lab, Sch Publ Hlth,Dept Epidemiol, Boston, MA 02115 USA; [Grontved, Anders] Univ So Denmark, Ctr Res Childhood Hlth, Dept Exercise Epidemiol, Inst Sport Sci & Clin Biomech, Odense, Denmark; [Hu, Frank B.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; University of Southern Denmark; Harvard University; Brigham & Women's Hospital	Hu, FB (corresponding author), Harvard Univ, Sch Med, Channing Lab, Sch Publ Hlth,Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Grøntved, Anders/AAA-8025-2022	Grontved, Anders/0000-0003-1584-679X	Danish Heart Foundation; Sygekassernes Helsefond; Oticon Foundation; Augustinus Foundation; National Institutes of Health [DK58845, P30 DK46200]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK058845] Funding Source: NIH RePORTER	Danish Heart Foundation; Sygekassernes Helsefond; Oticon Foundation; Augustinus Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mr Grontved is supported by the Danish Heart Foundation, Sygekassernes Helsefond (the Danish Health Fund), the Oticon Foundation, and the Augustinus Foundation. Dr Hu is supported by National Institutes of Health grant DK58845 and P30 DK46200.	Australian Bureau of Statistics, 2006, AUSTR US THEIR TIM; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekelund U, 2009, DIABETES CARE, V32, P1081, DOI 10.2337/dc08-1895; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Ford ES, 2010, J DIABETES, V2, P23, DOI 10.1111/j.1753-0407.2009.00047.x; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; Gidwani PP, 2002, PEDIATRICS, V110, P505, DOI 10.1542/peds.110.3.505; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; Hu FB, 2001, ARCH INTERN MED, V161, P1542, DOI 10.1001/archinte.161.12.1542; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Krishnan S, 2009, AM J EPIDEMIOL, V169, P428, DOI 10.1093/aje/kwn344; Leitzmann MF, 2007, ARCH INTERN MED, V167, P2453, DOI 10.1001/archinte.167.22.2453; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Nielsen Co, TV US TRENDS Q3 Q4 2; Office for Official Publications of the European Communities, 2003, TIM US DIFF STAG LIF; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Parsons TJ, 2008, EUR J CLIN NUTR, V62, P1355, DOI 10.1038/sj.ejcn.1602884; Robinson TN, 1999, JAMA-J AM MED ASSOC, V282, P1561, DOI 10.1001/jama.282.16.1561; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tobias A., 1999, STATA TECHNICAL B, V8, P15; US Centers for Disease Control and Prevention, 1980, CRUD AG ADJ INC DIAG; Vereecken CA, 2006, PUBLIC HEALTH NUTR, V9, P244, DOI 10.1079/PHN2005847; Warren TY, 2010, MED SCI SPORT EXER, V42, P879, DOI 10.1249/MSS.0b013e3181c3aa7e; Weller I, 1998, EPIDEMIOLOGY, V9, P632, DOI 10.1097/00001648-199811000-00012; Wiecha JL, 2006, ARCH PEDIAT ADOL MED, V160, P436, DOI 10.1001/archpedi.160.4.436; Wijndaele K, 2010, OBES REV S1, V11, P305; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wijndaele K, 2010, MED SCI SPORT EXER, V42, P1511, DOI 10.1249/MSS.0b013e3181d322ac; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1	39	581	599	2	81	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2448	2455		10.1001/jama.2011.812	http://dx.doi.org/10.1001/jama.2011.812			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673296	Green Accepted			2022-12-28	WOS:000291597300025
J	Issigonis, M; Matunis, E				Issigonis, Melanie; Matunis, Erika			SnapShot: Stem Cell Niches of the Drosophila Testis and Ovary	CELL			English	Editorial Material							DIVISION		[Issigonis, Melanie; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Issigonis, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.				NCRR NIH HHS [S10 RR024550] Funding Source: Medline; NICHD NIH HHS [R01 HD040307] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024550] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Cheng J, 2011, DEVELOPMENT, V138, P831, DOI 10.1242/dev.057901; DECUEVAS M, 2011, DEV IN PRESS, V138, DOI DOI 10.1242/DEV.056242; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Ueishi S, 2009, CELL STRUCT FUNCT, V34, P61, DOI 10.1247/csf.08042; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313	10	9	9	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					994	U197		10.1016/j.cell.2011.05.037	http://dx.doi.org/10.1016/j.cell.2011.05.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663800	Bronze			2022-12-28	WOS:000291461600025
J	Scott, CT; McCormick, JB; DeRouen, MC; Owen-Smith, J				Scott, Christopher Thomas; McCormick, Jennifer B.; DeRouen, Mindy C.; Owen-Smith, Jason			Democracy Derived? New Trajectories in Pluripotent Stem Cell Research	CELL			English	Editorial Material								How has the development of human induced pluripotent stem cells (hiPSCs) modified the trajectory of stem cell research? Here, coauthorship networks of stem cell research articles and analysis of cell lines used in stem cell research indicate that hiPSCs are not replacing human embryonic stem cells, but instead, the two cell types are complementary, interdependent research tools. Thus, we conclude that a ban on funding for embryonic stem cell research could have unexpected negative ramifications on the nascent field of hiPSCs.	[Scott, Christopher Thomas; DeRouen, Mindy C.] Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA; [McCormick, Jennifer B.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [McCormick, Jennifer B.] Mayo Clin, Div Hlth Care Policy Res, Rochester, MN 55905 USA; [Owen-Smith, Jason] Univ Michigan, Ann Arbor, MI 48109 USA	Stanford University; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan	Scott, CT (corresponding author), Stanford Univ, Stanford Univ Ctr Biomed Eth Program Stem Cells &, Stanford, CA 94305 USA.	cscott@stanford.edu; jdos@umich.edu	McBee, David J/F-3968-2012; Owen-Smith, Jason/B-3665-2012	DeRouen, Mindy/0000-0002-7198-7629; Owen-Smith, Jason/0000-0001-8007-1121	NCRR NIH HHS [UL1 RR024150-4, UL1 RR024150] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Moody J, 2004, AM SOCIOL REV, V69, P213, DOI 10.1177/000312240406900204; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Scott CT, 2010, NAT METHODS, V7, P866, DOI 10.1038/nmeth1110-866; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135	14	33	34	7	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					820	826		10.1016/j.cell.2011.05.032	http://dx.doi.org/10.1016/j.cell.2011.05.032			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663787	Green Accepted, Bronze			2022-12-28	WOS:000291461600009
J	Banwart, S				Banwart, Steve			Save our soils	NATURE			English	Editorial Material									[Banwart, Steve] Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England	University of Sheffield	Banwart, S (corresponding author), Univ Sheffield, Kroto Res Inst, Sheffield S3 7HQ, S Yorkshire, England.	s.a.banwart@sheffield.ac.uk	Banwart, Steven/B-3915-2016; Robinson, David A/A-6287-2010	Banwart, Steven/0000-0001-7223-6678; Robinson, David A/0000-0001-7290-4867				Alcamo J, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P541; Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; European Commission, 2006, COM2006231 EUR COMM; European Environmental Agency (EEA), 2006, URB SPRAWL EUR IGN C; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Shein E.V., 2005, KURS FIZIKI POCHV UC	7	126	135	2	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					151	152		10.1038/474151a	http://dx.doi.org/10.1038/474151a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21654781	Green Accepted			2022-12-28	WOS:000291397800025
J	Moore, W				Moore, Wendy			PAST CARING Shocking treatment	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2011	342								d3566	10.1136/bmj.d3566	http://dx.doi.org/10.1136/bmj.d3566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SO	21653623				2022-12-28	WOS:000291645500018
J	Gomez, MI; Barrett, CB; Buck, LE; De Groote, H; Ferris, S; Gao, HO; McCullough, E; Miller, DD; Outhred, H; Pell, AN; Reardon, T; Retnanestri, M; Ruben, R; Struebi, P; Swinnen, J; Touesnard, MA; Weinberger, K; Keatinge, JDH; Milstein, MB; Yang, RY				Gomez, M. I.; Barrett, C. B.; Buck, L. E.; De Groote, H.; Ferris, S.; Gao, H. O.; McCullough, E.; Miller, D. D.; Outhred, H.; Pell, A. N.; Reardon, T.; Retnanestri, M.; Ruben, R.; Struebi, P.; Swinnen, J.; Touesnard, M. A.; Weinberger, K.; Keatinge, J. D. H.; Milstein, M. B.; Yang, R. Y.			Research Principles for Developing Country Food Value Chains	SCIENCE			English	Editorial Material							MARKET PARTICIPATION; TRADE; STANDARDS; POVERTY; SAFETY; IMPACT		[Gomez, M. I.; Barrett, C. B.; Buck, L. E.; Gao, H. O.; Miller, D. D.; Pell, A. N.; Touesnard, M. A.; Milstein, M. B.] Cornell Univ, Ithaca, NY 14853 USA; [De Groote, H.] Int Maize & Wheat Improvement Ctr, Nairobi, Kenya; [Ferris, S.] Catholic Relief Serv, Baltimore, MD 21201 USA; [McCullough, E.] Bill & Melinda Gates Fdn, Seattle, WA 98102 USA; [Outhred, H.; Retnanestri, M.] Univ New S Wales, Sydney, NSW 2052, Australia; [Reardon, T.] Michigan State Univ, E Lansing, MI 48824 USA; [Ruben, R.] Radboud Univ Nijmegen, NL-6500 Nijmegen, Netherlands; [Struebi, P.] Fairtrasa, Michoacan 60080, Mexico; [Swinnen, J.] Katholieke Univ Leuven, B-3000 Louvain, Belgium; [Weinberger, K.] Ctr Alleviat Poverty Sustainable Agr, Bogor 16111, Indonesia; [Keatinge, J. D. H.; Yang, R. Y.] World Vegetable Ctr, Tainan 74199, Taiwan	Cornell University; Bill & Melinda Gates Foundation; University of New South Wales Sydney; Michigan State University; Radboud University Nijmegen; KU Leuven	Gomez, MI (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	mig7@cornell.edu	Gomez, Miguel I./AAD-3707-2019; Swinnen, Johan/AAC-1736-2021; Barrett, Christopher B./A-9750-2009; Pell, Alice/N-6607-2019; De Groote, Hugo/C-7525-2009	Swinnen, Johan/0000-0002-8650-1978; Barrett, Christopher B./0000-0001-9139-2721; De Groote, Hugo/0000-0002-5081-0189				[Anonymous], 1983, FOOD POLICY ANAL; Barrett CB, 2008, FOOD POLICY, V33, P299, DOI 10.1016/j.foodpol.2007.10.005; Burney J, 2010, P NATL ACAD SCI USA, V107, P1848, DOI 10.1073/pnas.0909678107; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; Food and Agriculture Organization of the United Nations (FAO), 2010, 13 UN FAO; Kader AA, 2005, ACTA HORTIC, P2169, DOI 10.17660/ActaHortic.2005.682.296; Lal R, 2010, CROP SCI, V50, pS120, DOI 10.2135/cropsci2010.01.0012; Lawrence M. A., 2008, ASIA PAC J CLIN N S3, V17, pS29; Maertens M, 2009, WORLD DEV, V37, P161, DOI 10.1016/j.worlddev.2008.04.006; Minten B, 2008, WORLD DEV, V36, P797, DOI 10.1016/j.worlddev.2007.05.004; Otsuki T, 2001, FOOD POLICY, V26, P495, DOI 10.1016/S0306-9192(01)00018-5; Reardon T., 2002, Development Policy Review, V20, P371, DOI 10.1111/1467-7679.00178; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Reardon T, 2009, WORLD DEV, V37, P1717, DOI 10.1016/j.worlddev.2008.08.023; Regmi A., 2005, Amber Waves, V3, P12; Renkow M, 2004, J DEV ECON, V73, P349, DOI 10.1016/j.jdeveco.2003.02.003; Ruben R, 2009, DEV PRACT, V19, P777, DOI 10.1080/09614520903027049; Silva-Barbeau Irma, 2005, Food and Nutrition Bulletin, V26, P297; Unnevehr LJ, 2007, AGR ECON-BLACKWELL, V37, P149, DOI 10.1111/j.1574-0862.2007.00241.x	19	85	86	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1154	1155		10.1126/science.1202543	http://dx.doi.org/10.1126/science.1202543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	772BO	21636760				2022-12-28	WOS:000291205200032
J	van Kuppeveld, FJM; van der Meer, JWM				van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.			XMRV and CFS-the sad end of a story	LANCET			English	Editorial Material							CHRONIC-FATIGUE-SYNDROME; VIRUS-RELATED VIRUS; NO ASSOCIATION; RETROVIRUS; FAILURE; ABSENCE; DETECT; BLOOD		[van Kuppeveld, Frank J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6500 HB Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Infect Inflammat & Immun, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	van der Meer, Jos W.M./C-8521-2013	van der Meer, Jos W.M./0000-0001-5120-3690; van Kuppeveld, Frank/0000-0001-5800-749X				Alberts B, 2011, SCIENCE, DOI [10.1126/science.1208542, DOI 10.1126/SCIENCE.1208542]; [Anonymous], 2011, LANCET, V377, P1808, DOI 10.1016/S0140-6736(11)60696-X; [Anonymous], PHOENIX RISING TREAT; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Furuta RA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-20; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Lloyd A, 2010, SCIENCE, V328, DOI 10.1126/science.1183706; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Marcus AD, 2011, WALL STREET J   0531, V31; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Schutzer SE, 2011, ANN NEUROL, V69, P735, DOI 10.1002/ana.22389; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; van Kuppeveld FJ, 2010, BMJ-BRIT MED J, V340, P1018; Weiss RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-124	21	11	11	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					E27	E28		10.1016/S0140-6736(11)60899-4	http://dx.doi.org/10.1016/S0140-6736(11)60899-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	21696817				2022-12-28	WOS:000300187800001
J	Larson, HJ; Cooper, LZ; Eskola, J; Katz, SL; Ratzan, S				Larson, Heidi J.; Cooper, Louis Z.; Eskola, Juhani; Katz, Samuel L.; Ratzan, Scott			New Decade of Vaccines 5 Addressing the vaccine confidence gap	LANCET			English	Article							ADVERSE EVENTS; TRUST; RISK; AUTISM; SAFETY; IMMUNIZATION; EXPERIENCE; RESISTANCE; INDIA	Vaccines-often lauded as one of the greatest public health interventions are losing public confidence. Some vaccine experts have referred to this decline in confidence as a crisis. We discuss some of the characteristics of the changing global environment that are contributing to increased public questioning of vaccines, and outline some of the specific determinants of public trust. Public decision making related to vaccine acceptance is neither driven by scientific nor economic evidence alone, but is also driven by a mix of psychological, sociocultural, and political factors, all of which need to be understood and taken into account by policy and other decision makers. Public trust in vaccines is highly variable and building trust depends on understanding perceptions of vaccines and vaccine risks, historical experiences, religious or political affiliations, and socioeconomic status. Although provision of accurate, scientifically based evidence on the risk benefit ratios of vaccines is crucial, it is not enough to redress the gap between current levels of public confidence in vaccines and levels of trust needed to ensure adequate and sustained vaccine coverage. We call for more research not just on individual determinants of public trust, but on what mix of factors are most likely to sustain public trust. The vaccine community demands rigorous evidence on vaccine efficacy and safety and technical and operational feasibility when introducing a new vaccine, but has been negligent in demanding equally rigorous research to understand the psychological, social, and political factors that affect public trust in vaccines.	[Larson, Heidi J.] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Cooper, Louis Z.] Columbia Univ, Coll Phys & Surg, Dept Paediat, New York, NY USA; [Eskola, Juhani] Natl Inst Hlth & Welf THL, Helsinki, Finland; [Katz, Samuel L.] Duke Univ, Dept Paediat, Durham, NC USA; [Ratzan, Scott] Johnson & Johnson, Govt Affairs & Policy, New Brunswick, NJ USA	University of London; London School of Hygiene & Tropical Medicine; Columbia University; Finland National Institute for Health & Welfare; Duke University; Johnson & Johnson; Johnson & Johnson USA	Larson, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	heidi.larson@lshtm.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583	Bill & Melinda Gates Foundation; Novartis	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Novartis(Novartis)	HJL is funded by the Bill & Melinda Gates Foundation as principal investigator for research on public confidence in immunisation. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of their employers. We thank David Salisbury for providing data for figure 2 and for useful discussion on the paper; Anne Louise-Kinmonth for reviewing subsquent drafts; and Pauline Brocard, Lee Barker, Caitlin Jarret, Isaac Ghinai, Jay Dowle, Larry Madoff, Melissa Cumming, and Louise Paushter for researching case studies.; JE received funding from Novartis for a pneumococcal advisory meeting and as a data and safety monitoring board member for meningococcal and typhoid vaccines. SR edits the Journal of Health Communication, with faculty appointments at Tufts School of Medicine and George Washington School of Public Health and Health Services. SR contributed independently of his principal employer, Johnson & Johnson. Some technical work, travel (LZC and SLK), and meetings relevant to this work were funded by the Bill & Melinda Gates Foundation. The funding organisation had no role in the drafting or direction of this report. HJL declares that she has no conflicts of interest.	Akehurst C, 1998, EURO SURVEILL, V2; Alesina A, 2002, J PUBLIC ECON, V85, P207, DOI 10.1016/S0047-2727(01)00084-6; Andrus JK, 2007, PUBLIC HEALTH REP, V122, P811; [Anonymous], WHO VACC PREV DIS MO; [Anonymous], MMWR, V581, P357; [Anonymous], J MCCARTHY JOINS DEF; [Anonymous], PROJECT SUPPORT PUBL; Autran B, 2009, EXPERT REV VACCINES, V8, P705, DOI [10.1586/erv.09.40, 10.1586/ERV.09.40]; Bean SJ, 2011, VACCINE, V29, P1874, DOI 10.1016/j.vaccine.2011.01.003; Bedford H, 2000, BMJ-BRIT MED J, V320, P240, DOI 10.1136/bmj.320.7229.240; Bingham A., 2009, OPEN VACCINE J, V2, P1, DOI DOI 10.2174/1875035400902010001; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Campbell P, PHIL T RO A IN PRESS; Centers for Disease Control and Prevention, IMP 1999 AAP USPHS J; Centers for Disease Control and Prevention, THIM VACC JOINT STAT; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Clements CJ, 2003, J MED ETHICS, V29, P22, DOI 10.1136/jme.29.1.22; Closser S, 2010, CHASING POLIO PAKIST; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Das J, 2003, SOC SCI MED, V57, P97, DOI 10.1016/S0277-9536(02)00302-7; Davis MM, 2010, VACCINE, V28, P1353, DOI 10.1016/j.vaccine.2009.11.007; Facebook, PRESS ROOM; FLYNN J, 1992, RISK ANAL, V12, P417, DOI 10.1111/j.1539-6924.1992.tb00694.x; Fombonne E, 2008, ARCH GEN PSYCHIAT, V65, P15, DOI 10.1001/archgenpsychiatry.2007.2; Fowler GL, 2007, VACCINE, V25, P3536, DOI 10.1016/j.vaccine.2007.01.082; Freed GL, 2010, PEDIATRICS, V125, P654, DOI 10.1542/peds.2009-1962; GALAZKA AM, 1995, EUR J EPIDEMIOL, V11, P95, DOI 10.1007/BF01719954; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Global Polio Eradication Initiative, REP WHO SECR 60 WORL; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Institute of Medicine, 2004, IMM SAF REV VACC AUT; John J, 2010, INDIAN J MED RES, V132, P463; Kasperson J.X., 2003, SOC CONTOURS RISK, p217.; Kirby D, 2005, EVIDENCE HARM MERCUR; Larson HJ, 2010, LANCET, V376, P572, DOI 10.1016/S0140-6736(10)60881-1; Larson HJ, 2010, JAMA-J AM MED ASSOC, V303, P271, DOI 10.1001/jama.2009.2023; Lone Z, 2010, INDIAN J MED RES, V132, P1; Lopalco PL, 2009, BUNDESGESUNDHEITSBLA, V52, P1095, DOI 10.1007/s00103-009-0960-z; Martin R, 2009, 4 ANN GLOB IMM M NEW; MCALISTER A, 1982, AM J PUBLIC HEALTH, V72, P43, DOI 10.2105/AJPH.72.1.43; Milstien J, 1995, REPROD HEALTH MATTER, V3, P24; Mnookin S., 2011, PANIC VIRUS; Mudur G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3508; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Offit Paul A., 2011, DEADLY CHOICES ANTIV; [Anonymous], 2008, Bull World Health Organ, V86, P425; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Poland GA, 2011, NEW ENGL J MED, V364, P97, DOI 10.1056/NEJMp1010594; Poland GA, 2010, VACCINE, V28, P6549, DOI 10.1016/j.vaccine.2010.08.032; Puliyel J, 2010, INDIAN J MED RES, V131, P588; Puliyel J, 2010, GUARDIAN LONDON 1027; PULIYEL JM, 2010, BMJ-BRIT MED J, V341, P266; SAVAGE I, 1993, RISK ANAL, V13, P413, DOI 10.1111/j.1539-6924.1993.tb00741.x; Saxena KB, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4001; Schechter R, 2008, ARCH GEN PSYCHIAT, V65, P19, DOI 10.1001/archgenpsychiatry.2007.1; Shetty P, 2010, LANCET, V375, P970, DOI 10.1016/S0140-6736(10)60421-7; Spier RE, 2001, VACCINE, V20, pS78, DOI 10.1016/S0264-410X(01)00306-1; Stephens J, 2009, WASHINGTON POST 0731; Stern P. C., 1996, UNDERSTANDING RISK I; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; TALWAR GP, 1994, P NATL ACAD SCI USA, V91, P8532, DOI 10.1073/pnas.91.18.8532; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Tollefson J, 2010, NATURE, V466, P24, DOI 10.1038/466024a; UK National Health Service, INCR MMR VACC COV EN; UNICEF, COMB ANT RUM LESS LE; United Nations Educational Scientific and Cultural Organization, 2005, PREC PRINC; US Food and Drug Administration, COMPL LIST VACC LIC; Viral hepatitis prevention board, 1999, VACCINE, V17, P2473; WHO, POL VIR RESP NO BORD; World Health Organization, 2009, STAT WORLDS VACC IMM; World Health Organization, WHO PREQ VACC; Wright JA, 2006, EUR J PUBLIC HEALTH, V16, P137, DOI 10.1093/eurpub/cki194; Wroe AL, 2005, VACCINE, V23, P1428, DOI 10.1016/j.vaccine.2004.10.004; Yahya M., 2006, 261 I DEV STUD	77	478	482	2	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2011	378	9790					526	535		10.1016/S0140-6736(11)60678-8	http://dx.doi.org/10.1016/S0140-6736(11)60678-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21664679				2022-12-28	WOS:000294077200032
J	Bannuru, RR; Dvorak, T; Obadan, N; Yu, WW; Patel, K; Chung, M; Ip, S				Bannuru, Raveendhara R.; Dvorak, Tomas; Obadan, Ndidiamaka; Yu, Winifred W.; Patel, Kamal; Chung, Mei; Ip, Stanley			Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; EXTERNAL-BEAM RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; POPULATION-BASED COHORT; DOSE-ESCALATION TRIAL; HYPOFRACTIONATED CONFORMAL RADIOTHERAPY; RANDOMIZED MULTICENTER TRIAL; PHASE-III TRIAL; ACUTE TOXICITY; STANDARD FRACTIONATION	Background: Radiation therapy is one of many treatment options for patients with prostate cancer. Purpose: To update findings on the clinical and biochemical outcomes of radiation therapies for localized prostate cancer. Data Sources: MEDLINE (2007 through March 2011) and the Cochrane Central Register of Controlled Trials (2007 through March 2011). Study Selection: Published English-language comparative studies involving adults with localized prostate cancer who either had first-line radiation therapy or received no initial treatment. Data Extraction: 6 researchers extracted information on study design, potential bias, sample characteristics, interventions, and outcomes and rated the strength of overall evidence. Data for each study were extracted by 1 reviewer and confirmed by another. Data Synthesis: 75 studies (10 randomized, controlled trials [RCTs] and 65 nonrandomized studies) met the inclusion criteria. No RCTs compared radiation therapy with no treatment or no initial treatment. Among the 10 RCTs, 2 compared combinations of radiation therapies, 7 compared doses and fraction sizes of external-beam radiation therapy (EBRT), and 1 compared forms of low-dose rate radiation therapy. Heterogeneous outcomes were analyzed. Overall, moderate-strength evidence consistently showed that a higher EBRT dose was associated with increased rates of long-term biochemical control compared with lower EBRT dose. The body of evidence was rated as insufficient for all other comparisons. Limitations: Studies inconsistently defined and reported outcomes. Much of the available evidence comes from observational studies with treatment selection biases. Conclusion: A lack of high-quality comparative evidence precludes conclusions about the efficacy of radiation treatments compared with no treatments for localized prostate cancer.	[Ip, Stanley] Tufts Univ, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Clin & Translat Sci Inst,Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Ip, S (corresponding author), Tufts Univ, Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Clin & Translat Sci Inst,Sch Med, Box 63,800 Washington St, Boston, MA 02111 USA.	sip@tuftsmedicalcenter.org	Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783	Agency for Healthcare Research and Quality [T32 HS0000060]; U.S. Department of Health and Human Services [290 2007 10055 I]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000060] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.r By AHRQ, U.S. Department of Health and Human Services (contract 290 2007 10055 I). Dr. Bannuru is supported by a grant (T32 HS0000060) from AHRQ.	Abdel-Wahab M, 2008, INT J RADIAT ONCOL, V72, P58, DOI 10.1016/j.ijrobp.2007.12.043; Agency for Healthcare Research and Quality, 2011, AHRQ PUBL, P11; Al-Mamgani A, 2010, RADIOTHER ONCOL, V96, P13, DOI 10.1016/j.radonc.2010.02.022; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; [Anonymous], 2010, COOP GROUP COMM TOX; Aoki M, 2009, JPN J RADIOL, V27, P444, DOI 10.1007/s11604-009-0369-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Choo R, 2010, SUPPORT CARE CANCER, V18, P715, DOI 10.1007/s00520-009-0675-6; Cooperberg MR, 2003, J UROLOGY, V170, pS21, DOI 10.1097/01.ju.0000095025.03331.c6; Franca CAD, 2010, BRACHYTHERAPY, V9, P307, DOI 10.1016/j.brachy.2009.07.011; Deutsch I, 2010, BRACHYTHERAPY, V9, P313, DOI 10.1016/j.brachy.2010.02.196; Eade TN, 2008, INT J RADIAT ONCOL, V71, P338, DOI 10.1016/j.ijrobp.2007.10.019; Eade TN, 2007, INT J RADIAT ONCOL, V68, P682, DOI 10.1016/j.ijrobp.2007.01.008; Elliott SP, 2007, J UROLOGY, V178, P529, DOI 10.1016/j.juro.2007.03.126; Ferrer M, 2008, INT J RADIAT ONCOL, V72, P421, DOI 10.1016/j.ijrobp.2007.12.024; Gaudet M, 2010, INT J RADIAT ONCOL, V77, P153, DOI 10.1016/j.ijrobp.2009.04.049; Goldner G, 2009, STRAHLENTHER ONKOL, V185, P94, DOI 10.1007/s00066-009-1970-3; Gondi V, 2007, UROLOGY, V69, P541, DOI 10.1016/j.urology.2006.12.015; Gore JL, 2009, J NATL CANCER I, V101, P888, DOI 10.1093/jnci/djp114; Hanssen S, 2008, ANTICANCER RES, V28, P2865; Herstein A, 2005, CANCER J, V11, P385, DOI 10.1097/00130404-200509000-00005; Howlader N, 2010, SEER CANC STAT REV; Ip S, 2010, AHRQ TECHNOLOGY ASSE; Jabbari S, 2010, INT J RADIAT ONCOL, V76, P36, DOI 10.1016/j.ijrobp.2009.01.029; Jani AB, 2007, PROSTATE CANCER P D, V10, P82, DOI 10.1038/sj.pcan.4500910; Jani AB, 2007, TECHNOL CANCER RES T, V6, P11, DOI 10.1177/153303460700600102; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Joseph KJ, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-20; Kalakota K, 2010, BRACHYTHERAPY, V9, P131, DOI 10.1016/j.brachy.2009.08.012; Katz AJ, 2010, BMC UROL, V10, DOI 10.1186/1471-2490-10-1; Kuban DA, 2008, INT J RADIAT ONCOL, V70, P67, DOI 10.1016/j.ijrobp.2007.06.054; Kupelian PA, 2008, INT J RADIAT ONCOL, V71, P16, DOI 10.1016/j.ijrobp.2007.09.020; Leborgne F, 2008, INT J RADIAT ONCOL, V72, P770, DOI 10.1016/j.ijrobp.2008.01.023; Leborgne F, 2009, INT J RADIAT ONCOL, V74, P1441, DOI 10.1016/j.ijrobp.2008.10.087; Lesperance RN, 2008, AM J SURG, V195, P616, DOI 10.1016/j.amjsurg.2007.12.037; Lev EL, 2009, SUPPORT CARE CANCER, V17, P509, DOI 10.1007/s00520-008-0493-2; Lin C, 2007, AUSTRALAS RADIOL, V51, P578, DOI 10.1111/j.1440-1673.2007.01896.x; Litwin MS, 2007, CANCER, V109, P2239, DOI 10.1002/cncr.22676; Lukka H, 2005, J CLIN ONCOL, V23, P6132, DOI 10.1200/JCO.2005.06.153; Martinez AA, 2011, INT J RADIAT ONCOL, V79, P363, DOI 10.1016/j.ijrobp.2009.10.035; Martinez AA, 2010, AM J CLIN ONCOL-CANC, V33, P481, DOI 10.1097/COC.0b013e3181b9cd2f; Merrick GS, 2007, AM J CLIN ONCOL-CANC, V30, P228, DOI 10.1097/01.coc.0000258110.11024.c4; Michalski JM, 2010, INT J RADIAT ONCOL, V76, P14, DOI 10.1016/j.ijrobp.2009.01.062; National Cancer Institute Cancer Therapy Evaluation Program, 1999, COMM TOX CRIT MAN; Nieder AM, 2008, J UROLOGY, V180, P2005, DOI 10.1016/j.juro.2008.07.038; Norkus D, 2009, MEDICINA-LITHUANIA, V45, P469, DOI 10.3390/medicina45060061; Pardo Y, 2010, J CLIN ONCOL, V28, P4687, DOI 10.1200/JCO.2009.25.3245; Pe ML, 2009, UROLOGY, V73, P1328, DOI 10.1016/j.urology.2008.09.078; Peeters STH, 2006, J CLIN ONCOL, V24, P1990, DOI 10.1200/JCO.2005.05.2530; Pickles T, 2010, INT J RADIAT ONCOL, V76, P43, DOI 10.1016/j.ijrobp.2009.01.081; Pollack A, 2006, INT J RADIAT ONCOL, V64, P518, DOI 10.1016/j.ijrobp.2005.07.970; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sathya JR, 2005, J CLIN ONCOL, V23, P1192, DOI 10.1200/JCO.2005.06.154; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Song Y, 2008, J APPL CLIN MED PHYS, V9, P2283; Soumarova R, 2007, TUMORI J, V93, P37; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; Stone NN, 2007, INT J RADIAT ONCOL, V69, P1472, DOI 10.1016/j.ijrobp.2007.05.002; Stone NN, 2009, INT J RADIAT ONCOL, V73, P341, DOI 10.1016/j.ijrobp.2008.04.038; Talcott JA, 2010, JAMA-J AM MED ASSOC, V303, P1046, DOI 10.1001/jama.2010.287; Tewari A, 2007, J UROLOGY, V177, P911, DOI 10.1016/j.juro.2006.10.040; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; Vora SA, 2007, INT J RADIAT ONCOL, V68, P1053, DOI 10.1016/j.ijrobp.2007.01.043; Wallner K, 2005, RADIOTHER ONCOL, V75, P307, DOI 10.1016/j.radonc.2005.03.019; Wallner K, 2003, INT J RADIAT ONCOL, V57, P1297, DOI 10.1016/S0360-3016(03)01448-2; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wong WW, 2009, CANCER-AM CANCER SOC, V115, P5596, DOI 10.1002/cncr.24558; Yeoh EE, 2006, INT J RADIAT ONCOL, V66, P1072, DOI 10.1016/j.ijrobp.2006.06.005; Yeoh EK, 2010, INT J RADIAT ONCOL, V78, P773, DOI 10.1016/j.ijrobp.2009.08.050; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V71, P1028, DOI 10.1016/j.ijrobp.2007.11.066; Zelefsky MJ, 2008, BRACHYTHERAPY, V7, P1, DOI 10.1016/j.brachy.2007.12.002; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044; Zhou EH, 2009, INT J RADIAT ONCOL, V73, P15, DOI 10.1016/j.ijrobp.2008.04.001; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475; Zilli T, 2010, TECHNOL CANCER RES T, V9, P263, DOI 10.1177/153303461000900305	78	28	30	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2011	155	3					171	+		10.7326/0003-4819-155-3-201108020-00347	http://dx.doi.org/10.7326/0003-4819-155-3-201108020-00347			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	800DJ	21646550				2022-12-28	WOS:000293339600005
J	Rappuoli, R; Black, S; Lambert, PH				Rappuoli, Rino; Black, Steven; Lambert, Paul Henri			New Decade of Vaccines 2 Vaccine discovery and translation of new vaccine technology	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; HEPATITIS-B-VACCINE; INFLUENZA VACCINES; SYSTEMS BIOLOGY; SAFETY; PREVENTION; EFFICACY; DIPHTHERIA; PERTUSSIS; DISEASE	An unprecedented increase in new vaccine development has occurred over the past three decades. This activity has resulted in vaccines that protect against an increased range of vaccine-preventable diseases, vaccines that reduce the number of required injections, and vaccines with improved safety and purity. New methods of discovery, such as reverse vaccinology, structural biology, and systems biology, promise new vaccines for different diseases and efficient development pathways for these vaccines. We expect development of vaccines not only for infectious diseases in children but also for healthy adults, pregnant women, and elderly people, and for new indications such as autoimmune disease and cancer. We have witnessed a concomitant development of new technology for assessment of vaccine safety to rapidly identify potential safety issues. Success of these new approaches will depend on effective implementation of vaccination programmes, creative thinking on the part of manufacturers and regulators as to how best to ensure that safe and effective vaccines are available in a timely manner, and improvement of public awareness about the benefits and risks of new vaccines in a way that encourages confidence in vaccines.	[Rappuoli, Rino] Novartis Vaccines, I-53100 Siena, Italy; [Black, Steven] Univ Cincinnati, Childrens Hosp, Ctr Global Hlth, Cincinnati, OH USA; [Lambert, Paul Henri] Univ Geneva, Ctr Vaccinol, Geneva, Switzerland	Novartis; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Geneva	Rappuoli, R (corresponding author), Novartis Vaccines, Via Fiorentina 1, I-53100 Siena, Italy.	rino.rappuoli@novartis.com						Alexander LN, 2004, JAMA-J AM MED ASSOC, V292, P1696, DOI 10.1001/jama.292.14.1696; [Anonymous], 2005, CUTTER INCIDENT AM 1; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BELL JF, 1949, P SOC EXP BIOL MED, V70, P457, DOI 10.3181/00379727-70-16960; BISNO AL, 1991, NEW ENGL J MED, V325, P783, DOI 10.1056/NEJM199109123251106; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; BLACK SB, 1988, PEDIATR INFECT DIS J, V7, P149, DOI 10.1097/00006454-198803000-00003; Bowden TA, 2010, BIOCHEM SOC T, V38, P1349, DOI 10.1042/BST0381349; Bringmann A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/623687; Burch P, 1994, PROSTATE, V60, P197; Centers for Disease Control and Prevention, 2011, 2011 CHILD AD IMM SC; Centers for Disease Control and Prevention, 2009, PREL RES SURV GUILL; Centers for Disease Control and Prevention, CDC IMM SCHED; Centers for Disease Control and Prevention, ACT BACT COR SURV; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; Clark TW, 2009, NEW ENGL J MED, V361, P1; Descamps D, 2009, HUM VACCINES, V5, P332, DOI 10.4161/hv.5.5.7211; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FENNER F, 1982, REV INFECT DIS, V4, P916; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Galazka AM, 1996, VACCINE, V14, P845, DOI 10.1016/0264-410X(96)00021-7; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goodman JL, M CHALLENGE PANDEMIC; Greco M, 2009, NEW GENERATION VACCI; HALLIDAY ML, 1990, ARCH INTERN MED, V150, P1195, DOI 10.1001/archinte.150.6.1195; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Immunization Action Coalition, HIST DAT EV REL VACC; Kamath AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005771; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kirkwood BR, 1995, B WORLD HEALTH ORGAN, V73, P793; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klein NP, 2010, PEDIATRICS, V126, pE1, DOI 10.1542/peds.2010-0665; MacDonald NE, 1998, JAMA-J AM MED ASSOC, V280, P1685, DOI 10.1001/jama.280.19.1685; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Moxon ER, 2011, LANCET, V378, P348, DOI 10.1016/S0140-6736(11)60407-8; NEDELEC J, 1990, J NEUROIMMUNOL, V29, P49, DOI 10.1016/0165-5728(90)90146-E; PIALOUX G, 1995, AIDS RES HUM RETROV, V11, P875; Plotkin S., 2008, VACCINES, P1; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Ray GT, 2006, PEDIATR INFECT DIS J, V25, P494, DOI 10.1097/01.inf.0000222403.42974.8b; Roberts L, 2008, SCIENCE, V320, P1712, DOI 10.1126/science.320.5884.1712; Rosenthal S, 1996, ARCH PEDIAT ADOL MED, V150, P457, DOI 10.1001/archpedi.1996.02170300011001; Serruto D, 2006, FEBS LETT, V580, P2985, DOI 10.1016/j.febslet.2006.04.084; STEVENS CE, 1987, JAMA-J AM MED ASSOC, V257, P2612, DOI 10.1001/jama.257.19.2612; Su LL, 2009, LANCET, V374, P1417, DOI 10.1016/S0140-6736(09)61854-7; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; Tsai T, 2010, VACCINE, V28, P1877, DOI 10.1016/j.vaccine.2009.11.077; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; Wenger JD, 1998, PEDIATR INFECT DIS J, V17, pS132, DOI 10.1097/00006454-199809001-00008; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; Zepp F, 2010, VACCINE, V28, pC14, DOI 10.1016/j.vaccine.2010.07.020; Zhang QB, 2010, J INFECT DIS, V201, P1753, DOI 10.1086/652495; Zhu W, 2010, VACCINE, V28, P2865, DOI 10.1016/j.vaccine.2010.01.060	61	66	69	0	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					360	368		10.1016/S0140-6736(11)60440-6	http://dx.doi.org/10.1016/S0140-6736(11)60440-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664687				2022-12-28	WOS:000293615800034
J	Walsh, KJ; Morbidelli, A; Raymond, SN; O'Brien, DP; Mandell, AM				Walsh, Kevin J.; Morbidelli, Alessandro; Raymond, Sean N.; O'Brien, David P.; Mandell, Avi M.			A low mass for Mars from Jupiter's early gas-driven migration	NATURE			English	Article							PROTOPLANETARY DISK; PLANET MIGRATION; SOLAR-SYSTEM; EVOLUTION; DYNAMICS; WATER; BELT	Jupiter and Saturn formed in a few million years (ref. 1) from a gas-dominated protoplanetary disk, and were susceptible to gas-driven migration of their orbits on timescales of only similar to 100,000 years (ref. 2). Hydrodynamic simulations show that these giant planets can undergo a two-stage, inward-then-outward, migration(3-5). The terrestrial planets finished accreting much later(6), and their characteristics, including Mars' small mass, are best reproduced by starting from a planetesimal disk with an outer edge at about one astronomical unit from the Sun(7,8) (1 AU is the Earth-Sun distance). Here we report simulations of the early Solar System that show how the inward migration of Jupiter to 1.5 AU, and its subsequent outward migration, lead to a planetesimal disk truncated at 1 AU; the terrestrial planets then form from this disk over the next 30-50 million years, with an Earth/Mars mass ratio consistent with observations. Scattering by Jupiter initially empties but then repopulates the asteroid belt, with inner-belt bodies originating between 1 and 3 AU and outer-belt bodies originating between and beyond the giant planets. This explains the significant compositional differences across the asteroid belt. The key aspect missing from previous models of terrestrial planet formation is the substantial radial migration of the giant planets, which suggests that their behaviour is more similar to that inferred for extrasolar planets than previously thought.	[Walsh, Kevin J.; Morbidelli, Alessandro] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, F-06304 Nice 4, France; [Walsh, Kevin J.] SW Res Inst, Dept Space Studies, Boulder, CO 80302 USA; [Raymond, Sean N.] Univ Bordeaux, Observ Aquitain Sci Univers, F-33270 Floirac, France; [Raymond, Sean N.] CNRS, UMR 5804, Lab Astrophys Bordeaux, F-33270 Floirac, France; [O'Brien, David P.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Mandell, Avi M.] NASA Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Walsh, KJ (corresponding author), Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, BP 4229, F-06304 Nice 4, France.	kwalsh@boulder.swri.edu	Mandell, Avi M/F-9361-2012	Mandell, Avi M/0000-0002-8119-3355; Raymond, Sean/0000-0001-8974-0758	Helmholtz Alliances; CNRS; NASA; Goddard Center for Astrobiology	Helmholtz Alliances; CNRS(Centre National de la Recherche Scientifique (CNRS)); NASA(National Aeronautics & Space Administration (NASA)); Goddard Center for Astrobiology	K.J.W. and A. M. were supported by the Helmholtz Alliances 'Planetary Evolution and Life' programme. S.N.R and A. M. M. were supported by the EPOV and PNP programmes of CNRS. D.P.O'B. was supported by the NASA PG&G programme. A. M. M. was also supported by the NASA post-doctoral programme and the Goddard Center for Astrobiology. We thank the Isaac Newton Institute DDP programme for hosting some of us at the initial stage of the project; we also thank J. Chambers for comments that improved the text. Computations were done on the CRIMSON Beowulf cluster at OCA.	Abe Y., 2000, ORIGIN EARTH MOON, P413; Batygin K, 2010, ASTROPHYS J, V716, P1323, DOI 10.1088/0004-637X/716/2/1323; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Gomes R, 2005, NATURE, V435, P466, DOI 10.1038/nature03676; Gounelle M., 2008, SOLAR SYSTEM NEPTUNE, P525; GRADIE J, 1982, SCIENCE, V216, P1405, DOI 10.1126/science.216.4553.1405; Haisch KE, 2001, ASTROPHYS J, V553, pL153, DOI 10.1086/320685; Hansen BMS, 2009, ASTROPHYS J, V703, P1131, DOI 10.1088/0004-637X/703/1/1131; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Masset FS, 2009, ASTROPHYS J, V703, P857, DOI 10.1088/0004-637X/703/1/857; Masset FS, 2003, ASTROPHYS J, V588, P494, DOI 10.1086/373892; Minton DA, 2010, ICARUS, V207, P744, DOI 10.1016/j.icarus.2009.12.008; Morbidelli A, 2007, ICARUS, V191, P158, DOI 10.1016/j.icarus.2007.04.001; Mothe-Diniz T, 2003, ICARUS, V162, P10, DOI 10.1016/S0019-1035(02)00066-0; Raymond SN, 2009, ICARUS, V203, P644, DOI 10.1016/j.icarus.2009.05.016; Wetherill G. W., 1978, IAU C, V52, P565	30	775	778	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 14	2011	475	7355					206	209		10.1038/nature10201	http://dx.doi.org/10.1038/nature10201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791UA	21642961	Green Submitted			2022-12-28	WOS:000292690500045
J	McGraw, CM; Samaco, RC; Zoghbi, HY				McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.			Adult Neural Function Requires MeCP2	SCIENCE			English	Article							RETT-SYNDROME; MOUSE		[McGraw, Christopher M.; Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [McGraw, Christopher M.; Samaco, Rodney C.; Zoghbi, Huda Y.] Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [McGraw, Christopher M.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Samaco, Rodney C.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; Samaco, Rodney/0000-0001-5636-5314	NIH [NS057819, HD024064, F31-NS073317, T32-NS043124]; International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057819, F31NS073317, T32NS043124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; Simons Foundation; Rett Syndrome Research Trust; Baylor Research Advocates for Student Scientists; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Baker, Y. Lee, A. Flora, and L. Chen for discussions and NIH (grants NS057819, HD024064 to H.Z.; F31-NS073317 to C.M.; T32-NS043124 to R.S.), Baylor Research Advocates for Student Scientists (C.M.), International Rett Syndrome Foundation, Simons Foundation, and Rett Syndrome Research Trust (H.Z.) for support.	Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	6	186	191	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					186	186		10.1126/science.1206593	http://dx.doi.org/10.1126/science.1206593			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636743	Green Accepted			2022-12-28	WOS:000292502700039
J	Gweon, H; Schulz, L				Gweon, Hyowon; Schulz, Laura			16-Month-Olds Rationally Infer Causes of Failed Actions	SCIENCE			English	Article							INFANTS		[Gweon, Hyowon; Schulz, Laura] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gweon, H (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hyora@mit.edu; lschulz@mit.edu						BALDWIN DA, 1993, CHILD DEV, V64, P711, DOI 10.2307/1131213; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Griffiths TL, 2009, PSYCHOL REV, V116, P661, DOI 10.1037/a0017201; Gweon H, 2010, P NATL ACAD SCI USA, V107, P9066, DOI 10.1073/pnas.1003095107; Kelley H.H., 1967, NEBRASKA S MOTIVATIO, P192; Russell S, 2009, ARTIFICIAL INTELLIGE	6	75	76	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1524	1524		10.1126/science.1204493	http://dx.doi.org/10.1126/science.1204493			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700866	Green Submitted			2022-12-28	WOS:000291990000035
J	Ye, HF; Daoud-El Baba, M; Peng, RW; Fussenegger, M				Ye, Haifeng; Daoud-El Baba, Marie; Peng, Ren-Wang; Fussenegger, Martin			A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice	SCIENCE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ECTOPIC EXPRESSION; VISUAL FUNCTION; MELANOPSIN; LIGHT; CELLS; RESPONSES; ROD; SYSTEMS	Synthetic biology has advanced the design of genetic devices that can be used to reprogram metabolic activities in mammalian cells. By functionally linking the signal transduction of melanopsin to the control circuit of the nuclear factor of activated T cells, we have designed a synthetic signaling cascade enabling light-inducible transgene expression in different cell lines grown in culture or bioreactors or implanted into mice. In animals harboring intraperitoneal hollow-fiber or subcutaneous implants containing light-inducible transgenic cells, the serum levels of the human glycoprotein secreted alkaline phosphatase could be remote-controlled with fiber optics or transdermally regulated through direct illumination. Light-controlled expression of the glucagon-like peptide 1 was able to attenuate glycemic excursions in type II diabetic mice. Synthetic light-pulse-transcription converters may have applications in therapeutics and protein expression technology.	[Ye, Haifeng; Peng, Ren-Wang; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Daoud-El Baba, Marie] IUT, Dept Genie Biol, F-69622 Villeurbanne, France; [Fussenegger, Martin] Univ Basel, Fac Sci, CH-4058 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Fussenegger, M (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	fussenegger@bsse.ethz.ch	Peng, Ren-Wang/AAM-8542-2021	Peng, Ren-Wang/0000-0003-1199-6520; Ye, Haifeng/0000-0002-5482-8116	Swiss National Science Foundation [31003A-126022]; EC	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EC(European CommissionEuropean Commission Joint Research Centre)	We thank I. Provencio for providing pIRES<INF>2</INF>-OPN<INF>4</INF>AI and G. Charpin for skillful assistance with the animal study. This work was supported by the Swiss National Science Foundation (grant 31003A-126022) and in part by the EC Framework 7 (Persist).	Busskamp V, 2010, SCIENCE, V329, P413, DOI 10.1126/science.1190897; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fu YB, 2005, P NATL ACAD SCI USA, V102, P10339, DOI 10.1073/pnas.0501866102; Fussenegger M, 1998, NAT BIOTECHNOL, V16, P468, DOI 10.1038/nbt0598-468; Greber D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn443; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; HOLZ GG, 1993, NATURE, V361, P362, DOI 10.1038/361362a0; Kemmer C, 2010, NAT BIOTECHNOL, V28, P355, DOI 10.1038/nbt.1617; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kielgast U, 2009, CURR DIABETES REV, V5, P266, DOI 10.2174/157339909789804413; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; NELSON DE, 1991, BRAIN RES, V554, P272, DOI 10.1016/0006-8993(91)90200-F; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Parsons GB, 2007, GENE THER, V14, P38, DOI 10.1038/sj.gt.3302842; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Weber W, 2007, CURR OPIN BIOTECH, V18, P399, DOI 10.1016/j.copbio.2007.09.002; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	35	315	341	3	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1565	1568		10.1126/science.1203535	http://dx.doi.org/10.1126/science.1203535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700876				2022-12-28	WOS:000291990000047
J	Snyder, SA; Gollner, A; Chiriac, MI				Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.			Regioselective reactions for programmable resveratrol oligomer synthesis	NATURE			English	Article							CARAGANA-SINICA; STEM BARK; 4-HYDROXYSTILBENES; OLIGOSTILBENES; PRODUCTS; DIMERS; PLANTS	Although much attention has been devoted to resveratrol, a unique polyphenol produced by plants and credited as potentially being responsible for the 'French paradox'-the observation that French people have a relatively low incidence of coronary heart disease, even though their diet is high in saturated fats-the oligomers of resveratrol have been largely ignored despite their high biological activity. Challenges in achieving their isolation in sufficient quantity from natural sources, coupled with an inability to prepare them easily synthetically, are seen as the main obstacles. Here we report a programmable, controlled and potentially scalable synthesis of the resveratrol family via a three-stage design. The synthetic approach requires strategy- and reagent-guided chemical functionalizations to differentiate two distinct cores possessing multiple sites with the same or similar reactivity, ultimately leading to five higher-order natural products. This work demonstrates that challenging, positionally selective functionalizations of complex materials are possible where biosynthetic studies have indicated otherwise, it provides materials and tools with which to unlock the full biochemical potential of this family of natural products, and it affords an intellectual framework within which other oligomeric families could potentially be accessed.	[Snyder, Scott A.; Gollner, Andreas; Chiriac, Maria I.] Columbia Univ, Dept Chem, New York, NY 10027 USA	Columbia University	Snyder, SA (corresponding author), Columbia Univ, Dept Chem, Havemeyer Hall,3000 Broadway, New York, NY 10027 USA.	sas2197@columbia.edu		Snyder, Scott/0000-0003-3594-8769; Gollner, Andreas/0000-0002-4347-8296	Columbia University; National Institutes of Health [R01-GM84994]; Bristol-Myers Squibb; Eli Lilly; Research Corporation for Science Advancement; Austrian Science Fund (FWF) [J2986-N19]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084994] Funding Source: NIH RePORTER	Columbia University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Research Corporation for Science Advancement(Research Corporation for Science Advancement); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Sukenick of The Memorial Sloan Kettering Cancer Research Institute and J. Decatur of Columbia University for NMR assistance, Y. Itagaki for mass spectrometric assistance, C. Stathakis for preliminary attempts to form dihydrofuran units on the pallidol core, A. ElSohly for theoretical calculations and discussions, and K. Shaw and J. Boyce for preparing some starting materials. Financial support was provided by Columbia University, the National Institutes of Health (R01-GM84994), Bristol-Myers Squibb, Eli Lilly, the Research Corporation for Science Advancement (Cottrell Scholar Award to S.A.S.), and the Austrian Science Fund (FWF, Schrodinger postdoctoral fellowship J2986-N19 to A.G.).	Abe N, 2010, J NAT PROD, V73, P1499, DOI 10.1021/np1002675; Atun S., 2008, J PHYS SCI, V19, P7; BACH NJ, 1980, J MED CHEM, V23, P481, DOI 10.1021/jm00179a003; BAKER R, 1987, CHEM COMMUN, P1102; Bertolini F, 2009, ORG PREP PROCED INT, V41, P385, DOI 10.1080/00304940903240836; BOGER DL, 1984, J ORG CHEM, V49, P4050, DOI 10.1021/jo00195a035; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; COREY EJ, 1965, J AM CHEM SOC, V87, P1353, DOI 10.1021/ja01084a034; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Gustafson JL, 2010, SCIENCE, V328, P1251, DOI 10.1126/science.1188403; He YH, 2006, HETEROCYCLES, V68, P93; Ito T, 2003, CARCINOGENESIS, V24, P1489, DOI 10.1093/carcin/bgg105; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jeffrey JL, 2009, ORG LETT, V11, P5450, DOI 10.1021/ol902141z; Kim I, 2009, ORG BIOMOL CHEM, V7, P2788, DOI 10.1039/b901911a; Kraus GA, 2009, TETRAHEDRON LETT, V50, P7180, DOI 10.1016/j.tetlet.2009.10.040; Kurosawa W, 2004, TETRAHEDRON, V60, P9615, DOI 10.1016/j.tet.2004.06.144; LANGCAKE P, 1977, J CHEM SOC CHEM COMM, P208, DOI 10.1039/c39770000208; Lewis CA, 2006, ANGEW CHEM INT EDIT, V45, P5616, DOI 10.1002/anie.200601490; Li WL, 2006, ANGEW CHEM INT EDIT, V45, P7609, DOI 10.1002/anie.200603097; Li WL, 2010, SYNLETT, P1247, DOI 10.1055/s-0029-1219787; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nicolaou KC, 2010, J AM CHEM SOC, V132, P7540, DOI 10.1021/ja102623j; OSHIMA Y, 1993, TETRAHEDRON, V49, P5801, DOI 10.1016/S0040-4020(01)87946-1; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Sako M, 2004, J ORG CHEM, V69, P2598, DOI 10.1021/jo035791c; Sculimbrene BR, 2002, J AM CHEM SOC, V124, P11653, DOI 10.1021/ja027402m; Snyder SA, 2007, ANGEW CHEM INT EDIT, V46, P8186, DOI 10.1002/anie.200703333; Snyder SA, 2011, NAT PROD REP, V28, P897, DOI 10.1039/c1np00001b; Snyder SA, 2010, J AM CHEM SOC, V132, P14303, DOI 10.1021/ja106813s; Snyder SA, 2009, J AM CHEM SOC, V131, P1753, DOI 10.1021/ja806183r; SOTHEESWARAN S, 1993, PHYTOCHEMISTRY, V32, P1083, DOI 10.1016/S0031-9422(00)95070-2; Takaya Y, 2005, TETRAHEDRON, V61, P10285, DOI 10.1016/j.tet.2005.08.023; Takaya Y, 2002, TETRAHEDRON, V58, P9265, DOI 10.1016/S0040-4020(02)01191-2; Takaya Y, 2002, TETRAHEDRON, V58, P7259, DOI 10.1016/S0040-4020(02)00785-8; Tanaka T, 2000, PHYTOCHEMISTRY, V54, P63, DOI 10.1016/S0031-9422(00)00026-1; Tanaka T, 2001, HETEROCYCLES, V55, P729, DOI 10.3987/COM-01-9166; Tsukamoto T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-46; Velu SS, 2008, CHEM-EUR J, V14, P11376, DOI 10.1002/chem.200801575; Wang SG, 2005, HELV CHIM ACTA, V88, P2315, DOI 10.1002/hlca.200590166; Wang SG, 2004, J ASIAN NAT PROD RES, V6, P241, DOI 10.1080/10286020310001653309; Yamada M, 2006, PHYTOCHEMISTRY, V67, P307, DOI 10.1016/j.phytochem.2005.11.001	45	161	162	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					461	466		10.1038/nature10197	http://dx.doi.org/10.1038/nature10197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21697944	Green Accepted			2022-12-28	WOS:000291939700038
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH 2020health	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3828	10.1136/bmj.d3828	http://dx.doi.org/10.1136/bmj.d3828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697216				2022-12-28	WOS:000292200500008
J	Dougados, M; Baeten, D				Dougados, Maxime; Baeten, Dominique			Spondyloarthritis	LANCET			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVE ANKYLOSING-SPONDYLITIS; SOCIETY CLASSIFICATION CRITERIA; CHIMERIC MONOCLONAL-ANTIBODY; UNFOLDED PROTEIN RESPONSE; MAJOR CLINICAL-RESPONSE; FACTOR-ALPHA INFLIXIMAB; LONG-TERM BIOLOGICS; OPEN-LABEL TRIAL; DOUBLE-BLIND	Spondyloarthritis is a group of several related but phenotypically distinct disorders: psoriatic arthritis, arthritis related to inflammatory bowel disease, reactive arthritis, a subgroup of juvenile idiopathic arthritis, and ankylosing spondylitis (the prototypic and best studied subtype). The past decade yielded major advances in the recognition of spondyloarthritis as an entity, the classification of the disease, and understanding of the genetic and pathophysiological mechanisms of disease-related inflammation and tissue damage. In parallel, new clinical and imaging outcomes have allowed the assessment of various therapeutic modalities. Blockers of tumour necrosis factor are a major therapeutic advance, but the exact roles of physiotherapy, and treatment with non-steroidal antiinflammatory drugs and other biological treatments are unknown. The major challenges with direct relevance for clinical practice for the next decade are the development of techniques for early diagnosis, therapeutic modulation of structural damage, and, ultimately, induction of long-term, drug-free remission.	[Dougados, Maxime] Univ Paris 05, Cochin Hosp, AP HP, Fac Med,Dept Rheumatol B,UPRES EA 4058, F-75014 Paris, France; [Baeten, Dominique] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; Academic Medical Center Amsterdam	Dougados, M (corresponding author), Univ Paris 05, Dept Rheumatol, Hop Cochin, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	m.doug@cch.aphp.fr			Abbott; Aventis; Pfizer; Roche; Sanofi; Shering Plough; UCB; Centocor; Novartis	Abbott(Abbott Laboratories); Aventis(Sanofi-Aventis); Pfizer(Pfizer); Roche(Roche Holding); Sanofi(Sanofi-Aventis); Shering Plough; UCB(UCB Pharma SA); Centocor; Novartis(Novartis)	MD has received consultancy fees, speaker's fees, and his department has received research grants from Abbott, Aventis, Pfizer, Roche, Sanofi, Shering Plough, and UCB. DB has received consultancy fees, speaker's fees, and research grants from Abbott, Centocor, Novartis, Pfizer, Shering Plough, and UCB.	AMOR B, 1990, REV RHUM, V57, P85; Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Atagunduz P, 2005, ARTHRITIS RHEUM-US, V52, P892, DOI 10.1002/art.20948; Baeten D, 2002, J PATHOL, V196, P343, DOI 10.1002/path.1044; Baeten D, 2005, ARTHRITIS RES THER, V7, pR359, DOI 10.1186/ar1501; Baeten D, 2003, ANN RHEUM DIS, V62, P829, DOI 10.1136/ard.62.9.829; Baraliakos X, 2005, ARTHRITIS RES THER, V7, pR439, DOI 10.1186/ar1693; Baraliakos X, 2009, ARTHRIT RHEUM-ARTHR, V61, P764, DOI 10.1002/art.24425; Baraliakos X, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2496; Barkham N, 2009, ARTHRITIS RHEUM-US, V60, P946, DOI 10.1002/art.24408; Benhamou M, 2010, RHEUMATOLOGY, V49, P536, DOI 10.1093/rheumatology/kep393; Bennett AN, 2011, ANN RHEUM DIS, V70, P25; Bochkova AG, 2010, RHEUMATOLOGY, V49, P749, DOI 10.1093/rheumatology/kep419; Brandt HC, 2007, ANN RHEUM DIS, V66, P1479, DOI 10.1136/ard.2006.068734; Brandt J, 2000, ARTHRITIS RHEUM-US, V43, P1346, DOI 10.1002/1529-0131(200006)43:6<1346::AID-ANR18>3.0.CO;2-E; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2003, ARTHRITIS RHEUM-US, V48, P1126, DOI 10.1002/art.10883; Breban M, 1999, ARTHRITIS RHEUM, V42, P580, DOI 10.1002/1529-0131(199904)42:3<580::AID-ANR27>3.0.CO;2-D; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Chan AT, 2005, ARTHRITIS RHEUM, V52, P3586, DOI 10.1002/art.21395; Chen J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004524.pub3; Chen J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004800.pub2; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Coates LC, 2008, RHEUMATOLOGY, V47, P897, DOI 10.1093/rheumatology/ken094; Coates LC, 2008, ANN RHEUM DIS, V67, P717, DOI 10.1136/ard.2007.082925; D'agostin MA, 2009, ARTHRIT RHEUM-ARTHR, V61, P61, DOI 10.1002/art.24369; Dagfinrud H, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002822.pub3; Dangoria NS, 2002, J BIOL CHEM, V277, P23459, DOI 10.1074/jbc.M110336200; Daoussis D, 2010, ARTHRITIS RHEUM-US, V62, P150, DOI 10.1002/art.27231; de Miguel E, 2009, ANN RHEUM DIS, V68, P169, DOI 10.1136/ard.2007.084251; De Rycke L, 2005, ARTHRITIS RHEUM-US, V52, P2146, DOI 10.1002/art.21155; Delay ML, 2009, ARTHRITIS RHEUM-US, V60, P2633, DOI 10.1002/art.24763; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dijkmans B, 2005, ARTHRITIS RHEUM-US, V52, pS634; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Dougados M, 2009, EULAR COMPENDIUM RHE, P92; Dougados M, 2010, ANN RHEUM DIS, V69, P1430, DOI 10.1136/ard.2009.121533; Edwards CK, 2006, ARTHRITIS RHEUM-US, V54, P2872, DOI 10.1002/art.22077; Feydy A, 2010, J RADIOL, V91, P140, DOI 10.1016/S0221-0363(10)70019-6; Francois RJ, 2000, ARTHRITIS RHEUM-US, V43, P2011, DOI 10.1002/1529-0131(200009)43:9<2011::AID-ANR12>3.0.CO;2-Y; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Haibel H, 2005, ANN RHEUM DIS, V64, P296, DOI 10.1136/ard.2004.023176; Haibel H, 2008, ARTHRITIS RHEUM-US, V58, P1981, DOI 10.1002/art.23606; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HERMANN E, 1993, LANCET, V342, P646, DOI 10.1016/0140-6736(93)91760-J; Huang F, 2002, ARTHRIT RHEUM-ARTHR, V47, P249, DOI 10.1002/art.10396; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kollnberger S, 2004, J IMMUNOL, V173, P1699, DOI 10.4049/jimmunol.173.3.1699; Lambert RGW, 2007, ARTHRITIS RHEUM, V56, P4005, DOI 10.1002/art.23044; Lories RJU, 2008, RHEUMATOLOGY, V47, P605, DOI 10.1093/rheumatology/ken082; Lories RJU, 2007, ARTHRITIS RHEUM, V56, P489, DOI 10.1002/art.22372; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Lories RJU, 2005, J CLIN INVEST, V115, P1571, DOI 10.1172/JCI23738; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Madsen KB, 2010, ARTHRIT CARE RES, V62, P11, DOI 10.1002/acr.20008; Maksymowych WP, 2010, J RHEUMATOL, V37, P1728, DOI 10.3899/jrheum.091043; Maksymowych WP, 2010, ARTHRIT CARE RES, V62, P4, DOI 10.1002/acr.20007; Maksymowych WP, 2009, ARTHRITIS RHEUM-US, V60, P93, DOI 10.1002/art.24132; Maksymowych WP, 2005, ARTHRIT RHEUM-ARTHR, V53, P502, DOI 10.1002/art.21337; Maksymowych WP, 2002, ARTHRITIS RHEUM, V46, P766, DOI 10.1002/art.10139; May E, 2003, J IMMUNOL, V170, P1099, DOI 10.4049/jimmunol.170.2.1099; McGonagle D, 2008, ARTHRITIS RHEUM, V58, P2694, DOI 10.1002/art.23755; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; McGonagle D, 2007, ARTHRITIS RHEUM, V56, P2482, DOI 10.1002/art.22758; Mear JP, 1999, J IMMUNOL, V163, P6665; Mease P, 2009, ARTHRITIS RHEUMATISM, V60, P1260; Mease PJ, 2006, ARTHRITIS RHEUM-US, V54, P1638, DOI 10.1002/art.21870; Melis L, 2010, ANN RHEUM DIS, V69, P618, DOI 10.1136/ard.2009.107649; MOLL JMH, 1974, MEDICINE, V53, P343, DOI 10.1097/00005792-197409000-00002; Munoz-Fernandez S, 2009, ARTHRITIS RHEUM-US, V60, P1985, DOI 10.1002/art.24636; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Nocturne G, 2010, ANN RHEUM DIS, V69, P471, DOI 10.1136/ard.2008.107102; Papp KA, 2007, J CUTAN MED SURG, V11, P57, DOI 10.2310/7750.2007.00006; Pedersen SJ, 2010, ANN RHEUM DIS, V69, P1065, DOI 10.1136/ard.2009.111187; Pointon JJ, 2010, GENES IMMUN, V11, P490, DOI 10.1038/gene.2010.17; Pointon JJ, 2010, ANN RHEUM DIS, V69, P1243, DOI 10.1136/ard.2009.115147; Ramos M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200; Rennie WJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1187, DOI 10.1002/art.24561; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Rudwaleit M, 2008, ANN RHEUM DIS, V67, P1276, DOI 10.1136/ard.2007.073098; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P1520, DOI 10.1136/ard.2009.110767; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rudwaleit M, 2009, ANN RHEUM DIS     S3, V68, P127; Said-Nahal R, 2001, ARTHRIT RHEUM-ARTHR, V45, P478, DOI 10.1002/1529-0131(200112)45:6<478::AID-ART372>3.0.CO;2-I; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2644, DOI 10.1002/art.24767; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Sieper J, 2008, ARTHRITIS RHEUM-US, V58, P649, DOI 10.1002/art.23260; Sims AM, 2008, ANN RHEUM DIS, V67, P1305, DOI 10.1136/ard.2007.081364; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Song IH, 2010, ARTHRITIS RHEUM-US, V62, P1290, DOI 10.1002/art.27383; Strangfeld A, 2009, JAMA-J AM MED ASSOC, V301, P737, DOI 10.1001/jama.2009.146; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; Taurog JD, 2009, ARTHRITIS RHEUM, V60, P1977, DOI 10.1002/art.24599; Thomas GP, 2010, IMMUNOL REV, V233, P162, DOI 10.1111/j.0105-2896.2009.00852.x; Tran TM, 2006, ARTHRITIS RHEUM-US, V54, P1317, DOI 10.1002/art.21740; Tsui FWL, 2008, ARTHRITIS RHEUM-US, V58, P3436, DOI 10.1002/art.23967; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Turner MJ, 2005, J IMMUNOL, V175, P2438, DOI 10.4049/jimmunol.175.4.2438; Uderhardt S, 2010, ANN RHEUM DIS, V69, P592, DOI 10.1136/ard.2008.102046; Van den Bosch F, 2000, ANN RHEUM DIS, V59, P428, DOI 10.1136/ard.59.6.428; Van den Bosch F, 2000, LANCET, V356, P1821, DOI 10.1016/S0140-6736(00)03239-6; Van den Bosch F, 2002, ARTHRITIS RHEUM, V46, P755, DOI 10.1002/art.511; van Denderen JC, 2005, ANN RHEUM DIS, V64, P1761, DOI 10.1136/ard.2005.036491; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2007, ARTHRITIS RHEUM, V56, P2698, DOI 10.1002/art.22805; van der Heijde D, 2005, J RHEUMATOL, V32, P2048; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vandooren B, 2004, ARTHRITIS RHEUM-US, V50, P2942, DOI 10.1002/art.20477; Vandooren B, 2008, ARTHRITIS RHEUM, V58, P3051, DOI 10.1002/art.23886; Vandooren B, 2008, ARTHRITIS RHEUM-US, V58, P718, DOI 10.1002/art.23290; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P3534, DOI 10.1002/art.27251; Vandooren B, 2009, ARTHRITIS RHEUM-US, V60, P966, DOI 10.1002/art.24406; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446; Weber U, 2010, ANN RHEUM DIS, V69, P648, DOI 10.1136/ard.2009.108274; Weber U, 2009, ARTHRIT RHEUM-ARTHR, V61, P893, DOI 10.1002/art.24542; Wei JCC, 2003, J RHEUMATOL, V30, P2627; Zinovieva E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000528; Zochling J, 2006, ANN RHEUM DIS, V65, P442, DOI 10.1136/ard.2005.041137	129	511	533	1	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2127	2137		10.1016/S0140-6736(11)60071-8	http://dx.doi.org/10.1016/S0140-6736(11)60071-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	783XI	21684383				2022-12-28	WOS:000292117800034
J	Jarvis, S; Nelson-Piercy, C				Jarvis, Sheba; Nelson-Piercy, Catherine			Management of nausea and vomiting in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INTRACTABLE HYPEREMESIS GRAVIDARUM; PLACEBO-CONTROLLED TRIAL; CHORIONIC-GONADOTROPIN; STEROID-THERAPY; WEIGHT-LOSS; CORTICOSTEROIDS; WOMEN; ONDANSETRON		[Jarvis, Sheba; Nelson-Piercy, Catherine] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0NN, England; [Nelson-Piercy, Catherine] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Nelson-Piercy, C (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London W12 0NN, England.	catherine.nelson-piercy@gstt.nhs.uk						Bondok RS, 2006, CRIT CARE MED, V34, P2781, DOI 10.1097/01.CCM.0000242156.15757.70; Chiossi G, 2006, OBSTET GYNECOL SURV, V61, P255, DOI 10.1097/01.ogx.0000206336.08794.65; Chou FH, 2008, INT J NURS STUD, V45, P1185, DOI 10.1016/j.ijnurstu.2007.08.004; Demir B, 2006, EUR J OBSTET GYN R B, V124, P193, DOI 10.1016/j.ejogrb.2004.11.012; Fejzo MS, 2009, J WOMENS HEALTH, V18, P1981, DOI 10.1089/jwh.2009.1431; Festin M, 2007, CLIN EVID, p[ii, 1405]; Flaxman SM, 2000, Q REV BIOL, V75, P113, DOI 10.1086/393377; Gill SK, 2011, THER DRUG MONIT, V33, P115, DOI 10.1097/FTD.0b013e3181ff8bc5; GOODWIN TM, 1992, J CLIN ENDOCR METAB, V75, P1333, DOI 10.1210/jc.75.5.1333; Jednak MA, 1999, AM J PHYSIOL-GASTR L, V277, pG855, DOI 10.1152/ajpgi.1999.277.4.G855; Jueckstock JK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-46; KLEBANOFF MA, 1985, OBSTET GYNECOL, V66, P612; Mansour GM, 2010, ARCH GYNECOL OBSTET; Mazzotta P, 2000, DRUGS, V59, P781, DOI 10.2165/00003495-200059040-00005; Mazzotta P, 2001, J PSYCHOSOM OBST GYN, V22, P7, DOI 10.3109/01674820109049946; Moran P, 2002, QJM-INT J MED, V95, P153, DOI 10.1093/qjmed/95.3.153; Mylonas I, 2007, DTSCH ARZTEBL, V104, pA; Nelson-Piercy C, 2001, BRIT J OBSTET GYNAEC, V108, P9; NELSONPIERCY C, 1994, BRIT J OBSTET GYNAEC, V101, P1013, DOI 10.1111/j.1471-0528.1994.tb13053.x; Niebyl JR, 2010, NEW ENGL J MED, V363, P1544, DOI 10.1056/NEJMcp1003896; Royal College of Obstetricians and Gynaecologists, 2009, GREEN TOP GUID 37A R; Sandven I, 2008, EUR J EPIDEMIOL, V23, P491, DOI 10.1007/s10654-008-9261-3; Siu SSN, 2002, EUR J OBSTET GYN R B, V105, P73, DOI 10.1016/S0301-2115(02)00116-1; Sullivan CA, 1996, AM J OBSTET GYNECOL, V174, P1565, DOI 10.1016/S0002-9378(96)70607-5; Tan PC, 2010, EUR J OBSTET GYN R B, V149, P153, DOI 10.1016/j.ejogrb.2009.12.031; Torgersen L, 2008, INT J EAT DISORDER, V41, P722, DOI 10.1002/eat.20564; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Vikanes A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2050; YAMAZAKI K, 1995, J CLIN ENDOCR METAB, V80, P473, DOI 10.1210/jc.80.2.473; Yost NP, 2003, OBSTET GYNECOL, V102, P1250, DOI 10.1016/j.obstetgynecol.2003.08.013	30	63	66	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2011	342								d3606	10.1136/bmj.d3606	http://dx.doi.org/10.1136/bmj.d3606			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LH	21685438				2022-12-28	WOS:000291933200004
J	Passacquale, G; Ferro, A				Passacquale, Gabriella; Ferro, Albert			THERAPEUTICS Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL-INFARCTION; COST-EFFECTIVENESS; ASPIRIN; THERAPY		[Passacquale, Gabriella; Ferro, Albert] Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England	University of London; King's College London	Ferro, A (corresponding author), Kings Coll London, Dept Clin Pharmacol, Div Cardiovasc, London SE1 9NH, England.	albert.ferro@kcl.ac.uk		Ferro, Albert/0000-0002-5486-9145				[Anonymous], 2009, PRAS TREATM AC COR S; Barnett H, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1805; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bennett CL, 2000, NEW ENGL J MED, V342, P1773, DOI 10.1056/NEJM200006153422402; Berg J, 2008, CURR MED RES OPIN, V24, P2089, DOI 10.1185/03007990802222261 ; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Chan FKL, 2005, NEW ENGL J MED, V352, P238, DOI 10.1056/NEJMoa042087; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Farid NA, 2010, J CLIN PHARMACOL, V50, P126, DOI 10.1177/0091270009343005; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Heeg BMS, 2007, PHARMACOECONOMICS, V25, P769, DOI 10.2165/00019053-200725090-00005; Jolly SS, 2009, EUR HEART J, V30, P900, DOI 10.1093/eurheartj/ehn417; McCarthy MW, 2003, ANN PHARMACOTHER, V37, P216; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; *NAT I HLTH CLIN E, AC COR SYND IN PRESS; National Institute for Health and Clinical Excellence, 2010, CLOP MOD REL DIP PRE; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Serebruany VL, 2010, CIRCULATION, V122, pE436, DOI 10.1161/CIRCULATIONAHA.110.936757; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; WHO, 2000, WHO DRUG INFORM, V14; Williams ET, 2008, DRUG METAB DISPOS, V36, P1227, DOI 10.1124/dmd.107.020248; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	32	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2011	342								d3488	10.1136/bmj.d3488	http://dx.doi.org/10.1136/bmj.d3488			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LH	21685436				2022-12-28	WOS:000291933200002
J	Kau, AL; Ahern, PP; Griffin, NW; Goodman, AL; Gordon, JI				Kau, Andrew L.; Ahern, Philip P.; Griffin, Nicholas W.; Goodman, Andrew L.; Gordon, Jeffrey I.			Human nutrition, the gut microbiome and the immune system	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; T-CELLS; SMALL-BOWEL; INTESTINAL MICROFLORA; CHILD UNDERNUTRITION; INSULIN-RESISTANCE; INNATE IMMUNITY; ADIPOSE-TISSUE; KEY ROLE; OBESITY	Marked changes in socio-economic status, cultural traditions, population growth and agriculture are affecting diets worldwide. Understanding how our diet and nutritional status influence the composition and dynamic operations of our gut microbial communities, and the innate and adaptive arms of our immune system, represents an area of scientific need, opportunity and challenge. The insights gleaned should help to address several pressing global health problems.	[Kau, Andrew L.; Ahern, Philip P.; Griffin, Nicholas W.; Goodman, Andrew L.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	ravegnini, gloria/K-1330-2016; Kau, Andrew/AGX-9881-2022	ravegnini, gloria/0000-0002-7774-402X; Kau, Andrew/0000-0002-9386-3766	National Institutes of Health [DK30292, DK70977, DK078669]; Crohn's and Colitis Foundation of America; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030292, P01DK078669, R37DK030292, R01DK070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to members of our laboratory, plus our colleagues C. Semenkovich and A. Shaw for many discussions. Work cited from our laboratory was supported by grants from the National Institutes of Health (DK30292, DK70977 and DK078669), the Crohn's and Colitis Foundation of America and the Bill and Melinda Gates Foundation.	Allen RH, 2008, AM J CLIN NUTR, V87, P1324, DOI 10.1093/ajcn/87.5.1324; Anderson PJ, 2008, J BACTERIOL, V190, P1160, DOI 10.1128/JB.01386-07; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Campbell DI, 2003, PEDIATR RES, V54, P306, DOI 10.1203/01.PDR.0000076666.16021.5E; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P80; Cha HR, 2010, J IMMUNOL, V184, P6799, DOI 10.4049/jimmunol.0902944; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Curtale F, 1995, J TROP PEDIATRICS, V41, P334, DOI 10.1093/tropej/41.6.334; Daniel C, 2008, J PHARMACOL EXP THER, V324, P23, DOI 10.1124/jpet.107.127209; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Ertesvag A, 2002, J IMMUNOL, V169, P5555, DOI 10.4049/jimmunol.169.10.5555; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Ferreira RBR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001190; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gaboriau-Routhiau V, 2003, PEDIATR RES, V54, P739, DOI 10.1203/01.PDR.0000086902.52137.C9; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ghoshal UC, 2003, J GASTROEN HEPATOL, V18, P540, DOI 10.1046/j.1440-1746.2003.03006.x; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Golden MHN, 1998, BRIT MED BULL, V54, P433, DOI 10.1093/oxfordjournals.bmb.a011699; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kim Go-Woon, 2010, Int J Cell Biol, V2010, P632739, DOI 10.1155/2010/632739; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lagos R, 1999, J INFECT DIS, V180, P1709, DOI 10.1086/315051; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; MENENDEZCORRADA R, 1986, LANCET, V2, P1183; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Michalek RD, 2010, IMMUNOL REV, V236, P190, DOI 10.1111/j.1600-065X.2010.00911.x; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nemes E, 2008, PEDIATRICS, V121, pE1570, DOI 10.1542/peds.2007-2446; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Peng LY, 2007, PEDIATR RES, V61, P37, DOI 10.1203/01.pdr.0000250014.92242.f3; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; REDDY BS, 1972, J NUTR, V102, P101, DOI 10.1093/jn/102.1.101; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; SOMMER A, 1987, AM J CLIN NUTR, V45, P977, DOI 10.1093/ajcn/45.5.977; Stockinger Brigitta, 2009, Journal of Biology (London), V8, P61, DOI 10.1186/jbiol170; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Werner T, 2011, GUT, V60, P325, DOI 10.1136/gut.2010.216929; Whitacre PT, 2010, IMPLEMENTING NEW BIO; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	100	1631	1727	25	915	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					327	336		10.1038/nature10213	http://dx.doi.org/10.1038/nature10213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677749	Green Accepted			2022-12-28	WOS:000291647100036
J	Skarnes, WC; Rosen, B; West, AP; Koutsourakis, M; Bushell, W; Iyer, V; Mujica, AO; Thomas, M; Harrow, J; Cox, T; Jackson, D; Severin, J; Biggs, P; Fu, J; Nefedov, M; de Jong, PJ; Stewart, AF; Bradley, A				Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Fu, Jun; Nefedov, Michael; de Jong, Pieter J.; Stewart, A. Francis; Bradley, Allan			A conditional knockout resource for the genome-wide study of mouse gene function	NATURE			English	Article							EMBRYONIC STEM-CELLS; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; NEGATIVE SELECTION; RAT BLASTOCYSTS; EXPRESSION; TRAP; MICE; REPORTER; VECTOR	Gene targeting in embryonic stem cells has become the principal technology for manipulation of the mouse genome, offering unrivalled accuracy in allele design and access to conditional mutagenesis. To bring these advantages to the wider research community, large-scale mouse knockout programmes are producing a permanent resource of targeted mutations in all protein-coding genes. Here we report the establishment of a high-throughput gene-targeting pipeline for the generation of reporter-tagged, conditional alleles. Computational allele design, 96-well modular vector construction and high-efficiency gene-targeting strategies have been combined to mutate genes on an unprecedented scale. So far, more than 12,000 vectors and 9,000 conditional targeted alleles have been produced in highly germline-competent C57BL/6N embryonic stem cells. High-throughput genome engineering highlighted by this study is broadly applicable to rat and human stem cells and provides a foundation for future genome-wide efforts aimed at deciphering the function of all genes encoded by the mammalian genome.	[Skarnes, William C.; Rosen, Barry; West, Anthony P.; Koutsourakis, Manousos; Bushell, Wendy; Iyer, Vivek; Mujica, Alejandro O.; Thomas, Mark; Harrow, Jennifer; Cox, Tony; Jackson, David; Severin, Jessica; Biggs, Patrick; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fu, Jun; Stewart, A. Francis] Tech Univ Dresden, Biotechnol Zentrum, D-01062 Dresden, Germany; [Nefedov, Michael; de Jong, Pieter J.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	Wellcome Trust Sanger Institute; Technische Universitat Dresden; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Skarnes, WC (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	skarnes@sanger.ac.uk	Stewart, A. Francis/E-7789-2010; Fu, Jun/C-9133-2011; Biggs, Patrick Jon/H-3355-2014; Severin, Jessica/AAQ-2723-2020	Biggs, Patrick Jon/0000-0002-0285-4101; Severin, Jessica/0000-0003-1274-208X; Harrow, Jennifer/0000-0003-0338-3070; Bradley, Allan/0000-0002-2349-8839; Thomas, Mark/0000-0001-7267-6884; Mott, Richard/0000-0002-1022-9330; Jackson, David/0000-0002-8090-9462	Wellcome Trust Sanger Institute; National Institutes of Health (KOMP) [U01-HG004080]; EU; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080] Funding Source: NIH RePORTER	Wellcome Trust Sanger Institute(Wellcome Trust); National Institutes of Health (KOMP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the following people for technical assistance: D. Klose, D. Oakley, W. Yang and L. Stebbings for informatics/vector design; R. Bennett, A. Horton and A. van Brunt for manual gene annotation/vector design; L. Cho, R. Li, J.-F. Popoff, M. Sharma and Y. Zhang for recombineering; G. Belteki, P. Tate, Y. Bekele and S. Borchia for targeting vectors; D. Fraser, J. Greystrong, N. Gueorguieva, M. Jackson, P. Ramagiri, I. Walczak, J. Woodward, E. Stebbings, M. Martinez, A. Tsang and Y. Yoshinaga for vector/ES quality control; and D. Edwards, S. Harris, N. Krishnappa, R. Leah and A. Tait for ES cells. We are grateful for advice on the Gateway system from J. Chesnut of Invitrogen. Finally, we wish to thank W. Wurst, K. Lloyd, and our EUCOMM and KOMP colleagues who are contributing to the production and distribution of the conditional knockout resource. This work was funded by the Wellcome Trust Sanger Institute, grants from the National Institutes of Health (KOMP, U01-HG004080 to W. C. S., P.J.d.J. and A. B.) from the EU Sixth Framework Programme (EUCOMM, to W.C.S., A.F.S. and A.B.).	Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Hope IA, 2004, GENOME RES, V14, P2070, DOI 10.1101/gr.2463804; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; Lay JM, 1998, TRANSGENIC RES, V7, P135, DOI 10.1023/A:1008876526826; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Osoegawa K, 2000, GENOME RES, V10, P116; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Ringwald M, 2011, NUCLEIC ACIDS RES, V39, pD849, DOI 10.1093/nar/gkq879; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Skarnes WC, 2005, P NATL ACAD SCI USA, V102, P13001, DOI 10.1073/pnas.0506279102; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; SKARNES WC, 1992, GENE DEV, V6, P903, DOI 10.1101/gad.6.6.903; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yanagawa Y, 1999, TRANSGENIC RES, V8, P215, DOI 10.1023/A:1008914020843; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	48	1118	1165	1	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					337	U361		10.1038/nature10163	http://dx.doi.org/10.1038/nature10163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677750	Green Accepted			2022-12-28	WOS:000291647100037
J	Haut, ER; Pronovost, PJ				Haut, Elliott R.; Pronovost, Peter J.			Surveillance Bias in Outcomes Reporting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEEP-VEIN THROMBOSIS; TRAUMA DATA-BANK; QUALITY; RATES; DVT		[Haut, Elliott R.; Pronovost, Peter J.] Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Div Acute Care Surg, Baltimore, MD 21287 USA; [Haut, Elliott R.; Pronovost, Peter J.] Johns Hopkins Univ Hosp, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Haut, Elliott R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Grad Training Program Clin Invest, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Haut, ER (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Dept Surg, Div Acute Care Surg, 600 N Wolfe St,625 Osler, Baltimore, MD 21287 USA.	ehaut1@jhmi.edu	Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X				Craig SL, 1999, AM J CLIN ONCOL-CANC, V22, P51, DOI 10.1097/00000421-199902000-00013; Haut ER, 2007, J TRAUMA, V63, P1132, DOI 10.1097/TA.0b013e31814856ad; Haut ER, 2011, J TRAUMA, V70, P27, DOI 10.1097/TA.0b013e3182077d55; Haut ER, 2009, J TRAUMA, V66, P994, DOI 10.1097/TA.0b013e3181991adc; Kardooni S, 2008, J TRAUMA, V64, P273, DOI 10.1097/TA.0b013e31816335ae; Lin MY, 2010, JAMA-J AM MED ASSOC, V304, P2035, DOI 10.1001/jama.2010.1637; Pierce CA, 2008, J TRAUMA, V64, P932, DOI 10.1097/TA.0b013e318166b808; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V301, P1273, DOI 10.1001/jama.2009.388; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Streiff MB, 2009, JAMA-J AM MED ASSOC, V301, P1063, DOI 10.1001/jama.301.10.1063	10	181	182	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2462	2463		10.1001/jama.2011.822	http://dx.doi.org/10.1001/jama.2011.822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673300				2022-12-28	WOS:000291597300029
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Crouching tiger, hidden surgeon	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3591	10.1136/bmj.d3591	http://dx.doi.org/10.1136/bmj.d3591			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677013				2022-12-28	WOS:000291932700002
J	Lin, YM; Valdes-Garcia, A; Han, SJ; Farmer, DB; Meric, I; Sun, YN; Wu, YQ; Dimitrakopoulos, C; Grill, A; Avouris, P; Jenkins, KA				Lin, Yu-Ming; Valdes-Garcia, Alberto; Han, Shu-Jen; Farmer, Damon B.; Meric, Inanc; Sun, Yanning; Wu, Yanqing; Dimitrakopoulos, Christos; Grill, Alfred; Avouris, Phaedon; Jenkins, Keith A.			Wafer-Scale Graphene Integrated Circuit	SCIENCE			English	Article							EPITAXIAL GRAPHENE; HIGH-FREQUENCY; TRANSISTORS; GROWTH	A wafer-scale graphene circuit was demonstrated in which all circuit components, including graphene field-effect transistor and inductors, were monolithically integrated on a single silicon carbide wafer. The integrated circuit operates as a broadband radio-frequency mixer at frequencies up to 10 gigahertz. These graphene circuits exhibit outstanding thermal stability with little reduction in performance (less than 1 decibel) between 300 and 400 kelvin. These results open up possibilities of achieving practical graphene technology with more complex functionality and performance.	[Lin, Yu-Ming; Valdes-Garcia, Alberto; Han, Shu-Jen; Farmer, Damon B.; Meric, Inanc; Sun, Yanning; Wu, Yanqing; Dimitrakopoulos, Christos; Grill, Alfred; Avouris, Phaedon; Jenkins, Keith A.] IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Lin, YM (corresponding author), IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	yming@us.ibm.com; avouris@us.ibm.com	WU, Yanqing/C-9737-2009	Dimitrakopoulos, Christos/0000-0003-1059-3498; Avouris, Phaedon/0000-0001-9902-8000	Defense Advanced Research Projects Agency (DARPA) [FA8650-08-C-7838]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	We are grateful to B. Ek and J. Bucchignano for technical assistance and to D. K. Gaskill for providing some epitaxial graphene wafers for testing. We also acknowledge discussions with F. Xia, T. Mcardle, H.-Y. Chiu, and C. Y. Sung. We thank Defense Advanced Research Projects Agency (DARPA) for financial support through the CERA program (contract FA8650-08-C-7838). The views, opinions, and/or findings contained here are those of the authors and do not represent the official views or policies of DARPA or the Department of Defense.	Avouris P, 2010, NANO LETT, V10, P4285, DOI 10.1021/nl102824h; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Dimitrakopoulos C, 2010, J VAC SCI TECHNOL B, V28, P985, DOI 10.1116/1.3480961; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Gaskill DK, 2009, ECS TRANSACTIONS, V19, P117, DOI 10.1149/1.3119535; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Kim S, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077021; Liao L, 2010, NATURE, V467, P305, DOI 10.1038/nature09405; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; MAAS SA, 1987, IEEE T MICROW THEORY, V35, P425, DOI 10.1109/TMTT.1987.1133665; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Moon JS, 2010, IEEE ELECTR DEVICE L, V31, P260, DOI 10.1109/LED.2010.2040132; Perebeinos V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195442; Wang H, 2010, IEEE ELECTR DEVICE L, V31, P906, DOI 10.1109/LED.2010.2052017; Wang H, 2009, IEEE ELECTR DEVICE L, V30, P547, DOI 10.1109/LED.2009.2016443; Wang QH, 2009, NAT CHEM, V1, P206, DOI [10.1038/NCHEM.212, 10.1038/nchem.212]; Wu YQ, 2011, NATURE, V472, P74, DOI 10.1038/nature09979; Xia FN, 2011, NAT NANOTECHNOL, V6, P179, DOI [10.1038/nnano.2011.6, 10.1038/NNANO.2011.6]; Yang XB, 2010, ACS NANO, V4, P5532, DOI 10.1021/nn1021583; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	23	701	722	10	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1294	1297		10.1126/science.1204428	http://dx.doi.org/10.1126/science.1204428			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659599				2022-12-28	WOS:000291441700038
J	Schmidt, WH; Houang, R; Cogan, LS				Schmidt, William H.; Houang, Richard; Cogan, Leland S.			Preparing Future Math Teachers	SCIENCE			English	Editorial Material									[Schmidt, William H.] Michigan State Univ, Dept Stat, E Lansing, MI 48824 USA; [Schmidt, William H.; Houang, Richard; Cogan, Leland S.] Michigan State Univ, Coll Educ, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Schmidt, WH (corresponding author), Michigan State Univ, Dept Stat, E Lansing, MI 48824 USA.	bschmidt@msu.edu	Schmidt, William/K-9673-2019	Schmidt, William/0000-0002-7933-5457				*AB FDN, 2001, TEACH CERT REC STUMB; Ball D. L., 2005, AM EDUC, V29, P14; Carnoy M., 2009, TEACHER ED DEV STUDY; Center for Research in Mathematics and Science Education, 2010, BREAK CYCL INT COMP; FERRINIMUNDY J, 2006, KNOWING MATH; Finn C., 1999, BETTER TEACHERS BETT; Holdren J. P., 2010, GLOBAL ENTREPRENEURS; MULLIS IVS, 2005, PROGR INT READING LI; Schmidt W., 1997, SPLINTERED VISION IN; Schmidt WH, 2011, J TEACH EDUC, V62, P138, DOI 10.1177/0022487110391987; Wilson SM, 2002, J TEACH EDUC, V53, P190, DOI 10.1177/0022487102053003002	11	22	22	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1266	1267		10.1126/science.1193855	http://dx.doi.org/10.1126/science.1193855			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	775EP	21659590				2022-12-28	WOS:000291441700028
J	Raghavan, R; Nuila, R				Raghavan, Rajeev; Nuila, Ricardo			Survivors - Dialysis, Immigration, and U.S. Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Raghavan, Rajeev; Nuila, Ricardo] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Raghavan, Rajeev] Baylor Coll Med, Div Nephrol, Houston, TX 77030 USA; [Nuila, Ricardo] Baylor Coll Med, Dept Family & Community Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Raghavan, R (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.							Campbell GA, 2010, AM J KIDNEY DIS, V55, P181, DOI 10.1053/j.ajkd.2009.06.039; Goldberg AM, 2007, TRANSPLANTATION, V83, P17, DOI 10.1097/01.tp.0000247795.41898.55; Raghavan R, 2011, DIALYSIS TRANSPLANT, V40, P78, DOI 10.1002/dat.20535; Sheikh-Hamad David, 2007, Tex Med, V103, P54; USRDS, 2008, ANN DAT REP ATL CHRO	5	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2183	2185		10.1056/NEJMp1101195	http://dx.doi.org/10.1056/NEJMp1101195			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21651391				2022-12-28	WOS:000291392100004
J	Stiopkin, IV; Weeraman, C; Pieniazek, PA; Shalhout, FY; Skinner, JL; Benderskii, AV				Stiopkin, Igor V.; Weeraman, Champika; Pieniazek, Piotr A.; Shalhout, Fadel Y.; Skinner, James L.; Benderskii, Alexander V.			Hydrogen bonding at the water surface revealed by isotopic dilution spectroscopy	NATURE			English	Article							ULTRAFAST INFRARED-SPECTROSCOPY; SUM-FREQUENCY GENERATION; MOLECULAR-DYNAMICS SIMULATIONS; LIQUID WATER; VIBRATIONAL SPECTROSCOPY; LINE-SHAPES; INTERFACE; SPECTRUM; H2O; D2O	The air-water interface is perhaps the most common liquid interface. It covers more than 70 per cent of the Earth's surface and strongly affects atmospheric, aerosol and environmental chemistry. The air-water interface has also attracted much interest as a model system that allows rigorous tests of theory, with one fundamental question being just how thin it is. Theoretical studies have suggested a surprisingly short 'healing length' of about 3 angstroms (1 angstrom = 0.1 nm), with the bulk-phase properties of water recovered within the top few monolayers(1-3). However, direct experimental evidence has been elusive owing to the difficulty of depth-profiling the liquid surface on the angstrom scale. Most physical, chemical and biological properties of water, such as viscosity, solvation, wetting and the hydrophobic effect, are determined by its hydrogen-bond network. This can be probed by observing the lineshape of the OH-stretch mode, the frequency shift of which is related to the hydrogen-bond strength(4-6). Here we report a combined experimental and theoretical study of the air-water interface using surface-selective heterodyne-detected vibrational sum frequency spectroscopy to focus on the 'free OD' transition found only in the topmost water layer. By using deuterated water and isotopic dilution to reveal the vibrational coupling mechanism, we find that the free OD stretch is affected only by intramolecular coupling to the stretching of the other OD group on the same molecule. The other OD stretch frequency indicates the strength of one of the first hydrogen bonds encountered at the surface; this is the donor hydrogen bond of the water molecule straddling the interface, which we find to be only slightly weaker than bulk-phase water hydrogen bonds. We infer from this observation a remarkably fast onset of bulk-phase behaviour on crossing from the air into the water phase.	[Stiopkin, Igor V.; Weeraman, Champika; Shalhout, Fadel Y.; Benderskii, Alexander V.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA; [Pieniazek, Piotr A.; Skinner, James L.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA	Wayne State University; University of Wisconsin System; University of Wisconsin Madison	Benderskii, AV (corresponding author), Wayne State Univ, Dept Chem, Detroit, MI 48202 USA.	alex.benderskii@usc.edu			NSF [CHE-0449720, CHE-0750307]; DOE [DE-FG02-09ER16110]	NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	The experiments presented here were supported by the NSF CAREER grant number CHE-0449720 (I.V.S., C.W., F.Y.S. and A.V.B.). J.L.S. thanks the NSF and the DOE for support from grants CHE-0750307 and DE-FG02-09ER16110, respectively.	Auer BM, 2009, J PHYS CHEM B, V113, P4125, DOI 10.1021/jp806644x; Auer BM, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012568; Barker EF, 1935, J CHEM PHYS, V3, P660, DOI 10.1063/1.1749572; Corcelli SA, 2005, J PHYS CHEM A, V109, P6154, DOI 10.1021/jp0506540; Corcelli SA, 2004, J CHEM PHYS, V120, P8107, DOI 10.1063/1.1683072; DU Q, 1994, SCIENCE, V264, P826, DOI 10.1126/science.264.5160.826; DU Q, 1993, PHYS REV LETT, V70, P2313, DOI 10.1103/PhysRevLett.70.2313; Fecko CJ, 2003, SCIENCE, V301, P1698, DOI 10.1126/science.1087251; Gan W, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179794; Ishiyama T, 2009, J PHYS CHEM C, V113, P16299, DOI 10.1021/jp9060957; Lawrence CP, 2003, CHEM PHYS LETT, V369, P472, DOI 10.1016/S0009-2614(02)02039-0; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; Loparo JJ, 2007, CHEM PHYS, V341, P218, DOI 10.1016/j.chemphys.2007.06.056; Max JJ, 2002, J CHEM PHYS, V116, P4626, DOI 10.1063/1.1448286; Morita A, 2000, CHEM PHYS, V258, P371, DOI 10.1016/S0301-0104(00)00127-0; Nagata Y, 2010, J AM CHEM SOC, V132, P6434, DOI 10.1021/ja100508n; Nihonyanagi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3135147; Ostroverkhov V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.046102; Raymond EA, 2003, J PHYS CHEM B, V107, P546, DOI 10.1021/jp021366w; Rey R, 2002, J PHYS CHEM A, V106, P11993, DOI 10.1021/jp026419o; Richmond GL, 2002, CHEM REV, V102, P2693, DOI 10.1021/cr0006876; Shimanouchi T, 1972, TABLES MOL VIBRATION, VI; Skinner JL, 2009, ADV CHEM PHYS, V142, P59, DOI 10.1002/9780470475935.ch2; Sovago M, 2009, CHEM PHYS LETT, V470, P7, DOI 10.1016/j.cplett.2009.01.009; Stiopkin IV, 2008, J AM CHEM SOC, V130, P2271, DOI 10.1021/ja076708w; Stiopkin IV, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3432776; Taylor RS, 1996, J PHYS CHEM-US, V100, P11720, DOI 10.1021/jp960615b; Tian CS, 2009, J AM CHEM SOC, V131, P2790, DOI 10.1021/ja809497y; TOWNSEND RM, 1985, J CHEM PHYS, V82, P4391, DOI 10.1063/1.448808; Woutersen S, 1999, NATURE, V402, P507, DOI 10.1038/990058	30	310	311	7	327	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					192	195		10.1038/nature10173	http://dx.doi.org/10.1038/nature10173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654801				2022-12-28	WOS:000291397800045
J	Spence, D				Spence, Des			FROM THE FRONTLINE Sing and dance	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2011	342								d3562	10.1136/bmj.d3562	http://dx.doi.org/10.1136/bmj.d3562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SO	21653622				2022-12-28	WOS:000291645500017
J	Moxon, ER; Siegrist, CA				Moxon, E. Richard; Siegrist, Claire-Anne			New Decade of Vaccines 1 The next decade of vaccines: societal and scientific challenges	LANCET			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; INFLUENZA VACCINE; HIV VACCINE; BELLS-PALSY; ANTIBODIES; EFFICACY; ADULTS; IMMUNOLOGY; IMMUNITY; DESIGN	Vaccines against microbial diseases have improved the health of millions of people. In the next decade and beyond, many conceptual and technological scientific advances offer extraordinary opportunities to expand the portfolio of immunisations against viral and bacterial diseases and to pioneer the first vaccines against human parasitic and fungal diseases. Scientists in the public and private sectors are motivated as never before to bring about these innovations in immunisation. Many societal factors threaten to compromise realisation of the public health gains that immunisation can achieve in the next decade and beyond understanding these factors is imperative. Vaccines are typically given to healthy individuals and safety issues loom high on the list of public concerns. The public needs to regain confidence in immunisation and trust the organisations responsible for the research, development, and implementation of vaccines. In the past, by use of a judicious amalgam of knowledge and empiricism, successful vaccines were largely developed by microbiologists who identified antigens that induced immune responses to conserved pathogen components. In the future, vaccines need to be developed against deadly diseases for which this strategy is often not feasible because of the extensive antigenic variability of relevant pathogens. High microbial diversity means that immunity after natural infection is often ineffective for prevention of disease on subsequent exposure, for example in HIV infection and malaria. Additionally, vaccines need to be generated to protect the people who are most vulnerable because of age or underlying diseases. Thus, in the future, a much deeper understanding of the immunological challenges including the diversifying role of host genetics and environmental factors, leading perhaps to more personalised approaches will be the touchstone for rational design and development of adjuvants that result in novel safe and effective vaccines.	[Moxon, E. Richard] Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Siegrist, Claire-Anne] Univ Hosp Geneva, Ctr Vaccinol, Geneva, Switzerland; [Siegrist, Claire-Anne] Univ Geneva, Fac Med, Geneva, Switzerland	University of Oxford; University of Geneva; University of Geneva	Moxon, ER (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.	richard.moxon@paediatrics.ox.ac.uk			GlaxoSmithKline; Sanofi Pasteur; Nasvax; DBV Technologies	GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Nasvax; DBV Technologies	ERM has received honoraria for work as a board member for Novartis and GlycoVaxyn, and as a consultant for Novartis. C-AS's institution has received grants from GlaxoSmithKline, Sanofi Pasteur, Nasvax, and DBV Technologies; and travel and accommodation expenses from GlaxoSmithKline and Sanofi Pasteur. C-AS and C-AS's institution have received royalties for the patent for Viavac; and C-AS has patents, which have not generated royalties, with Sanofi Pasteur and DBV Technologies.	Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Baumgartner CK, 2010, IMMUNOLOGY, V130, P16, DOI 10.1111/j.1365-2567.2010.03265.x; Bayer R, 2007, EMBO REP, V8, P1099, DOI 10.1038/sj.embor.7401134; Bekker A, 2009, CURR OPIN PEDIATR, V21, P122, DOI 10.1097/MOP.0b013e32832185af; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Bonanni P, 2007, HUM VACCINES, V3, P217, DOI 10.4161/hv.3.5.4351; Burton DR, 2010, SCIENCE, V329, P770, DOI 10.1126/science.1194693; Castellino F, 2009, EUR J IMMUNOL, V39, P2100, DOI 10.1002/eji.200939550; Chen WH, 2009, TRENDS IMMUNOL, V30, P351, DOI 10.1016/j.it.2009.05.002; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cohen SA, 2011, J AM GERIATR SOC, V59, P327, DOI 10.1111/j.1532-5415.2010.03271.x; CRAIG A, 2003, ANTIGENIC VARIATION, P432; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Deans GD, 2010, J INTERN MED, V267, P220, DOI 10.1111/j.1365-2796.2009.02201.x; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; DOBZHANSKY T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; FINNE J, 1983, LANCET, V2, P355; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Gilca V, 2006, PEDIATR INFECT DIS J, V25, P372, DOI 10.1097/01.inf.0000207468.04665.ad; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Gupta S, 1999, PARASITOL TODAY, V15, P497, DOI 10.1016/S0169-4758(99)01559-8; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hausdorff WP, 2001, LANCET, V357, P950, DOI 10.1016/S0140-6736(00)04222-7; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Heath PT, 1998, PEDIATR INFECT DIS J, V17, pS117, DOI 10.1097/00006454-199809001-00005; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JEFFERSON T, 2010, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004876.PUB3; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kyes S, 2001, ANNU REV MICROBIOL, V55, P673, DOI 10.1146/annurev.micro.55.1.673; Ladhani S, 2008, LANCET INFECT DIS, V8, P275, DOI 10.1016/S1473-3099(08)70078-1; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewis DJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006999; Malik B, 2010, CURR MOL MED, V10, P47, DOI 10.2174/156652410791065417; Malley R, 2010, J MOL MED, V88, P135, DOI 10.1007/s00109-009-0579-4; Manzoli L, 2009, LANCET INFECT DIS, V9, P482, DOI 10.1016/S1473-3099(09)70153-7; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nicolas JF, 2008, EXPERT REV VACCINES, V7, P1201, DOI 10.1586/14760584.7.8.1201; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Olszewska W, 2000, VIROLOGY, V272, P98, DOI 10.1006/viro.2000.0285; Pace D, 2009, VACCINE, V27, pB30, DOI 10.1016/j.vaccine.2009.05.003; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Pichichero ME, 2009, PEDIATRICS, V124, P1633, DOI 10.1542/peds.2008-3645; PITTMAN MARGARET, 1931, JOUR EXP MED, V53, P471, DOI 10.1084/jem.53.4.471; Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI [10.2217/pgs.09.25, 10.2217/PGS.09.25]; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Rappuoli R, 2011, LANCET, V378, P360, DOI 10.1016/S0140-6736(11)60440-6; Rinaudo CD, 2009, J CLIN INVEST, V119, P2515, DOI 10.1172/JCI38330; SABIN AB, 1954, J EXP MED, V99, P551, DOI 10.1084/jem.99.6.551; Sambhara S, 2009, CURR TOP MICROBIOL, V333, P413, DOI 10.1007/978-3-540-92165-3_20; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Siegrist CA, 2009, NAT REV IMMUNOL, V9, P185, DOI 10.1038/nri2508; Smith J, 2011, LANCET, V378, P428, DOI 10.1016/S0140-6736(11)60478-9; Stratton K, 2001, IMMUNIZATION SAFETY; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Trotter CL, 2009, EXPERT REV VACCINES, V8, P851, DOI [10.1586/erv.09.48, 10.1586/ERV.09.48]; TURK DC, 1967, HAEMOPHILUS INFLUENZ, P1; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; *US CDCP, 2009, MMWR-MORBID MORTAL W, V58, P1091; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO SAF INJ GLOB, 2010, SAF INJ GLOB NETW 20; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	88	43	46	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2011	378	9788					348	359		10.1016/S0140-6736(11)60407-8	http://dx.doi.org/10.1016/S0140-6736(11)60407-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	803XL	21664685				2022-12-28	WOS:000293615800033
J	Anthony, RM; Kobayashi, T; Wermeling, F; Ravetch, JV				Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.			Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway	NATURE			English	Article							DC-SIGN; ANTIINFLAMMATORY ACTIVITY; DENDRITIC CELL; IN-VIVO; BONE-MARROW; IMMUNE-RESPONSES; IL-4; INTERLEUKIN-4; ANTIBODIES; RECEPTORS	High-dose intravenous immunoglobulin is a widely used therapeutic preparation of highly purified immunoglobulin G (IgG) antibodies. It is administered at high doses (1-2 grams per kilogram) for the suppression of autoantibody-triggered inflammation in a variety of clinical settings'. This anti-inflammatory activity of intravenous immunoglobulin is triggered by a minor population of IgG crystallizable fragments (Fcs), with glycans terminating in alpha 2,6 sialic acids (sFc) that target myeloid regulatory cells expressing the lectin dendritic-cell-specific ICAM-3 grabbing non-integrin (DC-SIGN; also known as CD209)(2-4). Here, to characterize this response in detail, we generated humanized DC-SIGN mice (hDC-SIGN), and demonstrate that the anti-inflammatory activity of intravenous immunoglobulin can be recapitulated by the transfer of bone-marrow-derived sFc-treated hDC-SIGN(+) macrophages or dendritic cells into naive recipients. Furthermore, sFc administration results in the production of IL-33, which, in turn, induces expansion of IL-4-producing basophils that promote increased expression of the inhibitory Fc receptor Fc gamma RIIB on effector macrophages. Systemic administration of the T(H)2 cytokines IL-33 or IL-4 upregulates Fc gamma RIIB on macrophages, and suppresses serum-induced arthritis. Consistent with these results, transfer of IL-33-treated basophils suppressed induced arthritic inflammation. This novel DC-SIGN-T(H)2 pathway initiated by an endogenous ligand, sFc, provides an intrinsic mechanism for maintaining immune homeostasis that could be manipulated to provide therapeutic benefit in autoimmune diseases.	[Anthony, Robert M.; Kobayashi, Toshihiko; Wermeling, Fredrik; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019; Wermeling, Fredrik/AAA-6391-2019	Ravetch, Jeffrey/0000-0003-2024-9041; Wermeling, Fredrik/0000-0001-9633-677X	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035875, K22AI091684] Funding Source: NIH RePORTER	Wenner-Gren Foundations, Sweden; Virdante Pharmaceuticals; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank P. Smith, M. Kibe, J. Brown and K. Velinzon for technical support K. L. Jeffrey, C. Cheong, R. Steinman and J. J. Lee for discussions, M. Pack for providing human spleen sections, A. McKenzie for providing SIGN-R1<SUP>-/-</SUP> mice, T. Sparwasser for providing CD11c-hDC-SIGN mice, C. G. Park for providing hDC-SIGN and hDC-SIGN-R expressing cell lines, and H. Watarai for providing anti-IL-25R antibodies. R.M.A. is an Irvington Institute fellow of the Cancer Research Institute. F.W. is supported by the Wenner-Gren Foundations, Sweden. This work was performed with support from Virdante Pharmaceuticals and NIH grants to J.V.R.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; Cheong C, 2010, J IMMUNOL METHODS, V360, P66, DOI 10.1016/j.jim.2010.06.006; Finkelman F., 2003, CURR PROTOC IMMUNOL, P6281; FINKELMAN FD, 1993, J IMMUNOL, V151, P1235; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Hodges A, 2007, NAT IMMUNOL, V8, P569, DOI 10.1038/ni1470; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Lanoue A, 2004, J EXP MED, V200, P1383, DOI 10.1084/jem.20040795; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nimmerjahn F, 2008, ANNU REV IMMUNOL, V26, P513, DOI 10.1146/annurev.immunol.26.021607.090232; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; Ohmura K, 2005, ARTHRITIS RHEUM-US, V52, P1866, DOI 10.1002/art.21104; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; SEDER RA, 1991, INT ARCH ALLER A IMM, V94, P137, DOI 10.1159/000235345; Shinkai K, 2002, NATURE, V420, P825, DOI 10.1038/nature01202; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; Wang M, 1999, CLIN IMMUNOL, V90, P47, DOI 10.1006/clim.1998.4628; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685	41	434	452	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					110	U133		10.1038/nature10134	http://dx.doi.org/10.1038/nature10134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21685887	Green Accepted			2022-12-28	WOS:000292461300055
J	Lefort, K; Dotto, GP				Lefort, Karine; Dotto, G. Paolo			p63 and Epithelial Metaplasia: A Gutsy Choice	CELL			English	Editorial Material							LIMB	Barrett's esophagus is an epithelial metaplasia associated with an increased risk for cancer, but its underlying mechanisms have been debated. Now Wang et al. (2011) suggest an intriguing explanation for this puzzle: a population of residual embryonic cells, lacking the transcription factor p63, migrates and repopulates a normal tissue damaged by inflammation or gastroesophageal reflux.	[Lefort, Karine; Dotto, G. Paolo] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Dotto, G. Paolo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	University of Lausanne; Harvard University; Massachusetts General Hospital	Dotto, GP (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	paolo.dotto@unil.ch						Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; DOTTO GP, 2009, DEV CELL, V16, P588; Herfs M, 2009, TRENDS MOL MED, V15, P245, DOI 10.1016/j.molmed.2009.04.002; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Quinlan JM, 2007, BBA-REV CANCER, V1776, P10, DOI 10.1016/j.bbcan.2007.05.005; Wang X, 2011, CELL, V145, P1023, DOI 10.1016/j.cell.2011.05.026; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	9	7	8	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1003	1005		10.1016/j.cell.2011.06.008	http://dx.doi.org/10.1016/j.cell.2011.06.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703442	Bronze			2022-12-28	WOS:000292025700005
J	Shimamoto, Y; Maeda, YT; Ishiwata, S; Libchaber, AJ; Kapoor, TM				Shimamoto, Yuta; Maeda, Yusuke T.; Ishiwata, Shin'ichi; Libchaber, Albert J.; Kapoor, Tarun M.			Insights into the Micromechanical Properties of the Metaphase Spindle	CELL			English	Article							MITOTIC SPINDLE; MICROTUBULE DYNAMICS; CELL-DIVISION; MECHANICAL-PROPERTIES; TUBULIN; KINESIN; LENGTH; MOTOR; ORGANIZATION; CHROMOSOMES	The microtubule-based metaphase spindle is subjected to forces that act in diverse orientations and over a wide range of timescales. Currently, we cannot explain how this dynamic structure generates and responds to forces while maintaining overall stability, as we have a poor understanding of its micromechanical properties. Here, we combine the use of force-calibrated needles, high-resolution microscopy, and biochemical perturbations to analyze the vertebrate metaphase spindle's timescale- and orientation-dependent viscoelastic properties. We find that spindle viscosity depends on microtubule crosslinking and density. Spindle elasticity can be linked to kinetochore and nonkinetochore microtubule rigidity, and also to spindle pole organization by kinesin-5 and dynein. These data suggest a quantitative model for the micromechanics of this cytoskeletal architecture and provide insight into how structural and functional stability is maintained in the face of forces, such as those that control spindle size and position, and can result from deformations associated with chromosome movement.	[Shimamoto, Yuta; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Maeda, Yusuke T.; Libchaber, Albert J.] Rockefeller Univ, Lab Expt Condensed Matter Phys, New York, NY 10065 USA; [Ishiwata, Shin'ichi] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan	Rockefeller University; Rockefeller University; Waseda University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, 1230 York Ave, New York, NY 10065 USA.	kapoor@rockefeller.edu	Shimamoto, Yuta/AAH-3281-2019	Shimamoto, Yuta/0000-0003-0935-2793	National Institutes of Health/National Institute of General Medical Sciences [GM065933]; Grants-in-Aid for Scientific Research [21000011, 22227005] Funding Source: KAKEN; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.M.K. acknowledges support from the National Institutes of Health/National Institute of General Medical Sciences (GM065933). We also thank the Uehara memorial foundation (Y.S.) and the Japan Society for the Promotion of Science (Y.S. and Y.T.M.).	ALEXANDER SP, 1991, J CELL BIOL, V113, P805, DOI 10.1083/jcb.113.4.805; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Chakravarty A, 2004, MOL BIOL CELL, V15, P2116, DOI 10.1091/mbc.E03-08-0579; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Desai A, 1999, METHOD CELL BIOL, V61, P385; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Dumont S, 2009, CURR BIOL, V19, P1086, DOI 10.1016/j.cub.2009.05.056; EVANS RM, 2009, SOFT MATTER PHYS, V80; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gardel ML, 2008, METHOD CELL BIOL, V89, P487, DOI 10.1016/S0091-679X(08)00619-5; Gatlin JC, 2010, J CELL BIOL, V188, P481, DOI 10.1083/jcb.200907110; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Houghtaling BR, 2009, P NATL ACAD SCI USA, V106, P15338, DOI 10.1073/pnas.0902317106; Howard J., 2001, MECH MOTOR PROTEINS; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Itabashi T, 2009, NAT METHODS, V6, P167, DOI [10.1038/NMETH.1297, 10.1038/nmeth.1297]; Janmey PA, 2007, METHOD CELL BIOL, V83, P3, DOI 10.1016/S0091-679X(07)83001-9; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; LESLIE RJ, 1984, CELL, V36, P717, DOI 10.1016/0092-8674(84)90352-0; LIN Y, 1971, J CELL BIOL, V49, P468; McIntosh J R, 1975, Soc Gen Physiol Ser, V30, P31; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mitchison TJ, 2005, MOL BIOL CELL, V16, P3064, DOI 10.1091/mbc.E05-02-0174; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Nedelec F, 2001, METH MOL B, V164, P213; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NICKLAS RB, 1983, J CELL BIOL, V97, P542, DOI 10.1083/jcb.97.2.542; NICKLAS RB, 1965, J CELL BIOL, V25, P119, DOI 10.1083/jcb.25.1.119; Ohi R, 2007, CURR BIOL, V17, P953, DOI 10.1016/j.cub.2007.04.057; SALMON ED, 1984, J CELL BIOL, V99, P2165, DOI 10.1083/jcb.99.6.2165; SATO M, 1988, J CELL BIOL, V106, P1205, DOI 10.1083/jcb.106.4.1205; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; TAWADA K, 1991, J THEOR BIOL, V150, P193, DOI 10.1016/S0022-5193(05)80331-5; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Waters JC, 1996, J CELL SCI, V109, P2823; Wittmann T, 1999, METHOD CELL BIOL, V61, P137; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	50	76	76	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 24	2011	145	7					1062	1074		10.1016/j.cell.2011.05.038	http://dx.doi.org/10.1016/j.cell.2011.05.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703450	Green Accepted, Bronze			2022-12-28	WOS:000292025700013
J	Isakova, T; Xie, HL; Yang, W; Xie, DW; Anderson, AH; Scialla, J; Wahl, P; Gutierrez, OM; Steigerwalt, S; He, J; Schwartz, S; Lo, J; Ojo, A; Sondheimer, J; Hsu, CY; Lash, J; Leonard, M; Kusek, JW; Feldman, HI; Wolf, M				Isakova, Tamara; Xie, Huiliang; Yang, Wei; Xie, Dawei; Anderson, Amanda Hyre; Scialla, Julia; Wahl, Patricia; Gutierrez, Orlando M.; Steigerwalt, Susan; He, Jiang; Schwartz, Stanley; Lo, Joan; Ojo, Akinlolu; Sondheimer, James; Hsu, Chi-yuan; Lash, James; Leonard, Mary; Kusek, John W.; Feldman, Harold I.; Wolf, Myles		CRIC Study Grp	Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VASCULAR DYSFUNCTION; PARATHYROID-HORMONE; FGF RECEPTOR; HEMODIALYSIS; CALCITRIOL; DEATH; FIBROBLAST-GROWTH-FACTOR-23; PROGRESSION; PHOSPHORUS; PREDICTION	Context A high level of the phosphate-regulating hormone fibroblast growth factor 23 (FGF-23) is associated with mortality in patients with end-stage renal disease, but little is known about its relationship with adverse outcomes in the much larger population of patients with earlier stages of chronic kidney disease. Objective To evaluate FGF-23 as a risk factor for adverse outcomes in patients with chronic kidney disease. Design, Setting, and Participants A prospective study of 3879 participants with chronic kidney disease stages 2 through 4 who enrolled in the Chronic Renal Insufficiency Cohort between June 2003 and September 2008. Main Outcome Measures All-cause mortality and end-stage renal disease. Results At study enrollment, the mean (SD) estimated glomerular filtration rate (GFR) was 42.8 (13.5) mL/min/1.73 m(2), and the median FGF-23 level was 145.5 RU/mL (interquartile range [IQR], 96-239 reference unit [RU]/mL). During a median follow-up of 3.5 years (IQR, 2.5-4.4 years), 266 participants died (20.3/1000 person-years) and 410 reached end-stage renal disease (33.0/1000 person-years). In adjusted analyses, higher levels of FGF-23 were independently associated with a greater risk of death (hazard ratio [HR], per SD of natural log-transformed FGF-23, 1.5; 95% confidence interval [CI], 1.3-1.7). Mortality risk increased by quartile of FGF-23: the HR was 1.3 (95% CI, 0.8-2.2) for the second quartile, 2.0 (95% CI, 1.2-3.3) for the third quartile, and 3.0 (95% CI, 1.8-5.1) for the fourth quartile. Elevated fibroblast growth factor 23 was independently associated with significantly higher risk of endstage renal disease among participants with an estimated GFR between 30 and 44 mL/min/1.73 m(2) (HR, 1.3 per SD of FGF-23 natural log-transformed FGF-23; 95% CI, 1.04-1.6) and 45 mL/min/1.73 m(2) or higher (HR, 1.7; 95% CI, 1.1-2.4), but not less than 30 mL/min/1.73 m(2). Conclusion Elevated FGF-23 is an independent risk factor for end-stage renal disease in patients with relatively preserved kidney function and for mortality across the spectrum of chronic kidney disease. JAMA. 2011;305(23):2432-2439 www.jama.com	[Isakova, Tamara; Wahl, Patricia; Wolf, Myles] Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Div Nephrol & Hypertens, Miami, FL 33136 USA; [Xie, Huiliang; Yang, Wei; Anderson, Amanda Hyre; Feldman, Harold I.] Childrens Hosp Philadelphia, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Leonard, Mary] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Schwartz, Stanley; Feldman, Harold I.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Scialla, Julia] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Gutierrez, Orlando M.] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL USA; [Steigerwalt, Susan] St Johns Hlth Syst, Detroit, MI USA; [He, Jiang] Tulane Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA 70118 USA; [Lo, Joan] Kaiser Permanente, Oakland, CA USA; [Ojo, Akinlolu] Univ Michigan Hlth Syst, Dept Med, Div Nephrol, Ann Arbor, MI USA; [Sondheimer, James] Wayne State Univ, Sch Med, Dept Med, Div Nephrol, Detroit, MI 48201 USA; [Hsu, Chi-yuan] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Lash, James] Univ Illinois, Dept Med, Div Nephrol, Chicago, IL USA; [Kusek, John W.] NIDDK, Div Kidney Urol & Hematol Dis, Bethesda, MD USA	University of Miami; University of Miami; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; Tulane University; Kaiser Permanente; University of Michigan System; University of Michigan; Wayne State University; University of California System; University of California San Francisco; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wolf, M (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Nephrol & Hypertens, 1120 NW 14th St,CRB 819, Miami, FL 33136 USA.	mwolf2@med.miami.edu	Schwartz, S/I-9628-2019; He, Jiang/AAF-5303-2020; Yang, Wei/A-9223-2009	He, Jiang/0000-0002-8286-9652; Yang, Wei/0000-0001-8984-4389; Scialla, Julia/0000-0003-1707-691X; Hsu, Chi-yuan/0000-0001-8182-1238	National Institutes of Health [R01DK081374, K23DK087858, R01DK077128, UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, UL1RR024131]; National Institute of Diabetes and Digestive and Kidney Diseases [5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, 5U01DK060902]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500, UL1RR029879, UL1RR024134, M01RR013987, UL1RR024989, UL1RR024131, UL1RR025005, M01RR005096, M01RR000042, UL1RR024986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK087858, U01DK061028, U01DK060902, K24DK062234, U01DK060990, R01DK072231, U01DK060980, R56DK072231, R01DK077128, R01DK081374, R01DK076116, U01DK060984, U01DK060963, U01DK061021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This CRIC ancillary study was supported by National Institutes of Health grants R01DK081374 (Dr Wolf), K23DK087858 (Dr Isakova), and R01DK077128 (Dr Leonard). The CRIC Study is supported by cooperative agreement project grants 5U01DK060990, 5U01DK060984, 5U01DK06102, 5U01DK061021, 5U01DK061028, 5U01DK60980, 5U01DK060963, and 5U01DK060902 from the National Institute of Diabetes and Digestive and Kidney Diseases, and by grants UL1RR024134, UL1RR025005, M01RR16500, UL1RR024989, M01RR000042, UL1RR024986, UL1RR029879, RR05096, and UL1RR024131 from the National Institutes of Health.	Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Juppner H, 2010, J BONE MINER RES, V25, P2091, DOI 10.1002/jbmr.170; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Landray MJ, 2010, AM J KIDNEY DIS, V56, P1082, DOI 10.1053/j.ajkd.2010.07.016; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Mirza MAI, 2009, NEPHROL DIAL TRANSPL, V24, P3125, DOI 10.1093/ndt/gfp205; Mirza MAI, 2009, ATHEROSCLEROSIS, V205, P385, DOI 10.1016/j.atherosclerosis.2009.01.001; Norris KC, 2006, J AM SOC NEPHROL, V17, P2928, DOI 10.1681/ASN.2005101101; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Shimada T, 2010, J CLIN ENDOCR METAB, V95, P578, DOI 10.1210/jc.2009-1603; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; US Renal Data System, 2010, USRDS 2010 ANN DAT R; Wesseling-Perry K, 2011, KIDNEY INT, V79, P112, DOI 10.1038/ki.2010.352; Wolf M, 2011, J AM SOC NEPHROL, V22, P956, DOI 10.1681/ASN.2010080894; Wolf M, 2010, J AM SOC NEPHROL, V21, P1427, DOI 10.1681/ASN.2009121293; Yilmaz MI, 2010, KIDNEY INT, V78, P679, DOI 10.1038/ki.2010.194	32	769	813	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2432	2439		10.1001/jama.2011.826	http://dx.doi.org/10.1001/jama.2011.826			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673295	Green Accepted, Bronze			2022-12-28	WOS:000291597300023
J	Vakil, A; Engheta, N				Vakil, Ashkan; Engheta, Nader			Transformation Optics Using Graphene	SCIENCE			English	Article							METAMATERIALS	Metamaterials and transformation optics play substantial roles in various branches of optical science and engineering by providing schemes to tailor electromagnetic fields into desired spatial patterns. We report a theoretical study showing that by designing and manipulating spatially inhomogeneous, nonuniform conductivity patterns across a flake of graphene, one can have this material as a one-atom-thick platform for infrared metamaterials and transformation optical devices. Varying the graphene chemical potential by using static electric field yields a way to tune the graphene conductivity in the terahertz and infrared frequencies. Such degree of freedom provides the prospect of having different "patches" with different conductivities on a single flake of graphene. Numerous photonic functions and metamaterial concepts can be expected to follow from such a platform.	[Vakil, Ashkan; Engheta, Nader] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu			U.S. Air Force Office of Scientific Research (AFOSR) [FA9550-08-1-0220, FA9550-10-1-0408]	U.S. Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work is supported in part by the U.S. Air Force Office of Scientific Research (AFOSR) grants FA9550-08-1-0220 and FA9550-10-1-0408. Authors have no conflict of interest. A provisional patent application on the ideas presented in this manuscript has been filed by the University of Pennsylvania.	Alu A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.024304; Andersen DR, 2010, J OPT SOC AM B, V27, P818, DOI 10.1364/JOSAB.27.000818; Cai W, 2010, OPTICAL METAMATERIALS: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-1151-3; Cheianov VV, 2007, SCIENCE, V315, P1252, DOI 10.1126/science.1138020; Dehbashi R, 2010, IEEE J SEL TOP QUANT, V16, P394, DOI 10.1109/JSTQE.2009.2033818; Eleftheriades GV, 2005, NEGATIVE-REFRACTION METAMATERIALS: FUNDAMENTAL PRINCIPLES AND APPLICATIONS, P1, DOI 10.1002/0471744751; Engheta N., 2006, METAMATERIALS PHYS E, DOI 10.1002/0471784192.; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gusynin VP, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/2/026222; Hanson GW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2891452; Huidobro PA, 2010, NANO LETT, V10, P1985, DOI 10.1021/nl100800c; Hwang EH, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205418; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Mikhailov SA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016803; Mishchenko EG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.156806; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Papasimakis N, 2010, OPT EXPRESS, V18, P8353, DOI 10.1364/OE.18.008353; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Rana F, 2008, IEEE T NANOTECHNOL, V7, P91, DOI 10.1109/TNANO.2007.910334; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Zentgraf T, 2011, NAT NANOTECHNOL, V6, P151, DOI [10.1038/nnano.2010.282, 10.1038/NNANO.2010.282]	27	2192	2238	32	1133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1291	1294		10.1126/science.1202691	http://dx.doi.org/10.1126/science.1202691			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659598				2022-12-28	WOS:000291441700037
J	Zwilling, D; Huang, SY; Sathyasaikumar, KV; Notarangelo, FM; Guidetti, P; Wu, HQ; Lee, J; Truong, J; Andrews-Zwilling, Y; Hsieh, EW; Louie, JY; Wu, T; Scearce-Levie, K; Patrick, C; Adame, A; Giorgini, F; Moussaoui, S; Laue, G; Rassoulpour, A; Flik, G; Huang, YD; Muchowski, JM; Masliah, E; Schwarcz, R; Muchowski, PJ				Zwilling, Daniel; Huang, Shao-Yi; Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Patrick, Christina; Adame, Anthony; Giorgini, Flaviano; Moussaoui, Saliha; Laue, Grit; Rassoulpour, Arash; Flik, Gunnar; Huang, Yadong; Muchowski, Joseph M.; Masliah, Eliezer; Schwarcz, Robert; Muchowski, Paul J.			Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration	CELL			English	Article							QUINOLINIC ACID; MOUSE MODEL; TRYPTOPHAN-METABOLISM; ALZHEIMERS-DISEASE; GLUTAMATE UPTAKE; PATHWAY; EXPRESSION; AMINOTRANSFERASE; NEUROTOXICITY; INFLAMMATION	Metabolites in the kynurenine pathway, generated by tryptophan degradation, are thought to play an important role in neurodegenerative disorders, including Alzheimer's and Huntington's diseases. In these disorders, glutamate receptor-mediated excitotoxicity and free radical formation have been correlated with decreased levels of the neuroprotective metabolite kynurenic acid. Here, we describe the synthesis and characterization of JM6, a smallmolecule prodrug inhibitor of kynurenine 3-monooxygenase (KMO). Chronic oral administration of JM6 inhibits KMO in the blood, increasing kynurenic acid levels and reducing extracellular glutamate in the brain. In a transgenic mouse model of Alzheimer's disease, JM6 prevents spatial memory deficits, anxiety-related behavior, and synaptic loss. JM6 also extends life span, prevents synaptic loss, and decreases microglial activation in a mouse model of Huntington's disease. These findings support a critical link between tryptophan metabolism in the blood and neurodegeneration, and they provide a foundation for treatment of neurodegenerative diseases.	[Zwilling, Daniel; Huang, Shao-Yi; Lee, Jason; Truong, Jennifer; Andrews-Zwilling, Yaisa; Hsieh, Eric W.; Louie, Jamie Y.; Wu, Tiffany; Scearce-Levie, Kimberly; Huang, Yadong; Muchowski, Joseph M.; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Huang, Shao-Yi; Muchowski, Paul J.] Hellman Family Fdn Program Alzheimers Dis Res, San Francisco, CA 94158 USA; [Sathyasaikumar, Korrapati V.; Notarangelo, Francesca M.; Guidetti, Paolo; Wu, Hui-Qiu; Schwarcz, Robert] Univ Maryland, Maryland Psychiat Res Ctr, Sch Med, Baltimore, MD 21228 USA; [Patrick, Christina; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Giorgini, Flaviano] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Moussaoui, Saliha; Laue, Grit] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Rassoulpour, Arash; Flik, Gunnar] Brains On Line BV, NL-9713 AV Groningen, Netherlands	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego; University of Leicester; Novartis	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Schwarcz, Robert/P-3134-2018	Giorgini, Flaviano/0000-0001-7881-9508; Wu, Tiffany/0000-0002-9273-0574	J. David Gladstone Institutes; National Institutes of Health [AG022074, NS057715]; Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715, P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	J. David Gladstone Institutes(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taube-Koret Center for Huntington's Disease Research; Hellman Family Foundation; American Health Assistance Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the J. David Gladstone Institutes (P.J.M.), National Institutes of Health grants AG022074 (P.J.M., Y.H., and E.M.) and NS057715 (P.J.M. and R.S.), the Taube-Koret Center for Huntington's Disease Research and the Hellman Family Foundation Program in Alzheimer's Disease Research (P.J.M.), and a postdoctoral fellowship from the American Health Assistance Foundation (D.Z.). The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. The authors thank S. Ordway and G. Howard for editorial assistance and S. Finkbeiner for helpful discussions. This study is dedicated in loving memory to Dr. Paolo Guidetti (June 5, 1966-December 28, 2007), who tragically passed away during the course of this study after a battle with cancer.	ANDINE P, 1988, NEUROSCI LETT, V90, P208, DOI 10.1016/0304-3940(88)90813-0; BEAL MF, 1992, J NEUROL SCI, V108, P80; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; BOEGMAN RJ, 1985, NEUROBIOL AGING, V6, P331, DOI 10.1016/0197-4580(85)90012-0; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Carpenedo R, 2001, EUR J NEUROSCI, V13, P2141, DOI 10.1046/j.0953-816x.2001.01592.x; Carrillo-Mora P, 2010, BEHAV BRAIN RES, V210, P240, DOI 10.1016/j.bbr.2010.02.041; Cepeda C, 2003, J NEUROSCI, V23, P961; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Clark CJ, 2005, INFECT IMMUN, V73, P5249, DOI 10.1128/IAI.73.8.5249-5251.2005; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Eckstein JA, 2008, J MASS SPECTROM, V43, P782, DOI 10.1002/jms.1376; FILLIT H, 1991, NEUROSCI LETT, V129, P318, DOI 10.1016/0304-3940(91)90490-K; FOSTER AC, 1984, NEUROSCI LETT, V48, P273, DOI 10.1016/0304-3940(84)90050-8; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Gregoire L, 2008, BEHAV BRAIN RES, V186, P161, DOI 10.1016/j.bbr.2007.08.007; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2007, J NEUROCHEM, V102, P103, DOI 10.1111/j.1471-4159.2007.04556.x; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Gulaj E, 2010, ADV MED SCI-POLAND, V55, P204, DOI 10.2478/v10039-010-0023-6; Harris JA, 2010, J NEUROSCI, V30, P372, DOI 10.1523/JNEUROSCI.5341-09.2010; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; HEYES MP, 1992, BIOCHEM J, V283, P633, DOI 10.1042/bj2830633; Hilmas C, 2001, J NEUROSCI, V21, P7463, DOI 10.1523/JNEUROSCI.21-19-07463.2001; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Masliah E, 1996, ANN NEUROL, V40, P759, DOI 10.1002/ana.410400512; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Misztal M, 1996, NEUROPHARMACOLOGY, V35, P449, DOI 10.1016/0028-3908(96)00005-6; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Moroni F, 2005, NEUROPHARMACOLOGY, V48, P788, DOI 10.1016/j.neuropharm.2004.10.019; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NOZAKI K, 1992, J CEREBR BLOOD F MET, V12, P400, DOI 10.1038/jcbfm.1992.57; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Pellicciari R, 2006, CHEMMEDCHEM, V1, P528, DOI 10.1002/cmdc.200500095; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Rassoulpour A, 2005, J NEUROCHEM, V93, P762, DOI 10.1111/j.1471-4159.2005.03134.x; Rodgers J, 2009, BRAIN, V132, P1259, DOI 10.1093/brain/awp074; Romani L, 2008, J IMMUNOL, V180, P5157, DOI 10.4049/jimmunol.180.8.5157; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Sapko MT, 2006, EXP NEUROL, V197, P31, DOI 10.1016/j.expneurol.2005.07.004; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Silva-Adaya D, 2011, NEUROTOXICOL TERATOL, V33, P303, DOI 10.1016/j.ntt.2010.10.002; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Stoy N, 2005, J NEUROCHEM, V93, P611, DOI 10.1111/j.1471-4159.2005.03070.x; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yamamoto M, 2007, AM J PATHOL, V170, P680, DOI 10.2353/ajpath.2007.060378	54	352	362	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					863	874		10.1016/j.cell.2011.05.020	http://dx.doi.org/10.1016/j.cell.2011.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21640374	Green Accepted, Bronze			2022-12-28	WOS:000291461600014
J	Shetty, P				Shetty, Priya			Lunch with The Lancet David Eagleman	LANCET			English	Editorial Material												priya4876@gmail.com							0	0	0	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2011	377	9781					1910	1910		10.1016/S0140-6736(11)60797-6	http://dx.doi.org/10.1016/S0140-6736(11)60797-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21641467				2022-12-28	WOS:000291623200013
J	Delebecque, CJ; Lindner, AB; Silver, PA; Aldaye, FA				Delebecque, Camille J.; Lindner, Ariel B.; Silver, Pamela A.; Aldaye, Faisal A.			Organization of Intracellular Reactions with Rationally Designed RNA Assemblies	SCIENCE			English	Article							DNA	The rules of nucleic acid base-pairing have been used to construct nanoscale architectures and organize biomolecules, but little has been done to apply this technology in vivo. We designed and assembled multidimensional RNA structures and used them as scaffolds for the spatial organization of bacterial metabolism. Engineered RNA modules were assembled into discrete, one-dimensional, and two-dimensional scaffolds with distinct protein-docking sites and used to control the spatial organization of a hydrogen-producing pathway. We increased hydrogen output as a function of scaffold architecture. Rationally designed RNA assemblies can thus be used to construct functional architectures in vivo.	[Delebecque, Camille J.; Lindner, Ariel B.] INSERM, U1001, F-75015 Paris, France; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Delebecque, Camille J.; Silver, Pamela A.; Aldaye, Faisal A.] Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Delebecque, Camille J.; Lindner, Ariel B.] Paris Descartes Univ, Fac Med, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School; UDICE-French Research Universities; Universite Paris Cite	Lindner, AB (corresponding author), INSERM, U1001, F-75015 Paris, France.	ariel.lindner@inserm.fr; pamela_silver@hms.harvard.edu	Lindner, Ariel B/I-8503-2016; Lindner, Ariel/K-9247-2019	Lindner, Ariel B/0000-0001-5015-6511; Lindner, Ariel/0000-0001-5015-6511	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France; Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity; Natural Sciences and Engineering Research Council of Canada; Wyss Institute for Biologically Inspired Engineering	Enerbio-Tuck Foundation; Institut Francais du Petrole Energies Nouvelles; Agence Nationale de la Recherche France(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure; Axa Foundation Chair on Longevity(AXA Research Fund); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Wyss Institute for Biologically Inspired Engineering	This work was supported by from the Enerbio-Tuck Foundation and the Institut Francais du Petrole Energies Nouvelles (to C.J.D.); Agence Nationale de la Recherche France, Institut National de la Sante et de la Recherche Medicale-Institut National de Recherche en Informatique et en Automatique projet d'envergure, and Axa Foundation Chair on Longevity (to A. B. L.); Natural Sciences and Engineering Research Council of Canada (to F. A. A.); and the Wyss Institute for Biologically Inspired Engineering. We thank the Harvard Medical School Electron Microscopy Center for assistance in electron microscopy, and we thank the reviewers for their insight.	Barstow B, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-7; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Cayrol B, 2009, J AM CHEM SOC, V131, P17270, DOI 10.1021/ja906076e; Diestra E, 2009, J STRUCT BIOL, V165, P157, DOI 10.1016/j.jsb.2008.11.009; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Lin C, 2009, BIOCHEMISTRY-US, V48, P1663, DOI 10.1021/bi802324w; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Liu HP, 2006, ANGEW CHEM INT EDIT, V45, P1942, DOI 10.1002/anie.200504022; Liu HP, 2005, BIOMACROMOLECULES, V6, P2943, DOI 10.1021/bm050632j; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Savage DF, 2010, SCIENCE, V327, P1258, DOI 10.1126/science.1186090; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451	19	454	489	7	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					470	474		10.1126/science.1206938	http://dx.doi.org/10.1126/science.1206938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700839				2022-12-28	WOS:000292959600051
J	Dominguez-Escobar, J; Chastanet, A; Crevenna, AH; Fromion, V; Wedlich-Soldner, R; Carballido-Lopez, R				Dominguez-Escobar, Julia; Chastanet, Arnaud; Crevenna, Alvaro H.; Fromion, Vincent; Wedlich-Soeldner, Roland; Carballido-Lopez, Rut			Processive Movement of MreB-Associated Cell Wall Biosynthetic Complexes in Bacteria	SCIENCE			English	Article							PENICILLIN-BINDING PROTEINS; ACTIN-LIKE PROTEINS; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; SYNTHETIC COMPLEXES; SHAPE DETERMINATION; MORPHOGENESIS; LOCALIZATION; CYTOSKELETON; ELONGATION	The peptidoglycan cell wall and the actin-like MreB cytoskeleton are major determinants of cell shape in rod-shaped bacteria. The prevailing model postulates that helical, membrane-associated MreB filaments organize elongation-specific peptidoglycan-synthesizing complexes along sidewalls. We used total internal reflection fluorescence microscopy to visualize the dynamic relation between MreB isoforms and cell wall synthesis in live Bacillus subtilis cells. During exponential growth, MreB proteins did not form helical structures. Instead, together with other morphogenetic factors, they assembled into discrete patches that moved processively along peripheral tracks perpendicular to the cell axis. Patch motility was largely powered by cell wall synthesis, and MreB polymers restricted diffusion of patch components in the membrane and oriented patch motion.	[Dominguez-Escobar, Julia; Crevenna, Alvaro H.; Wedlich-Soeldner, Roland] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Chastanet, Arnaud; Carballido-Lopez, Rut] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Chastanet, Arnaud; Carballido-Lopez, Rut] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Fromion, Vincent] INRA, Math Informat & Genomes UR1077, F-78352 Jouy En Josas, France	Max Planck Society; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wedlich-Soldner, R (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	wedlich@biochem.mpg.de; rut.carballido-lopez@jouy.inra.fr	Crevenna, Alvaro/Q-4476-2019; Crevenna, Alvaro/E-9125-2016; LOPEZ, RUT CARBALLIDO/G-2283-2015	Crevenna, Alvaro/0000-0002-5580-3711; Crevenna, Alvaro/0000-0002-5580-3711; LOPEZ, RUT CARBALLIDO/0000-0001-9383-8811; CHASTANET, Arnaud/0000-0003-0320-4861	Human Frontier Science Program (HFSP) [HFSP-RGY0067/2009-C]; European Molecular Biology Organization; French National Research Agency (ANR) [ANR-08-JCJC-0024-01]; Max Planck society	Human Frontier Science Program (HFSP)(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); French National Research Agency (ANR)(French National Research Agency (ANR)); Max Planck society(Max Planck Society)	We thank R. Daniel and L. J. Wu for sharing unpublished strains and for helpful suggestions, D.-J. Scheffers for strains, N. Campo for the antibody against GFP, and P. Hardy for manuscript editing. This work was supported by a Human Frontier Science Program (HFSP) Young Investigator grant (R.C.-L. and R.W.-S., HFSP-RGY0067/2009-C); a European Molecular Biology Organization short-term fellowship (R.C.-L), The French National Research Agency (ANR) (R.C.-L., ANR-08-JCJC-0024-01), and the Max Planck society (R.W.-S.).	Barrett D, 2007, J BIOL CHEM, V282, P31964, DOI 10.1074/jbc.M705440200; BROWN ED, 1995, J BACTERIOL, V177, P4194, DOI 10.1128/jb.177.14.4194-4197.1995; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; Carballido-Lopez R, 2007, CURR OPIN MICROBIOL, V10, P611, DOI 10.1016/j.mib.2007.09.008; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Claessen D, 2008, MOL MICROBIOL, V68, P1029, DOI 10.1111/j.1365-2958.2008.06210.x; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Fleming TC, 2010, GENE DEV, V24, P1160, DOI 10.1101/gad.1925210; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Kahne D, 2005, CHEM REV, V105, P425, DOI 10.1021/cr030103a; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Murray T, 1997, J BACTERIOL, V179, P3021, DOI 10.1128/jb.179.9.3021-3029.1997; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Soufo HJD, 2006, MOL MICROBIOL, V62, P1340, DOI 10.1111/j.1365-2958.2006.05457.x; Soufo HJD, 2004, EMBO REP, V5, P789, DOI 10.1038/sj.embor.7400209; Uehara T, 2008, J BACTERIOL, V190, P3914, DOI 10.1128/JB.00207-08; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; White CL, 2010, MOL MICROBIOL, V76, P616, DOI 10.1111/j.1365-2958.2010.07108.x; Yu JH, 2011, J CELL SCI, V124, P1533, DOI 10.1242/jcs.079038	25	365	371	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					225	228		10.1126/science.1203466	http://dx.doi.org/10.1126/science.1203466			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21636744	Bronze, Green Published			2022-12-28	WOS:000292502700051
J	Kim, N; Huang, SYN; Williams, JS; Li, YC; Clark, AB; Cho, JE; Kunkel, TA; Pommier, Y; Jinks-Robertson, S				Kim, Nayun; Huang, Shar-yin N.; Williams, Jessica S.; Li, Yue C.; Clark, Alan B.; Cho, Jang-Eun; Kunkel, Thomas A.; Pommier, Yves; Jinks-Robertson, Sue			Mutagenic Processing of Ribonucleotides in DNA by Yeast Topoisomerase I	SCIENCE			English	Article							MISMATCH REPAIR PROTEINS; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION; CAMPTOTHECIN; INSTABILITY; ANTICANCER; SEQUENCE; H2	The ribonuclease (RNase) H class of enzymes degrades the RNA component of RNA:DNA hybrids and is important in nucleic acid metabolism. RNase H2 is specialized to remove single ribonucleotides [ribonucleoside monophosphates (rNMPs)] from duplex DNA, and its absence in budding yeast has been associated with the accumulation of deletions within short tandem repeats. Here, we demonstrate that rNMP-associated deletion formation requires the activity of Top1, a topoisomerase that relaxes supercoils by reversibly nicking duplex DNA. The reported studies extend the role of Top1 to include the processing of rNMPs in genomic DNA into irreversible single-strand breaks, an activity that can have distinct mutagenic consequences and may be relevant to human disease.	[Kim, Nayun; Li, Yue C.; Cho, Jang-Eun; Jinks-Robertson, Sue] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Huang, Shar-yin N.; Pommier, Yves] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Lab Mol Genet, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jessica S.; Clark, Alan B.; Kunkel, Thomas A.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	Duke University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jinks-Robertson, S (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	sue.robertson@duke.edu	Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788	NIH [R01 GM38464, R01 GM93197]; Center for Cancer Research, National Cancer Institute, NIH; Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences [Z01 ES065070, Z01 ES065089]; NATIONAL CANCER INSTITUTE [ZIABC006161, ZIABC006150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.J.-R. was supported by NIH grants R01 GM38464 and R01 GM93197; Y.P. was supported by the Intramural Program, Center for Cancer Research, National Cancer Institute, NIH; and T.A.K. was supported by Projects Z01 ES065070 and Z01 ES065089 from the Division of Intramural Research of the NIH, National Institute of Environmental Health Sciences.	Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; Clark AB, 2010, CELL CYCLE, V9, P4422, DOI 10.4161/cc.9.22.14052; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Greene CN, 1997, MOL CELL BIOL, V17, P2844, DOI 10.1128/MCB.17.5.2844; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; HSIANG YH, 1988, CANCER RES, V48, P1722; JAXEL C, 1991, J BIOL CHEM, V266, P20418; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; PORTER SE, 1989, MOL CELL BIOL, V9, P541, DOI 10.1128/MCB.9.2.541; Sekiguchi J, 1997, MOL CELL, V1, P89, DOI 10.1016/S1097-2765(00)80010-6; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	17	219	219	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1561	1564		10.1126/science.1205016	http://dx.doi.org/10.1126/science.1205016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700875	Green Accepted			2022-12-28	WOS:000291990000046
J	Lynd, LR; Woods, J				Lynd, Lee R.; Woods, Jeremy			A new hope for Africa	NATURE			English	Editorial Material									[Lynd, Lee R.] Dartmouth Coll Thayer Sch Engn, Hanover, NH USA; [Woods, Jeremy] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Dartmouth College; Imperial College London	Lynd, LR (corresponding author), Dartmouth Coll Thayer Sch Engn, Hanover, NH USA.	lee.r.lynd@Dartmouth.edu; Jeremy.woods@imperial.ac.uk	Lynd, Lee R/N-1260-2013	Lynd, Lee R/0000-0002-5642-668X; Woods, Jeremy/0000-0002-1542-8144					0	37	39	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S20	S21		10.1038/474S020a	http://dx.doi.org/10.1038/474S020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697839	Bronze, Green Submitted			2022-12-28	WOS:000291939700008
J	Lovett, KM; Liang, BA				Lovett, Kimberly M.; Liang, Bryan A.			Direct-to-Consumer Cardiac Screening and Suspect Risk Evaluation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lovett, Kimberly M.] Kaiser Permanente, San Diego, CA USA; [Liang, Bryan A.] UCSD Sch Med, San Diego Ctr Patient Safety, San Diego, CA USA; [Liang, Bryan A.] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA USA	Kaiser Permanente; University of California System; University of California San Diego	Lovett, KM (corresponding author), Kaiser Permanente, 1630 E Main St, El Cajon, CA 92021 USA.	klovett@ucsd.edu		Liang, Bryan/0000-0001-7801-5673				FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Health Fair, HLTH SCREEN TEST PAC; Healthy Life Screening, LV DYSF SUDD CARD DE; Lifeline Screening, ASS YOUR RISK CAR AR; U.S. Preventive Services Task Force (USPSTF), REC; US Department of Health and Human Services, 2011, MOL CLIN GEN PAN M M; *US FDA, DRAFT GUID IND CLIN; Vital Scanning Inc, ART STIFFN SCREEN; Wilson J JG, 1968, PUBLIC HLTH PAPERS, V34	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2567	2568		10.1001/jama.2011.865	http://dx.doi.org/10.1001/jama.2011.865			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693746				2022-12-28	WOS:000291860400025
J	Maciejewski, ML; Livingston, EH; Smith, VA; Kavee, AL; Kahwati, LC; Henderson, WG; Arterburn, DE				Maciejewski, Matthew L.; Livingston, Edward H.; Smith, Valerie A.; Kavee, Andrew L.; Kahwati, Leila C.; Henderson, William G.; Arterburn, David E.			Survival Among High-Risk Patients After Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; QUALITY IMPROVEMENT PROGRAM; TREATMENT SELECTION BIAS; AFFAIRS MEDICAL-CENTERS; GASTRIC BYPASS-SURGERY; VETERANS-AFFAIRS; PROPENSITY-SCORE; OBESITY; PERFORMANCE; PREVALENCE	Context Existing evidence of the survival associated with bariatric surgery is based on cohort studies of predominantly younger women with a low inherent obesity-related mortality risk. The association of survival and bariatric surgery for older men is less clear. Objective To determine whether bariatric surgery is associated with reduced mortality in a multisite cohort of predominantly older male patients who have a high baseline mortality rate. Design, Setting, and Participants Retrospective cohort study of bariatric surgery programs in Veterans Affairs medical centers. Mortality was examined for 850 veterans who had bariatric surgery in January 2000 to December 2006 (mean age 49.5 years; SD 8.3; mean body mass index [BMI] 47.4; SD 7.8) and 41 244 nonsurgical controls (mean age 54.7 years, SD 10.2; mean BMI 42.0, SD 5.0) from the same 12 Veteran Integrated Service Networks; the mean follow-up was 6.7 years. Four Cox proportional hazards models were assessed: unadjusted and controlled for baseline covariates on unmatched and propensity-matched cohorts. Main Outcome Measure All-cause mortality through December 2008. Results Among patients who had bariatric surgery, the 1-, 2-, and 6-year crude mortality rates were, respectively, 1.5%, 2.2%, and 6.8% compared with 2.2%, 4.6%, and 15.2% for nonsurgical controls. In unadjusted Cox regression, bariatric surgery was associated with reduced mortality (hazard ratio [HR], 0.64; 95% confidence interval [CI], 0.51-0.80). After covariate adjustment, bariatric surgery remained associated with reduced mortality (HR, 0.80; 95% CI, 0.63-0.995). In analysis of 1694 propensity-matched patients, bariatric surgery was no longer significantly associated with reduced mortality in unadjusted (HR, 0.83; 95% CI, 0.61-1.14) and time-adjusted (HR, 0.94; 95% CI, 0.64-1.39) Cox regressions. Conclusion In propensity score-adjusted analyses of older severely obese patients with high baseline mortality in Veterans Affairs medical centers, the use of bariatric surgery compared with usual care was not associated with decreased mortality during a mean 6.7 years of follow-up. JAMA. 2011;305(23):2419-2426 www.jama.com	[Maciejewski, Matthew L.; Smith, Valerie A.; Kavee, Andrew L.] Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC USA; [Livingston, Edward H.] Univ Texas SW Med Ctr Dallas, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Livingston, Edward H.] Vet Adm N Texas Hlth Care Syst, Dallas, TX USA; [Livingston, Edward H.] Univ Texas Arlington, Arlington, TX USA; [Kahwati, Leila C.] US Dept Vet Affairs, Natl Ctr Hlth Promot & Dis Prevent, Off Patient Care Serv, Durham, NC USA; [Henderson, William G.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Henderson, William G.] Univ Colorado, Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Henderson, William G.] Univ Colorado, Colorado Hlth Outcomes Program, Aurora, CO USA; [Arterburn, David E.] Grp Hlth Res Inst, Seattle, WA USA; [Arterburn, David E.] Univ Washington, Dept Med, Div Gen Internal Med, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System; University of Texas System; University of Texas Arlington; US Department of Veterans Affairs; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Washington; University of Washington Seattle	Maciejewski, ML (corresponding author), Durham VA Med Ctr, Ctr Hlth Serv Res Primary Care 152, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov		Smith, Valerie/0000-0001-5170-9819; Kahwati, Leila/0000-0001-6963-2848	Takeda Pharmaceuticals; Novartis; Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making [501[3]c]	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Surgical Review Corporation; Research Data and Assistance Center at the University of Minnesota; Texas Instruments; Foundation for Informed Medical Decision Making	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Maciejewski reports receiving consultation funds from Takeda Pharmaceuticals, Novartis, the Surgical Review Corporation, and the Research Data and Assistance Center at the University of Minnesota and owns stock in Amgen. Dr Livingston reports receiving consulting funds from Texas Instruments. Dr Arterburn reports receiving research funding and has received salary support as a medical editor for the not-for-profit (501[3]c) Foundation for Informed Medical Decision Making (http://www.fimdm.org), which develops content for patient education programs. The foundation has an arrangement with a for-profit company, Health Dialog, to coproduce and market these programs to health care organizations. Dr Arterburn was formerly with the Cincinnati Veterans Affairs and Dr Livingston was formerly with the Dallas Veterans Affairs. No other disclosures were reported.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Arterburn D, 2009, ARCH SURG-CHICAGO, V144, P914, DOI 10.1001/archsurg.2009.134; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2010, AM J EPIDEMIOL, V172, P1092, DOI 10.1093/aje/kwq224; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P136, DOI 10.1016/j.jclinepi.2009.05.009; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Beyersmann J, 2008, STAT MED, V27, P6439, DOI 10.1002/sim.3437; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Das SR, 2005, AM J PREV MED, V28, P291, DOI 10.1016/j.amepre.2004.12.007; Davis CL, 2007, J AM COLL SURGEONS, V204, P550, DOI 10.1016/j.jamcollsurg.2007.01.012; Fan VS, 2006, HEALTH SERV OUTCOME, V6, P21, DOI 10.1007/s10742-006-0004-1; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flum David R, 2006, Surg Obes Relat Dis, V2, P78, DOI 10.1016/j.soard.2006.02.008; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Hutter MM, 2009, OBESITY, V17, P924, DOI 10.1038/oby.2008.568; Lautz DB, 2007, J AM COLL SURGEONS, V204, P1261, DOI 10.1016/j.jamcollsurg.2007.04.003; Livingston EH, 2006, J AM COLL SURGEONS, V203, P625, DOI 10.1016/j.jamcollsurg.2006.07.006; Livingston EH, 2010, AM J SURG, V200, P378, DOI 10.1016/j.amjsurg.2009.11.007; Livingston EH, 2005, SURGERY, V137, P16, DOI 10.1016/j.surg.2004.05.049; Livingston EH, 2002, ANN SURG, V236, P576, DOI 10.1097/00000658-200211000-00007; MacDonald K G Jr, 1997, J Gastrointest Surg, V1, P213, DOI 10.1016/S1091-255X(97)80112-6; Maciejewski ML, 2010, SURG OBES RELAT DIS, V6, P601, DOI 10.1016/j.soard.2010.07.005; Maciejewski ML, 2010, MED CARE, V48, P989, DOI 10.1097/MLR.0b013e3181ef9cf7; Maciejewski ML, 2009, DIABETES CARE, V32, P75, DOI 10.2337/dc08-1099; Maciejewski ML, 2005, HEALTH SERV RES, V40, P887, DOI 10.1111/j.1475-6773.2005.00390.x; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Parsons, 2001, P 26 ANN SAS US GROU; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; *VET ADM, MAN OB OV	39	112	114	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2419	2426		10.1001/jama.2011.817	http://dx.doi.org/10.1001/jama.2011.817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21666276	Bronze			2022-12-28	WOS:000291597300021
J	Schlingmann, KP; Kaufmann, M; Weber, S; Irwin, A; Goos, C; John, U; Misselwitz, J; Klaus, G; Kuwertz-Broking, E; Fehrenbach, H; Wingen, AM; Guran, T; Hoenderop, JG; Bindels, RJ; Prosser, DE; Jones, G; Konrad, M				Schlingmann, Karl P.; Kaufmann, Martin; Weber, Stefanie; Irwin, Andrew; Goos, Caroline; John, Ulrike; Misselwitz, Joachim; Klaus, Guenter; Kuwertz-Broeking, Eberhard; Fehrenbach, Henry; Wingen, Anne M.; Gueran, Tuelay; Hoenderop, Joost G.; Bindels, Rene J.; Prosser, David E.; Jones, Glenville; Konrad, Martin			Mutations in CYP24A1 and Idiopathic Infantile Hypercalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SITE-DIRECTED MUTAGENESIS; VITAMIN-D; CALCITROIC ACID; METABOLISM; BONE; 1,25-DIHYDROXYVITAMIN-D3; PHARMACOKINETICS; INACTIVATION; MECHANISM; RESIDUES	BACKGROUND Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the potentially toxic effects of vitamin D, the recommendations for the optimal dose are still debated, in part owing to the increased incidence of idiopathic infantile hypercalcemia in Britain in the 1950s during a period of high vitamin D supplementation in fortified milk products. We investigated the molecular basis of idiopathic infantile hypercalcemia, which is characterized by severe hypercalcemia, failure to thrive, vomiting, dehydration, and nephrocalcinosis. METHODS We used a candidate-gene approach in a cohort of familial cases of typical idiopathic infantile hypercalcemia with suspected autosomal recessive inheritance. Identified mutations in the vitamin D-metabolizing enzyme CYP24A1 were evaluated with the use of a mammalian expression system. RESULTS Sequence analysis of CYP24A1, which encodes 25-hydroxyvitamin D 24-hydroxylase, the key enzyme of 1,25-dihydroxyvitamin D-3 degradation, revealed recessive mutations in six affected children. In addition, CYP24A1 mutations were identified in a second cohort of infants in whom severe hypercalcemia had developed after bolus prophylaxis with vitamin D. Functional characterization revealed a complete loss of function in all CYP24A1 mutations. CONCLUSIONS The presence of CYP24A1 mutations explains the increased sensitivity to vitamin D in patients with idiopathic infantile hypercalcemia and is a genetic risk factor for the development of symptomatic hypercalcemia that may be triggered by vitamin D prophylaxis in otherwise apparently healthy infants.	[Konrad, Martin] Univ Childrens Hosp, Dept Gen Pediat, D-48149 Munster, Germany; [Schlingmann, Karl P.; Goos, Caroline] Univ Childrens Hosp, Marburg, Germany; [Weber, Stefanie; Wingen, Anne M.] Univ Childrens Hosp, Essen, Germany; [John, Ulrike; Misselwitz, Joachim] Univ Childrens Hosp, Jena, Germany; [Klaus, Guenter] Kuratorium Heimdialyse Pediat Kidney Ctr, Marburg, Germany; [Fehrenbach, Henry] Childrens Hosp, Memmingen, Germany; [Kaufmann, Martin; Irwin, Andrew; Prosser, David E.; Jones, Glenville] Queens Univ, Kingston, ON, Canada; [Gueran, Tuelay] Univ Childrens Hosp, Istanbul, Turkey; [Hoenderop, Joost G.; Bindels, Rene J.] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University - Canada; Radboud University Nijmegen	Konrad, M (corresponding author), Univ Childrens Hosp, Dept Gen Pediat, Waldeyerstr 22, D-48149 Munster, Germany.	konradma@uni-muenster.de	Bindels, René JM/B-9824-2013; Hoenderop, Joost G.J./H-8047-2014	Bindels, René JM/0000-0003-1167-1339; Hoenderop, Joost G.J./0000-0002-1816-8544	Canadian Institutes of Health Research; Cytochroma	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cytochroma	Supported by grants from the Canadian Institutes of Health Research and Cytochroma (to Dr. Jones).	Annalora AJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P262, DOI 10.1016/j.abb.2006.11.018; [Anonymous], 1956, BRIT MED J, V2, P149; BEUREN AJ, 1962, CIRCULATION, V26, P1235, DOI 10.1161/01.CIR.26.6.1235; DeLuca HF, 2011, ARCH BIOCHEM BIOPHYS, V505, P226, DOI 10.1016/j.abb.2010.10.012; DELUCA HF, 1976, ANNU REV BIOCHEM, V45, P631, DOI 10.1146/annurev.bi.45.070176.003215; FANCONI G, 1951, SCHWEIZ MED WSCHR, V81, P908; FRASER DONALD, 1967, PEDIATRICS, V40, P1050; Hamamoto H, 2006, MOL PHARMACOL, V70, P120, DOI 10.1124/mol.106.023275; Hesse V, 1985, Kinderarztl Prax, V53, P383; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; LIGHTWOOD R, 1952, P ROY SOC MED, V45, P401; LIGHTWOOD R, 1953, LANCET, V265, P255; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; Misselwitz J, 1986, Kinderarztl Prax, V54, P431; Nguyen M, 2010, J PEDIATR-US, V157, P296, DOI 10.1016/j.jpeds.2010.02.025; Pronicka E, 1997, PEDIATR NEPHROL, V11, P2, DOI 10.1007/s004670050221; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Prosser DE, 2006, BIOPHYS J, V90, P3389, DOI 10.1529/biophysj.105.069369; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; RHANEY K, 1956, LANCET, V270, P1028; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SAMUEL H S, 1964, Br Med J, V1, P1659; SHEPARD RM, 1980, ARCH BIOCHEM BIOPHYS, V202, P43, DOI 10.1016/0003-9861(80)90404-X; SMITH DW, 1959, PEDIATRICS, V24, P258; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; STAPLETON T, 1957, AM J CLIN NUTR, V5, P533, DOI 10.1093/ajcn/5.5.533; WEISMAN Y, 1979, MED HYPOTHESES, V5, P379, DOI 10.1016/0306-9877(79)90019-7; WILLIAMS JC, 1961, CIRCULATION, V24, P1311, DOI 10.1161/01.CIR.24.6.1311	34	383	407	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2011	365	5					410	421		10.1056/NEJMoa1103864	http://dx.doi.org/10.1056/NEJMoa1103864			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	801NW	21675912	Bronze			2022-12-28	WOS:000293447800005
J	Ozawa, S; Nishimura, T; Suito, H; Kobayashi, T; Tobita, M; Imakiire, T				Ozawa, Shinzaburo; Nishimura, Takuya; Suito, Hisashi; Kobayashi, Tomokazu; Tobita, Mikio; Imakiire, Tetsuro			Coseismic and postseismic slip of the 2011 magnitude-9 Tohoku-Oki earthquake	NATURE			English	Article							NORTHEASTERN JAPAN; SUBDUCTION ZONE; CONTINUOUS GPS; SPATIAL-DISTRIBUTION; CRUSTAL DEFORMATION; PLATE BOUNDARIES; DATA INVERSION; FAULT SLIP; INTERPLATE; MODEL	Most large earthquakes occur along an oceanic trench, where an oceanic plate subducts beneath a continental plate. Massive earthquakes with a moment magnitude, M-w, of nine have been known to occur in only a few areas, including Chile, Alaska, Kamchatka and Sumatra. No historical records exist of a M-w = 9 earthquake along the Japan trench, where the Pacific plate subducts beneath the Okhotsk plate, with the possible exception of the AD 869 Jogan earthquake(1), the magnitude of which has not been well constrained. However, the strain accumulation rate estimated there from recent geodetic observations is much higher than the average strain rate released in previous interplate earthquakes(2-6). This finding raises the question of how such areas release the accumulated strain. A megathrust earthquake with M-w = 9.0 (hereafter referred to as the Tohoku-Oki earthquake) occurred on 11 March 2011, rupturing the plate boundary off the Pacific coast of northeastern Japan. Here we report the distributions of the coseismic slip and postseismic slip as determined from ground displacement detected using a network based on the Global Positioning System. The coseismic slip area extends approximately 400 km along the Japan trench, matching the area of the pre-seismic locked zone(4). The afterslip has begun to overlap the coseismic slip area and extends into the surrounding region. In particular, the afterslip area reached a depth of approximately 100 km, with M-w = 8.3, on 25 March 2011. Because the Tohoku-Oki earthquake released the strain accumulated for several hundred years, the paradox of the strain budget imbalance may be partly resolved. This earthquake reminds us of the potential for M-w approximate to 9 earthquakes to occur along other trench systems, even if no past evidence of such events exists. Therefore, it is imperative that strain accumulation be monitored using a space geodetic technique to assess earthquake potential.	[Ozawa, Shinzaburo; Nishimura, Takuya; Suito, Hisashi; Kobayashi, Tomokazu; Tobita, Mikio; Imakiire, Tetsuro] Geospatial Informat Author Japan, Tsukuba, Ibaraki 3050811, Japan		Ozawa, S (corresponding author), Geospatial Informat Author Japan, Tsukuba, Ibaraki 3050811, Japan.	ozawa@gsi.go.jp	Nishimura, Takuya/G-2789-2013	Nishimura, Takuya/0000-0002-2469-8146				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altamimi Z, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB004949; Apel EV, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026077; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Chlieh M, 2007, B SEISMOL SOC AM, V97, pS152, DOI 10.1785/0120050631; Global CMT, GLOB CENTR MOM TENS; Hashimoto C, 2009, NAT GEOSCI, V2, P141, DOI 10.1038/NGEO421; Hatanaka Y., 2003, B GEOGR SURV I, V49, P11; Heki K, 1997, NATURE, V386, P595, DOI 10.1038/386595a0; Hsu YJ, 2006, SCIENCE, V312, P1921, DOI 10.1126/science.1126960; Igarashi T, 2001, J GEOPHYS RES-SOL EA, V106, P2177, DOI 10.1029/2000JB900386; KATO T, 1983, TECTONOPHYSICS, V97, P183, DOI 10.1016/0040-1951(83)90147-6; Koji M., 2001, J NAT DISASTER SCI, V23, P83; Matsu'ura T, 2009, QUATERNARY RES, V71, P227, DOI 10.1016/j.yqres.2008.12.005; Melbourne TI, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000555; Moreno M, 2010, NATURE, V467, P198, DOI 10.1038/nature09349; Nakagawa H., 2009, J GEOG SURV I, V118, P1; Nakajima J, 2001, TECTONOPHYSICS, V341, P1, DOI 10.1016/S0040-1951(01)00181-0; Nakajima J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026773; Niell AE, 1996, J GEOPHYS RES-SOL EA, V101, P3227, DOI 10.1029/95JB03048; Nishimura T, 2004, GEOPHYS J INT, V157, P901, DOI 10.1111/j.1365-246X.2004.02159.x; Nishimura T, 2000, TECTONOPHYSICS, V323, P217, DOI 10.1016/S0040-1951(00)00108-6; Ozawa S, 2004, EARTH PLANETS SPACE, V56, P675, DOI 10.1186/BF03352530; Ozawa S, 2001, J GEOPHYS RES-SOL EA, V106, P787, DOI 10.1029/2000JB900317; PACHECO JF, 1993, J GEOPHYS RES-SOL EA, V98, P14133, DOI 10.1029/93JB00349; PETERSON ET, 1984, J GEOPHYS RES, V89, P233, DOI 10.1029/JB089iB12p10233; Pollitz FF, 1997, J GEOPHYS RES-SOL EA, V102, P17921, DOI 10.1029/97JB01277; PRESS HW, 1992, NUMERICAL RECIPES FO, P409; Sagiya T, 2000, PURE APPL GEOPHYS, V157, P2303; SAVAGE JC, 1983, J GEOPHYS RES, V88, P4984, DOI 10.1029/JB088iB06p04984; Sella GF, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000033; Shearer P, 2010, ANNU REV EARTH PL SC, V38, P103, DOI 10.1146/annurev-earth-040809-152537; Suito H, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005954; Suwa Y, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003203; Uchida N, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006962; UTSU T, 1982, B EARTHQ RES I TOKYO, V57, P401; YABUKI T, 1992, GEOPHYS J INT, V109, P363, DOI 10.1111/j.1365-246X.1992.tb00102.x	37	547	585	1	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 21	2011	475	7356					373	U123		10.1038/nature10227	http://dx.doi.org/10.1038/nature10227			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	794PA	21677648				2022-12-28	WOS:000292911200041
J	Bloom, JS; Giannios, D; Metzger, BD; Cenko, SB; Perley, DA; Butler, NR; Tanvir, NR; Levan, AJ; Brien, PTO; Strubbe, LE; De Colle, F; Ramirez-Ruiz, E; Lee, WH; Nayakshin, S; Quataert, E; King, AR; Cucchiara, A; Guillochon, J; Bower, GC; Fruchter, AS; Morgan, AN; van der Horst, AJ				Bloom, Joshua S.; Giannios, Dimitrios; Metzger, Brian D.; Cenko, S. Bradley; Perley, Daniel A.; Butler, Nathaniel R.; Tanvir, Nial R.; Levan, Andrew J.; Brien, Paul T. O'; Strubbe, Linda E.; De Colle, Fabio; Ramirez-Ruiz, Enrico; Lee, William H.; Nayakshin, Sergei; Quataert, Eliot; King, Andrew R.; Cucchiara, Antonino; Guillochon, James; Bower, Geoffrey C.; Fruchter, Andrew S.; Morgan, Adam N.; van der Horst, Alexander J.			A Possible Relativistic Jetted Outburst from a Massive Black Hole Fed by a Tidally Disrupted Star	SCIENCE			English	Article							ACTIVE GALACTIC NUCLEI; MARKARIAN 421; BLAZARS; FLARES; VARIABILITY; EMISSION; GALAXIES; MASSES; GIANT; JETS	Gas accretion onto some massive black holes (MBHs) at the centers of galaxies actively powers luminous emission, but most MBHs are considered dormant. Occasionally, a star passing too near an MBH is torn apart by gravitational forces, leading to a bright tidal disruption flare (TDF). Although the high-energy transient Sw 1644+57 initially displayed none of the theoretically anticipated (nor previously observed) TDF characteristics, we show that observations suggest a sudden accretion event onto a central MBH of mass about 10(6) to 10(7) solar masses. There is evidence for a mildly relativistic outflow, jet collimation, and a spectrum characterized by synchrotron and inverse Compton processes; this leads to a natural analogy of Sw 1644+57 to a temporary smaller-scale blazar.	[Bloom, Joshua S.; Cenko, S. Bradley; Perley, Daniel A.; Butler, Nathaniel R.; Strubbe, Linda E.; Quataert, Eliot; Cucchiara, Antonino; Bower, Geoffrey C.; Morgan, Adam N.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Giannios, Dimitrios; Metzger, Brian D.] Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA; [Tanvir, Nial R.; Brien, Paul T. O'; Nayakshin, Sergei; King, Andrew R.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Levan, Andrew J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Strubbe, Linda E.; Quataert, Eliot] Univ Calif Berkeley, Theoret Astrophys Ctr, Berkeley, CA 94720 USA; [De Colle, Fabio; Ramirez-Ruiz, Enrico; Guillochon, James] Univ Calif Santa Cruz, Astron & Astrophys Dept, Santa Cruz, CA 95064 USA; [Lee, William H.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico; [Cucchiara, Antonino] Univ Calif Berkeley, Lawrence Berkeley Lab, Computat Cosmol Ctr, Berkeley, CA 94720 USA; [Bower, Geoffrey C.] Univ Calif Berkeley, Radio Astron Lab, Berkeley, CA 94720 USA; [Fruchter, Andrew S.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [van der Horst, Alexander J.] Univ Space Res Assoc, Natl Space Sci & Technol Ctr, Huntsville, AL 35805 USA	University of California System; University of California Berkeley; Princeton University; University of Leicester; University of Warwick; University of California System; University of California Berkeley; University of California System; University of California Santa Cruz; Universidad Nacional Autonoma de Mexico; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Space Telescope Science Institute; Universities Space Research Association (USRA)	Bloom, JS (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	jbloom@astro.berkeley.edu	Guillochon, James/G-9351-2018; Bower, Geoffrey/ABC-8386-2020; De Colle, Fabio/F-8013-2014; Levan, Andrew/F-6179-2014	Guillochon, James/0000-0002-9809-8215; Bower, Geoffrey/0000-0003-4056-9982; Bloom, Joshua/0000-0002-7777-216X; Levan, Andrew/0000-0001-7821-9369; De Colle, Fabio/0000-0002-3137-4633; O'Brien, Paul/0000-0002-5128-1899; van der Horst, Alexander/0000-0001-9149-6707; Fruchter, Andrew/0000-0002-6652-9279; Strubbe, Linda/0000-0002-8670-5073; Giannios, Dimitrios/0000-0003-1503-2446	Department of Astrophysical Sciences at Princeton University; NASA [PF9-00065, NAS8-03060, NNX10A057G, NNH07ZDA001-GLAST]; NASA/Swift [NNX10AI21G]; NSF [AST-0908886]; Consejo Nacional de Ciencia y Tecnologia [83254];  [NASA/NNX10AF93G];  [NASA/NNX10AI28G];  [NSG/AST-100991]; Science and Technology Facilities Council [ST/H002235/1, ST/I005773/1, ST/F002599/1, PP/E002064/1, ST/H001972/1, ST/I001719/1] Funding Source: researchfish; STFC [ST/I005773/1, ST/I001719/1, ST/F002599/1, ST/H001972/1, PP/E002064/1, ST/H002235/1] Funding Source: UKRI; Direct For Mathematical & Physical Scien [0908886] Funding Source: National Science Foundation	Department of Astrophysical Sciences at Princeton University(Princeton University); NASA(National Aeronautics & Space Administration (NASA)); NASA/Swift(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ; ; ; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank R. Romani, C. McKee, L. Blitz, and J. Hjorth for close reads of drafts of this work and for helpful interactions. We are grateful to the entire Swift team for work on their remarkable observatory that enabled discovery of this event. Swift, launched in November 2004, is a NASA mission in partnership with the Italian Space Agency and the UK Space Agency. Swift is managed by NASA Goddard. Pennsylvania State University controls science and flight operations from the Mission Operations Center in University Park, PA. Los Alamos National Laboratory provides gamma-ray imaging analysis. J.S.B. and his group were partially supported by grants NASA/NNX10AF93G, NASA/NNX10AI28G, and NSG/AST-100991. D.G. acknowledges support from the Lyman Spitzer Jr. Fellowship awarded by the Department of Astrophysical Sciences at Princeton University. B.D.M. is a NASA Einstein Fellow and is supported by NASA through Einstein Postdoctoral Fellowship grant number PF9-00065 awarded by the Chandra X-ray Center, which is operated by the Smithsonian Astrophysical Observatory for NASA under contract NAS8-03060. S.B.C. acknowledges generous support from Gary and Cynthia Bengier, the Richard & Rhoda Goldman fund, NASA/Swift grant NNX10AI21G, NASA Fermi grant NNX10A057G, and NSF grant AST-0908886. N.R.B. is a NASA Einstein Fellow. W.H.L. is supported in part by Consejo Nacional de Ciencia y Tecnologia grant 83254. A.J.vdH. was supported by NASA grant NNH07ZDA001-GLAST. The primary references for the data presented here were given in the text and may be found in (20) or in the NASA/Swift archive (http://heasarc.nasa.gov/docs/swift/archive/).	Aller MF, 2003, ASTROPHYS J, V586, P33, DOI 10.1086/367538; BERGER E, 2011, 11854 GCN NASA GODD; BLOOM JS, 2011, 11847 GCN NASA GODD; Bottcher M, 2007, ASTROPHYS SPACE SCI, V309, P95, DOI 10.1007/s10509-007-9404-0; CAMPANA S, 2011, 11851 GCN NASA GODD; CENKO SB, 2011, PTF10IYA SHORT LIVED; CUMMINGS JR, 2011, 11823 GCN NASA GODD; DEALMEIDA UB, 2011, ENHANCED EMISSION GR; EVANS CR, 1989, ASTROPHYS J, V346, pL13, DOI 10.1086/185567; Farrar GR, 2009, ASTROPHYS J, V693, P329, DOI 10.1088/0004-637X/693/1/329; Fossati G, 2000, ASTROPHYS J, V541, P166, DOI 10.1086/309430; Gezari S, 2008, ASTROPHYS J, V676, P944, DOI 10.1086/529008; GIANNIOS D, 2011, RADIO TRANSIENTS STE; Giannios D, 2009, MON NOT R ASTRON SOC, V395, pL29, DOI 10.1111/j.1745-3933.2009.00635.x; Grindlay JE, 2004, AIP CONF PROC, V714, P413, DOI 10.1063/1.1781064; Komossa S, 1999, ASTRON ASTROPHYS, V349, pL45; Kormendy J, 2011, NATURE, V469, P374, DOI 10.1038/nature09694; Krawczynski H, 2004, ASTROPHYS J, V601, P151, DOI 10.1086/380393; Lauer TR, 2007, ASTROPHYS J, V662, P808, DOI 10.1086/518223; Levan AJ, 2011, SCIENCE, V333, P199, DOI 10.1126/science.1207143; Magorrian J, 1998, ASTRON J, V115, P2285, DOI 10.1086/300353; Maraschi L, 2003, ASTROPHYS J, V593, P667, DOI 10.1086/342118; Ramirez-Ruiz E, 2009, ASTROPHYS J LETT, V697, pL77, DOI 10.1088/0004-637X/697/2/L77; Rees M. J., 1992, MON NOT R ASTRON SOC, V258, P41; REES MJ, 1988, NATURE, V333, P523, DOI 10.1038/333523a0; Spada M, 2001, MON NOT R ASTRON SOC, V325, P1559, DOI 10.1046/j.1365-8711.2001.04557.x; Spruit HC, 2005, ASTROPHYS J, V629, P960, DOI 10.1086/431454; Strubbe LE, 2009, MON NOT R ASTRON SOC, V400, P2070, DOI 10.1111/j.1365-2966.2009.15599.x; Takahashi T, 1996, ASTROPHYS J, V470, pL89, DOI 10.1086/310302; VANVELZEN S, 2010, OPTICAL DISCOVERY ST; Vlahakis N, 2004, ASTROPHYS J, V605, P656, DOI 10.1086/382670; Wang JX, 2004, ASTROPHYS J, V600, P149, DOI 10.1086/379767; WAXMAN E, 1995, ASTROPHYS J, V452, pL1, DOI 10.1086/309715	35	400	401	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 8	2011	333	6039					203	206		10.1126/science.1207150	http://dx.doi.org/10.1126/science.1207150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	789GG	21680812	Green Submitted, Green Accepted			2022-12-28	WOS:000292502700044
J	Donlea, JM; Thimgan, MS; Suzuki, Y; Gottschalk, L; Shaw, PJ				Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.			Inducing Sleep by Remote Control Facilitates Memory Consolidation in Drosophila	SCIENCE			English	Article							VISUAL-PATTERN MEMORY; CENTRAL COMPLEX; NEURONS; BRAIN; DEPRIVATION; PLASTICITY; BEHAVIOR; NEUROPEPTIDES; MELANOGASTER; WAKEFULNESS	Sleep is believed to play an important role in memory consolidation. We induced sleep on demand by expressing the temperature-gated nonspecific cation channel Transient receptor potential cation channel (UAS-TrpA1) in neurons, including those with projections to the dorsal fan-shaped body (FB). When the temperature was raised to 31 degrees C, flies entered a quiescent state that meets the criteria for identifying sleep. When sleep was induced for 4 hours after a massed-training protocol for courtship conditioning that is not capable of inducing long-term memory (LTM) by itself, flies develop an LTM. Activating the dorsal FB in the absence of sleep did not result in the formation of LTM after massed training.	[Donlea, Jeffrey M.; Thimgan, Matthew S.; Suzuki, Yasuko; Gottschalk, Laura; Shaw, Paul J.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shaw, PJ (corresponding author), Washington Univ, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	shawp@pcg.wustl.edu			NIH [R01-NS051305-01A1, NS057105, T32GM008151, 5F31NS063514-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051305, P30NS057105, F31NS063514] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Taghert, E. Herzog, P. Gray, L. Seugnet, A. Diantonio, W. Vanderheyden, and B. van Swinderen for discussions. This work was supported by NIH grants R01-NS051305-01A1, NS057105, T32GM008151, and 5F31NS063514-02.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; BERGMANN BM, 1989, SLEEP, V12, P5, DOI 10.1093/sleep/12.1.5; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1982, GENETICS, V102, P771; Ganguly-Fitzgerald I, 2006, SCIENCE, V313, P1775, DOI 10.1126/science.1130408; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Kahsai L, 2010, J EXP BIOL, V213, P2256, DOI 10.1242/jeb.043190; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Walker MP, 2005, NEUROSCIENCE, V133, P911, DOI 10.1016/j.neuroscience.2005.04.007; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Young JM, 2010, J COMP NEUROL, V518, P1500, DOI 10.1002/cne.22284	33	223	225	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1571	1576		10.1126/science.1202249	http://dx.doi.org/10.1126/science.1202249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700877	Green Accepted			2022-12-28	WOS:000291990000049
J	Liu, W; Wen, WY; Wei, ZY; Yu, J; Ye, F; Liu, CH; Hardie, RC; Zhang, MJ				Liu, Wei; Wen, Wenyu; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Liu, Che-Hsiung; Hardie, Roger C.; Zhang, Mingjie			The INAD Scaffold Is a Dynamic, Redox-Regulated Modulator of Signaling in the Drosophila Eye	CELL			English	Article							PROTEIN-KINASE-C; PDZ-DOMAIN PROTEIN; PHOTORECEPTOR CELLS; LIGHT ADAPTATION; RETINAL DEGENERATION; VISUAL TRANSDUCTION; PHOSPHOLIPASE-C; TARGET BINDING; TRP CHANNELS; CA2+ CHANNEL	INAD is a scaffolding protein that regulates signaling in Drosophila photoreceptors. One of its PDZ domains, PDZ5, cycles between reduced and oxidized forms in response to light, but it is unclear how light affects its redox potential. Through biochemical and structural studies, we show that the redox potential of PDZ5 is allosterically regulated by its interaction with another INAD domain, PDZ4. Whereas isolated PDZ5 is stable in the oxidized state, formation of a PDZ45 "supramodule'' locks PDZ5 in the reduced state by raising the redox potential of its Cys606/Cys645 disulfide bond by similar to 330 mV. Acidification, potentially mediated via light and PLC beta-mediated hydrolysis of PIP(2), disrupts the interaction between PDZ4 and PDZ5, leading to PDZ5 oxidation and dissociation from the TRP Ca(2+) channel, a key component of fly visual signaling. These results show that scaffolding proteins can actively modulate the intrinsic redox potentials of their disulfide bonds to exert regulatory roles in signaling.	[Liu, Wei; Wei, Zhiyi; Yu, Jiang; Ye, Fei; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] Hong Kong Univ Sci & Technol, Inst Adv Studies, Kowloon, Hong Kong, Peoples R China; [Wen, Wenyu] Fudan Univ, Dept Chem, Shanghai 200032, Peoples R China; [Wen, Wenyu] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Liu, Che-Hsiung; Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Fudan University; Fudan University; University of Cambridge	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/B-5001-2010; Yu, Jiang/C-6980-2012; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Liu, Wei/0000-0001-8250-2562; Hardie, Roger/0000-0001-5531-3264; Zhang, Mingjie/0000-0001-9404-0190	Research Grants Council of Hong Kong [663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, AoE/B-15/01-II]; National Major Basic Research Program of China [2009CB918600]; Natural Science Foundation of China [30970574]; Shanghai Rising-Star Program [10QA1400700]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/G006865/1]; BBSRC [BB/G006865/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G006865/1] Funding Source: researchfish	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Major Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Drs. Quan Hao and Qun Liu for X-ray data collection, Dr. Zhenguo Wu and Dr. Yarui Diao for help in the protein kinase assays, and Mr. Anthony Zhang for critical reading of the manuscript. This work was supported by grants from the Research Grants Council of Hong Kong to M.Z. (663808, 664009, 660709, 663610, CA07/08.SC01, HKUST6/CRF/10, SEG_HKUST06, and AoE/B-15/01-II); the National Major Basic Research Program of China (2009CB918600), the Natural Science Foundation of China (30970574), and the Shanghai Rising-Star Program (10QA1400700) to W. W.; and BB/G006865/1 from the Biotechnology and Biological Sciences Research Council (BBSRC) to R.C.H.	Adamski FM, 1998, J BIOL CHEM, V273, P17713, DOI 10.1074/jbc.273.28.17713; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fox GC, 2007, NATURE, V447, P487, DOI 10.1038/nature05804; Gu YC, 2005, CURR BIOL, V15, P1228, DOI 10.1016/j.cub.2005.05.058; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 2008, SENSES COMPREHENSIVE, V1, P77; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Huber A, 1996, J BIOL CHEM, V271, P11710, DOI 10.1074/jbc.271.20.11710; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; Huber A, 2001, EUR J NEUROSCI, V14, P769, DOI 10.1046/j.0953-816x.2001.01704.x; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Keese MA, 1999, FEBS LETT, V447, P135, DOI 10.1016/S0014-5793(99)00296-3; Kemble DJ, 2009, P NATL ACAD SCI USA, V106, P5070, DOI 10.1073/pnas.0806117106; Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Long JF, 2003, J MOL BIOL, V327, P203, DOI 10.1016/S0022-2836(03)00113-X; Long JF, 2008, J MOL BIOL, V375, P1457, DOI 10.1016/j.jmb.2007.11.088; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Montell C, 2003, CELL CALCIUM, V33, P409, DOI 10.1016/S0143-4160(03)00053-8; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng L, 2008, J NEUROCHEM, V104, P1526, DOI 10.1111/j.1471-4159.2007.05096.x; Popescu DC, 2006, J NEUROSCI, V26, P8570, DOI 10.1523/JNEUROSCI.1478-06.2006; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Shieh BH, 1996, NEURON, V16, P991, DOI 10.1016/S0896-6273(00)80122-1; SMITH DP, 1991, SCIENCE, V254, P1478, DOI 10.1126/science.1962207; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhang MJ, 2003, ACCOUNTS CHEM RES, V36, P530, DOI 10.1021/ar020210b	48	50	55	1	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1088	1101		10.1016/j.cell.2011.05.015	http://dx.doi.org/10.1016/j.cell.2011.05.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703451	Bronze			2022-12-28	WOS:000292025700015
J	Brownell, KD; Koplan, JP				Brownell, Kelly D.; Koplan, Jeffrey P.			Front-of-Package Nutrition Labeling - An Abuse of Trust by the Food Industry?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brownell, Kelly D.] Yale Univ, New Haven, CT 06520 USA; [Koplan, Jeffrey P.] Emory Univ, Atlanta, GA 30322 USA	Yale University; Emory University	Brownell, KD (corresponding author), Yale Univ, New Haven, CT 06520 USA.							Koplan JP, 2010, JAMA-J AM MED ASSOC, V304, P1487, DOI 10.1001/jama.2010.1436; Pomeranz JL, 2011, AM J PREV MED, V40, P382, DOI 10.1016/j.amepre.2010.11.009; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P330, DOI 10.1017/S1368980007223870; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960	4	63	64	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2373	2375		10.1056/NEJMp1101033	http://dx.doi.org/10.1056/NEJMp1101033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696305				2022-12-28	WOS:000291936100001
J	Coplan, B; Meyer, JE				Coplan, Bettie; Meyer, James E.			Physician Assistants-One Less Doctor(ate) in the House	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Coplan, Bettie; Meyer, James E.] Midwestern Univ, Phys Assistant Program, Glendale, AZ 85308 USA	Midwestern University	Meyer, JE (corresponding author), Midwestern Univ, Phys Assistant Program, 19555 N 59th Ave, Glendale, AZ 85308 USA.	jmeyer@midwestern.edu						*AM PHYS THER ASS, VIS 2020; American College of Physicians, INT PHYS ASS TEAM BA; [Anonymous], 2004, AACN POS STAT PRACT; Cawley J. F., 2007, J PHYS ASSIST ED, V18, P6; Cecil G, MOVE CLIN DOCTORATE; Ohlemeier LS, 2008, J PHYS ASSIST ED, V19, P10, DOI [10.1097/01367895-200819020-00002, DOI 10.1097/01367895-200819020-00002]; Physician Assistant Education Association, PA CLIN DOCT SUMM FI; Rahr RR, 2009, J PHYS ASSIST ED, V20, P6; Siler WL, 2006, CHRONICLE REV, V52, pB12; Wetherbee E, 2007, J PHYS THER ED, V21, P48	10	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2571	2572		10.1001/jama.2011.877	http://dx.doi.org/10.1001/jama.2011.877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693748				2022-12-28	WOS:000291860400027
J	Solomon, DH; Massarotti, E; Garg, R; Liu, J; Canning, C; Schneeweiss, S				Solomon, Daniel H.; Massarotti, Elena; Garg, Rajesh; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian			Association Between Disease-Modifying Antirheumatic Drugs and Diabetes Risk in Patients With Rheumatoid Arthritis and Psoriasis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE; ANKYLOSING-SPONDYLITIS; MELLITUS; HYDROXYCHLOROQUINE; ATHEROSCLEROSIS; INFLAMMATION; DATABASES; ACCURACY; MARKERS; COHORT	Context Rheumatoid arthritis (RA) and psoriasis have been linked with insulin resistance and diabetes mellitus (DM). Prior investigations suggest that systemic immunosuppressive drugs may improve insulin resistance and reduce the risk of DM. Objective To compare the risk of newly recorded DM among participants diagnosed with RA or psoriasis based on use of a variety of disease-modifying antirheumatic drugs (DMARDs). Design, Setting, and Participants A retrospective cohort study among 121 280 patients with a diagnosis of either RA or psoriasis on at least 2 visits. The analyses were conducted in the context of 2 large health insurance programs, 1 in Canada and 1 in the United States, using administrative data. The mean follow-up was 5.8 months and began with the first prescription for a DMARD after study eligibility was met. Drug regimens were categorized into 4 mutually exclusive groups: (1) tumor necrosis factor (TNF) inhibitors with or without other DMARDs; (2) methotrexate without TNF inhibitors or hydroxychloroquine; (3) hydroxychloroquine without TNF inhibitors or methotrexate; or (4) other nonbiologic DMARDs without TNF inhibitors, methotrexate, or hydroxychloroquine (reference exposure). Main Outcome Measure Newly recorded DM as evidenced by a new diagnosis of DM with use of a DM-specific medication. Results The study cohort consisted of 13 905 participants with 22 493 treatment episodes starting 1 of the categories of DMARD regimens between January 1996 and June 2008. New diabetes cases and respective incidence rates per 1000 person-years were: other nonbiologic DMARDs (55 cases among 3993 treatment episodes; rate, 50.2; 95% confidence interval [CI], 47.3-53.2); TNF inhibitors (80 cases among 4623 treatment episodes; rate, 19.7; 95% CI, 19.1-20.3); methotrexate (82 cases among 8195 treatment episodes; rate, 23.8; 95% CI, 23.0-24.6); and hydroxychloroquine (50 cases among 5682 treatment episodes; rate, 22.2; 95% CI, 21.3-23.1). The multivariate adjusted hazard ratios for DM were 0.62 (95% CI, 0.42-0.91) for TNF inhibitors, 0.77 (95% CI, 0.53-1.13) for methotrexate, and 0.54 (95% CI, 0.36-0.80) for hydroxychloroquine compared with other nonbiologic DMARDS. Conclusion Among patients with RA or psoriasis, the adjusted risk of DM was lower for individuals starting a TNF inhibitor or hydroxychloroquine compared with initiation of other nonbiologic DMARDs. JAMA. 2011;305(24):2525-2531	[Solomon, Daniel H.; Massarotti, Elena] Brigham & Womens Hosp, Div Rheumatol, Dept Med, Boston, MA 02115 USA; [Solomon, Daniel H.; Liu, Jun; Canning, Claire; Schneeweiss, Sebastian] Brigham & Womens Hosp, Div Pharmacoepidemiol, Dept Med, Boston, MA 02115 USA; [Garg, Rajesh] Brigham & Womens Hosp, Div Endocrinol, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Solomon, DH (corresponding author), Brigham & Womens Hosp, Div Rheumatol, Dept Med, 75 Francis St,PBB B3, Boston, MA 02115 USA.	dsolomon@partners.org	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	Abbott; Bristol-Myers Squibb; Pfizer; EMD-Serono; UCB; Human Genome Sciences; Ampimmune; Policy Analysis Inc.; sanofi-aventis; Novartis; Biogen Idec; Teva; Agency for Healthcare Research and Quality; FDA; Amgen; Brigham and Women's Hospital	Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); EMD-Serono; UCB(UCB Pharma SA); Human Genome Sciences(GlaxoSmithKline); Ampimmune; Policy Analysis Inc.; sanofi-aventis(Sanofi-Aventis); Novartis(Novartis); Biogen Idec(Biogen); Teva(Teva Pharmaceutical Industries); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FDA(United States Department of Health & Human Services); Amgen(Amgen); Brigham and Women's Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Solomon reports having received support through a research grant from Abbott, directing an educational course supported by Bristol-Myers Squibb, and serving in an unpaid role on 2 Pfizer-sponsored trials. Dr Massarotti reports being a clinical investigator for an RA therapeutics trial sponsored by Bristol-Myers Squibb, and for 2 sponsored systemic lupus erythematosus trials, 1 funded by EMD-Serono, and the second as part of the Autoimmune Centers of Excellence through the National Institutes of Health; and receiving consulting fees from UCB, Human Genome Sciences, Pfizer, Ampimmune, and Policy Analysis Inc. Dr Garg (or spouse) reports having received consultant fees from sanofi-aventis, Pfizer, Novartis, Biogen Idec, Teva, and EMD Serono. Dr Schneeweiss is principal investigator of the Brigham and Women's Hospital DEcIDE Center on Comparative Effectiveness Research and the DEcIDE Methods Center both funded by Agency for Healthcare Research and Quality and of the Harvard-Brigham Drug Safety and Risk Management Research Center funded by the FDA. Dr Schneeweiss reports being a paid member of the scientific advisory board of HealthCore; a consultant to HealthCore and WHISCON; and a recipient of investigator-initiated grants from Pfizer and Novartis.; Amgen paid for the research through a research contract with the Brigham and Women's Hospital. Amgen reviewed the study protocol and reviewed a draft manuscript but had no editorial control.	Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; del Rincon I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397; Emami J, 1998, LIFE SCI, V64, P325, DOI 10.1016/S0024-3205(98)00568-2; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Gabriel SE, 2008, AM J MED, V121, P9, DOI 10.1016/j.amjmed.2008.06.011; GARCIAWEBB P, 1985, BIOCHEM BIOPH RES CO, V128, P487, DOI 10.1016/0006-291X(85)90073-7; Garg R, 2003, CURR DRUG TARGETS, V4, P487, DOI 10.2174/1389450033490920; Gelfand JM, 2003, ARCH DERMATOL, V139, P1425, DOI 10.1001/archderm.139.11.1425; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gerstein HC, 2002, DIABETES RES CLIN PR, V55, P209, DOI 10.1016/S0168-8227(01)00325-4; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Han CL, 2006, J RHEUMATOL, V33, P2167; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P722, DOI 10.1002/art.20878; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; O'Connor PJ, 1998, AM J MANAG CARE, V4, P335; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; QUATRARO A, 1990, ANN INTERN MED, V112, P678, DOI 10.7326/0003-4819-112-9-678; Qureshi AA, 2009, ARCH DERMATOL, V145, P379, DOI 10.1001/archdermatol.2009.48; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Singh JA, 2004, ARTHRIT RHEUM-ARTHR, V51, P952, DOI 10.1002/art.20827; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; Solomon DH, 2010, ANN RHEUM DIS, V69, P1920, DOI 10.1136/ard.2009.122226; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8; Wasko MCM, 2007, JAMA-J AM MED ASSOC, V298, P187, DOI 10.1001/jama.298.2.187; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102	36	281	293	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2525	2531		10.1001/jama.2011.878	http://dx.doi.org/10.1001/jama.2011.878			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693740	Bronze			2022-12-28	WOS:000291860400019
J	Cole, M				Cole, Mike			Poison in party pills is too much to swallow	NATURE			English	Editorial Material									Anglia Ruskin Univ, Cambridge, England	Anglia Ruskin University	Cole, M (corresponding author), Anglia Ruskin Univ, Cambridge, England.	Michael.cole@anglia.ac.uk							0	6	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					253	253		10.1038/474253a	http://dx.doi.org/10.1038/474253a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777TD	21677705	Bronze			2022-12-28	WOS:000291647100004
J	Ernst, S; Kirchner, S; Krellner, C; Geibel, C; Zwicknagl, G; Steglich, F; Wirth, S				Ernst, S.; Kirchner, S.; Krellner, C.; Geibel, C.; Zwicknagl, G.; Steglich, F.; Wirth, S.			Emerging local Kondo screening and spatial coherence in the heavy-fermion metal YbRh2Si2	NATURE			English	Article							CRYSTALLINE ELECTRIC-FIELD; HIDDEN ORDER; LATTICE	The entanglement of quantum states is both a central concept in fundamental physics and a potential tool for realizing advanced materials and applications. The quantum superpositions underlying entanglement are at the heart of the intricate interplay of localized spin states and itinerant electronic states that gives rise to the Kondo effect in certain dilute magnetic alloys(1). In systems where the density of localized spin states is sufficiently high, they can no longer be treated as non-interacting; if they form a dense periodic array, a Kondo lattice may be established(1). Such a Kondo lattice gives rise to the emergence of charge carriers with enhanced effective masses, but the precise nature of the coherent Kondo state responsible for the generation of these heavy fermions remains highly debated(1-3). Here we use atomic-resolution tunnelling spectroscopy to investigate the low-energy excitations of a generic Kondo lattice system, YbRh2Si2. We find that the hybridization of the conduction electrons with the localized 4f electrons results in a decrease in the tunnelling conductance at the Fermi energy. In addition, we observe unambiguously the crystal-field excitations of the Yb3+ ions. A strongly temperature-dependent peak in the tunnelling conductance is attributed to the Fano resonance(4,5) resulting from tunnelling into the coherent heavy-fermion states that emerge at low temperature. Taken together, these features reveal how quantum coherence develops in heavy 4f-electron Kondo lattices. Our results demonstrate the efficiency of real-space electronic structure imaging for the investigation of strong electronic correlations(6,7), specifically with respect to coherence phenomena, phase coexistence and quantum criticality.	[Ernst, S.; Kirchner, S.; Krellner, C.; Geibel, C.; Steglich, F.; Wirth, S.] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; [Kirchner, S.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Zwicknagl, G.] TU Braunschweig, Inst Math Phys, D-38106 Braunschweig, Germany	Max Planck Society; Max Planck Society; Braunschweig University of Technology	Wirth, S (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.	wirth@cpfs.mpg.de	Kirchner, Stefan/L-5971-2013; Krellner, Cornelius/A-5389-2009	Krellner, Cornelius/0000-0002-0671-7729; Kirchner, Stefan/0000-0003-1958-0810				Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; Burdin S, 2000, PHYS REV LETT, V85, P1048, DOI 10.1103/PhysRevLett.85.1048; Coleman P, 2005, NATURE, V433, P226, DOI 10.1038/nature03279; CORNUT B, 1972, PHYS REV B, V5, P4541, DOI 10.1103/PhysRevB.5.4541; Costi TA, 2002, J LOW TEMP PHYS, V126, P835, DOI 10.1023/A:1013882222679; Cox DL, 1998, ADV PHYS, V47, P599, DOI 10.1080/000187398243500; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; Danzenbacher S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045109; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Figgins J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.187202; Friedemann S, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035103; Fujimori S., J PHYS SOC IN PRESS; Hirjibehedin CF, 2007, SCIENCE, V317, P1199, DOI 10.1126/science.1146110; KIM CI, 1990, J PHYS SOC JPN, V59, P2414, DOI 10.1143/JPSJ.59.2414; Kohler U, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104412; Kroha J, 2003, PHYSICA E, V18, P69, DOI 10.1016/S1386-9477(02)00977-3; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Maltseva M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206402; MARTIN RM, 1982, PHYS REV LETT, V48, P362, DOI 10.1103/PhysRevLett.48.362; Nagaoka K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077205; Pruser H, 2011, NAT PHYS, V7, P203, DOI [10.1038/nphys1876, 10.1038/NPHYS1876]; Schiller A, 2000, PHYS REV B, V61, P9036, DOI 10.1103/PhysRevB.61.9036; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; Shiba H, 2005, J PHYS SOC JPN, V74; Stockert O, 2006, PHYSICA B, V378-80, P157, DOI 10.1016/j.physb.2006.01.059; Trovarelli O, 2000, PHYS REV LETT, V85, P626, DOI 10.1103/PhysRevLett.85.626; Ujsaghy O, 2000, PHYS REV LETT, V85, P2557, DOI 10.1103/PhysRevLett.85.2557; Wahl P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.176603; Wolfle P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246401; Yang YF, 2008, NATURE, V454, P611, DOI 10.1038/nature07157	31	125	127	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					362	366		10.1038/nature10148	http://dx.doi.org/10.1038/nature10148			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677755				2022-12-28	WOS:000291647100042
J	Lloyd, K; White, J				Lloyd, Keith; White, Jo			Democratizing clinical research	NATURE			English	Editorial Material									[Lloyd, Keith; White, Jo] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales	Swansea University	Lloyd, K (corresponding author), Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales.	k.r.lloyd@swansea.ac.uk	Lloyd, Keith/H-7458-2012	Lloyd, Keith/0000-0002-1440-4124				Chafe R, 2011, NATURE, V472, P410, DOI 10.1038/472410a; Cowan K., 2011, J LIND ALLIANCE GUID	2	57	59	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					277	278		10.1038/474277a	http://dx.doi.org/10.1038/474277a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777TD	21677725				2022-12-28	WOS:000291647100014
J	Sathyapalan, T; Aye, MM; Atkin, SL				Sathyapalan, T.; Aye, M. M.; Atkin, S. L.			RATIONAL TESTING Postural hypotension	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORTHOSTATIC HYPOTENSION; PARKINSONS-DISEASE; DIABETES-MELLITUS; PREVALENCE; MANAGEMENT; DIAGNOSIS; SYNCOPE; HYPOVOLEMIA; GUIDELINES; ADULTS		Michael White Diabet Ctr, Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull HU3 2RW, N Humberside, England	University of Hull; University of York - UK	Sathyapalan, T (corresponding author), Michael White Diabet Ctr, Hull York Med Sch, Acad Endocrinol Diabet & Metab, Kingston Upon Hull HU3 2RW, N Humberside, England.	Stephen.Atkin@hyms.ac.uk	atkin, stephen/D-7400-2014; Ziegler, Michael/L-4728-2019; Sathyapalan, Thozhukat/J-5212-2012; Atkin, stephen/ABE-7047-2020	atkin, stephen/0000-0002-5887-7257; Sathyapalan, Thozhukat/0000-0003-3544-2231; 				ALLI C, 1992, EUR HEART J, V13, P178, DOI 10.1093/oxfordjournals.eurheartj.a060143; Fedorowski A, 2010, EUR HEART J, V31, P85, DOI 10.1093/eurheartj/ehp329; Genuth S, 2003, DIABETES CARE, V26, P3160; Jacob G, 1997, AM J MED, V103, P128, DOI 10.1016/S0002-9343(97)00133-2; Laederach-Hofmann K, 1999, AM J MED, V106, P50, DOI 10.1016/S0002-9343(98)00367-2; Lahrmann H, 2006, EUR J NEUROL, V13, P930, DOI 10.1111/j.1468-1331.2006.01512.x; Low PA, 2008, CLIN AUTON RES, V18, P8, DOI 10.1007/s10286-007-1001-3; MADER SL, 1987, JAMA-J AM MED ASSOC, V258, P1511, DOI 10.1001/jama.258.11.1511; MATHIAS CJ, 1999, AUTONOMIC FAILURE TX; McGee S, 1999, JAMA-J AM MED ASSOC, V281, P1022, DOI 10.1001/jama.281.11.1022; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; *NIH CLIN EXC, 2010, 109 NIH CLIN EXC; Parry SW, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c880; ROBERTSON D, 1994, ARCH INTERN MED, V154, P1620, DOI 10.1001/archinte.154.14.1620; RUTAN GH, 1992, HYPERTENSION, V19, P508, DOI 10.1161/01.HYP.19.6.508; Senard JM, 1997, J NEUROL NEUROSUR PS, V63, P584, DOI 10.1136/jnnp.63.5.584; SPECKART PF, 1971, ARCH INTERN MED, V128, P761, DOI 10.1001/archinte.128.5.761; Weiss A, 2002, ARCH INTERN MED, V162, P2369, DOI 10.1001/archinte.162.20.2369; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Wu JS, 2009, DIABETES CARE, V32, P69, DOI 10.2337/dc08-1389	21	5	5	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2011	342								d3128	10.1136/bmj.d3128	http://dx.doi.org/10.1136/bmj.d3128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781LF	21680629				2022-12-28	WOS:000291933000003
J	Pearson, CG				Pearson, Chad G.			A Kinesin in Command of Primary Ciliogenesis	CELL			English	Editorial Material							PRIMARY CILIA; FLAGELLAR	Primary cilia sense extracellular cues and in response transmit signals required for development and tissue homeostasis. A new study by Kobayashi et al. (2011) reports that the kinesin Kif24 controls the formation of primary cilia by restricting the nucleation of cilia at centrioles.	Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Pearson, CG (corresponding author), Univ Colorado Denver, Dept Cell & Dev Biol, Aurora, CO 80045 USA.	chad.pearson@ucdenver.edu			NIGMS NIH HHS [R01 GM099820] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099820] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Seeley ES, 2009, CANCER RES, V69, P422, DOI 10.1158/0008-5472.CAN-08-1290; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					817	819		10.1016/j.cell.2011.05.023	http://dx.doi.org/10.1016/j.cell.2011.05.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663786	Bronze			2022-12-28	WOS:000291461600008
J	Davis, MM; Dayoub, EJ				Davis, Matthew M.; Dayoub, Elias J.			A Strategic Approach to Therapeutic Cancer Vaccines in the 21st Century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Davis, Matthew M.] Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Dayoub, Elias J.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Davis, MM (corresponding author), Univ Michigan, Div Gen Med, Div Gen Pediat, Child Hlth Evaluat & Res Unit, Ann Arbor, MI 48109 USA.	mattdav@med.umich.edu						Brower V, 2010, J NATL CANCER I, V102, P1108, DOI 10.1093/jnci/djq295; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P243; Davis MM, 2010, HUM VACCINES, V6, P689, DOI 10.4161/hv.6.9.13496; Howlader N, 2011, SEER CANC STAT UNPUB; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2343	2344		10.1001/jama.2011.814	http://dx.doi.org/10.1001/jama.2011.814			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642687				2022-12-28	WOS:000291349100028
J	Wasserman, S; Vallie, Y; Bryer, A				Wasserman, Sean; Vallie, Yakoob; Bryer, Alan			The great pretender	LANCET			English	Editorial Material									[Wasserman, Sean; Bryer, Alan] Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Neurol, ZA-7925 Cape Town, South Africa; [Vallie, Yakoob] Univ Cape Town, New Somerset Hosp, Dept Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Wasserman, S (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Med, Div Neurol, ZA-7925 Cape Town, South Africa.	sean.wasserman@uct.ac.za	Wasserman, Sean/AAR-1752-2021	Wasserman, Sean/0000-0002-3508-6719				Adams RD, 1944, MEDICINE, V23, P181, DOI 10.1097/00005792-194405000-00003; Conde-Sendin MA, 2004, EUR NEUROL, V52, P29, DOI 10.1159/000079391; JAFFE HW, 1982, REV INFECT DIS, V4, pS842; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Sinnreich M, 2005, NEUROLOGIST, V11, P63, DOI 10.1097/01.nrl.0000156314.24508.ed	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 4	2011	377	9781					1976	1976		10.1016/S0140-6736(11)60365-6	http://dx.doi.org/10.1016/S0140-6736(11)60365-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777LW	21641480				2022-12-28	WOS:000291623200034
J	Chou, HH; Chiu, HC; Delaney, NF; Segre, D; Marx, CJ				Chou, Hsin-Hung; Chiu, Hsuan-Chao; Delaney, Nigel F.; Segre, Daniel; Marx, Christopher J.			Diminishing Returns Epistasis Among Beneficial Mutations Decelerates Adaptation	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; FITNESS; ARCHITECTURE; LANDSCAPE; DYNAMICS; PROTEIN	Epistasis has substantial impacts on evolution, in particular, the rate of adaptation. We generated combinations of beneficial mutations that arose in a lineage during rapid adaptation of a bacterium whose growth depended on a newly introduced metabolic pathway. The proportional selective benefit for three of the four loci consistently decreased when they were introduced onto more fit backgrounds. These three alleles all reduced morphological defects caused by expression of the foreign pathway. A simple theoretical model segregating the apparent contribution of individual alleles to benefits and costs effectively predicted the interactions between them. These results provide the first evidence that patterns of epistasis may differ for within- and between-gene interactions during adaptation and that diminishing returns epistasis contributes to the consistent observation of decelerating fitness gains during adaptation.	[Chou, Hsin-Hung; Delaney, Nigel F.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Chiu, Hsuan-Chao; Segre, Daniel] Boston Univ, Grad Program Bioinformat, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Marx, Christopher J.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA	Harvard University; Boston University; Boston University; Boston University; Harvard University	Marx, CJ (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	cmarx@oeb.harvard.edu	Chiu, Hsuan-Chao/F-8963-2011; Segrè, Daniel/A-1993-2009	Chiu, Hsuan-Chao/0000-0001-9828-2955; Segrè, Daniel/0000-0003-4859-1914; CHOU, HSIN-HUNG/0000-0001-6003-5609	NIH [R01 GM078209]; NSF [DEB-0845893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078209] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kryazhminskiy, D. Weinreich, J. Weitz, C. Wilke, R. Whitaker, and members of the Marx and Segre labs for suggestions and discussions. Supported by NIH grant R01 GM078209, and NSF grant DEB-0845893. The resulting single-end 36-bp read data have been deposited in the NCBI Short Read Archive with accession no. SRA030695.1.	Applebee MK, 2008, J BACTERIOL, V190, P5087, DOI 10.1128/JB.01976-07; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; Kurland CG, 1996, MOL MICROBIOL, V21, P1, DOI 10.1046/j.1365-2958.1996.5901313.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Martin G, 2007, NAT GENET, V39, P555, DOI 10.1038/ng1998; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539	19	315	318	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1190	1192		10.1126/science.1203799	http://dx.doi.org/10.1126/science.1203799			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636771	Green Accepted			2022-12-28	WOS:000291205200046
J	Hargreaves, JR; Greenwood, B; Clift, C; Goel, A; Roemer-Mahler, A; Smith, R; Heymann, DL				Hargreaves, James R.; Greenwood, Brian; Clift, Charles; Goel, Akshay; Roemer-Mahler, Anne; Smith, Richard; Heymann, David L.			Making new vaccines affordable: a comparison of financing processes used to develop and deploy new meningococcal and pneumococcal conjugate vaccines	LANCET			English	Review							GROUP-A; NEISSERIA-MENINGITIDIS; IMMUNOGENICITY; DISEASE; SAFETY; ALLIANCE; EFFICACY; CHILDREN; TRIAL	Mechanisms to increase access to health products are varied and controversial. Two innovative mechanisms have been used to accelerate the development of low-price supply lines for conjugate vaccines. The Meningitis Vaccine Project is a so-called push mechanism that facilitated technology transfer to an Indian company to establish capacity to manufacture a vaccine. The Advanced Market Commitment for pneumococcal vaccines is a so-called pull mechanism that guarantees companies a supplement paid in addition to the purchase price for vaccines for a specific period. We compare these approaches, identifying key dimensions of each and considering their potential for replication. We also discuss issues that the Global Alliance for Vaccines and Immunisation (GAVI) face now that these new vaccines are available. Progress towards GAVI's strategic aims is needed and funding is crucial. Approaches that decrease the financial pressure on GAVI and greatly increase political and financial engagement by low-income countries should also be considered.	[Hargreaves, James R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Hargreaves, James R.; Clift, Charles; Roemer-Mahler, Anne; Smith, Richard; Heymann, David L.] Royal Inst Int Affairs, Chatham House Ctr Global Hlth Secur, London, England; [Goel, Akshay] MSD Wellcome Trust Hilleman Labs, Delhi, India	University of London; London School of Hygiene & Tropical Medicine	Hargreaves, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	james.hargreaves@lshtm.ac.uk		Hargreaves, James/0000-0002-3509-3572; Smith, Richard/0000-0003-3837-6559	PATH; WHO Department of Public Health, Innovation and Intellectual Property	PATH; WHO Department of Public Health, Innovation and Intellectual Property	BG's institution has received a grant from PATH for research into a pneumococcal protein vaccine. CC has received consultancy fees from the WHO Department of Public Health, Innovation and Intellectual Property. AG was an employee of SIIL during the period discussed in the paper. All other authors declare that they have no conflicts of interest.	Advance Market Commitments for Vaccines, 2006, 2 M HM TREAS LOND 9; Advance Market Commitments for Vaccines, 2008, ADV MARKET COMMITMEN; Advance Market Commitments for Vaccines, 2011, ADV MARKET COMMITMEN; Advance Market Commitments for Vaccines, 2010, ADV MARKET COMMITMEN; Advance Market Commitments for Vaccines, 2007, ADV MARK COMM VACC; AMC Implementation Working Group, 2008, IMPL WORK GROUP REP; [Anonymous], 2011, VACC PROV EP MEN CON; Berman D, 2011, HUMAN VACCINES, V7, P1; Birn AE, 2011, HUM VACCINES, V7, P291, DOI 10.4161/hv.7.3.15217; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Brooke S., 2007, Intellectual property management in health and agricultural innovation: a handbook of best practices, Volumes 1 and 2, P1755; Brown F. E., COMMUNICATION; Campagne G, 2000, PEDIATR INFECT DIS J, V19, P144, DOI 10.1097/00006454-200002000-00013; Campbell H, 2009, VACCINE, V27, pB20, DOI 10.1016/j.vaccine.2009.04.067; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; GAVI, 2008, MIN GAVI ALL FUND BO; GAVI, 2010, GAVI FIN FOR UPD NOV; GAVI, 2010, ADV MARK COMM VACC F; GAVI, 2010, NEXT STEPS PNEUM AMC; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Harrison LH, 2010, NAT REV DRUG DISCOV, V9, P429, DOI 10.1038/nrd3194; International Vaccine Institute, 2011, CHOL VACC IN CHOVI; Jodar L, 2003, LANCET, V361, P1902, DOI 10.1016/S0140-6736(03)13494-0; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; Lee K, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2004; Levine R, 2005, MAKING MARKETS VACCI; Light DW, 2011, HUM VACCINES, V7, P138, DOI 10.4161/hv.7.2.14919; Light DW, 2005, PLOS MED, V2, P934, DOI 10.1371/journal.pmed.0020271; Ministers of Health of African countries of the meningitis belt, 2008, MIN HLTH AFR COUNTR; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Patel M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001093.pub2; Policy Cures, 2011, G FIND 2010 NEGL DIS; Rennels MB, 1998, PEDIATRICS, V101, P604, DOI 10.1542/peds.101.4.604; Sabin Vaccine Institute, 2011, SAB VACC I CONV GLOB; Schwalbe N, 2010, LANCET, V375, P638, DOI [10.1016/S0140-6736(10)60268-1, 10.1016/S0140-6736(10)60267-X]; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; TWUMASI PA, 1995, J INFECT DIS, V171, P632, DOI 10.1093/infdis/171.3.632; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; WHO, 2007, WHO FAC INFL VACC TE; WHO, 2010, EST CONS EXP WORK GR; WHO, 2006, PUBL HLTH INN INT PR; WHO, 2009, GLOB PAND INFL ACT P; WHO delegates, 1998, JOINT REC DEV INTR C	45	18	18	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2011	378	9806					1885	1893		10.1016/S0140-6736(11)60687-9	http://dx.doi.org/10.1016/S0140-6736(11)60687-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857DQ	21664678				2022-12-28	WOS:000297695800033
J	Kempermann, G				Kempermann, Gerd			The Pessimist's and Optimist's Views of Adult Neurogenesis	CELL			English	Editorial Material							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; MICE	The reports by Bonaguidi et al. (in this issue of Cell) and Encinas et al. (in Cell Stem Cell) come to differing conclusions about whether and how the proliferation of radial glia-like stem cells of the adult hippocampus impacts their long-term potential for neurogenesis.	[Kempermann, Gerd] DFG Ctr Regenerat Therapies Dresden, CRTD, D-01307 Dresden, Germany; [Kempermann, Gerd] German Ctr Neurodegenerat Dis, DZNE, D-01307 Dresden, Germany	German Research Foundation (DFG); Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), DFG Ctr Regenerat Therapies Dresden, CRTD, Dresden Tatzberg 47-49, D-01307 Dresden, Germany.	gerd.kempermann@crt-dresden.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kunze A, 2006, NEUROBIOL DIS, V21, P324, DOI 10.1016/j.nbd.2005.07.013; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	10	31	32	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1009	1011		10.1016/j.cell.2011.06.011	http://dx.doi.org/10.1016/j.cell.2011.06.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703445	Bronze			2022-12-28	WOS:000292025700008
J	De Caterina, R				De Caterina, Raffaele			DRUG THERAPY n-3 Fatty Acids in Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CORONARY-HEART-DISEASE; FISH-OIL SUPPLEMENTATION; ALPHA-LINOLENIC ACID; EICOSAPENTAENOIC ACID; VENTRICULAR-FIBRILLATION; DIETARY SUPPLEMENTATION; DOUBLE-BLIND; HYPERCHOLESTEROLEMIC PATIENTS; ENDOTHELIAL ACTIVATION; SECONDARY PREVENTION		[De Caterina, Raffaele] Gabriele Annunzio Univ, Inst Cardiol, I-66013 Chieti, Italy; [De Caterina, Raffaele] Gabriele Annunzio Univ, Ctr Excellence Aging, I-66013 Chieti, Italy; [De Caterina, Raffaele] Gabriele Monasterio Fdn, Pisa, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	De Caterina, R (corresponding author), Gabriele Annunzio Univ, Inst Cardiol, Via Vestini, I-66013 Chieti, Italy.	rdecater@unich.it	De Caterina, Raffaele/K-3857-2016	De Caterina, Raffaele/0000-0003-1637-574X				Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; [Anonymous], 2009, Ann Nutr Metab, V55, P5; BANG HO, 1971, LANCET, V1, P1143, DOI 10.1016/S0140-6736(71)91658-8; BANG HO, 1976, ACTA MED SCAND, V200, P69; Billman GE, 1997, LIPIDS, V32, P1161, DOI 10.1007/s11745-997-0149-2; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; BJERREGAARD P, 1988, INT J EPIDEMIOL, V17, P514, DOI 10.1093/ije/17.3.514; Bolger PM, 2002, NEW ENGL J MED, V347, P1735, DOI 10.1056/NEJMp020139; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brouwer IA, 2009, EUR HEART J, V30, P820, DOI 10.1093/eurheartj/ehp003; Burr GO, 1930, J BIOL CHEM, V86, P0587; Burr GO, 1929, J BIOL CHEM, V82, P345; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; BURR ML, 1994, EUR HEART J, V15, P1152, DOI 10.1093/oxfordjournals.eurheartj.a060645; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; Christensen JH, 2001, CIRCULATION, V103, P651, DOI 10.1161/01.CIR.103.5.651; De Caterina R, 2005, J MEMBRANE BIOL, V206, P103, DOI 10.1007/s00232-005-0783-2; De Caterina R, 2004, AM HEART J, V147, P874; De Caterina R, 2003, AM HEART J, V146, P420, DOI 10.1016/S0002-8703(03)00327-2; De Caterina R, 1998, J LIPID RES, V39, P1062; De Caterina R, 2007, DIABETES CARE, V30, P1012, DOI 10.2337/dc06-1332; DECATERINA R, 1990, CIRCULATION, V82, P428, DOI 10.1161/01.CIR.82.2.428; [Department of Health Committee on Medical Aspect of Food Policy], 1994, NUTR ASP CARD DIS RE; Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; DYERBERG J, 1980, LANCET, V1, P199; Eaton SB, 1998, WORLD REV NUTR DIET, V83, P12; ENDRES S, 1989, NEW ENGL J MED, V320, P265, DOI 10.1056/NEJM198902023200501; FAULKNER WJ, 1977, SURG GYNECOL OBSTET, V144, P665; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; *GISSI PREV INV, 2001, LANCET, V357, P642; Goodfellow J, 2000, J AM COLL CARDIOL, V35, P265, DOI 10.1016/S0735-1097(99)00548-3; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 2007, LANCET, V369, P106; Harris WS, 2007, AM J CARDIOL, V99, p44C, DOI 10.1016/j.amjcard.2006.11.021; Harris WS, 2009, CIRCULATION, V119, P902, DOI 10.1161/CIRCULATIONAHA.108.191627; Hussein N, 2005, J LIPID RES, V46, P269, DOI 10.1194/jlr.M400225-JLR200; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Johansen O, 1999, J AM COLL CARDIOL, V33, P1619, DOI 10.1016/S0735-1097(99)00054-6; KANG JX, 1994, P NATL ACAD SCI USA, V91, P9886, DOI 10.1073/pnas.91.21.9886; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Konig A, 2005, AM J PREV MED, V29, P335, DOI 10.1016/j.amepre.2005.07.001; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, P151, DOI 10.1161/01.ATV.0000057393.97337.AE; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kristensen SD, 2001, LIPIDS, V36, pS79, DOI 10.1007/s11745-001-0671-2; KROMANN N, 1980, ACTA MED SCAND, V208, P401; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; LEAF A, 1988, NEW ENGL J MED, V318, P549, DOI 10.1056/NEJM198803033180905; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Leng GC, 1998, CLIN NUTR, V17, P265, DOI 10.1016/S0261-5614(98)80318-X; Lev EI, 2010, J AM COLL CARDIOL, V55, P114, DOI 10.1016/j.jacc.2009.08.039; Li QR, 2005, J LIPID RES, V46, P1904, DOI 10.1194/jlr.M500033-JLR200; Ma DWL, 2004, FASEB J, V18, P1040, DOI 10.1096/fj.03-1430fje; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Massaro M, 2002, THROMB HAEMOSTASIS, V88, P335; Massaro M, 2006, P NATL ACAD SCI USA, V103, P15184, DOI 10.1073/pnas.0510086103; Matsuzaki M, 2009, CIRC J, V73, P1283, DOI 10.1253/circj.CJ-08-1197; MCLENNAN PL, 1992, AM HEART J, V123, P1555, DOI 10.1016/0002-8703(92)90809-A; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; McLennan PL, 2001, LIPIDS, V36, pS111, DOI 10.1007/s11745-001-0692-x; Mozaffarian D, 2007, J CARDIOVASC MED, V8, pS23, DOI 10.2459/01.JCM.0000289279.95427.e2; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; MURNAGHAN MF, 1981, BRIT J PHARMACOL, V73, P909, DOI 10.1111/j.1476-5381.1981.tb08745.x; Ness AR, 2004, J HUM NUTR DIET, V17, P117, DOI 10.1111/j.1365-277X.2004.00506.x; NEWMAN WP, 1993, LANCET, V341, P1056, DOI 10.1016/0140-6736(93)92413-N; NIELSEN GL, 1992, EUR J CLIN INVEST, V22, P687, DOI 10.1111/j.1365-2362.1992.tb01431.x; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pottala JV, 2010, CIRC-CARDIOVASC QUAL, V3, P406, DOI 10.1161/CIRCOUTCOMES.109.896159; Radaelli A, 2006, J AM COLL CARDIOL, V48, P1600, DOI 10.1016/j.jacc.2006.05.073; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Ramsden CE, 2010, BRIT J NUTR, V104, P1586, DOI 10.1017/S0007114510004010; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Sadovsky R, 2009, POSTGRAD MED, V121, P145, DOI 10.3810/pgm.2009.07.2020; Savelieva I, 2010, N-S ARCH PHARMACOL, V381, P383, DOI 10.1007/s00210-010-0516-7; Savelieva I, 2010, N-S ARCH PHARMACOL, V381, P207, DOI 10.1007/s00210-009-0468-y; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; SINCLAIR HM, 1953, P NUTR SOC, V12, P69, DOI 10.1079/PNS19530016; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Skeaff CM, 2009, ANN NUTR METAB, V55, P173, DOI 10.1159/000229002; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tanaka K, 2008, STROKE, V39, P2052, DOI 10.1161/STROKEAHA.107.509455; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; von Schacky C, 2004, CURR OPIN CLIN NUTR, V7, P131, DOI 10.1097/00075197-200403000-00005; von Schacky C, 2006, VASC HEALTH RISK MAN, V2, P251, DOI 10.2147/vhrm.2006.2.3.251; von Schacky C, 2007, CURR OPIN CLIN NUTR, V10, P129, DOI 10.1097/MCO.0b013e3280127af0; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; YANO K, 1988, AM J EPIDEMIOL, V127, P476, DOI 10.1093/oxfordjournals.aje.a114824; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zampolli A, 2007, ENDOTHELIAL DYSFUNCT, P286	99	429	445	0	48	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2439	2450		10.1056/NEJMra1008153	http://dx.doi.org/10.1056/NEJMra1008153			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696310				2022-12-28	WOS:000291936100009
J	Jacobson, IM; McHutchison, JG; Dusheiko, G; Di Bisceglie, AM; Reddy, KR; Bzowej, NH; Marcellin, P; Muir, AJ; Ferenci, P; Flisiak, R; George, J; Rizzetto, M; Shouval, D; Sola, R; Terg, RA; Yoshida, EM; Adda, N; Bengtsson, L; Sankoh, AJ; Kieffer, TL; George, S; Kauffman, RS; Zeuzem, S				Jacobson, Ira M.; McHutchison, John G.; Dusheiko, Geoffrey; Di Bisceglie, Adrian M.; Reddy, K. Rajender; Bzowej, Natalie H.; Marcellin, Patrick; Muir, Andrew J.; Ferenci, Peter; Flisiak, Robert; George, Jacob; Rizzetto, Mario; Shouval, Daniel; Sola, Ricard; Terg, Ruben A.; Yoshida, Eric M.; Adda, Nathalie; Bengtsson, Leif; Sankoh, Abdul J.; Kieffer, Tara L.; George, Shelley; Kauffman, Robert S.; Zeuzem, Stefan		ADVANCE Study Team	Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALPHA-2B PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2B; HEPATOCELLULAR-CARCINOMA; GENOTYPE-1 PATIENTS; GENETIC-VARIATION; AMERICAN PATIENTS; IL28B	Background In phase 2 trials, telaprevir, a hepatitis C virus (HCV) genotype 1 protease inhibitor, in combination with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, has shown improved efficacy, with potential for shortening the duration of treatment in a majority of patients. Methods In this international, phase 3, randomized, double-blind, placebo-controlled trial, we assigned 1088 patients with HCV genotype 1 infection who had not received previous treatment for the infection to one of three groups: a group receiving telaprevir combined with peginterferon alfa-2a and ribavirin for 12 weeks (T12PR group), followed by peginterferon-ribavirin alone for 12 weeks if HCV RNA was undetectable at weeks 4 and 12 or for 36 weeks if HCV RNA was detectable at either time point; a group receiving telaprevir with peginterferon-ribavirin for 8 weeks and placebo with peginterferon-ribavirin for 4 weeks (T8PR group), followed by 12 or 36 weeks of peginterferon-ribavirin on the basis of the same HCV RNA criteria; or a group receiving placebo with peginterferon-ribavirin for 12 weeks, followed by 36 weeks of peginterferon-ribavirin (PR group). The primary end point was the proportion of patients who had undetectable plasma HCV RNA 24 weeks after the last planned dose of study treatment (sustained virologic response). Results Significantly more patients in the T12PR or T8PR group than in the PR group had a sustained virologic response (75% and 69%, respectively, vs. 44%; P<0.001 for the comparison of the T12PR or T8PR group with the PR group). A total of 58% of the patients treated with telaprevir were eligible to receive 24 weeks of total treatment. Anemia, gastrointestinal side effects, and skin rashes occurred at a higher incidence among patients receiving telaprevir than among those receiving peginterferon-ribavirin alone. The overall rate of discontinuation of the treatment regimen owing to adverse events was 10% in the T12PR and T8PR groups and 7% in the PR group. Conclusions Telaprevir with peginterferon-ribavirin, as compared with peginterferon-ribavirin alone, was associated with significantly improved rates of sustained virologic response in patients with HCV genotype 1 infection who had not received previous treatment, with only 24 weeks of therapy administered in the majority of patients.	[Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY 10021 USA; [Jacobson, Ira M.] Ctr Study Hepatitis C, New York, NY 10021 USA; [McHutchison, John G.; Muir, Andrew J.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [McHutchison, John G.; Muir, Andrew J.] Duke Univ, Med Ctr, Div Gastroenterol, Durham, NC USA; [Dusheiko, Geoffrey] Royal Free Hosp, Ctr Hepatol, London, England; [Di Bisceglie, Adrian M.] St Louis Univ, Sch Med, St Louis, MO 63103 USA; [Reddy, K. Rajender] Univ Penn, Div Gastroenterol, Philadelphia, PA 19104 USA; [Bzowej, Natalie H.] Calif Pacific Med Ctr, San Francisco, CA USA; [Marcellin, Patrick] Hop Beaujon, Serv Hepatol, Clichy, France; [Marcellin, Patrick] Hop Beaujon, INSERM, CRB3, Clichy, France; [Ferenci, Peter] Univ Vienna, Vienna, Austria; [Flisiak, Robert] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland; [George, Jacob] Univ Sydney, Westmead Millennium Inst Med Res, Westmead, NSW 2145, Australia; [George, Jacob] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Rizzetto, Mario] Univ Turin, Dept Gastroenterol, Turin, Italy; [Shouval, Daniel] Hadassah Hebrew Univ Hosp, Liver Unit, Jerusalem, Israel; [Sola, Ricard] Univ Autonoma Barcelona, Inst Municipal Invest Med, Hosp Mar, E-08193 Barcelona, Spain; [Terg, Ruben A.] Hosp Gastroenterol Dr Bonorino Udaondo, Buenos Aires, DF, Argentina; [Yoshida, Eric M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Vancouver Gen Hosp, Vancouver, BC, Canada; [Adda, Nathalie; Bengtsson, Leif; Sankoh, Abdul J.; Kieffer, Tara L.; George, Shelley; Kauffman, Robert S.] Vertex Pharmaceut, Cambridge, MA USA; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, Dept Internal Med, Frankfurt, Germany	Cornell University; Duke University; Duke University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Saint Louis University; University of Pennsylvania; California Pacific Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Vienna; Medical University of Bialystok; University of Sydney; University of Sydney; University of Turin; Hebrew University of Jerusalem; Hadassah University Medical Center; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of British Columbia; University of British Columbia; Vertex Pharmaceuticals; Goethe University Frankfurt	Jacobson, IM (corresponding author), Weill Cornell Med Coll, 1305 York Ave, New York, NY 10021 USA.	imj2001@med.cornell.edu	Zeuzem, Stefan/AAE-7435-2019; Shouval, Daniel/U-2779-2017; George, jacob/P-1496-2014; Andreone, Pietro/K-8050-2016; Vargas, Hugo E./K-1562-2019; Hug, Balthasar L./G-1568-2010; Flisiak, Robert/S-5356-2018	Shouval, Daniel/0000-0002-0512-6513; Andreone, Pietro/0000-0002-4794-9809; Vargas, Hugo E./0000-0002-7802-688X; Dienstag, Jules/0000-0001-7024-0980; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Flisiak, Robert/0000-0003-3394-1635; Afdhal, Nezam/0000-0002-7342-6593	Vertex Pharmaceuticals; Tibotec; Abbott; Achillion Pharmaceuticals; Anadys Pharmaceuticals; Biolex Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; GlobeImmune; Human Genome Sciences; Novartis; Pharmasset; Pfizer; Roche-Genentech; Sanofi-Aventis; ZymoGenetics; Schering-Plough (Merck); Idera Pharmaceuticals; Intarcia Therapeutics; Medtronics; Osiris Therapeutics; Hoffmann-La Roche; Idenix Pharmaceuticals; Salix Pharmaceuticals; Johnson Johnson; LifeCycle Pharma; InterMune; MSD Pharmaceuticals (Merck); Echosens; Santaris Pharma; Medtronic; Scynexis; Three Rivers Pharmaceuticals; Rottapharm Madaus; Debiopharm; Janssen-Cilag; SciGen; Biotest; Cangene; Tibotec-Janssen-Cilag; Fundacion CIDEA; Bayer; iTherX	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Tibotec; Abbott(Abbott Laboratories); Achillion Pharmaceuticals; Anadys Pharmaceuticals; Biolex Therapeutics; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); GlobeImmune; Human Genome Sciences(GlaxoSmithKline); Novartis(Novartis); Pharmasset; Pfizer(Pfizer); Roche-Genentech(Roche HoldingGenentech); Sanofi-Aventis(Sanofi-Aventis); ZymoGenetics; Schering-Plough (Merck)(Merck & CompanySchering Plough Corporation); Idera Pharmaceuticals; Intarcia Therapeutics; Medtronics; Osiris Therapeutics; Hoffmann-La Roche(Hoffmann-La Roche); Idenix Pharmaceuticals; Salix Pharmaceuticals; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); LifeCycle Pharma; InterMune; MSD Pharmaceuticals (Merck)(Merck & Company); Echosens; Santaris Pharma; Medtronic(Medtronic); Scynexis; Three Rivers Pharmaceuticals; Rottapharm Madaus; Debiopharm; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); SciGen; Biotest; Cangene; Tibotec-Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Fundacion CIDEA; Bayer(Bayer AG); iTherX	Supported by Vertex Pharmaceuticals and Tibotec.; Dr. Jacobson reports receiving consulting fees from Abbott, Achillion Pharmaceuticals, Anadys Pharmaceuticals, Biolex Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Novartis, Pharmasset, Pfizer, Roche-Genentech, Sanofi-Aventis, Schering-Plough (now part of Merck), Tibotec, Vertex Pharmaceuticals, and ZymoGenetics, lecture fees from Bristol-Myers Squibb, Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck), and grant support from Anadys Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlobeImmune, Human Genome Sciences, Novartis, Pfizer, Pharmasset, Roche-Genentech, Schering-Plough (Merck), Tibotec, Vertex Pharmaceuticals, and ZymoGenetics; Dr. McHutchison, being an employee of Gilead Sciences, participating in advisory committees or review panels for Abbott, Anadys Pharmaceuticals, Biolex, Gilead Sciences, National Genetics Institute, Pharmasset, Pfizer, United Therapeutics, and Vertex Pharmaceuticals, and receiving grant support from GlaxoSmithKline, GlobeImmune, Human Genome Sciences, Idera Pharmaceuticals, Intarcia Therapeutics, Medtronics, Novartis, Osiris Therapeutics, Roche-Genentech, Schering-Plough (Merck), and Vertex Pharmaceuticals; Dr. Dusheiko, receiving consulting fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Human Genome Sciences, Novartis, Pharmasset, Pfizer, Roche-Genentech, Schering-Plough (Merck), Tibotec, Vertex Pharmaceuticals, and ZymoGenetics, travel support from Gilead Sciences, and grant support from Gilead Sciences, Novartis, Pharmasset, Hoffmann-La Roche, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals; Dr. Di Bisceglie, receiving consulting fees from Abbott, Anadys Pharmaceuticals, Bristol-Myers Squibb, GlobeImmune, Idenix Pharmaceuticals, Pharmasset, Roche-Genentech, and Vertex Pharmaceuticals, and grant support from Bristol-Myers Squibb, Gilead Sciences, GlobeImmune, Idenix Pharmaceuticals, and Roche-Genentech; Dr. Reddy, receiving consulting fees from Human Genome Sciences, Roche-Genentech, Salix Pharmaceuticals, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals and grant support from Bristol-Myers Squibb, Gilead Sciences, Roche-Genentech, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals; Dr. Bzowej, receiving consulting fees from Gilead Sciences and Vertex Pharmaceuticals and grant support from Anadys Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Human Genome Sciences, Idenix Pharmaceuticals, Johnson & Johnson, LifeCycle Pharma, Pharmasset, Roche-Genentech, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals; Dr. Marcellin, receiving consulting fees from Abbott, Biolex Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, InterMune, MSD Pharmaceuticals (Merck), Novartis, Pfizer, Pharmasset, Roche-Genentech, Schering-Plough (Merck), Tibotec, Vertex Pharmaceuticals, and ZymoGenetics, lecture fees from Bristol-Myers Squibb, Gilead Sciences, InterMune, Novartis, Roche-Genentech, Schering-Plough (Merck), and Tibotec, and grant support from Echosens, Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck); Dr.; Muir, receiving consulting fees from Bristol-Myers Squibb, Pharmasset, Santaris Pharma, Schering-Plough (Merck), Vertex Pharmaceuticals, and ZymoGenetics and grant support from Anadys Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Idera Pharmaceuticals, Medtronic, Pfizer, Pharmasset, Santaris Pharma, Scynexis, Three Rivers Pharmaceuicals, Schering-Plough (Merck), and Vertex Pharmaceuticals; Dr. Ferenci, receiving consulting fees from Achillion Pharmaceuticals, Boehringer Ingelheim, MSD Pharmaceuticals (Merck), Novartis, Pfizer, Rottapharm Madaus, Roche-Genentech, Tibotec, and Vertex Pharmaceuticals and grant support from Roche-Genentech; Dr. Flisiak, receiving consulting fees from Bristol-Myers Squibb, Debiopharm, Human Genome Sciences, Novartis, Pfizer, Roche, and Schering-Plough (Merck) and lecture fees from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Roche, and Schering-Plough (Merck); Dr. J. George, receiving consulting fees from Bristol-Myers Squibb, Gilead Sciences, MSD Pharmaceuticals (Merck), and Roche-Genentech, lecture fees from Bristol-Myers Squibb, Gilead Sciences, MSD Pharmaceuticals (Merck), Novartis, and Roche-Genentech, and grant support from MSD Pharmaceuticals (Merck) and Roche-Genentech; Dr. Rizzetto, receiving consulting fees from Bristol-Myers Squibb, Janssen-Cilag, Roche-Genentech and Schering-Plough (Merck) and lecture fees from Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Roche-Genentech, and Schering-Plough (Merck); Dr. Shouval, receiving consulting fees from SciGen and Biotest, lecture fees from Cangene, Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck), and grant support from Human Genome Sciences, Novartis, Pfizer, Roche-Genentech, and Schering-Plough (Merck); Dr. Sola, receiving consulting fees from Bristol-Myers Squibb, Gilead Sciences, Novartis, Roche-Genentech, and Tibotec-Janssen-Cilag, lecture fees from Bristol-Myers Squibb, Gilead Sciences, Novartis, and Roche-Genentech, and grant support from Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck); Dr. Terg, receiving grant support from Fundacion CIDEA; Dr. Yoshida, receiving consulting fees from Cangene, Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck), lecture fees from Vertex Pharmaceuticals, and grant support from Boehringer Ingelheim, Cangene, Gilead Sciences, Human Genome Sciences, Novartis, Pfizer, Roche-Genentech, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals; L. Bengtsson and Drs. Adda, Sankoh, Kieffer, S. George, and Kauffman, being employees of and owning stock in Vertex Pharmaceuticals; and Dr. Zeuzem, receiving consulting fees from Abbott, Achillion Pharmaceuticals, Anadys Pharmaceuticals, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Human Genome Sciences, iTherX, Novartis, Pfizer, Pharmasset, Roche-Genentech, Santaris Pharma, Schering-Plough (Merck), Tibotec, and Vertex Pharmaceuticals and lecture fees from Bristol-Myers Squibb, Gilead Sciences, Roche-Genentech, and Schering-Plough (Merck). No other potential conflict of interest relevant to this article was reported.	Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Di Bisceglie AM, 2003, AM J GASTROENTEROL, V98, P2060, DOI 10.1111/j.1572-0241.2003.t01-1-07641.x; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2007, HEPATOLOGY, V46, P982, DOI 10.1002/hep.21670; Jeffers LJ, 2004, HEPATOLOGY, V39, P1702, DOI 10.1002/hep.20212; Jensen, 2006, HEPATOLOGY, V43, P1410, DOI 10.1002/hep.21245; Jensen DM, 2006, HEPATOLOGY, V43, P954, DOI 10.1002/hep.21159; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Mangia A, 2008, HEPATOLOGY, V47, P43, DOI 10.1002/hep.22061; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2010, NEW ENGL J MED, V362, P1647; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2009, NEW ENGL J MED, V361, P1027; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Moreno C, 2010, J HEPATOL, V52, P25, DOI 10.1016/j.jhep.2009.10.003; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Muir AJ, 2004, NEW ENGL J MED, V351, P1268; Thomas, 2010, J CLIN ONCOL, V28, P5350, DOI 10.1200/JCO.2010.33.8376; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Zeuzem S, 2006, J HEPATOL, V44, P97, DOI 10.1016/j.jhep.2005.10.003	27	1893	1992	0	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2405	2416		10.1056/NEJMoa1012912	http://dx.doi.org/10.1056/NEJMoa1012912			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21696307	Bronze, Green Published			2022-12-28	WOS:000291936100006
J	Groves, T				Groves, Trish			Commentary: Heading for a therapeutic stalemate	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Groves, T (corresponding author), BMJ, London WC1H 9JR, England.	tgroves@bmj.com	Groves, Trish/A-9119-2009	Groves, Trish/0000-0001-7915-6419				ALBERTS B, 2011, SCIENCE         0602; Hawkes N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3780; KNOX K, 2011, SCIENCE         0602; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; PAPROTKA T, 2011, SCIENCE         0602; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; DRUG INTERVENTION CH	7	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3774	10.1136/bmj.d3774	http://dx.doi.org/10.1136/bmj.d3774			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697225				2022-12-28	WOS:000292200500005
J	Gore, FM; Bloem, PJN; Patton, GC; Ferguson, J; Joseph, V; Coffey, C; Sawyer, SM; Mathers, CD				Gore, Fiona M.; Bloem, Paul J. N.; Patton, George C.; Ferguson, Jane; Joseph, Veronique; Coffey, Carolyn; Sawyer, Susan M.; Mathers, Colin D.			Global burden of disease in young people aged 10-24 years: a systematic analysis	LANCET			English	Article							RISK-FACTORS; HEALTH; SMOKING	Background Young people aged 10-24 years represent 27% of the world's population. Although important health problems and risk factors for disease in later life emerge in these years, the contribution to the global burden of disease is unknown. We describe the global burden of disease arising in young people and the contribution of risk factors to that burden. Methods We used data from WHO's 2004 Global Burden of Disease study. Cause-specific disability-adjusted life-years (DALYs) for young people aged 10-24 years were estimated by WHO region on the basis of available data for incidence, prevalence, severity, and mortality. WHO member states were classified into low-income, middle-income, and high-income countries, and into WHO regions. We estimated DALYs attributable to specific global health risk factors using the comparative risk assessment method. DALYs were divided into years of life lost because of premature mortality (YLLs) and years lost because of disability (YLDs), and are presented for regions by sex and by 5-year age groups. Findings The total number of incident DALYs in those aged 10-24 years was about 236 million, representing 15.5% of total DALYs for all age groups. Africa had the highest rate of DALYs for this age group, which was 2.5 times greater than in high-income countries (208 vs 82 DALYs per 1000 population). Across regions, DALY rates were 12% higher in girls than in boys between 15 and 19 years (137 vs 153). Worldwide, the three main causes of YLDs for 10-24-year-olds were neuropsychiatric disorders (45%), unintentional injuries (12%), and infectious and parasitic diseases (10%). The main risk factors for incident DALYs in 10-24-year-olds were alcohol (7% of DALYs), unsafe sex (4%), iron deficiency (3%), lack of contraception (2%), and illicit drug use (2%). Interpretation The health of young people has been largely neglected in global public health because this age group is perceived as healthy. However, opportunities for prevention of disease and injury in this age group are not fully exploited. The findings from this study suggest that adolescent health would benefit from increased public health attention.	[Gore, Fiona M.; Joseph, Veronique; Mathers, Colin D.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva 27, Switzerland; [Bloem, Paul J. N.; Ferguson, Jane] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva 27, Switzerland; [Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.] Royal Childrens Hosp, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	World Health Organization; University of Geneva; World Health Organization; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne	Gore, FM (corresponding author), WHO, Dept Hlth Stat & Informat, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	goref@who.int	Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022	Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Mathers, Colin/0000-0002-0617-6731				[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2010, CANC TRENDS PROGR RE; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Chaloupka FJ, 2001, EVIDENCE BASE REDUCI; CHASSIN L, 1990, HEALTH PSYCHOL, V9, P701, DOI 10.1037/0278-6133.9.6.701; DuRant RH, 1999, ARCH PEDIAT ADOL MED, V153, P286; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M., 2004, COMP QUANTIFICATION, V1; Faeh D, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-169; JESSOR R, 1991, J ADOLESCENT HEALTH, V12, P597, DOI 10.1016/1054-139X(91)90007-K; Kuh D, 1997, LIFE COURSE APPROACH; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Lule E, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1109; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; Murray C.J.L., 1996, GLOBAL BURDEN DIS CO, P295; Murray CJL, 1999, EPIDEMIOLOGY, V10, P594, DOI 10.1097/00001648-199909000-00029; Oosthuizen MA, 2008, INT J ENVIRON HEAL R, V18, P65, DOI 10.1080/09603120701309203; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patton GC, 2006, J ADOLESCENT HEALTH, V39, P214, DOI 10.1016/j.jadohealth.2005.11.027; Patton GC, 2010, J ADOLESCENT HEALTH, V47, P427, DOI 10.1016/j.jadohealth.2010.08.019; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Sarin R, 2008, J CANC RES THER, V4, P105, DOI 10.4103/0973-1482.43138; United Nations, 2009, WORLD POP PROSP 2008; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Bank, 2006, WORLD DEV REP 2007 D; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	30	1203	1234	3	128	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 18	2011	377	9783					2093	2102		10.1016/S0140-6736(11)60512-6	http://dx.doi.org/10.1016/S0140-6736(11)60512-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21652063				2022-12-28	WOS:000292117800031
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			Clinical Series and our clinical content	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2067	2067		10.1016/S0140-6736(11)60883-0	http://dx.doi.org/10.1016/S0140-6736(11)60883-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21684369				2022-12-28	WOS:000292117800010
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH The College of Medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						2010, BRIT MED J, V341, pC4073, DOI DOI 10.1136/BMJ.C4073; 2010, BRIT MED J, V341, pC6126, DOI DOI 10.1136/BMJ.C6126; 2010, BRIT MED J, V341, pC5129, DOI DOI 10.1136/BMJ.C5129	3	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 15	2011	342								d3712	10.1136/bmj.d3712	http://dx.doi.org/10.1136/bmj.d3712			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677014				2022-12-28	WOS:000291932700006
J	Ely, EW				Ely, E. Wesley			Cyanosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ely, E. Wesley] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Ely, E. Wesley] VA GRECC, Nashville, TN USA	Vanderbilt University; Geriatric Research Education & Clinical Center	Ely, EW (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.	wes.ely@vanderbilt.edu	Adeyinka, Adebayo/K-7917-2019; Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2388	2389		10.1001/jama.2011.816	http://dx.doi.org/10.1001/jama.2011.816			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673285				2022-12-28	WOS:000291597300001
J	Moszynski, P				Moszynski, Peter			INTERNATIONAL HEALTH South Sudan: a nation born in crisis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												globewisecom@hotmail.com						Aids Alliance, COUNTR STUD S SUD; [Anonymous], 2011, INTEGRATED REGI 0527; [Anonymous], 2011, SUDAN MSF NEWS  0526; [Anonymous], 2009, S SUD NAT BAS HOUS S; [Anonymous], 2011, INTEGRATED REGI 0606; [Anonymous], 2011, UN NEWS CTR     0607; [Anonymous], 2011, UN NEWS CTR 0608; Government of National Unity, 2006, GOV SO SUD SUD HOUS; Moszynski P, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7276; Price S, 2011, PHOTOBLOG       0527; Save the Children, 2011, VACC CHILDR S SUD	11	5	5	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2011	342								d3726	10.1136/bmj.d3726	http://dx.doi.org/10.1136/bmj.d3726			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781LC	21677009				2022-12-28	WOS:000291932700009
J	Vanderpump, MPJ; Lazarus, JH; Smyth, PP; Laurberg, P; Holder, RL; Boelaert, K; Franklyn, JA				Vanderpump, Mark P. J.; Lazarus, John H.; Smyth, Peter P.; Laurberg, Peter; Holder, Roger L.; Boelaert, Kristien; Franklyn, Jayne A.		British Thyroid Assoc UK Iodine Su	Iodine status of UK schoolgirls: a cross-sectional survey	LANCET			English	Article							CHILD-DEVELOPMENT; THYROID-FUNCTION; EARLY-PREGNANCY; FOLLOW-UP; DEFICIENCY; SUPPLEMENTATION; IRELAND; GOITER; WOMEN	Background Iodine deficiency is the most common cause of preventable mental impairment worldwide. It is defined by WHO as mild if the population median urinary iodine excretion is 50-99 mu g/L, moderate if 20-49 mu g/L, and severe if less than 20 mu g/L. No contemporary data are available for the UK, which has no programme of food or salt iodination. We aimed to assess the current iodine status of the UK population. Methods In this cross-sectional survey, we systematically assessed iodine status in schoolgirls aged 14-15 years attending secondary school in nine UK centres. Urinary iodine concentrations and tap water iodine concentrations were measured in June-July, 2009, and November-December, 2009. Ethnic origin, postcode, and a validated diet questionnaire assessing sources of iodine were recorded. Findings 810 participants provided 737 urine samples. Data for dietary habits and iodine status were available for 664 participants. Median urinary iodine excretion was 80.1 mu g/L (IQR 56.9-109.0). Urinary iodine measurements indicative of mild iodine deficiency were present in 51% (n=379) of participants, moderate deficiency in 16% (n=120), and severe deficiency in 1% (n=8). Prevalence of iodine deficiency was highest in Belfast (85%, n=135). Tap water iodine concentrations were low or undetectable and were not positively associated with urinary iodine concentrations. Multivariable general linear model analysis confirmed independent associations between low urinary iodine excretion and sampling in summer (p<0.0001), UK geographical location (p<0.0001), low intake of milk (p=0.03), and high intake of eggs (p=0-02). Interpretation Our findings suggest that the UK is iodine deficient. Since developing fetuses are the most susceptible to adverse effects of iodine deficiency and even mild perturbations of maternal and fetal thyroid function have an effect on neurodevelopment, these findings are of potential major public health importance. This study has drawn attention to an urgent need for a comprehensive investigation of UK iodine status and implementation of evidence-based recommendations for iodine supplementation.	[Vanderpump, Mark P. J.] Royal Free Hampstead NHS Trust, Dept Endocrinol, London NW3 2QG, England; [Lazarus, John H.] Cardiff Univ, Ctr Endocrine & Diabet Sci, Cardiff, S Glam, Wales; [Smyth, Peter P.] Univ Coll Dublin, UCD Sch Med, Dublin, Ireland; [Smyth, Peter P.] Natl Univ Ireland, Sch Phys, Galway, Ireland; [Smyth, Peter P.] Natl Univ Ireland, Environm Change Inst, Galway, Ireland; [Laurberg, Peter] Aarhus Univ Hosp, Aalborg Hosp, Dept Endocrinol, Aalborg, Denmark; [Holder, Roger L.] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Sch Hlth & Populat Sci,Primary Care Unit, Birmingham, W Midlands, England; [Boelaert, Kristien; Franklyn, Jayne A.] Univ Birmingham, Coll Med & Dent Sci, Inst Biomed Res, Sch Clin & Expt Med, Birmingham, W Midlands, England	University of London; University College London; Cardiff University; University College Dublin; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Aalborg University; Aalborg University Hospital; Aarhus University; University of Birmingham; University of Birmingham	Vanderpump, MPJ (corresponding author), Royal Free Hampstead NHS Trust, Dept Endocrinol, London NW3 2QG, England.	mark.vanderpump@nhs.net	Torlinska, Barbara/T-6173-2017; Torlinska, Barbara/AAQ-4321-2020; Lazarus, John H/H-5108-2017	Torlinska, Barbara/0000-0001-8284-1927; Torlinska, Barbara/0000-0001-8284-1927; Lazarus, John H/0000-0001-8852-704X; Vaidya, Bijay/0000-0002-2223-0494; Combet, Emilie/0000-0002-9302-8971; Han, Thang/0000-0003-2570-0938; Mullan, Karen R/0000-0002-6355-1964; Razvi, Salman/0000-0002-9047-1556	Clinical Endocrinology Trust; Medical Research Council [G0601811] Funding Source: researchfish; MRC [G0601811] Funding Source: UKRI	Clinical Endocrinology Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Clinical Endocrinology Trust.	Alvarez-Pedrerol M, 2010, CLIN ENDOCRINOL, V72, P81, DOI 10.1111/j.1365-2265.2009.03588.x; [Anonymous], WHO GLOB DAT IOD DEF; [Anonymous], 2007, ASS IOD DEF DIS MON; Bath S., 2008, Journal of Human Nutrition and Dietetics, V21, P379, DOI 10.1111/j.1365-277X.2008.00881_9.x; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; de Benoist B, 2008, FOOD NUTR BULL, V29, P195, DOI 10.1177/156482650802900305; *DEP HLTH SCOTT EX, 2000, 198 DEP HLTH SCOTT E; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; *EUR COMM, AGR RUR DEV APP 2 EU; Food Standards Agency, 2008, 0208 FSIS FOOD STAND; Gallego G, 2010, MED J AUSTRALIA, V192, P461, DOI 10.5694/j.1326-5377.2010.tb03586.x; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; HALDIMANN M, 2005, J FOOD COMPOS ANAL, V8, P171; Henrichs J, 2010, J CLIN ENDOCR METAB, V95, P4227, DOI 10.1210/jc.2010-0415; *INT COUNC CONTR I, 2008, IDD NEWSLETTER, V29; KIBIRIGE MS, 2004, ARCH DIS CHILD-FETAL, V89, P436; Lazarus JH, 2008, LANCET, V372, P888, DOI 10.1016/S0140-6736(08)61390-2; Li M, 2006, MED J AUSTRALIA, V184, P165, DOI 10.5694/j.1326-5377.2006.tb00177.x; Medical Research Goitre Subcommittee, 1944, LANCET, V243, P107; Mian C, 2009, CLIN ENDOCRINOL, V70, P776, DOI 10.1111/j.1365-2265.2008.03416.x; Nawoor Z, 2006, IRISH J MED SCI, V175, P21, DOI 10.1007/BF03167943; Ohashi T, 2000, CLIN CHEM, V46, P529; Pearce EN, 2010, J CLIN ENDOCR METAB, V95, P3207, DOI 10.1210/jc.2010-0014; Pedersen IB, 2011, CLIN ENDOCRINOL, V75, P120, DOI 10.1111/j.1365-2265.2011.04008.x; Pedersen KM, 1999, EUR J ENDOCRINOL, V140, P400, DOI 10.1530/eje.0.1400400; Phillips DIW, 1997, J EPIDEMIOL COMMUN H, V51, P391, DOI 10.1136/jech.51.4.391; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Stocks P, 1928, Q J MED, V21, P223, DOI 10.1093/qjmed/os-21.82.223; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Zimmermann MB, 2011, ANN ENDOCRINOL-PARIS, V72, P164, DOI 10.1016/j.ando.2011.03.023; Zimmermann MB, 2006, AM J CLIN NUTR, V83, P108; Zimmermann MB, 2009, ENDOCR REV, V30, P376, DOI 10.1210/er.2009-0011	32	234	241	1	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 11	2011	377	9782					2007	2012		10.1016/S0140-6736(11)60693-4	http://dx.doi.org/10.1016/S0140-6736(11)60693-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	782LR	21640375				2022-12-28	WOS:000292011700035
J	Dua, J; Cheung, WH; Russell, S				Dua, Janet; Cheung, Wui-hang; Russell, Sabina			CASE REPORT An unusual cause of fever of unknown origin	BRITISH MEDICAL JOURNAL			English	Editorial Material							ADULT STILLS-DISEASE; FERRITIN LEVELS; TOCILIZUMAB; MANAGEMENT; DIAGNOSIS; ANAKINRA; FEATURES		[Dua, Janet; Cheung, Wui-hang; Russell, Sabina] Chase Farm Hosp, London EN2 8JL, England	University of London; University College London; Royal Free London NHS Foundation Trust	Dua, J (corresponding author), Chase Farm Hosp, London EN2 8JL, England.	janetdua3000@yahoo.co.uk						Akritidis N, 1996, J RHEUMATOL, V23, P201; Andres E, 2003, HEPATO-GASTROENTEROL, V50, P192; Crispin JC, 2005, MEDICINE, V84, P331, DOI 10.1097/01.md.0000188009.47085.76; De Bandt M, 2009, ANN RHEUM DIS, V68, P153, DOI 10.1136/ard.2008.088179; Efthimiou P, 2006, ANN RHEUM DIS, V65, P564, DOI 10.1136/ard.2005.042143; ESDAILE JM, 2003, RHEUMATOLOGY, P793; Fautrel B, 2002, JOINT BONE SPINE, V69, P355, DOI 10.1016/S1297-319X(02)00409-8; Fautrel B, 2002, MEDICINE, V81, P194, DOI 10.1097/00005792-200205000-00003; Fautrel B, 2008, BEST PRACT RES CL RH, V22, P773, DOI 10.1016/j.berh.2008.08.006; Fitzgerald AA, 2005, ARTHRITIS RHEUM-US, V52, P1794, DOI 10.1002/art.21061; Hot A, 2010, MEDICINE, V89, P37, DOI 10.1097/MD.0b013e3181caf100; Husni ME, 2002, ARTHRITIS RHEUM, V46, P1171, DOI 10.1002/art.10231; Kelly J, 2001, J ROY SOC MED, V94, P400, DOI 10.1177/014107680109400807; Masson C, 1995, REV RHUM, V62, P758; Matsumoto K, 2009, CLIN RHEUMATOL, V28, P485, DOI 10.1007/s10067-009-1097-z; Min JK, 2003, SCAND J RHEUMATOL, V32, P119, DOI 10.1080/03009740310000148; Nakahara H, 2009, MOD RHEUMATOL, V19, P69, DOI 10.1007/s10165-008-0116-2; Naumann L, 2010, ANN RHEUM DIS, V69, P466, DOI 10.1136/ard.2009.108068; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Perez C, 2001, CLIN INFECT DIS, V32, pE105, DOI 10.1086/319342; POUCHOT J, 1991, MEDICINE, V70, P118, DOI 10.1097/00005792-199103000-00004; Powderly WG, 2004, INFECT DIS, P871; Rech J, 2011, ANN RHEUM DIS, V70, P390, DOI 10.1136/ard.2010.129403; Senthilvel E, 2010, J AM BOARD FAM MED, V23, P418, DOI 10.3122/jabfm.2010.03.090157; VANREETH C, 1994, J RHEUMATOL, V21, P890; Williams J, 2008, CLIN MED, V8, P526, DOI 10.7861/clinmedicine.8-5-526; WOUTERS JMGW, 1988, ANN RHEUM DIS, V47, P764, DOI 10.1136/ard.47.9.764; WOUTERS JMGW, 1986, Q J MED, V61, P1055; YAMAGUCHI M, 1992, J RHEUMATOL, V23, P712	29	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2011	342								d2984	10.1136/bmj.d2984	http://dx.doi.org/10.1136/bmj.d2984			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SO	21659365				2022-12-28	WOS:000291645500003
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH The International Alliance of Patients' Organisations	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d3485	10.1136/bmj.d3485	http://dx.doi.org/10.1136/bmj.d3485			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SL	21652745				2022-12-28	WOS:000291645200006
J	Baigent, C; Landray, MJ; Reith, C; Emberson, J; Wheeler, DC; Tomson, C; Wanner, C; Krane, V; Cass, A; Craig, J; Neal, B; Jiang, LX; Hooi, LS; Levin, A; Agodoa, L; Gaziano, M; Kasiske, B; Walker, R; Massy, ZA; Feldt-Rasmussen, B; Krairittichai, U; Ophascharoensuk, V; Fellstrom, B; Holdaas, H; Tesar, V; Wiecek, A; Grobbee, D; de Zeeuw, D; Gronhagen-Riska, C; Dasgupta, T; Lewis, D; Herrington, W; Mafham, M; Majoni, W; Wallendszus, K; Grimm, R; Pedersen, T; Tobert, J; Armitage, J; Baxter, A; Bray, C; Chen, YP; Chen, ZM; Hill, M; Knott, C; Parish, S; Simpson, D; Sleight, P; Young, A; Collins, R				Baigent, Colin; Landray, Martin J.; Reith, Christina; Emberson, Jonathan; Wheeler, David C.; Tomson, Charles; Wanner, Christoph; Krane, Vera; Cass, Alan; Craig, Jonathan; Neal, Bruce; Jiang, Lixin; Hooi, Lai Seong; Levin, Adeera; Agodoa, Lawrence; Gaziano, Mike; Kasiske, Bertram; Walker, Robert; Massy, Ziad A.; Feldt-Rasmussen, Bo; Krairittichai, Udom; Ophascharoensuk, Vuddidhej; Fellstrom, Bengt; Holdaas, Hallvard; Tesar, Vladimir; Wiecek, Andrzej; Grobbee, Diederick; de Zeeuw, Dick; Gronhagen-Riska, Carola; Dasgupta, Tanaji; Lewis, David; Herrington, William; Mafham, Marion; Majoni, William; Wallendszus, Karl; Grimm, Richard; Pedersen, Terje; Tobert, Jonathan; Armitage, Jane; Baxter, Alex; Bray, Christopher; Chen, Yiping; Chen, Zhengming; Hill, Michael; Knott, Carol; Parish, Sarah; Simpson, David; Sleight, Peter; Young, Alan; Collins, Rory		SHARP Investigators	The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; UNITED-KINGDOM HEART; CARDIOVASCULAR EVENTS; EFFICACY; DESIGN; OUTCOMES; SAFETY	Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary revascularisation in people without kidney disease, but its effects in people with moderate-to-severe kidney disease are uncertain. The SHARP trial aimed to assess the efficacy and safety of the combination of simvastatin plus ezetimibe in such patients. Methods This randomised double-blind trial included 9270 patients with chronic kidney disease (3023 on dialysis and 6247 not) with no known history of myocardial infarction or coronary revascularisation. Patients were randomly assigned to simvastatin 20 mg plus ezetimibe 10 mg daily versus matching placebo. The key prespecified outcome was first major atherosclerotic event (non-fatal myocardial infarction or coronary death, non-haemorrhagic stroke, or any arterial revascularisation procedure). All analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, NCT00125593, and I SRCTN54137607. Findings 4650 patients were assigned to receive simvastatin plus ezetimibe and 4620 to placebo. Allocation to simvastatin plus ezetimibe yielded an average LDL cholesterol difference of 0.85 mmol/L (SE 0.02; with about two-thirds compliance) during a median follow-up of 4.9 years and produced a 17% proportional reduction in major atherosclerotic events (526 [11.3%] simvastatin plus ezetimibe vs 619 [13.4%] placebo; rate ratio [RR] 0.83, 95% CI 0.74-0.94; log-rank p=0.0021). Non-significantly fewer patients allocated to simvastatin plus ezetimibe had a non-fatal myocardial infarction or died from coronary heart disease (213 [4.6%] vs 230 [5.0%]; RR 0.92,95% CI 0.76-1.11; p=0.37) and there were significant reductions in non-haemorrhagic stroke (131 [2.8%] vs 174 [3.8%]; RR 0.75,95% CI 0.60-0.94; p=0.01) and arterial revascularisation procedures (284 [6.1%] vs 352 [7.6%]; RR 0.79, 95% CI 0.68-0.93; p=0.0036). After weighting for subgroup-specific reductions in LDL cholesterol, there was no good evidence that the proportional effects on major atherosclerotic events differed from the summary rate ratio in any subgroup examined, and, in particular, they were similar in patients on dialysis and those who were not. The excess risk of myopathy was only two per 10 000 patients per year of treatment with this combination (9 [0.2%] vs 5 [0.1%]). There was no evidence of excess risks of hepatitis (21 [0.5%] vs 18 [0.4%]), gallstones (106 [2.3%] vs 106 [2.3%]), or cancer (438 [9.4%] vs 439 [9.5%], p=0.89) and there was no significant excess of death from any non-vascular cause (668 [14.4%] vs 612 [13.2%], p=0.13). Interpretation Reduction of LDL cholesterol with simvastatin 20 mg plus ezetimibe 10 mg daily safely reduced the incidence of major atherosclerotic events in a wide range of patients with advanced chronic kidney disease.	[Baigent, Colin; Landray, Martin J.; Reith, Christina; Emberson, Jonathan; Lewis, David; Herrington, William; Mafham, Marion; Wallendszus, Karl; Armitage, Jane; Baxter, Alex; Bray, Christopher; Chen, Yiping; Chen, Zhengming; Hill, Michael; Knott, Carol; Parish, Sarah; Simpson, David; Young, Alan; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Wheeler, David C.] UCL, London, England; [Tomson, Charles] N Bristol NHS Trust, Bristol, Avon, England; [Wanner, Christoph; Krane, Vera] Univ Wurzburg, Dept Med 1, Div Nephrol, Wurzburg, Germany; [Cass, Alan; Neal, Bruce] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Craig, Jonathan] Univ Sydney, Childrens Hosp Westmead, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia; [Jiang, Lixin] Fuwai Hosp, China Oxford Ctr Int Hlth Res, Beijing, Peoples R China; [Jiang, Lixin] Chinese Acad Med Sci, Beijing, Peoples R China; [Jiang, Lixin] Peking Union Med Coll, Beijing, Peoples R China; [Hooi, Lai Seong] Sultanah Aminah Hosp, Dept Med, Johor Baharu, Malaysia; [Hooi, Lai Seong] Sultanah Aminah Hosp, Haemodialysis Unit, Johor Baharu, Malaysia; [Levin, Adeera] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Agodoa, Lawrence] NIDDK, NIH, Bethesda, MD USA; [Gaziano, Mike] Harvard Univ, Brigham & Womens Hosp, Sch Med, VA Boston, Boston, MA 02115 USA; [Kasiske, Bertram] Univ Minnesota, Minneapolis, MN USA; [Walker, Robert] Univ Otago, Dunedin Sch Med, Otago, New Zealand; [Massy, Ziad A.] Amiens Univ Hosp, Div Clin Pharmacol, Amiens, France; [Massy, Ziad A.] Amiens Univ Hosp, Div Nephrol, Amiens, France; [Massy, Ziad A.] Univ Picardie Jules Verne, INSERM, ERI 12, Amiens, France; [Feldt-Rasmussen, Bo] Univ Copenhagen, Rigshosp, DK-2100 Copenhagen, Denmark; [Krairittichai, Udom] Rajavithi Hosp, Dept Med, Div Nephrol, Bangkok, Thailand; [Ophascharoensuk, Vuddidhej] Chiang Mai Univ, Fac Med, Dept Internal Med, Div Renal, Chiang Mai 50000, Thailand; [Fellstrom, Bengt] Univ Uppsala Hosp, Uppsala, Sweden; [Holdaas, Hallvard] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat,Renal Sect, N-0027 Oslo, Norway; [Tesar, Vladimir] Charles Univ Prague, Sch Med 1, Dept Nephrol, Prague, Czech Republic; [Tesar, Vladimir] Charles Univ Prague, Gen Univ Hosp, Prague, Czech Republic; [Wiecek, Andrzej] Med Univ Silesia, Dept Nephrol Endocrinol & Metab Dis, Katowice, Poland; [Grobbee, Diederick] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Zeeuw, Dick] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, NL-9713 AV Groningen, Netherlands; [Gronhagen-Riska, Carola] Helsinki Univ Hosp, Helsinki, Finland; [Dasgupta, Tanaji] Oxford Radcliffe Hosp NHS Trust, Oxford, England; [Majoni, William] Royal Darwin Hosp, Darwin, NT, Australia; [Grimm, Richard] Univ Minnesota, Hennepin Cty Med Ctr, Berman Ctr Outcomes & Clin Res, Minneapolis, MN 55415 USA; [Pedersen, Terje] Univ Oslo, Oslo, Norway; [Pedersen, Terje] Univ Oslo, Ulleval Hosp, Ctr Prevent Med, Oslo, Norway; [Tobert, Jonathan] Tobert Med Consulting LLC, Warren, NJ USA; [Sleight, Peter] John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of Oxford; University of London; University College London; North Bristol NHS Trust; University of Wurzburg; George Institute for Global Health; University of Sydney; University of Sydney; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of Otago; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Rigshospitalet; University of Copenhagen; Rajavithi Hospital; Chiang Mai University; Uppsala University; Uppsala University Hospital; University of Oslo; National Hospital Norway; Charles University Prague; Charles University Prague; General University Hospital Prague; Medical University Silesia; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Helsinki; Helsinki University Central Hospital; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo; University of Oslo; University of Oxford	Baigent, C (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	sharpclinical@ctsu.ox.ac.uk	Mantha, Murty/W-2825-2019; de Zeeuw, Dick/E-9080-2014; Rahimi, Kazem/Q-1279-2015; Craig, Jonathan/E-2813-2013; Aldigier, Jean/O-8551-2016; Healy, Helen/G-2686-2010; House, Andrew/G-3304-2011; Walker, Robert J/B-1498-2010; Maxwell, Patrick H/C-5557-2008; Gray, Nicholas Andrew/D-8340-2011; Ranganathan, Dwarakanathan/F-3315-2010; Collins, Rory/ABA-8487-2020; Mudge, David W./C-1438-2011; Beige, Joachim/A-3446-2017; Johnson, David/F-2897-2011; Colquhoun, David M/F-9078-2013; Tobe, Sheldon W/A-9202-2008; Tesar, Vladimir/O-2312-2017; Combe, Christian/N-3726-2015; Fassett, Robert G/F-1752-2010; Grobbee, Diederick/C-7651-2014; Tobert, Jonathan/AAD-2155-2020; Tylicki, Leszek/T-8466-2018; Kurnatowska, Ilona/S-9820-2016	de Zeeuw, Dick/0000-0003-3434-7777; Rahimi, Kazem/0000-0002-4807-4610; Craig, Jonathan/0000-0002-2548-4035; Aldigier, Jean/0000-0002-1804-981X; Healy, Helen/0000-0003-4342-5300; Walker, Robert J/0000-0003-3366-0956; Maxwell, Patrick H/0000-0002-0338-2679; Gray, Nicholas Andrew/0000-0001-9112-0304; Mudge, David W./0000-0002-4112-5550; Beige, Joachim/0000-0002-1907-825X; Johnson, David/0000-0001-5491-3460; Tesar, Vladimir/0000-0001-6982-0689; Combe, Christian/0000-0002-0360-573X; Fassett, Robert G/0000-0002-5318-6940; Grobbee, Diederick/0000-0003-4472-4468; Tobert, Jonathan/0000-0001-7105-299X; MORENA CARRERE, Marion/0000-0001-9563-5217; Cass, Alan/0000-0002-3923-3173; Haywood, Damian/0000-0001-8177-1058; Tylicki, Leszek/0000-0002-5515-5072; Young, Allan/0000-0003-2291-6952; Feldt-Rasmussen, Bo/0000-0002-8267-3027; Tomson, Charles/0000-0002-0224-8726; Denis, Emmanuelle/0000-0001-8463-1341; Habel, Ute/0000-0003-0703-7722; Mount, Peter/0000-0001-7637-3661; Nowicki, Michal/0000-0002-0823-5440; Minha, Sa'ar/0000-0002-1360-5733; Bray, Christopher/0000-0003-0781-0244; Bechtel-Walz, Wibke/0000-0001-6032-3627; Wallendszus, Karl/0000-0003-0971-3026; Ducloux, Didier/0000-0003-3841-1211; Kamper, Anne-Lise/0000-0001-7523-6569; Fahal, Ibrahim/0000-0003-4897-6427; Herrington, William/0000-0003-1172-8243; Neal, Bruce/0000-0002-0490-7465; RODRIGUEZ, Annie/0000-0002-9503-4523; Emberson, Jonathan/0000-0001-7792-9422; Yusuf, Salim/0000-0003-4776-5601; Ferrari, Paolo/0000-0002-9619-3104; Krajewska, Magdalena/0000-0002-2632-2409; Maxwell, Alexander P./0000-0002-6110-7253; Landray, Martin/0000-0001-6646-827X; GOH, BAK LEONG/0000-0002-4644-7743; Jayne, David/0000-0002-1712-0637; Kurnatowska, Ilona/0000-0003-3448-0682; Cureton, Lucy/0000-0003-0082-8468; Hooi, Lai Seong/0000-0002-4628-3806; Zawiasa-Bryszewska, Anna/0000-0002-7964-4268	Merck/Schering-Plough Pharmaceuticals; Australian National Health and Medical Research Council; British Heart Foundation; UK Medical Research Council; Merck/Schering-Plough Pharmaceuticals (North Wales, PA, USA); British Heart Foundation Centre of Research Excellence (Oxford, UK) [RE/08/04]; Medical Research Council [MC_U137686855, MC_EX_G0801669, MC_U137686853] Funding Source: researchfish; MRC [MC_U137686853, MC_EX_G0801669, MC_U137686855] Funding Source: UKRI	Merck/Schering-Plough Pharmaceuticals(Merck & Company); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Merck/Schering-Plough Pharmaceuticals (North Wales, PA, USA)(Merck & Company); British Heart Foundation Centre of Research Excellence (Oxford, UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Merck/Schering-Plough Pharmaceuticals; Australian National Health and Medical Research Council; British Heart Foundation; UK Medical Research Council.; We thank the participants in SHARP and the local clinical centre staff, regional and national coordinators, steering committee, and data monitoring committee. The study was funded by Merck/Schering-Plough Pharmaceuticals (North Wales, PA, USA), with additional support from the Australian National Health Medical Research Council, the British Heart Foundation, and the UK Medical Research Council. JE acknowledges support from the British Heart Foundation Centre of Research Excellence (Oxford, UK; RE/08/04).	[Anonymous], 2008, NICE CLIN GUID; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Baigent C, 2005, AM J KIDNEY DIS, V45, P473, DOI 10.1053/j.ajkd.2004.11.015; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Kidney disease outcomes quality initiative (KDOQI), KIDNEY DIS OUTCOMES, V39, pS46, DOI [10.1053/ajkd.2002.30943, DOI 10.1053/AJKD.2002.30943]; Kosoglou T, 2005, CLIN PHARMACOKINET, V44, P467, DOI 10.2165/00003088-200544050-00002; Landray M, 2006, AM J KIDNEY DIS, V47, P385, DOI 10.1053/j.ajkd.2005.11.018; LANG JM, 1991, STAT MED, V10, P1585, DOI 10.1002/sim.4780101010; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 2008, NEW ENGL J MED, V359, P1357, DOI 10.1056/NEJMsa0806603; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	26	1624	1699	2	300	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2011	377	9784					2181	2192		10.1016/S0140-6736(11)60739-3	http://dx.doi.org/10.1016/S0140-6736(11)60739-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	786XI	21663949	Green Published			2022-12-28	WOS:000292340800031
J	Frank, C; Werber, D; Cramer, JP; Askar, M; Faber, M; an der Heiden, M; Bernard, H; Fruth, A; Prager, R; Spode, A; Wadl, M; Zoufaly, A; Jordan, S; Kemper, MJ; Follin, P; Muller, L; King, LA; Rosner, B; Buchholz, U; Stark, K; Krause, G				Frank, Christina; Werber, Dirk; Cramer, Jakob P.; Askar, Mona; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Fruth, Angelika; Prager, Rita; Spode, Anke; Wadl, Maria; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.; Follin, Per; Muller, Luise; King, Lisa A.; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard		HUS Invest Team	Epidemic Profile of Shiga-Toxin-Producing Escherichia coli O104:H4 Outbreak in Germany	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEMOLYTIC-UREMIC-SYNDROME; MULTISTATE OUTBREAK; BLOODY DIARRHEA; STRAINS; O157-H7; IDENTIFICATION; INFECTION; HUMANS; GENES	BACKGROUND We describe an outbreak of gastroenteritis and the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli in Germany in May, June, and July, 2011. The consumption of sprouts was identified as the most likely vehicle of infection. METHODS We analyzed data from reports in Germany of Shiga-toxin-producing E. coli gastroenteritis and the hemolytic-uremic syndrome and clinical information on patients presenting to Hamburg University Medical Center (HUMC). An outbreak case was defined as a reported case of the hemolytic-uremic syndrome or of gastroenteritis in a patient infected by Shiga-toxin-producing E. coli, serogroup O104 or serogroup unknown, with an onset of disease during the period from May 1 through July 4, 2011, in Germany. RESULTS A total of 3816 cases (including 54 deaths) were reported in Germany, 845 of which (22%) involved the hemolytic-uremic syndrome. The outbreak was centered in northern Germany and peaked around May 21 to 22. Most of the patients in whom the hemolytic-uremic syndrome developed were adults (88%; median age, 42 years), and women were overrepresented (68%). The estimated median incubation period was 8 days, with a median of 5 days from the onset of diarrhea to the development of the hemolytic-uremic syndrome. Among 59 patients prospectively followed at HUMC, the hemolytic-uremic syndrome developed in 12 (20%), with no significant differences according to sex or reported initial symptoms and signs. The outbreak strain was typed as an enteroaggregative Shiga-toxin-producing E. coli O104:H4, producing extended-spectrum beta-lactamase. CONCLUSIONS In this outbreak, caused by an unusual E. coli strain, cases of the hemolytic-uremic syndrome occurred predominantly in adults, with a preponderance of cases occurring in women. The hemolytic-uremic syndrome developed in more than 20% of the identified cases.	[Frank, Christina; Werber, Dirk; Faber, Mirko; an der Heiden, Matthias; Bernard, Helen; Wadl, Maria; Rosner, Bettina; Buchholz, Udo; Stark, Klaus; Krause, Gerard] Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Fruth, Angelika; Prager, Rita] Robert Koch Inst, Dept Infect Dis, D-1000 Berlin, Germany; [Askar, Mona] Robert Koch Inst, Postgrad Training Appl Epidemiol Program, D-1000 Berlin, Germany; [Cramer, Jakob P.; Zoufaly, Alexander; Jordan, Sabine; Kemper, Markus J.] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, Hamburg, Germany; [Spode, Anke] Hamburg No Dist, Dept Hlth, Hamburg, Germany; [Follin, Per] Vastra Gotaland Reg, Dept Communicable Dis Control & Prevent, Gothenburg, Sweden; [Muller, Luise] Statens Serum Inst, DK-2300 Copenhagen, Denmark; [King, Lisa A.] Inst Veille Sanit, St Maurice, France	Robert Koch Institute; Robert Koch Institute; Robert Koch Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; Statens Serum Institut; Institute of Public Health Surveillance	Werber, D (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	werberd@rki.de	Werber, Dirk/L-2264-2019; Schink, Susanne Barbara/F-7758-2015; Adlhoch, Cornelia/AAH-5888-2021; zhang, weidong/N-1070-2014; alzahrani, saud hamed/C-2014-2012; Schink, Susanne Barbara/A-2669-2017; Faber, MIrko/O-1191-2018; Richter, Martin Heinrich/AAB-1929-2022	Adlhoch, Cornelia/0000-0002-8842-0469; zhang, weidong/0000-0002-8079-1185; Schink, Susanne Barbara/0000-0001-7542-9416; Faber, MIrko/0000-0002-9196-570X; Richter, Martin Heinrich/0000-0002-8649-5248; an der Heiden, Matthias/0000-0001-5863-4549; Nielsen, Stine/0000-0002-5931-5379; Rieck, Thorsten/0000-0002-8799-8744; Werber, Dirk/0000-0002-8076-788X; Krause, Gerard/0000-0003-3328-8808; Frank, Christina/0000-0001-6776-8450; Marti, Melanie/0000-0002-6800-760X; Altmann, Mathias/0000-0002-8977-9270; Dudareva, Sandra/0000-0003-1803-704X; nachtnebel, matthias/0000-0001-7077-5694				[Anonymous], 2011, LAB INF REG STEC OUT; [Anonymous], GERM NAT INF DIS NOT; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bielaszewska M, 2006, CLIN INFECT DIS, V43, P1160, DOI 10.1086/508195; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P1048; European Food Safety Authority, 2011, TECHN REP SHIG TOX V; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Fukushima H, 1999, PEDIATR INT, V41, P213, DOI 10.1046/j.1442-200X.1999.4121041.x; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; Gerber A, 2002, J INFECT DIS, V186, P493, DOI 10.1086/341940; Gould LH, 2009, CLIN INFECT DIS, V49, P1480, DOI 10.1086/644621; Guh A, 2010, CLIN INFECT DIS, V51, P1411, DOI 10.1086/657304; Jenkins C, 2006, DIAGN MICR INFEC DIS, V55, P13, DOI 10.1016/j.diagmicrobio.2005.10.019; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Matsell DG, 2009, KIDNEY INT, V75, pS35, DOI 10.1038/ki.2008.628; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Prager R, 2003, INT J MED MICROBIOL, V292, P477, DOI 10.1078/1438-4221-00226; Prager R, 2007, EHEC WORKSH 2007 WIL; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Scavia G, 2011, EMERG INFECT DIS, V17, P1957, DOI 10.3201/eid1710.111072; Scheutz F, 2011, EURO SURVEILL, V16; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Uber AP, 2006, FEMS MICROBIOL LETT, V256, P251, DOI 10.1111/j.1574-6968.2006.00124.x; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; World Health Organization, 2011, OUTBR E COL O104 H4	31	779	812	3	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1771	1780		10.1056/NEJMoa1106483	http://dx.doi.org/10.1056/NEJMoa1106483			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	21696328				2022-12-28	WOS:000296762800006
J	Eagle, RA; Tutken, T; Martin, TS; Tripati, AK; Fricke, HC; Connely, M; Cifelli, RL; Eiler, JM				Eagle, Robert A.; Tuetken, Thomas; Martin, Taylor S.; Tripati, Aradhna K.; Fricke, Henry C.; Connely, Melissa; Cifelli, Richard L.; Eiler, John M.			Dinosaur Body Temperatures Determined from Isotopic (C-13-O-18) Ordering in Fossil Biominerals	SCIENCE			English	Article							ENDOTHERMY; GROWTH; THERMOREGULATION; HISTOLOGY; EVOLUTION	The nature of the physiology and thermal regulation of the nonavian dinosaurs is the subject of debate. Previously, arguments have been made for both endothermic and ectothermic metabolisms on the basis of differing methodologies. We used clumped isotope thermometry to determine body temperatures from the fossilized teeth of large Jurassic sauropods. Our data indicate body temperatures of 36 degrees to 38 degrees C, which are similar to those of most modern mammals. This temperature range is 4 degrees to 7 degrees C lower than predicted by a model that showed scaling of dinosaur body temperature with mass, which could indicate that sauropods had mechanisms to prevent excessively high body temperatures being reached because of their gigantic size.	[Eagle, Robert A.; Martin, Taylor S.; Eiler, John M.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Eagle, Robert A.; Tripati, Aradhna K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Inst Geophys & Planetary Phys, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Fricke, Henry C.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA; [Connely, Melissa] Casper Coll, Tate Geol Museum, Casper, WY 82601 USA; [Cifelli, Richard L.] Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73019 USA; [Cifelli, Richard L.] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of Bonn; University of California System; University of California Los Angeles; Colorado College; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Eagle, RA (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	rob.eagle@gmail.com	Tripati, Aradhna/C-9419-2011; Martin, Taylor/AAJ-8728-2020; Tütken, Thomas/E-4988-2010; Eagle, Robert/A-2679-2011	Tripati, Aradhna/0000-0002-1695-1754; Martin, Taylor/0000-0002-6242-6782; Eagle, Robert/0000-0003-0304-6111; Tutken, Thomas/0000-0002-2590-8600	National Science Foundation [EAR-1024929, EAR-0949191]; Deutsche Forschungsgemeinschaft (DFG) [TU 148/2-1, TU 148/4-1]; Division of Physical Sciences at UCLA	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Division of Physical Sciences at UCLA	R.A.E. and J.M.E. are funded by National Science Foundation grant EAR-1024929. T. T. is funded by Deutsche Forschungsgemeinschaft (DFG) grants TU 148/2-1 and TU 148/4-1. A. K. T. is supported by the Division of Physical Sciences at UCLA and National Science Foundation grant EAR-0949191. We thank the Utah Museum of Natural History, the Oklahoma Museum of Natural History, the Berlin Museum fur Naturkunde, the Aathal Dinosaurier Museum, D. Chure at Dinosaur National Monument, and the Wyoming Dinosaur International Society for the provision of specimens for analysis. We thank D. Schwarz-Wings for specimen identification and D. Goodreau for curatorial assistance. We also thank the stable isotope laboratories at Tubingen and Lyon for conducting phosphate delta<SUP>18</SUP>O measurements. Lastly, thanks to J. Gillooly for provision of published data. This is contribution number 113 of the DFG Research Unit 533 "Biology of the Sauropod Dinosaurs: The Evolution of Gigantism." R. A. E. designed the project and experiments, performed the experiments, analyzed the data, and wrote the manuscript. J. M. E. and A. K. T. assisted with experimental design and data interpretation. Clumped isotope analyses were conducted in the lab of J. M. E. T. T. provided samples for the study, conducted phosphate oxygen isotope analysis, and assisted with data interpretation. T. S. M. assisted with isotope measurements and petrographic analyses. H. C. F., M. C., and R. L. C. provided samples for analysis and insights into the provenance of samples and data interpretation.	Alexander RM, 1998, PALAEONTOLOGY, V41, P1231; Amiot R, 2006, EARTH PLANET SC LETT, V246, P41, DOI 10.1016/j.epsl.2006.04.018; [Anonymous], 1980, COLD LOOK WARM BLOOD; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; BAKKER RT, 1980, COLD LOOK WARM BLOOD, P351; BARRICK RE, 1994, SCIENCE, V265, P222, DOI 10.1126/science.265.5169.222; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; COLBERT EH, 1993, AM J SCI, V293A, P1, DOI 10.2475/ajs.293.A.1; Dennis KJ, 2010, GEOCHIM COSMOCHIM AC, V74, P4110, DOI 10.1016/j.gca.2010.04.005; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Eagle RA, 2010, P NATL ACAD SCI USA, V107, P10377, DOI 10.1073/pnas.0911115107; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Farlow J.O., 1990, P43; Fricke HC, 2000, GEOLOGY, V28, P799, DOI 10.1130/0091-7613(2000)028<0799:MTMLAT>2.3.CO;2; Fricke HC, 2008, PALAEOGEOGR PALAEOCL, V266, P13, DOI 10.1016/j.palaeo.2008.03.030; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Gillooly JF, 2006, PLOS BIOL, V4, P1467, DOI 10.1371/journal.pbio.0040248; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; O'Connor MP, 1999, PALEOBIOLOGY, V25, P341, DOI 10.1017/S0094837300021321; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; Pontzer H, 2009, PLOS ONE, V4, pA127, DOI 10.1371/journal.pone.0007783; Ricqles A. de, 1974, EVOL THEORY, V1, P51; Ruben John, 1997, P505; RUSSELL LORE S., 1965, J PALEONTOL, V39, P497; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Seebacher F, 1999, J EXP BIOL, V202, P77; Seebacher F, 2003, PHYSIOL BIOCHEM ZOOL, V76, P348, DOI 10.1086/375426; Seebacher F, 2003, PALEOBIOLOGY, V29, P105, DOI 10.1666/0094-8373(2003)029<0105:DBTTOO>2.0.CO;2; Spotila J.R., 1991, Modern Geology, V16, P203; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2	36	107	112	2	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 22	2011	333	6041					443	445		10.1126/science.1206196	http://dx.doi.org/10.1126/science.1206196			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	795FR	21700837				2022-12-28	WOS:000292959600042
J	Tinetti, ME; Studenski, SA				Tinetti, Mary E.; Studenski, Stephanie A.			Comparative Effectiveness Research and Patients with Multiple Chronic Conditions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OLDER PERSONS		[Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Studenski, Stephanie A.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA; [Studenski, Stephanie A.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.							Alecxih L., 2010, INDIVIDUALS LIVING C; Fried TR, 2008, J AM GERIATR SOC, V56, P1839, DOI 10.1111/j.1532-5415.2008.01923.x; Gill TM, 2001, ANN INTERN MED, V135, P313, DOI 10.7326/0003-4819-135-5-200109040-00007; Manton KG, 2008, J GERONTOL B-PSYCHOL, V63, pS269, DOI 10.1093/geronb/63.5.S269; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	5	107	108	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	2011	364	26					2478	2481		10.1056/NEJMp1100535	http://dx.doi.org/10.1056/NEJMp1100535			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AM	21696327				2022-12-28	WOS:000292199800003
J	McKeegan, KD; Kallio, APA; Heber, VS; Jarzebinski, G; Mao, PH; Coath, CD; Kunihiro, T; Wiens, RC; Nordholt, JE; Moses, RW; Reisenfeld, DB; Jurewicz, AJG; Burnett, DS				McKeegan, K. D.; Kallio, A. P. A.; Heber, V. S.; Jarzebinski, G.; Mao, P. H.; Coath, C. D.; Kunihiro, T.; Wiens, R. C.; Nordholt, J. E.; Moses, R. W., Jr.; Reisenfeld, D. B.; Jurewicz, A. J. G.; Burnett, D. S.			The Oxygen Isotopic Composition of the Sun Inferred from Captured Solar Wind	SCIENCE			English	Article							ALUMINUM-RICH INCLUSIONS; EARLIEST PROCESSED SOLIDS; SHORT-LIVED BE-10; ELEMENTAL FRACTIONATION; ORDINARY CHONDRITES; DUST PARTICLES; ALLENDE CAI; SYSTEM; NEBULA; ORIGIN	All planetary materials sampled thus far vary in their relative abundance of the major isotope of oxygen, O-16, such that it has not been possible to define a primordial solar system composition. We measured the oxygen isotopic composition of solar wind captured and returned to Earth by NASA's Genesis mission. Our results demonstrate that the Sun is highly enriched in O-16 relative to the Earth, Moon, Mars, and bulk meteorites. Because the solar photosphere preserves the average isotopic composition of the solar system for elements heavier than lithium, we conclude that essentially all rocky materials in the inner solar system were enriched in O-17 and O-18, relative to O-16, by similar to 7%, probably via non-mass-dependent chemistry before accretion of the first planetesimals.	[McKeegan, K. D.; Kallio, A. P. A.; Heber, V. S.; Jarzebinski, G.; Mao, P. H.; Coath, C. D.; Kunihiro, T.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Mao, P. H.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Coath, C. D.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England; [Kunihiro, T.] Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan; [Wiens, R. C.; Nordholt, J. E.; Moses, R. W., Jr.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Reisenfeld, D. B.] Univ Montana, Dept Phys & Astron, Missoula, MT 59812 USA; [Jurewicz, A. J. G.] Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA; [Burnett, D. S.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; California Institute of Technology; University of Bristol; Okayama University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Montana System; University of Montana; Arizona State University; Arizona State University-Tempe; California Institute of Technology	McKeegan, KD (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	mckeegan@ess.ucla.edu	Reisenfeld, Daniel/F-7614-2015; Kunihiro, Tak/B-1896-2011; McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X; Jurewicz, Amy/0000-0002-3282-5782; Kallio, Antti/0000-0002-1466-3118; Coath, Christopher/0000-0002-6520-2223	NASA; UCLA	NASA(National Aeronautics & Space Administration (NASA)); UCLA(University of California System)	We gratefully acknowledge financial support from the NASA programs Discovery, SRLIDAP/LARS, and Cosmochemistry. The ultimate success of the Genesis Discovery Mission would not have been possible without major engineering contributions from the Los Alamos National Laboratory (Concentrator), Jet Propulsion Laboratory (payload, mission operations, management), Lockheed Martin Aerospace (spacecraft and re-entry capsule), and the Johnson Space Center (payload integration and curation). The MegaSIMS laboratory received financial support from UCLA and NASA as well as important technical support from the National Electrostatics Corporation, Kore Technology Ltd, CAMECA, and R. Plue. We benefited from expert advice from J. Huneke, C. Evans Jr., M. Suter, H. Synal, K. Grabowski, S. Smith, and P. Williams. We appreciate collaborations with the accelerator team at Orsay, led by J. Duprat and G. Slodzian. The sample investigated here was well cared for by J. Allton, E. Stansbery, and their Johnson Space Center team. We are grateful for help and advice from A. Davis, D. Papanastassiou, N. Vogel, R. Wieler, D. Woolum, the reviewers of this manuscript, and the entire Genesis Science Team.	Aleon J, 2009, GEOCHIM COSMOCHIM AC, V73, P4558, DOI 10.1016/j.gca.2009.04.034; Ali A, 2007, ASTRON ASTROPHYS, V467, P919, DOI 10.1051/0004-6361:20066925; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Ayres TR, 2006, ASTROPHYS J SUPPL S, V165, P618, DOI 10.1086/504847; Bodmer P, 1998, ASTRON ASTROPHYS, V337, P921; Bodmer R, 2000, J GEOPHYS RES-SPACE, V105, P47, DOI 10.1029/1999JA900434; Burnett DS, 2003, SPACE SCI REV, V105, P509, DOI 10.1023/A:1024425810605; Chaussidon M, 2006, GEOCHIM COSMOCHIM AC, V70, P224, DOI 10.1016/j.gca.2005.08.016; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; Dominguez G, 2010, ASTROPHYS J LETT, V713, pL59, DOI 10.1088/2041-8205/713/1/L59; Fagan TJ, 2001, METEORIT PLANET SCI, V36, P223, DOI 10.1111/j.1945-5100.2001.tb01866.x; FAHEY AJ, 1987, ASTROPHYS J, V323, pL91, DOI 10.1086/185064; Fujimoto K, 2009, GEOCHEM J, V43, pE11, DOI 10.2343/geochemj.1.0057; Gloeckler G., 2000, ASP C SERIES, V198, P224; Guan Y, 2000, EARTH PLANET SC LETT, V181, P271, DOI 10.1016/S0012-821X(00)00218-1; Hashizume K, 2005, NATURE, V434, P619, DOI 10.1038/nature03432; Hashizume K, 2009, GEOCHIM COSMOCHIM AC, V73, P3038, DOI 10.1016/j.gca.2009.02.024; Heber V. S., 2009, LUNAR PLANET SCI, VXL, P2503; Heber VS, 2011, METEORIT PLANET SCI, V46, P493, DOI 10.1111/j.1945-5100.2011.01170.x; Heber VS, 2009, GEOCHIM COSMOCHIM AC, V73, P7414, DOI 10.1016/j.gca.2009.09.013; Ireland TR, 2006, NATURE, V440, P776, DOI 10.1038/nature04611; Jurewicz AJG, 2003, SPACE SCI REV, V105, P535, DOI 10.1023/A:1024469927444; Kallenbach R, 1998, SPACE SCI REV, V85, P357, DOI 10.1023/A:1005131424697; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Krot AN, 2010, ASTROPHYS J, V713, P1159, DOI 10.1088/0004-637X/713/2/1159; Liu MC, 2009, GEOCHIM COSMOCHIM AC, V73, P5051, DOI 10.1016/j.gca.2009.02.039; Lyons JR, 2009, GEOCHIM COSMOCHIM AC, V73, P4998, DOI 10.1016/j.gca.2009.01.041; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; Mao PH, 2008, APPL SURF SCI, V255, P1461, DOI 10.1016/j.apsusc.2008.05.175; Marcus RA, 2004, J CHEM PHYS, V121, P8201, DOI 10.1063/1.1803507; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; MCKEEGAN KD, 1987, SCIENCE, V237, P1468, DOI 10.1126/science.237.4821.1468; McKeegan KD, 2000, SCIENCE, V289, P1334, DOI 10.1126/science.289.5483.1334; McKeegan KD, 1998, SCIENCE, V280, P414, DOI 10.1126/science.280.5362.414; McKeegan KD, 2001, REV MINERAL GEOCHEM, V43, P279, DOI 10.2138/gsrmg.43.1.279; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Nittler LR, 2008, ASTROPHYS J, V682, P1450, DOI 10.1086/589430; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; Scott PC, 2006, ASTRON ASTROPHYS, V456, P675, DOI 10.1051/0004-6361:20064986; Smith RL, 2009, ASTROPHYS J, V701, P163, DOI 10.1088/0004-637X/701/1/163; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; THIEMENS MH, 1995, GEOPHYS RES LETT, V22, P255, DOI 10.1029/94GL02996; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Turcotte S, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2002JA009418; Wiens RC, 2003, SPACE SCI REV, V105, P601, DOI 10.1023/A:1024474028352; Yamada A., 2011, LUNAR PLANET SCI, VXLII, P1707; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; Young ED, 2007, EARTH PLANET SC LETT, V262, P468, DOI 10.1016/j.epsl.2007.08.011; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	52	276	277	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 24	2011	332	6037					1528	1532		10.1126/science.1204636	http://dx.doi.org/10.1126/science.1204636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	782EE	21700868				2022-12-28	WOS:000291990000037
J	Watanabe, K; Nakaya, M				Watanabe, Kenta; Nakaya, Muneo			Laryngopharyngeal Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Watanabe, Kenta; Nakaya, Muneo] Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan		Watanabe, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Tokyo, Japan.	quentaw@aol.com							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					E55	E55		10.1056/NEJMicm1009578	http://dx.doi.org/10.1056/NEJMicm1009578			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781MG	21696304				2022-12-28	WOS:000291936100012
J	Greenhalgh, T				Greenhalgh, Trisha			OUTSIDE THE BOX Doctor Doctor	BRITISH MEDICAL JOURNAL			English	Editorial Material									Barts & London Queen Marys Sch Med & Dent, London, England	University of London; Queen Mary University London	Greenhalgh, T (corresponding author), Barts & London Queen Marys Sch Med & Dent, London, England.	p.greenhalgh@qmul.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088					0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 22	2011	342								d3887	10.1136/bmj.d3887	http://dx.doi.org/10.1136/bmj.d3887			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AT	21697229				2022-12-28	WOS:000292200500011
J	Rothman, SM				Rothman, Sheila M.			Health Advocacy Organizations and Evidence-Based Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rothman, Sheila M.] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA	Columbia University	Rothman, SM (corresponding author), Ctr Study Soc & Med, 630 W 168th St, New York, NY 10032 USA.	smr4@columbia.edu						American Cancer Society, WHO NEEDS FLOW GIV M; Autism Speaks, WHAT IS AUT; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Centers for Disease Control and Prevention, CHRON DIS POW PREV C; Institute of Medicine, 2010, ESS HLTH BEN PUBL CO; Institute of Medicine, DET ESS BEN PACK; Mental Health America, POS STAT 32 ACC MED; O'Hanlon M, 2008, WASHINGTON TIME 1029; Susan G, SG KOM CUR REC NO IM	9	10	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2011	305	24					2569	2570		10.1001/jama.2011.866	http://dx.doi.org/10.1001/jama.2011.866			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	780MF	21693747				2022-12-28	WOS:000291860400026
J	Massey, BT				Massey, Benson T.			Review: Evidence on PPIs for nonspecific chronic cough in adults with gastroesophageal reflux disease is inconsistent	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Coll Wisconsin, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Massey, BT (corresponding author), Med Coll Wisconsin, Milwaukee, WI 53226 USA.							Chang AB, 2011, ARCH DIS CHILD, V96, P468, DOI 10.1136/adc.2009.177733; Reimer C, 2009, GASTROENTEROLOGY, V137, P80, DOI 10.1053/j.gastro.2009.03.058; Shaheen NJ, 2011, ALIMENT PHARM THER, V33, P225, DOI 10.1111/j.1365-2036.2010.04511.x; Smith JA, 2010, GASTROENTEROLOGY, V139, P754, DOI 10.1053/j.gastro.2010.06.050	4	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-9	10.7326/0003-4819-154-12-201106210-02009	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690587				2022-12-28	WOS:000291800500008
J	Miller, PE; Zurflu, E; Jaipaul, CK				Miller, P. Elliott; Zurflu, Erin; Jaipaul, C. Komal			Return of the usual suspect	LANCET			English	Editorial Material							LARYNGEAL TUBERCULOSIS		[Miller, P. Elliott; Zurflu, Erin; Jaipaul, C. Komal] Georgetown Univ Hosp, Div Gen Internal Med, Dept Internal Med, Washington, DC 20007 USA	Georgetown University	Jaipaul, CK (corresponding author), Georgetown Univ Hosp, Div Gen Internal Med, Dept Internal Med, BG-005,3800 Reservoir Rd, Washington, DC 20007 USA.	CKJ01@gunet.georgetown.edu	Miller, Elliott/AAM-5774-2021					Bhat VK, 2009, AM J OTOLARYNG, V30, P327, DOI 10.1016/j.amjoto.2008.07.005; Harney M, 2000, J LARYNGOL OTOL, V114, P878; Sherrell JC, 2000, AM J MED SCI, V320, P403, DOI 10.1097/00000441-200012000-00009; Wang CC, 2007, OTOLARYNG HEAD NECK, V137, P582, DOI 10.1016/j.otohns.2007.04.002	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2150	2150		10.1016/S0140-6736(11)60443-1	http://dx.doi.org/10.1016/S0140-6736(11)60443-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21684385				2022-12-28	WOS:000292117800036
J	Baernighausen, T; Bloom, DE; Humair, S				Baernighausen, Till; Bloom, David E.; Humair, Salal			Going Horizontal - Shifts in Funding of Global Health Interventions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Baernighausen, Till; Bloom, David E.; Humair, Salal] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Baernighausen, Till] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Humair, Salal] Lahore Univ Management Sci, Sch Sci & Engn, Lahore, Pakistan	Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; Lahore University of Management Sciences	Baernighausen, T (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.		Bärnighausen, Till/Y-2388-2019	Humair, Salal/0000-0002-9354-5389	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058482] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Barnighausen T, 2010, B WORLD HEALTH ORGAN, V88, P951, DOI 10.2471/BLT.09.073890; Sepulveda J, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, pXIII; *US GLOB HTLH IN, 2009, IMPL GLOB HLTH IN CO; *US PRES EM PLAN A, 2009, EX SUMM PEPFARS STRA; *US PRES EM PLAN A, 2010, HLTH SYST STRENGTH	5	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 9	2011	364	23					2181	2183		10.1056/NEJMp1014255	http://dx.doi.org/10.1056/NEJMp1014255			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	774NA	21651390				2022-12-28	WOS:000291392100003
J	Carvajal, RD; Antonescu, CR; Wolchok, JD; Chapman, PB; Roman, RA; Teitcher, J; Panageas, KS; Busam, KJ; Chmielowski, B; Lutzky, J; Pavlick, AC; Fusco, A; Cane, L; Takebe, N; Vemula, S; Bouvier, N; Bastian, BC; Schwartz, GK				Carvajal, Richard D.; Antonescu, Cristina R.; Wolchok, Jedd D.; Chapman, Paul B.; Roman, Ruth-Ann; Teitcher, Jerrold; Panageas, Katherine S.; Busam, Klaus J.; Chmielowski, Bartosz; Lutzky, Jose; Pavlick, Anna C.; Fusco, Anne; Cane, Lauren; Takebe, Naoko; Vemula, Swapna; Bouvier, Nancy; Bastian, Boris C.; Schwartz, Gary K.			KIT as a Therapeutic Target in Metastatic Melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR TYROSINE KINASE; PROTOONCOGENE C-KIT; PHASE-II TRIAL; IMATINIB MESYLATE; EXPRESSION; MUTATIONS; RESISTANCE; GENE; BRAF; ACTIVATION	Context Some melanomas arising from acral, mucosal, and chronically sun-damaged sites harbor activating mutations and amplification of the type III transmembrane receptor tyrosine kinase KIT. We explored the effects of KIT inhibition using imatinib mesylate in this molecular subset of disease. Objective To assess clinical effects of imatinib mesylate in patients with melanoma harboring KIT alterations. Design, Setting, and Patients A single-group, open-label, phase 2 trial at 1 community and 5 academic oncology centers in the United States of 295 patients with melanoma screened for the presence of KIT mutations and amplification between April 23, 2007, and April 16, 2010. A total of 51 cases with such alterations were identified and 28 of these patients were treated who had advanced unresectable melanoma arising from acral, mucosal, and chronically sun-damaged sites. Intervention Imatinib mesylate, 400 mg orally twice daily. Main Outcome Measures Radiographic response, with secondary end points including time to progression, overall survival, and correlation of molecular alterations and clinical response. Results Two complete responses lasting 94 (ongoing) and 95 weeks, 2 durable partial responses lasting 53 and 89 (ongoing) weeks, and 2 transient partial responses lasting 12 and 18 weeks among the 25 evaluable patients were observed. The overall durable response rate was 16% (95% confidence interval [CI], 2%-30%), with a median time to progression of 12 weeks (interquartile range [IQR], 6-18 weeks; 95% CI, 11-18 weeks), and a median overall survival of 46.3 weeks (IQR, 28 weeks-not achieved; 95% CI, 28 weeks-not achieved). Response rate was better in cases with mutations affecting recurrent hotspots or with a mutant to wild-type allelic ratio of more than 1 (40% vs 0%, P = .05), indicating positive selection for the mutated allele. Conclusions Among patients with advanced melanoma harboring KIT alterations, treatment with imatinib mesylate results in significant clinical responses in a subset of patients. Responses may be limited to tumors harboring KIT alterations of proven functional relevance.	[Carvajal, Richard D.; Wolchok, Jedd D.; Chapman, Paul B.; Roman, Ruth-Ann; Fusco, Anne; Cane, Lauren; Schwartz, Gary K.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Antonescu, Cristina R.; Busam, Klaus J.; Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Teitcher, Jerrold] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA; [Panageas, Katherine S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Bastian, Boris C.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Chmielowski, Bartosz] Univ Calif Los Angeles, Med Ctr, Dept Med, Los Angeles, CA 90024 USA; [Lutzky, Jose] Mt Sinai Med Ctr, Dept Med, Miami Beach, FL 33140 USA; [Pavlick, Anna C.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Takebe, Naoko] NCI, Div Canc Treatment, Canc Therapy Evaluat Program, Invest Drug Branch, Bethesda, MD 20892 USA; [Vemula, Swapna; Bouvier, Nancy; Bastian, Boris C.] Univ Calif San Francisco, Dept Dermatol, Med Ctr, San Francisco, CA 94143 USA; [Vemula, Swapna; Bouvier, Nancy; Bastian, Boris C.] Univ Calif San Francisco, Dept Pathol, Med Ctr, San Francisco, CA 94140 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Mount Sinai Medical Center; New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Carvajal, RD (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	carvajar@mskcc.org	Carvajal, Richard/ABA-3285-2021	Lutzky, Jose/0000-0002-9503-2130; Chmielowski, Bartosz/0000-0002-2374-3320; Bastian, Boris/0000-0003-1836-6062	US Food and Drug Administration [R01FD003445-01]; National Institutes of Health [N01CM62206, P30 CA008748]; American Society of Clinical Oncology; American Skin Association; Live4Life Foundation; FOOD AND DRUG ADMINISTRATION [R01FD003445] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, K12CA120121] Funding Source: NIH RePORTER	US Food and Drug Administration; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology; American Skin Association; Live4Life Foundation; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grant R01FD003445-01 from the US Food and Drug Administration; grants N01CM62206 and P30 CA008748 from the National Institutes of Health; American Society of Clinical Oncology; American Skin Association; and Live4Life Foundation. The Division of Cancer Treatment and Diagnosis at the National Cancer Institute provided the imatinib mesylate for this clinical trial.	Alexeev V, 2006, J INVEST DERMATOL, V126, P1102, DOI 10.1038/sj.jid.5700125; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Ashida A, 2009, INT J CANCER, V124, P862, DOI 10.1002/ijc.24048; Atkins MB, 1999, J CLIN ONCOL, V17, P2105, DOI 10.1200/JCO.1999.17.7.2105; Bastian BC, 1998, CANCER RES, V58, P2170; Beadling C, 2008, CLIN CANCER RES, V14, P6821, DOI 10.1158/1078-0432.CCR-08-0575; Chapman PB, 1999, J CLIN ONCOL, V17, P2745, DOI 10.1200/JCO.1999.17.9.2745; Chen H, 2003, INT J CANCER, V105, P130, DOI 10.1002/ijc.11025; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Geller AC, 2002, JAMA-J AM MED ASSOC, V288, P1719, DOI 10.1001/jama.288.14.1719; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hou L, 2000, DEVELOPMENT, V127, P5379; Huang SY, 1996, ONCOGENE, V13, P2339; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang XF, 2008, CLIN CANCER RES, V14, P7726, DOI 10.1158/1078-0432.CCR-08-1144; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim KB, 2008, BRIT J CANCER, V99, P734, DOI 10.1038/sj.bjc.6604482; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; LASSAM N, 1992, ONCOGENE, V7, P51; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Lutzky J, 2008, PIGM CELL MELANOMA R, V21, P492, DOI 10.1111/j.1755-148X.2008.00475.x; Montone KT, 1997, MODERN PATHOL, V10, P939; NATALI PG, 1992, INT J CANCER, V52, P197, DOI 10.1002/ijc.2910520207; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Ugurel S, 2005, BRIT J CANCER, V92, P1398, DOI 10.1038/sj.bjc.6602529; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Woodman SE, 2009, MOL CANCER THER, V8, P2079, DOI 10.1158/1535-7163.MCT-09-0459; Wyman K, 2006, CANCER-AM CANCER SOC, V106, P2005, DOI 10.1002/cncr.21834; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZAKUT R, 1993, ONCOGENE, V8, P2221	44	571	608	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2327	2334		10.1001/jama.2011.746	http://dx.doi.org/10.1001/jama.2011.746			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642685	Green Accepted, Bronze			2022-12-28	WOS:000291349100026
J	Smith, G				Smith, George			Willard Boyle (1924-2011) OBITUARY	NATURE			English	Biographical-Item									Bell Labs, Barnegat, NJ 08005 USA	AT&T	Smith, G (corresponding author), Bell Labs, Barnegat, NJ 08005 USA.	apogee2@comcast.net						BOYLE W, PUBLICATION LIST	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					37	37		10.1038/474037a	http://dx.doi.org/10.1038/474037a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637246	Bronze			2022-12-28	WOS:000291156700027
J	Waldrop, MM				Waldrop, M. Mitchell			The disruptor	NATURE			English	News Item														Waldrop, M Mitchell/0000-0002-8063-1472					0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	2011	474	7349					20	+		10.1038/474020a	http://dx.doi.org/10.1038/474020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637234	Bronze			2022-12-28	WOS:000291156700016
J	Sievers, SA; Karanicolas, J; Chang, HW; Zhao, A; Jiang, L; Zirafi, O; Stevens, JT; Munch, J; Baker, D; Eisenberg, D				Sievers, Stuart A.; Karanicolas, John; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Zirafi, Onofrio; Stevens, Jason T.; Muench, Jan; Baker, David; Eisenberg, David			Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation	NATURE			English	Article							PAIRED HELICAL FILAMENTS; TAU-PROTEIN; PEPTIDE INHIBITORS; ALZHEIMERS-DISEASE; AGGREGATION; BINDING; MECHANISM; TOXICITY; MODEL	Many globular and natively disordered proteins can convert into amyloid fibrils. These fibrils are associated with numerous pathologies(1) as well as with normal cellular functions(2,3), and frequently form during protein denaturation(4,5). Inhibitors of pathological amyloid fibril formation could be useful in the development of therapeutics, provided that the inhibitors were specific enough to avoid interfering with normal processes. Here we show that computer-aided, structure-based design can yield highly specific peptide inhibitors of amyloid formation. Using known atomic structures of segments of amyloid fibrils as templates, we have designed and characterized an all-D-amino-acid inhibitor of the fibril formation of the tau protein associated with Alzheimer's disease, and a non-natural L.-amino-acid inhibitor of an amyloid fibril that enhances sexual transmission of human immunodeficiency virus. Our results indicate that peptides from structure-based designs can disrupt the fibril formation of full-length proteins, including those, such as tau protein, that lack fully ordered native structures. Because the inhibiting peptides have been designed on structures of dual-beta-sheet 'steric zippers', the successful inhibition of amyloid fibril formation strengthens the hypothesis that amyloid spines contain steric zippers.	[Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Sievers, Stuart A.; Chang, Howard W.; Zhao, Anni; Jiang, Lin; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Karanicolas, John; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Karanicolas, John; Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Ctr Bioinformat, Lawrence, KS 66045 USA; [Karanicolas, John; Stevens, Jason T.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Zirafi, Onofrio; Muench, Jan] Univ Hosp Ulm, Inst Mol Virol, D-89081 Ulm, Germany	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Kansas; University of Kansas; Ulm University	Eisenberg, D (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu	Eisenberg, David/E-2447-2011; Jiang, Lin/G-1575-2010; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Jan, Munch/0000-0001-7316-7141	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award; Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING [R01AG029430, P50AG016570] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science, Baden-Wurttemberg; UCLA-IGERT; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. I. Ivanova, J. Corn, T. Kortemme, D. Anderson, M. R. Sawaya, M. Phillips, S. Sambashivan, J. Park, M. Landau, A. Laganowsky, Q. Zhang, R. Clubb, F. Guo, T. Yeates, J. Nowick, J. Zheng and M. J. Thompson for discussions; the HHMI, NIH, NSF, Gates Foundation and Joint Center for Translational Medicine for support; R. Peterson for help with NMR experiments; E. Mandelkow for providing tau constructs; R. Rick for providing amyloid-beta; and J. Stroud for amyloid-beta preparation. Support came from the Damon Runyon Cancer Research Foundation (J.K.), the Ruth L. Kirschstein National Research Service Award (H.W.C.), the programme for junior professors by the Ministry of Science, Baden-Wurttemberg (J.M.), and a UCLA-IGERT bioinformatics traineeship (S.A.S.).	ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barghorn Stefan, 2004, V299, P35; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chen ZJ, 2005, J MOL BIOL, V354, P760, DOI 10.1016/j.jmb.2005.09.055; DeLano W.L., 2002, PYMOL MOL VIEWER; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Findeis Mark A., 2002, Current Topics in Medicinal Chemistry, V2, P417, DOI 10.2174/1568026024607508; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; Kokkoni N, 2006, BIOCHEMISTRY-US, V45, P9906, DOI 10.1021/bi060837s; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Larbig G, 2007, CURR ALZHEIMER RES, V4, P315; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002; Perez M, 1996, J NEUROCHEM, V67, P1183; Petrassi HM, 2000, J AM CHEM SOC, V122, P2178, DOI 10.1021/ja993309v; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quijano FAR, 2006, BIOCHEMISTRY-US, V45, P4638, DOI 10.1021/bi052226q; Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt K, 1999, J NEUROSCI METH, V87, P195, DOI 10.1016/S0165-0270(99)00003-5; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Team RC., 2022, LANG ENV STAT COMP; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wiesehan K, 2003, CHEMBIOCHEM, V4, P748, DOI 10.1002/cbic.200300631; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643	49	341	354	2	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 7	2011	475	7354					96	U117		10.1038/nature10154	http://dx.doi.org/10.1038/nature10154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	788RE	21677644	Green Accepted, Green Submitted			2022-12-28	WOS:000292461300052
J	Rees, H; Madhi, SA				Rees, Helen; Madhi, Shabir A.			Will the Decade of Vaccines mean business as usual?	LANCET			English	Editorial Material							CHILDREN YOUNGER; DISEASE; MORTALITY; BURDEN		[Rees, Helen] WHO Strateg Advisory Grp Experts Immunizat, Geneva, Switzerland; [Rees, Helen] Univ Witwatersrand, Wits Reprod Hlth, ZA-2038 Johannesburg, Hillbrow, South Africa; [Rees, Helen] Univ Witwatersrand, HIV Inst, ZA-2038 Johannesburg, Hillbrow, South Africa; [Rees, Helen] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Madhi, Shabir A.] Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, Gauteng Prov, South Africa; [Madhi, Shabir A.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Vaccine Preventable Dis, ZA-2038 Johannesburg, Gauteng Prov, South Africa	University of Witwatersrand; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Research Foundation - South Africa; University of Witwatersrand	Rees, H (corresponding author), WHO Strateg Advisory Grp Experts Immunizat, Geneva, Switzerland.	hrees@rhru.co.za		Rees, Helen/0000-0003-1442-6734				*BILL M GAT FDN, 2010, DEC VACC; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Levine OS, 2011, LANCET, V378, P439, DOI 10.1016/S0140-6736(11)60406-6; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Senouci K, 2010, VACCINE, V28, pA26, DOI 10.1016/j.vaccine.2010.02.028; Usher AD, 2010, LANCET, V375, P791, DOI 10.1016/S0140-6736(10)60328-5; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; *WHO, 2010, PROGR GLOB IMM GOALS; World Health Organization (WHO), 2009, M STRAT ADV GROUP EX, P518	11	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2011	378	9789					382	385		10.1016/S0140-6736(11)60710-1	http://dx.doi.org/10.1016/S0140-6736(11)60710-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	803XM	21664683				2022-12-28	WOS:000293615900008
J	Trajkovski, M; Hausser, J; Soutschek, J; Bhat, B; Akin, A; Zavolan, M; Heim, MH; Stoffel, M				Trajkovski, Mirko; Hausser, Jean; Soutschek, Juergen; Bhat, Bal; Akin, Akinc; Zavolan, Mihaela; Heim, Markus H.; Stoffel, Markus			MicroRNAs 103 and 107 regulate insulin sensitivity	NATURE			English	Article							RESISTANCE; ADIPOSE; EXPRESSION; CAVEOLIN; RECEPTOR; MECHANISMS; STEATOSIS; HORMONE; OBESITY	Defects in insulin signalling are among the most common and earliest defects that predispose an individual to the development of type 2 diabetes(1-3). MicroRNAs have been identified as a new class of regulatory molecules that influence many biological functions, including metabolism(4,5). However, the direct regulation of insulin sensitivity by microRNAs in vivo has not been demonstrated. Here we show that the expression of microRNAs 103 and 107 (miR-103/107) is upregulated in obese mice. Silencing of miR-103/107 leads to improved glucose homeostasis and insulin sensitivity. In contrast, gain of miR-103/107 function in either liver or fat is sufficient to induce impaired glucose homeostasis. We identify caveolin-1, a critical regulator of the insulin receptor, as a direct target gene of miR-103/107. We demonstrate that caveolin-1 is upregulated upon miR-103/107 inactivation in adipocytes and that this is concomitant with stabilization of the insulin receptor, enhanced insulin signalling, decreased adipocyte size and enhanced insulin-stimulated glucose uptake. These findings demonstrate the central importance of miR-103/107 to insulin sensitivity and identify a new target for the treatment of type 2 diabetes and obesity.	[Trajkovski, Mirko; Hausser, Jean; Heim, Markus H.; Stoffel, Markus] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Trajkovski, Mirko; Stoffel, Markus] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland; [Soutschek, Juergen; Bhat, Bal] Regulus Therapeut Inc, San Diego, CA 92121 USA; [Akin, Akinc] Alnylam Pharmaceut, Cambridge, MA 02142 USA; [Heim, Markus H.] Univ Basel Hosp, CH-4031 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel; Isis Pharmaceuticals Inc; University of Basel	Stoffel, M (corresponding author), ETH, Competence Ctr Syst Physiol & Metab Dis, Schafmattstr 18,HPM F 39-1, CH-8093 Zurich, Switzerland.	stoffel@imsb.biol.ethz.ch	Heim, Markus/A-7526-2008; Xie, Huangming/B-2260-2012; Zavolan, Mihaela/S-3888-2016	Heim, Markus/0000-0002-7523-4894; Zavolan, Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199; Stoffel, Markus/0000-0003-1304-5817; Trajkovski, Mirko/0000-0002-3152-9551	Juvenile Diabetes Research Foundation International; Swiss National Science Foundation (SNF); European Community; Leducq Foundation	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); European Community(European Commission); Leducq Foundation(Leducq Foundation)	We would like to thank F. Preitner and B. Thorens for the hyperinsulinaemic euglycaemic clamp studies. M. T. was supported by a fellowship from the Juvenile Diabetes Research Foundation International. The work was supported in part by the Swiss National Science Foundation (SNF, LiverX), the European Community (SIROCCO, ERC and MetaboloMirs) and the Leducq Foundation.	Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cohen AW, 2003, AM J PHYSIOL-ENDOC M, V285, pE1151, DOI 10.1152/ajpendo.00324.2003; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Hansen LH, 1998, MOL ENDOCRINOL, V12, P1140, DOI 10.1210/me.12.8.1140; Herrera BM, 2010, DIABETOLOGIA, V53, P1099, DOI 10.1007/s00125-010-1667-2; Kahn C Ronald, 2003, Exp Diabesity Res, V4, P169, DOI 10.1155/EDR.2003.169; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Otsu K, 2010, AM J PHYSIOL-CELL PH, V298, pC450, DOI 10.1152/ajpcell.00077.2009; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TOZZO E, 1995, AM J PHYSIOL-ENDOC M, V268, pE956, DOI 10.1152/ajpendo.1995.268.5.E956; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	27	734	783	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 30	2011	474	7353					649	U127		10.1038/nature10112	http://dx.doi.org/10.1038/nature10112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	785CF	21654750	Green Published			2022-12-28	WOS:000292204300041
J	Ma, DH; Taneja, TK; Hagen, BM; Kim, BY; Ortega, B; Lederer, WJ; Welling, PA				Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.			Golgi Export of the Kir2.1 Channel Is Driven by a Trafficking Signal Located within Its Tertiary Structure	CELL			English	Article							ANDERSEN-TAWIL-SYNDROME; RECTIFIER POTASSIUM CHANNELS; CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; SORTING SIGNALS; CELL-SURFACE; TRANSMEMBRANE PROTEINS; PROTEOMIC ANALYSIS; MEMBRANE-PROTEINS; PLASMA-MEMBRANE	Mechanisms that are responsible for sorting newly synthesized proteins for traffic to the cell surface from the Golgi are poorly understood. Here, we show that the potassium channel Kir2.1, mutations in which are associated with Andersen-Tawil syndrome, is selected as cargo into Golgi export carriers in an unusual signal-dependent manner. Unlike conventional trafficking signals, which are typically comprised of short linear peptide sequences, Golgi exit of Kir2.1 is dictated by residues that are embedded within the confluence of two separate domains. This signal patch forms a recognition site for interaction with the AP1 adaptor complex, thereby marking Kir2.1 for incorporation into clathrin-coated vesicles at the trans-Golgi. The identification of a trafficking signal in the tertiary structure of Kir2.1 reveals a quality control step that couples protein conformation to Golgi export and provides molecular insight into how mutations in Kir2.1 arrest the channels at the Golgi.	[Ma, Donghui; Taneja, Tarvinder Kaur; Hagen, Brian M.; Kim, Bo-Young; Ortega, Bernardo; Lederer, W. Jonathan; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu			NIH [P01 HL70709, R01 DK54231, R01 DK 63049, T32-HL-072751]; American Heart Association [0855321E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070709, T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK054231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by funds from the NIH (P01 HL70709, R01 DK54231, R01 DK 63049, and T32-HL-072751) and the American Heart Association (0855321E). We thank Drs. Ora Weisz and S. Kornberg for reagents, Dr. Terry Rogers for support and advice, and Dr. William R. Randall for help with adenovirus production.	ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Campo C, 2005, REV PHYSIOL BIOCH P, V153, P47, DOI 10.1007/s10254-004-0037-1; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Donaldson MR, 2004, ANN MED, V36, P92, DOI 10.1080/17431380410032490; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Kohout TA, 1996, CIRC RES, V78, P971, DOI 10.1161/01.RES.78.6.971; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LeBorgne R, 1996, J BIOL CHEM, V271, P2162; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; LeMaout S, 1997, P NATL ACAD SCI USA, V94, P13329, DOI 10.1073/pnas.94.24.13329; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; O'Connell AD, 2005, P NATL ACAD SCI USA, V102, P9954, DOI 10.1073/pnas.0504332102; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Prescott AR, 1997, EUR J CELL BIOL, V72, P238; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; RALSTON E, 1993, J CELL BIOL, V120, P399, DOI 10.1083/jcb.120.2.399; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198	68	76	76	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 24	2011	145	7					1102	1115		10.1016/j.cell.2011.06.007	http://dx.doi.org/10.1016/j.cell.2011.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	782QV	21703452	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000292025700016
J	Larsson, J; Fransson, C; Ostlin, G; Groningsson, P; Jerkstrand, A; Kozma, C; Sollerman, J; Challis, P; Kirshner, RP; Chevalier, RA; Heng, K; McCray, R; Suntzeff, NB; Bouchet, P; Crotts, A; Danziger, J; Dwek, E; France, K; Garnavich, PM; Lawrence, SS; Leibundgut, B; Lundqvist, P; Panagia, N; Pun, CSJ; Smith, N; Sonneborn, G; Wang, L; Wheeler, JC				Larsson, J.; Fransson, C.; Ostlin, G.; Groningsson, P.; Jerkstrand, A.; Kozma, C.; Sollerman, J.; Challis, P.; Kirshner, R. P.; Chevalier, R. A.; Heng, K.; McCray, R.; Suntzeff, N. B.; Bouchet, P.; Crotts, A.; Danziger, J.; Dwek, E.; France, K.; Garnavich, P. M.; Lawrence, S. S.; Leibundgut, B.; Lundqvist, P.; Panagia, N.; Pun, C. S. J.; Smith, N.; Sonneborn, G.; Wang, L.; Wheeler, J. C.			X-ray illumination of the ejecta of supernova 1987A	NATURE			English	Article							HUBBLE-SPACE-TELESCOPE; SN 1987A; REVERSE SHOCK; LINE EMISSION; LIGHT-CURVE; EVOLUTION; RING; SN-1987A; REMNANT; STARS	When a massive star explodes as a supernova, substantial amounts of radioactive elements-primarily Ni-56, Ni-57 and Ti-44-are produced(1). After the initial flash of light from shock heating, the fading light emitted by the supernova is due to the decay of these elements(2). However, after decades, the energy powering a supernova remnant comes from the shock interaction between the ejecta and the surrounding medium(3). The transition to this phase has hitherto not been observed: supernovae occur too infrequently in the Milky Way to provide a young example, and extragalactic supernovae are generally too faint and too small. Here we report observations that show this transition in the supernova SN 1987A in the Large Magellanic Cloud. From 1994 to 2001, the ejecta faded owing to radioactive decay of Ti-44 as predicted. Then the flux started to increase, more than doubling by the end of 2009. We show that this increase is the result of heat deposited by X-rays produced as the ejecta interacts with the surrounding material. In time, the X-rays will penetrate farther into the ejecta, enabling us to analyse the structure and chemistry of the vanished star.	[Larsson, J.; Fransson, C.; Ostlin, G.; Groningsson, P.; Jerkstrand, A.; Kozma, C.; Sollerman, J.; Lundqvist, P.] Stockholm Univ, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Challis, P.; Kirshner, R. P.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Chevalier, R. A.] Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; [Heng, K.] Eidgenossische Tech Hsch, Inst Astron, CH-8093 Zurich, Switzerland; [McCray, R.] Univ Colorado, JILA, Boulder, CO USA; [Suntzeff, N. B.] Texas A&M Univ, George P & Cynthia Woods Mitchell Inst Fundamenta, Dept Phys & Astron, College Stn, TX 77843 USA; [Bouchet, P.] DSM IRFU Serv Astrophys Commissariat Energie Alte, FR-91191 Gif Sur Yvette, France; [Crotts, A.] Columbia Univ, Dept Astron, New York, NY 10027 USA; [Dwek, E.; Sonneborn, G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Danziger, J.] Osserv Astron Trieste, I-34131 Trieste, Italy; [France, K.] Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80309 USA; [Garnavich, P. M.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Lawrence, S. S.] Hofstra Univ, Dept Phys & Astron, Hempstead, NY 11549 USA; [Leibundgut, B.] ESO, D-85748 Garching, Germany; [Panagia, N.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Panagia, N.] Osserv Astrofis Catania, INAF CT, I-95123 Catania, Italy; [Pun, C. S. J.] Univ Hong Kong, Dept Phys, Hong Kong, Hong Kong, Peoples R China; [Smith, N.] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Wheeler, J. C.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	Oskar Klein Centre; Stockholm University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Virginia; University of Colorado System; University of Colorado Boulder; Texas A&M University System; Texas A&M University College Station; Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Istituto Nazionale Astrofisica (INAF); University of Colorado System; University of Colorado Boulder; University of Notre Dame; Hofstra University; Space Telescope Science Institute; Istituto Nazionale Astrofisica (INAF); University of Hong Kong; University of Arizona; University of Texas System; University of Texas Austin	Larsson, J (corresponding author), Stockholm Univ, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden.	josefin.larsson@astro.su.se; claes@astro.su.se	Jerkstrand, Anders R/K-9648-2015; Dwek, Eli/C-3995-2012; Lawrence, Stephen/R-6057-2019; Sonneborn, George/D-5255-2012; Pun, Chun Shing Jason/AAO-9345-2020; Jerkstrand, Anders/AAJ-7018-2021	Jerkstrand, Anders R/0000-0001-8005-4030; Lawrence, Stephen/0000-0002-7491-7052; Leibundgut, Bruno/0000-0002-4413-7733; Sollerman, Jesper/0000-0003-1546-6615; Suntzeff, Nicholas/0000-0002-8102-181X; FRANCE, KEVIN/0000-0002-1002-3674; /0000-0003-0065-2933; Dwek, Eli/0000-0001-8033-1181	Swedish Research Council; Swedish National Space Board; Space Telescope Science Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish National Space Board; Space Telescope Science Institute(Space Telescope Science Institute)	This work was supported by the Swedish Research Council and the Swedish National Space Board. Support for the HST observing programme was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc.	Blinnikov S, 2000, ASTROPHYS J, V532, P1132, DOI 10.1086/308588; Chugai NN, 1997, ASTROPHYS J, V483, P925, DOI 10.1086/304253; Diehl R, 1998, PUBL ASTRON SOC PAC, V110, P637, DOI 10.1086/316169; Dwek E, 2010, ASTROPHYS J, V722, P425, DOI 10.1088/0004-637X/722/1/425; France K, 2010, SCIENCE, V329, P1624, DOI 10.1126/science.1192134; Fransson C, 2002, NEW ASTRON REV, V46, P487, DOI 10.1016/S1387-6473(02)00188-4; Graves GJM, 2005, ASTROPHYS J, V629, P944, DOI 10.1086/431422; Groningsson P, 2008, ASTRON ASTROPHYS, V492, P481, DOI 10.1051/0004-6361:200810551; Heng K, 2006, ASTROPHYS J, V644, P959, DOI 10.1086/503896; Jerkstrand A., 2011, ASTRON ASTR IN PRESS; LUCY LB, 1991, SUPERNOVAE //, P82; McKee CF, 2001, AIP CONF PROC, V565, P17, DOI 10.1063/1.1377069; Michael E, 2003, ASTROPHYS J, V593, P809, DOI 10.1086/376725; Morris T, 2007, SCIENCE, V315, P1103, DOI 10.1126/science.1136351; Racusin JL, 2009, ASTROPHYS J, V703, P1752, DOI 10.1088/0004-637X/703/2/1752; SHIGEYAMA T, 1990, ASTROPHYS J, V360, P242, DOI 10.1086/169114; Smith N, 2005, ASTROPHYS J, V635, pL41, DOI 10.1086/499101; Timmes FX, 1996, ASTROPHYS J, V464, P332, DOI 10.1086/177323; WOODEN DH, 1993, ASTROPHYS J SUPPL S, V88, P477, DOI 10.1086/191830; WOOSLEY SE, 1989, ASTROPHYS J, V346, P395, DOI 10.1086/168019; Woosley SE, 2002, REV MOD PHYS, V74, P1015, DOI 10.1103/RevModPhys.74.1015; Zanardo G, 2010, ASTROPHYS J, V710, P1515, DOI 10.1088/0004-637X/710/2/1515; Zhekov S. A., 2010, MON NOT R ASTRON SOC, V721, P518	24	52	52	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	2011	474	7352					484	486		10.1038/nature10090	http://dx.doi.org/10.1038/nature10090			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	781NJ	21654749	Green Submitted			2022-12-28	WOS:000291939700042
J	Robbins, M				Robbins, Martin			Fuelling politics	NATURE			English	Editorial Material																			0	21	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S22	S24		10.1038/474S022a	http://dx.doi.org/10.1038/474S022a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697840	Bronze			2022-12-28	WOS:000291939700009
J	Bisgaier, J; Rhodes, KV				Bisgaier, Joanna; Rhodes, Karin V.			Auditing Access to Specialty Care for Children with Public Insurance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH-CARE; PRIVATE INSURANCE; PHYSICIANS PARTICIPATION; MEDICAID PATIENTS; ORTHOPEDIC CARE; FOLLOW-UP; CALIFORNIA; PEDIATRICIANS; FRACTURES; SERVICES	Background Health care reform has expanded eligibility to public insurance without fully addressing concerns about access. We measured children's access to outpatient specialty care to identify disparities in providers' acceptance of Medicaid and the Children's Health Insurance Program (CHIP) versus private insurance. Methods Between January and May 2010, research assistants called a stratified, random sample of clinics representing eight specialties in Cook County, Illinois, which has a high proportion of specialists. Callers posed as mothers of pediatric patients with common health conditions requiring outpatient specialty care. Two calls, separated by 1 month, were placed to each clinic by the same person with the use of a standardized clinical script that differed by insurance status. Results We completed 546 paired calls to 273 specialty clinics and found significant disparities in provider acceptance of Medicaid-CHIP versus private insurance across all tested specialties. Overall, 66% of Medicaid-CHIP callers (179 of 273) were denied an appointment as compared with 11% of privately insured callers (29 of 273) (relative risk, 6.2; 95% confidence interval [CI], 4.3 to 8.8; P<0.001). Among 89 clinics that accepted both insurance types, the average wait time for Medicaid-CHIP enrollees was 22 days longer than that for privately insured children (95% CI, 6.8 to 37.5; P = 0.005). Conclusions We found a disparity in access to outpatient specialty care between children with public insurance and those with private insurance. Policy interventions that encourage providers to accept patients with public insurance are needed to improve access to care.	[Bisgaier, Joanna; Rhodes, Karin V.] Univ Penn, Sch Social Policy & Practice, Philadelphia, PA 19104 USA; [Rhodes, Karin V.] Univ Penn, Sch Med, Div Emergency Care Policy Res, Dept Emergency Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rhodes, KV (corresponding author), Univ Penn, Sch Social Policy & Practice, 3815 Walnut St, Philadelphia, PA 19104 USA.	kvr@sp2.upenn.edu			state of Illinois	state of Illinois	Supported by the state of Illinois, which provided funding, detailed physician-licensure data, data regarding Medicaid and state-employee health insurance claims, and dummy Medicaid identification numbers as a result of a court-ordered consent decree stemming from class-action litigation on behalf of Cook County children enrolled in Medicaid.	Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; *ASS AM MED COLL, TEACH HOSP MED SCH F; Backus L, 2001, J GEN INTERN MED, V16, P815, DOI 10.1046/j.1525-1497.2001.01239.x; Berman S, 2002, PEDIATRICS, V110, P239, DOI 10.1542/peds.110.2.239; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; *CENS BUR, 2010 CENS DAT RED DA; Chen AH, 2010, HEALTH AFFAIR, V29, P969, DOI 10.1377/hlthaff.2010.0027; *CHILDR HLTH INS P, 2010, PLANT ACT APR 23; Coburn AF, 1999, INQUIRY-J HEALTH CAR, V36, P265; COUGHLIN TA, 2007, RACE TOP ILLINOISS K; Cunningham PJ, 2008, MILBANK Q, V86, P91, DOI 10.1111/j.1468-0009.2007.00514.x; Cunningham PJ, 2005, MED CARE RES REV, V62, P676, DOI 10.1177/1077558705281061; Decker S. L., 2007, REV ECON HOUSEHOLD, V5, P95, DOI DOI 10.1007/S11150-007-9000-7; Dubay L, 2007, HEALTH AFFAIR, V26, P370, DOI 10.1377/hlthaff.26.2.370; Ferrer RL, 2007, ANN FAM MED, V5, P492, DOI 10.1370/afm.746; Fix Michael E., 1993, CLEAR CONVINCING EVI; Forrest CB, 2009, ARCH INTERN MED, V169, P1062, DOI 10.1001/archinternmed.2009.114; Galbraith AA, 2005, PEDIATRICS, V116, P1148, DOI 10.1542/peds.2004-2584; Gold M, 2006, J AMBUL CARE MANAG, V29, P36, DOI 10.1097/00004479-200601000-00005; Greene J, 2006, MILBANK Q, V84, P239, DOI 10.1111/j.1468-0009.2006.00447.x; Hwang AH, 2005, UROLOGY, V66, P170, DOI 10.1016/j.urology.2005.01.065; Iglehart JK, 2010, HEALTH AFFAIR, V29, P230, DOI 10.1377/hlthaff.2010.0010; *IL DEP HEALTHC FA, PHYS FEE SCHED KEY R; Iobst C, 2010, J PEDIATR ORTHOPED, V30, P244, DOI 10.1097/BPO.0b013e3181d413c5; Kasser JR, 2005, CLIN ORTHOP RELAT R, P110, DOI 10.1097/01.blo.0000162410.47731.69; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; Kogan MD, 2010, NEW ENGL J MED, V363, P841, DOI 10.1056/NEJMsa0909994; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; MARGOLIS PA, 1992, JAMA-J AM MED ASSOC, V267, P1942, DOI 10.1001/jama.267.14.1942; McManus M, 2009, ARCH PEDIAT ADOL MED, V163, P200, DOI 10.1001/archpediatrics.2009.8; *MED CHILDR, 2009, TITL 19 SEDS REP; ML Millman, 1993, ACC HLTH CAR AM, P229; Newacheck PW, 1998, JAMA-J AM MED ASSOC, V280, P1789, DOI 10.1001/jama.280.20.1789; Ortega AN, 2001, MED CARE, V39, P1065, DOI 10.1097/00005650-200110000-00004; PERLOFF JD, 1995, HEALTH SERV RES, V30, P7; Porterfield SL, 2007, AM J PUBLIC HEALTH, V97, P323, DOI 10.2105/AJPH.2004.055921; Rosenbaum S, 2010, NEW ENGL J MED, V362, P1952, DOI 10.1056/NEJMp1003890; SEBELIUS K, CHIPRA ONE YEAR LATE; SEBELIUS K, 2010, ENSURING SUCCESS MUS; Skaggs DL, 2006, J PEDIATR ORTHOPED, V26, P400, DOI 10.1097/01.bpo.0000217715.87857.24; Skaggs DL, 2001, PEDIATRICS, V107, P1405, DOI 10.1542/peds.107.6.1405; Skinner AC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-194; Stille CJ, 2006, PEDIATRICS, V118, P1341, DOI 10.1542/peds.2005-3010; Wang EC, 2004, PEDIATRICS, V114, pE584, DOI 10.1542/peds.2004-0210; 2009, CHIP EVER ENROLLED Y; MARKET SHARE REPORTS	46	212	213	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2324	2333		10.1056/NEJMsa1013285	http://dx.doi.org/10.1056/NEJMsa1013285			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777RZ	21675891				2022-12-28	WOS:000291643800010
J	DeVries, AS; Harper, J; Murray, A; Lexau, C; Bahta, L; Christensen, J; Cebelinski, E; Fuller, S; Kline, S; Wallace, GS; Shaw, JH; Burns, CC; Lynfield, R				DeVries, Aaron S.; Harper, Jane; Murray, Andrew; Lexau, Catherine; Bahta, Lynn; Christensen, Jaime; Cebelinski, Elizabeth; Fuller, Susan; Kline, Susan; Wallace, Gregory S.; Shaw, Jing H.; Burns, Cara C.; Lynfield, Ruth			Vaccine-Derived Poliomyelitis 12 Years after Infection in Minnesota	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POLIOVIRUS; STRAIN	A 44-year-old woman with long-standing common variable immunodeficiency who was receiving intravenous immune globulin suddenly had paralysis of all four limbs and the respiratory muscles, resulting in death. Type 2 vaccine-derived poliovirus was isolated from stool. The viral capsid protein VP1 region had diverged from the vaccine strain at 12.3% of nucleotide positions, and the two attenuating substitutions had reverted to the wild-type sequence. Infection probably occurred 11.9 years earlier (95% confidence interval [CI], 10.9 to 13.2), when her child received the oral poliovirus vaccine. No secondary cases were identified among close contacts or 2038 screened health care workers. Patients with common variable immunodeficiency can be chronically infected with poliovirus, and poliomyelitis can develop despite treatment with intravenous immune globulin.	[DeVries, Aaron S.; Harper, Jane; Murray, Andrew; Lexau, Catherine; Bahta, Lynn; Christensen, Jaime; Cebelinski, Elizabeth; Fuller, Susan; Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN 55164 USA; [Kline, Susan] Univ Minnesota, Minneapolis, MN USA; [Wallace, Gregory S.; Shaw, Jing H.; Burns, Cara C.] Ctr Dis Control & Prevent, Atlanta, GA USA	Minnesota Department of Health (MHD); University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA	DeVries, AS (corresponding author), Minnesota Dept Hlth, POB 64975, St Paul, MN 55164 USA.	aaron.devries@state.mn.us		DeVries, Aaron/0000-0001-9211-0722	Centers for Disease Control and Prevention [3U01CI000313]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000313] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported in part by a grant (3U01CI000313) from the Emerging Infections Program, Centers for Disease Control and Prevention.	Adu F, 2007, VIRUS RES, V127, P17, DOI 10.1016/j.virusres.2007.03.009; Alexander JP, 2009, J INFECT DIS, V199, P391, DOI 10.1086/596052; Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; [Anonymous], 2006, EXPL ROL ANT DRUGS E; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1002; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P950; De Jesus NH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-70; EXPLORING THE, 2006, NATL ACADEMIES PRESS; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; MACADAM AJ, 1993, VIROLOGY, V192, P18, DOI 10.1006/viro.1993.1003; MacLennan C, 2004, LANCET, V363, P1509, DOI 10.1016/S0140-6736(04)16150-3; Prevots D R, 2000, MMWR Recomm Rep, V49, P1; REN R, 1991, J VIROL, V65, P1377, DOI 10.1128/JVI.65.3.1377-1382.1991; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Sutter RW, 1994, INFECT MED, V11, P426; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003	21	53	56	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	2011	364	24					2316	2323		10.1056/NEJMoa1008677	http://dx.doi.org/10.1056/NEJMoa1008677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777RZ	21675890				2022-12-28	WOS:000291643800009
J	Shen, YC; Hsia, RY				Shen, Yu-Chu; Hsia, Renee Y.			Association Between Ambulance Diversion and Survival Among Patients With Acute Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPITAL CARDIAC-ARREST; LENGTH-OF-STAY; EMERGENCY-DEPARTMENTS; MORTALITY; IMPACT; DELAYS; TIMES; CARE	Context Ambulance diversion, a practice in which emergency departments (EDs) are temporarily closed to ambulance traffic, might be problematic for patients experiencing time-sensitive conditions, such as acute myocardial infarction (AMI). However, there is little empirical evidence to show whether diversion is associated with worse patient outcomes. Objective To analyze whether temporary ED closure on the day a patient experiences AMI, as measured by ambulance diversion hours of the nearest ED, is associated with increased mortality rates among patients with AMI. Design, Study, and Participants A case-crossover design of 13 860 Medicare patients with AMI from 508 zip codes within 4 California counties (Los Angeles, San Francisco, San Mateo, and Santa Clara) whose admission date was between 2000 and 2005. Data included 100% Medicare claims data that covered admissions between 2000 and 2005, linked with date of death until 2006, and daily ambulance diversion logs from the same 4 counties. Among the hospital universe, 149 EDs were identified as the nearest ED to these patients. Main Outcome Measures The percentage of patients with AMI who died within 7 days, 30 days, 90 days, 9 months, and 1 year from admission (when their nearest ED was not on diversion and when that same ED was exposed to <6, 6 to <12, and >= 12 hours of diversion out of 24 hours on the day of admission). Results Between 2000 and 2006, the mean (SD) daily diversion duration was 7.9 (6.1) hours. Based on analysis of 11 625 patients admitted to the ED between 2000 and 2005, and whose nearest ED had at least 3 diversion exposure levels (3541, 3357, 2667, and 2060 patients for no exposure, exposure to <6, 6 to <12, and >= 12 hours of diversion, respectively), there were no statistically significant differences in mortality rates between no diversion and exposure to less than 12 hours of diversion. Exposure to 12 or more hours of diversion was associated with higher 30-day mortality vs no diversion status (unadjusted mortality rate, 392 patients [19%] vs 545 patients [15%]; regression adjusted difference, 3.24 percentage points; 95% confidence interval [CI], 0.60-5.88); higher 90-day mortality (537 patients [26%] vs 762 patients [22%]; 2.89 percentage points; 95% CI, 0.13-5.64); higher 9-month mortality (680 patients [33%] vs 980 patients [28%]; 2.93 percentage points; 95% CI, 0.15-5.71); and higher 1-year mortality (731 patients [35%] vs 1034 patients [29%]; 3.04 percentage points; 95% CI, 0.33-5.75). Conclusion Among Medicare patients with AMI in 4 populous California counties, exposure to at least 12 hours of diversion by the nearest ED was associated with increased 30-day, 90-day, 9-month, and 1-year mortality. JAMA. 2011;305(23):2440-2447 www.jama.com	[Shen, Yu-Chu] USN, Postgrad Sch, Grad Sch Business & Publ Policy, Monterey, CA 93943 USA; [Shen, Yu-Chu] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hsia, Renee Y.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Emergency Med, San Francisco, CA USA	United States Department of Defense; United States Navy; Naval Postgraduate School; National Bureau of Economic Research; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Shen, YC (corresponding author), USN, Postgrad Sch, Grad Sch Business & Publ Policy, 555 Dyer Rd,Code GB, Monterey, CA 93943 USA.	yshen@nps.edu			Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative [63974]; National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science [KL2 RR024130]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000143] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative(Robert Wood Johnson Foundation (RWJF)); National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)University of California System); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grant 63974 from the Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative (Dr Shen), grant KL2 RR024130 from the National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science (Dr Hsia), and the Robert Wood Johnson Foundation Physician Faculty Scholars (Dr Hsia).	ANDRULIS DP, 1991, ANN EMERG MED, V20, P980, DOI 10.1016/S0196-0644(05)82976-2; Auerbach J, 0807494 DHCQ; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Buchmueller TC, 2006, J HEALTH ECON, V25, P740, DOI 10.1016/j.jhealeco.2005.10.006; Burke Laura, 2010, Virtual Mentor, V12, P483, DOI 10.1001/virtualmentor.2010.12.6.pfor2-1006; Burt Catharine W, 2006, Adv Data, P1; Burt Catharine W, 2004, Vital Health Stat 13, P1; Burt CW, 2006, ANN EMERG MED, V47, P317, DOI 10.1016/j.annemergmed.2005.12.001; Cameron Peter, 2002, Aust Health Rev, V25, P59; Castillo EM, 2011, J EMERG MED, V40, P300, DOI 10.1016/j.jemermed.2010.02.023; Cuong J, 2006, ACAD EMERG MED, V13, P1220, DOI 10.1197/j.aem.2006.05.024; Derlet RW, 2000, ANN EMERG MED, V35, P63, DOI 10.1016/S0196-0644(00)70105-3; Greene W.H., 2012, ECONOMETRIC ANAL, V7th; Health Economics Research Center, I EST TRAV COSTS; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Institute of Medicine, 2007, HOSP BAS EM CAR BREA; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Magid DJ, 2004, ANN EMERG MED, V44, P586, DOI 10.1016/j.annemergmed.2004.07.449; Mailer's Software, 2006, MAIL SOFTW ZIP DAT; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, ANN EMERG MED, V45, P471, DOI 10.1016/j.annemergmed.2004.10.032; Millard WB, 2011, ANN EMERG MED, V57, p15A, DOI 10.1016/j.annemergmed.2011.03.015; National Association of State EMS Officials, IMPL STAT AMB NO DIV; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2007, ANN EMERG MED, V50, P510, DOI 10.1016/j.annemergmed.2007.07.021; Pines JM, 2010, ACAD EMERG MED, V17, P834, DOI 10.1111/j.1553-2712.2010.00780.x; Robert Wood Johnson Foundation, EM DEP UT CAP; Schafermeyer Robert W, 2003, Emerg Med (Fremantle), V15, P22, DOI 10.1046/j.1442-2026.2003.00403.x; Schneider S, 2001, ACAD EMERG MED, V8, P1044, DOI 10.1111/j.1553-2712.2001.tb01113.x; Schull MJ, 2004, ANN EMERG MED, V44, P577, DOI 10.1016/j.annemergmed.2004.05.004; Schull MJ, 2003, ACAD EMERG MED, V10, P709, DOI 10.1111/j.1553-2712.2003.tb00064.x; Shenoi RP, 2009, ACAD EMERG MED, V16, P116, DOI 10.1111/j.1553-2712.2008.00317.x; Skinner J, 2009, NBER TECHNICAL WORKI; Stock JH, 2006, NBER TECHNICAL WOR T; Tang N, 2010, JAMA-J AM MED ASSOC, V304, P664, DOI 10.1001/jama.2010.1112; WILSON M, 2004, BURSTING SEAMS IMPRO; Yankovic N, 2010, INQUIRY-J HEALTH CAR, V47, P81, DOI 10.5034/inquiryjrnl_47.01.81	41	63	63	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2440	2447		10.1001/jama.2011.811	http://dx.doi.org/10.1001/jama.2011.811			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777EB	21666277	Green Accepted			2022-12-28	WOS:000291597300024
J	Schwartlander, B; Stover, J; Hallett, T; Atun, R; Avila, C; Gouws, E; Bartos, M; Ghys, PD; Opuni, M; Barr, D; Alsallaq, R; Bollinger, L; de Freitas, M; Garnett, G; Holmes, C; Legins, K; Pillay, Y; Stanciole, AE; McClure, C; Hirnschall, G; Laga, M; Padian, N				Schwartlaender, Bernhard; Stover, John; Hallett, Timothy; Atun, Rifat; Avila, Carlos; Gouws, Eleanor; Bartos, Michael; Ghys, Peter D.; Opuni, Marjorie; Barr, David; Alsallaq, Ramzi; Bollinger, Lori; de Freitas, Marcelo; Garnett, Geoffrey; Holmes, Charles; Legins, Ken; Pillay, Yogan; Stanciole, Anderson Eduardo; McClure, Craig; Hirnschall, Gottfried; Laga, Marie; Padian, Nancy		Investment Framework Study Grp	Towards an improved investment approach for an effective response to HIV/AIDS	LANCET			English	Article							SUB-SAHARAN AFRICA; COMMUNITY-HEALTH WORKERS; ANTIRETROVIRAL THERAPY; HIV PREVENTION; TUBERCULOSIS-CONTROL; MALE CIRCUMCISION; SOUTH-AFRICA; TRANSMISSION; INTERVENTIONS; CHALLENGES	Substantial changes are needed to achieve a more targeted and strategic approach to investment in the response to the HIV/AIDS epidemic that will yield long-term dividends. Until now, advocacy for resources has been done on the basis of a commodity approach that encouraged scaling up of numerous strategies in parallel, irrespective of their relative effects. We propose a strategic investment framework that is intended to support better management of national and international HIV/AIDS responses than exists with the present system. Our framework incorporates major efficiency gains through community mobilisation, synergies between programme elements, and benefits of the extension of antiretroviral therapy for prevention of HIV transmission. It proposes three categories of investment, consisting of six basic programmatic activities, interventions that create an enabling environment to achieve maximum effectiveness, and programmatic efforts in other health and development sectors related to HIV/AIDS. The yearly cost of achievement of universal access to HIV prevention, treatment, care, and support by 2015 is estimated at no less than US$22 billion. Implementation of the new investment framework would avert 12.2 million new HIV infections and 7.4 million deaths from AIDS between 2011 and 2020 compared with continuation of present approaches, and result in 29.4 million life-years gained. The framework is cost effective at $1060 per life-year gained, and the additional investment proposed would be largely offset from savings in treatment costs alone.	[Schwartlaender, Bernhard] Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, Geneva, Switzerland; [Stover, John; Bollinger, Lori] Futures Inst, Glastonbury, CT USA; [Hallett, Timothy; Garnett, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Business Sch, London, England; [Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Barr, David] Int Treatment Preparedness Coalit, New York, NY USA; [Alsallaq, Ramzi] Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [de Freitas, Marcelo] Natl AIDS Programme, Brasilia, DF, Brazil; [Holmes, Charles; Padian, Nancy] Off US Global AIDS Coordinator, US Presidents Emergency Plan AIDS Relief, Washington, DC USA; [Padian, Nancy] Bill & Melinda Gates Fdn, Seattle, WA USA; [Legins, Ken] UNICEF, New York, NY USA; [Pillay, Yogan] Strateg Hlth Programmes, Dept Hlth, Johannesburg, South Africa; [Stanciole, Anderson Eduardo] World Bank, Global HIVAIDS Unit, Washington, DC 20433 USA; [McClure, Craig; Hirnschall, Gottfried] WHO, CH-1211 Geneva, Switzerland; [Laga, Marie] Inst Trop Med, B-2000 Antwerp, Belgium	UNAIDS; Imperial College London; Imperial College London; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; UNICEF; The World Bank; World Health Organization; Institute of Tropical Medicine (ITM)	Schwartlander, B (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Evidence Strategy & Results Dept, 20 Ave Apia, Geneva, Switzerland.	schwartlanderb@unaids.org	Garnett, Geoffrey P/A-9312-2008; Atun, Rifat/AAH-5537-2021	Opuni, Marjorie/0000-0002-0939-7695; Atun, Rifat/0000-0002-1531-5983; Hallett, Timothy/0000-0002-9681-0424	Pangea Global AIDS Foundation; Wellcome Trust; GlaxoSmithKline; Merck; Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation; MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719, G0600719B] Funding Source: researchfish	Pangea Global AIDS Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Sanofi Pasteur MSD for HPV vaccination works; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DB received consultation fees payment from Pangea Global AIDS Foundation and unrelated honoraria from UNAIDS, International Civil Society Support Project and Merck Foundation. GG received grant from the Wellcome Trust and was paid consultancy fees by GlaxoSmithKline, Merck and Sanofi Pasteur MSD for HPV vaccination works. TH received grant from Wellcome Trust for Fellowship and received grants and consultation fees from the Bill & Melinda Gates Foundation. NP received consultation fees from the Bill & Melinda Gates Foundation. The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the US Department of State.	*AIDS 2031 COSTS F, COSTS CHOIC FIN LONG; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2010, NEW HIV INF MOD TRAN; Atun RA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2165; Atun R, 2010, INT J DRUG POLICY, V21, P103, DOI 10.1016/j.drugpo.2010.01.002; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; Brinkhof MWG, 2007, CLIN INFECT DIS, V45, P1518, DOI 10.1086/522986; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; DiClemente RJ, 2007, J PEDIATR PSYCHOL, V32, P888, DOI 10.1093/jpepsy/jsm056; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Frumence G, 2010, SAHARA J-J SOC ASP H, V7, P9, DOI 10.1080/17290376.2010.9724964; Ghys PD, 2010, SEX TRANSM INFECT, V86, pI1, DOI [10.1136/sti.2010.047852, 10.1136/sti.2010.044933]; *GLOB FUND FIGHT A, 3 REPL 2011 13 FIN H; *GLOB FUND FIGHT A, 2008, 18 BOARD M NOV; *GLOB FUND FIGHT A, 2010, 22 BOARD M DEC; *GLOB FUND FIGHT A, GLOB FUND 2010 INN I; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; GROWN C, FINANCIAL REQUIREMEN; Hallett T B, 2006, Sex Transm Infect, V82 Suppl 1, pi1; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; Hayes R, 2010, AIDS, V24, pS81, DOI 10.1097/01.aids.0000390710.04255.2b; Hermann K, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-31; HESTER V, ASSESSING C IN PRESS; Hirnschall G, 2011, LANCET, V378, P209, DOI 10.1016/S0140-6736(11)60247-X; JOUQUET G, 2009, 5 INT AIDS SOC C CAP; Kenya National Aids Control Council, 2009, KEN HIV PREV RESP MO; Kunihira NR, 2010, AFR HEALTH SCI, V10, P120; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; LOEVINSOHN M, 2003, 157 FCND INT FOOD PO; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Low-Beer D., 2010, GLOB HLTH GOV, V4, P1; Macneil J, 2011, DRUG ALCOHOL REV, V30, P26, DOI 10.1111/j.1465-3362.2010.00188.x; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marseille E, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-108; Menzies NA, 2011, AIDS, V25, P1753, DOI 10.1097/QAD.0b013e3283463eec; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Middelkoop K, 2011, JAIDS-J ACQ IMM DEF, V56, P263, DOI 10.1097/QAI.0b013e31820413b3; Mofenson LM, 2010, CLIN INFECT DIS, V50, pS130, DOI 10.1086/651484; Narayanan S, 2011, INT J DRUG POLICY, V22, P311, DOI 10.1016/j.drugpo.2011.01.002; *NAT I ALL INF DIS, QUEST ANSW HPTN 052; Nyamathi AM, 2011, HEALTH CARE WOMEN IN, V32, P300, DOI 10.1080/07399332.2010.536282; Oosterhoff P, 2008, REPROD HEALTH MATTER, V16, P162, DOI 10.1016/S0968-8080(08)32408-2; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; PADIAN NS, LANCET IN PRESS; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; *PEPFAR, 2011, PEPFAR MAK SMART INV; Philips M, 2008, LANCET, V371, P682, DOI 10.1016/S0140-6736(08)60307-4; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Reynolds SJ, 2011, AIDS, V25, P473, DOI 10.1097/QAD.0b013e3283437c2b; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Rhodes T., 2010, EMCDDA MONOGRAPHS HA; ROSEN S, 2011, PEPFAR SUPPORTED EVA; SABAPATHY K, 2011, J ACQ IMMUN DEF SYND, DOI DOI 10.1097/QA1.0B013E318218A713; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Scalway T., 2010, PRESENTING EVIDENCE; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schwartlander B, 2001, SCIENCE, V292, P2434, DOI 10.1126/science.1062876; Shin S, 2011, HEALTH SOC CARE COMM, V19, P261, DOI 10.1111/j.1365-2524.2010.00968.x; Sidibe M., 2010, GLOBAL HLTH GOVERNAN, V4, P1; STOVER J, 2010, FINANCIAL RESOURCES; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; TEMIN M, HIV SENSITIVE SOCIAL; *UN, REP SECR GEN UN UN A; *UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS, 2011, UNAIDS 2011 2015 STR; *UNAIDS, 2009, P THINK TANK EV METH; *UNAIDS, TREATM 2 0; *UNAIDS, 2011, AIDS 2011 PROGR OWN; UNAIDS, 2009, WHAT COUNTR NEED INV; *UNAIDS, FIN RESP AIDS LOW MI; UNICEF UNAIDS WHO UNFPA UNESCO, 2010, CHILDR AIDS 5 STOCKT; United Nations June, 2001, DECL COMM HIV AIDS U; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; *WHO, 2010, COUNTR HLTH INF; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams BG, 2010, P NATL ACAD SCI USA, V107, P19485, DOI 10.1073/pnas.1005660107; World Health Organisation (WHO), 2009, WHO UNODC UNAIDS TEC; World Health Organization, 2003, WHO GUID COST EFF AN	87	355	358	1	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 11	2011	377	9782					2031	2041		10.1016/S0140-6736(11)60702-2	http://dx.doi.org/10.1016/S0140-6736(11)60702-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	782LR	21641026				2022-12-28	WOS:000292011700038
J	Iovino, N; Cavalli, G				Iovino, Nicola; Cavalli, Giacomo			Rolling ES Cells Down the Waddington Landscape with Oct4 and Sox2	CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL NETWORK; SELF-RENEWAL; DIFFERENTIATION	Embryonic stem cell (ESC) pluripotency is maintained by core transcriptional circuits whereby critical factors sustain their own expression while preventing the expression of genes required for differentiation. Thomson et al. (2011) now show that two core components of the pluripotency circuit, Oct4 and Sox2, are also critical for germ layer fate choice.	[Iovino, Nicola; Cavalli, Giacomo] CNRS, Inst Genet Humaine, F-34396 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Cavalli, G (corresponding author), CNRS, Inst Genet Humaine, 141 Rue Cardonille, F-34396 Montpellier, France.	giacomo.cavalli@igh.cnrs.fr	Cavalli, Giacomo/A-7958-2008; cavalli, giacomo/Z-2754-2019	Cavalli, Giacomo/0000-0003-3709-3469; cavalli, giacomo/0000-0003-3709-3469				Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Jackson SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010706; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185	10	18	20	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					815	817		10.1016/j.cell.2011.05.027	http://dx.doi.org/10.1016/j.cell.2011.05.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663785	Green Submitted, Bronze			2022-12-28	WOS:000291461600007
J	Luo, DG; Yue, WWS; Ala-Laurila, P; Yau, KW				Luo, Dong-Gen; Yue, Wendy W. S.; Ala-Laurila, Petri; Yau, King-Wai			Activation of Visual Pigments by Light and Heat	SCIENCE			English	Article							DARK NOISE; SPECTRAL PROPERTIES; THERMAL-ACTIVATION; ROD PHOTORECEPTORS; RETINAL CONES; TOAD RETINA; PHOTOTRANSDUCTION; PHOTOACTIVATION; CHROMOPHORE; RHODOPSIN	Vision begins with photoisomerization of visual pigments. Thermal energy can complement photon energy to drive photoisomerization, but it also triggers spontaneous pigment activation as noise that interferes with light detection. For half a century, the mechanism underlying this dark noise has remained controversial. We report here a quantitative relation between a pigment's photoactivation energy and its peak-absorption wavelength, lambda(max). Using this relation and assuming that pigment activations by light and heat go through the same ground-state isomerization energy barrier, we can predict the relative noise of diverse pigments with multi-vibrational-mode thermal statistics. The agreement between predictions and our measurements strongly suggests that pigment noise arises from canonical isomerization. The predicted high noise for pigments with lambda(max) in the infrared presumably explains why they apparently do not exist in nature.	[Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yau, King-Wai] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Luo, Dong-Gen; Yue, Wendy W. S.; Yau, King-Wai] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Yue, Wendy W. S.] Johns Hopkins Univ, Sch Med, Biochem Cellular & Mol Biol Grad Program, Baltimore, MD 21205 USA; [Ala-Laurila, Petri] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Ala-Laurila, Petri] Univ Helsinki, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Helsinki	Luo, DG (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dgluo@jhmi.edu; kwyau@mail.jhmi.edu	Ala-Laurila, Petri/AAE-1203-2019; Luo, Donggen/D-5990-2011	Ala-Laurila, Petri/0000-0002-6139-6825; 	U.S. NIH [EY06837]; Antonio Champalimaud Vision Award; Academy of Finland [123231]; NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award; Academy of Finland(Academy of Finland); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a U.S. NIH grant (EY06837) and the Antonio Champalimaud Vision Award (Portugal) to K.-W.Y and a grant (123231) from the Academy of Finland to P. A.-L. We thank R. S. Molday and J.-X. Ma for the antibodies against rhodopsin and blue cone pigment, respectively; J. Chen for the transgenic mouse line expressing mouse S-cone opsin in the rods; X. Lin for mathematical help; M. T. H. Do for critique; T. Xue and Y. P. Wang for computational help; and V. S. Batista, R. R. Birge, P. J. Dagdigian, T. Ebrey, B. Honig, M. Karplus, J. E. Kim, B. E. Knox, C. L. Makino, R. A. Mathies, J. Nathans, T. P. Sakmar, J. L. Schnapf, K. Schulten, T. G. Wensel, T. B. Woolf, and E. C. Y. Yan for discussions. D.-G. L. and K.-W.Y. designed the experiments, did the data analysis, developed the theory, and wrote the paper; D.-G. L. performed all of the electrophysiological experiments; W. W. S. Y did the retinal immunolabeling and participated in the measurement of thermal activity of Bufo red rods as well as writing; and P. A.-L. contributed to the theory and participated in discussion.	Ala-Laurila P, 2004, VISION RES, V44, P2153, DOI 10.1016/j.visres.2004.03.031; Ala-Laurila P, 2004, BIOPHYS J, V86, P3653, DOI 10.1529/biophysj.103.035626; Ala-Laurila P, 2003, VISUAL NEUROSCI, V20, P411, DOI 10.1017/S0952523803204065; Ala-Laurila P, 2002, VISUAL NEUROSCI, V19, P781, DOI 10.1017/S0952523802196088; Ala-Laurila P, 2007, J PHYSIOL-LONDON, V585, P57, DOI 10.1113/jphysiol.2007.142935; Atkins P., 2018, PHYS CHEM; BARLOW HB, 1957, NATURE, V179, P255, DOI 10.1038/179255b0; BARLOW RB, 1993, NATURE, V366, P64, DOI 10.1038/366064a0; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BIRGE RR, 1990, BIOCHIM BIOPHYS ACTA, V1016, P293, DOI 10.1016/0005-2728(90)90163-X; COOPER A, 1979, NATURE, V282, P531, DOI 10.1038/282531a0; CRESCITELLI F, 1984, VISION RES, V24, P1551, DOI 10.1016/S0042-6989(84)80004-8; DONNER K, 1990, J PHYSIOL-LONDON, V428, P673, DOI 10.1113/jphysiol.1990.sp018234; Dukkipati A, 2002, BIOCHEMISTRY-US, V41, P9842, DOI 10.1021/bi025883g; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Goodeve C. F., 1936, P ROY SOC LOND A MAT, V155, P664; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hinshelwood C. N., 1940, KINETICS CHEM CHANGE, p[39, 79]; Holbrook K. A., 1996, UNIMOLECULAR REACTIO, P1; Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992; Kefalov VJ, 2005, NEURON, V46, P879, DOI 10.1016/j.neuron.2005.05.009; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Luo DG, 2005, J GEN PHYSIOL, V126, P263, DOI 10.1085/jgp.200509342; Luo DG, 2008, P NATL ACAD SCI USA, V105, P9855, DOI 10.1073/pnas.0708405105; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MANSFIELD RJW, 1985, VISUAL SYSTEM, P89; Mathies R A, 1999, Novartis Found Symp, V224, P70; Mathies RA, 1999, NOVART FDN SYMP, V224, P84; MATSUMOTO H, 1975, BIOCHIM BIOPHYS ACTA, V404, P300, DOI 10.1016/0304-4165(75)90337-2; MATTHEWS G, 1984, J PHYSIOL-LONDON, V349, P607, DOI 10.1113/jphysiol.1984.sp015176; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Sakurai K, 2007, J GEN PHYSIOL, V130, P21, DOI 10.1085/jgp.200609729; Sampath AP, 2002, BIOPHYS J, V83, P184, DOI 10.1016/S0006-3495(02)75160-6; Shi G, 2007, J NEUROSCI, V27, P10084, DOI 10.1523/JNEUROSCI.2211-07.2007; STGEORGE RCC, 1952, J GEN PHYSIOL, V35, P495, DOI 10.1085/jgp.35.3.495; Stiles W. S., 1948, T OPTICAL CONVENTION, P97	41	91	94	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	2011	332	6035					1307	1312		10.1126/science.1200172	http://dx.doi.org/10.1126/science.1200172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659602	Green Accepted			2022-12-28	WOS:000291441700042
J	Dolgin, E				Dolgin, Elie			The murine candidate	NATURE			English	Editorial Material							HEPATITIS-C; INFECTION; MODEL; MICE											Amako Y, 2010, J VIROL, V84, P303, DOI 10.1128/JVI.01448-09; Bissig KD, 2010, J CLIN INVEST, V120, P924, DOI 10.1172/JCI40094; Brenndorfer ED, 2010, HEPATOLOGY, V52, P1553, DOI 10.1002/hep.23870; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Ohara E, 2011, J HEPATOL, V54, P872, DOI 10.1016/j.jhep.2010.08.033; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001	7	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					S14	S15		10.1038/474S14a	http://dx.doi.org/10.1038/474S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774PE	21666729				2022-12-28	WOS:000291397800009
J	Ralph, DC				Ralph, D. C.			The electromotive force of MnAs nanoparticles	NATURE			English	Letter									[Ralph, D. C.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Ralph, D. C.] Cornell Univ, Kavli Inst Cornell, Ithaca, NY 14853 USA	Cornell University; Cornell University	Ralph, DC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	ralph@ccmr.cornell.edu						Hai PN, 2009, NATURE, V458, P489, DOI 10.1038/nature07879	1	10	10	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 9	2011	474	7350					E6	E6		10.1038/nature10142	http://dx.doi.org/10.1038/nature10142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774PE	21654757	Bronze			2022-12-28	WOS:000291397800001
J	Jin, HJ; Weissmuller, J				Jin, Hai-Jun; Weissmueller, Joerg			A Material with Electrically Tunable Strength and Flow Stress	SCIENCE			English	Article							CRYSTAL PLASTICITY; SURFACE STRESS; DEFORMATION; METALS; STRAIN; ADSORPTION; BEHAVIOR; GOLD; AU	The selection of a structural material requires a compromise between strength and ductility. The material properties will then be set by the choice of alloy composition and microstructure during synthesis and processing, although the requirements may change during service life. Materials design strategies that allow for a recoverable tuning of the mechanical properties would thus be desirable, either in response to external control signals or in the form of a spontaneous adaptation, for instance in self-healing. We have designed a material that has a hybrid nanostructure consisting of a strong metal backbone that is interpenetrated by an electrolyte as the second component. By polarizing the internal interface via an applied electric potential, we accomplish fast and repeatable tuning of yield strength, flow stress, and ductility. The concept allows the user to select, for instance, a soft and ductile state for processing and a high-strength state for service as a structural material.	[Jin, Hai-Jun] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Jin, Hai-Jun] Karlsruhe Inst Technol, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Weissmueller, Joerg] Tech Univ Hamburg, Inst Werkstoffphys & Technol, D-21073 Hamburg, Germany; [Weissmueller, Joerg] Helmholtz Zentrum Geesthacht, Inst Werkstoffphys, D-21502 Geesthacht, Germany	Chinese Academy of Sciences; Institute of Metal Research, CAS; Helmholtz Association; Karlsruhe Institute of Technology; Hamburg University of Technology; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Jin, HJ (corresponding author), Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.	hjjin@imr.ac.cn	Weissmüller, Jörg/C-3967-2009; Jin, Hai-Jun/E-5179-2010	Weissmüller, Jörg/0000-0002-8958-4414; Jin, Hai-Jun/0000-0002-9445-2651	Deutsche Forschungsgemeinschaft [We1424/14]; Chinese Academy of Sciences	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Chinese Academy of Sciences(Chinese Academy of Sciences)	Supported by Deutsche Forschungsgemeinschaft grant We1424/14 and by the Hundred Talents Program of the Chinese Academy of Sciences (H.-J.J.). We thank L. Kurmanaeva and Y. Ivanisenko for assistance with the compression experiments, K. Sieradzki and H. Gleiter for stimulating discussions, and K. Lu for critical reading of the manuscript.	Biener J, 2006, NANO LETT, V6, P2379, DOI 10.1021/nl061978i; CONWAY BE, 1995, PROG SURF SCI, V49, P331, DOI 10.1016/0079-6816(95)00040-6; Corcoran SG, 1998, MATER RES SOC SYMP P, V505, P77; Diao JK, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075413; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Gibson J.L., 1997, CELLULAR SOLIDS STRU, DOI [10.1017/cbo9781139878326, DOI 10.1017/CBO9781139878326]; GILMAN JJ, 1961, PHILOS MAG, V6, P159, DOI 10.1080/14786436108238360; Gsell M, 1998, SCIENCE, V280, P717, DOI 10.1126/science.280.5364.717; Ibach H, 1997, SURF SCI, V375, P107, DOI 10.1016/S0039-6028(96)01252-6; Jin HJ, 2010, ADV ENG MATER, V12, P714, DOI 10.1002/adem.200900329; Jin HJ, 2009, ACTA MATER, V57, P2665, DOI 10.1016/j.actamat.2009.02.017; Jin HJ, 2008, SURF SCI, V602, P3588, DOI 10.1016/j.susc.2008.09.038; Kibler LA, 2005, ANGEW CHEM INT EDIT, V44, P2080, DOI 10.1002/anie.200462127; KOLB DM, 1986, ELECTROCHIM ACTA, V31, P929, DOI 10.1016/0013-4686(86)80005-6; Kramer D, 2007, SURF SCI, V601, P3042, DOI 10.1016/j.susc.2007.05.005; Mathur A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2436718; Motz C, 2009, ACTA MATER, V57, P1744, DOI 10.1016/j.actamat.2008.12.020; NABARRO FRN, 1967, THEORY CRYSTAL DISLO, P294; PFUTZENREUTER A, 1951, Z METALLKD, V42, P361; REHBINDER P, 1947, NATURE, V159, P866, DOI 10.1038/159866a0; Shan ZW, 2008, NAT MATER, V7, P115, DOI 10.1038/nmat2085; SIERADZKI K, 1985, PHILOS MAG A, V51, P95, DOI 10.1080/01418618508245272; Smetanin M, 2009, PHYS CHEM CHEM PHYS, V11, P9008, DOI 10.1039/b913448d; Uchic MD, 2004, SCIENCE, V305, P986, DOI 10.1126/science.1098993; VANDERWEKKEN CJ, 1982, J ELECTROCHEM SOC, V129, P706, DOI 10.1149/1.2123955; Volkert CA, 2006, PHILOS MAG, V86, P5567, DOI 10.1080/14786430600567739; Weinberger CR, 2011, SCRIPTA MATER, V64, P529, DOI 10.1016/j.scriptamat.2010.11.037; Weissmuller J, 2011, PHYS CHEM CHEM PHYS, V13, P2114, DOI 10.1039/c0cp01742f; Weissmuller J, 2009, MRS BULL, V34, P577, DOI 10.1557/mrs2009.157; Weissmuller J, 2003, SCIENCE, V300, P312, DOI 10.1126/science.1081024; WESTWOOD AR, 1962, PHILOS MAG, V7, P633, DOI 10.1080/14786436208212629; WESTWOOD ARC, 1976, MATER SCI ENG, V25, P225, DOI 10.1016/0025-5416(76)90074-4	32	147	153	5	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1179	1182		10.1126/science.1202190	http://dx.doi.org/10.1126/science.1202190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636769				2022-12-28	WOS:000291205200043
J	Qian, L; Winfree, E				Qian, Lulu; Winfree, Erik			Scaling Up Digital Circuit Computation with DNA Strand Displacement Cascades	SCIENCE			English	Article							AMPLIFICATION; EXPRESSION; LANGUAGE; MACHINE	To construct sophisticated biochemical circuits from scratch, one needs to understand how simple the building blocks can be and how robustly such circuits can scale up. Using a simple DNA reaction mechanism based on a reversible strand displacement process, we experimentally demonstrated several digital logic circuits, culminating in a four-bit square-root circuit that comprises 130 DNA strands. These multilayer circuits include thresholding and catalysis within every logical operation to perform digital signal restoration, which enables fast and reliable function in large circuits with roughly constant switching time and linear signal propagation delays. The design naturally incorporates other crucial elements for large-scale circuitry, such as general debugging tools, parallel circuit preparation, and an abstraction hierarchy supported by an automated circuit compiler.	[Qian, Lulu; Winfree, Erik] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Winfree, E (corresponding author), CALTECH, Pasadena, CA 91125 USA.	winfree@caltech.edu	Winfree, Erik/L-4002-2013	Winfree, Erik/0000-0002-5899-7523	NSF [0728703, 0832824]; Human Frontier Science Program [RGY0074/2006-C]	NSF(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program)	We thank D. Y. Zhang for providing useful comments on the manuscript. Supported by NSF grants 0728703 and 0832824 (Molecular Programming Project) and Human Frontier Science Program award RGY0074/2006-C.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BAUM EB, 1995, SCIENCE, V268, P583, DOI 10.1126/science.7725109; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Bois J. S., 2007, THESIS CALTECH; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiniforooshan E, 2011, LECT NOTES COMPUT SC, V6518, P25, DOI 10.1007/978-3-642-18305-8_3; Choi HMT, 2010, NAT BIOTECHNOL, V28, P1208, DOI 10.1038/nbt.1692; Dirks RM, 2004, P NATL ACAD SCI USA, V101, P15275, DOI 10.1073/pnas.0407024101; Dittmer WU, 2004, ANGEW CHEM INT EDIT, V43, P3550, DOI 10.1002/anie.200353537; Eckhoff G., 2010, J SYST CHEM, V1, P13, DOI DOI 10.1186/1759-2208-1-13; Elbaz J, 2010, NAT NANOTECHNOL, V5, P417, DOI [10.1038/NNANO.2010.88, 10.1038/nnano.2010.88]; Goel A, 2009, LECT NOTES COMPUT SC, V5877, P67, DOI 10.1007/978-3-642-10604-0_7; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Muller D. E., 1963, SWITCHING THEORY SPA, P289; Phillips A, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0072.focus; Qian L, 2011, J R SOC INTERFACE, V8, P1281, DOI 10.1098/rsif.2010.0729; Qian L, 2011, LECT NOTES COMPUT SC, V6518, P123, DOI 10.1007/978-3-642-18305-8_12; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Soloveichik D, 2010, P NATL ACAD SCI USA, V107, P5393, DOI 10.1073/pnas.0909380107; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; Turberfield AJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.118102; Venkataraman S, 2010, P NATL ACAD SCI USA, V107, P16777, DOI 10.1073/pnas.1006377107; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Yurke B., 2003, Genetic Programming and Evolvable Machines, V4, P111, DOI 10.1023/A:1023928811651; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532; Zhang DY, 2009, J AM CHEM SOC, V131, P17303, DOI 10.1021/ja906987s	32	923	980	43	580	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	2011	332	6034					1196	1201		10.1126/science.1200520	http://dx.doi.org/10.1126/science.1200520			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636773				2022-12-28	WOS:000291205200048
J	Finn, A; Savulescu, J				Finn, Adam; Savulescu, Julian			Is immunisation child protection?	LANCET			English	Editorial Material							VACCINE; RIGHTS		[Savulescu, Julian] Univ Oxford, Fac Philosophy, Oxford OX1 1PT, England; [Finn, Adam] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Oxford; University of Bristol	Savulescu, J (corresponding author), Univ Oxford, Fac Philosophy, Oxford OX1 1PT, England.	julian.savulescu@philosophy.ox.ac.uk		Finn, Adam/0000-0003-1756-5668				Bridson JM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3884; Diekema DS, 2005, PEDIATRICS, V115, P1428, DOI 10.1542/peds.2005-0316; Finn A, 1998, ARCH DIS CHILD, V78, P571, DOI 10.1136/adc.78.6.571; Frader JE, 1997, PEDIATRICS, V99, P279; Hope T., 2008, MED ETHICS LAW, V2nd; Isaacs D, 2004, J PAEDIATR CHILD H, V40, P392, DOI 10.1111/j.1440-1754.2004.00399.x; Isaacs D, 2009, J PAEDIATR CHILD H, V45, P627, DOI 10.1111/j.1440-1754.2009.01620.x; Lopalco PL, 2010, EUROSURVEILLANCE, V15; Poland GA, 2009, VACCINE, V27, P3240, DOI 10.1016/j.vaccine.2009.01.069; Woolley S, 2005, ARCH DIS CHILD, V90, P715, DOI 10.1136/adc.2004.067843	10	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 6	2011	378	9790					465	468		10.1016/S0140-6736(11)60695-8	http://dx.doi.org/10.1016/S0140-6736(11)60695-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	809SO	21664677				2022-12-28	WOS:000294077200008
J	Davis, B				Davis, Brent			Mathematics Teachers' Subtle, Complex Disciplinary Knowledge	SCIENCE			English	Editorial Material							MATH		[Davis, Brent] Univ Calgary, Fac Educ, Calgary, AB T2N 1N4, Canada	University of Calgary	Davis, B (corresponding author), Univ Calgary, Fac Educ, Calgary, AB T2N 1N4, Canada.	brent.davis@ucalgary.ca						Ball D. L., 2005, AM EDUC, V29, P14; Ball D. L., 2002, P 2002 ANN M CAN MAT, P3; Baumert J, 2010, AM EDUC RES J, V47, P133, DOI 10.3102/0002831209345157; Davis B., 2010, P 34 C INT GROUP PSY, V1, P63; Davis B., 2008, MATH TEACH MIDDLE SC, V14, P86, DOI [10.5951/MTMS.14.2.0086, DOI 10.5951/MTMS.14.2.0086]; English L. D., 2008, INT HDB RES MATH ED; ENGLISH LD, 1997, MATH REASONING ANALO; Hiebert J., 2003, 2003013 NCES US DEP; Kaminski JA, 2008, SCIENCE, V320, P454, DOI 10.1126/science.1154659; Lakoff G., 1966, PHILOS FLESH EMBODIE; Ma L., 1999, KNOWING TEACHING ELE, DOI [10.4324/9781410602589, DOI 10.4324/9780203856345]; MAZUR B, 2003, IMAGINING NUMBERS PA; National Council of Teachers of Mathematics [NCTM], 2000, PRINC STAND SCH MATH; Polanyi Michael, 1999, TACIT DIMENSION; Richland LE, 2006, J EXP CHILD PSYCHOL, V94, P249, DOI 10.1016/j.jecp.2006.02.002; Schmidt WH, 2011, SCIENCE, V332, P1266, DOI 10.1126/science.1193855; Schubert W. H., 1985, CURRICULUM PERSPECTI; Sfard A, 2008, LEARN DOING, P1, DOI 10.1017/CBO9780511499944; SWETZ FJ, 1994, 5 FINGERS INFINITY J; Zook KB, 1991, EDUC PSYCHOL REV, V3, P41, DOI 10.1007/BF01323662	21	10	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 24	2011	332	6037					1506	1507		10.1126/science.1193541	http://dx.doi.org/10.1126/science.1193541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	782EE	21700857				2022-12-28	WOS:000291990000026
J	Gilbert, N				Gilbert, Natasha			The seeds of an economy	NATURE			English	Editorial Material									Nature, London, England		Gilbert, N (corresponding author), Nature, London, England.								0	14	15	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 23	2011	474	7352					S18	S19		10.1038/474S018a	http://dx.doi.org/10.1038/474S018a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	781NJ	21697837	Bronze			2022-12-28	WOS:000291939700007
J	Cuervo, AM				Cuervo, Ana Maria			Autophagy's Top Chef	SCIENCE			English	Editorial Material							DISEASES		[Cuervo, Ana Maria] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Studies, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	ana-maria.cuervo@einstein.yu.edu		Cuervo, Ana Maria/0000-0002-0771-700X				Lamark T, 2009, CELL CYCLE, V8, P1986, DOI 10.4161/cc.8.13.8892; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	15	32	33	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1392	1393		10.1126/science.1208607	http://dx.doi.org/10.1126/science.1208607			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680833				2022-12-28	WOS:000291689000029
J	Lizak, C; Gerber, S; Numao, S; Aebi, M; Locher, KP				Lizak, Christian; Gerber, Sabina; Numao, Shin; Aebi, Markus; Locher, Kaspar P.			X-ray structure of a bacterial oligosaccharyltransferase	NATURE			English	Article							N-LINKED GLYCOSYLATION; HYDROXY AMINO-ACID; PROTEIN GLYCOSYLATION; COMPLEX; TRANSFERASE; GLYCOPROTEIN; PEPTIDE; SPECIFICITY; BIOLOGY; SYSTEM	Asparagine-linked glycosylation is a post-translational modification of proteins containing the conserved sequence motif Asn-X-Ser/Thr. The attachment of oligosaccharides is implicated in diverse processes such as protein folding and quality control, organism development or host-pathogen interactions. The reaction is catalysed by oligosaccharyltransferase (OST), a membrane protein complex located in the endoplasmic reticulum. The central, catalytic enzyme of OST is the STT3 subunit, which has homologues in bacteria and archaea. Here we report the X-ray structure of a bacterial OST, the PglB protein of Campylobacter lari, in complex with an acceptor peptide. The structure defines the fold of STT3 proteins and provides insight into glycosylation sequon recognition and amide nitrogen activation, both of which are prerequisites for the formation of the N-glycosidic linkage. We also identified and validated catalytically important, acidic amino acid residues. Our results provide the molecular basis for understanding the mechanism of N-linked glycosylation.	[Lizak, Christian; Gerber, Sabina; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Lizak, Christian; Numao, Shin; Aebi, Markus] ETH, Dept Biol, Inst Microbiol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch		Numao, Shin/0000-0002-6204-7117	NCCR Structural Biology Zurich; Swiss National Science Foundation [SNF 31003A-127098/1, SNF 31003A-131075/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank the beamline staff at the Swiss Light Source for assistance with data collection, S. Fleurkens and M. Bucher for technical assistance, and D. Arigoni for discussions. E. coli SCM6 was provided by C. Marolda and M. Valvano. C. L. was affiliated with the Life Science Zurich Graduate School. This research was supported by the NCCR Structural Biology Zurich (grant to K. P. L.) and Swiss National Science Foundation grants to M. A. (SNF 31003A-127098/1) and K. P. L. (SNF 31003A-131075/1).	Abu-Qarn M, 2006, MOL MICROBIOL, V61, P511, DOI 10.1111/j.1365-2958.2006.05252.x; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BAUSE E, 1984, BIOCHEM SOC T, V12, P514, DOI 10.1042/bst0120514; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y; Chen MM, 2007, BIOCHEMISTRY-US, V46, P5579, DOI 10.1021/bi602633n; Chen WJ, 2000, TERR ATMOS OCEAN SCI, V11, P765, DOI 10.3319/TAO.2000.11.4.765(A); CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7942, DOI 10.1021/ja00046a068; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Kowarik M, 2006, EMBO J, V25, P1957, DOI 10.1038/sj.emboj.7601087; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Li H, 2008, STRUCTURE, V16, P432, DOI 10.1016/j.str.2007.12.013; Li L, 2010, BIOCHEM BIOPH RES CO, V394, P1069, DOI 10.1016/j.bbrc.2010.03.126; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250; Maita N, 2010, J BIOL CHEM, V285, P4941, DOI 10.1074/jbc.M109.081752; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MESCHER MF, 1976, J BIOL CHEM, V251, P2005; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz F, 2011, GLYCOBIOLOGY, V21, P45, DOI 10.1093/glycob/cwq130; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; Unligil UM, 2000, CURR OPIN STRUC BIOL, V10, P510, DOI 10.1016/S0959-440X(00)00124-X; Valliere-Douglass JF, 2009, J BIOL CHEM, V284, P32493, DOI 10.1074/jbc.M109.014803; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; WIBERG KB, 1992, J AM CHEM SOC, V114, P831, DOI 10.1021/ja00029a005; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012; ZUFFEREY R, 1995, EMBO J, V14, P4949, DOI 10.1002/j.1460-2075.1995.tb00178.x	53	266	276	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					350	U377		10.1038/nature10151	http://dx.doi.org/10.1038/nature10151			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677752				2022-12-28	WOS:000291647100039
J	Chang, HJ				Chang, Huan J.			Superficial Corneal Growth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tina.chang@jama-archives.org						Enzinger FM, 2007, SOFT TISSUE TUMORS, P1039; Graue-Hernandez EO, 2010, CORNEA, V29, P283, DOI 10.1097/ICO.0b013e3181b7658d; Hansen LH, 2004, ACTA OPHTHALMOL SCAN, V82, P224, DOI 10.1111/j.1600-0420.2004.00249.x; Jhanji V, BR J OPHTHALMOL; Peralta RJ., 2010, ARCH OPHTHALMOL-CHIC, V128, P933, DOI [10.1001/archophthalmol.2010.129, DOI 10.1001/ARCHOPHTHALMOL.2010.129]; PerezGrossmann RA, 1997, CORNEA, V16, P498; Soong T, 2008, CORNEA, V27, P1186, DOI 10.1097/ICO.0b013e31817a5d0b; Wollensak G, 2002, JPN J OPHTHALMOL, V46, P193, DOI 10.1016/S0021-5155(01)00493-2	8	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2011	305	23					2467	2468		10.1001/jama.2011.783	http://dx.doi.org/10.1001/jama.2011.783			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777EB	21673302				2022-12-28	WOS:000291597300031
J	Ana, J				Ana, Joseph			Are traditional birth attendants good for improving maternal and perinatal health? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jneana@yahoo.co.uk						Ana J, 2009, BMJ W AFRICA; [Anonymous], TASKSHIFTING IMPROVE; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Gorman A, 2011, REPORT VISIT SIERRA; Ngozo C, 2011, GLOBAL ISSUES    MAR; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; World Health Organisation, WHO SKILL BIRTH ATT	9	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 14	2011	342								d3310	10.1136/bmj.d3310	http://dx.doi.org/10.1136/bmj.d3310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	781KY	21673001				2022-12-28	WOS:000291932100006
J	Clasquin, MF; Melamud, E; Singer, A; Gooding, JR; Xu, XH; Dong, AP; Cui, H; Campagna, SR; Savchenko, A; Yakunin, AF; Rabinowitz, JD; Caudy, AA				Clasquin, Michelle F.; Melamud, Eugene; Singer, Alexander; Gooding, Jessica R.; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Campagna, Shawn R.; Savchenko, Alexei; Yakunin, Alexander F.; Rabinowitz, Joshua D.; Caudy, Amy A.			Riboneogenesis in Yeast	CELL			English	Article							PENTOSE-PHOSPHATE PATHWAY; SACCHAROMYCES-CEREVISIAE STRAINS; RED BLOOD CELL; HUMAN-ERYTHROCYTES; SEDOHEPTULOSE DIPHOSPHATE; METABOLOMIC ANALYSIS; OCTULOSE PHOSPHATES; F-TYPE; C-13; MUTANTS	Glucose is catabolized in yeast via two fundamental routes, glycolysis and the oxidative pentose phosphate pathway, which produces NADPH and the essential nucleotide component ribose-5-phosphate. Here, we describe riboneogenesis, a thermodynamically driven pathway that converts glycolytic intermediates into ribose-5-phosphate without production of NADPH. Riboneogenesis begins with synthesis, by the combined action of transketolase and aldolase, of the seven-carbon bisphosphorylated sugar sedoheptulose-1,7-bisphosphate. In the pathway's committed step, sedoheptulose bisphosphate is hydrolyzed to sedoheptulose-7-phosphate by the enzyme sedoheptulose-1,7-bisphosphatase (SHB17), whose activity we identified based on metabolomic analysis of the corresponding knockout strain. The crystal structure of Shb17 in complex with sedoheptulose-1,7-bisphosphate reveals that the substrate binds in the closed furan form in the active site. Sedoheptulose-7-phosphate is ultimately converted by known enzymes of the nonoxidative pentose phosphate pathway to ribose-5-phosphate. Flux through SHB17 increases when ribose demand is high relative to demand for NADPH, including during ribosome biogenesis in metabolically synchronized yeast cells.	[Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.; Caudy, Amy A.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Clasquin, Michelle F.; Melamud, Eugene; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Singer, Alexander; Xu, Xiaohui; Dong, Aiping; Cui, Hong; Savchenko, Alexei; Yakunin, Alexander F.] Univ Toronto, Dept Chem Engn & Appl Chem, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Gooding, Jessica R.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	Princeton University; Princeton University; University of Toronto; University of Tennessee System; University of Tennessee Knoxville	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu; amy.caudy@utoronto.ca	Rabinowitz, Joshua/GPP-4019-2022; Yakunin, Alexander/J-1519-2014	Rabinowitz, Joshua/0000-0002-1247-4727; Caudy, Amy/0000-0001-6307-8137; Campagna, Shawn/0000-0001-6809-3862; Yakunin, Alexander/0000-0003-0813-6490	NSF [MCB-0643859]; NIH [GM071508, AI078063]; Merck and Company; Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association [0635188N]; DOE; government of Canada through Genome Canada; Ontario Genomics Institute [2009-OGI-ABC-1405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Company(Merck & Company); Lewis-Sigler Fellows program; Beckman Foundation; American Heart Association(American Heart Association); DOE(United States Department of Energy (DOE)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NSF Career Award MCB-0643859 to J.D.R. and NIH Grant GM071508 for the Center of Quantitative Biology at Princeton University. M.F.C. gratefully acknowledges financial support from Merck and Company through a Doctoral Research Fellowship and A.A.C. support through the Lewis-Sigler Fellows program. Additional support came from the Beckman Foundation, American Heart Association Grant 0635188N, NSF Career Award MCB-0643859, NIH Grant AI078063, the DOE Biohydrogen program (to J.D.R.), and the government of Canada through Genome Canada and the Ontario Genomics Institute (2009-OGI-ABC-1405) (to A.F.Y.). We thank Kate Kuznetsova for providing purified proteins, Wenyun Lu and Saw Kyin for assistance with mass spectrometry, and Dannie Durand and David Botstein for helpful discussions.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Amberg DC., 2005, METHODS YEAST GENETI; BARTLETT GR, 1968, BIOCHIM BIOPHYS ACTA, V156, P240, DOI 10.1016/0304-4165(68)90253-5; BARTLETT GR, 1960, BIOCHEM BIOPH RES CO, V3, P474, DOI 10.1016/0006-291X(60)90158-3; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; BERTHON HA, 1993, BIOCHEM J, V296, P379, DOI 10.1042/bj2960379; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Brown G, 2009, J BIOL CHEM, V284, P3784, DOI 10.1074/jbc.M808186200; BUCOLO G, 1960, BIOCHEM BIOPH RES CO, V3, P620, DOI 10.1016/0006-291X(60)90073-5; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hegeman AD, 2007, ANAL CHEM, V79, P6912, DOI 10.1021/ac070346t; HORECKER BL, 1982, ANN NY ACAD SCI, V378, P215, DOI 10.1111/j.1749-6632.1982.tb31198.x; Jeppsson M, 2002, APPL ENVIRON MICROB, V68, P1604, DOI 10.1128/AEM.68.4.1604-1609.2002; Kleijn RJ, 2005, FEBS J, V272, P4970, DOI 10.1111/j.1742-4658.2005.04907.x; KOERNER TAW, 1973, BIOCHEM BIOPH RES CO, V51, P543, DOI 10.1016/0006-291X(73)91348-X; KUCHEL PW, 1990, BIOMED BIOCHIM ACTA, V49, pS105; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Kuznetsova E, 2010, J BIOL CHEM, V285, P21049, DOI 10.1074/jbc.M110.118315; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MCINTYRE LM, 1989, EUR J BIOCHEM, V180, P399, DOI 10.1111/j.1432-1033.1989.tb14662.x; Meijer A E, 1984, Acta Histochem Suppl, V29, P141; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; PAOLETTI F, 1979, ARCH BIOCHEM BIOPHYS, V198, P620, DOI 10.1016/0003-9861(79)90539-3; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; Rutthard H, 2001, J BIOL CHEM, V276, P18728, DOI 10.1074/jbc.M102122200; Saghatelian A, 2005, LIFE SCI, V77, P1759, DOI 10.1016/j.lfs.2005.05.019; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saito N, 2006, J PROTEOME RES, V5, P1979, DOI 10.1021/pr0600576; SCHAAFFGERSTENS.GE, 1993, EUR J BIOCHEM, V217, P487; SGD Project, 2010, SACCH GEN DAT; SMYRNIOTIS PZ, 1956, J BIOL CHEM, V218, P745; Szyperski T, 1996, TRENDS BIOTECHNOL, V14, P453, DOI 10.1016/S0167-7799(96)10056-1; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; VALENTIN ML, 1993, TETRAHEDRON LETT, V34, P8103, DOI 10.1016/S0040-4039(00)61463-6; Walther T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.100; Wang LQ, 2006, METAB ENG, V8, P142, DOI 10.1016/j.ymben.2005.11.002; WEBB M, 1964, ENZYMES; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang BL, 2000, J BIOL CHEM, V275, P25299, DOI 10.1074/jbc.M001027200; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	51	81	82	2	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					969	980		10.1016/j.cell.2011.05.022	http://dx.doi.org/10.1016/j.cell.2011.05.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663798	Bronze, Green Accepted			2022-12-28	WOS:000291461600022
J	Bonadona, V; Bonaiti, B; Olschwang, S; Grandjouan, S; Huiart, L; Longy, M; Guimbaud, R; Buecher, B; Bignon, YJ; Caron, O; Colas, C; Nogues, C; Lejeune-Dumoulin, S; Olivier-Faivre, L; Polycarpe-Osaer, F; Nguyen, TD; Desseigne, F; Saurin, JC; Berthet, P; Leroux, D; Duffour, J; Manouvrier, S; Frebourg, T; Sobol, H; Lasset, C; Bonaiti-Pellie, C				Bonadona, Valerie; Bonaiti, Bernard; Olschwang, Sylviane; Grandjouan, Sophie; Huiart, Laetitia; Longy, Michel; Guimbaud, Rosine; Buecher, Bruno; Bignon, Yves-Jean; Caron, Olivier; Colas, Chrystelle; Nogues, Catherine; Lejeune-Dumoulin, Sophie; Olivier-Faivre, Laurence; Polycarpe-Osaer, Florence; Nguyen, Tan Dat; Desseigne, Francoise; Saurin, Jean-Christophe; Berthet, Pascaline; Leroux, Dominique; Duffour, Jacqueline; Manouvrier, Sylvie; Frebourg, Thierry; Sobol, Hagay; Lasset, Christine; Bonaiti-Pellie, Catherine		French Canc Genetics Network	Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; CUMULATIVE LIFETIME INCIDENCE; AGE-OF-ONSET; ESTIMATING PENETRANCE; ENDOMETRIAL CANCER; PROVEN MUTATIONS; 121 FAMILIES; GRL METHOD; CARRIERS; HNPCC	Context Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome. Objective To estimate the age-specific cumulative risks of developing various tumors using a large series of families with mutations of the MLH1, MSH2, and MSH6 genes. Design, Setting, and Participants Families with Lynch syndrome enrolled between January 1, 2006, and December 31, 2009, from 40 French cancer genetics clinics participating in the ERISCAM (Estimation des Risques de Cancer chez les porteurs de mutation des genes MMR) study; 537 families with segregating mutated genes (248 with MLH1; 256 with MSH2; and 33 with MSH6) were analyzed. Main Outcome Measure Age-specific cumulative cancer risks estimated using the genotype restricted likelihood (GRL) method accounting for ascertainment bias. Results Significant differences in estimated cumulative cancer risk were found between the 3 mutated genes (P=.01). The estimated cumulative risks of colorectal cancer by age 70 years were 41% (95% confidence intervals [CI], 25%-70%) for MLH1 mutation carriers, 48% (95% CI, 30%-77%) for MSH2, and 12% (95% CI, 8%-22%) for MSH6. For endometrial cancer, corresponding risks were 54% (95% CI, 20%-80%), 21% (95% CI, 8%-77%), and 16% (95% CI, 8%-32%). For ovarian cancer, they were 20% (95% CI, 1%-65%), 24% (95% CI, 3%-52%), and 1% (95% CI, 0%-3%). The estimated cumulative risks by age 40 years did not exceed 2% (95% CI, 0%-7%) for endometrial cancer nor 1% (95% CI, 0%-3%) for ovarian cancer, irrespective of the gene. The estimated lifetime risks for other tumor types did not exceed 3% with any of the gene mutations. Conclusions MSH6 mutations are associated with markedly lower cancer risks than MLH1 or MSH2 mutations. Lifetime ovarian and endometrial cancer risks associated with MLH1 or MSH2 mutations were high but do not increase appreciably until after the age of 40 years. JAMA. 2011;305(22):2304-2310 www.jama.com	[Lasset, Christine] Ctr Leon Berard, Prevent & Genet Epidemiol Unit, F-69373 Lyon 08, France; [Bonadona, Valerie; Lasset, Christine] Univ Lyon 1, CNRS, UMR 5558, F-69622 Villeurbanne, France; [Bonaiti, Bernard; Bonaiti-Pellie, Catherine] INSERM, U669, Villejuif, France; [Bonaiti, Bernard] INRA, GABI, Jouy En Josas, France; [Olschwang, Sylviane; Huiart, Laetitia; Sobol, Hagay] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Olschwang, Sylviane; Sobol, Hagay] INSERM, U891, F-13258 Marseille, France; [Grandjouan, Sophie] APHP, Paris, France; [Huiart, Laetitia] INSERM, UMR 912, F-13258 Marseille, France; [Longy, Michel] Inst Bergonie, Bordeaux, France; [Guimbaud, Rosine] Inst Claudius Regaud, Toulouse, France; [Guimbaud, Rosine] Ctr Hosp Univ, Toulouse, France; [Buecher, Bruno] CHU Nantes, F-44035 Nantes 01, France; [Bignon, Yves-Jean] Ctr Jean Perrin, Clermont Ferrand, France; [Caron, Olivier] Inst Gustave Roussy, Villejuif, France; [Colas, Chrystelle] Grp Hosp Pitie Salpetriere, APHP, INSERM, UMRS 938, F-75634 Paris, France; [Colas, Chrystelle] Univ Paris 06, Paris, France; [Nogues, Catherine] Hop Rene Huguenin, Inst Curie, St Cloud, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] CHRU, Lille, France; [Lejeune-Dumoulin, Sophie; Manouvrier, Sylvie] Univ Lille 2, Lille, France; [Olivier-Faivre, Laurence] Hop Enfants, Dijon, France; [Polycarpe-Osaer, Florence] Ctr Paul Strauss, Strasbourg, France; [Nguyen, Tan Dat] Inst Jean Godinot, Reims, France; [Saurin, Jean-Christophe] Hop Edouard Herriot, Lyon, France; [Berthet, Pascaline] Ctr Francois Baclesse, F-14021 Caen, France; [Leroux, Dominique] CHU Grenoble, F-38043 Grenoble, France; [Duffour, Jacqueline] Ctr Val Aurelle, Montpellier, France; [Frebourg, Thierry] INSERM, U614, Rouen, France; [Frebourg, Thierry] CHU, Rouen, France; [Sobol, Hagay] Univ Mediterranee, Marseille, France; [Bonaiti-Pellie, Catherine] Univ Paris Sud, Villejuif, France	UNICANCER; Centre Leon Berard; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut National de la Sante et de la Recherche Medicale (Inserm); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UNICANCER; Institut Bergonie; UNICANCER; Institut Claudius Regaud; CHU de Toulouse; Nantes Universite; CHU de Nantes; UNICANCER; Centre Jean Perrin; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Rene Huguenin Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille; CHU Dijon Bourgogne; UNICANCER; Centre Paul Strauss; UNICANCER; Institut Jean Godinot; CHU Lyon; UNICANCER; Centre Francois Baclesse; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Saclay	Lasset, C (corresponding author), Ctr Leon Berard, Prevent & Genet Epidemiol Unit, 28 Rue Laennec, F-69373 Lyon 08, France.	lasset@lyon.fnclcc.fr	, bignon/Y-3243-2019; Huiart, Laetitia/GQB-4064-2022; Olschwang, Sylviane/G-2716-2013; Laurent-Puig, Pierre/K-3641-2019; saurin, jean christophe/AAB-4077-2020; Frebourg, Thierry/AAK-8390-2020; Colas, Chrystelle/ABA-3212-2020; laurent-puig, pierre/B-2226-2013; GUIMBAUD, Rosine/M-7503-2014; Leroux, Dominique/G-7309-2014	Olschwang, Sylviane/0000-0001-7078-3029; Laurent-Puig, Pierre/0000-0001-8475-5459; laurent-puig, pierre/0000-0001-8475-5459; Faivre, Laurence/0000-0001-9770-444X; Frebourg, Thierry/0000-0003-0399-4007; BAERT-DESURMONT, Stephanie/0000-0002-1172-4157; Bonneau, Dominique/0000-0002-6886-0969	Fondation de France	Fondation de France(Fondation de France)	This work was supported by the Fondation de France.	Aarnio M, 1999, INT J CANCER, V81, P214, DOI 10.1002/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.3.CO;2-C; Alarcon F, 2007, EUR J HUM GENET, V15, P831, DOI 10.1038/sj.ejhg.5201843; Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Barrow E, 2008, CLIN GENET, V74, P233, DOI 10.1111/j.1399-0004.2008.01035.x; Barrow E, 2009, CLIN GENET, V75, P141, DOI 10.1111/j.1399-0004.2008.01125.x; Belot A, 2008, REV EPIDEMIOL SANTE, V56, P159, DOI 10.1016/j.respe.2008.03.117; Bonaiti B, 2011, EUR J HUM GENET, V19, P173, DOI 10.1038/ejhg.2010.158; Capelle LG, 2010, GASTROENTEROLOGY, V138, P487, DOI 10.1053/j.gastro.2009.10.051; Carayol J, 2004, GENET EPIDEMIOL, V27, P109, DOI 10.1002/gepi.20007; Carayol J, 2002, J MED GENET, V39, P335, DOI 10.1136/jmg.39.5.335; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Choi YH, 2009, HERED CANCER CLIN PR, V7, DOI 10.1186/1897-4287-7-14; DEVATHAIRE F, 1996, ESTIMATION INCIDENCE; Dunlop MG, 1997, HUM MOL GENET, V6, P105, DOI 10.1093/hmg/6.1.105; Green J, 2002, DIS COLON RECTUM, V45, P1223, DOI 10.1007/s10350-004-6397-4; Hampel H, 2005, GASTROENTEROLOGY, V129, P415, DOI 10.1053/j.gastro.2005.05.011; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jenkins MA, 2006, CLIN GASTROENTEROL H, V4, P489, DOI 10.1016/j.cgh.2006.01.002; Kastrinos F, 2009, JAMA-J AM MED ASSOC, V302, P1790, DOI 10.1001/jama.2009.1529; Kauff ND, 2007, J CLIN ONCOL, V25, P2921, DOI 10.1200/JCO.2007.11.3449; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Offit K, 2006, NEW ENGL J MED, V354, P293, DOI 10.1056/NEJMe058284; Olschwang S, 2004, B CANCER, V91, P303; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Quehenberger F, 2005, J MED GENET, V42, P491, DOI 10.1136/jmg.2004.024299; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Schmeler KM, 2006, NEW ENGL J MED, V354, P261, DOI 10.1056/NEJMoa052627; Stoffel E, 2009, GASTROENTEROLOGY, V137, P1621, DOI 10.1053/j.gastro.2009.07.039; Terdiman JP, 2001, GASTROENTEROLOGY, V120, P21, DOI 10.1053/gast.2001.20874; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 2010, FAM CANCER, V9, P109, DOI 10.1007/s10689-009-9291-3; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Vasen HFA, 2001, J CLIN ONCOL, V19, P4074, DOI 10.1200/JCO.2001.19.20.4074; Watson P, 2008, INT J CANCER, V123, P444, DOI 10.1002/ijc.23508	36	655	686	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	2011	305	22					2304	2310		10.1001/jama.2011.743	http://dx.doi.org/10.1001/jama.2011.743			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	773YV	21642682				2022-12-28	WOS:000291349100023
J	Singha, A; Gibertini, M; Karmakar, B; Yuan, S; Polini, M; Vignale, G; Katsnelson, MI; Pinczuk, A; Pfeiffer, LN; West, KW; Pellegrini, V				Singha, A.; Gibertini, M.; Karmakar, B.; Yuan, S.; Polini, M.; Vignale, G.; Katsnelson, M. I.; Pinczuk, A.; Pfeiffer, L. N.; West, K. W.; Pellegrini, V.			Two-Dimensional Mott-Hubbard Electrons in an Artificial Honeycomb Lattice	SCIENCE			English	Article							MEAN-FIELD THEORY; DIRAC FERMIONS; GAS; GRAPHENE; PHYSICS	Artificial crystal lattices can be used to tune repulsive Coulomb interactions between electrons. We trapped electrons, confined as a two-dimensional gas in a gallium arsenide quantum well, in a nanofabricated lattice with honeycomb geometry. We probed the excitation spectrum in a magnetic field, identifying collective modes that emerged from the Coulomb interaction in the artificial lattice, as predicted by the Mott-Hubbard model. These observations allow us to determine the Hubbard gap and suggest the existence of a Coulomb-driven ground state.	[Singha, A.; Gibertini, M.; Karmakar, B.; Polini, M.; Pellegrini, V.] CNR, Ist Nanosci, I-56126 Pisa, Italy; [Singha, A.; Gibertini, M.; Karmakar, B.; Polini, M.; Pellegrini, V.] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Yuan, S.; Katsnelson, M. I.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Polini, M.; Vignale, G.] Chinese Acad Sci, Kavli Inst Theoret Phys China, Beijing 100190, Peoples R China; [Vignale, G.] Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA; [Pinczuk, A.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Pinczuk, A.] Columbia Univ, Dept Phys, New York, NY USA; [Pfeiffer, L. N.; West, K. W.] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Radboud University Nijmegen; Chinese Academy of Sciences; University of Missouri System; University of Missouri Columbia; Columbia University; Columbia University; Princeton University	Pellegrini, V (corresponding author), CNR, Ist Nanosci, I-56126 Pisa, Italy.	m.polini@sns.it; vp@sns.it	karmakar, biswajit/E-1523-2013; Yuan, Shengjun/B-4518-2008; Katsnelson, Mikhail I./D-4359-2012; Gibertini, Marco/A-1866-2017; Polini, Marco/L-3419-2013	Gibertini, Marco/0000-0003-3980-5319; Vignale, Giovanni/0000-0003-3851-5790; Yuan, Shengjun/0000-0001-6208-1502	Chinese Academy of Sciences [KJCX2.YW.W10]; FOM (Foundation for Fundamental Research on Matter), the Netherlands; NSF [DMR-0803691, CHE-0641523, DMR-0705460]; Italian Ministry of research; Gordon and Betty Moore Foundation; NSF Materials Research Science and Engineering Centers through the Princeton Center for Complex Materials [DMR-0819860]	Chinese Academy of Sciences(Chinese Academy of Sciences); FOM (Foundation for Fundamental Research on Matter), the Netherlands(FOM (The Netherlands)Netherlands Government); NSF(National Science Foundation (NSF)); Italian Ministry of research(Ministry of Education, Universities and Research (MIUR)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF Materials Research Science and Engineering Centers through the Princeton Center for Complex Materials	We acknowledge financial support by the Project "Knowledge Innovation Program" (PKIP) of the Chinese Academy of Sciences, grant no. KJCX2.YW.W10 (M.P. and G.V.); FOM (Foundation for Fundamental Research on Matter), the Netherlands (S.Y. and M.I.K.); NSF grants DMR-0803691 (A.P.), CHE-0641523 (A.P.), and DMR-0705460 (G.V.); and the Italian Ministry of research through the FIRB (Fondo per gli Investimenti della Ricerca di Base) and PRIN (Programmi di ricerca de Relevante Interesse Nazionale) programs (V.P.). S.Y. and M.I.K. acknowledge computer time from NCF (the Netherlands). Work at Princeton University was partially funded by the Gordon and Betty Moore Foundation as well as the NSF Materials Research Science and Engineering Centers Program through the Princeton Center for Complex Materials (grant DMR-0819860). We thank R. Fazio, A. MacDonald, and P. Pingue for useful conversations.	Abanin DA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.176803; Abergel DSL, 2010, ADV PHYS, V59, P261, DOI 10.1080/00018732.2010.487978; Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Alicea J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075422; Ashcroft N.W., 1976, SOLID STATE PHYS; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Buluta I, 2009, SCIENCE, V326, P108, DOI 10.1126/science.1177838; Byrnes T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075320; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; De Simoni G, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3493189; Garcia CP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.266806; Gibertini M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241406; Gusynin VP, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195429; HUBBARD J, 1964, PROC R SOC LON SER-A, V281, P401, DOI 10.1098/rspa.1964.0190; Kalliakos S, 2008, NAT PHYS, V4, P467, DOI 10.1038/nphys944; Katsnelson MI, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/38/382201; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; Kotliar G, 2004, PHYS TODAY, V57, P53, DOI 10.1063/1.1712502; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Melinte S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036802; Meng ZY, 2010, NATURE, V464, P847, DOI 10.1038/nature08942; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Park CH, 2009, NANO LETT, V9, P1793, DOI 10.1021/nl803706c; PINCZUK A, 1992, PHYS REV LETT, V68, P3623, DOI 10.1103/PhysRevLett.68.3623; Raghu S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.156401; Vollhardt D, 2010, AIP CONF PROC, V1297, P339, DOI 10.1063/1.3518901; Yuan SJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115448; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806	31	159	159	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1176	1179		10.1126/science.1204333	http://dx.doi.org/10.1126/science.1204333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636768	Green Submitted			2022-12-28	WOS:000291205200042
J	del Rio, L; Aberg, J; Renner, R; Dahlsten, O; Vedral, V				del Rio, Lidia; Aberg, Johan; Renner, Renato; Dahlsten, Oscar; Vedral, Vlatko			The thermodynamic meaning of negative entropy	NATURE			English	Article							QUANTUM INFORMATION; MAXWELLS DEMON; COMPUTATION; PRINCIPLE; PHYSICS; ERASURE	The heat generated by computations is not only an obstacle to circuit miniaturization but also a fundamental aspect of the relationship between information theory and thermodynamics. In principle, reversible operations may be performed at no energy cost; given that irreversible computations can always be decomposed into reversible operations followed by the erasure of data(1,2), the problem of calculating their energy cost is reduced to the study of erasure. Landauer's principle states that the erasure of data stored in a system has an inherent work cost and therefore dissipates heat(3-8). However, this consideration assumes that the information about the system to be erased is classical, and does not extend to the general case where an observer may have quantum information about the system to be erased, for instance by means of a quantum memory entangled with the system. Here we show that the standard formulation and implications of Landauer's principle are no longer valid in the presence of quantum information. Our main result is that the work cost of erasure is determined by the entropy of the system, conditioned on the quantum information an observer has about it. In other words, the more an observer knows about the system, the less it costs to erase it. This result gives a direct thermodynamic significance to conditional entropies, originally introduced in information theory. Furthermore, it provides new bounds on the heat generation of computations: because conditional entropies can become negative in the quantum case, an observer who is strongly correlated with a system may gain work while erasing it, thereby cooling the environment.	[del Rio, Lidia; Aberg, Johan; Renner, Renato; Dahlsten, Oscar] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Dahlsten, Oscar; Vedral, Vlatko] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Dahlsten, Oscar; Vedral, Vlatko] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; [Vedral, Vlatko] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Oxford; National University of Singapore; National University of Singapore	del Rio, L (corresponding author), ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland.	delrio@phys.ethz.ch	vedral, vlatko/P-1712-2014; Vedral, Vlatko/L-3270-2016	Vedral, Vlatko/0000-0002-8588-2940; Dahlsten, Oscar/0000-0003-3921-6071; del Rio, Lidia/0000-0002-2445-2701; vedral, vlatko/0000-0003-4561-5124	Swiss National Science Foundation [200021-119868]; Portuguese Fundacao para a Ciencia e Tecnologia [SFRH/BD/43263/2008]; European Research Council [258932]; Singapore's National Research Foundation and Ministry of Education	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Portuguese Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Singapore's National Research Foundation and Ministry of Education(Ministry of Education, SingaporeNational Research Foundation, Singapore)	We thank R. Colbeck for discussions. We acknowledge support from the Swiss National Science Foundation (L.d.R., J.A., R.R. and O.D.; grant no. 200021-119868 and the NCCR QSIT), the Portuguese Fundacao para a Ciencia e Tecnologia (L.d.R.; grant no. SFRH/BD/43263/2008), the European Research Council (R.R.; grant no. 258932) and Singapore's National Research Foundation and Ministry of Education (V.V.).	Alicki R, 2004, OPEN SYST INF DYN, V11, P205, DOI 10.1023/B:OPSY.0000047566.72717.71; Bennett CH, 2003, STUD HIST PHILOS M P, V34B, P501, DOI 10.1016/S1355-2198(03)00039-X; BENNETT CH, 1982, INT J THEOR PHYS, V21, P905, DOI 10.1007/BF02084158; BENNETT CH, 1973, IBM J RES DEV, V17, P525, DOI 10.1147/rd.176.0525; Berta M, 2010, NAT PHYS, V6, P659, DOI 10.1038/NPHYS1734; Cavalcanti D, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.032324; Dahlsten OCO, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/5/053015; Dupuis F., 2009, THESIS U MONTREAL; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; Horodecki M, 2005, NATURE, V436, P673, DOI 10.1038/nature03909; Horodecki M, 1996, PHYS LETT A, V223, P1, DOI 10.1016/S0375-9601(96)00706-2; Landauer R., 1961, IBM J RES DEV, V5, P148; Leff H., 1990, MAXWELLS DEMON ENTRO; Leff Harvey S., 2002, MAXWELLS DEMON 2 ENT; Maruyama K, 2009, REV MOD PHYS, V81, P1, DOI 10.1103/RevModPhys.81.1; Modi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.080501; Ollivier H, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017901; Oppenheim J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.180402; Piechocinska B, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.062314; Plenio MB, 2001, CONTEMP PHYS, V42, P25, DOI 10.1080/00107510010018916; Renner R, 2005, THESIS ETH ZURICH; Schulman L. J., 1999, Proceedings of the Thirty-First Annual ACM Symposium on Theory of Computing, P322, DOI 10.1145/301250.301332; SHIZUME K, 1995, PHYS REV E, V52, P3495, DOI 10.1103/PhysRevE.52.3495; Tomamichel M, 2010, IEEE T INFORM THEORY, V56, P4674, DOI 10.1109/TIT.2010.2054130; Tomamichel M, 2009, IEEE T INFORM THEORY, V55, P5840, DOI 10.1109/TIT.2009.2032797; Zurek WH, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.012320; Zurek WH, 2000, ANN PHYS-BERLIN, V9, P855, DOI 10.1002/1521-3889(200011)9:11/12<855::AID-ANDP855>3.0.CO;2-K	28	232	232	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	2011	474	7349					61	63		10.1038/nature10123	http://dx.doi.org/10.1038/nature10123			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	771KV	21637254	Green Submitted			2022-12-28	WOS:000291156700036
J	Goss, PE; Ingle, JN; Ales-Martinez, JE; Cheung, AM; Chlebowski, RT; Wactawski-Wende, J; McTiernan, A; Robbins, J; Johnson, KC; Martin, LW; Winquist, E; Sarto, GE; Garber, JE; Fabian, CJ; Pujol, P; Maunsell, E; Farmer, P; Gelmon, KA; Tu, D; Richardson, H				Goss, Paul E.; Ingle, James N.; Ales-Martinez, Jose E.; Cheung, Angela M.; Chlebowski, Rowan T.; Wactawski-Wende, Jean; McTiernan, Anne; Robbins, John; Johnson, Karen C.; Martin, Lisa W.; Winquist, Eric; Sarto, Gloria E.; Garber, Judy E.; Fabian, Carol J.; Pujol, Pascal; Maunsell, Elizabeth; Farmer, Patricia; Gelmon, Karen A.; Tu, Dongsheng; Richardson, Harriet		NCIC CTG MAP 3 Study Investigators	Exemestane for Breast-Cancer Prevention in Postmenopausal Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; BONE-MINERAL DENSITY; NONSTEROIDAL AROMATASE INHIBITORS; RANDOMIZED-TRIAL; PHARMACOLOGICAL INTERVENTIONS; INCLUDING TAMOXIFEN; AMERICAN-SOCIETY; RISK; RALOXIFENE; LETROZOLE	Background Tamoxifen and raloxifene have limited patient acceptance for primary prevention of breast cancer. Aromatase inhibitors prevent more contralateral breast cancers and cause fewer side effects than tamoxifen in patients with early-stage breast cancer. Methods In a randomized, placebo-controlled, double-blind trial of exemestane designed to detect a 65% relative reduction in invasive breast cancer, eligible postmenopausal women 35 years of age or older had at least one of the following risk factors: 60 years of age or older; Gail 5-year risk score greater than 1.66% (chances in 100 of invasive breast cancer developing within 5 years); prior atypical ductal or lobular hyperplasia or lobular carcinoma in situ; or ductal carcinoma in situ with mastectomy. Toxic effects and health-related and menopause-specific qualities of life were measured. Results A total of 4560 women for whom the median age was 62.5 years and the median Gail risk score was 2.3% were randomly assigned to either exemestane or placebo. At a median follow-up of 35 months, 11 invasive breast cancers were detected in those given exemestane and in 32 of those given placebo, with a 65% relative reduction in the annual incidence of invasive breast cancer (0.19% vs. 0.55%; hazard ratio, 0.35; 95% confidence interval [CI], 0.18 to 0.70; P = 0.002). The annual incidence of invasive plus noninvasive (ductal carcinoma in situ) breast cancers was 0.35% on exemestane and 0.77% on placebo (hazard ratio, 0.47; 95% CI, 0.27 to 0.79; P = 0.004). Adverse events occurred in 88% of the exemestane group and 85% of the placebo group (P = 0.003), with no significant differences between the two groups in terms of skeletal fractures, cardiovascular events, other cancers, or treatment-related deaths. Minimal quality-of-life differences were observed. Conclusions Exemestane significantly reduced invasive breast cancers in postmenopausal women who were at moderately increased risk for breast cancer. During a median follow-up period of 3 years, exemestane was associated with no serious toxic effects and only minimal changes in health-related quality of life.	[Goss, Paul E.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Garber, Judy E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ingle, James N.] Mayo Clin, Rochester, MN USA; [Ales-Martinez, Jose E.] Hosp Nuestra Senora Sonsoles, Avila, Spain; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Buffalo, NY 14260 USA; [McTiernan, Anne] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Robbins, John] Univ Calif Davis, Sacramento, CA 95817 USA; [Johnson, Karen C.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Martin, Lisa W.] George Washington Univ, Sch Med, Washington, DC USA; [Sarto, Gloria E.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Fabian, Carol J.] Univ Kansas, Med Ctr, Kansas City, KS USA; [Pujol, Pascal] Univ Arnaud Villeneuve, Ctr Hosp, Montpellier, France; [Cheung, Angela M.] Univ Hlth Network, Toronto, ON, Canada; [Winquist, Eric] London Hlth Sci Ctr, London, ON, Canada; [Maunsell, Elizabeth] Univ Laval, Unit Rech Sante Populat, Quebec City, PQ, Canada; [Farmer, Patricia] Univ Pathol & Mol Med, Kingston, ON, Canada; [Gelmon, Karen A.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Tu, Dongsheng; Richardson, Harriet] NCIC Clin Trials Grp, Kingston, ON, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Fred Hutchinson Cancer Center; University of California System; University of California Davis; University of Tennessee System; University of Tennessee Health Science Center; George Washington University; University of Wisconsin System; University of Wisconsin Madison; University of Kansas; University of Kansas Medical Center; Universite de Montpellier; CHU de Montpellier; University of Toronto; University Toronto Affiliates; University Health Network Toronto; London Health Sciences Centre; Laval University; British Columbia Cancer Agency; Queens University - Canada; Canadian Cancer Trials Group	Goss, PE (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Lawrence House,LRH 302, Boston, MA 02114 USA.	pgoss@partners.org	FRAU, ADOLFO/W-9901-2019; Wactawski-Wende, Jean/AGH-5457-2022; Ales-Martinez, Jose E/D-6927-2016; Blanco, Ignacio/D-2565-2013; Calvo, Lourdes/M-2352-2014; Pharoah, Paul/V-6658-2019; Blanco, Ignacio/AAN-5426-2021; Avisar, Eli/D-3008-2013; Brunet, Joan/C-5292-2018	Wactawski-Wende, Jean/0000-0003-3096-9595; Ales-Martinez, Jose E/0000-0002-4256-0060; Blanco, Ignacio/0000-0002-7414-7481; Pharoah, Paul/0000-0001-8494-732X; Blanco, Ignacio/0000-0002-7414-7481; Adrover, Encarna/0000-0001-8676-8560; Martin, Lisa Warsinger/0000-0003-4352-0914; Cheung, Angela M./0000-0001-8332-0744; Ellard, Susan/0000-0001-5757-9787; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Brunet, Joan/0000-0003-1945-3512	Canadian Cancer Society Research Institute; Canadian Institutes for Health Research; Pfizer; Avon Foundation; Pfizer Pharmaceuticals	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer); Avon Foundation; Pfizer Pharmaceuticals(Pfizer)	Supported by the Canadian Cancer Society Research Institute, the Canadian Institutes for Health Research, Pfizer, and the Avon Foundation.; We thank the 4560 women (2824 from the United States, 1285 from Canada, 432 from Spain, and 19 from France) who agreed to participate in this study; the trial committee; the many investigators, pharmacists, and clinical research associates involved in the trial; Drs. Joe Pater and Lois Shepherd, Dianne Johnston, and Andrea Hiltz for their enthusiastic and unwavering support; the members of the NCIC CTG Data Safety Monitoring Committee; the Central Office staff of the NCIC CTG who contributed to the conduct of the trial; and Pfizer Pharmaceuticals for support and for providing exemestane and placebo.	Ahlgren M, 2004, NEW ENGL J MED, V351, P1619, DOI 10.1056/NEJMoa040576; Armstrong K, 2006, ARCH INTERN MED, V166, P2260, DOI 10.1001/archinte.166.20.2260; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Baum M, 2003, Cancer, V98, P1802; Cancer Therapy Evaluation Program, 2003, COMM TERM CRIT ADV E; Chlebowski RT, 2002, J CLIN ONCOL, V20, P3328, DOI 10.1200/JCO.2002.06.029; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Coleman RE, 2010, BREAST CANCER RES TR, V124, P153, DOI 10.1007/s10549-010-1121-7; Coombes RC, 2006, NEW ENGL J MED, V355, P1746; Coombes RC, 2004, NEW ENGL J MED, V351, P2461; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Cuzick J, 2010, CANCER PREV RES, V3, P689, DOI 10.1158/1940-6207.CAPR-10-0096; DECOSTER R, 1992, CANCER RES, V52, P1240; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Eastell R, 2011, ANN ONCOL, V22, P857, DOI 10.1093/annonc/mdq541; Eastell R, 2008, J CLIN ONCOL, V26, P1051, DOI 10.1200/JCO.2007.11.0726; Eliassen AH, 2008, CANCER EPIDEM BIOMAR, V17, P2029, DOI 10.1158/1055-9965.EPI-08-0262; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2011, STAT MED, V30, P1090, DOI 10.1002/sim.4187; Geisler J, 2006, EUR J CANCER, V42, P2968, DOI 10.1016/j.ejca.2006.07.005; Goss PE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1757; Goss PE, 2004, BONE, V34, P384, DOI 10.1016/j.bone.2003.11.006; Goss PE, 2003, J STEROID BIOCHEM, V86, P487, DOI 10.1016/S0960-0760(03)00378-9; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Hilditch JR, 1996, MATURITAS, V25, P231; Ingle JN, 2006, BREAST CANCER RES TR, V99, P295, DOI 10.1007/s10549-006-9207-y; Johannessen DC, 1997, CLIN CANCER RES, V3, P1101; Lippman SM, 2006, NAT CLIN PRACT ONCOL, V3, P523, DOI 10.1038/ncponc0609; LUBET RA, 1994, CARCINOGENESIS, V15, P2775, DOI 10.1093/carcin/15.12.2775; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Perez EA, 2006, J CLIN ONCOL, V24, P3629, DOI 10.1200/JCO.2005.05.4882; Ropka ME, 2010, J CLIN ONCOL, V28, P3090, DOI 10.1200/JCO.2009.27.8077; SCHIEWECK K, 1993, J STEROID BIOCHEM, V44, P633, DOI 10.1016/0960-0760(93)90270-7; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Thurlimann B, 2006, NEW ENGL J MED, V354, P2200; TU D, 2010, ENCY BIOPHARMACEUTIC, P795; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Waters EA, 2010, CANCER EPIDEM BIOMAR, V19, P443, DOI 10.1158/1055-9965.EPI-09-0930; Whelan TJ, 2005, J CLIN ONCOL, V23, P6931, DOI 10.1200/JCO.2005.11.181; Wyrwich KW, 2003, J GEN INTERN MED, V18, P196, DOI 10.1046/j.1525-1497.2003.20203.x	52	622	640	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	2011	364	25					2381	2391		10.1056/NEJMoa1103507	http://dx.doi.org/10.1056/NEJMoa1103507			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	781MG	21639806	Green Submitted, Green Published			2022-12-28	WOS:000291936100004
J	Hobbs, FDR; Roalfe, AK; Lip, GYH; Fletcher, K; Fitzmaurice, DA; Mant, J				Hobbs, F. D. R.; Roalfe, A. K.; Lip, G. Y. H.; Fletcher, K.; Fitzmaurice, D. A.; Mant, J.			Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTING STROKE; STRATIFICATION SCHEMES; PREVENTION; THROMBOEMBOLISM; COMMUNITY; ASPIRIN; AGE; ANTICOAGULANTS; VALIDATION; THERAPY	Objective To compare the predictive power of the main existing and recently proposed schemes for stratification of risk of stroke in older patients with atrial fibrillation. Design Comparative cohort study of eight risk stratification scores. Setting Trial of thromboprophylaxis in stroke, the Birmingham Atrial Fibrillation in the Aged (BAFTA) trial. Participants 665 patients aged 75 or over with atrial fibrillation based in the community who were randomised to the BAFTA trial and were not taking warfarin throughout or for part of the study period. Main outcome measures Events rates of stroke and thromboembolism. Results 54 (8%) patients had an ischaemic stroke, four (0.6%) had a systemic embolism, and 13 (2%) had a transient ischaemic attack. The distribution of patients classified into the three risk categories (low, moderate, high) was similar across three of the risk stratification scores (revised CHADS(2), NICE, ACC/AHA/ESC), with most patients categorised as high risk (65-69%, n=460-457) and the remaining classified as moderate risk. The original CHADS(2) (Congestive heart failure, Hypertension, Age >= 75 years, Diabetes, previous Stroke) score identified the lowest number as high risk (27%, n=180). The incremental risk scores of CHADS(2), Rietbrock modified CHADS(2), and CHA(2)DS(2)-VASc (CHA(2)DS(2)-Vascular disease, Age 65-74 years, Sex) failed to show an increase in risk at the upper range of scores. The predictive accuracy was similar across the tested schemes with C statistic ranging from 0.55 (original CHADS(2)) to 0.62 (Rietbrock modified CHADS(2)), with all except the original CHADS(2) predicting better than chance. Bootstrapped paired comparisons provided no evidence of significant differences between the discriminatory ability of the schemes. Conclusions Based on this single trial population, current risk stratification schemes in older people with atrial fibrillation have only limited ability to predict the risk of stroke. Given the systematic undertreatment of older people with anticoagulation, and the relative safety of warfarin versus aspirin in those aged over 70, there could be a pragmatic rationale for classifying all patients over 75 as "high risk" until better tools are available.	[Hobbs, F. D. R.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Roalfe, A. K.; Fletcher, K.; Fitzmaurice, D. A.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Lip, G. Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England; [Mant, J.] Univ Cambridge, Dept Gen Practice, Cambridge, England	University of Oxford; University of Birmingham; University of Birmingham; University of Cambridge	Hobbs, FDR (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	richard.hobbs@phc.ox.ac.uk; roalfeak@bham.ac.uk		Mant, Jonathan/0000-0002-9531-0268; hobbs, richard/0000-0001-7976-7172	Medical Research Council [G9900264]; National Institute for Health Research (NIHR); NIHR National School for Primary Care Research; MRC [G9900264] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR National School for Primary Care Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BAFTA was funded by the Medical Research Council, grant G9900264, with additional Service Support funding from the National Institute for Health Research (NIHR). The analyses in this paper were supported by Clinical Trial Unit core funding from the NIHR Health Technology Assessment and by the NIHR National School for Primary Care Research.	Aguilar MI, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001927.PUB2; Brophy MT, 2004, J AM GERIATR SOC, V52, P1151, DOI 10.1111/j.1532-5415.2004.52314.x; Burton C, 2006, BRIT J GEN PRACT, V56, P697; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dubhghaill C T O, 2003, Ir Med J, V96, P296; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Friberg L, 2006, EUR HEART J, V27, P1954, DOI 10.1093/eurheartj/ehl146; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gensch C, 2011, CLIN RES CARDIOL, V100, P1, DOI 10.1007/s00392-010-0270-3; Gudmundsdottir Ingibjoerg J, 2002, Laeknabladid, V88, P299; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; KOUDSTAAL PJ, 1996, COCHRANE DB SYST REV, V1; Laguna P, 2004, ANN EMERG MED, V44, P3, DOI 10.1016/j.annemergmed.2004.01.010; LaPointe NMA, 2007, AM HEART J, V154, P893, DOI 10.1016/j.ahj.2007.06.035; Laupacis A, 1998, CHEST, V114, p579S, DOI 10.1378/chest.114.5_Supplement.579S; Lip GYH, 2007, LANCET NEUROL, V6, P981, DOI 10.1016/S1474-4422(07)70264-8; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lip GYH, 1997, BRIT J GEN PRACT, V47, P285; Mant J, 2004, HLTH CARE NEEDS ASSE, P141; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; *NIH CLIN EXC, 2006, CG36 NICE, P47; *NIH CLIN EXC, 2006, ATR FIBR MAN ATR FIB; Olesen Jonas Bjerring, 2011, BMJ, V342, pd124, DOI 10.1136/bmj.d124; Partington SL, 2007, THROMB RES, V120, P663, DOI 10.1016/j.thromres.2006.12.019; Pradhan A A, 2002, Can J Clin Pharmacol, V9, P199; Reynolds MR, 2006, AM J CARDIOL, V97, P538, DOI 10.1016/j.amjcard.2005.09.086; Rietbrock S, 2008, AM HEART J, V156, P57, DOI 10.1016/j.ahj.2008.03.010; Rutten FH, 2003, FAM PRACT, V20, P16, DOI 10.1093/fampra/20.1.16; Sato H, 2006, STROKE, V37, P447, DOI 10.1161/01.STR.0000198839.61112.ee; Savage M, 2006, IRISH J MED SCI, V175, P46, DOI 10.1007/BF03167949; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Simpson CR, 2005, STROKE, V36, P1771, DOI 10.1161/01.STR.0000173398.99163.9e; van Walraven C, 2003, ARCH INTERN MED, V163, P936, DOI 10.1001/archinte.163.8.936; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; van Walraven C, 2009, STROKE, V40, P1410, DOI 10.1161/STROKEAHA.108.526988; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wheeldon NM, 1998, HEART, V79, P50, DOI 10.1136/hrt.79.1.50; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	43	32	32	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2011	342								d3653	10.1136/bmj.d3653	http://dx.doi.org/10.1136/bmj.d3653			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	785AU	21700651	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000292200600001
J	Cohn, JN				Cohn, Jay N.			Review: Antihypertensive treatment prevents cardiovascular events and mortality in cardiovascular disease without hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Cohn, JN (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.							Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12							JC6-6	10.7326/0003-4819-154-12-201106210-02006	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690584				2022-12-28	WOS:000291800500005
J	Girgis, A; Stacey, F; Lee, T; Black, D; Kilbreath, S				Girgis, Afaf; Stacey, Fiona; Lee, Teresa; Black, Deborah; Kilbreath, Sharon			Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; PSYCHOLOGICAL DISTRESS; EARLY-DIAGNOSIS; ARM LYMPHEDEMA; SURGERY; NEEDS; MORBIDITY; SURVIVORS; PERCEPTIONS; CARE	Objective To explore the perceived unmet needs among women treated for breast cancer and in whom symptoms and signs indicate the presence of lymphoedema. Design Population based cross sectional survey with a purpose designed questionnaire (60 items). Setting Cancer registries of New South Wales, Victoria, and South Australia. Participants 237 women with symptoms and signs indicative of lymphoedema from an initial 1930 eligible women. Main outcome measure Unmet needs in the previous month across psychological, health system and information, physical and daily living, patient care and support, sexuality needs, body image, and financial domains. Results The 10 items most commonly identified as a "moderate to high current need" included having their doctor and allied health workers being fully informed about lymphoedema, acknowledge the seriousness of the condition, and be willing to treat it. Women also wanted access to up to date treatments, both mainstream and alternative, and financial assistance for their garments. The three factors that explained most of the variance were: information and support (11 items), which accounted for 49% of the variance; body image and self esteem (seven items; 7% variance); and health system (seven items; 5% variance). Examination of these three factors showed that while the levels of need were generally low, they were common. Conclusion To address the needs of women with lymphoedema and perhaps to prevent progression of lymphoedema, it is important that practitioners do not dismiss mild symptoms and that women are referred to an appropriate specialist.	[Black, Deborah; Kilbreath, Sharon] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Stacey, Fiona] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Lee, Teresa] Royal N Shore Hosp, Canc Serv, St Leonards, NSW 2065, Australia	University of Sydney; University of Newcastle; Royal North Shore Hospital	Kilbreath, S (corresponding author), Univ Sydney, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	sharon.kilbreath@sydney.edu.au	black, deborah/C-2829-2017; Girgis, Afaf/G-8660-2011; Stacey, Fiona/G-7715-2013	black, deborah/0000-0001-9174-1565; Girgis, Afaf/0000-0003-4101-4006; Kilbreath, Sharon/0000-0002-8024-8641	National Breast Cancer Foundation	National Breast Cancer Foundation	This study was funded by a grant in aid from the National Breast Cancer Foundation; SK is funded by the National Breast Cancer Foundation.	Armer Jane M, 2009, J Lymphoedema, V4, P14; Bonevski B, 2000, CANCER, V88, P217, DOI 10.1002/(SICI)1097-0142(20000101)88:1<217::AID-CNCR29>3.0.CO;2-Y; Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022; Carter B J, 1997, Oncol Nurs Forum, V24, P875; Collins LG, 2004, SUPPORT CARE CANCER, V12, P106, DOI 10.1007/s00520-003-0554-5; Cormier JN, 2009, LYMPHOLOGY, V42, P161; Cornish BH, 1996, BREAST CANCER RES TR, V38, P169, DOI 10.1007/BF01806671; Cornish BH, 2000, ANN NY ACAD SCI, V904, P571; DUNN SM, 1993, J CLIN ONCOL, V11, P2279, DOI 10.1200/JCO.1993.11.11.2279; Gergich NLS, 2008, CANCER-AM CANCER SOC, V112, P2809, DOI 10.1002/cncr.23494; Girgis A, 2000, AUST NZ J PUBL HEAL, V24, P166, DOI 10.1111/j.1467-842X.2000.tb00137.x; Goldberg JI, 2010, ANN SURG ONCOL, V17, P3278, DOI 10.1245/s10434-010-1155-4; Greenslade M Victoria, 2006, Can Oncol Nurs J, V16, P165; Hayes S, 2008, LYMPHOLOGY, V41, P18; Hayes SC, 2008, J CLIN ONCOL, V26, P3536, DOI 10.1200/JCO.2007.14.4899; Johansson K, 2003, SCAND J CARING SCI, V17, P35, DOI 10.1046/j.1471-6712.2003.00119.x; Kilbreath SL, 2010, BREAST CANCER RES TR, V120, P649, DOI 10.1007/s10549-010-0793-3; Lacomba MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5396; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Lee TS, 2010, ONCOL NURS FORUM, V37, P85, DOI 10.1188/10.ONF.85-91; Lee TS, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-75; Lee TS, 2009, ONCOL NURS FORUM, V36, P454, DOI 10.1188/09.ONF.454-462; MAUNSELL E, 1993, CAN J SURG, V36, P315; McNeely ML, 2011, CANCER-AM CANCER SOC, V117, P1136, DOI 10.1002/cncr.25513; Meeske KA, 2009, BREAST CANCER RES TR, V113, P383, DOI 10.1007/s10549-008-9940-5; Newman ML, 1996, J PAIN SYMPTOM MANAG, V12, P376, DOI 10.1016/S0885-3924(96)00187-X; Norman SA, 2009, J CLIN ONCOL, V27, P390, DOI 10.1200/JCO.2008.17.9291; Oliveri Jill M, 2008, J Cancer Surviv, V2, P233, DOI 10.1007/s11764-008-0065-y; Passik SD, 1998, CANCER, V83, P2817, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2817::AID-CNCR32>3.0.CO;2-2; Sanson-Fisher R, 2000, CANCER, V88, P226, DOI 10.1002/(SICI)1097-0142(20000101)88:1<226::AID-CNCR30>3.0.CO;2-P; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Stanton A W B, 2003, Lymphat Res Biol, V1, P121, DOI 10.1089/153968503321642615; TOBIN MB, 1993, CANCER-AM CANCER SOC, V72, P3248, DOI 10.1002/1097-0142(19931201)72:11<3248::AID-CNCR2820721119>3.0.CO;2-Z; Towers A, 2008, J PALLIAT CARE, V24, P134, DOI 10.1177/082585970802400302; Woods M, 1995, CANCER NURS, V18, P467	36	26	26	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2011	342								d3442	10.1136/bmj.d3442	http://dx.doi.org/10.1136/bmj.d3442			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	785AO	21693532	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000292200000002
J	Seibert, D; Hong, CH; Takeuchi, F; Olsen, C; Hathaway, O; Moss, J; Darling, TN				Seibert, Diane; Hong, Chien-Hui; Takeuchi, Fumiko; Olsen, Cara; Hathaway, Olonda; Moss, Joel; Darling, Thomas N.			Recognition of Tuberous Sclerosis in Adult Women: Delayed Presentation With Life-Threatening Consequences	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY LYMPHANGIOLEIOMYOMATOSIS; CLINICAL CHARACTERISTICS; RENAL ANGIOMYOLIPOMA; CONSENSUS CONFERENCE; FORME-FRUSTE; COMPLEX; PREVALENCE; DIAGNOSIS; MUTATION; ASSOCIATION	Background: Tuberous sclerosis complex (TSC) is associated with tumor development in the brain, retina, kidney, skin, heart, and lung. Seizures, intellectual disability, and characteristic skin lesions commonly manifest in early childhood, but some findings, notably renal angiomyolipomas and pulmonary lymphangioleiomyomatosis (LAM), emerge later, placing adults with undiagnosed TSC at increased risk for morbidity and mortality. Objective: To describe the clinical presentation and severity of TSC in adult women. Design: Retrospective cohort study. Setting: National Institutes of Health Clinical Center, Bethesda, Maryland, 1995 to 2010. Patients: 79 women aged 18 years or older who were enrolled in an observational cohort study of TSC to evaluate disease manifestations. Measurements: History, physical examination, pulmonary function testing, chest radiography, abdominal computed tomography, high-resolution chest computed tomography, and brain magnetic resonance imaging were used to evaluate patients. Results: Among the 45 patients who received a diagnosis of TSC in adulthood, 21 presented with symptoms due to LAM, 19 with renal angiomyolipomas, and 10 with seizures. Of the 45 patients, 30 met clinical criteria for TSC in childhood that remained undiagnosed for a median of 21.5 years and 15 were older than 18 years before meeting the clinical criteria for TSC. Patients diagnosed in adulthood and those diagnosed in childhood had similar occurrences of pneumothorax, shortness of breath, hemoptysis, nephrectomy, and death. Limitation: No men were included in the study, and selection was biased toward patients having pulmonary LAM. Conclusion: Women who received a TSC diagnosis in adulthood had minimal morbidity during childhood but were still at risk for life-threatening pulmonary and renal manifestations.	[Darling, Thomas N.] Uniformed Serv Univ Hlth Sci, Dept Dermatol, Bethesda, MD 20814 USA; NHLBI, Bethesda, MD 20892 USA; Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Kaohsiung Veterans General Hospital	Darling, TN (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Dermatol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	mossj@nhlbi.nih.gov; tdarling@usuhs.mil	Seibert, Diane/S-9611-2019	Darling, Thomas/0000-0002-5161-1974	National Institutes of Health, National Heart, Lung, and Blood Institute; National Cancer Institute [R01 CA100907]; Congressionally Directed Medical Research Programs [TS080064]; NATIONAL CANCER INSTITUTE [R01CA100907] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: From the Intramural Research Program, National Institutes of Health, National Heart, Lung, and Blood Institute, and grants from the National Cancer Institute (R01 CA100907; Dr. Darling) and the Congressionally Directed Medical Research Programs (TS080064; Dr. Darling).	Aldrich SL, 2010, J AM ACAD DERMATOL, V63, P244, DOI 10.1016/j.jaad.2009.08.042; An KS, 2004, J CHILD NEUROL, V19, P699, DOI 10.1177/08830738040190091101; Avila NA, 2010, RADIOLOGY, V254, P851, DOI 10.1148/radiol.09090227; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Camposano SE, 2009, ANN HUM GENET, V73, P141, DOI 10.1111/j.1469-1809.2008.00496.x; Chu-Shore CJ, 2010, EPILEPSIA, V51, P1236, DOI 10.1111/j.1528-1167.2009.02474.x; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2002, AM J HUM GENET, V71, P750, DOI 10.1086/342718; Devlin LA, 2006, DEV MED CHILD NEUROL, V48, P495, DOI 10.1017/S0012162206001058; Ewalt DH, 2005, J UROLOGY, V174, P1764, DOI 10.1097/01.ju.0000177497.31986.64; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Gomez MR, 1988, TUBEROUS SCLEROSIS; Hancock E, 2002, RESP MED, V96, P7, DOI 10.1053/rmed.2001.1206; HUNT A, 1984, J MED GENET, V21, P272, DOI 10.1136/jmg.21.4.272; Jansen AC, 2006, ANN NEUROL, V60, P528, DOI 10.1002/ana.21037; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; KERR LA, 1993, UROLOGY, V41, P440, DOI 10.1016/0090-4295(93)90504-4; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Lendvay TS, 2003, J UROLOGY, V169, P1635, DOI 10.1097/01.ju.0000058253.40352.60; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Moss J, 2001, AM J RESP CRIT CARE, V164, P669, DOI 10.1164/ajrccm.164.4.2101154; Moss J, 2001, JAMA-J AM MED ASSOC, V286, P1879, DOI 10.1001/jama.286.15.1879; Muzykewicz DA, 2009, J MED GENET, V46, P465, DOI 10.1136/jmg.2008.065342; Neumann H P, 1998, Semin Pediatr Neurol, V5, P269, DOI 10.1016/S1071-9091(98)80005-3; O'Callaghan FJ, 2004, BJU INT, V94, P853, DOI 10.1111/j.1464-410X.2004.05046.x; O'Callaghan FJ, 2000, ARCH DIS CHILD, V83, P140, DOI 10.1136/adc.83.2.140; O'Callaghan FJK, 1998, LANCET, V351, P1490, DOI 10.1016/S0140-6736(05)78872-3; Pulsifer MB, 2007, EPILEPSY BEHAV, V10, P402, DOI 10.1016/j.yebeh.2007.02.004; Qin W, 2010, HUM GENET, V127, P573, DOI 10.1007/s00439-010-0801-z; Quist SR, 2010, J AM ACAD DERMATOL, V62, P159, DOI 10.1016/j.jaad.2009.01.021; Roach ES, 1999, J CHILD NEUROL, V14, P401, DOI 10.1177/088307389901400610; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; SAMPSON JR, 1989, J MED GENET, V26, P28, DOI 10.1136/jmg.26.1.28; Seyam RM, 2008, UROLOGY, V72, P1077, DOI 10.1016/j.urology.2008.07.049; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SHEPHERD CW, 1991, ARCH NEUROL-CHICAGO, V48, P400, DOI 10.1001/archneur.1991.00530160068015; SIEGEL JM, 1974, ARCH DERMATOL, V110, P476; Sparling MJD, 2007, J AM ACAD DERMATOL, V56, P786, DOI 10.1016/j.jaad.2006.11.019; Staley BA, 2011, PEDIATRICS, V127, pE117, DOI 10.1542/peds.2010-0192; Taveira-DaSilva AM, 2011, ANN INTERN MED, V154, P797, DOI 10.7326/0003-4819-154-12-201106210-00007; Vail EA, 2009, CLIN GENET, V75, P282, DOI 10.1111/j.1399-0004.2008.01129.x; Webb DW, 1996, DEV MED CHILD NEUROL, V38, P146	43	43	45	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					806	813		10.7326/0003-4819-154-12-201106210-00008	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21690595	Green Accepted			2022-12-28	WOS:000291800500016
J	Clark, S				Clark, Stephanie			Health initiatives by Indigenous people in Australia	LANCET			English	Editorial Material									[Clark, Stephanie] The Lancet, London NW1 7BY, England		Clark, S (corresponding author), The Lancet, London NW1 7BY, England.							Arabena K, 2011, MED J AUSTRALIA, V194, P532, DOI 10.5694/j.1326-5377.2011.tb03091.x; Australian Bureau of Statistics, 2011, HLTH WELF AUSTR AB T; Australian Bureau of Statistics and Australian Institute of Health and Welfare, 2008, HLTH WELF AUSTR AB T; Australian Indigenous HealthInfoNet, OV AUSTR IND HLTH ST; Australian Medical Association, 2010, 2010 11 AMA IND HLTH; ELLIOT E, 2011, J PAEDIAT CHILD H S2, V47, P11; OSCAR J, 2011, J PAEDIAT CHILD H S2, V47, P12	7	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2066	2067		10.1016/S0140-6736(11)60884-2	http://dx.doi.org/10.1016/S0140-6736(11)60884-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21684368	Green Submitted			2022-12-28	WOS:000292117800009
J	Mohnen, D; Tierney, ML				Mohnen, Debra; Tierney, Mary L.			Plants Get Hyp to O-Glycosylation	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; PROLYL 4-HYDROXYLASE; HYDROXYPROLINE; MUTANTS		[Mohnen, Debra] Univ Georgia, BioEnergy Sci Ctr, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Tierney, Mary L.] Univ Vermont, Dept Plant Biol, Burlington, VT 05405 USA	University System of Georgia; University of Georgia; University of Vermont	Mohnen, D (corresponding author), Univ Georgia, BioEnergy Sci Ctr, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.	dmohnen@ccrc.uga.edu; mary.tierney@uvm.edu						Asif MH, 2009, FUNCT INTEGR GENOMIC, V9, P525, DOI 10.1007/s10142-009-0118-y; Bertozzi C. R., 2009, ESSENTIALS GLYCOBIOL, P23; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Petersen B. L., 2011, ANN PLANT REV, V41, P305; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657	15	7	7	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	2011	332	6036					1393	1394		10.1126/science.1208641	http://dx.doi.org/10.1126/science.1208641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680834				2022-12-28	WOS:000291689000030
J	Zeng, QS; Sheng, HW; Ding, Y; Wang, L; Yang, WG; Jiang, JZ; Mao, WL; Mao, HK				Zeng, Qiaoshi; Sheng, Hongwei; Ding, Yang; Wang, Lin; Yang, Wenge; Jiang, Jian-Zhong; Mao, Wendy L.; Mao, Ho-Kwang			Long-Range Topological Order in Metallic Glass	SCIENCE			English	Article							NON-CRYSTALLINE SOLIDS; CHALCOGENIDE ALLOYS; LIQUIDS; ZEOLITES; PRESSURE; DISORDER	Glass lacks the long-range periodic order that characterizes a crystal. In the Ce75Al25 metallic glass (MG), however, we discovered a long-range topological order corresponding to a single crystal of indefinite length. Structural examinations confirm that the MG is truly amorphous, isotropic, and unstrained, yet under 25 gigapascals hydrostatic pressures, every segment of a centimeter-length MG ribbon devitrifies independently into a face-centered cubic (fcc) crystal with the identical orientation. By using molecular dynamics simulations and synchrotron x-ray techniques, we elucidate that the mismatch between the large Ce and small Al atoms frustrates the crystallization and causes amorphization, but a long-range fcc topological order still exists. Pressure induces electronic transition in Ce, which eliminates the mismatch and manifests the topological order by the formation of a single crystal.	[Zeng, Qiaoshi; Jiang, Jian-Zhong; Mao, Wendy L.; Mao, Ho-Kwang] Zhejiang Univ, Int Ctr New Struct Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Zeng, Qiaoshi; Jiang, Jian-Zhong; Mao, Wendy L.; Mao, Ho-Kwang] Zhejiang Univ, Dept Mat Sci & Engn, Lab New Struct Mat, Hangzhou 310027, Zhejiang, Peoples R China; [Zeng, Qiaoshi; Ding, Yang; Wang, Lin; Yang, Wenge; Mao, Ho-Kwang] Carnegie Inst Sci, Geophys Lab, HPSynC, Argonne, IL 60439 USA; [Sheng, Hongwei] George Mason Univ, Sch Phys Astron & Computat Sci, Fairfax, VA 22030 USA; [Wang, Lin] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Mao, Wendy L.] Stanford Univ, Stanford, CA 94305 USA; [Mao, Wendy L.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Mao, Ho-Kwang] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Zhejiang University; Zhejiang University; Carnegie Institution for Science; George Mason University; Jilin University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Carnegie Institution for Science	Jiang, JZ (corresponding author), Zhejiang Univ, Int Ctr New Struct Mat, Hangzhou 310027, Zhejiang, Peoples R China.	jiangjz@zju.edu.cn; mao@gl.ciw.edu	Mao, Wendy/D-1885-2009; Yang, Wenge/H-2740-2012; Ding, Yang/K-1995-2014; Wang, Lin/N-4161-2017; Yang, Wenge/ABD-6594-2020; WANG, LIN/G-7884-2012; Sheng, Howard/B-2033-2013; zeng, qiaoshi/V-8250-2019	Ding, Yang/0000-0002-8845-4618; zeng, qiaoshi/0000-0001-5960-1378; Sheng, Howard/0000-0002-6134-0354	U.S. Department of Energy (DOE), Energy Frontier Research Center [DE-SC0001057]; Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas; DOE-National Nuclear Security Administration; DOE-Basic Energy Sciences; NSF [DMR-0907325]; DOE [DE-AC02-76SF00515]; National Natural Science Foundation of China [10979002, 50920105101, 51050110136]; China Postdoctoral Science Foundation; Zhejiang University; Ministry of Education of China; Zhejiang Provincial Department of Science and Technology; Division Of Materials Research [0907325] Funding Source: National Science Foundation	U.S. Department of Energy (DOE), Energy Frontier Research Center(United States Department of Energy (DOE)); Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas(United States Department of Energy (DOE)); DOE-National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); DOE-Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhejiang University; Ministry of Education of China(Ministry of Education, China); Zhejiang Provincial Department of Science and Technology; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based on work funded by the U.S. Department of Energy (DOE), Energy Frontier Research Center grant DE-SC0001057 (EFree). We thank C. L. Qin for synthesis of the MG, B. Sa and Z. Sun for initial calculations, R. E. Cook and R. Koritala for helping ED and TEM measurements, and S. Sinogeikin and Y. Meng for the x-ray beamline support. The use of HPCAT, APS is supported by Carnegie Institute of Washington, Carnegie DOE Alliance Center, University of Nevada at Las Vegas, and Lawrence Livermore National Laboratory through funding from DOE-National Nuclear Security Administration, DOE-Basic Energy Sciences, and NSF. The TEM measurements were conducted at the Electron Microscopy Center at ANL. The computational work was supported by NSF grant DMR-0907325 and conducted on the supercomputing system supported by the Center for Computational Materials Science, Tohoku University. The SLAC effort is supported by DOE and DE-AC02-76SF00515. The Zhejiang University participants are supported by the National Natural Science Foundation of China (grants 10979002, 50920105101, and 51050110136), the China Postdoctoral Science Foundation, the Zhejiang University-Helmholtz Cooperation Fund, the Ministry of Education of China, and Zhejiang Provincial Department of Science and Technology.	Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; BERNAL JD, 1959, NATURE, V183, P141, DOI 10.1038/183141a0; Chen SH, 2003, SCIENCE, V300, P619, DOI 10.1126/science.1082364; Cheng YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245501; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Greaves GN, 2003, NAT MATER, V2, P622, DOI 10.1038/nmat963; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; Haines J, 2009, J AM CHEM SOC, V131, P12333, DOI 10.1021/ja904054v; Hufnagel TC, 2004, NAT MATER, V3, P666, DOI 10.1038/nmat1227; KAUZMANN W, 1948, CHEM REV, V43, P219, DOI 10.1021/cr60135a002; Louzguine-Luzgin DV, 2009, INTERMETALLICS, V17, P477, DOI 10.1016/j.intermet.2008.12.008; Luo WK, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.145502; Ma D, 2009, NAT MATER, V8, P30, DOI [10.1038/nmat2340, 10.1038/NMAT2340]; Miracle DB, 2007, MRS BULL, V32, P629, DOI 10.1557/mrs2007.124; Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219; Navrotsky A, 2003, NAT MATER, V2, P571, DOI 10.1038/nmat969; PHILLIPS JC, 1981, J NON-CRYST SOLIDS, V43, P37, DOI 10.1016/0022-3093(81)90172-1; PHILLIPS JC, 1979, J NON-CRYST SOLIDS, V34, P153, DOI 10.1016/0022-3093(79)90033-4; Salmon PS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.235502; Salmon PS, 2005, NATURE, V435, P75, DOI 10.1038/nature03475; Sheng HW, 2007, NAT MATER, V6, P192, DOI 10.1038/nmat1839; Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421; TSE JS, 1994, NATURE, V369, P724, DOI 10.1038/369724a0; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Yarger JL, 2004, SCIENCE, V306, P820, DOI 10.1126/science.1104417; Yavari AR, 2007, NAT MATER, V6, P181, DOI 10.1038/nmat1853; Zeng QS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.105702; Zeng QS, 2009, P NATL ACAD SCI USA, V106, P2515, DOI 10.1073/pnas.0813328106	28	158	166	10	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	2011	332	6036					1404	1406		10.1126/science.1200324	http://dx.doi.org/10.1126/science.1200324			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778FT	21680837				2022-12-28	WOS:000291689000034
J	Karijolich, J; Yu, YT				Karijolich, John; Yu, Yi-Tao			Converting nonsense codons into sense codons by targeted pseudouridylation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; U2 SNRNA; RNA; SITE; GENE; RECOGNITION; TERMINATION; TURNOVER	All three translation termination codons, or nonsense codons, contain a uridine residue at the first position of the codon(1-3). Here, we demonstrate that pseudouridylation (conversion of uridine into pseudouridine (Psi), ref. 4) of nonsense codons suppresses translation termination both in vitro and in vivo. In vivo targeting of nonsense codons is accomplished by the expression of an H/ACA RNA capable of directing the isomerization of uridine to Psi within the nonsense codon. Thus, targeted pseudouridylation represents a novel approach for promoting nonsense suppression in vivo. Remarkably, we also show that pseudouridylated nonsense codons code for amino acids with similar properties. Specifically, Psi AA and Psi AG code for serine and threonine, whereas Psi GA codes for tyrosine and phenylalanine, thus suggesting a new mode of decoding. Our results also suggest that RNA modification, as a naturally occurring mechanism, may offer a new way to expand the genetic code.	[Karijolich, John; Yu, Yi-Tao] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Yu, YT (corresponding author), Univ Rochester, Med Ctr, Dept Biochem & Biophys, 601 Elmwood Ave, Rochester, NY 14642 USA.	yitao_yu@urmc.rochester.edu			NIGMS NIH HHS [R01 GM062937-09, R21 GM078223-02, R01 GM062937, R21 GM078223] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062937, R21GM078223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; Agris PF, 1996, PROG NUCLEIC ACID RE, V53, P79, DOI 10.1016/S0079-6603(08)60143-9; ATKINS JF, 1979, CELL, V18, P1119, DOI 10.1016/0092-8674(79)90225-3; Auffinger P, 1997, J MOL BIOL, V269, P326, DOI 10.1006/jmbi.1997.1022; BRENNER S, 1967, NATURE, V213, P449, DOI 10.1038/213449a0; BRENNER S, 1965, NATURE, V206, P994, DOI 10.1038/206994a0; Charette M, 2000, IUBMB LIFE, V49, P341; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; COHN WE, 1959, BIOCHIM BIOPHYS ACTA, V32, P569, DOI 10.1016/0006-3002(59)90644-4; Davis DR, 1995, NUCLEIC ACIDS RES, V23, P5020, DOI 10.1093/nar/23.24.5020; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; HAMER DH, 1985, SCIENCE, V228, P685, DOI 10.1126/science.3887570; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; LESSER CF, 1993, GENETICS, V133, P851; Ma XJ, 2005, EMBO J, V24, P2403, DOI 10.1038/sj.emboj.7600718; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; WEIGERT MG, 1965, NATURE, V206, P992, DOI 10.1038/206992a0; Wilusz CJ, 2001, GENE DEV, V15, P2781; Wu GW, 2011, EMBO J, V30, P79, DOI 10.1038/emboj.2010.316; Yu YT, 2000, METHOD ENZYMOL, V318, P71; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461; Zhao XL, 2004, RNA, V10, P996, DOI 10.1261/rna.7110804; Zhao XL, 2004, RNA, V10, P681, DOI 10.1261/rna.5159504	27	209	224	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	2011	474	7351					395	+		10.1038/nature10165	http://dx.doi.org/10.1038/nature10165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777TD	21677757	Green Accepted			2022-12-28	WOS:000291647100049
J	Mineur, YS; Abizaid, A; Rao, Y; Salas, R; DiLeone, RJ; Gundisch, D; Diano, S; De Biasi, M; Horvath, TL; Gao, XB; Picciotto, MR				Mineur, Yann S.; Abizaid, Alfonso; Rao, Yan; Salas, Ramiro; DiLeone, Ralph J.; Guendisch, Daniela; Diano, Sabrina; De Biasi, Mariella; Horvath, Tamas L.; Gao, Xiao-Bing; Picciotto, Marina R.			Nicotine Decreases Food Intake Through Activation of POMC Neurons	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; BODY-WEIGHT; SMOKING; RECEPTOR; BRAIN; OBESITY; MICE	Smoking decreases appetite, and smokers often report that they smoke to control their weight. Understanding the neurobiological mechanisms underlying the anorexic effects of smoking would facilitate the development of novel treatments to help with smoking cessation and to prevent or treat obesity. By using a combination of pharmacological, molecular genetic, electrophysiological, and feeding studies, we found that activation of hypothalamic alpha 3 beta 4 nicotinic acetylcholine receptors leads to activation of pro-opiomelanocortin (POMC) neurons. POMC neurons and subsequent activation of melanocortin 4 receptors were critical for nicotinic-induced decreases in food intake in mice. This study demonstrates that nicotine decreases food intake and body weight by influencing the hypothalamic melanocortin system and identifies critical molecular and synaptic mechanisms involved in nicotine-induced decreases in appetite.	[Mineur, Yann S.; DiLeone, Ralph J.; Picciotto, Marina R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Abizaid, Alfonso; Rao, Yan; Diano, Sabrina; Horvath, Tamas L.; Gao, Xiao-Bing] Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06508 USA; [Salas, Ramiro; De Biasi, Mariella] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Guendisch, Daniela] Univ Hawaii, Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA	Yale University; Yale University; Baylor College of Medicine; University of Hawaii System; University Hawaii Hilo	Picciotto, MR (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St,3rd Floor Res, New Haven, CT 06508 USA.	marina.picciotto@yale.edu	Mineur, Yann/E-2487-2018; Salas, Ramiro/A-9602-2015; Picciotto, Marina R./F-8747-2012; Gao, Xiao-Bing/C-3121-2011; De Biasi, Mariella/M-7646-2017	Mineur, Yann/0000-0002-8030-6776; Picciotto, Marina R./0000-0002-4404-1280; Gao, Xiao-Bing/0000-0002-2035-4936; De Biasi, Mariella/0000-0002-0687-8872; Abizaid, Alfonso/0000-0001-9303-3511; DiLeone, Ralph/0000-0002-4770-2590	NIH [DA14241, DA00436, AA15632]; Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada; American Diabetes Association [1-08-RA-36, DK070039];  [DK070723];  [RR016467];  [DA017173];  [OD006850];  [DK080000]; NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070723, R01DK070039, R01DK080000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017173, R01DA014241, K02DA000436] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006850] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Transdisciplinary Tobacco Use Research Center; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Diabetes Association(American Diabetes Association); ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by grants DA14241, DA00436, and AA15632 from the NIH. X.-B.G. was supported by DK070723. Y.M. was supported by a Transdisciplinary Tobacco Use Research Center young investigator pilot grant. Alfonso Abizaid was supported by a postdoctoral fellowship from the Natural Science and Engineering Research Council of Canada. D. G. was supported by RR016467. Y.R., X.-B.G., and S. D. were supported by American Diabetes Association grants 1-08-RA-36 and DK070039. M. D. was supported by DA017173. T. L. H. was supported by OD006850 and DK080000. The authors gratefully acknowledge U. Hochgeschwender (Oklahoma Medical Research Foundation) for providing heterozygous POMC breeding pairs.	ALBANES D, 1987, AM J PUBLIC HEALTH, V77, P439, DOI 10.2105/AJPH.77.4.439; Backberg M, 2004, SYNAPSE, V52, P245, DOI 10.1002/syn.20024; Filozof C, 2004, Obes Rev, V5, P95, DOI 10.1111/j.1467-789X.2004.00131.x; Freeman M E, 2008, NEUROSCIENCE MED, P301; Fulkerson JA, 2003, J ADOLESCENT HEALTH, V32, P306, DOI 10.1016/S1054-139X(02)00566-9; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; GRUNBERG NE, 1987, PSYCHOPHARMACOLOGY, V91, P221; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Krude H, 2003, J CLIN ENDOCR METAB, V88, P4633, DOI 10.1210/jc.2003-030502; Majkutewicz I, 2010, ACTA NEUROBIOL EXP, V70, P28; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Phillis J. W., 2005, Critical Reviews in Neurobiology, V17, P161; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Pistelli F, 2009, Monaldi Arch Chest Dis, V71, P81; Schafer MKH, 1998, NEUROSCIENCE, V84, P331, DOI 10.1016/S0306-4522(97)00516-2; Smart JL, 2003, ANN NY ACAD SCI, V994, P202, DOI 10.1111/j.1749-6632.2003.tb03181.x; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Voorhees CC, 2002, PREV MED, V34, P616, DOI 10.1006/pmed.2002.1026; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; Williams DL, 2005, AM J PHYSIOL-REG I, V289, pR2, DOI 10.1152/ajpregu.00226.2005; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M	21	274	282	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1330	1332		10.1126/science.1201889	http://dx.doi.org/10.1126/science.1201889			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659607	Green Accepted			2022-12-28	WOS:000291441700047
J	Schreiner, PR; Reisenauer, HP; Ley, D; Gerbig, D; Wu, CH; Allen, WD				Schreiner, Peter R.; Reisenauer, Hans Peter; Ley, David; Gerbig, Dennis; Wu, Chia-Hua; Allen, Wesley D.			Methylhydroxycarbene: Tunneling Control of a Chemical Reaction	SCIENCE			English	Article							PYRUVIC-ACID; GAS-PHASE; HYDROXYETHYLIDENE CH3-C-OH; VINYL ALCOHOL; CHEMISTRY; HYDROXYMETHYLENE; HYDROXYCARBENE; ISOMERIZATION; DECOMPOSITION	Chemical reactivity is conventionally understood in broad terms of kinetic versus thermodynamic control, wherein the decisive factor is the lowest activation barrier among the various reaction paths or the lowest free energy of the final products, respectively. We demonstrate that quantum-mechanical tunneling can supersede traditional kinetic control and direct a reaction exclusively to a product whose reaction path has a higher barrier. Specifically, we prepared methylhydroxycarbene (H(3)C-C-OH) via vacuum pyrolysis of pyruvic acid at about 1200 kelvin (K), followed by argon matrix trapping at 11 K. The previously elusive carbene, characterized by ultraviolet and infrared spectroscopy as well as exacting quantum-mechanical computations, undergoes a facile [1,2] hydrogen shift to acetaldehyde via tunneling under a barrier of 28.0 kilocalories per mole (kcal mol(-1)), with a half-life of around 1 hour. The analogous isomerization to vinyl alcohol has a substantially lower barrier of 22.6 kcal mol(-1) but is precluded at low temperature by the greater width of the potential energy profile for tunneling.	[Schreiner, Peter R.; Reisenauer, Hans Peter; Ley, David; Gerbig, Dennis] Univ Giessen, Inst Organ Chem, D-35392 Giessen, Germany; [Wu, Chia-Hua; Allen, Wesley D.] Univ Georgia, Dept Chem, Athens, GA 30602 USA; [Wu, Chia-Hua; Allen, Wesley D.] Univ Georgia, Ctr Computat Chem, Athens, GA 30602 USA	Justus Liebig University Giessen; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Schreiner, PR (corresponding author), Univ Giessen, Inst Organ Chem, Heinrich Buff Ring 58, D-35392 Giessen, Germany.	prs@org.chemie.uni-giessen.de; wdallen@uga.edu	Gerbig, Dennis/F-4887-2011; Allen, Wesley D./C-9867-2010; Schreiner, Peter Richard R/A-4084-2008; Gerbig, Dennis/GPF-4513-2022	Gerbig, Dennis/0000-0002-7023-8298; Allen, Wesley D./0000-0002-4288-2297; Schreiner, Peter Richard R/0000-0002-3608-5515; Gerbig, Dennis/0000-0002-7023-8298	European Research Area Chemistry; Fonds der Chemischen Industrie; Hessische Graduiertenforderung; U.S. Department of Energy, Office of Basic Energy Sciences [DE-FG02-97ER14748]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; EPSRC [EP/G012636/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G012636/1] Funding Source: researchfish	European Research Area Chemistry; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Hessische Graduiertenforderung; U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work in Giessen was supported by European Research Area Chemistry (administered by the Deutsche Forschungsgemeinschaft), the Fonds der Chemischen Industrie (fellowship to D. L.), and the Hessische Graduiertenforderung (fellowship to D. G.). P. R. S. thanks A. G. Csaszar for discussions. The research in Athens was funded by the U.S. Department of Energy, Office of Basic Energy Sciences, Combustion Program (grant no. DE-FG02-97ER14748); resources were used from the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231.	AHMED SN, 1985, J AM CHEM SOC, V107, P1320, DOI 10.1021/ja00291a035; Amiri S, 2010, J AM CHEM SOC, V132, P15902, DOI 10.1021/ja107531y; ANDERSON RB, 1984, FISCHERTROPSCH SYNTH; Bell R, 1980, TUNNEL EFFECT CHEM; BELL RP, 1959, T FARADAY SOC, V55, P1, DOI 10.1039/tf9595500001; BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008; Bucher G, 2008, ANGEW CHEM INT EDIT, V47, P6957, DOI 10.1002/anie.200803195; CARPENTER BK, 1983, J AM CHEM SOC, V105, P1700, DOI 10.1021/ja00344a073; CATCHPOLE AG, 1944, J CHEM SOC, V11, P8; Chipman DM, 2005, CURR OPIN CHEM BIOL, V9, P475, DOI 10.1016/j.cbpa.2005.07.002; Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Gerbig D, 2010, J AM CHEM SOC, V132, P7273, DOI 10.1021/ja9107885; Koziol L, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2925452; LAIDLER KJ, 1983, J PHYS CHEM-US, V87, P2657, DOI 10.1021/j100238a002; Liu XP, 2005, J PHYS CHEM A, V109, P2183, DOI 10.1021/jp0452094; Macoas EMS, 2004, J PHYS CHEM A, V108, P3380, DOI 10.1021/jp037840v; MULLER P, 1994, PURE APPL CHEM, V66, P1077, DOI 10.1351/pac199466051077; Pettersson M, 2002, J CHEM PHYS, V117, P9095, DOI 10.1063/1.1521429; Rasanen M, 2008, NATURE, V453, P862, DOI 10.1038/453862a; Reva ID, 2001, J PHYS CHEM A, V105, P4773, DOI 10.1021/jp0101458; RODLER M, 1984, J AM CHEM SOC, V106, P4029, DOI 10.1021/ja00326a025; ROSENFELD RN, 1983, J AM CHEM SOC, V105, P3485, DOI 10.1021/ja00349a019; SAITO K, 1994, J PHYS CHEM-US, V98, P3756, DOI 10.1021/j100065a034; Schreiner PR, 2008, ANGEW CHEM INT EDIT, V47, P7071, DOI 10.1002/anie.200802105; Schreiner PR, 2008, NATURE, V453, P906, DOI 10.1038/nature07010; SKELL PS, 1970, J AM CHEM SOC, V92, P836; SMITH BJ, 1991, J AM CHEM SOC, V113, P6452, DOI 10.1021/ja00017a015; TURECEK F, 1986, J ORG CHEM, V51, P4066, DOI 10.1021/jo00371a028; WEINER BR, 1983, J ORG CHEM, V48, P5362, DOI 10.1021/jo00174a042; WESDEMIOTIS C, 1987, J AM CHEM SOC, V109, P4760, DOI 10.1021/ja00249a071; WIBERG KB, 1991, J AM CHEM SOC, V113, P3447, DOI 10.1021/ja00009a033; Woodward RB, 1944, J AM CHEM SOC, V66, P645, DOI 10.1021/ja01232a042; YAMAMOTO S, 1985, CAN J CHEM, V63, P549, DOI 10.1139/v85-089	34	216	216	5	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 10	2011	332	6035					1300	1303		10.1126/science.1203761	http://dx.doi.org/10.1126/science.1203761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	775EP	21659600				2022-12-28	WOS:000291441700040
J	Simons, BD; Clevers, H				Simons, Benjamin D.; Clevers, Hans			Strategies for Homeostatic Stem Cell Self-Renewal in Adult Tissues	CELL			English	Review							MOUSE SMALL-INTESTINE; DROSOPHILA POSTERIOR MIDGUT; HAIR FOLLICLE; PROGENITOR CELLS; NICHE; EPIDERMIS; SKIN; EPITHELIUM; DIVISION; FATE	In adult tissues, an exquisite balance exists between stem cell proliferation and the generation of differentiated offspring. Classically, it has been argued that this balance is obtained at the level of a single stem cell, which divides strictly into a new stem cell and a progenitor. However, recent evidence suggests that balance can also be achieved at the level of the stem cell population. Some stem cells might be lost due to differentiation or damage, whereas others divide symmetrically to fill this gap. Here, we consider the general strategies for stem cell self-renewal and review the evidence for stochastic stem cell fate in adult tissues across a range of tissue types and organisms.	[Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Simons, Benjamin D.] Univ Cambridge, Cavevdish Lab, Dept Phys, Cambridge CB3 0HE, England; [Simons, Benjamin D.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Cambridge	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071	EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; De Rooij DG, 2000, J ANDROL, V21, P776; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hou SX, 2010, J CELL PHYSIOL, V224, P581, DOI 10.1002/jcp.22194; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Klein AM, 2010, P NATL ACAD SCI USA, V107, P270, DOI 10.1073/pnas.0909738107; KLEIN AM, 2011, DEVELOPMENT IN PRESS; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; MACKENZIE IC, 1970, NATURE, V226, P653, DOI 10.1038/226653a0; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Potten CS, 2002, J INVEST DERMATOL, V119, P888, DOI 10.1046/j.1523-1747.2002.00020.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wright NA, 2000, INT J EXP PATHOL, V81, P117, DOI 10.1046/j.1365-2613.2000.00146.x; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yamashita YM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001313; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	78	338	345	0	60	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 10	2011	145	6					851	862		10.1016/j.cell.2011.05.033	http://dx.doi.org/10.1016/j.cell.2011.05.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663791	Bronze			2022-12-28	WOS:000291461600013
J	Zaslaver, A; Baugh, LR; Sternberg, PW				Zaslaver, Alon; Baugh, L. Ryan; Sternberg, Paul W.			Metazoan Operons Accelerate Recovery from Growth-Arrested States	CELL			English	Article							ELEGANS DAUER LARVA; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; GLOBAL ANALYSIS; GENOME; ORGANIZATION; PROMOTERS; DYNAMICS; SEQUENCE; CHORDATE	Existing theories explain why operons are advantageous in prokaryotes, but their occurrence in metazoans is an enigma. Nematode operon genes, typically consisting of growth genes, are significantly upregulated during recovery from growth-arrested states. This expression pattern is anticorrelated to nonoperon genes, consistent with a competition for transcriptional resources. We find that transcriptional resources are initially limiting during recovery and that recovering animals are highly sensitive to any additional decrease in transcriptional resources. We provide evidence that operons become advantageous because, by clustering growth genes into operons, fewer promoters compete for the limited transcriptional machinery, effectively increasing the concentration of transcriptional resources and accelerating recovery. Mathematical modeling reveals how a moderate increase in transcriptional resources can substantially enhance transcription rate and recovery. This design principle occurs in different nematodes and the chordate C. intestinalis. As transition from arrest to rapid growth is shared by many metazoans, operons could have evolved to facilitate these processes.	[Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Zaslaver, Alon; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Baugh, L. Ryan] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Baugh, L. Ryan] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Duke University; Duke University	Sternberg, PW (corresponding author), CALTECH, Howard Hughes Med Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	pws@caltech.edu	Baugh, L. Ryan/GRS-0507-2022	Baugh, L. Ryan/0000-0003-2148-5492; Sternberg, Paul/0000-0002-7699-0173	Genome Canada; European Molecular Biology Organization (EMBO); Human Frontier Science Program (HFSP); Caltech Center for Biological Circuit Design; HHMI	Genome Canada(Genome Canada); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Caltech Center for Biological Circuit Design; HHMI(Howard Hughes Medical Institute)	We are grateful to Tom Blumenthal, Erich Schwarz, Hillel Schwartz, Shalev Itzkovitz, Ronen Zaidel-Bar, and Ron Milo for critical review and helpful comments. We thank Elodie Ghedin for sharing the list of operon genes in B. malayi, the Mitani laboratory and the Caenorhabditis Genetics Center for deletion strains, WormBase, and the Genome BC C. elegans Gene Expression Consortium http://elegans.bcgsc.bc.ca/ for SAGE data (produced at the Michael Smith Genome Sciences Centre with funding from Genome Canada). A.Z. was supported by the European Molecular Biology Organization (EMBO), the Human Frontier Science Program (HFSP), and the Caltech Center for Biological Circuit Design. L.R.B. was an ACS postdoctoral fellow. P.W.S. is an Investigator with the HHMI, which supported this work. A.Z. conceived the idea of this study, designed and performed all of the experiments and the mathematical modeling, and carried out all of the data and bioinformatics analyses. L.R.B. contributed experimental tools, shared unpublished data, and helped to analyze and interpret the data. A.Z. and P.W.S. wrote the paper.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alon U., 2006, INTRO SYSTEMS BIOL D; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; BLACKWELL TK, 2006, TRANSCRIPTION MECH, P1; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Blumenthal Thomas, 2003, Nature Reviews Genetics, V4, P112; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen NS, 2006, GENOME RES, V16, P606, DOI 10.1101/gr.4515306; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DALLEY BK, 1992, DEV BIOL, V151, P80, DOI 10.1016/0012-1606(92)90215-3; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Ganot P, 2004, MOL CELL BIOL, V24, P7795, DOI 10.1128/MCB.24.17.7795-7805.2004; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Hillier LW, 2005, GENOME RES, V15, P1651, DOI 10.1101/gr.3729105; Huang PM, 2007, GENOME RES, V17, P1478, DOI 10.1101/gr.6824707; JACOB F, 1960, CR HEBD ACAD SCI, V250, P1727; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; KLASS M, 1976, NATURE, V260, P523, DOI 10.1038/260523a0; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Price MN, 2005, GENOME RES, V15, P809, DOI 10.1101/gr.3368805; Qian WF, 2008, GENOME RES, V18, P412, DOI 10.1101/gr.7112608; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Reinke V, 2009, GENETICS, V181, P1219, DOI 10.1534/genetics.108.099283; SANFORD T, 1983, J BIOL CHEM, V258, P2804; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0	44	35	38	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2011	145	6					981	992		10.1016/j.cell.2011.05.013	http://dx.doi.org/10.1016/j.cell.2011.05.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	775LS	21663799	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000291461600023
J	Woods, LM; Coleman, MP; Lawrence, G; Rashbass, J; Berrino, F; Rachet, B				Woods, Laura M.; Coleman, Michel P.; Lawrence, Gill; Rashbass, Jem; Berrino, Franco; Rachet, Bernard			Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; RADIOTHERAPY; COUNTRIES; AUSTRALIA; EUROCARE; ENGLAND; EUROPE	Objectives To simulate each of two hypothesised errors in the National Cancer Registry (recording of the date of recurrence of cancer, instead of the date of diagnosis, for registrations initiated from a death certificate; long term survivors who are never notified to the registry), to estimate their possible effect on relative survival, and to establish whether lower survival in the UK might be due to one or both of these errors. Design Simulation study. Setting National Cancer Registry of England and Wales. Population Patients diagnosed as having breast (women), lung, or colorectal cancer during 1995-2007 in England and Wales, with follow-up to 31 December 2007. Main outcome measure Mean absolute percentage change in one year and five year relative survival associated with each simulated error. Results To explain the differences in one year survival after breast cancer between England and Sweden, under the first hypothesis, date of diagnosis would have to have been incorrectly recorded by an average of more than a year for more than 70% of women known to be dead. Alternatively, under the second hypothesis, failure to register even 40% of long term survivors would explain less than half the difference in one year survival. Results were similar for lung and colorectal cancers. Conclusions Even implausibly extreme levels of the hypothesised errors in the cancer registry data could not explain the international differences in survival observed between the UK and other European countries.	[Woods, Laura M.; Coleman, Michel P.; Rachet, Bernard] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, London WC1E 7HT, England; [Lawrence, Gill] Univ Birmingham, W Midlands Canc Intelligence Unit, Birmingham BT5 2TT, W Midlands, England; [Rashbass, Jem] Eastern Canc Registry & Informat Ctr, Cambridge CB22 3AD, England; [Berrino, Franco] Ist Nazl Tumori, Fdn IRCCS, Dept Predict & Prevent Med, I-20133 Milan, Italy	Cancer Research UK; University of London; London School of Hygiene & Tropical Medicine; University of Birmingham; Fondazione IRCCS Istituto Nazionale Tumori Milan	Woods, LM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Canc Res UK Canc Survival Grp, Keppel St, London WC1E 7HT, England.	laura.woods@lshtm.ac.uk	Coleman, Michel/AAA-9543-2020; Berrino, Franco/AAC-2364-2020; Woods, Laura M/Q-1714-2017	Coleman, Michel/0000-0001-8940-3807; Berrino, Franco/0000-0002-4858-1866; Woods, Laura M/0000-0002-2178-1577; Rachet, Bernard/0000-0001-5837-7773	Cancer Research UK [11700, 11415] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Anderson GF, 2007, HEALTH AFFAIR, V26, P1481, DOI 10.1377/hlthaff.26.5.1481; Autier P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3620; Bentzen SM, 2005, RADIOTHER ONCOL, V75, P355, DOI 10.1016/j.radonc.2004.12.007; Beral V, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4112; Berrino F, 2003, ANN ONCOL, V14, pV9, DOI 10.1093/annonc/mdg750; Berrino F, 1999, SURVIVAL CANC PATIEN; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Bray F, 2009, EUR J CANCER, V45, P747, DOI 10.1016/j.ejca.2008.11.032; Brenner H, 1997, J CLIN EPIDEMIOL, V50, P211, DOI 10.1016/S0895-4356(97)00280-1; Brenner H, 2009, INT J CANCER, V125, P432, DOI 10.1002/ijc.24344; *CANC RES UK CANC, 2006, STREL COMP PROGR VER, V5; Coleman MP, 2003, ANN ONCOL, V14, pV128, DOI 10.1093/annonc/mdg756; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Coleman MP, 2008, LANCET ONCOL, V9, P730, DOI 10.1016/S1470-2045(08)70179-7; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; Department of Health, 2000, NHS CANC PLAN; Department of Health, 2007, CANC REF STRAT; EDERER FRED, 1961, NATL CANCER INST MONOGR, V6, P101; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Kaye JA, 2000, BRIT J CANCER, V83, P1556, DOI 10.1054/bjoc.2000.1493; Laurenti R, 2000, DEATH CERTIFICATION; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; *OFF NAT STAT, 2008, SER MB1 OFF NAT STAT, V37; Organisation for Economic Co Operation and Development, 2009, HLTH GLANC 2009; Rachet B, 2009, LANCET ONCOL, V10, P351, DOI 10.1016/S1470-2045(09)70028-2; Rooney C, 1999, HLTH STAT Q, P21; Sant M, 2003, INT J CANCER, V106, P416, DOI 10.1002/ijc.11226; Sant M., 1995, SURVIVAL CANC PATIEN; Stotter A, 2000, BRIT MED J, V321, P214, DOI 10.1136/bmj.321.7255.214; UK Association of Cancer Registries, 2010, UKACR QUAL PERF IND; Wilkinson E, 2009, LANCET, V374, P964, DOI 10.1016/S0140-6736(09)61648-2; Williams MV, 2007, CLIN ONCOL-UK, V19, P273, DOI 10.1016/j.clon.2007.03.011; Williams MV, 2009, CLIN ONCOL-UK, V21, P575, DOI 10.1016/j.clon.2009.07.003; Woods LM, 2009, INT J CANCER, V124, P2391, DOI 10.1002/ijc.24233; 2011, EUROCARE 4 DATABASE	35	38	38	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2011	342								d3399	10.1136/bmj.d3399	http://dx.doi.org/10.1136/bmj.d3399			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	777SR	21659366	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000291645800003
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING AIDS at 30: a chance to treat is now a chance to prevent	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				BROWN D, 2011, WASHINGTON POST 0530; *CDC, 1981, MMWR-MORBID MORTAL W, V30, P1; FAUCI AS, 2011, WASHINGTON POST 0528	3	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 7	2011	342								d3512	10.1136/bmj.d3512	http://dx.doi.org/10.1136/bmj.d3512			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777SL	21652746				2022-12-28	WOS:000291645200007
J	Lawrence, C				Lawrence, Christopher			Historical keyword Doctor	LANCET			English	Editorial Material												c.lawrence645@btinternet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 4	2011	377	9781					1910	1910		10.1016/S0140-6736(11)60798-8	http://dx.doi.org/10.1016/S0140-6736(11)60798-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	777LW	21641468				2022-12-28	WOS:000291623200014
J	Remorino, A; Korendovych, IV; Wu, YB; DeGrado, WF; Hochstrasser, RM				Remorino, Amanda; Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.; Hochstrasser, Robin M.			Residue-Specific Vibrational Echoes Yield 3D Structures of a Transmembrane Helix Dimer	SCIENCE			English	Article							2-DIMENSIONAL INFRARED-SPECTROSCOPY; MOLECULAR-STRUCTURE DETERMINATION; 2D IR; XPLOR-NIH; PROTEINS; DYNAMICS; WATER; CONFORMATION; SIMULATIONS; PEPTIDES	Two-dimensional (2D) vibrational echo spectroscopy has previously been applied to structural determination of small peptides. Here we extend the technique to a more complex, biologically important system: the homodimeric transmembrane dimer from the alpha chain of the integrin alpha(IIb)beta(3). We prepared micelle suspensions of the pair of 30-residue chains that span the membrane in the native structure, with varying levels of heavy ((13)C=(18)O) isotopes substituted in the backbone of the central 10th through 20th positions. The constraints derived from vibrational coupling of the precisely spaced heavy residues led to determination of an optimized structure from a range of model candidates: Glycine residues at the 12th, 15th, and 16th positions form a tertiary contact in parallel right-handed helix dimers with crossing angles of -58 degrees +/- 9 degrees and interhelical distances of 7.7 +/- 0.5 angstroms. The frequency correlation established the dynamical model used in the analysis, and it indicated the absence of mobile water associated with labeled residues. Delocalization of vibrational excitations between the helices was also quantitatively established.	[Remorino, Amanda; Hochstrasser, Robin M.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Korendovych, Ivan V.; Wu, Yibing; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Hochstrasser, RM (corresponding author), Univ Penn, Dept Chem, Philadelphia, PA 19104 USA.	hochstra@sas.upenn.edu			NSFCHE [NIH-GM12592, NIH-RR01348]; NSF-MRSEC [NIH-GM54616, NIH-GM60610, NIH-GM56423]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM012592, R01GM056423, R01GM012592, R01GM060610, R37GM054616, R01GM054616] Funding Source: NIH RePORTER	NSFCHE(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by grants NIH-GM12592, NIH-RR01348, and NSFCHE (to R.M.H.) and NIH-GM54616, NIH-GM60610, NSF-MRSEC, and NIH-GM56423 (to W.F.D.). We thank C. Schwieters and M. Clore for providing us with the Xplor-NIH source code.	Berger BW, 2010, P NATL ACAD SCI USA, V107, P703, DOI 10.1073/pnas.0910873107; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Fang C, 2003, CHEM PHYS LETT, V382, P586, DOI 10.1016/j.cplett.2003.10.111; Fang C, 2006, P NATL ACAD SCI USA, V103, P16740, DOI 10.1073/pnas.0608243103; Ghosh A, 2011, P NATL ACAD SCI USA, V108, P6115, DOI 10.1073/pnas.1103027108; Hamm P, 1998, J PHYS CHEM B, V102, P6123, DOI 10.1021/jp9813286; Hamm P, 1999, P NATL ACAD SCI USA, V96, P2036, DOI 10.1073/pnas.96.5.2036; Kim YS, 2005, J PHYS CHEM B, V109, P7511, DOI 10.1021/jp044989d; Kim YS, 2009, P NATL ACAD SCI USA, V106, P17751, DOI 10.1073/pnas.0909888106; Kolano C, 2006, NATURE, V444, P469, DOI 10.1038/nature05352; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Kwac K, 2003, J CHEM PHYS, V119, P2256, DOI 10.1063/1.1580808; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Marecek J, 2007, ORG LETT, V9, P4935, DOI 10.1021/ol701913p; Mukamel S., 1995, PRINCIPLES NONLINEAR, V1st; Mukherjee P, 2006, P NATL ACAD SCI USA, V103, P3528, DOI 10.1073/pnas.0508833103; Rubtsov IV, 2002, J PHYS CHEM B, V106, P9165, DOI 10.1021/jp020837b; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sul S, 2006, J PHYS CHEM B, V110, P19891, DOI 10.1021/jp062039h; TORII H, 1992, J CHEM PHYS, V96, P3379, DOI 10.1063/1.461939; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang JP, 2004, CHEM PHYS, V297, P195, DOI 10.1016/j.chemphys.2003.10.013; WERTHEIMER R, 1980, CHEM PHYS LETT, V75, P243, DOI 10.1016/0009-2614(80)80505-7; Woutersen S, 2000, J PHYS CHEM B, V104, P11316, DOI 10.1021/jp001546a; Woys AM, 2010, J AM CHEM SOC, V132, P2832, DOI 10.1021/ja9101776; Zhuang W, 2009, ANGEW CHEM INT EDIT, V48, P3750, DOI 10.1002/anie.200802644	28	89	89	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 3	2011	332	6034					1206	1209		10.1126/science.1202997	http://dx.doi.org/10.1126/science.1202997			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	772BO	21636774	Green Accepted			2022-12-28	WOS:000291205200050
